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Abstract 
Introduction  
Increasing lower-limb sensation could improve walking post-stroke but evidence 
for this is limited.  
 
This thesis reports:  
1) Review of published literature on somatosensory stimulation of the foot to 
enhance lower-limb function post-stroke.  
2) Development of standardised intervention protocols for testing in a feasibility 
trial.  
3) Feasibility trial of somatosensory stimulation interventions combined with 
functional activity.  
 
Methods  
1) Systematic review with narrative synthesis of somatosensory stimulation to 
the foot to improve balance and gait post-stroke.  
2) Modified Nominal Group Technique with experienced therapists, informed by 
literature, to develop and seek consensus on three standardised therapy 
protocols.  
a) lower-limb mobilization and tactile stimulation (MTS)  
b) textured insole wearing (TI)  
c) task-specific gait training (TSGT)  
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3) Mixed-methods, single-blind feasibility study explored: recruitment, 
participant characteristics, attrition, intervention and outcome measures 
acceptability (responses, feasibility, costs), sample size requirements, and 
participants’ experiences. Adults 42–112 days post-stroke were randomized to 
either TIs+TSGT or MTS+TSGT. Lower-limb sensorimotor and functional 
outcomes were measured pre-randomization, post-intervention, and one-month 
later. Participants’ experiences and acceptability of interventions and outcomes 
were explored in focus groups, with qualitative data analysed thematically. 
Quantitative feasibility outcomes were analysed using descriptive statistics, and 
within-group changes calculated.  
 
Results  
1) Seventeen trials included in the review confirmed that evidence for 
somatosensory stimulation to improve lower-limb function post-stroke is limited.  
2) Validated trial intervention protocols for MTS, TIs and TSGT were developed, 
with consensus. 
3) Thirty-four stroke survivors were recruited and completed the trial, with 
acceptable recruitment (48.57%) and attrition (5.88%) rates. Feasibility of 
outcomes, costs, delivery and acceptability of interventions and outcome 
measures were confirmed. Potential response to treatment was noted. 
 
Conclusion  
Somatosensory stimulation of the foot post-stroke warrants investigation. 
Feasibility of a larger trial of somatosensory stimulation interventions was 
confirmed. Participant characteristics, response over time, and variance of 
outcome measures will inform a future larger trial.  
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1 CHAPTER ONE: INTRODUCTION 
Every two seconds somebody in the world will experience a stroke. Currently, in 
the United Kingdom (UK), there are more than 1.2 million stroke survivors 
(Stroke-Association, 2018, p4). The consequences of stroke can be challenging 
(Patel et al., 2000), with the various impairments in bodily function impacting on 
independence (Rathore et al., 2002). Somatosensory impairment post-stroke is 
common, and has been reported to be experienced by between 65% 
(Feigenson et al., 1977b) and 85% (Kim and Choi-Kwon, 1996) of stroke 
survivors, with specific impairment relating to the lower limb found to be present 
in between 45% (Tyson et al., 2013a) and 56% (Gorst et al., 2018). The impact 
of a somatosensory impairment makes everyday tasks difficult (Patel et al., 
2000; Tyson et al., 2013a) and decreases the potential for achieving 
independent walking following stroke. In the event of a pure motor deficit, the 
likelihood of achieving independent mobility is reported to be 87.5%, whereas if 
a somatosensory impairment is also present it is only 55.9%, and an extended 
period of rehabilitation should be expected. This percentage further decreases 
to just 30.8% achieving independent ambulation if hemianopia is also present 
(Sanchez-Blanco et al., 1999). 
 
Regaining the ability to walk is a priority for many stroke survivors. Effective 
treatment to address mobility, exercise and fitness has been identified by the 
James Lind Alliance as one of the top ten research priorities for stroke (Pollock 
et al., 2014b). Diverse rehabilitation strategies may be used to address different 
deficits caused by stroke, with the aim of helping stroke survivors to return to 
functional walking.  
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The complex nature of therapy interventions has been acknowledged by the 
Medical Research Council (MRC) (Craig et al., 2006) and, due to this 
complexity, with many separate but inter-related constituents (Walker et al., 
2017),  developing an evidence base of complex interventions for stroke 
rehabilitation is challenging (Langhorne et al., 2011). However, there is now 
evidence to support the use of task-specific training to improve recovery of 
motor function after stroke, and some evidence emerging to support the use of 
sensory stimulation and retraining, particularly for the upper limb after stroke 
(Carey et al., 2011; Hunter et al., 2008; Winter et al., 2013).  
 
Evidence based clinical guidelines exist to inform clinicians of interventions 
seen as best practice for implementation within stroke rehabilitation; however, 
these guidelines are not always followed. In a survey of 1755 clinicians 
(occupational therapists, physiotherapists and speech and language 
pathologists) undertaken by Rochette et al. (2007) it was found that, despite 
evidence indicating the importance of a family-related focus for stroke survivors, 
this approach was not implemented. This finding was concurred in Denmark 
where it was found that research-based evidence in its entirety was not 
delivered when the notes written by 13 clinicians (occupational therapists and 
physiotherapists) of 131 patients were analysed in an observational prospective 
cohort study (Kristensen et al., 2016).  The main barriers cited relating to the 
delayed implementation of research into practice are staffing issues, challenges 
over time, education of staff, the therapists’ selection of therapy strategies and 
prioritization of workload (Bayley et al., 2012). 
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Whilst clinical guidelines only recommend interventions for which robust 
evidence exists, clinicians may consider that other interventions are effective 
based upon their clinical experience. Conflicting expert opinion and evidence 
based guidelines can create tension for clinicians where evidence for an 
intervention does not currently exist (Grant, 2019). Nonetheless, this highlights 
the importance of researchers working closely with clinicians in order to create 
evidence which has clinical reality. Clinicians need to perceive the research as 
relevant to their practice in order to want to implement the findings i.e. research 
needs to be externally valid (Knottnerus and Dinant, 1997). Internal validity also 
needs to be maintained; pragmatic trials can be undertaken, aiming to make a 
difference for clinical practice (Knottnerus and Tugwell, 2017). 
 
Retraining sensory impairment is an important, under-researched, strategy 
within stroke rehabilitation. It is known that afferent input can influence motor 
control (Chersi et al., 2011; Laaksonen et al., 2012; Rossignol et al., 2006); it 
therefore has the potential to improve motor control and optimize function which 
is clearly important following stroke (Abbruzzese and Berardelli, 2003). 
However, the use of somatosensory stimulation applied to the foot and lower 
leg to improve motor control and function, such as balance and walking, has not 
been well researched to date, despite it being used in clinical practice. 
Somatosensory stimulation can be delivered through hands-on physical therapy 
interventions, such as mobilization and tactile stimulation (MTS) (Hunter et al., 
2008; Winter et al., 2013), which involves intensive proprioceptive and tactile 
stimulation; however, the effects of this have only been investigated on the 
upper limb after stroke. Other hands-off methods could include the use of 
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equipment, for example, textured insoles (TIs) (Christovão et al., 2013; Orth et 
al., 2013), the effects of which have been investigated through early phase 
research in healthy populations (Hatton et al., 2009; Hatton et al., 2011) and 
people affected by Multiple Sclerosis (Dixon et al., 2014).   
 
A task-specific approach is recommended to retrain walking post-stroke 
(Wiener et al., 2018), with the National Guideline for Stroke, Fifth Edition (Rudd 
et al., 2016)  advocating intensive, repetitive, task-orientated intervention; 
however, it is not known whether combining somatosensory stimulation with 
task-specific training would increase the effects of the training.  
 
This thesis represents the beginning of a process of original investigation into 
the effectiveness of intensive somatosensory stimulation applied to the lower 
limb and foot, combined with task-specific gait training (TSGT), to improve 
balance and walking post-stroke. 
 
 Overview, outline and structure of the thesis 
The thesis has been divided into eight separate chapters. Following this 
preliminary introductory chapter, chapter two will discuss the evidence for 
somatosensory loss after stroke and rehabilitative strategies to address it. 
Chapter three is a systematic review of the effectiveness of somatosensory 
stimulation for the lower limb and foot after stroke - Study 1. Chapter four will 
detail the aims and objectives of studies 2 and 3, which are also reported in this 
thesis, with an overview and justification of the methodologies. Chapter five, 
Study 2, involved the necessary development of intervention protocols that 
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were planned to be used in Study 3, a randomized, blinded, mixed-methods 
feasibility study, which is reported in full in chapter six. Chapter seven 
summarizes and interprets the findings of the research conducted. Finally, in 
chapter eight, conclusions are drawn, and recommendations made for further 
research. 
 
A reference list follows the main body of the thesis and pertinent, relevant 
supporting documents relating to the studies are in the appendices, which are 
placed after the reference list.  
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2 CHAPTER TWO: BACKGROUND AND RATIONALE 
 Stroke 
  Definition and cause 
Stroke is a common disease; indeed, every year 15 million people in the world 
experience a new stroke (Mackay and Mensah, 2004).  Approximately 150,000 
of these people reside in the UK (Townsend et al., 2012). The definition of 
stroke, widely recognized internationally, is: “rapidly developing clinical signs of 
focal (or global) disturbance of cerebral function, with symptoms lasting 24 
hours or longer or leading to death, with no apparent cause other than of 
vascular origin” (Hatano, 1976, p. 541). A stroke, usually caused by either 
ischaemic or hemorrhagic damage, alters brain function as a consequence of a 
lack of blood supply to a particular area, resulting in a contralesional upper 
motor neurone lesion (Kumar and Clark, 1998).  
 
  Clinical presentation  
Clinical presentation of disturbed cerebral function may include a combination 
of sensorimotor dysfunction (Nudo, 2013), primarily affecting the contralesional 
side of the body (face, trunk, limbs), communication and speech disorders 
(Bonini and Radanovic, 2015), visual impairment (Ali et al., 2013), and/or higher 
cognitive dysfunctions (Bear et al., 2007). Common features of an upper motor 
neurone lesion can be classified as positive, negative (Burke, 1988; Goldstein, 
2001) or adaptive. Negative features present as weakness, diminshed 
cutaneous reflexes, and a loss of dexterity, with early signs and symptoms 
identified as decreased muscle strength (Goldstein, 2001; Neckel et al., 2006) 
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and as the negative features occur as a result of ‘lost elements’  (O'Dwyer et 
al., 1996 p.1737) this would also include sensory loss. This results in poorly 
scheduled or graded tonic muscle activity (Olney and Richards, 1996). Later, 
positive features occur, when spasticity and its effects can be exacerbated by 
contractures (Ward, 2012). In addition, changes in the mechanical properties of 
the muscle (adaptive features) are seen, which further alter movement 
dysfunction (Dietz and Berger, 1984), and impact on independence in activities 
of daily living (ADL). Whilst the ability to undertake ADL, including functional 
walking, is something that most healthy people take for granted, 83% of stroke 
survivors have difficulty balancing and, therefore, walking after stroke (Tyson et 
al., 2006a). Sensorimotor dysfunction occurs when there is disruption to any of 
the systems (motor, sensory, perception) that integrate to enable the production 
of coordinated movement (Cohen, 1999), and is often significant following a 
stroke. 
 
 Balance and walking after stroke 
Regaining the ability to walk is important for stroke survivors (Pollock et al., 
2014b). Posture and balance are essential for independence in standing and 
walking (Shumway-Cook and Woollacott, 2012). Postural control is defined as 
‘the act of maintaining, achieving or restoring a state of balance during any 
posture or activity’ (Pollock et al., 2000, p.404). Balance can be defined as ‘an 
even distribution of weight ensuring stability’ (Pearsall, 1999, p. 101) and is a 
complex multi-faceted process involving the coordination of sensory, motor and 
biomechanical aspects, with vision, vestibular and somatosensory inputs 
combining to enable balance to be achieved (Jacobson and Shephard, 2016). 
8 
 
Locomotion implies  ‘movement or the ability to move from one place to 
another’ (Pearsall, 1999, p.833), ambulate ‘to move about’ (Pearsall, 1999, 
p.42), and to walk is to ‘move at a regular and fairly slow pace by lifting and 
setting down each foot in turn’ (Pearsall, 1999, p.1611). The term gait is defined 
as ‘a person’s manner of walking’ (Pearsall, 1999, p.579), and gait analysis is 
the methodical analysis of human walking (Whittle, 2007).  
 
In a study where 40 older adults with hemiparesis were compared with 40 
healthy older adults on the EquiTest system, it was found that a deficit in 
postural control predisposes stroke survivors to instability during balance, with 
73% of the participants with stroke falling during the sensory organisation test 
(Marigold et al., 2004). Stroke survivors have an inherently high risk of falling 
(Beyaert et al., 2015), usually towards the contralesional side (Verma et al., 
2012). In a cross-sectional observational study of 41 stroke survivors, over half 
of the participants reported falls and nearly 80% reported near falls, with 80% of 
the falls occurring in the home environment (Hyndman et al., 2002). Sometimes 
balance and walking are difficult because of loss of motor control, for example, 
difficulty in controlling foot placement during walking (Zissimopoulos et al., 
2015). However, somatosensory dysfunction can also have a detrimental effect 
on balance and walking (Tyson et al., 2013a), which can be associated with 
poor integration and weighting of afferent input (Marigold et al., 2004).   
 
A large prospective study of acute stroke survivors (n=804) living within the 
community reported that 50% became independently mobile following 
rehabilitation, although 18% were still unable to walk, 11% required assistance 
and 21% had died (Jorgensen et al., 1995). Further evidence from a systematic 
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review reported that 60% of stroke survivors (n=1373) who were managed in a 
rehabilitation unit, and still immobile at one month, did eventually achieve 
independent walking (with or without an aid, but with no assistance) (Preston et 
al., 2011). The ability to achieve this independent walking is associated with the 
type of impairment following stroke (Tyson et al., 2008); where both sensory 
and motor impairment occur together after stroke, the time to achieve 
independent walking is extended, reportedly more than five months longer than 
where there is just motor impairment (Sanchez-Blanco et al., 1999).  
 
 Sensory dysfunction after stroke 
Sensory loss is a recognized feature of upper motor neurone lesions such as 
stroke (Feigenson et al., 1977a; Gorst et al., 2018; Kim and Choi-Kwon, 1996; 
Tyson et al., 2013a), although its assessment and treatment is frequently 
overlooked by clinicians (Carey, 1995). Somatosensory can be defined as 
‘relating to or denoting a sensation which can occur anywhere in the body’ 
(Pearsall, 1999 p. 1367). Somatosensory function relates to the ability to detect, 
discriminate and recognize sensations and includes tactile sensation, vibration, 
pressure, proprioception, temperature and pain (Carey, 2012). Sensations can 
be received from stimuli external to the body, for example light touch, pain, 
pressure, vibration and temperature, whereas other sources of afferent stimuli 
are internal to the body, including information relating to position and movement 
of the limbs e.g. proprioception. 
 
Reporting of the presence of sensory loss following stroke is limited and results 
are variable. Kim and Choi-Kwon (1996) reported that 85% of people post-
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stroke experienced sensory loss as measured by two-point discrimination, point 
localization, position sense, stereognosis and texture discrimination; however, 
their study focused only on the upper limb. Feigenson et al. (1977a) reported 
that the prevalence of somatosensory dysfunction was 65%, but there are no 
details as to how or where this had been measured. Meyer et al (2016) 
conducted a cross-sectional observational study of stroke survivors (n=122) 
between 12 days and six months post-stroke (median 82 days) and found that 
somatosensory deficits are common within the subacute phase post stroke, and 
that somatosensory impairments are more strongly associated with motor 
impairments when visuospatial neglect is present. 
 
Two studies have specifically reported the presence of somatosensory loss for 
the lower limb post-stroke:  Tyson et al. (2013a) undertook a pooled analysis of 
data from 459 stroke survivors (tactile and proprioceptive loss), reporting that 
55% had intact sensation. This meant 45% of stroke survivors had 
somatosensory dysfunction, which was reported to impact on functional 
activities such as balance and walking. Gorst et al. (2018) identified the 
presence of somatosensory impairment (measured using the Erasmus MC 
modified version of the (revised) Nottingham Sensory Assessment) in 56% of a 
cohort of 157 stroke survivors. Interestingly, although Tyson et al. (2013a) 
highlighted the detrimental effect of somatosensory loss on function, Gorst et al. 
(2018) did not identify this finding in their study. 
 
Visual deficits have also been noted post-stroke (Ali et al., 2013), which can 
affect the interactions between the vestibular, somatosensory and visual 
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systems, resulting in loss of balance (Marigold et al., 2004). Thus, the complex 
nature of sensory loss inevitably contributes to making everyday tasks, such as 
balance and walking, difficult (Patel et al., 2000). The integration of sensory and 
motor information is key to enable controlled movement (Abbruzzese and 
Berardelli, 2003; Bolognini et al., 2016), and the importance of addressing 
sensory loss after stroke must not be underestimated.  
 
 Socio-economic impact of stroke 
The often challenging personal implications for stroke survivors, and the global 
socio-economic effects of stroke throughout both developed and developing 
countries have been recognized (Wolfe, 2000). The ageing population means 
the financial burden of stroke is inevitably set to increase over and above the 
present high costs of providing long-term health and social care for stroke 
survivors; it is, therefore, imperative that care and rehabilitation strategies are 
effective, and further developed to reduce disability after stroke (Chevreul et al., 
2013). As National Health Services (NHS) are becoming increasingly 
constrained, with the inexorable reduction of finances (Klein, 2013), it is 
essential that therapy time is optimized, to facilitate stroke survivors to reach 
their full potential.  
 
 Recovery from stroke  
The recovery of brain function and the return of sensorimotor control is 
influenced by a process known as neuroplasticity, in response to the injury, and 
due to changing influences from the environment and altered patterns of use, 
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resulting in neurons adjusting their activity and even their morphology (Selzer, 
2006). Neuroplasticity can result in altered size and arrangement of cortical 
areas that represent different body parts (Nudo and Milliken, 1996; Sens et al., 
2012) on the motor and sensory homunculi (Penfield and Boldrey, 1937). These 
changes can occur extremely quickly, for example within one hour (Weiss et al., 
2004). An enriched environment and engagement in therapeutic activities, with 
varying afferent input (Jenkins et al., 1990) is important for facilitating positive 
neuroplastic changes (Danzl et al., 2012), and it has been acknowledged that 
stroke rehabilitation requires interdisciplinary collaboration (Levin et al., 2009). 
Environmental stimuli are important to drive experience-dependent plasticity 
(Carey et al., 2019) and therefore rehabilitation potential can be further 
enhanced by adopting a 24-hour approach to rehabilitation after stroke (Aries 
and Hunter, 2014).  
 
Re-organisation of cortical control can occur, for example via the contralesional 
primary motor cortex, bilateral ventral premotor cortex (Rizzolatti et al., 2002) 
and supplementary motor area (Rehme et al., 2012), which has been shown to 
play a role in the control of anticipatory postural adjustments (Jacobs et al., 
2009). These normal anticipatory postural adjustments are reliant upon 
appropriate afferent information and are particularly dependent upon feedback 
from proprioceptors (Palluel et al., 2008a). Further, compensatory cortical 
control can involve ipsilateral control of movement via the transcallosal fibres 
(Boussaoud et al., 2005; Liu et al., 2002), which provide inhibition under 
voluntary control from one hemisphere to the other, or via other pathways, for 
example the reticulospinal fibres (Zaaimi et al., 2012), which are important for 
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control of muscle tone and rhythmic movements (Takakusaki et al., 2016), and 
the rubrospinal tract fibres (Belhaj-Saïf and Cheney, 2000), which are involved 
in the control of movement via spinal interneurons exciting flexor pathways and 
inhibiting extensor mechanisms via the 1a inhibitory neurons (Jankowska, 
1988).  
 
These changes to cortical representation may be facilitated by neuronal 
sprouting (dendritic or axonal growth) which, although generally inhibited after 
stroke, can be facilitated by molecular manipulation and behavioural activity, 
promoting plasticity and improving function (Overman and Carmichael, 2014). 
Furthermore, the extensive intracortical system allows for new routes of 
organisation within the cortex in response to appropriate cortical facilitation or 
inhibition (Nudo, 2013). Behavioural experience has therefore been shown to 
facilitate neuroplasticity and recovery post-stroke (Selzer, 2006) and this 
important principle for rehabilitation has emerged from a better understanding 
of motor control, the importance of afferent information, and the mechanisms of 
neuroplasticity after stroke.  
 
 The importance of afferent information for motor control  
Afferent information from the periphery is important for motor control, 
particularly when performing a voluntary activity that requires good coordination 
and control (Chersi et al., 2011; Laaksonen et al., 2012; Rossignol et al., 2006). 
Afferent information guides the motor system, informing the conscious mind 
about both the external world (exteroceptive) and internal information 
(interoceptive) (Patel et al., 2014). Afferent pathways are directly linked to 
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motor areas in the cortex; elimination of input via the dorsal columns results in a 
severe motor deficit, indicating the importance of afferent input to enable 
coordinated voluntary activity (Asanuma and Arissian, 1984). Many bodily 
systems function in association with each other to control the body’s position in 
space (Shumway-Cook and Woollacott, 2007), and sensorimotor integration 
plays an important part in the production of controlled movement (Campfens et 
al., 2015). An adaptable environment results in constant changes, and the 
interaction that occurs between ascending afferent input and descending goal-
focused mechanisms can result in conscious experience (Squire et al., 2008). 
Information, which is selective to the particular receptor cell, travels to the 
central nervous system (CNS) via the posterior root ganglion and spinal cord, 
communicating with specific postsynaptic targets (Squire et al., 2008). Signals 
then continue through the brainstem to the thalamus before reaching the 
cerebral cortex (Bear et al., 2007), where sensory processes are analysed and 
compared with past experiences (Squire et al., 2008), and motor function is 
modulated, as required. An important sensory modality which is essential for 
balance and walking is proprioception. 
 
 Proprioception 
Defined as ‘the sensory processes involved in the conscious appreciation of 
posture and movement’ (Cohen, 1999, p.111), proprioception enables the 
ability to sense the position of the limbs in space, with forces generated by the 
muscles, creating movement which is detected in the muscles, tendons, joints 
and skin (Cohen, 1999).  Afferent information from the muscle spindles and 
Golgi tendon organs also provide proprioceptive information that is below 
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conscious awareness; this travels to the cerebellum (Moore, 2007), enabling 
facilitation of movement by making predictions relating to sensory function and 
controlled movement patterns (Therrien and Bastian, 2015). This process is 
essential to enable the cerebellum to compare feedforward prediction of 
movement with feedback information (Brownstone et al., 2015). The fact that 
anticipatory adjustments are modulated by cerebellar input (Takakusaki, 2017) 
indicates the important role proprioceptors play in control of posture. 
 
 Muscles and tendons  
Golgi tendon organs provide information relating to the tension within muscles, 
and muscle spindles also contribute to proprioceptive functioning by monitoring 
and responding to length changes of muscles (Leonard, 1998). The Golgi 
tendon organs are mechanoreceptors in the musculotendinous junction, which 
send a signal to the spinal cord via 1b afferents, triggering inhibition of the 
alpha motor neurone which creates force within the muscle, resulting in 
reduced muscle activity; at the same time the antagonist muscle is excited via a 
process called reciprocal excitation (Tortora and Derrickson, 2011). This 
process serves to protect the muscle complex, preventing spontaneous small 
ruptures at the musculotendinous junction (Cohen, 1999). 
 
Recording of muscle afferent activity (from muscle spindles and Golgi Tendon 
Organs) within the triceps surae via micro-electrodes has shown that stretch of 
a muscle during contraction, or application of a vibratory stimulus over the 
muscle, produces proprioceptive (stretch) reflexes. In an experiment by Burke 
et al. (1983), the Achilles tendon was percussed (1ms pulse duration and 
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frequency of 1Hz) with a tendon hammer triggering a light vibration response. It 
was found that the inevitable activity within other mechanoreceptors in the skin 
and other muscles, as a result of the percussion to the tendon, potentially 
affected the excitatory post-synaptic potential of motor neurones. The changes 
to the triceps surae muscles also resulted in a reciprocal increased ability to 
actively recruit the ankle dorsiflexors, which further contributed an inhibitory 
reflex effect on the motor neurones of soleus (Burke et al., 1983). Other 
sensory stimulation may, perhaps, have similar effects.  
 
The important function of the proprioceptors at the ankle mediating activity of 
muscles during stance phase of gait was demonstrated in a study of 30 healthy 
volunteers (aged 22-38), using electromyography (EMG) to record the response 
to a perturbation of the plantar flexor muscles during treadmill walking (Grey et 
al., 2004). In this study, cutaneous afferent feedback was blocked by an 
anaesthetic nerve block in ten of the subjects. This nerve block did not 
influence the EMG from soleus in stance phase, and the authors concluded that 
it must be proprioceptive feedback, rather than cutaneous feedback, which 
facilitates the excitability of soleus in the late stance phase of gait. The afferent 
information to soleus is important in gait, ensuring swing phase does not 
commence until the extensor muscles are no longer loaded; there is continuous 
regulation of muscle tone in response to proprioceptive feedback during gait 
(Takakusaki, 2013).  
 
Another important contributor to proprioception is the afferent information from 
joints and their surrounding structures particularly the articular capsules integral 
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within synovial joints, with free nerve endings and Ruffini endings detecting 
pressure. Also, acceleration and deceleration of joint movement is detected by 
small Pacinian corpuscles exterior to the capsule, and the ligaments also 
contain receptors comparable to Golgi tendon organs to detect extreme strain, 
effecting a reflex inhibition of the muscles concerned (Tortora and Derrickson, 
2011).  
 
Cutaneous mechanoreceptors in the glabrous (non-hairy) skin on the plantar 
surface of the foot relay afferent information to the CNS and are classified 
according to the speed with which they adapt to the stimulus and the area of 
the receptive field. There are four different types of receptor: fast adapting (FA), 
which are also known as rapidly adapting, of which there are two types (FA I 
and FA II), and slowly adapting (SA) Type I and II receptors (SA I and SA II) 
(Johansson and Vallbo, 1983; Vallbo and Johansson, 1984). The fast-acting 
receptors only provide information during onset and release of the deformation 
of the skin, whereas the slow-acting provide information from the time of 
stimulus application and throughout the time the stimulus is present; type I fibre 
types have small receptive fields, with a clear boundary, and type II receptors 
have large receptive fields (Cohen, 1999).  FA I sensory units detect rapid skin 
displacement via Meissner’s corpuscles, and FA II fibres detect high-frequency 
mechanical vibrations via Pacinian corpuscles. SA I fibres detect deformation of 
the skin via Merkel’s discs, with SA II receptors detecting skin stretch and joint 
movement, by virtue of the large receptive area, via Ruffini endings (Cohen, 
1999). Kennedy and Inglis (2002) explored the activity of the cutaneous 
mechanoreceptors in the glabrous skin of the plantar surface of the foot 
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identifying 104 mechanoreceptors, 59 of which were FA I (57%), 14 FA II 
(14%), 15 SA I (14%) and 16 SA II (15%), and they were widely distributed in 
the foot. 
 
All the same types of mechanoreceptors present in the hand are also found in 
the foot (Hennig and Sterzing, 2009), enabling detection of both the position 
and velocity of the contact (pressure or indentation) made with the foot 
(Magnusson et al., 1990).  The function of the foot is different from the intricate 
work required of the hand. The mechanoreceptors in the foot can modulate 
reflex activity facilitating muscle activity around the ankle joint (Fallon et al., 
2005). To achieve this, there is a robust coupling of FA1 mechanoreceptors, 
followed by SA 1 mechanoreceptors. Important feedback from initial foot 
contact is detected by FA I mechanoreceptors (Fallon et al., 2005), and there is 
a predominance of this type of receptor under the foot (Kennedy and Inglis, 
2002). However, key information relating to continuing contact of the foot on the 
supporting surface is received via SA I mechanoreceptors. This information 
from the SA I mechanoreceptors enables ongoing monitoring of ankle muscle 
activity, which is considered important when controlling posture, balance and 
gait during walking (Fallon et al., 2005; Hennig and Sterzing, 2009). 
 
Sensory receptors, for example, those on the plantar surface of the foot, 
respond to specific stimuli and have particular features, enabling transfer of 
information into a signal recognized by neurons. Afferent information from the 
foot and ankle is therefore crucial for postural control and walking capacity 
(Smania et al., 2003). 
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 The importance of somatosensory input for postural 
control and balance  
Somatosensory input from the plantar surface of the foot is important for 
achieving and maintaining balance in upright standing. Stabilometry is 
commonly used in research to assess balance by measuring the dynamic 
changes of the body’s centre of pressure (COP) migration (Degani et al., 2017). 
Increased stability would be observed if the movement of the COP is shown to 
decrease in either an anterior-posterior (AP) or mediolateral (ML) direction; 
conversely, an increase in the deviation of COP movement would indicate a 
loss of stability. Despite some methodological weaknesses (lack of blinding or 
control), a study of 10 healthy subjects aged 21–46 years suggested that the 
effect of forefoot anaesthesia on the COP exerted through the lower limb and 
foot on a force platform, when vision was occluded, was modest but significant 
(p = 0.004), resulting in a medio-lateral balance deficit during bipedal stance 
(Meyer et al., 2004). Further studies of somatosensory stimulation of the plantar 
surface of the foot, involving indentation of plantar skin via a fixed pin matrix, 
with pins protruding 1.5 mm through holes of a moveable plate (eight healthy 
participants, mean age (standard deviation (SD)) 36 (9) years and four people 
with vestibular dysfunction  35 (3) years) (Maurer et al., 2001), or shot-gun ball 
plates to alter pressure (n=16, healthy males mean age 24.5 years) (Watanabe 
and Okubo, 1981), reported increased control of body sway. Interestingly, it has 
also been shown that postural sway cannot be fully compensated for by visual 
or vestibular systems when there is even just a slight amount of somatosensory 
loss in the foot of healthy individuals (n=21, mean age 23 years) (Wang and 
Lin, 2008). The addition of afferent stimulation to the plantar surface of the foot 
20 
 
was also explored by Zehr et al. (2014) (healthy individuals, n=14), showing 
that afferent electrical stimulation delivered as five times 1.0 ms pulses at 300 
Hz to discrete regions (five sites on the plantar surface of the foot) could steer 
foot positioning, altering the ankle trajectory and guiding foot placement. It is 
recognized that the research which has been undertaken relating to 
somatosensory input for postural control and balance is limited, with small 
numbers of participants, and the work has generally been undertaken in healthy 
participants. 
 
Afferent information is important in the maintenance of upright posture and 
equilibrium during gait where the body’s centre of mass needs to be maintained 
over the base of support (Dietz, 1996). A complex collaboration of bodily 
systems is required: sufficient muscle activity to counteract the forces of gravity 
in the upright position; higher level planning structures (motor cortex) and brain 
stem and spinal networks for coordination; along with internal representations 
and adaptive and anticipatory mechanisms (Shumway-Cook and Woollacott, 
2007). Essential sensory information from visual, vestibular and somatosensory 
systems is integrated to enable the maintenance of postural stability, balance 
and prevention of falls (Cohen, 1999; Marigold et al., 2004), and is crucial for 
functional walking. Postural sway is the interaction between the changing forces 
acting on the body, resulting in decreased stability, and the ability of the body to 
correct these alterations during quiet standing, to prevent a loss of balance 
(Pavol, 2005). 
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One important way that upright posture and balance are achieved is through 
interlimb coordination, with automatic harmonisation of muscle action in both 
legs, which is necessary because the strength of muscle activity and timing of 
movements in one leg has a direct impact on the other leg (Dietz, 1996); 
however, independent operation of each of the legs is possible (Verma et al., 
2012). Walking involves repeated loss of balance as the line of gravity 
continuously moves out of the base of support formed by the feet; this 
necessitates the placement of the swinging foot ahead and lateral to the centre 
of mass as it moves in a forward direction, to prevent a fall (Lugade et al., 2011; 
Shumway-Cook and Woollacott, 2012). There needs to be appropriate postural 
control to maintain stability upright against gravity; however, the purpose of 
walking is to move from one place to another, so dynamic stability of the 
moving body is required, and an ability to adapt to challenges within the 
environment (Shumway-Cook and Woollacott, 2012). Different levels of stability 
are required in accordance with the task being undertaken. Dynamic stability is 
required to control the body as it moves from behind the supporting foot to a 
position in advance of the supporting foot; therefore, as the limb is loaded, the 
extensor muscles at both the hip and knee are required to function to prevent 
the fall of body weight (Perry and Burnfield, 2010). 
 
Sensory feedback is key during human locomotion, involving constant 
assessment of the length (by muscle spindles), and tension (by Golgi tendon 
organs) of muscles; the muscle spindles contribute via both a feedback process 
and also for feedforward control (Leonard, 1998).  Proprioceptors within the hip 
are vital for controlling stance phase in gait (Takakusaki, 2013). When a muscle 
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is put on stretch, an example being the hip flexors at the end of stance phase, 
the muscle spindle is activated and transmits information in the 1a afferent, 
resulting in monosynaptic excitation of the hip flexors, facilitating activity in 
these muscles to initiate the swing phase of gait. The 1a afferents from the hip 
flexors also inhibit the antagonistic hip extensor muscles by virtue of synapsing 
with a 1a inhibitory interneuron  (Leonard, 1998). Afferent information relating to 
the changing conditions is also sent to higher centres via the 1a afferents, with 
the premotor cortex key to the preparatory phase, during sequenced 
movement, responding to afferent feedback (Cohen, 1999), resulting in 
modification of gamma and alpha motor neurone discharge; hence, adaptation 
takes place, fulfilling the requirements of the feedforward mechanism (Leonard, 
1998). The connectivity between the prefrontal and premotor areas is predictive 
of performance (Tsvetanov et al., 2018). 
 
 Normal gait 
Within the scope of this thesis, it is not possible to highlight all the important 
components relating to normal and pathological gait and readers are directed to 
more specific published literature  (e.g. Perry and Burnfield, 2010; Whittle, 
2007). However, an overview and summary of some of the key aspects relating 
to control of movement, stability and somatosensory stimulation, in retraining 
balance and gait post-stroke, are presented. 
 
Locomotion can arise in response to either volitional or emotional processing 
within the brain and occurs for a purpose - fulfilling a goal (Takakusaki, 2013). 
Volitional movement, including walking, is not simple; it involves a myriad of 
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components with integrated activity within the brain, spinal cord, peripheral 
nerves, muscles and joints (Whittle, 2007). Despite the complex nature of 
walking, it is remarkable how easy it appears as a task; this is because of 
connections between spinal interneurons, sensory input, locomotor areas in the 
brainstem and higher level cortical centres (Whelan, 1996). Walking 
necessitates maintenance of balance and upright posture while the body moves 
forwards as a result of repeated limb motions; where pathology is absent the 
resultant ‘normal’ gait is coordinated, efficient and effortless (Perry and 
Burnfield, 2010). Mobility is important for independence in many ADL; hence, 
focusing on therapy to achieve independent ambulation is imperative (Durward, 
1998). Improving somatosensory function may be beneficial for helping stroke 
survivors return to independent walking.   
 
Walking consists of periods of time when both feet are in contact with the 
ground (double support), followed by phases when only one foot is in contact 
with the ground and supporting the body weight; the other foot is moving above 
the ground at that point in time during swing phase (single support) (Durward, 
1998). Stance phase occurs for approximately 60% of the gait cycle, with the 
swing phase accounting for 40% of the cycle, with values of 62% and 38% 
observed at the normal speed of walking of 82m/min (Perry and Burnfield, 
2010). Figure 2.1 shows the different parts of the gait cycle: initial contact (heel 
strike), loading response, mid stance, terminal stance, pre-swing, initial swing, 
mid-swing and terminal swing.  
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Figure 2.1 Subdivisions of stance and swing phase in gait (Perry and 
Burnfield, 2010)  [Image provided by Paul Bailey and Aseel Aburub] 
 
The control of walking has been studied in many ways, with much of the 
information relating to locomotion established in the 20th century by working 
with the decerebrate cat (Whelan, 1996). However, recent advances in medical 
science are beginning to enable real-life studies, and functional magnetic 
imaging resonance has been suggested as a useful tool for the future to study 
strategies for improving gait (Dobkin et al., 2004). Walking can either be a 
controlled process requiring input from the cortex or can occur on an automatic 
basis without higher levels of control (Schneider and Shiffrin, 1977). In 
automatic gait, utilisation of a learned sequence of events occurs, directed by 
the functions of the locomotor region in the midbrain in association with the 
central pattern generator (CPG) at a spinal level (Takakusaki et al., 2008).  
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The vestibular system plays an important role in balance, contributing to a 
stable, upright body posture by synchronising head and neck movements with 
trunk and body alignments (Cullen, 2012). Vestibular reflexes are active in 
dynamic activity, modulated by the differing demands of the task, neural 
pathways, muscle activity, and sensory feedback (Forbes et al., 2015). It works 
discreetly, combining with visual and proprioceptive inputs to detect motion; 
sensory integration is necessary to allow success in undertaking everyday 
activities, with triggering of appropriate postural responses as required, for 
example, if a trip occurs during walking or running (Cullen, 2012). The 
vestibular system works closely with the visual system during termination of gait 
to assist with the necessary slowing of the forwards centre of mass motion, and 
the ability to gain stability over the base of support (Perry et al., 2001). The 
vestibular system does not work in isolation; it works with the cerebellum 
enabling the production of coordinated voluntary activity, fine-tuning of 
sensorimotor information and promotion of plasticity (Manzoni, 2007). Input 
from brainstem areas is important for muscle tone regulation, with both 
excitatory and inhibitory influences counteracting each other; postural tone is 
increased as a response to the excitatory reticulospinal tract from the ventro 
medullary reticular formation but inhibited via an inhibitory area in the 
pedunculopontine tegmental nucleus (Takakusaki, 2013). 
 
The extent of cortical control in human gait still requires further clarification 
(Koenraadt et al., 2014; Wang et al., 2008).  Automatic actions of the CPGs are 
reported to be modified by information from the motor cortex, enabling ADL 
involving gait to be undertaken, for example when moving around an obstacle. 
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These supraspinal inputs are stated as being more important in humans than 
animals (Verma et al., 2012), evolving over time as a response to the complex 
behavioural requirements of human beings (Drew et al., 2008). 
 
The cerebellum and basal ganglia work in conjunction with each other, and with 
the cerebral cortex. An essential role of the cerebellum is for the coordination of 
smooth movement, with it playing a role in preparation for movement, pre-
setting the body ready for optimal function. The cerebellum is a regulator of 
both automatic and volitional movement influencing both the cerebral cortex 
and brainstem areas (Takakusaki, 2013). The cerebellum’s important function 
relating to feedback during movement allows coordinated movement in a 
changing environment and also enables learning to occur; the cerebellum is, 
therefore, key for both the development and on-going monitoring of gait 
(Leonard, 1998). The basal ganglia contribute to motor control by maintaining a 
memory of movements which can later be reproduced as basic movement 
patterns (Whittle, 2007). In experiments involving monkeys, evidence was 
provided of the basal ganglia and cerebellum participating in several discrete 
loops with the cerebral cortex, involving connections with the premotor, 
oculomotor, prefrontal and inferotemporal areas of the cortex (Middleton and 
Strick, 2000). The caudate nucleus has been identified as being particularly 
involved in locomotion alongside the cerebellum (Pérennou and Hillier, 2014). 
 
The thalamus is a significant structure essential for perceptual awareness. All 
the sensory systems in the body deliver information to the thalamus, which is 
imperative for conscious awareness of sensory experiences putting them into 
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context with emotional aspects and memories (Leonard, 1998). Therefore, it 
should not be forgotten when considering the importance of sensory information 
for function and gait.   
 
Takakusaki et al. (2008) summarized the mechanisms involved in the neuronal 
control of bi-pedal locomotion from literature relating to both animal and human 
experiments. They identified three key elements for coordinated gait: firstly, 
extensive neural connections, such as the cortico-basal ganglia loop and basal 
ganglia-brainstem system; secondly, appropriate postural muscle activity and a 
synchronized musculoskeletal system; and lastly correct sensory processing. 
Furthermore, they highlighted that locomotion is dependent upon the locomotor 
(rhythm generating) system and the excitatory system creating appropriate 
muscle activity, with pathways descending from the midbrain locomotor region 
to the locomotor CPG in the spinal cord.  
 
Figure 2.2 summarizes the multiple systems involved in voluntary, emotional 
and automatic processes, based on cat locomotor behaviours. Whilst it is 
acknowledged that figure 2.2 relates to cat behaviour systems, imaging of 
human supraspinal locomotor centres in the brainstem and cerebellum supports 
the view that supraspinal organisations are similar for both bipedal and 
quadrupedal mammals; multiple systems integrate to facilitate gait, including 
the motor cortices (enabling volitional control), the limbic system (emotional 
processing) and the many automatic processes that occur (Takakusaki et al., 
2008). 
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 Modular control of muscles 
To control gait, interactions involving the whole of the musculoskeletal system 
and the nervous system are required (Takakusaki, 2013).  In cats, groups of 
muscles work together to achieve a goal, initiated by one neural signal (Torres-
Oviedo et al., 2006). These modular control mechanisms (or modules), 
originate centrally and coordinate appropriate movement in response to a 
specific task, enabling automatic postural adjustments to occur quickly by virtue 
of limited degrees of freedom at joints, and muscle activation with consistent 
features. Similar muscle synergies, defined as ‘a group of muscles activated in 
synchrony with fixed relative gains’ (Torres-Oviedo and Ting, 2007, p.2144), are 
also present in humans. EMG activity monitored sixteen muscles in the legs 
and lower trunk, and a maximum of six muscle synergies, similar in terms of 
both muscle activation and timing across individuals, were observed when 
postural responses for each participant were analysed. Combinations of 
synergies can occur to stabilize the centre of mass during motion; therefore, 
although movement patterns are constrained within the synergies, the differing 
amount of input from separate synergies working together enables variable 
responses to achieve stability and movement.  
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 Figure 2.2 Framework of the cat locomotor behaviours. A - Signal flow involved in the volitional, emotional, and 
automatic processes of generating cat locomotor behaviours. B - Spinal locomotor network. Abbreviations: CPG, Central 
pattern generator; E, extensor motorneurons; F, flexor motorneurons; GPi, internal segment of globus pallidus; MLR, midbrain 
locomotor region; PPN, pedunculopontine pontine tegmental nucleus; SNr, substantia nigra pars reticulata; A is modified from 
Takakusaki, et al.  (2006).  
             B is modified from Rossignol et al. (2006) 
            (Takakusaki et al., 2008) [reproduced with permission] 
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 Automacy of gait and the importance of afferent input 
Nielsen and Sinkjaer (2002) report two main roles for afferent information 
participating with the motor system to enable movement: the first method is via 
internal feedback influencing the output of neurones during volitional 
movement; and the second is a role in feedback to the CNS, enabling error 
correction. Automatic locomotor rhythmic activity, which enables walking 
without conscious input (Verma et al., 2012), is moderated in response to 
stimulation of proprioceptive and skin receptors, influencing motor output 
(Takakusaki et al., 2008). This modification occurs throughout all movements, 
as a result of both internal and external afferent changes (Leonard, 1998). 
Motor patterns are constantly modulated by sensory inputs, resulting in the 
dynamic sensorimotor interactions during gait (Rossignol et al., 2006). The 
primary somatosensory area in the parietal lobe has extensive connections with 
the frontal lobes (Bear et al., 2007), facilitating these sensorimotor interactions. 
Electroencephalogram readings in a study involving healthy individuals (n=10) 
showed activity within the posterior parietal lobe during gait and concluded that 
it plays a role in controlling the lower limb during gait (Bulea et al., 2015). This 
influence from sensory feedback occurs via a fast learning ability to reorganize 
the network, strengthening existing connections and weakening other pathways 
(Chersi et al., 2011). 
 
 Speed of gait 
To achieve functional mobility, it is essential to be able to walk at a reasonable 
pace. Walking speed is the distance walked in a given time, usually measured 
in m/s (Perry and Burnfield, 2010; Whittle, 2007). In comparison to the average 
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speed of walking specified as 82m/minute (1.36m/s) for healthy adults (Perry 
and Burnfield, 2010), a speed of 0.8m/s (58.8% of the rate of normal walking) 
has been reported as being adequate for functional community ambulation 
(Perry et al., 1995). However, in one study it was found that, despite an 
average speed of walking of 0.898 m/s, 33% of  stroke survivors were unable to 
walk without supervision in their community (Lord et al., 2004). It is 
acknowledged that functional ambulation involves many different aspects. A 
definition for community ambulation was derived following analysis of 
questionnaire results in a cohort of stroke survivors living at home (n=115); 
‘independent mobility outside the home, which includes the ability to confidently 
negotiate uneven terrain, private venues, shopping centres and other public 
venues’ (Lord et al., 2004, p.236). Using voxel-based lesion-symptom mapping 
it has been shown that involvement of the insula, lateral and anterior putamen 
and external capsule have a detrimental effect upon walk speed response post-
stroke (Jones et al., 2016a). 
 
 Kinematic deviations in gait after stroke 
The changes that occur in gait after stroke are related to: the pathological 
effects of the stroke itself; resultant secondary problems, for example, 
shortening of muscles due to altered movement patterns; and the interactions 
of these issues within the complex motor control system. Alterations in gait 
pattern can, therefore, occur due to the original loss of motor control (negative 
features), sensorimotor dysfunction, for example, reduced power of the hip 
extensors, or because of the adaptation (adaptive features), for instance when 
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a muscle develops shortening due to a contracture, or as a compensatory 
strategy adopted to address muscle weakness (Moseley et al., 1993).  
 
Common kinematic deviations can be observed during stance phase following a 
stroke. A seminal paper by Moseley et al (1993) provided an insight into 
hemiplegic gait biomechanics from a clinical perspective. Several aspects are 
presented in the paper. The importance of the position of other joints on the 
alignment of the ankle and foot is discussed; for example, that the degree of 
flexion/extension at the knee or hip will influence the alignment at the ankle 
and, therefore, alter the ability to be able to transfer the weight over the foot. 
Appropriate hip extension at the end of stance phase is important to allow 
weight to be transferred over the stance foot, promoting a more normal swing 
phase with better alignment at the foot and ankle. Reduced maximum hip 
extension has also been associated with reduced gait velocity (Cruz et al., 
2009; De Quervain et al., 1996). Altered pelvic displacement (which can be 
associated with eversion of the foot during early stance) is another potential gait 
deviation, as well as reduced knee flexion/hyperextension, or increased knee 
flexion during stance, in addition to reduced ankle plantar flexion at toe-off 
(Moseley et al., 1993). Distal alterations also influence proximal movement: an 
adaptive shortening of the posterior tibial muscles, or inability of these muscles 
to work in a controlled manner eccentrically, will prevent the ability to transfer 
the weight appropriately over the foot, resulting in a kinematic deviation at the 
hip (Moseley et al., 1993). All these deviations will affect the contact of the 
plantar surface of the foot with the floor and the transition of weight over the 
foot during stance. If shortening or poor eccentric muscle activity of the plantar 
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flexor group of muscles exists, it will be difficult to transfer the weight forwards 
over the foot with adequate control (Moseley et al., 1993). 
 
Consideration of how the deviations alter foot position is important. 
Hyperextension of the knee is associated with an equinus foot posture (a 
position of increased plantar flexion) at initial contact (Higginson et al., 2006), 
and this combination results in difficulty bringing the body weight over the foot 
during stance.  Contralesional knee hyperextension during stance phase has 
been reported to be common, in 67% of stroke survivors (n=12) (Kim and Eng, 
2004) and 65% of heterogenous stroke survivors (n=25) recruited between 
seven weeks and more than one year after the onset of stroke symptoms, with 
variable gait patterns and abilities (Knutsson and Richards, 1979). Again, the 
small sample sizes should be noted. 
 
Reduced contralesional ankle plantarflexion at toe-off is associated with a lack 
of push-off, attributed to inappropriate activity of the plantar flexors at the 
beginning of stance phase (Burdett et al., 1988; Knutsson and Richards, 1979). 
Decreased activity of the tibialis anterior muscles to produce dorsiflexion, in 
preparation for initial contact, results in the foot being placed on the floor in a 
more plantar flexed position during loading; the result of this is premature 
plantar flexor (PPF) muscle activity, initiated by a stretch response. This strong 
contraction of the plantar flexors occurs at a point in time where the centre of 
mass of the body is behind the foot and, as a result, there is a backward thrust 
of the leg as inertia carries the body forwards, and hyperextension of the knee 
occurs. The result of this situation is that the plantar flexors are unable to propel 
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the body forwards at toe-off. Consequently, increased activity of the hip flexors 
is needed as a compensatory strategy to enable faster walking (Nadeau et al., 
1999; Perry, 1993). 
 
The causes of the PPF activity in gait were explored in an observational study 
(Fujita et al., 2018). A total of 31 independently mobile stroke survivors, at least 
six months post-stroke, with moderate degrees of spasticity (assessed using 
the Modified Ashworth Scale (MAS)) were recruited. Following assessment, the 
group was divided into two; those with PPF activity (n=13), and those without 
PPF (n=18). EMG results showed that the PPF group demonstrated 
significantly reduced activity in the tibialis anterior muscle during swing phase 
(p < 0.05), with significantly increased activity in both rectus femoris and biceps 
femoris muscles throughout swing phase (p < 0.05), with activity triggered 
significantly earlier than for the non-PPF participants (p < 0.01) and seen to 
continue during the loading response phase (p < 0.05). The authors suggest 
that rehabilitation plans to address weakness in the hip and knee extensors 
may help to reduce PPF. However, it must be taken into consideration that the 
sample size within this study was small. Addressing other aspects, for example, 
shortened posterior tibial muscles by using mobilizing and stretching techniques 
to enable a better foot position during stance, could perhaps also help to 
address PPF; however, this strategy has not been explored.  
 
Varus deformity, ‘an inward angulation of the rearfoot and/or forefoot, generally 
measured in the frontal plane, which is the result of abnormal muscle activity 
and posturing,’ can also be observed after stroke (Reynard et al., 2009, p.69). 
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Gait analysis and EMG readings in stroke survivors who displayed varus 
deformity of the foot demonstrated an imbalance between tibialis anterior and 
extensor digitorum longus, with less activity (shorter and weaker) within the 
extensor digitorum longus and, therefore, an unopposed pull into inversion; this 
presentation tended to occur in conjunction with PPF activity, and varus 
deformity is associated with ankle plantar flexion and claw toes (Reynard et al., 
2009). Furthermore, the patterning was suggested to be seen due to the 
presence of a primitive mass flexion synergy of hip flexion, abduction and 
lateral rotation associated with knee flexion and supination of the foot. This 
results in weight being taken on the lateral aspect of the foot during initial 
contact, with poor weight bearing under the 1st metatarsal head (Perry et al., 
1978). 
 
Different biomechanics following stroke result in altered sensory input from the 
foot and ankle during walking, in view of the importance of sensory feedback for 
regaining controlled motor function (Patel et al., 2014), this may be further 
compounding the issues of regaining the ability to walk after stroke. It is also 
interesting that hyperextension patterning of the knee has been observed not to 
occur when there was normal weight acceptance through the foot i.e. via the 
heel and not the forefoot (Kim and Eng, 2004). Foot position and activation is 
therefore important to address within therapy rehabilitation. 
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 The potential for regaining the ability to balance and 
walk after stroke 
Functional recovery of the upper limb after stroke has been extensively 
researched; however, limited knowledge exists relating to the recovery systems 
to restore lower limb function and walking after stroke (Peters et al., 2018). In a 
study utilising magnetic resonance imaging (MRI) and clinical motor 
assessments in stroke survivors (n=43) with an average age of  59.7 (11.2) 
years and time post stroke 64.4 (58.8) months, it was found that functional 
activity of the lower limbs is not so dependent upon an intact corticospinal tract; 
other pathways are involved to control lower limb movement and gait, such as 
the reticulospinal, rubrospinal and vestibulospinal tracts (Peters et al., 2018).  
 
It is of interest to consider prognostic indicators for achieving functional walking 
after stroke, in order to contemplate who may benefit from enhanced sensory 
input strategies. Various prognostic indicators for independent walking have 
been identified. A prospective cohort study (n=101) explored predictive 
indicators within the first 10 weeks after stroke, finding that the age of the 
patient and the Barthel index were key factors (Kollen et al., 2006); however, 
sitting balance (identified using the Trunk Control Test) and strength of the 
hemiparetic leg (assessed by Motricity Index) have also been suggested as key 
measures for predicting the ability to walk in 154 first-ever ischaemic stroke 
patients (Veerbeek et al., 2011). Standing balance measured by the timed 
balance test or Fugl-Meyer balance test was also found to be a key determinant 
for recovering the ability to walk (Kollen et al., 2005).  More recently a study 
undertaken by (Smith et al., 2017) found that a Trunk Control Test of > 40 and 
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hip extension strength of 3 or more on the Medical Research Council grading 
were an indication of the likelihood of regaining independent gait. 
 
Cortical damage following stroke may affect the cortical control of walking; 
integration of sensory input and motor output, and somatosensory impairment 
all contribute to a reduction in automaticity of movement (Clark et al., 2014). A 
study by Chen et al (2000) of 55 hemiplegic patients assessed (by MRI) at one 
and six months post-stroke showed that the site and size of a lesion within the 
brain has a significant effect on the potential for motor recovery and function; 
for example, when a lesion affects the premotor cortex, there is an impact on 
walking disability post-stroke (Sullivan et al., 2009) and a loss of independence 
(Patel et al., 2000). Many people are unable to return to work or social 
engagements after stroke or may even require long-term support or care (Perry 
et al., 1995).   
 
In a cross-sectional study, which compared 19 people with a right middle 
cerebral infarct and 20 people with a left middle cerebral infact with 108 
controls, it was found that the severity of gait impairment following a stroke is 
associated with the integrity of gray matter in non-infarcted areas of the brain 
and not just the extent of the lesion itself (Chen et al., 2014). It has been shown 
that the potential for neuroplastic changes and the ability of the cortex to re-
organise depends upon functional connections between the primary motor 
cortex and supplementary motor area of the ipsilesional hemisphere, with the 
red nucleus also being important (Peters et al., 2018). The red nucleus is 
important because it provides another potential method for controlling 
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movement via the rubrospinal pathways (Jankowska, 1988). In a study where 
participants were prospectively recruited for the Soft-Scotch Walking Initial 
FooT (SWIFT) trial, a multiple regression model showed that damage to the 
corticospinal tract was predictive of a poorer response as measured by 
changes to the results of both the Functional Ambulation Classification (FAC) 
(p=0.030) and modified Rivermead Mobility Index (mRMI) (p=0.024) following 
rehabilitation, but not associated with speed of walking (p=.060) (Jones et al., 
2016a). This is perhaps due to the ability to retain control of walking on an 
automatic level.  
 
A lack of automaticity of movement (Clark et al., 2014) is, however, increased in 
stroke survivors due to the nature of stroke being a disease predominant in the 
elderly; the ageing process itself may also contribute to impaired walking ability, 
and in this group even routine walking can be classed as a complex task, and is 
not controlled purely on an automatic level (Hausdorff et al., 2005). However, 
the spinal control of walking will remain unimpaired, and this may partly explain 
the higher levels of recovery of walking compared to the levels of upper limb 
recovery e.g. reach and grasp, which are under cortical control. Nevertheless, 
recovery of walking after stroke remains a challenge; in a group of stroke 
survivors (n=99) 78% still experienced problems walking three months after 
stroke (Algurén et al., 2010). Indeed, many stroke survivors report that difficulty 
walking affects their quality of life (Alguren et al., 2012).   
 
Gait asymmetry has been correlated with a loss of balance (measured using 
the Berg Balance Scale (BBS)) (Lewek et al., 2014). In a cohort of 39 stroke 
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survivors, comfortable gait speed was significantly related to step length           
(r = -.55; p < .001), stance time (r = -.41; p = .010), and swing time                    
(r = -.57; p < .001), which were used to assess for asymmetry. The BBS was 
negatively correlated with both step length asymmetry (r = -.61; p < .001) and 
swing time asymmetry (r = -.36; p = .025). The authors suggest that the 
asymmetry and loss of balance predispose stroke survivors to falls. It is not 
known whether some of the asymmetry could be attributed to altered sensation 
and a reluctance to weight bear on the contralesional side, or if increasing the 
somatosensory input from the foot and ankle may alter gait asymmetry, balance 
potential and risk of falls.  Asymmetric gait pattern has been associated with 
lesions involving the inferior portion of the posterolateral putamen, potentially 
resulting in a loss of communication between the motor areas in the cortex and 
those in subcortical regions, when 17 chronic stroke survivors with a 
symmetrical gait were compared with 20 with an asymmetrical pattern of 
walking (Alexander et al., 2009).   
 
 Effect of lesion location on recovery of balance and walking  
A slower gait with greater asymmetry, taking less weight for a shorter period of 
time on the affected side, is seen more often in right hemisphere strokes, 
particularly when the right middle cerebral artery (MCA) is involved (Chen et al., 
2014). Also, when stroke survivors with a right MCA (n=17, mean (SD) age 65 
(8) years, mean (SD) time post-stroke 7(6) years) were compared with stroke 
survivors with a left MCA infarct (n=20, mean (SD) age 65(8) years, mean (SD) 
time post-stroke 7(6) years) and controls (n=55, mean (SD) age 65(8) years), it 
was found that people with a right MCA lesion exhibited increased postural 
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sway in the absence of visual input, suggesting a reliance on vision to control 
postural sway (Manor et al., 2010). Perhaps this is due in part to a loss of 
afferent input on the contralesional side.  
 
Chen et al. (2014) explored the effect of infarct hemisphere and non-infarcted 
brain volumes on locomotor performance following stroke and found a 
difference in gait speed between right and left MCA infarcts, with a correlation 
between speed of walking and volume of gray matter in the caudate nucleus 
(r=0.57, p< 0.001) and the cerebellum (r=0.57, p=0.02) noted in patients with 
right MCA infarct only. The authors suggested this was an indication of brain 
reserve that can be utilized within the locomotor control system following 
lesions; however, it has been shown that the right hemisphere is key for 
sensorimotor control with an influence on both the contralateral and ipsilateral 
sides (Hom and Reitan, 1982). This could be the reason behind the evident 
disadvantage for regaining the ability to walk following a right hemisphere 
stroke. It is not known whether addressing the loss of somatosensory control 
might improve the potential to walk after a right MCA stroke.  
 
 Influence of weak dorsiflexors and somatosensory impairment 
after stroke 
Overall predictors for recovery of gait post-stroke have been discussed in 
section 2.7; distal influences will now be considered.  In a study of 147 stroke 
survivors (mean (SD) age 55.5 (12.2) years), muscle strength and 
proprioception were proposed as the two most relevant impairments to be 
measured when assessing walking potential following stroke (Perry et al., 
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1995). Weakness of dorsiflexors on the contralesional side was related to gait 
asymmetry and decreased velocity in 21 people more than six months post-
stroke (Lin, 2005), and indications are that afferent information from the foot 
and ankle can influence balance and walking (Annino et al., 2015; Chien et al., 
2017). 
 
Whilst research exploring the contribution of proprioception to facilitate balance 
during gait is sparse in both healthy individuals and following a stroke (Mullie 
and Duclos, 2014), impaired proprioception in the ankle has been found in 
small studies of stroke survivors. Lee et al. (2005) reported significantly 
(p<0.001) reduced proprioception in the contralesional ankle of 11 ambulating 
survivors of chronic stroke compared to the ipsilesional ankle movement (sense 
of dorsi/plantar flexion movement was assessed using a linear servo-motor 
controlled by a variable ramp generator) and suggested that this loss of 
proprioception may affect foot placement and weight-bearing during 
ambulation. Although the sample size was small, the reliability of the 
assessment tool was reported to be moderate to high (ICC 0.58 to 0.76).  
Similarly, Yalcin et al. (2012) measured proprioception of the ankle using an 
isokinetic dynamometer and reported significant proprioceptive impairment in 
both the contralesional (p<0.05) and ipsilesional (p<0.05) ankles compared to 
healthy controls. These authors suggested that proprioceptive integration 
involves both cerebral hemispheres.  
 
Impaired ankle joint position sense has been associated with altered step 
length in chronic stroke (n=68) (Lin, 2005), and with postural sway in acute and 
sub-acute stroke (n=30) (Niam et al., 1999). However, contrasting evidence 
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from a larger study of 147 stroke survivors (>3 months post-stroke, able to walk 
>6m), suggested that proprioception (a combined measure of the contralesional 
hip knee and ankle) was not correlated with the level of walking handicap (Perry 
et al., 1995).  The categories of walking handicap ranged from unable and then 
physiological, with a mean (SD) walking velocity of 0.1 (0.05) m/s, to community 
walkers with a mean (SD) walking velocity of 0.8 (0.18) m/s. However, the 
findings from this study cannot be generalized to non-ambulatory stroke 
survivors and, therefore, it is unclear whether ankle proprioception is associated 
with inability to walk. Furthermore, the assessments of walking in these studies 
were on a floor or treadmill surface that was flat; however, it has been shown 
that afferent feedback is crucial during stepping on sloping surfaces (af Klint et 
al., 2008), where proprioceptive input modulates the motor response, a 
situation that more closely resembles real-life community ambulation over 
uneven ground. 
 
Although balance and function have been shown to improve in healthy 
participants in response to afferent input, it is important to consider whether the 
findings are transferrable to stroke survivors. Stroke survivors themselves have 
indicated, in semi-structured interviews (n=13), that a loss of sensation within 
the foot does adversely affect function and the ability to walk, especially when 
coping with the challenge of walking over rough ground (Gorst et al., 2016). 
However, objective measurements from a cross-sectional observational study 
by the same authors (n=163 ambulatory chronic stroke survivors, mean (SD) 
age 67(12) years, mean (SD) time since stroke 29 (46) months), did not 
triangulate their qualitative study, and indicated a lack of correlation between 
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somatosensory impairment and the ability to walk (Gorst et al., 2018).  One of 
the outcome measures (OMs) for this study was the 10-metre walk test 
(10MWT); it has been shown that it is only when walking speed is greater than 
0.8 metres per second (m/s) that this measure is reflective of community 
ambulation (Taylor et al., 2006). Within the Gorst et al. (2018) study, the mean 
(SD) gait velocity for the stroke survivors was 1.1(0.6) m/s; therefore, some of 
the participants would not have been able to walk at the required speed to 
reflect abilities within a community environment.  
 
Walker et al. (2014) explored foot placement in people who were at least six 
months post-stroke (n=12), finding that sensory stimulation at 30Hz electrical 
stimulation to the medial plantar nerve of the paretic foot, reduced medio-lateral 
targeting error (p=0.008). These authors advocate that the inclusion of 
somatosensory stimulation work to the foot in rehabilitation could enhance the 
ability to walk; however insufficient evidence exists presently to draw these 
conclusions. It must be considered that this was a small study with no 
randomization or blinding and a high potential for bias.   
 
 Rehabilitation of lower limb function after stroke  
 Rehabilitation strategies 
The International Classification of Functioning, Disability and Health advises  
delivering holistic rehabilitation, addressing activity and participation, and not 
just bodily function (Bruyère et al., 2005). A 24-hour approach to rehabilitation 
in a stimulated, enriched environment is thought to be important in facilitating 
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recovery post-stroke (Aries and Hunter, 2014). Restoring sensorimotor 
connections and interactions is necessary to improve motor function, and 
interventions to target the retraining or reactivation of an impaired sensory 
system have been advocated (Bolognini et al., 2016). A selection of sensory 
modalities are encompassed when considering sensory interventions (e.g. 
somatosensory, vestibular, auditory and multisensory) (Schaaf and Case-
Smith, 2014). 
 
Pomeroy et al. (2011) proposed three important rehabilitation strategies to 
facilitate activity-driven motor cortex plasticity following stroke, promoting better 
function and independence: priming, augmenting and practice. Priming 
strategies involve techniques that prepare the sensorimotor system for motor 
function, specifically where there is limited or no volitional control of movement; 
augmenting techniques enhance somatosensation during activity, thereby 
improving motor output; and task-specific practice is recommended where the 
stroke survivor has the ability to repeat and practice movements (Pomeroy et 
al., 2011).  
 
In relation to the foot, intensive somatosensory stimulation of foot and ankle 
proprioceptors as well as the cutaneous mechanoreceptors on the plantar 
surface of the foot could be considered to be a priming technique, which could 
enhance motor control and alignment of the foot, creating the ability to place 
and transfer weight over the foot, and permitting adaptation of the foot to 
different floor surfaces.  
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Once volitional activity is achievable, augmenting techniques can be used to 
improve voluntary control and muscle strength during functional activities 
facilitating better sensory awareness under the foot. Augmenting techniques 
could enhance the interaction of the foot with the supporting surface, which is 
important for functional activity; for example, sensory input through the heel 
during sitting to standing is considered to enhance activity of proprioceptors, 
facilitating activity within the lower limb muscles, promoting a more automatic 
patterning during sit to stand (Raine et al., 2009).  
 
Practice and repetition of movement is then the most effective method of 
improving recovery of motor control following stroke, once sufficient muscle 
strength and voluntary control is available (Pomeroy et al., 2011). Practice is 
widely recognized as an important aspect of retraining sensorimotor function 
following stroke. 
 
Consideration should be given to rehabilitation aims, and specifically whether 
the aim is to facilitate restoration of motor function by modification of underlying 
neural mechanisms, e.g. by encouraging repetition, or to adjust to a loss of 
neurological control by using adaptive interventions (compensatory strategies) 
as an alternative means of completing a task (Pomeroy et al., 2011).  The 
stroke recovery and rehabilitation roundtable (SRRR) task force suggest that 
recovery ‘reflects the extent to which body structure and functions, as well as 
activities, have returned to their pre-stroke state’ (Bernhardt et al., 2017b, 
p794). However, compensation can be seen as the ‘patient’s ability to 
accomplish a goal through substitution with a new approach rather than using 
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their normal pre-stroke behavioral repertoire’ and is a process that also involves 
learning (Bernhardt et al., 2017b, p794).  With a better understanding of 
neuroplasticity principles, recovery is now often the aim in therapy rather than 
compensation strategies (Shumway-Cook and Woollacott, 2012), although a 
mixture of the two approaches may be necessary and is dependent upon time 
after stroke (McWain et al., 2012). 
 
 Therapy to the foot to improve balance and gait 
Since some of the consequences of stroke directly impact on the biomechanics 
of the foot and ankle, the ability to balance and walk is affected (Fujita et al., 
2018; Higginson et al., 2006; Reynard et al., 2009); see section 2.6. The foot 
and ankle play an essential part in enabling walking; consequently, any 
restriction to either passive or active range of movement can have a detrimental 
effect (Roy et al., 2013). Clearly, a kinematic alteration at any joint in the lower 
limb will have a direct effect on the other joints and the ability of the muscles to 
control movement appropriately. Therapy needs to be targeted at the 
underlying movement problem, whether it arises from the distal or proximal 
components of the limb, in order to improve foot alignment and placement 
during balance and gait. 
 
The aims of therapy treatment in relation to the foot and ankle have been 
reported in the literature to be:  
• prevent contractures (McWain et al., 2012) and, therefore, PPF by 
normalizing ankle motion from terminal swing to weight bearing during 
gait (Fujita et al., 2018);  
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• facilitate ankle strategy with better foot contact on the floor by optimizing 
length/tension of muscles, as well as strength (Raine et al., 2009); 
• strengthen and promote selective control of muscles, especially 
dorsiflexors, which concentrically assist with foot clearance during swing 
and eccentrically control the fall of the forefoot on heel strike, and plantar 
flexors, which enable eccentric control of the shank of the leg over the 
foot during stance phase, and appropriate toe off at the end of stance 
(Raine et al., 2009). 
 
Notable by its absence from this summary of aims is the retraining of sensory 
function in the foot and ankle. This is noteworthy since an exploratory study of 
therapists’ experiences of conventional therapy for the lower limb post-stroke 
identified the attention given to sensory stimulation of the foot in routine 
practice. This focus group study, involving seven qualified clinicians identified 
that hands-on somatosensory stimulation of the plantar surface of the foot is 
frequently used, in conjunction with mobilization of joints and soft tissues in the 
foot and lower leg, to prepare the foot for standing and balance, prior to task-
specific gait training (Aries et al., 2019). 
 
A Cochrane review of 27 controlled trials (3423 participants) (Pollock et al., 
2014a) found moderate quality evidence in support of physical rehabilitation to 
improve recovery of postural control and lower limb function, including gait, and 
achievement of independence in ADL, compared to no treatment (mean 
standard difference (MSD) 0.78 (95% confidence interval (CI) 0.58, 0.97) for 
independence in ADL) after stroke. However, no one specific physical therapy 
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approach was found to be more effective than another (Pollock et al., 2014a). 
Many of the included trials were of high or unclear risk of bias, and significant 
heterogeneity was an issue. The authors recommended that further research 
was still required to explore whether specific focused physical therapies applied 
to the lower limb and foot enhance recovery of balance and walking after 
stroke. 
 
Subsequently, the Royal College of Physicians (RCP) stroke guideline (fifth 
edition) stated that ‘people with significant impairment of their balance and 
walking ability after stroke should receive progressive balance training, 
functional task-specific training, lower limb strengthening exercises and be 
considered for an ankle-foot orthosis’ (Rudd et al., 2016 p. 73). The guideline 
reported that electromechanical assisted gait training (Mehrholz et al., 2013) 
was supported by evidence, as well as the use of ankle-foot orthoses (Tyson 
and Kent, 2013) and functional electrical stimulation (NIHR, 2009) when there is 
limited ability to dorsiflex the foot. However, the section in the guideline relating 
to sensation is limited and stated that ‘there is no good evidence to support any 
particular passive or active intervention for sensory impairment after stroke’ 
(Rudd et al., 2016 p.82). When considering the literature that informs the 
guidelines, it is important to remember that “no evidence of effect” does not 
equate to “evidence of no effect” (Oxman, 1994: p650). Therefore, it must be 
remembered that a lack of evidence does not mean that sensory interventions 
are not effective. It simply indicates that the research relating to this aspect of 
stroke rehabilitation has not yet been undertaken.  
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The next sections will consider further the evidence for task-specific gait 
training and somatosensory stimulation of the lower limb to improve balance 
and gait post-stroke, since these have been highlighted by experienced 
clinicians to be components of routine stroke rehabilitation (Aries et al., 2019). 
 
 Task-specific gait training to promote improvement of balance and 
walking 
Task-specific training is one aspect of therapy where there is general 
agreement regarding effectiveness following stroke (French et al., 2016(Rudd 
et al., 2016). The underlying mechanism of effect is facilitation of neuroplasticity 
(Kattenstroth et al., 2012), and repetition of skilled motor tasks is required 
(Nudo, 2013). The ability to transfer knowledge and skills from treatment to 
function is fundamental to enable independence in daily life (Geusgens et al., 
2007) and task-specific training promotes this principle. Although high level of 
repetitions are not generally achieved in conventional stroke rehabilitation 
(Tyson et al., 2018), a proof-of-concept study has demonstrated the feasibility 
of stroke survivors achieving 300 repetitions in a single one-hour session of 
treatment (Birkenmeier et al., 2010). 
 
There is strong evidence that task-specific gait training (TSGT) can be used to 
improve walking after stroke (Wiener et al., 2018). Addressing weakness, for 
example of the dorsiflexors, by strengthening through functional activities is 
important, and this can include stepping practice and facilitation of the ankle 
strategy to enhance balance (McWain et al., 2012). However, for those stroke 
survivors who have severe muscle weakness and are, therefore, unable to 
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engage in task-specific training and repetitive practice, other treatments are 
needed to prepare or enhance the sensorimotor system (Hunter et al., 2011), to 
help improve movement and function. Within conventional stroke rehabilitation, 
sensory retraining can be used as an adjunct to task-specific practice to 
enhance neuroplasticity (Kattenstroth et al., 2012). 
 
 Somatosensory stimulation as treatment post-stroke 
Passive sensory stimulation consists of non-specific high-intensity stimulation, 
such as rubbing/icing or electrical stimulation without active muscle contraction 
(Schabrun and Hillier, 2009). In contrast, active stimulation involves conscious 
awareness and mechanisms to retrain sensory awareness, for example, 
practicing identifying different textures and detecting the position of body parts 
in space (Schabrun and Hillier, 2009). Active sensory retraining involves 
attentive training as the important element (Carey, 2012), for example, 
attending to an object or stimulus with vision occluded (Carey 1995), and use of 
feedback to enable learning and retraining of sensory perception. However, as 
some rehabilitation interventions include aspects of both passive and active 
stimulation, they may be difficult to categorize as one or the other.  
 
Schabrun and Hillier (2009) systematically reviewed 14 studies (n=199 
participants) involving passive and active sensory interventions for the upper 
and lower limb following stroke. Their findings supported the value of passive 
sensory training (electrical stimulation) for hand function (Jebsen-Taylor Hand 
Function Test). A meta-analysis of three studies (Celnik et al., 2007; Conforto et 
al., 2007; Wu et al., 2006) resulted in a total effect of 8.72 (95% CI 2.48,14.95) 
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in favour of the experimental groups. However, research related to active 
sensory training (education, localizing and discriminating sensations, sensory 
recognition, hardness discrimination and proprioceptive training) was found to 
be limited, with small sample sizes (n=3 to n=39), and a wide diversity of study 
designs and methodological quality. The findings of the review indicate that the 
evidence base for sensory stimulation post-stroke is confounded by a sparsity 
of research, heterogeneity of subjects, and unreliable OMs. There is a need for 
further high-quality research to determine the effectiveness of sensory training 
in stroke rehabilitation. Strengths of the review include clearly specified search 
terms and inclusion criteria, and the use of two independent reviewers when 
assessing methodological quality of studies. The Schabrun and Hillier (2009) 
review was updated by Serrada et al. (2019), with similar findings: there was 
some support for passive sensory interventions but limited evidence for active 
sensory interventions for upper and lower limbs following stroke.  
 
A potential limitation of these reviews was the inclusion of sensory training for 
both the upper limb and the lower limb. These treatments may not be directly 
comparable in view of the neurophysiological differences relating to upper and 
lower limb control; it could be expected that there may be differences in relation 
to the outcomes from sensory retraining programmes. Voluntary movement in 
the upper limb is predominantly controlled by the primary motor cortex (M1) in 
the contralesional hemisphere of the brain, with direct corticospinal input 
enabling great dexterity of movement of the hand through monosynaptic 
corticomotoneuronal connections (Porter and Lemon, 1995). This differs from 
the control of walking, which can be more automatic with less input from higher 
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centres (Schneider and Shiffrin, 1977). An extensive neural network is present 
at spinal level which is able to facilitate inter-limb coordination following afferent 
input (Cohen, 1999), enabling walking which, in contrast to upper limb function, 
is much more automatic, with pattern-generating networks in the brainstem 
working in conjunction with the reticular formation and spinal cord, coordinating 
activity within the various muscle groups (Shumway-Cook and Woollacott, 
2007). In the case of the lower limb, longer latency of response has been 
observed using EMG, between stimulation and muscle contraction (Cody, 
1995), and this could have implications for the ability to control and change 
motor output in response to afferent input.  
 
The other issue to consider is that the foot invariably receives sensory 
stimulation much earlier than the hand post-stroke, by being placed in contact 
with a surface (the floor) and it is further stimulated through compression in 
standing, since early mobilization is commonly advocated (Cumming et al., 
2011). In contrast, the upper limb is often neglected in the early stages of stroke 
rehabilitation, and its relatively poor recovery is considered to be associated 
with learned non-use (André et al., 2004; Taub and Uswatte, 1999). These key 
differences mean the upper limb might receive less afferent input following 
stroke and this may affect results of studies, theoretically meaning that the 
upper limb has a greater potential to demonstrate change following subsequent 
additional experimental sensory stimulation compared to the lower limb.  
 
Other aspects may also need to be considered when implementing 
sensorimotor training strategies, for example, it has been suggested that 
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different interventions may be necessary when working with stroke survivors 
with neglect (Meyer et al., 2016). 
 
 Somatosensory stimulation and re-training for the upper limb 
post-stroke 
Sensory impairment in the upper limb is experienced by up to 80% of stroke 
survivors (Doyle et al., 2010). Given the similarity in cutaneous receptors in the 
glabrous skin of the hand and foot, it is of interest to briefly consider the 
evidence relating to sensory interventions for the upper limb.  
 
A recent cross-sectional survey (SUPPLES-UK: Stockley et al., (2019) of 
current therapy delivered by UK therapists for the upper limb post-stroke 
identified that therapy for severe stroke included therapist-delivered and 
facilitated range of movement exercises. However, no interventions were 
reported for sensory loss or spasticity, and no technique adaptations for people 
with unilateral neglect were identified. A strength of the questionnaire was that it 
was designed with consideration of the UK stroke guidelines and the Template 
for Intervention Description and Replication (TIDieR) checklist. However, limited 
detail is presented in relation to the exact content of the therapy treatments or 
how treatments were adapted to address the heterogeneity of stroke. 
Furthermore, the overall response rate to the questionnaire is unknown and 
there is potential selection bias, which is acknowledged by the authors.   
 
From various systematic reviews of sensory interventions for the upper limb, 
there is some promising but limited evidence in support of thermotherapy 
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(Doyle et al., 2010), intermittent pneumatic compression (Doyle et al., 2010), 
mirror therapy (Thieme et al., 2018), electrical stimulation (Veerbeek et al., 
2014), biofeedback (Wattchow et al., 2018), and retraining of sensory 
discrimination (Turville et al., 2019). In contrast, Grant et al. (2018) found no 
evidence to support the use of sensory electrical stimulation or therapist 
delivered sensory stimulation (thermal stimulation, inflatable splint, and 
proprioceptive stimulation). However, it is important to note that the one study 
included in Grant et al. (2018) that involved therapist delivered (hands-on) 
proprioceptive stimulation of the hand (Hunter et al., 2011) was not an 
effectiveness study, but instead was a dose-finding study to identify the 
maximum feasible dose of therapy that could be delivered in an NHS ward-
based service. Consequently, the conclusion drawn by Grant et al. (2018) about 
lack of effectiveness of therapist-delivered somatosensory (proprioceptive) 
stimulation is unfounded and inappropriate. Somatosensory (proprioceptive) 
function is important for upper limb function post-stroke (Meyer et al., 2014), 
and therapist-delivered intensive sensory stimulation and retraining of 
proprioception post-stroke should not be dismissed as being ineffective by a 
misunderstanding of the purpose and findings of the one study of this 
intervention (Hunter et al., 2008) included in a systematic review.  
 
Whilst most systematic reviews of sensory interventions for the upper limb have 
included only RCTs or controlled clinical trials, there have been several other 
studies undertaken to explore the effects of sensory stimulation or retraining for 
the upper limb post-stroke using quasi-experimental and other designs. These 
comprise of replicated single-system studies using A-B (Carey et al., 1993; 
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Hunter et al., 2008; Winter et al., 2013), a cohort study (Carey and Matyas, 
2005), controlled trial (Yekutiel and Guttman, 1993) and a cross over trial 
(Celnik et al., 2007). Whilst there are some possible limitations with these 
quasi-experimental designs, the single-system studies all indicate promising 
effects of either sensory re-training techniques, involving specific graded 
discrimination tasks and attentive exploration of stimuli with vision occluded 
(Carey et al., 1993), or mobilization and tactile stimulation (MTS) which involves 
intensive hands-on proprioceptive stimulation (Hunter et al., 2008; Winter et al., 
2013). 
 
 Mobilization and Tactile Stimulation (MTS) 
MTS is an intervention that involves application of a combination of physical 
therapy techniques (Hunter et al., 2006).  It is a ‘module’ of conventional hands-
on therapist-delivered physical therapy that was described and defined by 
experienced physiotherapists in a study that used consensus methodology 
(modified nominal group technique) (Hunter et al., 2006). Seven senior (Band 
7) NHS physiotherapists were initially interviewed, individually, and asked to 
describe the treatment they would provide for an upper limb that was severely 
affected by stroke (Hunter et al., 2008). Data from the interviews were 
synthesized into a draft MTS upper limb treatment schedule, and following a 
series of iterations, reviewed and revised by the therapists individually; a final 
comprehensive treatment schedule was agreed through group discussion and 
piloted in clinical practice. Following the pilot, further feedback on the format of 
the treatment schedule was used to further refine the final schedule (Appendix 
1).  
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The final MTS upper limb schedule comprised of all the interventions that the 
therapists identified. These were grouped into categories that included: joint 
and soft tissue mobilization and manipulation techniques (passive movements, 
accessory movements, massage, soft tissue stretch); active retraining of 
selective movements in the hand, wrist and forearm; sensory stimulation of 
mechanoreceptors (in joints/ligaments and the glabrous (non-hairy) skin, using 
touch, pressure, compression, stretch); and retraining of functional patterns of 
movement. MTS involves active and not passive sensory stimulation and 
retraining, since the patient is encouraged to attend to the limb and the afferent 
stimulation throughout the treatment.  
 
MTS is considered to ‘prime’ the sensorimotor system, increasing excitability 
and preparing it for activity, through intensive stimulation of cutaneous 
mechanoreceptors in the glabrous skin of the hand, using touch, pressure, and 
stretch or cutaneous deformation, and proprioceptors in connective tissue, 
muscle and joints (Winter et al., 2013). The MTS upper limb schedule included 
the aims of MTS identified by the therapists: recover normal extensibility of the 
skin, muscle, connective tissues, tendons and joints; decrease hypersensitivity; 
reduce pain; increase awareness of movement and coordination of movement, 
normalizing afferent information during functional activity (Hunter et al., 2008).   
 
Thus, MTS addresses muscle and soft tissue shortening, which is predominant 
in the limbs due to inactivity post-stroke. Chronic disuse results in altered 
afferent input and changes to the CNS, with subsequent development of a 
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vicious circle (Gracies, 2005). Cutaneous and proprioceptive stimulation 
techniques, such as MTS, facilitate motor activity by increasing excitability in 
the central nervous system; the mechanism is hypothesized to be as a result of 
the enhanced proprioceptive input decreasing pre-synaptic inhibition, with 
changes seen particularly in people severely affected by stroke (Hummelsheim 
et al., 1995). MTS is considered to work by reawakening the limb and preparing 
the motor system, prior to retraining motor activity and function, promoting 
facilitation of plasticity as a reaction to subsequent practice of tasks (e.g. 
through task-specific training) (Pomeroy et al., 2011).  
 
Following the development of the MTS upper limb schedule, the intervention 
was validated using a postal survey of therapy for the upper limb, involving 
members of the Association of Chartered Physiotherapists in Neurology 
(ACPIN). The treatment schedule was sent to a random sample of ACPIN 
members (n=400) who were asked to review the content of the schedule and 
send comments back to the researchers about whether the content reflected 
their own practice of treating the severely affected upper limb post-stroke, and 
identify whether any additional interventions or techniques were missing from 
the schedule. The response rate 30% (n=120) and the overwhelming feedback 
was that the content of the MTS upper limb schedule reflected conventional 
hands-on physical therapy for the upper limb (Hunter et al. unpublished)1. 
 
The effects of MTS ,applied to the upper limb, on motor impairment (Motricity 
Index arm section – MI), functional capacity (Action Research Arm Test – 
 
1 Hunter, S.M., Coleman, C., Pomeroy, V.M. Generalisability of the MTS treatment schedule. 
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ARAT), and somatosensation (touch/pressure sensory thresholds) were 
investigated through replicated single system experimental studies, which 
employed an A-B-A design, in sub-acute (Hunter et al., 2008) and chronic 
(Winter et al., 2013) stroke. Having established a stable baseline, Hunter et al. 
(2008) used visual analysis of data plotted over the three phases (baseline, 
intervention, withdrawal) to identify changes in trend, level, slope and variability 
between the baseline and intervention phases, and appropriate statistical 
analysis accounting for autocorrelation and serial dependency of the data. 
Winter et al. (2013) randomized duration of the baseline phase, and analysed 
the plotted data using the same visual analysis, but also included randomization 
tests. Clinically significant improvements were seen in the ARAT (increase of 6 
or more points) and MI during the intervention (B) phase compared with the 
initial A (baseline or control) phase in both studies.  
 
In Hunter et al.(2008), all six participants showed a change in trend, level or 
slope of the ARAT scores between baseline (A) and intervention (B) phases, 
with a mean (SD) increase of 16.17 (8.28) points, which was statistically 
significant (p<.001) for three of the six participants: participant 2 scores 
increased from 16–33 points, participant 5 scores increased from 13–22 points, 
and participant 6 from 4–14. MI scores also increased (mean (SD) increase of 
25.33 (16.88) points) with statistical significance (p<.001) reached for 
participant 2 (increased score from 57–68), participant 3 (increased scored from 
33–57), participant 4 (increased score from 19–43), participant 5 (increased 
score from 58–74), and participant 6 (increased score from 42–54). In five of 
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the six cases, improvements were maintained during the two weeks following 
withdrawal of the intervention (the second A phase). 
 
In Winter et al. (2013), the ARAT score increased for seven of the eight 
participants (one participant achieved full marks at baseline and therefore there 
was no opportunity for change); the other change scores ranged from 1–24 
points, but did not reach a level of statistical significance. The MI scores 
improved for all the participants and the total change scores ranged from 9–37. 
The improvements were maintained indicating stability of the impairment and 
activity limitation, and clinically significant differences were achieved for the 
ARAT in four of the eight cases.  
 
Whilst quasi-experimental studies are not considered to be as high a level of 
evidence as an RCT or controlled clinical trial, according to the hierarchy of 
research evidence, the methodology of these single system studies was robust 
and of high quality. This included replication of findings across more than three 
cases, valid and reliable OMs, regular and frequent collection of data points 
(>8) in all phases, and appropriate visual and statistical analysis of the data, all 
of which increased the internal validity of the studies. The evidence therefore 
supports the use of MTS as an effective sensory stimulation intervention to 
enhance recovery of the upper limb post stroke. Unfortunately, because of the 
quasi-experimental methodology, this evidence has not been included in 
systematic reviews of sensory interventions for the upper limb.  
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The benefits of MTS seen in sub-acute stroke (Hunter et al., 2008), replicated 
by Winter et al. (2013) in chronic stroke, demonstrate the potential for recovery 
even during the chronic stage of stroke, when stroke survivors would be 
unlikely to be receiving routine therapy, reducing confounding factors. 
Therefore, in the absence of other therapy, it can be assumed that the 
beneficial effects seen during the intervention (B) phase compared to the 
control or baseline (A) phase were due to the MTS intervention. The justification 
behind this assumption is inherent to the single system study design; 
participants were all stable at baseline, and as the only change in the 
intervention (B) phase was the introduction of the MTS intervention, it is 
possible to conclude that the MTS (the independent variable) produced the 
observed changes.  
 
It has been identified in a focus group with experienced physical therapists 
(Aries et al., 2019), that MTS is an intervention that is also applied to the lower 
limb and foot in conventional stroke rehabilitation, to prepare the foot and lower 
limb for activity in standing. This is supported by another study that explored the 
content of physiotherapy interventions for acute stroke (Tyson et al., 2009), 
which showed that hands-on facilitation techniques are commonly used to 
facilitate postural control and walking and that specific mobilization techniques, 
such as those used in MTS, constituted 6% of the total interventions of routine 
physical therapy to prepare the foot and leg. Yet, to date, the effects of MTS 
applied to the foot and lower leg have not been investigated in research. 
However, despite the positive effects seen for the upper limb, the differing 
neurophysiological processes related to upper and lower limbs requires 
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consideration, and there is uncertainty as to whether the results are directly 
transferable to the lower limbs.  
 
There is a move towards promotion of more ‘hands-off’ therapy approaches in 
the literature, based on the evidence in support of repetitive practice and a task-
orientated approach (Veerbeek et al., 2014), the inclusion of unsupervised 
practice in rehabilitation (Stockley et al., 2019), and the ever increasing 
financial and time pressures of healthcare (Chevreul et al., 2013). 
Nevertheless, hands-on interventions continue to be utilized post stroke (de 
Almeida et al., 2015; Duncan et al., 2005), and it is important to investigate the 
value of therapist-led one-to-one treatments, such as MTS, which are resource 
intensive, but which represent clinical reality and conventional practice.  
 
 Somatosensory stimulation of the lower limb  
A small number of studies have investigated the effectiveness of 
somatosensory stimulation applied to the lower limb (Goliwas et al., 2015; 
Hillier and Dunsford, 2006; Kim et al., 2015; Lynch et al., 2007; Morioka et al., 
2009). Systematic reviews have reported effectiveness of placing textured 
materials beneath the foot to improve postural balance and control (Orth et al., 
2013), and the use of different insoles to improve perceptual motor 
performance (Christovão et al., 2013). 
 
Orth et al. (2013) reviewed 21 studies and two conference proceedings, with a 
range of study designs, involving somatosensory stimulation of the foot through 
standing on textured materials, to improve postural balance and control (n= 743 
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participants including young adults (18-51 years), and older adults aged 64.7-
79.4 years), as well as healthy people and people with chronic ankle instability, 
falls, Multiple Sclerosis, Parkinson’s, and plantar insensitivity. The Cochrane 
Risk of Bias Tool was used to assess methodological quality. Despite 
acknowledgement of significant heterogeneity (I2 = 85.98%), meta-analysis was 
used to demonstrate effectiveness of textured materials in improving 
perceptual-motor function in young healthy individuals (MSD -0.28; 95%CI -
0.46, -0.09). However, only six studies were included in the elderly group meta-
analysis and further research was advocated for the elderly and clinical 
populations (MSD-0.31, 95%CI -0.66, 0.05). Greater detail regarding the search 
strategy for this review would have improved its quality.  
 
Christovão et al. (2013) reviewed the evidence from 12 controlled trials utilising 
textured surfaces, involving 392 participants with a mix of populations including 
functional ankle instability, older adults, fallers, stroke and diabetic neuropathy. 
A variety of different insoles were included: vibrating; textured; quick-comfort 
(prefabricated orthotics); insoles with spikes; flat insoles with different Shore A 
hardness (which includes most rubber materials); insoles with wedges; and 
balance-enhancing insoles, which were designed to facilitate foot-plantar 
surface sensation. They used the PEDro scale to assess for methodological 
quality, utilising two blinded assessors. Three studies in this review support the 
benefits of using vibrating insoles to enhance balance and postural control 
(Hijmans et al., 2008; Priplata et al., 2006; Wang and Yang, 2012), which 
improved balance and oscillation velocity in an antero-posterior (AP) direction. 
These three studies included people with diabetic neuropathy (n=17) and 
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healthy controls (n=15) (Hijmans et al. (2008), people with diabetic neuropathy 
(n=15) and stroke (n=15) (Priplata et al. (2006), and elderly fallers (n=26) and 
healthy subjects (n=16) (Wang and Yang (2012). Textured insoles (TIs) or 
textured surfaces showed a decrease in mediolateral postural oscillations and 
facilitated activation of tibialis anterior in healthy subjects in four studies (Hatton 
et al., 2009; Hatton et al., 2011; Palluel et al., 2008b; Qiu et al., 2012). 
However, the search strategy and terms in this systematic review were not 
clearly stated, so the study would not be repeatable.  
 
The wearing of TIs to provide somatosensory stimulation to the plantar surface 
of the foot can be considered a therapeutic strategy to augment somatosensory 
awareness. Simply standing on textured material or placing TIs in the shoes 
gives passive stimulation to the plantar surface of the foot. However, TIs are 
designed to stimulate and enhance afferent input during activity, for example 
when walking.  
 
Different types of foot wear and insoles may have potential to alter sensory 
input and, consequently, the biomechanics of gait when walking. Walking 
barefoot or wearing shoes with differing levels of support has been shown to 
influence the degree of muscle activity required for walking in healthy adults: 
walking barefoot or in minimally supportive footwear decreases activity of 
tibialis anterior at initial stance due to placing of the foot in a more plantar flexed 
position at heel strike (Franklin et al., 2018). It is unclear whether this is due to 
the difference in support offered by the different footwear, a slower walking 
speed when barefoot, or perhaps the differing afferent input. Furthermore, it is 
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unclear whether these changes seen in healthy adults are also seen in stroke 
survivors. The enhanced somatosensory feedback from TIs has been found to 
decrease metabolic activity within the pre-frontal cortex in older adults with 
minor mobility issues (n=14, mean (SD) age 77.1 (5.56) years), suggesting that 
wearing the insoles results in more automatic control of gait, with less attention 
required, compared to walking in shoes without insoles (Clark et al., 2014).  
However, caution must be applied when interpreting this research in view of the 
small sample size. 
 
Taking into consideration the importance of afferent information from the plantar 
surface of the foot to control balance (Kennedy and Inglis, 2002), other potential 
mechanisms of increasing plantar stimulation have been explored.  
 
Although the central nervous system can be primed for activity using 
techniques such as MTS, or sensory information can be augmented, for 
example, by the use of TIs, the aim of these strategies is to influence motor 
activity and function. It is, therefore, common practice within therapy sessions 
to deliver combination treatments; for example: somatosensory electrical 
stimulation and task-specific training (Fleming et al., 2015); repetitive facilitative 
exercises plus an ankle-foot orthosis (Kazutoshi et al., 2017); or mirror therapy 
plus task-specific training (Hsieh et al., 2018). Developing evidence for complex 
hands-on therapy and applying the findings of research to practice within stroke 
rehabilitation is particularly challenging, due in part to a limited understanding 
and knowledge of therapy treatments (Langhorne et al., 2011), which involve 
many different aspects (Craig et al., 2006) and potential combinations. 
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 Sensory re-training for the foot and ankle after stroke 
Somatosensory stimulation of the foot and ankle after stroke has been 
investigated with the purpose of improving balance or gait in a small number of 
studies (Hillier and Dunsford, 2006; Kim et al., 2015; Lynch et al., 2007; 
Morioka and Yagi, 2003).  
 
Hillier and Dunsford (2006) used a single-case repeated measures quasi-
experimental design, with three subjects who had a right-sided stroke more 
than two years previously. A retraining intervention was delivered that included: 
education; practice in detection and localization; hardness, texture and 
temperature discrimination; and proprioceptive training. Measures were 
undertaken twice at baseline and twice post-intervention. All participants 
demonstrated a positive trend for improved tactile appreciation, with two 
reaching statistical significance (subject one p=0.01 for detection; subject three 
p=0.03 for detection and localization). Subject two recorded a significant 
change in duration of single leg stance (p=0.017), and one subject reported a 
‘sensory reawakening’, stating ‘thank you for helping me find my foot again’ 
(Hillier and Dunsford, 2006, p.240).  
 
Lynch et al. (2007) and Morioka and Yagi (2003) both undertook randomized 
controlled pilot trials. Lynch et al. (2007) included 21 stroke survivors between 
13 days and four months post-stroke, and compared a sensory retraining 
programme (the same as delivered by Hillier and Dunsford, (2006)), for the 
more affected lower limb with a sham intervention (relaxation). Significant 
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improvements (p=<0.05) were seen over time for light touch, postural control, 
timed gait and use of a walking aid. Morioka and Yagi (2003) investigated the 
effect of perceptual learning exercises for hardness discrimination on standing 
balance for stroke survivors (one to four months post-stroke) (n=26). They used 
feedback to enable learning, through an exercise to discriminate the hardness 
of sponge rubber placed under the plantar surface of the foot. They also 
reported improvements in postural control, with postural sway decreasing 
significantly (p< 0.01).  
 
These promising results for all these studies were achieved within just two 
weeks. However, the result for Morioka and Yagi (2003) could possibly be 
attributed to increased time spent in standing for the experimental group over 
the control group, and not necessarily the sensory intervention. It is not known 
whether a change in sensory awareness contributed to the results, or perhaps 
just an increase in muscle strength associated with the extra standing practice. 
 
Strengths of the Hillier and Dunsford (2006) study were the clearly stated 
inclusion and exclusion criteria, the use of a blinded assessor and testing of 
intra-rater reliability for OMs. Also, the inclusion of stroke survivors two years 
post-stroke, who were able to stand but not necessarily walk, means the work 
could be applicable to many stroke survivors; however, there is no justification 
offered as to why only participants with right-sided strokes were included. 
Nevertheless, due to the design of these studies, neither Hillier and Dunsford 
(2006) nor Lynch et al. (2007) can fully corroborate the benefits of sensory re-
training for the lower limb post-stroke. Hillier and Dunsford (2006) included just 
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three single case studies, and Lynch et al. (2007) acknowledged a reduced 
power of the study, with recruitment of just 21 participants as opposed to the 32 
stipulated by the power calculation; therefore, it was not possible to detect 
between-group changes. There was also no long-term follow up to allow 
assessment of the carryover effect of the intervention, and the inclusion criteria 
required participants to be able to walk 10 metres (10m), so many stroke 
survivors who may have benefitted from sensory re-training could potentially 
have been excluded. Strengths to note relating to Lynch et al. (2007) and 
Morioka and Yagi (2003) are randomization of participants to group allocation, 
and blinded assessment, both of which help reduce potential for bias. However, 
there is no statement relating to ethical approval in the Morioka and Yagi (2003) 
study. Also worth noting is that, although significant changes were reported for 
the BBS in Lynch et al. (2007), it is not clear whether the change reached the 
level of 5–7 BBS points, which is the necessary change to assure the changes 
were associated with the intervention (Stevenson, 2001). 
 
Kim et al. (2015) concluded that even a single dose of somatosensory 
stimulation, involving stretching, distraction and compression to the foot and 
ankle, had a significant effect (p<0.05) on the BBS score of six stroke survivors 
who were independently mobile (MD 3.16) and six who were unable to walk 
unassisted (MD 7.33). This latter group reached the necessary 5–7 BBS point 
change, whereas the independently mobile group did not. This was potentially 
due to the higher functioning participants reaching the ceiling threshold that has 
been reported for the BBS (Blum and Korner-Bitensky, 2008).  
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It is important to consider the dose and intensity of the treatments delivered. A 
single dose of this same sensory intervention (n=14) was compared with 24 
sessions given three times per week for eight weeks (n=16) (Kim, 2015). The 
trunk impairment scale was used to assess static and dynamic sitting balance 
and also trunk coordination (Verheyden et al., 2004). The author infers that the 
BBS measures static balance and reports that the scores for static balance did 
not reach significant levels for either group; contrary to this opinion, the BBS 
actually measures both static and dynamic balance (Blum and Korner-Bitensky, 
2008). However, even the single dose of sensory intervention resulted in a 
significant change in dynamic balance as measured by the trunk impairment 
scale (p<0.01) and significant changes were seen for both dynamic balance 
and trunk coordination for the group who received eight weeks of intervention 
(p<0.01) (Kim, 2015). It must be remembered that the trunk impairment scale is 
only assessing changes to the trunk in sitting and, therefore, the noted changes 
in dynamic balance may not be transferrable to function, for example walking. 
Also, of note were small sample sizes, absence of consideration of the reliability 
of the OMs, neither of these studies included random allocation, and assessors 
were not blinded, so the possibility of bias cannot be ruled out. Again, the 
results of these trials should be interpreted with caution. Furthermore, there 
were no follow-up measurements undertaken, and it is not known whether any 
changes would have been maintained. In view of these major limitations it is not 
possible to draw relevant conclusions from these studies. Although a statement 
is included that the research ‘conformed to the ethical principles of the 
Declaration of Helsinki’ it is unclear whether specific ethical permission was 
granted for the study (Kim et al., 2015 p.1080). 
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 TIs or textured surfaces as sensory stimulation 
The influence of textured surfaces has been investigated, with some studies 
standing participants on a textured surface (Clark et al., 2014; Corbin et al., 
2007; Hatton et al., 2009; Hatton et al., 2011; Hatton et al., 2012; Kelleher et 
al., 2010; Nurse et al., 2005) and others exploring the effects of wearing TIs in 
the shoe (Aruin and Kanekar, 2013; Baron et al., 2014; Dixon et al., 2014; 
Hartmann et al., 2010; Kalron et al., 2015).  
 
In an observational study of 33 healthy adults (Corbin et al., 2007), balance was 
measured in three planes using the AccuSway PLUS Balance Platform; TIs 
were shown to improve postural control in standing when worn just for testing, 
with a significant interaction between vision and texture for COP deviation in 
bilateral stance (F1,32 =5.11, p =0.03). Testing with the eyes closed without 
wearing the TIs resulted in a significant difference (increase) in COP deviation 
in comparison to the eyes open test; however, when the TIs were worn there 
was no significant difference in COP deviation between eyes open and closed.  
 
When used with people with Multiple Sclerosis, both smooth and TIs resulted in 
improved spatiotemporal parameters of gait (measured with the GAITRite 
system), with mean stride increases of 3.5cm for the 46 participants (Dixon et 
al., 2014). This could perhaps be attributed to the fact that an insole (regardless 
of whether it was smooth or textured) provided a tighter fit of the shoe, giving a 
sense of greater stability, which itself had an effect on gait parameters.  
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Interestingly, Aruin and Kanekar (2013) applied a TI to the ipsilesional foot post-
stroke, creating discomfort, with the aim of facilitating better weight transference 
to the contralesional side. They found that improved weight transference 
through this leg did occur. However, the results of this study need to be 
interpreted with caution, as it included a sample of just four stroke survivors, 
with no mention of how the sample was recruited; consequently, the potential 
for bias within the study is high.  
 
The wearing of TIs, which provide sensory stimulation to the plantar surface of 
the foot, is not currently part of routine therapy post-stroke, despite them having 
been shown to improve both balance (Christovão et al., 2013) and gait 
variables in people with other neurological conditions affecting sensibility in the 
foot, such as Multiple Sclerosis (Dixon et al., 2014). 
 
 Vibration 
The addition of increased afferent input via vibration has also been explored. 
One pilot RCT of 44 chronic stroke survivors applied low-amplitude segmental 
muscle vibration therapy at 120Hz, to the tibialis anterior muscle, exploring its 
effects on gait speed (Paoloni et al., 2010); and in a pre-experimental study of 
non-specified stroke duration (n=13), vibration was applied to the gluteus 
medius muscle and the anterior tibial muscle at 83Hz (Kawahira et al., 2004). 
Both studies reported significantly increased gait speed with the stimulation 
(p<0.01) and Paoloni et al. (2010) also reported increased activation of tibialis 
anterior, as monitored by surface EMG, in the experimental group. The 
methodology of Paoloni et al. (2010) was rigorous, in that it included 
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randomization, with strict inclusion criteria, and gait analysis was undertaken 
offline by an assessor blinded to group allocation. The results of Kawahira et al. 
(2004) should be interpreted with caution because there was no control group, 
no mention of blinding within the study and no summary data were presented; 
hence, there is the potential for a high risk of bias within this study.  
 
Application of vibration at 80Hz and 1mm in amplitude, applied to the Achilles 
tendon, with the purpose of interfering with ankle proprioception, was also 
explored in a cross-sectional study (convenience sample) of ambulatory stroke 
survivors (both acute and chronic stroke, n=35) (Lin et al., 2012). Participants 
were grouped according to intact or impaired joint position sense; no significant 
effects were found for plantar sensitivity or leg muscle strength between the 
groups. The differences in stride characteristics were non-significant for both 
vibration and non-vibration conditions (p =.354). It should be noted that there 
was no blinding within this study for either assessments or analysis.   
 
It has also been found that sub-sensory vibrations (with noise amplitudes set to 
90% of sensory threshold, band-limited to 100Hz) applied to the feet of elderly 
recurrent fallers (n=18) and non-fallers (n=18) reduced the stride (F1,45 = 9.85, 
p=0.003), stance (F1,45 = 13.60, p<0.001 and swing phase (F1,45 = 7.40, 
p=0.009) variability when walking (Galica et al., 2009). However, there were 
limitations to this study including small sample size, no randomization or 
blinding within the study and the fact that the sub-sensory threshold could not 
be set for some participants because they were unable to feel the vibrations 
from the insole on a maximum setting.  
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 Combination treatments 
Due to the heterogeneous nature of stroke, specific stand-alone rehabilitation 
treatments are rarely delivered, and combinations of different treatments form a 
regular part of conventional rehabilitation (section 2.8.7). An excellent example 
of a combination intervention for the upper limb post-stroke is the COMPoSE 
study, which combines both somatosensory and motor training delivered 
contemporaneously in a specific task, facilitating sensorimotor integration 
(Gopaul et al., 2018). However, the effects of combining a sensory intervention, 
to prime or augment motor activity and motor control, with repetitive task-
specific practice has not yet been explored for the lower limb post-stroke.  
 
 Summary 
This chapter has highlighted that various different sensory interventions have 
been explored in a range of different study designs, utilising a selection of 
different treatment interventions. Many of the reviews discussed relate to 
sensory stimulation or retraining for the upper limb post-stroke. It is also 
recognised that sensory information from other modalities e.g. vestibular, 
auditory and multisensory, influences movement (Schaaf and Case-Smith, 
2014); nevertheless, it is not possible to explore these within the scope of this 
thesis.  Sensory stimulation techniques are applied to the lower limb within 
clinical practice, and yet there is no systematic review or synthesis of the 
findings of somatosensory interventions for the lower limb to improve balance 
and gait post-stroke. Hence, this is the focus of this thesis. It is important that 
research for healthcare interventions is informed by best available evidence 
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from systematic reviews and patients’ views and experience (Gopalakrishnan, 
2013). To gain a more in-depth insight into the extent and quality of evidence 
already undertaken relating to somatosensory stimulation for the lower limb 
post-stroke, a systematic review was undertaken: Study 1 of this thesis.   
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3 CHAPTER THREE: STUDY 1 – EFFECTIVENESS OF 
SOMATOSENSORY STIMULATION FOR THE LOWER 
LIMB AND FOOT AFTER STROKE: A SYSTEMATIC 
REVIEW 
 
This chapter comprises of the methods and results of Study 1 of this thesis:  
a systematic review relating to somatosensory stimulation for the lower limb 
and foot after stroke. 
 
 Research aims and objectives: 
The research aim was: 
To explore the evidence around somatosensory stimulation of the foot and 
lower leg to improve function after stroke. 
 
Research objective: 
1.1 To systematically review the published literature investigating the 
effectiveness of somatosensory stimulation applied to the lower leg and foot to 
improve balance and mobility after stroke. 
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 Methodology for Study 1 
 Design 
To address the research aim, a systematic review was undertaken, which 
involved identification of relevant literature related to somatosensory stimulation 
to the lower limb after stroke; extraction of pertinent data was undertaken, with 
appraisal of study designs. A systematic review enables synthesis of 
information from several separate studies (Green, 2005); rigorous methodology 
is important when assimilating the extensive amount of literature available, 
informing healthcare decisions (Clarke, 2007). Indeed, it has been suggested 
that no research should be initiated without first undertaking a systematic 
review of previous research; important design implications for future studies can 
be understood based upon preceding literature (Clarke, 2004).  
 
It was not possible to simply update an existing review, because a review did 
not exist which solely focused on somatosensory stimulation to the lower limb. 
For example, Schabrun and Hillier (2009) included interventions for both the 
upper and lower limbs, categorising these interventions into active and passive 
sensory stimulation; it is not always possible to classify in this manner. Sensory 
interventions can include aspects to re-train sensation, and these can 
specifically involve active attention, for example discrimination of textures 
through touch (Carey et al., 2011); nevertheless, it may be that passive 
stimulation could also influence movement and function of the lower limb as it 
was shown to for the upper limb (Celnik et al., 2007; Conforto et al., 2007; Wu 
et al., 2006). Therefore, the decision was made to include all interventions 
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which could be referred to as sensory stimulation whether this was a passive 
intervention or active retraining in this current systematic review.  
 
A systematic review of published literature (1st January 1997 to 28th November 
2018) relating to effectiveness of somatosensory stimulation of the lower limb in 
stroke survivors to improve balance and gait was undertaken.  
 
 Search strategy 
A search strategy was developed with support from a health librarian using the 
following key words linked with Boolean operators: 
• “Cerebrovascular accident” OR CVA OR “acquired brain injury” OR 
“traumatic brain injury” OR “head injury” OR “TBI” OR “ABI” OR hemiplegia 
OR hemiparesis OR “upper motor neuron lesion”  
AND 
• Sens* OR stimulat* OR somatosens* OR propriocept* OR afferent OR 
mobilisation OR mobilization OR manipulat*  
AND 
• Foot OR leg OR “lower limb” OR “lower extremity” 
AND 
• Walk* OR gait OR mobil* OR step OR stance OR ambulat* OR “weight 
bear*” 
AND 
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• Randomised controlled trial OR “randomised controlled trial” OR 
randomized controlled trial OR “randomized controlled trial” 
NOT 
•  “Functional electrical stimulation” OR functional electrical stimulation OR 
FES 
 
The full search strategy is presented in Appendix 2. 
  
Using the EBSCO search engine, the following databases were searched on 
28th November 2018: AgeLine, AMED, CINAHL PLUS, MEDLINE, 
PsycARTICLES, PsycINFO, SPORTDiscus. On the same date, Web of 
Science, Cochrane trials and PEDro databases were also searched. Important 
health databases were therefore included (Boland et al., 2017).  
 
 Inclusion/exclusion criteria 
Inclusion of studies was based on PICOS  (Population, Intervention, 
Comparison, Outcome, Study type) (Akobeng, 2005): 
● Population: adult stroke survivors aged ≥18 years 
● Intervention: somatosensory intervention involving sensory stimulation 
(mechanical or tactile, thermal, electrical for the purpose of sensory 
stimulation only, and proprioception) of the contralesional lower limb 
and/or foot 
● Comparison: where applicable, standard care, routine/conventional 
therapy, or placebo (control) 
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● Outcome: valid and reliable outcomes related to gait and/or balance, for 
example, gait parameters, BBS 
● Study type: RCTs, published in English language, with a clear statement 
of appropriate ethics approval. 
 
Studies were excluded if they involved: participants with neurological conditions 
other than stroke; functional electrical stimulation and other interventions with 
the purpose of eliciting muscle contraction; sensory stimulation combined 
simultaneously with active or active assisted movement e.g. Proprioceptive 
Neuromuscular Facilitation (PNF); acupuncture; transcranial magnetic 
stimulation; transcranial direct-current stimulation; visual or auditory stimulation 
or feedback only, including visual biofeedback. Conference abstracts or other 
‘grey’ literature, including unpublished studies and theses, were also excluded. 
 
 Procedures 
Following the search, citations were exported to Endnote, where duplicates 
were identified and removed; this was checked manually for accuracy using a 
database exported from EBSCO and Web of Science.  
 
The remaining titles and abstracts were screened independently by two 
researchers (AA, SH) according to inclusion and exclusion criteria; following 
discussion and subsequent agreement, non-relevant citations were excluded. 
The full texts of the remaining articles were retrieved and again screened 
independently by the same two researchers. Discussion and agreement about 
inclusion/exclusion of individual studies resulted in the final citations being 
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identified for review. A third researcher (VP) was also available in case of any 
disagreement. If uncertainty existed as to whether the electrical treatment 
delivered was of a sensory nature as opposed to creating a muscle contraction, 
authors were contacted via email for clarification to ensure the studies met the 
inclusion criteria of the systematic review. The reference lists of the included 
studies were hand-searched and any further citations that appeared to be 
appropriate for review were identified and screened by both researchers 
independently, according to the procedures above. Details are presented in the 
PRISMA flow diagram (Moher et al., 2009) (figure 3.1). 
 
 Data extraction and analysis 
Data from included studies were extracted (by AA) using a data extraction tool 
(Appendix 3) to identify and summarize pertinent data: information about the 
study design, sample, interventions, OMs, results, and authors’ conclusions 
were extracted and tabulated to facilitate narrative synthesis of findings (tables 
3.2 and 3.3). Due to heterogeneity of studies, specifically populations/samples, 
interventions and outcomes, meta-analysis of data was not undertaken. 
However, where effect sizes were not stated, or had been calculated using an 
alternative method, these were calculated wherever possible.  Prior to 
calculating the effect size, the pooled SD was calculated. The baseline SD, 
pooled over the two (or more) groups as the denominator (Sim and Wright, 
2000), was used when calculating the effect size; this method was selected to 
enable the SD to be based on a larger sample size, and thus be more precise, 
than if only the SD of the control group had been used.  
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If both groups were the same size this was calculated using the equation below: 
 
 
However, if the group sizes differed, a weighted pooled SD was calculated 
using the following equation: 
 
 
The between-group effect size was then calculated by the following method: 
 
                 (post-intervention mean 1 - post-intervention mean 2) 
              pooled SD at baseline 
 
Effect sizes calculated from studies with a small sample were indicated by an 
asterisk in the table of results (table 3.5). A threshold of 30 (total sample for the 
study) was used to indicate a small sample. This was based upon the value that 
is suggested for the central limit theorem (Kwak and Kim, 2017). The principle 
of the central limit theorem is that as the sample size drawn from a population 
grows, its mean will more closely match the population mean, with less 
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variation in the results (Kwak and Kim, 2017).This process therefore enabled 
small studies (n≤30) with a potentially skewed distribution to be identified.  
 
 Assessment of methodological quality 
Methodological quality of the studies was assessed by the researcher (AA) 
using the Cochrane Collaboration tool to assess risk of bias in RCTs (Higgins et 
al., 2011) (table 3.4). Assessment of quality was judged according to the 
Agency for Healthcare Research and Quality standards (Lohr and Carey, 
1999), using the criteria in table 3.1. 
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Table 3.1 Thresholds for Converting the Cochrane Risk of Bias Tool to 
Agency for Healthcare Research and Quality Standards  
(Good, Fair, and Poor) 
 
Quality level Threshold 
 
Good All criteria met (i.e. low for each domain) 
Fair One criterion not met (i.e. high risk of bias for one domain) 
or two criteria unclear, and the assessment that this was 
unlikely to have biased the outcome 
Poor One criterion not met (i.e. high risk of bias for one domain) 
or two criteria unclear, and the assessment that this was 
likely to have biased the outcome, and there are important 
limitations that could invalidate the results, or two or more 
criteria listed as high or unclear risk of bias 
 
 
 Results of Study 1 
The initial search identified 433 citations (details of number of citations 
identified from each database are available in Appendix 4), of which 144 
duplicates were removed. Of the 289 studies screened from titles and 
abstracts, 254 were removed, leaving 35 studies for review from the full text. Of 
those, 24 were excluded2 for the following reasons: not RCT (n=3 ), conference 
abstract only (n=1), thesis (2), balance and gait were not outcomes measured 
(n=1), intervention also included muscle contraction (n=11), not sensory 
 
2 (An and Jo, (2017); Bae et al. (2015); Chen et al. (2011); Cheng et al. (2010); Choi et al. 
(2013); Ertzgaard et al. (2018); Hsu et al. (2013); Knutson et al. (2013); Koseoglu et al. (2017); 
Kwong et al. (2018); Lau (2011); Lau (2013); Lee et al. (2016); Liang et al. (2012); Maupas et 
al. (2017); Morreale et al. (2016); Ng (2005); Okawara and Usuda, (2015); Park et al. (2015); 
Ribeiro et al, (2013); Spaich et al. (2014); Sungkarat et al. (2011); Xu et al. (2017); Yavuzer et 
al. (2016)). 
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stimulation/sensory stimulation not manipulated (n=4), sensory stimulation was 
visual or auditory not mechanical (n=1), no statement of appropriate ethics 
approval (n=1). Details of the studies that were excluded after reading the full 
texts, with reasons for exclusion, are given in Appendix 5. Figure 3.1, a 
PRISMA flowchart, summarizes the process and reasons for exclusion.  
 
A total of 17 trials were included in the review. Further articles identified from 
manual searching of the reference lists of included studies, and their suitability 
for inclusion or exclusion (with reasons), are detailed in Appendix 6.  
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Figure 3.1  Flowchart of the data collection and screening process, based 
on 2009 PRISMA flow diagram 
    
 (Moher et al., 2009) 
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Titles/abstracts screened 
n = 289 
Records excluded 
n = 254 
Full-text articles 
assessed for eligibility 
n = 35  
 
 
 
Full-text articles excluded, with reasons  
n = 24 
Reasons for exclusion: 
• Not RCT (3) 
• Abstract only (1) 
• Thesis (2) 
• Outcomes not balance or gait (1) 
• Involved muscle contraction (11)  
• Not sensory stimulation/ not 
manipulated (4) 
• Auditory or visual stimulation (1) 
• No statement of appropriate ethics 
approval (1) 
 
Studies considered to 
be eligible for inclusion 
n =11 
Duplicates removed 
n=144 
Additional studies eligible for inclusion 
following hand search of reference 
lists of included studies:  
n= 6 
Studies included in the 
review 
n =17 
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Table 3.2 Details of study participants and group allocation 
Study Study 
design/ 
sample size 
Study group No of 
partici- 
pants 
Sex M/F Side of 
paresis 
L/R 
Age 
Mean (SD) 
Mean (SD) 
time post-
stroke 
Type of 
stroke: 
Infarct/ 
haemorrhage 
No. finished 
intervention 
Bayouk 
et al. 
(2006) 
Matched 
pairs RCT 
n=16 
Task orientated training (TOT), different 
surfaces proprioception feet/ankles 
and/or vision manipulated (Total 16 hours) 
8 6/2 6/2 68.4 (7.1) yrs 7.1 (12.5) yrs  
 
Not stated 8 
TOT eyes open, hard surface 8 3/5 4/4 62.0 (4.6) yrs  5.7 (6.9) yrs 8 
Brogårdh 
et al. 
(2012) 
Double-
blinded RCT 
n=31 
Whole body vibration (WBV) training 
(Total 9 hours) 
16 13/3 9/7 61.3 (8.5) yrs 37.4 (31.8) 
months 
14/2 16 
Placebo vibrating 
platform (0.2mm amplitude) 
15  
 
12/3 7/8 63.9 (5.8) yrs  33.1(29.2) 
months 
13/2 15 
Cho et al. 
(2013) 
Randomized           
placebo-
controlled 
trial n=42 
TENS 
(Total 1 hour) 
22 14/8 Not stated 55.2 (11.49) 
yrs  
15 (4.9) 
months 
15/7 22 
Placebo TENS 20 13/7 Not stated 55.7 (8.6) yrs  13.9 (5.1) 
months 
14/6 20 
Ferreira 
et al. 
(2018) 
RCT 
n=24 
Postural insoles influencing muscle 
proprioception (3 months of insole use) 
12 11/1 6/6 59.2(10.4) 
yrs 
3.9 (1.5) yrs 10/2 12 
Placebo insoles, no corrective elements. 12 5/3 6/2 60.3(13.3) 
yrs 
3.3 (1.1) yrs  6/2 8 
Goliwas 
et al. 
(2015) 
RCT 
n=27 
Standard 6-week therapeutic rehabilitation 
programme + 15 or 20 mins (UNCLEAR) of 
sensorimotor foot stimulation (SFS)  
(Total approx. 22.5hrs) 
13 5/3 2/6 62.3(9.4) yrs 
 
4.4(3.1) yrs 
 
8/0 8 
Standard 6-week therapeutic rehabilitation 
programme 
14  7/8 5/7 67.7 (9.2) yrs   4.1 (2.8) yrs 12/0 12 
Guo et al. 
(2015) 
RCT  
n=30 
WBV training (Total =53.33 hours) 
 
15 Not 
stated 
Not stated 53.8 (6.0) yrs 66.9 (42.9) 
days 
10/5 15 
Placebo WBV (machine off) 15 Not 
stated 
Not stated 54.3 (6.8) yrs  59.4 (61.4) 
days 
12/3 15 
Jung et 
al. (2017) 
RCT 
n=41 
TENS to peroneal nerve + Sit to stand 
(STS) training, 15 mins/day, 5x/week + 
20 11/9 10/10 56.2 (10.4) 
yrs 
 6.5 (2.7) 
months 
12/8 20 
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therapy, 1 hour a day, 5x/week, six weeks 
(Total 37.5 hours) 
Placebo TENS + same STS training therapy, 
1 hour/day, 5x/week, 6 weeks 
21 12/8 11/9 56.3 (10.2) 
yrs 
6.6 (2.5) 
months 
11/9 20 
Kluding 
and 
Santos 
(2008) 
Pilot RCT  
n=17 
2/week therapy for 4 weeks involving 
functional training + Contralesional ankle 
joint mobilizations (5 minutes) 2x/week 
(Total =2.67 hours) 
8 4/4 4/4 55.5 (10.8) 
yrs 
 
18.3 (11.8) 
months 
Not stated 8 
2x/week therapy for 4 weeks involving 
functional training 
9 5/3 7/1 56.1 (13.7) 
yrs 
24.6 (15.7) 
months 
Not stated 8 
Lau et al. 
(2012) 
Single 
blinded RCT 
n=82 
WBV training 3x/wk for 8 wks, 24 treatments 
(Total 10 hours, but only 4.2 hours WBV) 
41 26/15 20/21 57.3 (11.3) 
yrs 
4.6 (3.5) yrs 20/21 38 
Same exercises on platform but with no 
vibration. 
41 32/9 14/27 57.4 (11.1) 
yrs   
5.3 (4.2) yrs 21/20 38 
Lynch et 
al. (2007) 
Pilot single-
blind RCT 
n=21  
Daily 1-hour group session: lower-limb 
strength, balance/cardiovascular fitness, + 
30–60 minutes/day individual therapy session 
+ ten 30-minute sensory retraining 
sessions (2-week period) (Total =12.5 hrs) 
10 7/3 5/5 61.0 (15.8) 
yrs 
 
48.7 (31.1) 
days 
9/1 10 
Daily 1-hour group session: lower-limb 
strength, balance/cardiovascular fitness, + 
30–60 minutes/day individual therapy session 
+standing same time period (eyes closed) 
and 30 mins of relaxation techniques 
(supine, eyes closed) 
11 9/2 3/8 62.0 (12.3) 
yrs 
  
47.8 (27.7) 
days 
9/2 11 
Ng and 
Hui-Chan 
(2009) 
Randomized 
placebo-
controlled 
clinical trial 
(4 groups) 
n=109 
TENS + Exercise (Total 40 hours, 20 hours 
TENS and 20 hours exercise) 
27 21/6 17/10 57.8 (7.3) yrs 4.7 (2.8) yrs 11/16 26 
TENS 28 24/4 18/10 56.5 (8.2) yrs 4.9 (3.9) yrs 13/15 25 
Placebo stimulation + Exercise 25 20/5 13/12 56.9 (8.6) yrs 4.7 (3.4) yrs 15/10 23 
Control  29 20/9 20/9 55.5 (8.0) yrs 5.0 (3.0) yrs 16/13 27 
Paoloni 
et al. 
(2010) 
RCT  
n=44 
50 minutes physical therapy session, 3 
x/week, (4 weeks) + segmental muscle 
vibration 
22 19/3 11/11 59.5 (13.3) 
yrs 
1.9 (0.59) Not stated 22 
50 minutes physical therapy session, 3 
x/week, (4 weeks) (Total = 10 hours) 
22 20/2 10/12 62.6 (9.5) yrs   1.86 (0.61) 
yrs 
Not stated 22 
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Park et 
al. (2014) 
RCT 
n=34 
30-min exercise with a physical therapist 
+TENS (Total = 30 hours, 15 hours TENS 
and 15 hours exercise) 
17 (but 
characteris
tics for 15) 
12/3 10/5 71.2 (3.46) 
yrs 
 
18.7 (2.46) 
months 
 
Not stated 15 
30-min exercise with physical therapist + 
placebo TENS 
17 (but 
characteris
tics for 14) 
8/6 8/7 14 (3.8) yrs 
 
18.6 (1.7) 
months 
Not stated 14 
Suh et al. 
(2014) 
 
Single-blind 
RCT 
n=42  
30 mins standard rehab + Electrical 
stimulation- 60 mins single session, 
interferential current (Total 1 hour) 
21 15/6 Not stated 54.4 (12.1) 
yrs 
 
15.05 (4.9) 
months 
14/6 (? Why 
n=20, not n=21) 
21 
30 mins standard rehab + Sham electrical 
stimulation- 60 mins single session, 
interferential current 
21 14/7 Not stated 53.9 (12.4) 
yrs 
 
13.9 (5.1) 
months 
15/5 (? Why 
n=20, not n=21) 
21 
Tankishe
va et al. 
(2014) 
RCT 
n=15 
WBV training (Total 9 hours) 7 4/3 3/4 57.4 (13.0) 
yrs 
7.71 (8.6) yrs 6/1 6 
No additional training program; asked not to 
change lifestyle 
8 6/2 4/4 65.3 (3.7) yrs 5.28 (3.6) yrs 4/4 7 
van Nes 
et al. 
(2006) 
RCT 
n=53 
 
WBV training (Total 9 hours, 1.5 hours 
WBV) 
27 16/11 13/14 59.7 (12.3) 
yrs 
38.9 (9.2) 
days 
16/11 27 
Exercise therapy on music (ETM), four 
sessions of 45 seconds stimulation 5x/week, 
6 weeks. During ETM, patients adopted 
standing position as during the WBV. 
26 14/12 15/11 62.6 (7.6) yrs 
  
34.2 (11.1) 
days 
22/4 24 
Yan and 
Hui-Chan 
(2009) 
Single blind 
stratified 
RCT 
n=56 
Standard rehab (OT & PT) each lasting for 60 
min + transcutaneous electrical 
stimulation (TES) (Total = 15 hours) 
19 9/10 11/8 68.4 (9.6) yrs 9.2 (4.4) 
days 
16/3 17 
Placebo stimulation 19 10/9 11/8 72.8 (7.4) yrs 9.9 (2.6) 
days 
16/3 17 
Standard rehab (OT & PT) each lasting for 60 
min 
18 9/9 11/7 70.4 (7.6) yrs 8.7 (3.3) 
days 
15/3 16 
Abbreviations: Min minutes, SD Standard deviation, SFS Sensorimotor foot stimulation, STS Sit to stand, TOT Task orientated training, TENS/TES 
Transcutaneous electrical nerve stimulation, yrs=years, WBV whole body vibration, Wk=Week  
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Table 3.3 Outcome measures, results and effect sizes 
Study Study 
design 
Intervention group and dose Oms Results Effect size 
and 
(between-
group effect 
size) 
Bayouk 
et al. 
(2006) 
Matched 
pairs RCT 
TOT, different surfaces proprio-
ception feet/ankles and/or vision 
manipulated 
1 hour, 2x/week (8 weeks), 30 mins 
session aimed at improving static and 
dynamic balance, exercises executed 
while proprioception of feet and ankles 
and/or vision was manipulated. 
Timed 10m walking test (10MWT) 
 
 
Displacement of COP (Matscan 
system) during double-legged stance 
and sit-to-stand (STS) tasks 
10MWT: significant ↓ time (p<.05): 12.2%.  
COP variability: significant ↓ COP variability (p<.05) in 
ML (eyes open, firm surface) and AP directions (eyes 
open, soft surface). 
COP total excursion for STS under all 4 conditions: 
significant ↓ (p<0.05) COP total excursion, AP axis for 
eyes open/soft surface. No significant main effects of 
group x test interaction under other sensory conditions. 
10MWT: 
*0.22 (0.12) $   
TOT eyes open, hard surface 10MWT: significant ↓ time (p<.05): 12%  
COP total excursion for STS under all 4 conditions: 
significant ↓ (p<0.05) COP total excursion, AP axis for 
eyes open soft surface condition. No significant main 
effects of group x test interaction with other conditions. 
*0.24 (0.12) $ 
Brogårdh 
et al. 
(2012) 
Double-
blinded 
RCT 
Whole body vibration (WBV) 
training Session ≤ 45 minutes 
Amplitude 3.75, frequency 25Hz. 
Standing, knee flexion 45─60˚. 
12 sessions (2x/week for 6 weeks) 
WBV ↑ 40─60 seconds per repetition, 
number of repetitions from 4─12.  
Isokinetic and isometric knee 
muscle strength (Biodex Multi-Joint 
System 3 PRO dynamometer) 
standard protocol 
Modified Ashworth scale (MAS): hip 
adductors, hip and knee 
extensors/flexors, and ankle 
dorsi/plantarflexors 
Berg Balance Scale (BBS) 
Timed Up & Go (TUG) test 
10MWT comfortable and fast gait 
speed (CGS and FGS) 6-minute 
Walk Test (6 minWT) 
Stroke Impact Scale (SIS) 
Adjustments made for between-group differences at 
baseline in TUG, 6minWT, and BBS. Non-significant 
differences in all OMs after training.  
Significant but small improvements were found within 
both groups after WBV training. Intervention group 
improved significantly in balance (4%; p<.05) and gait 
performance (TUG, 8%; CGS and 6minWT, 5%; 
p<.05). 
BBS: 
0.91 (0.09) $ 
Placebo vibrating 
platform Amplitude 0.2mm, frequency 
25Hz 
Significant but small improvements found within both 
groups after training. Control group improved 
significantly in isometric knee extension strength in the 
paretic limb (12%; p<.05) and in gait performance 
(TUG and 6minWT, 6%; p<.05). 
0.13 (0.09) $ 
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Cho et al. 
(2013) 
Random-
ized 
placebo-
controlled 
trial 
TENS to gastrocnemius Frequency 
100 Hz, pulse width 200 μs (2-3 times 
sensory threshold, 60 mins) 
MAS Spasticity of ankle plantarflexor. 
Handheld dynamometer (HHD) to 
measure the resistive force (kg) 
caused by spasticity 
Postural sway length (PSL) while 
standing with eyes open, then closed, 
and on an unstable surface with eyes 
open 
MAS: Spasticity ↓ by 29%  
Handheld Dynamometer (HHD) resistance ↓30%  
Postural imbalance: 
Eyes-open: PSL ↓16%  
Eyes closed: PSL ↓ significantly (p<.05) by 23%, the 
only condition with a significant difference (sig diff) 
between groups (p<.05)  
Unstable surface/eyes open: PSL ↓ by 16% Results: 
back at baseline values after a day. 
 
 
 
 
 
 
 
 
 
 
No SDs 
presented; 
effect sizes 
could not be 
calculated 
Placebo TENS  
Same electrode placement; no 
electrical stimulation 
MAS: Spasticity ↓ by 13%  
Handheld Dynamometer (HHD) - resistance ↓ 19%  
Postural imbalance: 
Eyes-open: Postural sway length (PSL) ↓ 9%  
Eyes closed: PSL ↓ significantly (p<.05) by 8. Only 
condition with sig diff between groups (p<.05)  
Unstable surface eyes open: PSL ↓ by 9% in control. 
Results back at baseline values after a day. 
Ferreira 
et al. 
(2018) 
RCT Postural insoles with pronating heel 
wedge (6 mm), a pronating band and 
metatarsal-phalangeal inlay to stabilize 
different segments of foot in neutral 
position, designed for equinovarus 
foot.  
Evaluations on placement of postural 
insoles and after three months insole 
use (barefoot, self-selected pace over 
10m). Three-dimensional gait 
analysis (SMART-D 140® system) 1) 
barefoot, 2) with habitual shoes 3) with 
habitual shoes + insoles 
Kinematic data with force plate (Kistler, 
model 9286BA): COP displacement + 
time of contact between foot and 
surface of force plate 
Gait analysis: No statistical sig diff for gait velocity.  
Kinematic aspects: intra-group analysis. After three 
months of insole use, significant gains in ankle 
dorsiflexion (p=0.007), peak knee flexion (p=0.038) in 
comparison to the control group. No sig diffs found 
regarding the hip and pelvis. 
Mean velocity 
*0.06 (0) 
 
Placebo insoles, no corrective 
elements. 
Gait analysis/kinematic aspects: No significant 
changes observed. 
*0.03 (0) 
 
Goliwas 
et al. 
(2015) 
RCT Standard six-week therapeutic 
rehabilitation programme + 15 or 20 
mins (UNCLEAR) of sensorimotor foot 
stimulation (SFS) 15 or 20 mins 
(UNCLEAR) of SFS (25 sessions) 
Zebris FDM-TDL treadmill with Win 
FDM-T software (5,376 pressure 
sensors) measured weight 
distribution on the feet. Taken first 
and last day in rehabilitation facility. 
Eyes open/closed. 
Differences in weight distribution: End test eyes 
open and closed – sig diff (p<0.05) between baseline 
and end, 30.6 ± 19.6% to17.8 ± 15.2% (p<.05), 
Reduction of the differences in weight distribution: 
Sig diff seen between experimental group (12.2 ± 
12.9%, p<.05) vs control group, (2.4 ± 4.9%) with eyes 
open (p>0.05).  
Difference in 
weight 
distribution  
*0.68 (0.05) $ 
79 
 
Standard 6-week therapeutic 
rehabilitation programme 
Differences in weight distribution: End test with 
eyes open and eyes closed: 20.1 ± 18.4% 18.7 ± 
18.2% (p >.05) 
Reduction of the differences in weight distribution:  
There were no sig diffs seen. 
*0.07 (0.05) $ 
Guo et al. 
(2015) 
RCT  WBV training (I-VIB5050, Body 
Green, Taiwan), Magnitude 6─10 Hz, 
amplitude 4.0mm (8 weeks). Semi-
squat position, 60 secs vibration/10 
seconds rest,10 rounds per set, eight 
sets per day… ? daily NOT CLEAR 
Before and after 8-week treatment: 
Fugl-Meyer (FMA-L) for lower 
extremity assessment (17 items, total 
score 34 points), 
 
10MWT 
 
Subjective observation of knee 
hyperextension 
FMA-L score improved significantly p=0.000, 95%CI 
[3.309,9.891]; 
10MWT p=0.000, 95%CI [5.214,11.39]  
Times of knee hyperextensions decreased 
significantly p= 0.000 95%CI [19.05,12.35].  
 
10MWT 
2.53 (0.86) $ 
 
Placebo WBV (machine off) 
Same exercises/procedures, vibration 
machine off 
FMA-L score improved significantly (p=0.000/, 95%CI 
[5.549,12.45] 
10MWT: p=0.000/ 95%CI [9.423,15.98] 
Times of knee hyperextensions decreased 
significantly (p= 0.000 95% CI [16.52,22.28].  
1.65 (0.86) $ 
Jung et 
al. (2017) 
RCT TENS to peroneal nerve + STS 
training 15 mins/day, 5x/week + 
therapy, 1 hour a day, 5x/week, six 
weeks. TENS-7000, Koalaty Products 
Inc., USA used. Intensity – 2x sensory 
threshold, no muscle contraction. 
Pulse width 200 ms; frequency 100Hz. 
Wii Balance Board [WBB]) (force 
platform) to assess postural sway. 
(eyes closed, eyes open) conditions. 
Hand-held dynamometer (HHD) 
(Model 01163, Lafayette Inc., IN, USA) 
measured isometric strength in 
extensors of hip, knee and ankle. 
Composite Spasticity Score (CSS) to 
evaluate spasticity of the ankle plantar 
flexor. 
Postural sway: significant ↓ eyes open/closed (mean 
change, each 21.0 (16.2), 26.4 (19.9) cm), p<.05,  
Muscle strength: Muscle strength hip extensor 
significantly ↑ (p<.05), No sig diff in muscle strength 
knee and ankle extensors TENS vs placebo group.  
CCS: significant (mean change, 2.6 (0.8)) 
Postural 
sway 
(distance cm)  
0.65 (0.50) $ 
 
Placebo TENS + same STS training + 
therapy, 1 hour/day, 5x/week, 6 weeks 
Postural sway: smaller, but significant ↓ eyes open/ 
closed (mean change, 8.8(13.1),13.1(13.0) cm), p<.05.  
Muscle strength: Muscle strength hip extensor 
significantly ↑ (p<.05) in placebo stimulation group.  
0.27 (0.50) $ 
Kluding 
and 
Santos 
(2008) 
Pilot RCT  2x/week therapy for 4 weeks involving 
functional training + Contra-lesional 
ankle joint mobilizations (5 minutes) 
2x/week. Grade I or II manual traction 
and gliding 1st session; grade III other 
sessions + 15 mins functional training 
Passive and active range ankle 
d/flexion 
Ankle kinematics and weight-
bearing symmetry during functional 
activities (3D Optotrak 3020a motion 
system): 
Peak dorsiflexion during STS and 
stance phase 
Goniometer: Passive and active ankle range: 
Passive change: 5.7(3.1), 95% CI mean diff: 2.5 to 
8.6 active:10.8 (7.5); 95% CI mean diff: 0.5 to 16.6;  
Ankle kinematics and weight-bearing symmetry 
during functional activities: 
Peak d/flexion (STS): 1.88(4.72),95% CI: 7.95,1.36,  
Peak d/flexion (gait): 0.38(3.44), 95% CI: 9.27, 4.97  
Peak weight-bearing diffs during STS (%): -
0.79(4.9) 95% CI 3.59, 29.37  
Effect sizes 
for peak 
weight-
bearing diffs 
during STS:  
* 0.03 (0.51) 
(in favour of 
control 
group)  
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Weight-bearing differences during 
STS and static standing 
 
Time to perform STS 
 
MAS: passive resistance in ankle 
plantarflexors. 
 
Rivermead Mobility Index (RMI) 
Average weight-bearing difference in STS 3.37(5.29) 
(%): 95% CI 3.26,19.46 
Total STS time: Significant ↓ in experimental group 
compared to control: -0.82(0.91), 95% CI -1.9, -0.1s. 
Other measurements of function no diffs between 
groups.  RMI score: 0.75(0.71), 95% CI: -0.84,1.09 
 
 
2x/week therapy for 4 weeks involving 
functional training 
Goniometer: Passive and active ankle range: 
Passive change: 0.2(6.2), 95% CI for mean diff: 2.5, 
8.6; active: 2.3(7.6) 95% CI for mean diff: 0.5, 16.6;  
Ankle kinematics and weight-bearing symmetry 
during functional activities: 
Peak d/flexion (STS): 1.42(3.93) 95% CI -7.95, 1.36,  
Peak d/flexion (gait): 2.58(8.14) 95% CI -9.27, 4.97  
Peak weight-bearing diffs (STS) (%): -14.9(15.0) 
95% CI 3.59, 29.37  
Average weight-bearing diff in STS (%): -9.5(6.47), 
95% CI 3.26, 19.46 
Total STS time: Significant ↓ in experimental group 
compared to control:  0.17(0.77) 95%CI -1.9, -0.1s. 
Other measurements of function no diffs between 
groups.  RMI score: Exp:0.75(0.71), control: 0.63(1.1) 
95% CI: -0.84,1.09 
*0.91 (0.51) (in 
favour of 
control 
group) 
Lau et al. 
(2012) 
Single 
blinded 
RCT 
WBV training 3x/wk for 8 wks, 24 
treatments Exercises while standing on 
platform. Vertical (synchronous) WBV 
signals (Jet-Vibe System). frequency 
range 20–30 Hz, amplitude 0.44–0.60 
mm peak acceleration 9.5–15.8 mIsj2 
and g force of 0.97g–1.61g. 
At baseline, after 24 sessions, + 1-
month post-intervention. Chedoke–
McMaster stroke assessment Falls 
last 3 mths. 
BBS 
Limit-of stability (LOS) test (SMART 
balance system (NeuroCom, SMART 
EquiTest; NeuroCom Int, Inc., 
Clackamas, OR) Movement velocity 
(MVL); average speed of COP 
movement in degrees per second), 
end point excursions (EPE); Distance 
COP travelled. Maximum excursion 
(MXE); maximum distance travelled by 
ANOVA revealed a significant time effect for the 
BBS score, 10MWT, 6minWT, isometric knee 
flexion and extension muscle strength, and ABC 
score (P < 0.05). Interaction effects of time x group 
and group effects not significant for these variables (P 
>0.05). 
For the LOS test, a significant time effect identified for 
MVL, EPE, and MXE (P <0.05) but no time effect for 
DCL (P > 0.05). No significant time x group interaction 
or group effects for these variables related to the LOS 
test. Significant improvement immediately after training 
period in both groups (P <0.05) and values remained 
stable during 1-month follow-up period (P > 0.05;). No 
significant between-group difference in the incidence of 
BBS:  
0.22 (0.04) $ 
 
Same exercises on platform but with 
no vibration. 
0.002 (0.04) $ 
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COP Directional control (DCL); 
comparison of amount of movement 
toward target with that away from it. 
10MWT, 6minWT 
Cybex dynamometer Computer 
Sports Medicine, Inc., 
Stoughton,MA for isometric knee 
flexion and (70knee flexion). 
Activities Specific Balance 
Confidence (ABC) scale to evaluate 
fall-related self-efficacy. Falls logbook 
falls, with three subjects in each of group reporting a 
fall during the 6-month follow-up period (Chi squared = 
0.000, p= 1.000), also, no significant change found in 
the proportion of fallers before and after the treatment 
period in either group (McNemar test, p = 1.000. 
Lynch et 
al. (2007) 
Pilot 
single 
blind RCT  
Daily 1-hour group session: lower-limb 
strength, balance /cardiovascular 
fitness, + 30–60 minutes/day individual 
therapy session + ten 30-minute 
sensory retraining sessions (2-week 
period). Total treatment time divided 
evenly between education regarding 
sensation and sensory retraining; 
touch detection and localization at 7 
points on soles of feet; hardness, 
texture and temperature discrimination: 
feet on various surfaces, sitting and 
standing with vision obscured; 
proprioception training (big toe and/or 
ankle); specific, graded stimulation 
tasks, emphasis on tasks subject able 
to do; attentive exploration of stimuli; 
prevention of visual dominance; 
comparison with ipsilesional side; 
quantitative feedback on performance. 
SWMs to assess light touch at 7 
points on soles of feet (big toe, little 
toe, 1st metatarsal, 5th metatarsal, 
lateral border of, medial border, and 
heel) 
Distal Proprioception Test (DPT)
 
(out of 10) to assess proprioception 
of big toe. 
BBS to assess postural control. 
Gait assessment: time taken to walk 
the middle 10m of a 14-m walking 
track; Iowa Level of Assistance 
Scale (ILAS) - amount of therapist 
assistance and mobility aid. 
Light Touch: 
Improved significantly at 3 points of affected foot: heel 
(p=.03), lateral border (p=.02), and big toe (p=.01).  
Between-group differences in sensation- not 
significant at these 3 points at any time points. Time 
had no significant effect on sensation at the remaining 
4 points of the feet. Significant between-group 
difference in light touch sensation at first metatarsal 
at follow-up, with experimental group showing 
significantly improved detection of light touch 
compared to control group (p=.01); differences 
remained after 4-week period, even in the 3 points of 
the feet that had shown sig. improvements in sensation 
over time (Mann-Whitney U tests: big toe, p=.001, 
lateral border of the foot, p=.005; heel, p=.045).  
DPT: No sig diff over time in scores (p= .55); no 
significant between-group difference (p=.06). 
Balance: Within group significant diffs baseline to end 
of treatment for both groups (p<.005); no significant 
between-group diffs at end and follow-up. 
Timed Gait: No between-group differences found  
Level of Assistance  
No significant change observed over time or between 
groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*No SD 
presented so 
effect sizes 
could not be 
calculated. 
Daily 1-hour group session: lower-limb 
strength, balance/cardiovascular 
fitness, + 30–60 mins/day individual 
therapy session+relaxation techniques 
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Ng and 
Hui-Chan 
(2009) 
Randomi-
zed 
placebo-
controlled 
clinical 
trial (4 
groups) 
TENS + Exercise: 20 sessions 
treatment 5 x/ week (4 weeks). 8 
instruction sessions for home program. 
60 mins TENS, via two pairs of 
electrodes placed on 4 acupuncture 
points of affected lower extremity: ST 
36 (Zusanli), LV 3 (Taichong), GB 34 
(Yanglinquan) and UB 60 (Kunlun), 
cathodes proximal. Pulses:100 Hz 
using a square pulse stimulator (pulse 
width 0.2 ms). Stimulus intensity 
approx 2x patient’s sensory threshold  
+ 60 minutes task-related exercises, 
involving 4 weight bearing and 
stepping exercises using wooden 
blocks of 2.5 or 5 cm in height:  
1) loading affected leg;  
2) stepping up with affected leg;  
3) stepping down with unaffected leg;  
4) heel lifts from a dorsiflexed position 
in standing. 
Also, functional training;  
5) stand from chair, walk short 
distance, and return to chair;   
6) walking with rhythmic auditory cues. 
Progression: higher wooden blocks 
and ↑ repetitions in 10 minutes. 
Walking progressed by ↑ speed. 
OMs: Completed at baseline, after two 
weeks, after four weeks and at four 
weeks follow-up. 
Gait velocity: 4.6m long instrumented 
carpet (GAITRite). During testing, 
subjects walked with comfortable 
footwear at normal speed, and gait 
velocity calculated by GAITRite 
software. 
6-minute walk test 
(6minWT): 
Walking endurance 
Timed up and go (TUG) test: 
Functional mobility. 
 
 
 
 
Participants showed significant improvements in gait 
velocity from week 2 (baseline: 47.9 (26.8), week 2 
63.2(32.2) (p<0.01). Improvements maintained at 
follow-up, four weeks after treatment ended (70.2 
(32.7)). 
When compared with the control group, the two 
exercise groups (TENS+exercise baseline 191.9 (89.4) 
to follow-up 245.5 (99.7) and placebo Stimulation + 
exercise (baseline: 175.9 (81.9) to follow-up 206.82 
(85.8)) showed significantly greater absolute and 
percentage ↑ in average distance covered in the 
6minWT (p <0.01) at follow-up. All three intervention 
groups showed significant decreases in their average 
TUG time scores (p <0.01) at week 4 compared with 
that of the control group, but only the two exercise 
groups (TENS + exercise and placebo stimulation + 
exercise) maintained improvements at 
follow-up. Compared with the control and TENS 
groups, 
only the combined TENS + exercise group covered 
significantly more distance in the 6minWT from week 2 
onwards. 
Gait velocity: 
0.73 (0.22) $ 
 
TENS: 60 mins identical TENS 
treatment, as described. 
0.12 (0) 
 
Placebo stimulation + Exercise: 
60 mins placebo stimulation + 60 
minutes of same exercise program 
0.39 (0.01) 
 
Control: No treatment, attended four 
assessment sessions 
 
0.08  
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Paoloni 
et al. 
(2010) 
RCT  
 
50 mins physical therapy session, 3 
x/week, (4 weeks) stretching, muscle 
strengthening, balance, and 
overground walking training + 30 mins 
segmental muscle vibration (SMV) 
to contralesional tibialis anterior and 
peroneus longus. Low-amplitude SMV 
delivered by commercial acoustic wave 
vibratory device (commercial device: 
Horus; Akropolis, Rome, Italy); 
frequency 120 Hz; Vibration 
amplitude:10 mm. 30 mins stimulation 
in trains of 6 seconds divided by 1 
second pauses. 
 
Gait analysis: kinematic variables 
using ELITE stereophotogrammetric 
system (BTS, Milan, Italy), 8 infrared 
video cameras (TVC; BTS) 
Time–Distance Data 
Data collected paretic and normal 
sides: stride length (m); step width (m); 
step length (m); stance duration and 
swing velocity (m/s). 
Cadence and gait speed (m/s). Mean 
of 3 trials. 
Kinematic Data 
3D marker trajectories during walking 
(Tracklab; BTS). 
Electromyographic (EMG): 
Surface EMG signal -TA and 
Gastrocnemius Medialis muscles, 
paretic and normal, (walking). Subjects 
instructed to walk at self-selected 
speed along a level surface 10 m in 
length; 5 trials. 
Time–distance gait parameters: Significant treatment 
effect (2-way ANOVA p<.01) for gait speed: 
Significant effect (p<.01) also seen for: ipsilesional side 
swing velocity, stride length both sides, and toe-off 
percentage on ipsilesional side. 
Significant diff in kinematic evaluation (stance phase) 
for both ankle d/flexion angles at heel contact (2-way 
ANOVA p<.01); no significant changes in other 
parameters  
Significant diffs observed in max degrees of ankle 
d/flexion and plantarflexion - contralesional side swing 
phase, (2-way ANOVA; p <.01).   
Significant increase in surface EMG % activation of 
contralesional TA muscle pretreatment to 
posttreatment assessments (p<.01). 
Effect size .61 for max ankle d/flexion during 
contralesional swing phase.   
Gait speed: 
0.51 (0.4) $  
 
50 minutes physical therapy session, 3 
x/week, (4 weeks), stretching, muscle 
strengthening, balance, and 
overground walking training. 
No sig diffs observed 0.11 (0.4) $ 
Park et 
al. (2014) 
RCT 30-min exercise with a physical ther-
apist +TENS, 1:1 ROM exercise (10 
min), mat exercise (10 min), gait 
exercise (10 min). Exercise program 
according to pre-set principles. 7 
education/practice sessions in total. 
+ Two-channel TENS (TENS-7000, 
Koalaty Products Inc., USA). 
Electrodes (5 cm2)- affected lower 
extremity lateral and medial 
quadriceps and gastrocnemius 
Frequency:100 Hz; pulse width: 200μs. 
Stimulation 30 min, sub-sensory. 
MAS 
Good Balance (Metitur Ltd, Finland, 
2008) device to measure static 
balance with eyes open and closed for 
30s; 3 times. Average used as an in-
dicator of AP and ML postural sway, 
speed, and speed moment. 
The TUG test to assess dynamic 
balance. 
A gait analyzer (OptoGait, Microgate 
S.r.l, Italy, 2010) to test the gait 
pattern of patients and quantity of gait 
analysis. Temporal and spatial gait 
were measured. 
MAS Significant reductions (p<.05) 
Static balance: A sig diff in eyes closed and opened, 
AP, ML postural sway velocity, and velocity moment 
observed in TENS group before and after test (p<.05), 
and in mean difference from pre- and post-test 
between the 2 groups (p<.05). 
TUG: Sig diff before/after test (p<.05), TENS group 
improved more than placebo TENS group (p<.05). 
Gait analysis test: Sig diffs in velocity, cadence, step 
length and stride length of paretic side in TENS group 
before and after test (p<.05) Greater improvements of 
cadence, step length of paretic side, and stride length 
of paretic side than placebo TENS group (p<.05). 
Gait velocity:  
*0.4 (0.2) $ 
Same 30-min exercise + placebo 
TENS. Two-channel TENS used in 
Velocity showed a sig diff before and after test (p<.05) *0.03 (0.2) $ 
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same manner, however, no stimulation 
given,patients were informed that the 
treatment would be imperceptible. 
Suh et al. 
(2014) 
 
Single-
blind RCT  
Prior to intervention 30 minutes of 
standard rehabilitation based on the 
Bobath technique + Electrical 
stimulation- 60 mins single session, 
interferential current,via four electrodes 
to ipsilateral, medial and lateral 
gastrocnemius fibers (spastic muscle). 
Frequency:100Hz, approx. 2─3 x 
sensory threshold. 
MAS to assess gastrocnemius 
spasticity. 
Functional Reach Test and BBS 
TUG Test 
10MWT 
MAS: Significant ↓ in spasticity after therapeutic 
intervention; magnitude of ↓ significantly greater in the 
experimental group 41% (p<0.001) 
Functional Reach test: 19%, significant improvement  
p<0.001;  
BBS: 5%, significant improvement, p<0.001 
TUG: Significant ↑ for experimental group -19% 
(p<0.001) 
10MWT improved by 16%(p<0.001). 
Effect size: 
0.44 (0.39) $  
Control group 30 minutes standard 
rehabilitation + Sham electrical 
stimulation 60 mins single session, 
interferential current. Electrodes 
attached, no stimulation applied. 
MAS: Significant ↓ in spasticity 11% (p<0.002) 
Functional Reach test: 11% improvement; (p>.05) 
BBS  1% improvement, (p>0.05) 
TUG: Significant increase - 6% (p=0.006).  
10MWT improved by 4% p=0.011 
0.12 (0.39) $ 
Tankishe
va et al. 
(2014) 
RCT WBV training 
Vertical vibration platform (power 
plate) 3x/week for 6 weeks, minimum 
rest of 1 day between training 
sessions. Exercises: standing on toes, 
knee flexion of 50─60 (high squat), 
knee flexion of 90 (deep squat), wide-
stance squat, and 1-legged squat. 
Training intensity ↑ progressively by 
increasing the frequency (35 and 
40Hz) or the amplitude (1.7 and 
2.5mm) of vibration signal or 
increasing both. Vibration intensity 
gradually ↑ in first 12 sessions, more 
intensive in last 6 sessions. Training 
volume also increased systematically. 
At baseline, after intervention and at 6 
weeks follow-up. 
Standard clinical neurologic 
examination. 
Barthel Index 
Functional Ambulation 
Classification (FAC). 
Brunnstrom-Fugl-Meyer test 
(sensori-motor impairment). 
Borg’s perceived exertion scale. 
Ashworth scale 
Isokinetic dynamometer (Biodex 
System 
Dynamic posturography platform 
(Equitest) 
Sensory Organization Test (SOT) 
(postural control via visual, vestibular, 
and proprioceptive information). 
Ashworth scale – no sig diffs (p >.05). 
Muscle strength (paretic leg) significant between-
group differences in favour of the vibration group only 
in isometric knee extension strength (paretic leg), 
baseline: 43.1 (10.1), follow-up: 48.1 (7.9), (p=.022) 
after 6 weeks of intervention and in isokinetic knee 
extension strength after a 6-week follow-up period 
(p=.005). 
Postural control improved after 6 weeks of vibration 
in the intervention group when the patients had normal 
vision and a sway-referenced support surface (p<.05). 
 
Postural 
control 
equilibrium 
score 
*1.56 (0.57) $  
No additional training program; asked 
not to change lifestyle 
Ashworth scale – no sig diff (p >.05). 
Muscle strength -significant between-group 
differences in favour of vibration group (isometric knee 
*0.66 (0.57) $ 
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extension, paretic leg) Baseline: 30.5 (27.2), follow-up: 
35.2 (25.7), not significant for control (p=.022) 
Isokinetic knee extension strength after a 6-week 
follow-up period not significant (p=.005). 
van Nes 
et al. 
(2006) 
RCT WBV training – each working day for 
4 weeks + individualized treatment 
program (at least five 30-min individual 
sessions of physical therapy, five 60-
min group sessions of physical 
therapy, and three 30-minndividual 
sessions OT augmented with speech 
and language therapy + psychologic 
treatment if nec). Four sessions of 45s 
WBV stimulation with 1-minute break 
between sessions. 120 treatment 
sessions in total. Vibration amplitude 
approx. 3 mm. Frequency: 30 Hz. 
Patients adopted a “squat”, with hand 
support. Patients unable to stand 
independently were supported at their 
buttocks by a height-adjustable bench 
with their knees and hips in 45° flexion. 
At baseline, after 6 weeks of WBV or 
ETM treatment, as well as after 6 
weeks follow-up. At baseline: Motricity 
Index and MAS, Somatosensory 
threshold of the affected leg, and 
the presence of hemineglect. 
Somatosensory threshold determined 
for pressure sensitivity at tip of hallux 
using 5 calibrated monofilaments 
(2.83, 3.61, 4.31, 4.56, and 6.65). To 
determine the presence of neglect a 
computerized visual reaction-time task 
was used. 
BBS, Barthel Index, 
Trunk Control Test, Rivermead 
Mobility Index, 
FAC 
The Motricity Index  
Somatosensory threshold affected 
leg. 
 
 
 
 
 
 
Both groups showed a main effect of time on the BBS 
(F [2,50] =56.67, p<0.01). 
An effect of time was also seen for the Barthel Index 
F [2,50] =97.12, p<0.01),  
Rivermead Mobility Index (F [2,50] =76.20, p<0.01),  
Trunk Control Test (F [2,50] =11.83, p<0.01),  
FAC score (F [2,50] =76.48, 
p<0.01),  
Motricity Index (F [2,50] =26.85, p<0.01) 
Somatosensory 
threshold (F [2,50] =3.92, p<0.05). Improvements 
most pronounced during the intervention period, but 
patients continued to improve during the follow-up 
period. There were no group time interactions, 
indicating similar recovery profiles for both treatment 
groups 
BBS:  
0.996 (0.03), 
in favour of 
control group.  
Exercise therapy on music (ETM) -4 
sessions 45s stimulation 5x/wk, 6wks. 
In standing position as during WBV + 
same physical therapy, OT, SALT and 
psychologic treatment  
1.04 (0.03), in 
favour of 
control group. 
Yan and 
Hui-Chan 
(2009) 
Single 
blind 
stratified 
RCT 
Standard rehab (OT & PT) each lasting 
for 60 min + TES applied with 0.2 ms 
pulses, at 100 Hz in the constant mode 
within the subject’s tolerance level, via 
(5 x 3.5 cm) electrodes over 
acupuncture points on affected lower 
extremity: St 36, Lv 3, GB 34, Bl 60. 
Treatment lasted 60 min per session, 5 
days/ week for 3 weeks 
Composite Spasticity Scale (CSS) - 
for assessing spasticity of affected 
ankle plantar flexors. 
Maximum isometric voluntary 
contraction (MIVC) of ankle 
dorsiflexor and plantarflexor muscles, 
recorded by torque and surface EMG, 
in supine. 
 
Composite spasticity scale  
TES group showed less ↑ in muscle tone than other 2 
groups over time. Sig diff in % participants with normal 
resistance between TES and control groups from week 
1 onwards (Chi square test, p=0.001–0.013), and 
between TES and PS groups at week 3 (p=0.016). No 
sig diffs found between PS and control groups  
Max Isometric Voluntary Contraction (MIVC)  
Sig. ↑ (p<.05) in magnitude and % ↑ in ankle 
TUG: TES 
2.43 (1.65) $ 
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Standard rehab + placebo stim 
Same electrodes, locations and 
device, but circuit disconnected. 
Subjects told that they might or might 
not feel the simulation. 60 min per 
session, 5 days a week for 3 weeks 
 
TUG test – to assess functional 
mobility when a subject could walk 7–8 
m without personal assistance 
dorsiflexion torque and ↓ in EMG co-contraction ratio in 
TES group compared to control group, from week 2 
and 3. By week 8 post-stroke (5 weeks after TES 
stopped), magnitude and % ↑ in MIVC dorsiflexion 
torque in the TES group was sig. > those of the PS 
group (p<.05). Also, significantly greater ↓ in EMG co-
contraction ratio during d/flexion (p<.01, at wk 8).  
No sig diff among 3 groups using the Chi square test. 
0.93 (0.93) in 
favour of 
placebo 
stimulation 
group 
+exercise vs 
control 
Standard rehab (OT & PT) each 
lasting for 60 min 
0.58 
 
Abbreviations: 10MWT 10 metre walk test, BBS Berg balance Scale, CSS Composite Spasticity Scale, D/flexion dorsiflexion, EMG Electromyography, FAC 
Functional Ambulation Classification, HHD Hand held dynamometer COP Centre of pressure, MAS Modified Ashworth Scale, Mths Months,  MVL Movement 
velocity,P/flexion Plantar flexion, OM Outcome measure, PSL Postural sway length RMI Rivermead Mobility Index, ROM Range of movement, s second,  
SFS Sensorimotor foot stimulation, SD Standard deviation, Sig diff Significant difference, STS Sit to stand TOT Task orientated training, TENS/TES 
Transcutaneous electrical nerve stimulation, WBV whole body vibration, Wk week.  $ - in favour of experimental group * = sample size in study <30 
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 Assessment of methodological quality - results 
The results of the quality assessment and risk of bias within the studies are summarized in table 3.4. 
 
Table 3.4 Quality assessment of included studies 
 
 Selection bias Reporting bias Performance bias Detection bias Attrition bias 
 Random 
sequence 
generation1 
Allocation 
concealment2 
Selective reporting3 Other sources 
of bias4 
Blinding 
(participants and 
personnel) 
Blinding (outcome 
assessment) 
Incomplete outcome 
data5 
Bayouk et al. 
(2006) UNCLEAR UNCLEAR UNCLEAR UNCLEAR UNCLEAR UNCLEAR UNCLEAR 
Brogårdh et 
al. (2012) 
LOW LOW LOW LOW LOW LOW LOW 
Cho et al. 
(2013) 
LOW 
 UNCLEAR UNCLEAR UNCLEAR UNCLEAR LOW  UNCLEAR 
Ferreira et 
al. (2018) UNCLEAR UNCLEAR LOW LOW LOW UNCLEAR LOW 
Goliwas et 
al. (2015) UNCLEAR UNCLEAR UNCLEAR UNCLEAR LOW UNCLEAR HIGH 
Guo et al. 
(2015) UNCLEAR UNCLEAR UNCLEAR HIGH LOW UNCLEAR LOW 
Jung et al. 
(2017) HIGH UNCLEAR UNCLEAR LOW UNCLEAR LOW UNCLEAR 
Kluding and 
Santos 
(2008) 
HIGH UNCLEAR  LOW LOW HIGH HIGH UNCLEAR 
Lau et al. 
(2012) LOW LOW LOW LOW UNCLEAR UNCLEAR LOW 
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Lynch et al. 
(2007) LOW HIGH UNCLEAR UNCLEAR LOW LOW LOW 
Ng and Hui-
Chan (2009) LOW LOW LOW LOW LOW UNCLEAR LOW 
Paoloni et al. 
(2010) UNCLEAR LOW UNCLEAR UNCLEAR HIGH LOW LOW 
Park et al. 
(2014) LOW LOW LOW LOW UNCLEAR UNCLEAR UNCLEAR 
Suh et al. 
(2014) LOW LOW UNCLEAR UNCLEAR UNCLEAR UNCLEAR LOW 
Tankishieva 
et al. (2014) LOW LOW UNCLEAR LOW HIGH HIGH UNCLEAR 
Van Nes et 
al. (2006) LOW LOW LOW LOW LOW UNCLEAR LOW 
Yan & Hui-
Chan (2009) LOW UNCLEAR UNCLEAR UNCLEAR HIGH LOW UNCLEAR 
 
 
UNCLEAR – Insufficient information provided in the publication 
1Describe the method used to describe the allocation concealment used to generate the allocation sequence in sufficient detail to allow the assessment of   
  whether it should produce comparable groups 
2 Describe the method used to conceal the allocation concealment in sufficient detail to determine whether intervention allocations could have been foreseen in  
  advance of or during enrolment 
3State how the possibility of selective outcome reporting was examined by the authors and what was found 
4Any important concerns not addressed above; if particular questions/entries were pre-specified in the studies protocol, responses should be provided for each  
  question / entry 
5 Describe the completeness of outcome data for each main outcome including attrition and exclusions from the analysis, stated whether attrition and exclusions  
  were reported, the numbers in each intervention group (compared with total randomized participants); reasons for attrition/exclusions were reported 
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 Sample size and chronicity of stroke 
Sample sizes ranged from 16 (Bayouk et al., 2006) to 109 (Ng and Hui-Chan, 
2009). The mean (SD) ages of the samples ranged from 54.04 (6.41) (Guo et al., 
2015) to 71.17 (13.23) years (Park et al., 2014). The time post-stroke of 
participants in trials ranged from 9.27 (3.52) days (Yan and Hui-Chan, 2009) to 
6.50 (6.41) years (Tankisheva et al., 2014). The chronicity of stroke in the trial 
samples is summarized in Appendix 7. 
 
 Interventions 
Six trials involved sensory electrical stimulation. Five of those involved 
transcutaneous electrical nerve stimulation (TENS) (Cho et al., 2013; Jung et al., 
2017; Ng and Hui-Chan, 2009; Park et al., 2014; Yan and Hui-Chan, 2009); one 
other involved interferential therapy (Suh et al., 2014). Six trials involved vibration, 
either whole body vibration (WBV) (Brogårdh et al., 2012; Guo et al., 2015; Lau et 
al., 2012; Tankisheva et al., 2014; van Nes et al., 2006) or segmental muscle 
vibration (SMV) (Paoloni et al., 2010). The other five trials used non-electrical 
interventions: task-oriented exercise with proprioception of the feet, ankles and/or 
vision manipulated under varying conditions (eyes open/eyes closed) and on 
different surfaces (firm/soft) (Bayouk et al., 2006), wearing postural insoles with a 
sensory effect on the soles of the feet, influencing muscle proprioception (Ferreira 
et al., 2018), sensorimotor foot stimulation (Goliwas et al., 2015), ankle joint 
mobilizations (Kluding and Santos, 2008), and a sensory retraining programme 
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(Lynch et al., 2007). A summary of the interventions and comparisons are 
presented in Appendix 8. 
 
 Outcomes 
Various outcomes were measured across the studies, relating to spasticity, 
balance, gait, motor impairment and functional independence, including analysis of 
sit to stand, falls risk, and sensation. A table listing the range of OMs used across 
the studies is available in Appendix 9.  
 
 Spasticity 
Three scales were used within the studies to measure spasticity: the MAS, which 
was used in six studies (Brogårdh et al., 2012; Cho et al., 2013; Kluding and 
Santos, 2008; Park et al., 2014; Suh et al., 2014; van Nes et al., 2006); the 
Ashworth Scale (Tankisheva et al., 2014); and the Composite Spasticity Scale 
(Jung et al., 2017; Yan and Hui-Chan, 2009). Of note, the Ashworth scale and 
MAS are measures of passive resistance and not spasticity, resistance being 
increased by the visco-elastic properties (stiffness) of the tissues (Pandyan et al., 
1999). Inter-rater reliability of both the Ashworth scale and the MAS has been 
found to be poor when used as a tool for measuring the lower limb (Pandyan et al., 
1999). 
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 Analysis of balance 
Balance or postural control was measured in seven studies (Bayouk et al., 2006; 
Cho et al., 2013; Goliwas et al., 2015; Jung et al., 2017; Lau et al., 2012; Park et 
al., 2014; Tankisheva et al., 2014). Postural sway/displacement of COP was 
measured in six studies using a variety of methods: Matscan (Tekscan) system 
(Bayouk et al., 2006); Zebris forceplate  (Cho et al., 2013; Goliwas et al., 2015); 
Wii balance board (Jung et al., 2017); dynamic posturography platform, SMART 
balance system (Equitest) (Lau et al., 2012; Tankisheva et al., 2014); and the 
Good Balance (Meitur Ltd) device (Park et al., 2014). The BBS, which has been 
shown to be sensitive to change and able to reflect large effect sizes for change 
(English et al., 2006), was used in five studies (Brogårdh et al., 2012; Lau et al., 
2012; Lynch et al., 2007; Suh et al., 2014; van Nes et al., 2006).  
 
 Sit to stand analysis 
Sit to stand was analysed using ankle kinematics, weight bearing difference and 
timed sit to stand (Kluding and Santos, 2008). 
 
 Analysis of gait 
Six studies used the 10MWT (Bayouk et al., 2006; Brogårdh et al., 2012; Guo et 
al., 2015; Lau et al., 2012; Lynch et al., 2007; Suh et al., 2014), and the TUG was 
measured in five (Brogårdh et al., 2012; Ng and Hui-Chan, 2009; Park et al., 2014; 
Suh et al., 2014; Yan and Hui-Chan, 2009). Walking speed was measured using a 
GAITRite mat (Ng and Hui-Chan, 2009), an ELITE stereophotogrammatic system 
92 
 
(Paoloni et al., 2010), and other gait kinematics were measured in three other 
studies (Ferreira et al., 2018; Paoloni et al., 2010; Park et al., 2014). Observation 
of gait was also reported by Guo et al. (2015); however, the subjectivity and 
reliability of this measure needs to be questioned as there is no mention of 
following a strict protocol during observation, or videotaping to aid analysis, which 
increases reliability when observing gait (Ferrarello et al., 2013). Walking ability 
and mobility function was measured using the FAC (Tankisheva et al., 2014; van 
Nes et al., 2006), the level of assistance scale (Lynch et al., 2007), the Rivermead 
Mobility Index (Kluding and Santos, 2008; van Nes et al., 2006), and walking 
endurance was tested using the 6 minute walk test (6minWT) (Brogårdh et al., 
2012; Lau et al., 2012; Ng and Hui-Chan, 2009). Tankisheva et al. (2014) also 
measured endurance using the Borg’s rating of perceived exertion scale.  
 
 Motor impairment and functional independence 
Motor impairment was measured using the MRC scale (Jung et al., 2017), Fugl-
Meyer (lower limb) scale (Guo et al., 2015), isometric muscle strength (Brogårdh et 
al., 2012; Lau et al., 2012; Yan and Hui-Chan, 2009), isokinetic strength (Brogårdh 
et al., 2012; Tankisheva et al., 2014), EMG (Paoloni et al., 2010), the Chedoke-
McMaster Stroke Assessment (Lau et al., 2012), the Motricity Index (van Nes et 
al., 2006) and the Brunnstrom Fugl-Meyer Test (Tankisheva et al., 2014).  
 
Functional independence was measured using the Barthel Index (Tankisheva et 
al., 2014; van Nes et al., 2006), which is a valid tool for measuring activities of 
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daily living and independence (Grau et al., 2015; Mahoney and Barthel, 1965). The 
scoring for the Barthel index indicates how much care someone requires, 
therefore, some may consider it to be a measure of carer burden; however, it was 
originally designed as a measure of function (Mahoney and Barthel, 1965). The 
Barthel index has been reported as having acceptable reliability from various 
studies, ranging from moderate to very good (k=0.41–1.00) (Quinn et al., 2011). 
Participation was measured with the Stroke Impact Scale (Brogårdh et al., 2012). 
The Trunk Control Test was also undertaken by van Nes et al. (2006).  
 
 Sensory threshold and proprioception 
Only one study measured sensation in the foot (Lynch et al., 2007) using SWMs to 
record touch/pressure sensory thresholds, and the Distal Proprioception Test. 
 
 Comparison of interventions 
 Electrical nerve sensory stimulation versus placebo  
All six trials exploring sensory electrical stimulation (Cho et al., 2013; Jung et al., 
2017; Ng and Hui-Chan, 2009; Park et al., 2014; Suh et al., 2014; Yan and Hui-
Chan, 2009) compared the stimulation to a sham or placebo stimulation. Ng and 
Hui-Chan (2009) and Yan and Hui-Chan (2009) also had groups which received no 
treatment at all. All of the studies recruited a sample size of more than 30, with the 
smallest sample size being 34 (Park et al., 2014) and the largest 109 (Ng and Hui-
Chan, 2009). Mean age (SD) ranged from 54.13 (12.25) (Suh et al., 2014) to 71.17 
(13.23) (Park et al., 2014). There was a range between the studies relating to time 
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post-stroke with Yan and Hui-Chan (2009) recruiting participants very early after 
stroke (9.28 (3.52) days), whereas, Ng and Hui-Chan (2009) recruited chronic 
stroke survivors 4.74 (3.4) years post-stroke. The other studies recruited 
participants in the sub-acute (6.55 (2.60) months; (Jung et al., 2017) to chronic 
stage post-stroke (18.62 (2.08) months; (Park et al., 2014). All studies delivered 
sensory stimulation without muscle contraction using a frequency of 100Hz; for all 
the studies using TENS the pulse width was also the same, reported as either 200 
μs (microseconds) or 0.2ms (milliseconds). The length of time of the interventions 
were either 30 minutes (Jung et al., 2017; Park et al., 2014) or 60 minutes (Cho et 
al., 2013; Ng and Hui-Chan, 2009; Suh et al., 2014; Yan and Hui-Chan, 2009). 
Two of the studies only applied the electrical stimulation once (Cho et al., 2013; 
Suh et al., 2014). The other studies all applied the TENS five times a week, for 
three weeks (Yan and Hui-Chan, 2009), four weeks (Ng and Hui-Chan, 2009), or 
six weeks (Jung et al., 2017; Park et al., 2014). The total number of hours of TENS 
(plus exercise, where appropriate) delivered ranged from 1 hour (Cho et al., 2013; 
Suh et al., 2014) to 40 hours (20 TENS and 20 exercise) (Ng and Hui-Chan, 2009). 
Three of the studies applied the stimulation to the gastrocnemius muscle on the 
affected side (Cho et al., 2013; Park et al., 2014; Suh et al., 2014), although Park 
et al. (2014) also applied the stimulation to quadriceps. Jung et al. (2017) placed 
the electrodes over the peroneal nerve on the affected side and both Ng and Hui-
Chan (2009) and Yan and Hui-Chan (2009) attached the electrodes to 
acupuncture points on the lower extremity. All of the studies demonstrated a 
positive effect for the experimental group. Between-group effect at post 
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intervention ranged from a small effect (0.2) of TENS (100Hz, 200 μs, for 30 
minutes, 5 times per week for 6 weeks) on gait velocity in chronic stroke (Park et 
al., 2014), to a very large effect (1.65) of TENS (100Hz, 200 μs , for 30 minutes, 
five times per week for 3 weeks) on timed up and go (TUG) in acute stroke (Yan 
and Hui-Chan, 2009) Interestingly, Suh et al. (2014) (n=42) delivered just a single 
session of electrical stimulation to the gastrocnemius for 60 minutes and 
demonstrated a between-group effect for the 10MWT of 0.39.  
 
 Whole body vibration (WBV) or segmental muscle vibration (SMV) 
versus no vibration 
Of the studies involving vibration (either WBV or SMV), the sample sizes ranged 
from 15 (Tankisheva et al., 2014) to 82 (Lau et al., 2012) and the mean (SD) age 
of the participants ranged from 54.0(6.41) (Guo et al., 2015) to 62.53(7.32) 
(Brogårdh et al., 2012). There was also a large range in the time post-stroke with 
Guo et al. (2015) and van Nes et al. (2006) recruiting participants within the acute 
phase post-stroke (63.15(52.96) days and 36.59(10.18) days respectively), but 
Tankisheva et al. (2014) recruiting participants at 6.52(6.41) years post-stroke.  
 
For the WBV, comparison interventions included sham/placebo vibration, with 
Brogårdh et al. (2012) comparing with a sham vibrating platform (amplitude of just 
0.2mm) and other studies using vibration platforms that were not switched on (Guo 
et al., 2015; Lau et al., 2012). All three of these study controls involved participants 
undertaking the same exercises or standing position as the experimental group. 
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The control group in Tankisheva et al. (2014) were not involved in any additional 
training programme and were asked not to change their lifestyle, whereas, in van 
Nes et al. (2006) the control involved exercise therapy to music.  
 
The training protocols varied between the studies: three involved six weeks of 
WBV, either twice per week (Brogårdh et al., 2012), three times per week 
(Tankisheva et al., 2014), or five times per week (van Nes et al., 2006). The other 
two involved eight weeks of intervention: although Guo et al. (2015) did not state 
how many treatments each week were undertaken, daily treatments were stated, 
so it can presumed this is likely to be five times per week (based on a normal 
‘working’ week);  Lau et al. (2012) delivered treatments three times per week. The 
total intervention times for the studies therefore ranged from 10 hours, but with just 
1.5 hours of WBV in the intervention (van Nes et al., 2006), to 53.33 hours (Guo et 
al., 2015). The amplitudes used within the studies ranged from 0.44–0.60mm (Lau 
et al., 2012) to 4mm (Guo et al., 2015), and the frequencies from 6–10Hz (Guo et 
al., 2015) up to 50Hz (Lau et al., 2012). In summary, a different protocol was used 
for each of the studies investigating WBV.  
 
The effect sizes for these studies ranged from experimental group 0.22, control 
0.002 and between-group difference at post intervention 0.04 for the BBS following 
24 sessions of WBV training (three times per week for eight weeks) at frequency 
20–30Hz and amplitude 0.44–0.60mm, compared to sham WBV training (Lau et 
al., 2012), to experimental group 2.53, control group 1.65 and between-group 
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difference 0.86 following daily WBV training for eight weeks at frequency 6–10Hz 
and amplitude 4.0mm, compared to sham/placebo WBV training (Guo et al., 2015). 
Interestingly, Guo et al. (2015) used the lowest frequency (6–10 Hz) and the 
highest amplitude (4 mm) and demonstrated the greatest effect (0.86) for the 
10MWT. Tankisheva et al. (2014) also demonstrated a medium effect size (0.57) 
for postural control; however, this result needs to be interpreted with caution 
because the control group received no therapeutic input at all and it could just 
have been the standing practice which had an effect. The other three studies 
(Brogårdh et al., 2012; Lau et al., 2012; van Nes et al., 2006) did not demonstrate 
any benefit from the WBV in relation to the BBS (effect sizes 0.09, 0.04 and 0.03 
respectively). It is worth noting that the three studies that did not identify an effect 
following WBV (Brogårdh et al., 2012; Lau et al., 2012; van Nes et al., 2006) were 
of a better quality than the studies that showed an effect. However, the frequency 
and amplitude were different between the studies, which makes comparison 
difficult.  
 
Paoloni et al. (2010) applied SMV three times a week for four weeks to the 
contralesional tibialis anterior and peroneus longus (amplitude 10mm and 
frequency of 120Hz), delivered in trains of six seconds divided by one second 
pauses. The control group just received the same therapy as the experimental 
group and no sham vibration. Effects sizes of 0.51 for the experimental group and 
0.11 for the control group, with a between-group effect size of 0.4 in favour of the 
experimental group, were observed for gait velocity (cm/s). 
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 Specific sensory input to the foot or ankle 
Five studies applied specific sensory input to the foot or ankle via: manipulation of 
proprioception of feet, ankles, or vision, during task orientated training (Bayouk et 
al., 2006); a postural insole which was designed to have a sensory effect on the 
plantar surface of the foot (Ferreira et al., 2018); sensory motor foot stimulation, 
which involved 25 sessions of 20 minutes stretching soft tissues, facilitating 
sensory awareness and selective movement and function (Goliwas et al., 2015); 
ankle joint mobilizations (manual traction and gliding) (Kluding and Santos, 2008); 
or sensory training (discrimination and localization of touch, hardness, texture, 
temperature; graded proprioception training) (Lynch et al., 2007). 
 
The sample sizes for these five studies were all <30, ranging from 16 (Bayouk et 
al., 2006; Kluding and Santos, 2008) to 27 (Goliwas et al., 2015). Mean (SD) ages 
of the participants ranged from 55.8(11.9) (Kluding and Santos, 2008) to 
65.2(5.98) years (Bayouk et al., 2006). There was also a large variability of mean 
(SD) time post-stroke, which ranged from 48.23(29.36) days (Lynch et al., 2007) to 
6.4(10.10) years (Bayouk et al., 2006).  
 
Four studies (Bayouk et al., 2006; Goliwas et al., 2015; Kluding and Santos, 2008; 
Lynch et al., 2007) involved both groups undertaking an exercise programme of 
varying content and duration, with the intervention group receiving additional 
sensory stimulation, and the control groups either receiving just the exercise 
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programme or additional ‘placebo’ therapy. Bayouk et al. (2006 p.53) delivered a 
task orientated exercise programme, one hour per week for eight weeks (total 16 
hours), performed under two different vision conditions (eyes open/eyes closed) 
and on different surfaces (firm/soft) for the intervention group; 30 minutes of the 
session was 'aimed at improving static and dynamic balance by executing 
exercises while the proprioception of the feet and ankles and/or vision was 
manipulated'. The control group undertook the same exercises, but just with the 
eyes open, on a hard surface. In the study by  Lynch et al. (2007), all participants 
in both groups completed the same daily one hour group exercise programme 
(lower limb strength, balance, cardiovascular fitness) plus 30–60 minutes of 
individual therapy, over a 2-week period, amounting to between 12.5 and 20 hours 
in total. The intervention group also received a further 5 hours of additional 
sensory retraining (30 minutes per day, five days per week, over a 2-week period), 
and the control group stood with their eyes closed for the same period of time as 
the intervention group and then rested with eyes closed (in supine) for the rest of 
the 30-minute session, with guided relaxation techniques. The control groups in 
Goliwas et al. (2015) (total intervention 22.5 hours) and Kluding and Santos (2008) 
(total intervention 2.67 hours) just received the exercise programme and no 
additional therapy. In the fifth study, by Ferreira et al. (2018), the intervention 
group wore a postural insole with corrective elements for three months, and the 
control group wore a postural insole with no corrective elements.  
 
In relation to the studies delivering specific sensory input to the foot or ankle, effect 
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sizes were calculated for all except Lynch et al (2007), which did not provide SDs. 
However, the effect sizes should be interpreted with caution in view of the small 
sample sizes. No effect was seen on mean velocity (m/s) for the insoles in the 
study by Ferreira et al. (2018) (experimental group 0.06, control group 0.03 and 
between-group effect size 0.0). Goliwas et al. (2015) did demonstrate an effect on 
difference in weight distribution (%): experimental group 0.68, control group 0.07; 
however, the between-group effect size was only 0.05. Effect sizes for the 10MWT 
were 0.22 (experimental), 0.24 (control) and 0.12 (between-group) for Bayouk et 
al. (2006), and for Kluding and Santos (2008), the between-group effect size was 
0.51 in favour of the control group. However, it should be noted that the studies by 
Bayouk et al. (2006) and Kluding and Santos (2008) only included 16 participants.  
 
 Effectiveness of interventions 
Effect size calculations for selected balance or gait OMs are presented in table 3.5, 
according to intervention. Two of the studies did not present SDs and therefore it 
was not possible to calculate effect sizes (Cho et al., 2013; Lynch et al., 2007). 
Four of the studies reported effect sizes (Kluding and Santos, 2008; Lau et al., 
2012; Paoloni et al., 2010; Tankisheva et al., 2014); however, the methods of 
calculating the effect sizes were either inconsistent or not reported and therefore 
effect sizes for the 15 articles, for which it was possible to report a balance or gait 
effect size, were calculated using the pooled SD for both groups as the 
denominator. The selected OMs for which effect sizes could be calculated included 
gait assessments in the form of the 10MWT (Bayouk et al., 2006; Guo et al., 2015; 
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Suh et al., 2014), gait velocity or speed (Ferreira et al., 2018; Ng and Hui-Chan, 
2009; Paoloni et al., 2010; Park et al., 2014), and the TUG (Yan and Hui-Chan, 
2009). Balance was also evaluated by several studies with OMs including the BBS 
(Brogårdh et al., 2012; Lau et al., 2012; van Nes et al., 2006), postural sway or 
control (Jung et al., 2017; Tankisheva et al., 2014) and differences in weight 
distribution during stance (Goliwas et al., 2015), or on sitting to standing (Kluding 
and Santos, 2008). A total of seven of the 17 studies had sample sizes of ≤ 30 
(indicated by an * in table 3.5), and therefore these effect sizes need to be 
interpreted with caution.  
 
Calculation of effect sizes showed twelve of the studies demonstrating an effect in 
favour of the experimental group, with effect sizes ranging from 0.04 (Lau et al., 
2012) to 1.65 (Yan and Hui-Chan, 2009). However, one study showed no effect 
(Ferreira et al., 2018), and two studies showed an effect in favour of the control 
group at 0.51 for Kluding and Santos (2008) and 0.03 for van Nes et al. (2006). 
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* Indicates the sample size was < 30, $ indicates the effect was in favour of the experimental group 
Intervention Author OM Effect size 
experimental 
group 
 
Effect 
size 
control 
group 
Effect size 
placebo 
stimulation 
group 
Effect 
size 
other 
group 
Between 
group effect 
size (post 
intervention) 
Non-
electrical  
Bayouk et al. 
(2006) * 
10MWT 0.22 0.24   0.12 $ 
Ferreira et al. 
(2018) * 
Mean 
velocity(m/s) 
0.06 0.03   0 
Goliwas et al. 
(2015) * 
 
Diff weight 
distribution 
(standing) 
0.68 0.07   0.05 $ 
Kluding and 
Santos 
(2008) * 
Peak weight 
distribution 
difference STS 
(%) 
0.03 0.91   0.51 (in favour 
of control group) 
Lynch et al. 
(2007) * 
 Results displayed in graphs only, no SDs presented 
Vibration, 
WBV or 
segmental 
Brogardh et 
al. (2012)  
BBS 0.91 0.13   0.09 $ 
Guo et al. 
(2015) 
10MWT 2.53 1.65   0.86 $ 
Lau et al. 
(2012) 
BBS 0.22 0.002   0.04 $ 
Paoloni et al. 
(2010) 
Gait speed 
(m/s) 
0.51 0.11   0.4 $ 
Tankisheva 
et al.   
(2014) * 
Postural 
control: 
equilibrium 
score  
1.56 0.66   0.57 $ 
Van Nes et 
al. (2006) 
BBS 0.996 1.04   0.03 (in favour 
of control group) 
Electrical 
nerve 
stimulation 
Cho et al. 
(2013) 
Postural 
sway No SDs given 
Jung et al. 
(2017) 
Postural 
sway  
0.65 0.27   0.50 $ 
Ng and Hui-
Chan (2009)  
Gait velocity 
(cm/s) 
TENS + Ex 
0.73 
CONTRO
L 
0.08 
PLACEBO + EX 
0.39 
TENS 
0.12 
TENS+Ex= 
0.22 $ 
TENS= 0 
Placebo stim + 
Ex= 0.01 
Park et al. 
(2014) * 
Gait velocity 
(cm/s) 
0.40 0.03   0.2 $ 
Suh et al. 
(2014) 
10MWT 0.44 0.12   0.39 $ 
Yan and Hui-
Chan (2009) 
TUG TES 
2.43 
STANDA
RD 
REHAB 
0.58 
PLACEBO 
TES 
0.93 
 TES=1.65 $ 
Placebo vs 
control=0.93 (in 
favour of placebo 
TES group) 
Table 3.5  Effect size for each group and between-group effect sizes 
according to intervention 
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 Assessment of quality of the included studies 
Of the seventeen studies included, only three (Brogårdh et al., 2012; Ng and Hui-
Chan, 2009; van Nes et al., 2006) were assessed as being of ‘good’ quality, 
according to the Agency for Healthcare Research and Quality standards (Lohr and 
Carey, 1999). Two were deemed to be of ‘fair’ quality (Lau et al., 2012; Lynch et 
al., 2007) and the other twelve studies of ‘poor’ quality (Bayouk et al., 2006; Cho et 
al., 2013; Ferreira et al., 2018; Goliwas et al., 2015; Guo et al., 2015; Jung et al., 
2017; Kluding and Santos, 2008; Paoloni et al., 2010; Park et al., 2014; Suh et al., 
2014; Tankisheva et al., 2014; Yan and Hui-Chan, 2009).  
 
 Summary of key findings 
In terms of electrical stimulation, all the sample sizes were greater than 30 and 
there was consistency in relation to the frequency of the stimulation (100Hz) and 
the pulse width (0.2ms). However, there was great heterogeneity in relation to the 
mean (SD) time post-stroke, which ranged from 9.28(3.52) days to 4.74(3.40) 
years. There was also variability between the experimental protocols in relation to 
the positioning of the electrodes and number of sessions, with total time of the 
interventions ranging from just one hour (Cho et al., 2013; Suh et al., 2014) to 40 
hours (Ng and Hui-Chan, 2009). However, it is important to note that all the studies 
demonstrated an effect size in favour of the experimental group.  
 
In relation to the vibration interventions, there was a range of sample sizes from 15 
(Tankisheva et al., 2014) to 82 (Lau et al., 2012). The protocols delivered varied 
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widely, with Brogårdh et al. (2012) delivering just 12 sessions and van Nes et al. 
(2006) including 30 sessions (although this did not mean greater WBV time); 
amplitudes ranging from 0.44–0.60mm (Lau et al., 2012) to 4mm (Guo et al., 2015) 
and frequencies from 6-10Hz (Guo et al., 2015) up to 50Hz (Lau et al., 2012). A 
range of between-group effect sizes were observed from 0.03, in favour of the 
control group (van Nes et al., 2006) to 0.86 in favour of the experimental group 
(Guo et al., 2015). The heterogeneity of the regimes makes comparison 
challenging. 
 
The five studies that applied specific sensory input to the foot and ankle via 
differing mechanisms all had small sample sizes (<30) and there was a wide range 
of mean (SD) time post-stroke, from 48.23(29.36) days (Lynch et al., 2007) to 6.4 
(10.10) years (Bayouk et al., 2006). None of the studies resulted in more than a 
small between-group effect size in favour of the intervention group, with 0.12 being 
the largest (Bayouk et al., 2006); one study found a medium sized between-group 
effect size (0.51) in favour of the control group (Kluding and Santos, 2008). In view 
of the heterogeneity of the treatment interventions, small sample sizes and range 
of group characteristics, the effect sizes for these studies should be interpreted 
with caution.  
 
 Discussion 
The inferences of these findings from Study 1, along with strengths and limitations 
of the systematic review will be discussed in detail in chapter seven. It is perhaps 
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useful to highlight some of the differing results from this current systematic review 
in relation to the recently published systematic review undertaken by Serrada et al. 
(2019). The current review adopted a more focussed search strategy around 
sensory stimulation to the lower extremity with OMs relating to balance and gait 
and included only randomized controlled trials. Consequently, the search identified 
fewer citations for initial screening: 433 as opposed to 14,446 in Serrada et al., 
2019. The current review included studies of interventions that involved specifically 
sensory stimulation, and so any intervention that also clearly included active 
movement was excluded. In contrast, Serrada et al. (2019) included studies of 
thermal stimulation that prompted the participant to actively move away from a 
noxious heat source (Chen et al., 2011; Hsu et al., 2013; Liang et al., 2012); 
similarly, a study involving electrical stimulation applied to stimulate muscle 
contraction (Yavuzer et al (2007), included in Serrada et al (2019, was excluded 
from this current study, as only electrical stimulation with a purely sensory effect 
was included. Further, Serrada et al. excluded whole body vibration as a sensory 
stimulation; yet, in the current review it was included because this stimulation was 
delivered through the plantar surface of the feet and, therefore, considered an 
appropriate sensory stimulation to the lower extremities. One paper which was 
included in both reviews may not at first glance be identifiable as being the same 
paper, because it appears to be by different authors: Jung et al. (2017) was 
incorrectly cited as In and Cho (2017) in Serrada et al. (2019). In addition, Morioka 
and Yagi (2009), included in Serrada et al. (2019), did not meet the inclusion 
criteria for this current review because there was no clear statement that ethical 
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approval had been granted for the study. Tyson et al. (2013b), also included in 
Serrada et al. (2019), was not included in the current review because it was a 
crossover trial and not a true randomized controlled trial. Finally, 26 of the 38 
studies included in the Serrada et al. review related to sensory stimulation of the 
upper limb, and one to the trunk (Thielman, 2010), and not just to the lower limb, 
which was the focus of this current review. Of interest, there were two papers (Lee 
et al., 2013; Ng et al., 2016) in Serrada et al. (2019) which could have fulfilled the 
requirements for the current review but were not identified from the search for the 
current review. The reason for this is unclear. 
 
Of the three studies included in both the Serrada review and the current review, 
there are some slight differences in quality assessment of the studies. Jung et al. 
(2017) stated that participants were randomly assigned using a selection envelope; 
presumably this procedure was undertaken by the researcher and may not be 
considered a rigorous method of randomization; the current review therefore 
assessed the risk of bias to be high, whereas, Serrada et al (2019) assessed this 
to be low risk bias for random sequence generation. Also, there was insufficient 
information relating to blinding of participants and personnel, and attrition; 
therefore, the risk of bias for these sections were assessed as unclear in the 
current review but assessed as low in the Serrada et al review. There was also 
some difference of opinion for the Lynch et al. (2007) study relating to selection 
and reporting bias. This may be accounted for by one of the authors for the 
Serrada et al review also being a co-author of Lynch et al. (2007), with greater 
insight into the procedures implemented within the study. 
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It is also important to highlight some implications for therapy treatment which have 
arisen from undertaking the review. The findings of this systematic review are 
similar to the findings of the systematic review undertaken by Schabrun and Hillier 
(2009), in which some support for passive sensory training was identified. There 
was no strong evidence to support the use of the sensory stimulation interventions 
included in the trials reviewed in this current systematic review, although there was 
some evidence to support using TENS. Evidence for use of electrical stimulation is 
the strongest from this review, and the promising use of electrical stimulation for 
retraining sensation has already been acknowledged in the fifth edition of the 
National Clinical Guideline for Stroke (Rudd et al., 2017).  Nevertheless, a distinct 
lack of empirical studies supporting active sensory training was observed, and the 
interventions identified from both reviews do not accurately reflect all aspects of 
conventional physical therapy practice in preparing and retraining the lower limb 
for balance and gait following stroke; many hands-on somatosensory stimulation 
interventions are notably absent and clearly have not yet been investigated. 
However, clinicians have reported that they use hands-on techniques such as 
MTS, to provide somatosensory/proprioceptive stimulation to the foot (Aries et al., 
2019), and so there is clearly a gap in the research and the literature, indicating 
that it is an area requiring further research. Similarly, evidence from other studies 
of other clinical populations has shown that wearing TIs has been effective in other 
clinical populations but not in stroke, hence the reason for them not having been 
not included in this review.  
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Based on this highlighted gap in the research literature, both MTS (to prime the 
motor system) and wearing of TIs (to augment the somatosensory input) were 
considered to be interventions that were worthy of further investigation. They were 
therefore justified as the chosen interventions to research, in conjunction with 
TSGT, which has an established evidence base, as combined interventions: 
MTS+TSGT and wearing TIs+TSGT. If the wearing of TIs is no less effective than 
MTS as an additional sensory stimulation combined with TSGT (to be evidenced in 
a subsequent randomized controlled trial), this could be recommended for use in 
clinical practice as a cost-saving but effective alternative treatment strategy post-
stroke.  
 
This systematic review has therefore informed the need for Study 2 (intervention 
modelling) and Study 3 the mixed methods, randomized, blinded feasibility study 
exploring somatosensory stimulation of the foot and ankle early post-stroke.   
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4  CHAPTER FOUR: METHODOLOGY 
In Chapter two, the important role of afferent input, particularly proprioception, in 
control of movement was highlighted. Study 1, the systematic review, presented in 
chapter three identified the limited research presently available to support the 
effectiveness of somatosensory stimulation for the lower limb after stroke. Chapter 
four will summarize the research questions arising from the literature review, and 
the methodology of two further studies detailed in the rest of this thesis. The 
specific aims of the research and objectives of the studies that have been 
completed will be stated. Chapters five and six will then report the specific 
methods and findings of these two studies, respectively. The implications of the 
findings of all three studies will be discussed in chapter seven. 
 
 Rationale 
Interventions that deliver intensive proprioceptive stimulation through hands-on 
physiotherapy, to prime the sensorimotor system, have been identified and 
described in previous studies, and given the collective name of Mobilization and 
Tactile Stimulation (MTS) (Hunter et al., 2006). However, the effects of MTS 
applied to the foot and lower leg have not been investigated. Similarly, the wearing 
of TIs has been shown to improve gait in people with multiple sclerosis (Dixon et 
al., 2014), but the effect of these on balance and gait post-stroke has not been 
explored. There is a body of evidence to support the use of TSGT to improve 
walking ability post-stroke. However, it is not known whether combining TSGT with 
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a sensory intervention is more effective than TSGT alone; furthermore, it is not 
known whether combining TSGT with a priming intervention might be more or less 
effective than combining TSGT with an augmenting intervention. Therefore, the 
benefits of priming the sensorimotor system prior to activity, such as TSGT, and 
augmenting the sensorimotor system during activities such as TSGT, warrant 
further exploration. 
 
 Research questions 
An overarching research question evolved: is there a difference in outcomes of 
balance and gait post-stroke when comparing: a) TSGT alone, b) TSGT following a 
priming intervention (MTS), or c) TSGT augmented by wearing a TI? 
 
Two potential null hypotheses need to eventually be addressed: 
1. There is no difference in outcomes of balance and gait when TSGT alone is 
compared with priming the sensorimotor system using MTS prior to TSGT. 
2. There is no difference in outcomes of balance and gait when TSGT alone is 
compared with augmenting the sensorimotor system by wearing TIs prior to 
and during TSGT. 
 
However, before exploring the effectiveness of these combined interventions, more 
information is required relating to an appropriate dose and intensity of the three 
separate treatments: MTS, wearing TIs and TSGT. Consequently, exploratory, 
development research needed to be undertaken.  
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 Evaluating complex therapy interventions 
It has been acknowledged that therapy interventions are complex, often 
multifaceted, with many inter-dependent aspects (Walker et al., 2017) and applying 
the evidence to stroke rehabilitation is challenging (Langhorne et al., 2011). The 
MRC has recognized the difficulties relating to research and produced a framework 
for developing and evaluating complex interventions (Craig et al., 2006). This 
framework highlights the importance of taking time to develop and standardize 
complex interventions, making them repeatable, to enable rigorous analysis in 
future larger trials. Four distinct phases have been identified for the development 
and implementation phases of research; feasibility/piloting, evaluation, 
implementation and development as shown in figure 4.1 (Craig et al., 2006). 
 
 
Figure 4.1    Key elements of the development and process of evaluating 
complex interventions. Reproduced with permission, (Craig et al., 2006) 
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Careful preliminary work is essential when researching complex interventions, and 
a feasibility or pilot study is advocated as an important step prior to proceeding to 
larger RCTs (Tickle-Degnen, 2013). Input at an early stage of research 
development should involve identification of the current evidence base and 
theories (Craig et al., 2006), as well as considering the opinions of clinicians to 
increase the external validity of the investigation (Samuel and Bucher, 2017), and 
input from patient and public involvement and engagement (PPIE) volunteers to 
ensure quality, relevance and importance of the research (Haywood et al., 2017).  
The intervention modelling study was undertaken following initial consultation at an 
early stage with clinicians and patient and public involvement advisors; time was 
dedicated to researching the evidence base, identifying and developing theory and 
integrating this information into the process of developing the interventions, as 
suggested in the development section of the MRC guidance (Figure 4.1). 
Consensus-based core recommendations have been developed from the SRRR to 
help improve the development, monitoring and reporting of research relating to 
stroke rehabilitation (Walker et al., 2017), and many of the suggested practices 
were followed in both the intervention modelling study and the feasibility study 
which were undertaken.  
 
The development of standardized therapy protocols and subsequent evaluation of 
the effectiveness of the intervention are both important stages in the MRC 
framework; all therapy treatments involve many different components that interact 
and they can, therefore, be categorized as complex interventions (Craig et al., 
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2006). Therapy interventions include talking to the patient as well as hands-on and 
independent techniques, and treatments could be influenced by the motivation and 
enthusiasm of the therapist and the patient; personalised treatment plans are 
common and communication and environmental issues are key (Tickle-Degnen, 
2013). Indeed, the holistic nature of therapy interventions is referred to as a ‘black 
box’ of approaches and strategies, and a need for treatment to be individualised is 
acknowledged to meet the specific requirements of each stroke survivor, with a 
suggestion that rehabilitation is not a homogenous activity and can be influenced 
by multiple features (Ballinger et al., 1999). For this reason, it was important that 
the protocols within the MoTaStim-Foot trial enabled individualised treatment to 
also be delivered. When referring to the MRC guidelines, it was appropriate to 
undertake a feasibility study after the modelling study. This would allow for testing 
of the developed protocols, assessment of recruitment and attrition and collection 
of information to enable a sample size calculation.  
 
Co-design has been defined as ‘a collaboration between healthcare professionals 
and patients to develop clinical and educational interventions’ (Green, 2018, p.50). 
It is a process which enables insight from the lived experience of a condition to be 
considered equally, along with professional expertise, empowering people to 
contribute to important issues (for example when developing rehabilitation 
interventions) that may directly affect them (Burkett, 2017). The importance of 
stakeholder involvement to enhance success when developing interventions is 
being increasingly recognized (Andersson, 2017). Healthcare professionals may 
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be considered the experts, with an ability to validate instruments and treatments; 
however, the importance of a patient who has experience of a particular condition 
is paramount, and was highly valued in relation to this study, because it has been 
described as being able to offer ‘the ultimate expert opinion’ (Hobart et al., 2004, 
p.9). 
 
The feasibility and pilot stage of the MRC framework involves testing the 
acceptability of procedures, estimating probable recruitment and retention rates, 
and collecting data that can be used to calculate an appropriate sample size for a 
larger clinical trial (Craig et al., 2006). This study was undertaken early in the 
research process, and therefore a feasibility study was more appropriate than 
attempting to undertake a pilot study; OMs needed to be explored and a primary 
OM selected prior to a formal pilot which involves exact replication in a small form 
of the planned future study  (NIHR, 2017). The National Institute for Health 
Research (NIHR) (2017, p.2) suggests the important question to be considered is 
‘Can this study be done?’ and advises that feasibility studies should not involve 
evaluation of the effectiveness of the treatment intervention. As well as whether it 
is possible to undertake the trial, consideration needs to be given to whether the 
work should be taken forwards to a large trial (Horne et al., 2018). 
 
A mixed-methods approach has been advocated, involving the collection of both 
qualitative and quantitative data to enhance knowledge relating to the suitability of 
the interventions and to explore any barriers to participation (Craig et al., 2006). In 
order to answer research questions, a methodological eclecticism approach can be 
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adopted using mixed methods, enabling the researcher to be a ‘connoisseur of 
methods’, selecting appropriate qualitative or quantitative approaches from the 
‘toolbox’ (Teddlie and Tashakkori, 2012 p.777). Whilst there are a number of 
conceptual frameworks for research, quantitative methods sit under the umbrella of 
the positivist paradigm, whereas qualitative methods are encompassed within the 
constructivist (Tashakkori and Teddlie, 1998) and interpretivist paradigms which 
aid understanding of the social world (Chowdhury, 2014). Whilst ‘paradigm wars’ 
have existed over the years (Tashakkori and Teddlie, 1998), the compatibility of 
qualitative and quantitative methods has been advocated within the social and 
behavioural sciences; consequently, a different paradigm was suggested, named 
by some as pragmatism, with mixed methodologies emerging that combine both 
quantitative and qualitative approaches (Tashakkori and Teddlie, 1998).  
 
Once feasibility has been established, evaluation of the complex intervention 
should take place in a larger trial. Even if the decision is made that the work should 
not be taken forwards it is still important to disseminate the findings to inform other 
research and potentially save any waste of valuable resources (Thabane et al., 
2010). Dissemination of information, ideally at protocol stage, and when the results 
are available, is important, along with monitoring of the success of implementation 
of the techniques into clinical practice (Craig et al., 2006). When reporting the 
information from studies it is essential to include sufficient detail for replication of 
the work (Ioannidis et al., 2014), enabling synthesis of the information and 
facilitating implementation of the intervention (Craig et al., 2006).  This whole 
process, from trial to implementation of findings into practice, has been suggested 
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as taking up to seventeen years (Grant et al., 2000) - known as the knowledge to 
practice gap - fostering a predominance of relying on clinical experience rather 
than evidence reported in the literature to support practice (Manns et al., 2015).  
 
 Implementation of evidence into clinical practice 
Although global stroke evidence has been collated and disseminated through 
guidelines, this by itself is still insufficient to change clinical practice (Walker et al., 
(2013). Indeed, a cross-sectional, self-administered online survey of 172 
occupational therapist and physiotherapist clinicians in Australia found that 
selection of treatment choices was mainly (‘often’ or ‘all the time’) based upon 
previous experience with similar conditions and presentations in the past (78%), or 
from colleagues (74%), whereas, only 42% of clinicians regularly used research 
literature for the basis of informing their clinical decision-making (Pumpa et al., 
(2015).  
 
The challenges of implementation of research findings has been highlighted on 
many occasions; discussion often relates to bridging the evidence-to-clinical 
practice gap. As implied by the term ‘bridge’ this gap is a two-way phenomenon 
(Negrini et al., 2016). Not only does consideration need to be given to the fact that 
evidence needs to be implemented, but also to the issue that evidence for clinical 
practice may just not exist, even though the techniques appear to be effective to 
the clinicians involved i.e. no evidence of effectiveness is not evidence of 
ineffectiveness. This would account for the findings of Pumpa et al. (2015). The 
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relatively newly formed Cochrane rehabilitation group has acknowledged this issue 
and aims not only to apply evidence developed via Cochrane to rehabilitation, but 
also to identify the needs and specific aspects of rehabilitation that need to be 
researched to inform the clinical rehabilitation in the future (Negrini et al., 2018).  
 
 Research aims and objectives: 
Hence, it was not appropriate to consider a large, powered RCT to investigate the 
effectiveness of the interventions of MTS and TI combined with TSGT until the 
development and feasibility stages had been completed. The decision was 
therefore made to undertake a feasibility study: the MoTaStim-Foot trial, the 
acronym arising from Mobilization and Tactile Stimulation to the Foot (post-
stroke).  
  
 Research aims: 
The first research aim of this thesis was: 
1. To explore the evidence around somatosensory stimulation of the foot and 
lower leg to improve function after stroke. This was undertaken as Study 1 of 
this thesis, and the results have been presented in chapter three.  
 
Study 1 led to the development of the null hypotheses presented in section 4.2; 
further aims were identified: 
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2. To develop standardized intervention protocols for sensory stimulation 
interventions for the lower limb (MTS, wearing TIs) and for TSGT, through co-
design with expert clinicians, informed by the literature, which will be delivered 
in a trial. 
3. To investigate the feasibility of delivering an RCT of sensory stimulation (MTS, 
TIs) combined with TSGT to improve balance and mobility following stroke. 
4. To explore acceptability of the interventions and OMs to participants.  
 
 Research objectives: 
Study 1: Systematic review of the literature (aim 1) 
Objective 1.1: to systematically review the published literature investigating 
effectiveness of somatosensory stimulation applied to the lower leg and foot to 
improve balance and mobility after stroke. 
 
Study 2: Intervention protocol development and co-design (aim 2) 
Objective 2.1: in conjunction with expert clinicians and informed by the literature, 
develop and gain consensus on standardized treatment protocols for delivering: 
 a) MTS for the lower limb, b) wearing TIs, and c) TSGT to stroke survivors. 
 
Clinical trials often provide insufficient information for clinicians to understand the 
full details regarding the interventions explored and therefore translation into 
clinical practice is inhibited (Duff et al., 2010); in particular, details relating to 
duration and dose of treatment are often omitted (Glasziou et al., 2008). It was 
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important to ensure that the three protocols developed for this research were 
replicable. Details of how these protocols were developed is presented in chapter 
five.  A detailed trial protocol is important so the rationale behind decisions and the 
methods are explicit; it describes how aspects of a trial should be carried out from 
the inception of the trial, through to the final reporting of the trial (Tetzlaff et al., 
2012). Trial interventions need to be valid (supported by research), described in 
sufficient detail to enable replication (Schroter et al., 2012), and acceptable to 
patients in terms of the setting and specific treatment, as well as to clinicians who 
will administer the interventions (Sekhon et al., 2017). Development of clear, 
standardized protocols is imperative, enabling clinicians to interpret and consider 
them for clinical practice (Schroter et al., 2012); correct interpretation and 
replication of the findings of the research will aid translation into clinical practice 
where indicated, and permit other researchers to conduct further research relating 
to the specific intervention (Hoffmann et al., 2014) . The Consolidated Standards of 
Reporting Trials (CONSORT)  2010 Statement (Schulz et al., 2011) was consulted 
when developing the interventions for the MoTaStim-Foot feasibility study. This 
document highlights the importance of describing interventions in sufficient detail 
to enable them to be repeated. Further guidance is also offered within the 
CONSORT extension statement, the SPIRIT (Standard Protocol Items: 
Recommendations for Interventional Trials) guideline (Chan et al., 2013) 
suggesting content for trial protocols. This includes the development of rigorous 
treatment intervention protocols and treatment schedules for documenting the 
elements of the intervention undertaken. Although the development of a protocol 
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involves consideration of every individual aspect – for example, why, what, how, 
delivered by who and with what modifications etc. (TIDieR checklist, Hoffmann et 
al., 2014) – it is important to have a clear way of reporting exactly what has been 
undertaken in the intervention/treatment, and the development of a schedule 
facilitates this process.  A schedule enables the recording of details relating to a 
treatment delivered and can be used to document completed therapy interventions  
(Jarvis et al., 2014). Development of treatment schedules is important to enable 
clinicians to be aware of the specific elements that have been evaluated (Hunter et 
al., 2006). Therefore, development of treatment schedules for MTS (lower limb), 
and TSGT was undertaken in this study, with the intention that the schedules 
would be used to standardize delivery of the interventions in a subsequent 
feasibility study (Study 2). A treatment schedule for TIs was not required as there 
was a simple wearing protocol which was followed (chapter five, section 5.3.4, 
table 5.3).  
 
Study 3: Mixed-methods feasibility study (aims 3 and 4) 
Objective 3.1: To determine feasibility of delivering a trial comparing MTS+TSGT 
with TIs+TSGT.  
A 3rd group, exploring TSGT alone, was considered; however, this was not 
deemed necessary for this feasibility study. Evidence already exists that TSGT is 
effective and has already been delivered in previous trials (Blennerhassett and 
Dite, 2004; Dean et al., 2000; Monger et al., 2002; Salbach et al., 2004; Scianni et 
al., 2010). It was not the purpose of the feasibility trial to compare effects of 
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MTS+TSGT or TIs+TSGT with TSGT alone. Effectiveness will be explored in a 
larger trial in the future. Objective 3.1 was achieved through a number of more 
specific objectives: 
3a Find out if recruitment methods were effective, by analysing the recruitment 
rate and associated data including number of people invited to participate, the 
number and proportion of those agreeing to consent to participate, and those 
eligible to participate. 
 
3b Monitor and analyse the number of people who drop out of the trial (attrition 
rate).  
 
3c Gain pertinent information to inform an appropriate and feasible sample size for 
a future study.  
3d Explore participants’ experiences of interventions and their views on the 
acceptability of the treatments and method of delivery as interventions for a 
future study. 
 
3e  Investigate whether daily diaries and focus groups (FGs) are suitable ways to 
capture and explore stroke survivors’ experiences of the interventions. 
 
3f Investigate feasibility (cost and acceptability to participants) of a battery of OMs 
for sensorimotor impairment and lower limb function and balance, to inform the 
choice of primary and secondary OMs for a future trial. 
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3g  Explore responses to the interventions (MTS plus TSGT or TIs plus TSGT) 
over time and in relation to the number of treatment sessions delivered; this will 
help to determine the most appropriate duration of therapy in a future trial. 
 
3h Generate information regarding the participants recruited i.e. participant 
demographics, clinical characteristics, including time since stroke, type of 
stroke and previous impairment affecting the ability to walk to ensure baseline 
characteristics of the two groups are comparable and to inform future studies. 
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Criteria for assessing feasibility: 
• 3a - Recruit 34 participants within a period of 18 months, achieving a 
recruitment rate of >5%. 
• 3b - Attrition rate <15%. 
• 3c - Gain relevant data (e.g. standard deviation) to enable a sample size 
calculation to be undertaken prior to a future trial.  
• 3d - Deliver the interventions to the participant safely (monitored by pain, 
fatigue and adverse events), in various venues (hospital/home) according to 
protocol (fidelity and adherence to dose). 
• 3e - Focus groups (>n=17, 50% of total number of participants) are 
achievable to explore stroke survivors’ experiences of the interventions and 
OMs 
• 3f - OMs completed for all participants. 
 
Criteria for assessing acceptability: 
• 3d - Participants inform (from daily diaries or FGs) that the treatments 
(MTS, TIs and TSGT) and method of delivery as interventions are 
comfortable and acceptable.  
• 3d - Venue (for example the home or hospital environment) for undertaking 
interventions and OMs is appropriate and acceptable to the participants. 
• 3f -OMs are acceptable for participants to undertake. 
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 Methodology for Studies 2 and 3 
 
 Study 2: Intervention modelling 
Study 2 was an intervention modelling study in which standardized procedures for 
all three interventions (MTS, wearing TIs and TSGT) were developed. An 
intervention development study involves a rigorous, repeatable process at an early 
stage of research, between the original inception of an intervention and the point in 
time when it is ready for piloting, or formal feasibility or efficacy testing (Hoddinott, 
2015). Decision-making processes should be transparent, and detailed information 
about the intervention, including training needs, should be developed (Hoddinott, 
2015).   
 
Study 2 addressed research aim 2 and involved a consensus methodology, 
utilising a modified Nominal Group Technique (mNGT) (Potter et al., 2004), for 
development and agreement of the treatment protocols. Consensus methodology 
involves seeking opinions of several neurological expert clinicians, with the aim of 
addressing specific problems, developing new concepts and deciding priorities 
(McMillan et al., 2016), and has been used in previous studies to identify 
interventions used in clinical practice (Taflampas et al., 2018). 
 
NGT was first described and developed by Andre Delbecq and Andrew Van de 
Ven as far back as 1968 (Delbecq et al., 1975). The traditional format of NGT has 
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been developed from social-psychological research and is a group process 
involving a very structured meeting format with pre-arranged steps enabling 
thought processes, discussion, and due consideration to the problems and issues, 
with the facilitator also contributing to the process (Delbecq et al., 1975). It has 
been suggested that a mixture of both quantitative and qualitative methods is 
utilized within the NGT (Potter et al., 2004). An NGT allowed the use of an 
interacting group situation, enabling unstructured discussions, with members 
interdependent upon one another (Richards and Cuffe, 1972). One of the 
disadvantages of an interacting group could be that a few key dominant characters 
within the group do not enable others to express their independent thoughts, and 
this can restrict the generation of ideas, often resulting in the discussion of just one 
or two aspects (Delbecq et al., 1975); careful moderation is required.  
 
The structure of an NGT meeting enables detailed consideration of each idea, and 
increases the opportunity for individual participation, ensuring everyone’s ideas are 
taken forwards for discussion; this results in people feeling that they have 
contributed and makes them feel valued (Delbecq et al., 1975). The Delphi 
technique, which is also a consensus method was considered and it would also 
have offered the opportunity of generating new independent ideas; however, the 
Delphi technique requires a long period of time to complete, often as much as 
several weeks or even months (Delbecq et al., 1975; McMillan et al., 2016), due to 
the necessity for several rounds of assimilating opinions from the experts (Sim and 
Wright, 2000), and was deemed to not be feasible. The busy nature of the 
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clinicians’ working lives was considered; although organization of an NGT requires 
a significant amount of time for the researcher to prepare (Delbecq et al., 1975), it 
traditionally involves participants for just a few hours and results are quickly 
evident (McMillan et al., 2016). An NGT has been described as a ‘hybrid’ of the 
Delphi method and the FG (Sim and Wright, 2000, p.79), suggested as suitable for 
use in physiotherapy research (Potter et al., 2004). Hence, in view of the many 
advantages of the NGT, this was the method selected for Study 2 of this feasibility 
study.  
 
Five steps have been described for an NGT meeting (based on Potter et al., 2004): 
1. Firstly, the facilitator welcomes the group and gives specific guidance relating 
to the format of the meeting.  
2. After this, the participants sit in silence and consider their own responses to the 
problems or issues that need to be addressed, documenting them for sharing 
later.  
3. Ideas are then collected and recorded on a flip chart. This is achieved via a 
round-robin process, with each participant given the opportunity to share an 
idea prior to moving on to the next person. All participants are therefore 
encouraged to participate equally.  
4. Following clarification of any of the ideas presented, a group discussion takes 
place, with the facilitator ensuring all participants contribute to the discussion 
and comparable time is devoted to each idea, rather than focusing on one 
issue. 
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5. Finally, ideas are prioritized and a vote takes place, (usually not a public vote, 
to ensure independent thoughts are taken forwards, without influence from 
other participants (Sim and Wright, 2000)), resulting in immediate knowledge of 
the results of the study (Delbecq et al., 1975; Potter et al., 2004).  
 
However, modifications were made to the above steps for Study 2 (discussed in 
detail in chapter five, section 5.3), to enable development of three distinct 
protocols, which needed to be achieved with just one face to face mNGT session. 
The NGT has been reported to be flexible (McMillan et al., 2016), and the 
traditional format has previously been adapted by some researchers; for example, 
Allen et al. (2004) included in their study a stage in advance of the NGT meeting, 
which involved sending a postal survey to the participants, collecting data that was 
used to inform the NGT meeting itself.  
 
One of the modifications to the NGT in Study 2 involved undertaking scoping 
reviews relating to wearing TIs and TSGT in advance of the NGT meeting; the 
purpose was to enable an informed discussion of a summary of the information 
related to these interventions at the NGT meeting, facilitating development of 
protocols for these interventions at the mNGT meeting. Scoping reviews are a 
comparatively new method of reviewing the literature (Pham et al., 2014), allowing 
assessment of the evidence evolving in a subject area (Peterson et al., 2017). 
Research of various designs can be included, across wide-ranging topic areas, 
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with potentially a rigorous and transparent method; however, they do not formally 
assess the quality of the literature (Arksey and O'Malley, 2005).   
 
The five steps were followed at the mNGT meeting, with a slight adaptation to step 
two. Part of step two (participants considering their own opinions) had been 
undertaken in advance of the meeting; and participants came to the meeting with 
ideas for discussion relating to the MTS protocol, in view of the work that had been 
conducted in advance of the meeting. The process will be discussed in detail in 
chapter five. 
 
 Study 3: Mixed-methods single-blind randomized feasibility study 
In order to address research aims 3 and 4, and specific objectives 3a to 3h (see 
section 4.4.2.3), Study 3 involved delivering the interventions, modelled and 
agreed in Study 2, in a randomized, blinded mixed-method feasibility study 
(MoTaStim-Foot Trial), which included collection and analysis of both quantitative 
and qualitative data, as recommended by the MRC guidance (Craig et al., 2006).  
 
It is widely acknowledged that an RCT methodology can reduce potential bias 
within a study (Boutron et al., 2007) and, although difficult to accomplish within 
research, blinding is a key element required to reduce this bias (Houweling et al., 
2014). Randomization is also important, ensuring an equal chance of group 
allocation and comparability of the groups (Sim and Wright, 2000). Even though 
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the RCT is recognized as the ‘gold-standard’ methodology for undertaking 
research (Backmann, 2017), adoption of a mixed-methods design within an RCT 
offers advantages.  
 
Exploratory research involving qualitative data offers a holistic insight (French et 
al., 2001), and can allow a detailed understanding of a person’s experience, within 
the context of their particular situation; experimental research involves the 
collection of numerical or quantitative data (Hicks, 2010). Implementation of mixed-
methods research permits the collection of both these data types in a single study 
(Sockolow et al., 2016), enabling different aspects relating to the research question 
to be explored, making the study more complete (O'Cathain et al., 2007). It has 
been suggested that a pragmatic researcher who is willing to use both quantitative 
and qualitative techniques has an advantage, with the flexibility to address different 
types of research questions (Onwuegbuzie and Leech, 2005). Combining both 
methods in a single investigation enables different research strategies to address 
the research question, for example, allowing the participant’s voice to be heard, 
(which was an essential element of this feasibility study), as well as producing 
quantitative data, with the different methods complementing each other and 
potentially providing a more complete outcome from the research (Hicks, 2010), by 
triangulation of the findings (O'Cathain et al., 2010).  
 
One important purpose of a feasibility study is to monitor and appraise recruitment 
strategies (Hubbard et al., 2015; O'Cathain et al., 2015) to inform any planned 
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large RCT (objective 3a of this work). Evaluation of recruitment numbers and 
strategies, along with potential eligibility and screening to recruitment ratios is 
important to inform future trials, for example, how many sites will need to be 
included, how long the trial may take, and whether the inclusion criteria are 
suitable (El-Kotob and Giangregorio, 2018). Another essential role of the feasibility 
study is to explore the feasibility and acceptability of the interventions (O'Cathain et 
al., 2015) and OMs (objectives 3d and 3f). Acceptability involves many different 
aspects including: an ability to understand the intervention; perceived ability to 
participate (self-efficacy); effectiveness, as well as consideration of own 
perceptions of the intervention (‘affective attitude’); burden, including necessary 
compromises to enable participation; and ‘ethicality’ (whether the intervention fits 
into the participant’s value system) (Sekhon et al., 2017, p.8). 
 
Assessment of acceptability was operationalized within the MoTaStim-Foot 
feasibility study by several mechanisms. The ability to understand the intervention 
would be assessed by independent observation of all research therapists and post 
hoc analysis of aspects of intervention that were delivered. The ability to 
participate, burden for the participants, and ethicality would be judged by the 
attrition rates and comments in the dairies and focus groups. An insight into 
potential effectiveness would be gained from the analysis of change scores from 
baseline to end of intervention and one month follow up, which would be 
undertaken to enable selection of a primary OM for future trials. Declaration of 
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researcher’s assumption in advance of the study would be undertaken to address 
reflexivity in the study (affective attitude). 
 
As part of the feasibility of delivering the interventions, fidelity of delivery should be 
monitored and explored (El-Kotob and Giangregorio, 2018). One particular 
consideration for this study was whether the participants would be willing to wear 
the TIs. By undertaking a mixed-methods design, with FGs and daily diaries, it was 
possible to capture participants’ perceptions, identifying the acceptability of 
interventions and OMs delivered, as well as exploring the potential effect size and 
its variance, therefore meeting the aims and objectives of undertaking a feasibility 
study. Study 3 is presented in chapter six.  
 
 Focus Groups (FGs) 
In order to address research aim 4 and research objectives 3d, 3e and 3f, to 
explore the feasibility and acceptability of the interventions and OMs, FGs were 
undertaken (Sim and Snell, 1996; Tong et al., 2007). A FG is a form of group 
interview, ideally with a homogeneous group, which is led by a moderator who 
encourages interactive conversation and seeks opinions from the group, 
generating qualitative data relating to specific topic areas (Sim and Snell, 1996).  A 
sample size of 9–12 is suggested as being ideal for generating a wide range of 
opinions in a group that is controllable (Allen et al., 2004). People who feel self-
conscious or intimidated may be more likely to speak out in a FG situation than in 
an interview, and a variety of forms of communication can be utilized including 
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anecdotal stories, mocking and jokes (Kitzinger, 1995). A FG can provide a large 
quantity of rich data in a short period of time, allowing the researcher to find out 
'what people really think and feel' (Krueger and Casey, 2000, p.7). Offering stroke 
survivors an opportunity to recount their experiences, and analysis of their 
personal accounts, has been suggested as essential to developing evidence-
based practice within stroke rehabilitation (Merlo et al., 2013). The interaction 
between members of the FG is a strength, creating impulsivity, which adds another 
dimension to the data collection process, enabling triggering of ideas in response 
to comments within the group (Sim and Snell, 1996).  
 
The inclusion of an additional member of the research team as observer and field-
note taker during the FG provides additional insights and context behind the 
interactions of participants, providing investigator triangulation, reducing the bias 
associated with a single investigator (Archibald, 2016). In a seminal text, Lincoln 
and Guba (1985) discussed that credibility in qualitative studies can be enhanced 
by using different sources for the same information, introducing triangulation, 
helping to provide a more comprehensive representation of the issues being 
explored. Within the MoTaStim-Foot trial, triangulation of different data collection 
methods and researcher triangulation (Nowell et al., 2017) were used as a means 
of increasing credibility.  
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 Daily diaries 
Daily diaries were also used to address research objectives 3d, 3e and 3f.  Asking 
participants to keep a researcher-driven diary, to inform the researcher of 
particular aspects relating to the interventions delivered and the OMs used (Elliott, 
1997), enables the researcher to gain insights into the participants’ experiences of 
the research (Mackrill, 2008). Use of a diary provides an opportunity to collect 
more precise information relating to the research and helps prevent issues relating 
to recall (Roghmann and Haggerty, 1972). However, there are challenges with the 
use of diaries, for example recall bias (Lyons and Pahwa, 2007; Papapetropoulos, 
2012), poor compliance and diary fatigue (Papapetropoulos, 2012), or duplicate 
entries for the same date, as well as incomplete or illegible entries (Lyons and 
Pahwa, 2007). These are all issues that could threaten or bias the validity of the 
content.  
 
 Patient and Public Involvement and Engagement (PPIE) 
Before designing the MoTaStim-Foot feasibility study, group stakeholder 
consultation was undertaken with both clinicians and PPIE volunteers on two 
occasions. Some early preliminary work occurred to explore the opinions of 
therapist clinicians (Aries et al., 2019), and those of stroke survivors and carers 
attending a local stroke club, as to whether the research being proposed was 
relevant and appropriate. Further insight from both clinicians and PPIE advisors 
was possible because of an NIHR Research Design Service (RDS) PPI grant, 
directly informing the research proposal for the feasibility study.   
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 Summary 
This chapter has summarized the aims and objectives of the work detailed in this 
thesis. Justification has been provided for the chosen methodologies for Study 2, 
an intervention modelling study, which will be presented in chapter five, and also 
the mixed-methods feasibility study (MoTaStim-Foot), Study 3, which is discussed 
in chapter six. 
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5 CHAPTER FIVE: STUDY 2 – INTERVENTION 
MODELLING 
 Purpose  
Study 2 addressed the second aim of the work in this thesis, to develop 
standardized intervention protocols for sensory stimulation interventions for the 
lower limb that will be delivered in a trial. In line with the complex intervention 
development guidelines, the process of intervention modelling was a ‘dynamic 
iterative process, involving stakeholders, and reviewing published research 
evidence, drawing on existing theories’ (O'Cathain et al., 2019 p.1). The objective 
was, through co-design with expert clinicians and informed by the literature, to 
develop and gain consensus on standardized treatment protocols for delivering a) 
MTS for the lower limb, b) wearing TIs, and c) TSGT to stroke survivors.  
 
The TIDieR guidelines (Hoffmann et al., 2014), Consolidated Standards of 
Reporting Trials (CONSORT)  2010 Statement (Schulz et al., 2011), and SPIRIT 
(Standard Protocol Items: Recommendations for Interventional Trials) guideline 
(Chan et al., 2013) were followed or considered when developing the interventions 
for the subsequent MoTaStim-Foot feasibility trial. This was to ensure that rigorous 
treatment intervention protocols and treatment schedules for documenting the 
elements of the intervention undertaken were developed.  
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 Ethics approval 
Research ethics approval for Study 2 was obtained via the Keele University Ethics 
Review Panel (Appendix 10). Participants provided written informed consent and 
were asked to sign a statement in the consent form (Appendix 11) agreeing to 
maintain confidentiality regarding group discussions and participant attendance. 
Anonymity of all participants was maintained using participant numbers or 
pseudonyms when presenting the work and in any subsequent write-up and 
dissemination. A list correlating numbers with specific participants was kept in a 
password protected file accessible to the researcher.  
 
Personal information of participants was only accessible to the researcher and the 
supervisor. Data were stored securely on a password-protected computer or in a 
locked filing cabinet within the School of Health and Rehabilitation, at Keele 
University. All data were collected and stored in accordance with the Data 
Protection Acts, 1998 and 2018 (Legislation.gov.uk, 1998; Legislation.gov.uk, 
2018), and will be stored securely for ten years after the end of study declaration, 
in line with Keele University policy. 
 
 Design 
An mNGT was undertaken - full details of the stages are documented in chapter 
four (section 4.5.1). As discussed in section 4.5.1 the NGT was modified (mNGT)  
in this study in three ways: firstly, by the inclusion of independent clinician activity 
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(by suggesting the changes required for the upper-limb MTS schedule and the first 
iteration of the lower limb MTS schedule) in advance of the mNGT meeting, to limit 
direct face-to-face time with the busy clinicians. Therefore, part of step two 
(participants considering their own opinions) had been undertaken in advance of 
the meeting; and participants came to the meeting with ideas for discussion 
relating to the MTS protocol. The upper-limb MTS schedule was to be adapted for 
a lower-limb MTS intervention and individual opinions of clinicians were important 
to ensure that all potential lower limb interventions were considered during protocol 
development, in readiness for discussion at the collaborative mNGT meeting. 
Details of the protocol development process are described in this chapter.  
 
Secondly, in advance of the mNGT meeting, the researcher undertook scoping 
reviews of published literature relating to wearing TIs and TSGT, to inform the 
discussion in the meeting. The third modification related to the use of some small 
group work during the mNGT to develop the TSGT protocol. It was felt that the use 
of the small group work, within the mNGT meeting, prior to a full group discussion 
would enhance the depth of the discussions. A flowchart summarizing the process 
is available in figure 5.1. 
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Figure 5.1  Stages of the modified Nominal Group Technique 
 
 
 
 
  
 
Prior to 
NGT 
Meeting 
 
 
 
 
 
 
 
 
 
At the  
NGT 
meeting 
 
Upper limb MTS schedule emailed to 
participants for consideration 
Analysis of the results to alter the MTS 
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Step 6: Voting and ranking 
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insoles and task 
specific gait 
training 
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  Participants 
A sample of 12 expert therapists (physiotherapists/occupational therapists) was 
recruited from NHS Trusts in the North Midlands, Staffordshire, and Shropshire 
through local networks: North Staffordshire Special Interest Group for Neurological 
Therapists, and the Keele Regional Hub of the Council for Allied Health 
Professions Research (CAHPR). Members of these groups were sent an email 
with a letter of invitation (Appendix 12), through the Special Interest Group for 
Neurotherapist’s Chairperson and the CAHPR Keele Regional Hub Leader, 
outlining the project with an invitation to participate. Those who responded with a 
request for further information were sent a participant information sheet (PIS) 
(Appendix 13) and invited to ask questions of the researcher. The first twelve 
participants meeting the inclusion criteria and providing written informed consent 
(Appendix 11), either via email or in person prior to the commencement of the 
study, were recruited. 
 
Inclusion Criteria             
• Physiotherapists or occupational therapists working in the NHS at Band 6 or 
above 
• At least two years of experience working in stroke rehabilitation 
• Participants reported they had experience of hands-on sensory stimulation of the 
foot and ankle post-stroke, delivering MTS within conventional therapy 
• Agreement to take part in all stages of the study 
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Exclusion Criteria             
• Specialists in paediatric neurological therapy and, therefore, insufficient 
experience in applying sensory stimulation to the foot and ankle post-stroke in 
the adult population (≥ 18 years) 
 
 Systematic literature searches - scoping reviews 
In preparation for the mNGT session, scoping reviews of the literature were 
undertaken relating to: 
1) the use of textured surfaces as a rehabilitation intervention to improve gait 
and balance in standing   
2) TSGT after stroke 
The purposes of the scoping reviews were to: 1) provide an overview of the range 
of types and wearing protocols for TIs reported in the literature to enhance sensory 
input through the plantar surface of the foot; and 2) to provide a comprehensive 
summary of the content and dose of TSGT reported in published studies of TSGT 
for stroke, noting individual exercises and suggested ways for progression. It was 
not the purpose of the scoping review to provide a theoretical background relating 
to TIs; augmentation of sensation is discussed in the rehabilitation strategies 
section (section 2.8). 
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No scoping review was indicated for the MTS because there is already a 
theoretical backgound exisiting for sensory facilitation techniques (Hummelsheim 
et al., 1995) and the decision was made that it was appropriate to adapt the 
previously developed upper limb MTS protocol for the lower limb. 
 
The databases searched were: Ageline, AMED, CINAHLplus with full text, Medline, 
PsycARTICLES, PsycINFO and SPORTdiscus with full text. For the TI scoping 
search, the databases were searched individually identifying all appropriate studies 
relating to either textured material or TIs. Searches relating to TIs were undertaken 
from inception to 27th September 2015. However, for the TSGT scoping search, 
the databases were searched together, with dates of search from January 1990 to 
August 2015. This was deemed to be appropriate as it would still highlight 
necessary pertinent information related to TSGT and fulfilled the purpose of the 
search. 
 
Relevant studies were identified by reading titles and abstracts and accessing full 
texts where appropriate; reference lists were also checked, and any further 
suitable articles accessed. All types of research methodology were included, to 
ensure pertinent information was not missed. Articles were excluded if they were 
not written in English or were grey literature. Relevant information was extracted to 
inform the mNGT meeting participants and facilitate the development of 
standardized protocols, meeting research objective 2.1. Specific information 
extracted is detailed below in relation to the two different interventions. 
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 Search terms and inclusion criteria for TI search  
In relation to the TIs, specific questions to be addressed by the scoping search 
related to types of material, footwear worn, and duration and timing of wearing the 
TI or standing on the textured material. Therefore, the following search terms and 
strategy were used, summarized in table 5.1: 
• 'Textur*' OR 'textured insoles' OR 'textured surface' 
AND 
• rehab* OR 'physical therapy' OR physiotherapy 
AND 
• Gait OR walk OR stand OR balance 
Table 5.1 Search strategy for scoping review related to TIs 
Search Term 
S1 Textur* 
S2 Textured insoles 
S3 Textured surface 
S4 S1 OR S2 OR S3 
S5  Rehab* 
S6 Physical therapy 
S7 Physiotherapy 
S8 S5 OR S6 OR S7 
S9 Gait 
S10 Walk 
S11 Stand 
S12 Balance 
S13 S9 OR S10 OR S11 OR S12 
S14 S4 AND S8 and S13 
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 Types of participants 
To ensure all information relating to textured materials or TIs was accessed, the 
type of participants included: healthy young and older adults, older adults with self-
reported history of falls, older adults with mild mobility and somatosensory deficits, 
survivors of acute or chronic stroke, adults with multiple sclerosis, adults with type 
II diabetes, or adults with Parkinson’s disease.  
 
 Types of interventions and outcomes 
Articles were included if they related to standing on textured surfaces or wearing 
TIs and referred to outcomes of balance or walking.  
A flowchart representing the TI search is presented in figure 5.2. Summary data 
are presented in table 5.2 and full details, including OMs, results and author’s 
conclusions are available in the table in Appendix 14.   
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32 Articles identified 
7 duplicates 
25 Articles identified after removal 
of duplicates: 
n=12 Medline,  
n=1 Amed,  
n=4 Cinahl plus, 
n=5 Sportdiscus,  
n=3 PsycINFO 
  
n =14 
excluded from 
the title as not 
being relevant  
Abstracts of 11 articles read 
and full text accessed for all 
11 articles 
Reference lists of 
articles checked, and 6 
further articles identified 
  
A total of 17 articles were 
identified from this search 
  
2 further systematic 
reviews previously 
identified 
19 articles  2 further articles 
identified from 
reference lists = 21 
articles  
Relevant information 
presented at the 
Physiotherapy 
Research Society 
conference n=1 
Final total of 22 articles 
for discussion at the 
mNGT meeting 
Figure 5.2 Flowchart of the process for identifying studies related to TIs 
 4.2  Flowchart of process for Identifying studies relating to TIs  
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 Characteristics of the included studies 
A final total of 22 articles were included in the scoping review. Studies were 
included if they involved different textured surfaces under the plantar aspect of the 
foot, as not all studies used textured insoles per se. 
Types of study included: RCTs (Hartmann et al., 2010); experimental designs with 
order of testing randomized (Dixon et al., 2014; Qiu et al., 2012; Qiu et al., 2013), 
and experimental designs (Aruin et al., 2000; Aruin and Kanekar, 2013; Clark et 
al., 2014; Corbin et al., 2007; Hatton et al., 2009; Hatton et al., 2011; Hatton et al., 
2012; Kalron et al., 2015; Kelleher et al., 2010; Nurse et al., 2005; Palluel et al., 
2008b; Palluel et al., 2009; Preszner-Domjan et al., 2012; Silva et al., 2015; Wilson 
et al., 2008).  
 
Two other systematic reviews had been identified in earlier searches related to TIs 
(Christovão et al., 2013; Orth et al., 2013), so these articles were also included 
because they were deemed relevant for inclusion. A search of their reference lists 
identified two of the included studies which have been named above (Hartmann et 
al., 2010; Preszner-Domjan et al., 2012). A presentation given at the 
Physiotherapy Research Society highlighted additional relevant information (Baron 
et al., 2014), which was also included in the summary presented to the 
participants.  
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 Descriptions extracted 
Information extracted included: study objective, sample, study design, type of 
textured material or TI, details of the intervention or testing conditions, OMs, 
results and conclusions. Details of the interventions used in the literature were 
examined and protocols for the wearing of TIs synthesized, noting dose, how long 
the TIs were worn or whether they were only worn for testing (table 5.2). Whilst 
reviewing the literature relating to TIs information regarding the type of exercises 
undertaken in TSGT and how these were progressed was also extracted (tables 
5.5 and 5.6). 
 
 Wearing time of the TIs 
In nine experimental studies, participants simply stood on the textured material or 
wore the TIs during testing (Aruin et al., 2000; Aruin and Kanekar, 2013; Clark et 
al., 2014; Corbin et al., 2007; Hatton et al., 2009; Hatton et al., 2011; Hatton et al., 
2012; Kelleher et al., 2010; Nurse et al., 2005). Four studies encouraged 
participants to wear TIs as much as possible while undertaking their usual 
functional activities (Baron et al., 2014; Dixon et al., 2014; Hartmann et al., 2010; 
Kalron et al., 2015).  
 
Participants in Dixon et al., (2014) wore TIs for a mean of 11 (out of 14) days (SD 
4, range 3–14); of the 14 participants in Hartmann et al., (2010), four wore insoles 
all day, four wore them for half a day, four for two hours per day, and two for less 
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than one hour per day. In contrast, participants in Kalron et al., (2015) reportedly 
wore TIs constantly throughout the day for four weeks.  
 
 Texture types 
Different types of texture and insoles were used and these, along with the trial 
descriptions and sample sizes are presented in table 5.2. It should also be noted 
that Aruin et al (2000) and Aruin and Kanekar (2013) applied a shoe lift or a TI to 
the ipsilesional side, respectively, causing discomfort with the purpose of 
compelling weight shift through the contralesional side. The motive behind the use 
of these strategies is therefore different from the current MoTaStim-Foot feasibility 
study.  
 
 Synthesis of descriptions 
Information gained from the scoping review of TIs was synthesized, summarized 
and presented to the participants, providing 22 pieces of research for discussion. 
The focus of the information presented included details of interventions, specifically 
types of textured material used, or TIs worn, and the protocols for wearing the TIs 
(table 5.2). 
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Table 5.2 Summary of the types of study, sample sizes and types of texture explored in the studies 
Author and 
date 
Sample Study design Textured material or insole 
Aruin et al. 
(2000)  
n=8, acute and chronic stroke 
n=5 subjects wore Ankle Foot 
Orthosis (AFO) (not during 
testing) 
n=1 6/52 therapy programme 
(Pre-) experimental single group, pre- 
and post-intervention 
No blinding 
No random allocation 
Lift put in shoe on the non-paretic side. 
Regular shoes worn. Just worn for testing. Although n=1 has a six-week therapy 
programme – insole worn all day and during all daily activities. 
Aruin and 
Kanekar, 
(2013)  
n=11 healthy subjects 
Pilot data from individuals with 
stroke n=4 
(Pre-) Experimental (pre-post 
intervention, single group). No control, 
no blinding, no random allocation 
Single TI, a D-insole made of polyvinyl chloride with small pyramidal peaks (3mm 
height and centre to centre distance 10mm), standardized footwear. Just worn for 
testing. 
Baron et al. 
(2014) 
(conference 
proceedings) 
n=46 Patients with Multiple 
Sclerosis (MS). Able to walk 
100m  
Exploratory (qualitative) study: Semi-
structured interviews with participants 
on study exploring the effects of three 
different TIs  
Control: smooth 
Algeos TI - Algeos Evalite Pyramid EVA, 3mm thickness, with small pyramidal 
peaks, centre to centre distances of approximately 2.mm 
Crocs TI - insoles with small nubs of approx. 1mm height 
Part of Dixon et al., (2014) trial – told to wear them as much as possible for two 
weeks 
Christovão 
et al. (2013) 
1) Controlled clinical trials 
2 Intervention – insole,  
3) Postural balance OMs 
4) published 2005-2012 
12 studies included (n=392) 
Mainly ‘older volunteers’ 
A systematic review Quick comfort insole, soft gel and hard insole, TI, vibrating insole, insole with 
spikes, insole with a wedge, balance-enhancing insole, flat insole 
Clark et al. 
(2014) 
 
n=14 older adults with mild 
mobility deficits and mild 
somatosensory deficits 
Experimental study  
No blinding 
No random allocation 
Made of thin semi-rigid plastic with firm raised (1.5mm) nodules 1.5 cm apart on a 
grid pattern. Just worn for testing. 
Corbin et al. 
(2007) 
 
n=33 healthy participants A cross over trial  
No blinding 
No random allocation 
TIs made from plastic floor matting purchased from local hardware store, with 
rounded plastic nubs, raised about ¼ cm off the plastic surface. Participants wore 
thin socks and their own athletic shoes for testing Just worn for testing 
Dixon et al. 
(2014) 
 
Part 1: n=46 Patients with MS, 
who could walk 100m 
unassisted or using one 
stick/crutch.  
 
Design: 3 groups, within-session 
repeated-design with exploratory 
follow-up period. Blinding. 
Random allocation order of insole 
wearing.  
1) Control (smooth surface) 
2) Texture 1 - Algeos Evalite Pyramid EVA, 3mm thickness, with small pyramidal 
peaks, centre to centre distances of approximately 2.mm 
3) Texture 2 - Crocs silver insoles with small nubs of approx. 1mm height  
Told to wear them as much as possible for two weeks. 
Hartmann et 
al. (2010) 
 
n=28 
Independent living, or older 
adults aged 65 to 91 years  
RCT pre/post-intervention. 3 groups: 
Insole plus training (IG) group 
Just training group (TG), Control group 
(no intervention), Random allocation 
No blinding  
Med Reflex shoe insoles with raised projections to improve afferent feedback from 
the foot.  Subjects asked to wear insoles as much as possible and use them 
during everyday life and during training sessions. 
Hatton et al. 
(2009) 
n =24  
Young adults 
Within-subject experiment 
Sequence of test condition randomized 
Three different textured surfaces used: 
1: Evalite to pyramid EVA 3 mm thickness, with small pyramidal peaks texture 
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 No blinding 2: Nora Luna soft mini non-slip 3mm thickness with convex circular patterning 
3: control condition used a completely flat surface texture medium density Eva 
3mm thickness. Just worn for testing 
Hatton et al. 
(2011)  
n=50 healthy older adults Within-subject experimental  
Sequence of trials randomized /  
No blinding 
Texture 1: Evalite to pyramid EVA 3mm thickness, with small pyramidal peaks  
Texture 2:  Nora Luna soft mini non slip 3mm thickness with convex circular 
patterning. Just worn for testing 
Hatton et al. 
(2012) 
n= 30 older adults, with self-
reported history of falls 
Within subject experimental  
Sequence of textures worn, eyes open 
or closed. No blinding  
TIs: Evalite to pyramid EVA 3mm thickness, with small pyramidal peaks. Centre to 
centre distance approx 2.5mm 
Control - completely flat surface texture medium density Eva 3mm thick. Just 
worn for testing 
Kalron et al. 
(2015) 
 
n=25 patients with relapsing-
remitting MS 
Within-subject experimental design 
with a four-week intervention phase  
No blinding 
No randomization 
Insoles customized for left and right feet. Insoles 3mm thick and made of elastic 
rubber and fabric. Coarse texture of insole designed with miniature square 
pyramids organised in a grid pattern. Participants were instructed to wear the TIs 
throughout the day for four weeks and to continue their usual activities. 
Kelleher et 
al. (2010) 
n=14 
patients with MS and 10 
healthy controls 
Experimental with control group  
No control healthy age-matched, no 
blinding. Trials with and without insoles 
were randomized. 
Fine leather insoles were cut, Grade P80 wet and dry sandpaper adhered to 
leather base, ' considered sufficiently rough to provide sensory feedback but not 
so rough as to cause skin discomfort. For testing only 
Nurse et al. 
(2005) 
 
n=15 
healthy participants 
Experimental design  
No blinding 
No randomization 
Two shoe insert conditions: 1) Control insert made from 3mm thick EVA foam 
(Shore C 60) 2) Textured insert 3 mm thick EVA foam insert cut from commercially 
available sandal; textured with semi-circular mounds with centre distances of 
8mm. Worn for testing only 
Orth et al. 
(2013)  
 Systematic review  
Palluel et al. 
(2008) 
 
19 healthy elderly participants 
and 19 healthy young adults. 
Within-subject experimental design  
No blinding 
No randomization 
Footwear - Arena® NewMarco sandals (designed for pool activities). Entire insole 
had spikes made with semi-rigid PVC (density: 4 spikes/cm2; height of a spike: 5 
mm; diameter: 3 mm) and uniformly distributed under feet except on medial arch 
where spikes were bigger (density: 2 spikes/cm2; height: 1 cm; diameter: 5mm). 
Just worn for 5 minutes each time during testing 
Palluel et al. 
(2009)  
 
n=19 healthy elderly, n=17 
healthy young adults 
Within-subject experimental design  
No blinding 
No randomization  
Entire insole had spikes made with semi-rigid PVC (density: 4 spikes/cm2; height 
of a spike: 5 mm; diameter: 3 mm) and uniformly distributed under feet except on 
medial arch where spikes were bigger (density: 2 spikes/cm2; height: 1 cm; 
diameter: 5 mm). Just worn for 5 minutes each time during testing 
Preszner-
Domjan et al. 
(2012) 
n=50 healthy young adults Experimental study  
No blinding 
No randomization 
Thin elastic layer of rubber with spiked layer (density 5 spikes/cm2, height of 
spikes 7mm, diameter of spikes 2mm), and it was placed onto the force plate. Just 
worn for testing. 
Qiu et al. 
(2012) 
 
10 younger and 7 older 
participants  
Experimental study  
Order of insoles were randomized 
Both insole surfaces (International Children’s Orthotic Laboratory, Australia) were 
1.5mm thick and had granulations with a diameter of 5.0 mm and a height of 
3.1mm that were distributed evenly across the upper surface. Just worn for testing. 
Qiu et al. 
(2013) 
 
20 healthy elderly participants 
and 20 healthy young adults. 
Within-subject experimental design  
No blinding 
No randomization 
Insoles were 1.5mm thick and with soft insole material (270 density Ethylene Vinyl 
Acetate (EVA). The textured surface comprised granulations measuring 5.0mm in 
diameter and 3.1mm in height that were distributed evenly across the upper 
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Abbreviations: AFO Ankle foot orthosis, EVA Ethylene Vinyl Acetate, FO Foot orthosis, PVC Polyvinyl Chloride, TI textured insole
surface, accentuated by two raised compliant ridges measuring 3.1mm in height 
and 3.1mm in width which were located around the lateral perimeter of the insole 
and around the heel of the foot. The smooth insoles - same materials and had the 
same height and dimensions as the TIs, but without texture and raised ridges, 
ensuring a standard insole surface. Just worn for testing. 
Silva et al. 
(2015) 
 
n=12 with type II diabetes Experimental design  
No randomization 
No blinding 
13 stations with different textures one included proprioceptive balls with 8 cm 
diameter and external projections placed on the floor. Somatosensory training for 
45 mins twice a week for 12 weeks.  
Wilson et al.  
(2008) 
 
Convenience sample of 40 
healthy female subjects (Age 
51.1 +/- 5.8 years) 
Test-re-test prospective pilot single-
blind randomized clinical trial  
Control group (n=10) fitted with shoes with a standard Hotter shoe insole (Shore 
value A20 – soft)  
n=10 - shoes fitted with a flat, plain, and smooth surfaced foot orthosis (FO), made 
of three millimetres thick EVA. The shoes of the second intervention group 
n = 10 - a dimpled surfaced FO (1mm raised circles, with a diameter of 3mm 
spaced 5mm apart covering the entire surface of the FO).  
N=10 - raised grid pattern fitted into their shoes (1 mm raised square pyramid 
shapes, side length two-point 5 mm, peaks spaced 2.5 mm apart covering the 
entire surface of the FO). Subjects required to wear the shoes for 4 weeks, for a 
minimum of 6 hours per day 
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  Development of the textured insole (TI) protocol 
At the mNGT meeting participants deliberated over the literature presented to them 
about TI wearing protocols and were given opportunity to ask questions of the 
facilitator, to discuss and assess commercially available textured materials, and to 
try out some TIs previously made by the researcher from sheets of textured 
material, making evaluations in relation to the different types of materials. 
Participants examined eighteen different types of textured material produced by 
Algeos.3  Issues such as size, nature and type of texture, accompanying footwear, 
cost, and potential comfort/discomfort were all considered by the group, along with 
the length of time and activity involved during the gait-training phase of wearing the 
insoles. 
 
 All the materials tested had non-slip properties and a Shore value of A (indicating 
a softer material); however, these ranged from A45 (softer) to A90 (harder), with a 
thickness of the materials between 1.8mm and 8mm. Some materials had 
pyramidal or round peaks at varying distances and others were ribbed in differing 
widths. They were all made of compact rubber with differing degrees of flexibility 
and bounce.  
 
Participants discussed the information in the literature related to the different types 
of textured materials and insoles used within studies, and the duration of wearing 
the insoles or standing on the textured material, as well as specifics related to 
 
3 Algeos UK Ltd: http://www.algeos.com/  
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footwear worn. One important point for discussion was whether the TIs should be 
worn on both sides, or just in the contralesional shoe, with a purpose of increasing 
stimulation on the contralesional side. Information from the scoping review was 
considered in relation to this aspect. A lengthy discussion ensued relating to the 
pros and cons of wearing the TIs on both sides or just the contralesional side; the 
facilitator gave all participants an opportunity to vote and agreement was reached.  
 
 Results 
Consensus was attained regarding the choice of a textured material (details 
below), which was felt to have sufficient depth to the texture to increase the 
afferent input to the plantar surface of the foot, but not so rough as to cause friction 
and injury. The plan was that the insoles should then be cut to size for each 
participant. 
 
One aspect debated, with conclusions drawn by the participants, related to the 
duration of wearing the TIs. Various suggestions were made by the participants: 
• Trial participants should be in control of the duration of wearing the TIs each 
day; recording the actual wearing time would provide some insights into 
what might be a feasible dose for a future larger trial. 
• TIs could be worn as much as the participants chose throughout the trial 
intervention period, an approach adopted by Dixon et al., (2014), who found 
improvements in gait in people with multiple sclerosis after a two-week 
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intervention period. Also, it was felt that giving control relating to the 
duration of wearing TIs to stroke survivors might increase their autonomy.  
• Some stroke survivors may not physically be able to insert or remove the 
TIs from their shoes themselves without assistance from a therapist or 
carer. For those such trial participants, who perhaps do not have access to 
a carer to assist them, a research therapist would insert them into the shoe 
at the beginning of the TSGT session and remove them afterwards. It was 
therefore decided that, as a minimum, TIs should be worn during all 
sessions of TSGT, each lasting 30 minutes in duration.  
 
Regarding whether a TI should be worn in the ipsilesional shoe as well as the 
contralesional shoe, or just in the contralesional shoe, there was an initial 
dichotomy in the group. Discussion and debate took place about the potential for a 
TI in the ipsilesional shoe to cause sensory extinction, where sensory stimulation 
of the contralesional side may not be perceived if stimulation is given 
simultaneously on both sides (de Haan et al., 2012). Following a vote, a decision 
was made that the TI should only be worn in the shoe of the contralesional side, 
but a smooth insole should be worn simultaneously in the ipsilesional shoe to 
ensure equal changes in shoe tightness or shoe sole thickness on both sides. 
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By the end of the mNGT meeting there was agreement on the following specific 
points relating to the insoles: 
• an insole with a smooth surface (of medium density EVA, 3-mm thickness, 
Shore value A50, black, OG1304 manufactured by Algeos UK Ltd., 
Liverpool, UK4.) should be worn in the ipsilesional shoe. 
• A black TI, OG1549, (with small, pyramidal peaks, with centre-to-centre 
distances of approximately 2.5 mm Evalite Pyramid EVA, of 3-mm 
thickness, Shore value A50 manufactured by Algeos UK Ltd), should be 
worn in the contralesional shoe (figure 5.3).  
• The insoles were to be participant specific and cut to size to fit well in each 
individual participant’s shoes. The TI protocol is presented in table 5.3. 
 
4 Algeos UK Ltd (http://www.algeos.com/)  
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Figure 5.3  Smooth and TI, with a close-up of the pyramidal peaks of the 
textured material 
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Table 5.3  Protocol for the textured insole group (based on the Template 
for Intervention Description and Replication, TIDieR checklist) 
 
1 Name: Textured insole (TI) protocol for TI group 
2 Rationale: The plantar (sole of the foot) mechanoreceptors are key, 
sending information to the CNS, and plantar stimulation 
has been shown to result in increased control of body 
sway (Watanabe and Okubo, 1981). In view of the 
importance of cutaneous information from the plantar 
surface of the foot to control balance (Kennedy and 
Inglis, 2002), other potential mechanisms of increasing 
plantar stimulation have been explored. TIs have been 
shown to improve postural control in standing in healthy 
participants (Corbin et al., 2007), and to improve walking 
patterns for people with multiple sclerosis (Dixon et al., 
2014). However, the combination of wearing TIs and 
task-specific gait training (TSGT) has not been 
evaluated to determine the benefits for balance and 
walking recovery early after stroke. The use of TIs in the 
shoes of stroke survivors involves a hands-off (therapist 
independent) approach, which may potentially be a 
more economical option for achieving increased sensory 
stimulation to the foot and is therefore important to 
investigate. 
3 Materials: Smooth and TIs will be used. The insole with the smooth 
surface will be of medium density EVA, 3mm thickness, 
Shore value A50, black, OG1304 manufactured by 
Algeos UK Ltd., Liverpool, UK. The TI has small, 
pyramidal peaks with centre-to-centre distances of 
approximately 2.5mm Evalite Pyramid EVA, 3mm 
thickness, Shore value A50, black, OG1549 
manufactured by Algeos UK Ltd. The insoles will be 
patient specific and cut to size so they fit in the 
participant’s shoe.  
4 Procedures: This group of participants will be encouraged to wear the 
TI on the hemiparetic side (and a smooth insole on the 
opposite side), as much as possible (to ‘augment’ the 
sensorimotor system), during the 4–6-week period of 
intervention, apart from when the outcomes are being 
assessed. In addition to wearing the TIs participants will 
also receive 20 sessions of TSGT (30 minutes for each 
session), during the intervention period. The specific 
content of each treatment session will be documented, 
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and daily diaries will inform the researcher of the extent 
of wearing of the TIs. OMs will be undertaken without 
the participant wearing TIs, so it is the same conditions 
as the mobilization and tactile stimulation group, which 
is the other arm of the trial. 
5 Provided by: The participant will be responsible for wearing the 
textured/smooth insoles. If help is required to put the TIs 
into shoes and put on footwear (and no family support is 
available), a Research Therapist will assist, prior to 
TSGT.   
6 Mode of 
delivery: 
Participant controlled – wearing the TIs for as much as 
possible during the 4–6-week intervention period. The 
Research Therapist will help if required to put the TIs 
into shoes and put on footwear prior to TSGT if required. 
The participant will, therefore, wear the TIs a minimum 
of 30 minutes 4–5 times per week.  
7 Location: The participants will be encouraged to wear the TIs and 
receive the TSGT in their own environment, whether this 
is as an inpatient or their own home.  
8 When and how 
much: 
Time wearing the insoles will vary. Some participants 
may just wear them during the TSGT and others may 
wear them for long periods in the day. Participants will 
be encouraged to record the length of time insoles are 
worn on the daily diaries. 
9 Tailoring: As the participant is in control of how long they wear the 
insoles for, they can tailor the intervention to their own 
comfort and needs.  
10 Modifications: Any modifications to the TI protocol will be recorded. 
11 Intervention 
adherence and 
fidelity- 
planning: 
Intervention adherence and fidelity will be assessed. 
Strategies to improve fidelity and adherence include: 
research therapist training, encouragement and 
motivation regarding wearing of TIs by the research 
therapist delivering the TSGT and the keeping of daily 
diaries which will be collected weekly. A record of the 
length of time wearing the insoles will be included as a 
prompt in the simple diaries and this information will 
enable monitoring of adherence and fidelity. The 
information from the daily diaries will be analysed by the 
Chief Investigator, with guidance from her supervisors.  
12 Intervention 
adherence and 
fidelity - How 
well (actual): 
The analysis of the daily diary sheets will give an 
indication of adherence to the intervention. The FGs will 
enable further opportunity of assessing the adherence, 
fidelity and acceptability of the intervention. 
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 Search strategy for scoping review related to task-specific gait 
training (TSGT) 
The search terms below were used to access pertinent literature: 
• ‘Lower limb’ OR ‘Lower extremity’ 
AND 
• Stroke OR CVA OR ‘cerebrovascular accident’ OR ‘brain attack’ 
AND 
• ‘task specific’ OR ‘task-specific’ OR ‘task orientated’ OR ‘task-orientated’ OR ‘Motor 
learning’ OR relearning 
 
Table 5.4 Search strategy for scoping review related to task-specific gait 
training after stroke 
 
Search Term 
S1 Lower limb 
S2 Lower extremity 
S3 S1 OR S2 
S4 Stroke 
S5 CVA 
S6 ‘cerebrovascular accident’ 
S7 Brain attack 
S8 S4 OR S5 OR S6 OR S7 
S9 ‘task specific’ 
S10 ‘task-specific’ 
S11 ‘task orientated’ 
S12 ‘task-orientated’ 
S13 ‘Motor learning’ 
S14  Relearning 
S15 S9 OR S10 OR S11 OR S12 OR S13 OR S14 
S16 S3 and S8 and S15 
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 Types of participants 
Only studies involving stroke survivors were included, in either the acute, sub-
acute or chronic stage post-stroke. 
 
 Types of interventions and outcomes  
Any studies of task-specific training to improve balance and gait were included. 
Two of the twenty full-text articles accessed focused on task-specific training for 
the upper limb (Donaldson et al., 2009; McDonnell et al., 2007); however, some 
useful information in these articles was used to inform the intensity and 
progression strategies for task-specific training.  All training was based on 
repetitive, progressive exercises. Studies that included pertinent information 
relating to researched strategies for undertaking TSGT were included and 
individual exercises and ways of progressing the exercises were recorded.  
 
 Findings 
A flowchart for identifying the TSGT literature is presented in figure 5.4. The 
searches identified 140 citations; after removal of 53 duplicates, 87 sources were 
left, of which 43 were excluded following reading the title: 14 were excluded 
because they were books (it was felt sufficient more current information was 
available within published journals), dissertations or government documents, and a 
further 10 were excluded after reading the abstracts. Full texts were accessed for 
20 articles which were then read and pertinent information relating to TSGT was 
extracted. Information is summarized in Appendix 15. 
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Figure 5.4  Flowchart of the process for identifying studies related to TSGT 
as an intervention 
 
Data bases searched: Medline, 
Amed, Ageline,Cinahl plus, 
with full text, Sportdiscus, with 
full text, PsycINFO and 
PsycARTICLES 
140 Articles identified 
  
53 duplicates 
removed 
Final total of 20 articles for 
discussion at the mNGT 
meeting 
  
87 articles 
screened by title 
and abstract 
  
70 excluded 
  
3 articles 
added from 
checking the 
reference lists 
17 articles 
identified 
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 Characteristics of the included studies 
Twenty studies were identified: twelve RCTs (Blennerhassett and Dite, 2004; 
Cooke et al., 2010b; Dean et al., 2000; Donaldson et al., 2009; Jonsdottir et al., 
2010; McDonnell et al., 2007; Mead et al., 2007; Pang et al., 2005; Salbach et 
al., 2004; Scianni et al., 2010; van de Port et al., 2009; Yang et al., 2006), 
(although two were just protocols: Scianni et al., 2010; van de Port et al., 2009),  
one pre- post-test design (Monger et al., 2002), two randomized trials (with no 
control group) (n=22 and n=80) (Peurala et al., 2007; Sullivan et al., 2007), one 
repeated measures design (n=22) (Straube et al., 2014), and four systematic 
reviews (French et al., 2007; Pollock et al., 2014a; Pollock et al., 2007; Wevers 
et al., 2009). All of the articles involved TSGT being delivered to stroke 
survivors. Six of the studies delivered the intervention in a group situation and 
ten included individual treatments. This is an important consideration when 
considering potential costs during implementation of any study findings. Four of 
the sources included people following acute stroke, two sub-acute strokes, 
three a mixture of sub-acute and chronic stroke and seven chronic stroke 
survivors. The four systematic reviews all included people at any stage after 
stroke.  
 
 Exercises/activities reported  
The types of exercises included in the studies are summarized in Appendices 
15, 16 ,17 and table 5.5. Interventions included circuit training, progressive 
endurance and resistive training, and functional tasks.  Duration of treatment 
ranged from 20 minutes (Monger et al., 2002) to 75 minutes (Mead et al., 
2007). However, Mead et al. (2007) included tea and chat in that time. The 
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most common length of treatment was 60 minutes (Blennerhassett and Dite, 
2004; Cooke et al., 2010b; Dean et al., 2000; Pang et al., 2005; Peurala et al., 
2007; van de Port et al., 2009). Frequency of treatments ranged from twice a 
week (van de Port et al., 2009) to five times a week (Blennerhassett and Dite, 
2004); and the number of sessions ranged from 18 (Salbach et al., 2004) to 57 
delivered over a 19-week period (Pang et al., 2005). Information regarding 
intensity and progression of exercise was summarized (table 5.6). 
 
Treatments were progressed by using repetition and increasing resistance, with 
the number of exercises graded to the ability of the participants. The planned 
TSGT protocol for the MoTaStim-Foot trial would not involve a formal 
progressive strength training regime; it was just planned to be a small part of 
the module of treatment enabling treatment to be individualised according to the 
participant’s presentation on the day. The number of repetitions would be 
increased each treatment where possible, this approach for progression 
observed in the literature was noted and discussed with the clinicians at the 
mNGT meeting. A variety of exercises were researched within the various 
articles, but commonly the programmes included sit-to-stand practice, stepping, 
walking, squatting, standing on one leg, balance work, heel lifts and kicking a 
ball.  
 
 Synthesis of descriptions 
A list of all potential TSGT exercises was formulated (table 5.5) and information 
summarized relating to exercise intensity and how exercises could 
appropriately be progressed (table 5.6).   
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Table 5.5 Summary of categories and tasks/activities involved in TSGT 
as reported in the literature  
 
Category Task / activity 
Warm Up Marching on-the-spot 
 Arm lifts 
 Ankle circles 
 Stretching of the trunk, thigh, and calf muscles 
Other   
Sitting 
Exercises 
Sitting at a table and reaching in different directions for objects located beyond 
arm’s length to promote loading of the affected leg and activation of affected leg 
muscles 
Other   
Sit to stand to 
sit  
Sit to stand from various chair heights to strengthen the affected leg extensor 
muscles and practice this task 
Other   
Standing Standing with the base of support constrained, with feet in parallel and tandem 
conditions reaching for objects, including down to the floor, to improve standing 
balance. 
 Standing and reaching 
 Heel lifts in standing to strengthen the affected plantar flexor muscles 
 Reciprocal leg flexion and extension using the Kinetron in standing to strengthen 
leg muscles 
 'standing balance'/balance control 
 Standing with one foot in front of the other 
 Kicking ball with either foot 
 Balance beam - walking forwards, sidewards, and backwards between two parallel 
lines, 20 cm apart, progressing to using one line, to using a balanced beam, and 
finally to lateral stepping on the floor, feet crossing over in front or in back, and 
then alternating 
 Stand on one leg 
 Squat on one leg 
 Stand on the paretic leg, then perform plantarflexion 
Other   
Stepping Stepping forward, backward, and sideways onto blocks of various heights to 
strengthening affected leg muscles.  
 Stair climbing and descending exercise progressing from taking one step at a time 
to taking alternating steps, from using, then not using the handrail, and to achieving 
a greater number of flights 
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 Step ups progressed by increasing the height of the step or reducing arm support 
 Step on block with the paretic limb 
 Step on block with the non-paretic limb 
 Step sideways on a block 
Other   
Gait Standing up from a chair, walking and short distance, and returning to the chair, to 
promote a smooth transition  
 Walking on a treadmill 
 Walking over various surfaces and obstacles 
 Walking in different directions 
 Tandem walking 
 Walking over slopes and stairs, providing the opportunity for walking practice under 
variant conditions 
 Inside and outside walking 
 Sudden stops and turns during walking 
 Walking on different surfaces (carpet, foam)  
 Standing on foam, balance disc, or wobble board  
 Walking through an obstacle course 
 Speed walking  
 Walk on foot prints 
 Walk between lines 
 Walking and picking up various objects from the ground 
Other   
Functional 
Tasks 
Bed mobility 
 Turning 
 Obstacle course e.g. stepping onto, along, and down from an aerobics step, 
walking over a mat, or a ramp, and returning, progressing by increasing the heights 
and number of obstacles, and from completing the course walking forwards to 
walking backwards.  
 Walk and carry - continuous walking carrying a grocery bag, progressing to 
carrying a bag in each hand, to increasing the weight of the bag, to carrying a 
laundry basket, and to stopping on command.  
Other   
Strengthening Progressive-resistive exercise program for paretic hip flexors and extensors, knee 
flexors and extensors, and ankle dorsiflexors and plantar flexors.  
 Partial squats: progressed by increasing movement magnitude 
 Toe rises: progressed from bilateral to unilateral rises on either side 
 Progressed by increasing number of repetitions (from 2 sets of 10 to 3 sets of 15), 
reducing arm support, or both 
Other   
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Table 5.6 TSGT information in the literature relating to intensity and 
progression:  
Intensity 
(mins) 
Frequency 
(days per 
week) 
Duration 
(weeks) 
Total time 
per week 
(mins) 
Overall 
total time 
(mins) 
Comments 
60 5 4 300 1200 UL 
60 4 6 240 1440 LL 
60 3 4 180 720 LL 
60 4 6 240 1440 UL 
75 3 12 225 2700 Exercise management training 
based on falls exercise 
management study UL and LL 
40 3 3 120  3-week home-based exercise 
programme of sit to stand 
60 3 19 180 3420 Exercise programme. 
3 stations:  
1 Cardiorespiratory fitness* 
2) Mobility and balance 
3) Leg muscle strength  
 
*10 minutes initially, with incremental increase of 5 minutes every week, up to 30 minutes of 
continuous exercise as tolerated per day (for cardio-respiratory fitness), intensity: started at 
40% to 50% heart rate reserve (HRR), with increment of 10% HRR every 4 weeks, up to 70% to 
80% HRR, as tolerated. 
 
Treatment was progressed systematically using repetition and increasing 
resistance by, for example, changing the limb’s relationship to gravity or 
increasing the range of motion or distance over which body weight was 
transported. Progression also included altering the height of the seat, reducing 
arm support, increasing the height of the step and increasing speed. Exercises 
were progressed as appropriate for the individual’s ability.  Some of the studies 
used equipment, and some studies used no equipment.  
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 Development of the task-specific gait training (TSGT) protocol 
 Methods 
The literature upon which the TSGT could be based (table 5.5), along with 
equipment, intensity, progression (table 5.6) and length of treatment sessions 
were discussed at the mNGT meeting. It is acknowledged that some reviews 
exploring task-specific training following stroke have previously been 
undertaken (Pollock et al., 2014a; Veerbeek et al., 2014).  However, these 
reviews only included RCTs; it was important to be inclusive and 
comprehensive, capturing all possible interventions; hence additional scoping 
searches were undertaken, so all potentially suitable tasks and exercises could 
be presented to the group for the expert clinicians to discuss. It needs to also 
be recognized that it can be challenging to distinguish between specific 
functional task training and practice of an active movement (Pollock et al., 
2014a). As the aim of this work was to develop clinically relevant protocols the 
experienced clinicians were given the autonomy to decide what they believed 
were exercises and strategies which should be included in the task-specific gait 
training protocol.  
 
The NGT was modified (mNGT) to enable small group work (two groups, with 
four participants in each), facilitating discussion regarding which exercises 
should be included in the TSGT protocol (content of the TSGT). In their groups, 
participants discussed the information and decided upon the relevance of the 
different exercises and rehabilitation strategies for stroke survivors. The list of 
exercises and activities developed from the literature around TSGT for stroke 
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survivors (table 5.5) was analysed by the participants, and the suitability of 
each exercise or activity assessed. Participants were asked to consider the 
exercises they felt would be suitable for stroke survivors with different levels of 
capability (immobile, able to walk with assistance, or able to walk 
independently). This was to help the participants think carefully about relevant 
exercises for all stroke survivors. Furthermore, participants considered whether 
any other exercises should be added to the list.  
 
The small groups each shared their views with the larger group and frank 
discussion ensued about which exercises should be included. Consensus was 
sought for inclusions rather than exclusions, enabling techniques to be included 
even when only a few participants felt the technique was important. The group 
then considered the summarized information from the literature about dose of 
TSGT, progression of activities, and equipment used in TSGT (table 5.6); 
further in-depth discussion took place, consensus was reached, and the final 
TSGT protocol developed (table 5.7). 
 
 Results 
Following in-depth discussion, group consensus agreed that:  
• the programme of TSGT exercises should be individualized for each 
participant. 
• TSGT should be delivered at an appropriate intensity; in view of the 
heterogenic nature of stroke survivors, the intensity would be decided by 
the research therapist delivering the intervention; progression would be 
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within the limits of the participant’s abilities. This reflects conventional 
therapy practice for stroke survivors. The TSGT schedule allowed for the 
recording of specific numbers of exercises undertaken and pertinent 
comments related to the exercise if required.  
• A dose of 30 minutes of TSGT per day was appropriate. 
• A total of 20 sessions of intervention was appropriate.  
 
As co-design was utilized and the clinicians were given the autonomy to include 
all exercises that they felt would be appropriate in an inclusive intervention 
package of TSGT, the heterogeneity of the included exercises in the final TSGT 
protocol is justified. Some preparatory exercises are included (for example 
exercises in lying, lifting leg on/off a box), because the expert clinicians 
selected what, in their expert opinion, could potentially be used in gait training 
in clinical practice. This was, therefore, not the researcher’s opinion, but a 
bottom-up design respecting expert clinical opinion. 
 
A detailed protocol for the TSGT was agreed and is summarized in table 5.7. 
The recording sheet for the TSGT is presented in table 5.8.  
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Table 5.7  TSGT protocol based on the Template for Intervention 
Description and Replication (TIDieR) checklist 
1 Name: Task-specific gait training (TSGT) group. 
2 Rationale: Walking is a priority for many stroke survivors, 
confirmed by studies undertaken to define a 
national research agenda, which identified 
physical therapy to address balance and gait 
(walking) post-stroke within the top ten research 
priorities (James Lind Alliance, Pollock et al., 
2014b). There is strong evidence that task-
specific walking practice can be used to improve 
walking after stroke (Wiener et al., 2018). 
3 Materials: Based upon a review of the literature and a FG 
with experienced clinicians a few pieces of 
equipment will be required including theraband, 
football, chair, foam cushion, gym ball a stair or 
step and a wobble board. 
4 Procedures: 30 minutes of TSGT will be supervised by the 
research therapist, with 20 sessions being 
delivered over a 4–6-week intervention period. 
The TSGT will be undertaken immediately after 
the Mobilization and Tactile Stimulation (MTS) for 
the MTS group. The TSGT will be undertaken 
whilst wearing a TI on the side affected by the 
stroke and a smooth insole on the other side, for 
the TI group 
5 Provided by: The TSGT will be delivered by a research 
therapist (Band 6), with experience of working 
with stroke patients. A log will be kept of which 
research therapist provides which treatment for 
each participant and this information will be 
analysed on completion of the trial.  
6 Mode of delivery: The research therapist will provide the TSGT in a 
1:1 situation. 
7 Location: The TSGT will take place in either an inpatient 
clinical setting within an NHS organisation or a 
University research setting or the participant’s 
own home. 
8 When and how 
much: 
All participants in BOTH groups/arms of the trial 
will receive 20 sessions of 30 minutes of TSGT 
within a 4–6-week period. 
9 Tailoring: Although a standardized protocol will be followed 
for the TSGT the research therapist will choose 
appropriate exercises and adapt them as required 
to suit the requirements of each individual 
participant, due to differences in presentation 
following a stroke. This reflects how TSGT would 
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usually be implemented in conventional 
rehabilitation. Details of actual intervention 
delivered will be recorded on the treatment 
schedule. 
10 Modifications: Any modifications to the TSGT protocol will be 
monitored and reported appropriately. 
11 Intervention 
adherence and 
fidelity- planned: 
Intervention adherence and fidelity will be 
analysed. Strategies to improve fidelity and 
adherence include 1:1 intervention plus 
encouragement and motivation strategies by the 
research therapist during the TSGT, as in usual 
therapy rehabilitation.  A log will be kept detailing, 
for each participant, which research therapist has 
delivered the TSGT. 
12 Intervention 
adherence and 
fidelity - How well 
(actual): 
The case report files completed by the research 
therapists will give an indication of adherence to 
the intervention. The FGs will enable further 
opportunity of assessing the adherence, fidelity 
and acceptability of the intervention. 
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Table 5.8 Task-Specific Gait (Walking) Training (TSGT) schedule for 
recording treatments delivered 
NB Standard exercises for TSGT will be delivered (20 sessions of 30 minutes), 
however, they will be individualised for each participant according to need. It is 
essential that the research therapist liaises with the clinician responsible for routine 
therapy treatment for the participant, to ensure the participant does not become 
fatigued by the extra therapy. 
Description Task Tick  
(If done) 
Details 
Warm Up Stepping in sitting   
 Reaching/Rolling gymball forwards in sitting   
 Pelvic tilt – ant/post/lateral   
 Hip flexion/inner range quads   
 Ankle circles/dorsiflexion/plantar flexion/heel/toe   
 Stretching of the trunk, thigh, and calf muscles   
 Weight transfer in standing   
 Marching on-the-spot   
Other     
Lying  
Exercises 
Lifting leg on/off block 
 
 
 
  
Sitting 
Exercises 
Postural re-education   
 Sitting at a table and reaching in different directions for objects 
located beyond arm’s length to promote loading of the affected leg 
and activation of affected leg muscles 
  
 Lifting leg on/off block   
 Heel lifts in sitting to strengthen the affected plantar muscles   
 Rolling ball with foot/kicking ball   
 Wobble board/balance exercises   
 Wobble cushion in sitting   
 Heel lift in sitting   
 Theraband/strengthening    
 Exercise bike   
Other:    
Sit to stand to 
sit 
Sit to stand from various chair heights to strengthen the affected 
leg extensor muscles and practice this task 
  
 One leg stand/foot not affected by stroke in front/on step   
Other:    
Standing Weight shift left/right   
 Standing and reaching   
 Standing with the base of support constrained, with feet in parallel 
and tandem conditions reaching for objects, including down to the 
floor, to improve standing balance. 
  
 Heel lifts in standing to strengthen the affected plantar flexor 
muscles 
  
 Reciprocal leg flexion and extension in standing to strengthen leg 
muscles 
  
 'standing balance'/balance control   
172 
 
 Step standing    
 Kicking ball with either foot   
 Balance beam - walking forwards/sidewards/backwards between 
two parallel lines, 20 cm apart, progressing to using one line, to 
using a balanced beam, and finally to lateral stepping on the floor, 
feet crossing over in front or in back, and then alternating 
  
 Bilateral squats   
 Stand on one leg   
 Squat on one leg   
 Stand on the paretic leg, then perform plantarflexion   
Other:    
Stepping Stepping forwards/backwards/sideways onto blocks of various 
heights to strengthening affected leg muscles.  
  
 Stair climbing and descending exercise progressing from taking 
one step at a time to taking alternating steps, from using then not 
using the handrail, and to achieving a greater number of flights 
  
 Step ups progressed by increasing the height of the step, 
reducing arm support 
  
 Step on block with the paretic limb   
 Step on block with the non-paretic limb   
 Step sideways on a block   
Other:    
Gait Standing up from a chair, walking and short distance, and 
returning to the chair to promote a smooth transition  
  
 Walking on a treadmill   
 Walking over various surfaces and obstacles   
 Walking in different directions   
 Tandem walking   
 Walking over slopes and stairs providing the opportunity for 
walking of practice under various- conditions 
  
 Inside and outside walking   
 Sudden stops and turns during walking   
 Walking on different surfaces (carpet, foam)    
 Standing on foam, balance disc, or wobble board    
 Walking through an obstacle course   
 Speed walking    
 Walk on foot prints   
 Walk between lines   
 Walking and picking up various objects from the ground   
 Gait re-education with or without aids (please specify)   
Other:    
Functional 
Tasks 
Bed mobility   
 Turning whilst walking   
 Obstacle course e.g. stepping onto/along/down from an aerobics 
step, walking over a mat, or a ramp, and returning, progressing by 
increasing the heights and number of obstacles, and from 
completing the course walking forwards to walking backwards.  
  
 Walk and carry - continuous walking carrying a grocery bag, 
progressing to carrying a bag in each hand, to increasing the 
weight of the bag, to carrying a laundry basket, and to stopping on 
command.  
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 Stairs   
 Kitchen work   
 Personal care   
 Leisure/hobbies   
Other:    
Strengthening Progressive-resistive exercise program for paretic hip 
flexors/extensors and ankle dorsiflexors/plantar flexors.  
  
 Progressive-resistive exercise program for paretic knee flexors 
and extensors 
  
 Partial squats: progressed by increasing movement magnitude   
 Toe rises: progressed from bilateral to unilateral rises on either 
side 
  
 Leg press   
Other:    
Stretching Calf stretch - Standing with affected knee straight and extended 
arm/s resting on the wall: keeping the body straight, pivot the body 
forward at the ankles keeping heel on the floor until you feel the calf 
muscle is stretched. Hold for 2 minutes, relax, repeat 10 times. 
  
 Hamstring stretch in sitting   
Other:    
Endurance/ 
Aerobic 
Bike (if available)   
 Treadmill (if available)   
 Brisk walking   
 Raising and lowering a 1.4-kg, 55-cm exercise ball (care taken of 
the shoulder) 
  
 Shuttle walking   
 Standing chest press   
Other:    
Progression 
For specific strengthening - progress by increasing number of repetitions (e.g. from 2 sets of 10 
to 3 sets of 10), according to the level of ability, and progress as they improve, also progress by 
reducing arm support. Other treatment progressions include increasing resistance e.g. in 
relation to gravity, increasing the range of movement or distance over which body weight is 
transported, changing weight of external objects, altering the height of seat/step and walking 
longer distances. 
  
174 
 
 Developing the MTS protocol using an mNGT  
It has been advised that research should consider existing evidence and build 
upon biological and physical rationales and theories (Walker et al., 2017). A 
scoping search relating to MTS was therefore not required because an upper 
limb MTS treatment schedule had already been developed by a rigorous 
process (Hunter et al., 2006). The development of this upper limb schedule 
involved firstly a systematic search of the literature, followed by semi-structured 
interviews with experienced neurotherapists (n=7); a detailed analysis was 
undertaken by two independent researchers, resulting in a preliminary list of 
interventions which were then discussed at a focus group meeting (n=6). This 
detailed development process enabled current therapy techniques to be 
evaluated resulting in the development of the upper limb MTS treatment sheet 
which was piloted and then has since been implemented in follow-up single 
system studies (Hunter et al., 2008; Winter et al., 2013).  MTS is a module 
rather than a single intervention and therefore allows the flexibility to provide 
appropriate intervention to each patient within the confines of the module 
(Hunter et al., 2006). However, this published MTS schedule was specific to the 
upper limb and a decision was made to adapt this upper limb schedule to one 
that reflected MTS more specifically for the lower limb. An iterative cycle is 
advocated during intervention development (Jones et al., 2016b), and this is 
what occurred during the development of the lower limb MTS protocol; 
assessment of acceptability and feasibility of the intervention was possible as a 
result of the MoTaStim-Foot feasibility study (utilising both quantitative and 
qualitative aspects) as suggested by O’Cathain (2019). 
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The development of the MTS protocol for the lower limb involved three phases: 
• Phase one: Alteration of the upper limb MTS protocol (iteration one) to 
create an MTS protocol for the lower limb (iteration two) 
• Phase two: Refining iteration two, and development of iteration three 
• Phase three: Ultimate refining of iteration three to enable development of 
the final standardized MTS schedule for LL.  
 
Phases one and two occurred prior to the group meeting. All participants were 
sent an electronic copy of the upper limb MTS schedule by email and asked to 
consider, independently and without collaboration, how the different 
subsections of the upper limb schedule might be appropriately adapted as an 
intervention for the lower limb. Participants were asked to annotate the 
schedule according to how it should be modified to reflect current conventional 
therapy for the foot and ankle in preparation for standing and balance. In 
addition, they were asked to consider the aims, and rank (with 1 as most 
important and 9 as least important) the order of importance, and frequency of 
use, of each of the intervention subsections for application to the lower limb: 
passive movements through anatomical range; accessory movements; 
massage; soft tissue stretch; placing; isolated/selective joint movement; 
compression; specific sensory input; and patterns of coordinated movement 
underlying functional activity. Participants were asked to return the annotated 
schedule by email to the researcher, who collated and analysed all the 
responses, and developed a second iteration, based on those responses.  
 
176 
 
This second iteration of the modified schedule (Appendix 18) was returned by 
email to the participants, who were asked to independently review it, and 
provide feedback on how comprehensive the schedule was, and how 
accurately it reflected their experiences and practice of retraining 
somatosensation in the foot when preparing the foot for standing and for 
balance in standing. Feedback on this second iteration was returned to the 
researcher by email, who collated and analysed the responses and developed 
a third iteration (Appendix 19).  
 
The third iteration was emailed to the participants prior to their attendance at a 
group meeting at Keele University. Again, the participants were asked to 
consider, in advance of the meeting, the applicability of the schedule.  
 
The final phase of the mNGT, the group meeting, took place at Keele 
University. The plan for the session is available in Appendix 20.  At the group 
meeting, the content of iteration three of the schedule was discussed, along 
with all other protocol considerations, such as appropriate treatment dose 
(intensity, frequency and duration). In-depth discussion continued until 
consensus on the content and format of the schedule and overall protocol for 
delivering MTS to the lower limb was achieved. The final schedule was then 
agreed.    
 
To ensure that the final protocol was comprehensive, including all the 
interventions that the group considered to be relevant for inclusion in this 
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protocol, consensus was sought for inclusions rather than exclusions. This 
enabled techniques/interventions to be included even if only a few participants 
considered the technique to be important.  For example, only one participant 
felt dissociation of gastrocnemius from soleus was an important technique to 
add. The protocol was designed so therapists could record, using tick boxes, 
just the techniques they felt were appropriate to apply to each individual 
participant; it was not intended that all the techniques would be delivered in one 
treatment session. Including all identified techniques in the schedule therefore 
allowed for flexibility and appropriate selection and accurate recording of all 
techniques applied. In chapter seven there will be further discussion relating to 
this aspect.  
 
 The mNGT meeting 
One group meeting was held which lasted for just over three hours, with breaks 
built into the afternoon as required. The group facilitator (AA) provided a brief 
introduction, thanking the participants for their contribution to the study so far, 
and for attending the meeting. The purpose and content of the meeting were 
stated, and consent, confidentiality and anonymity discussed. The rationale 
underpinning the research was explained and it was made clear that the three 
protocols to be developed were MTS for the lower limb, TSGT, and wearing 
TIs. Participants were given an opportunity to ask questions or seek clarification 
on any matter relating to the study. With agreement from participants, 
discussion during the meeting was audiotaped.  
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During the group meeting, the facilitator (AA) ensured that individual responses 
were heard and prompted all group members to participate. Ideas from 
participants were then prioritized by the group, following the five-step strategy 
discussed in chapter four. All three protocols were finalized in one afternoon 
and it was important to keep the focus of the participants.  Whilst the principles 
of the NGT were followed and all participants’ views were respected and heard, 
its format was modified, as discussed in chapter four, to meet the study 
objective, 2.1. The mNGT created sufficient opportunities for individual ideas 
and opinions to be considered, enabling all to participate and feel valued  
(Delbecq et al., 1975), evidenced by quotations from the participants.    
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 Results 
Eleven physiotherapists and one occupational therapist were recruited. They 
were all skilled therapists with experience of working with stroke survivors; all 
were female, and worked in the NHS, within three separate trusts, in posts 
ranging from Band 6 to Band 8. The protocols for MTS and TSGT were 
developed by these experienced clinicians and therefore they were based upon 
current therapy practice.  Examples of content and face validity are given in 
section 5.3.13 (quotations from participants) in relation to the protocols 
developed being aligned with current conventional therapy and rehabilitation 
techniques; the use of a mNGT facilitated the process of validation of the 
protocols. This, in turn, contributed to the external validity of the protocols for 
MTS and TSGT.  The wearing of TIs is not standard practice within stroke 
rehabilitation, and it was not possible to assess external validity related to this 
aspect.  
 
All 12 participants contributed to phase 1, providing feedback on how the upper 
limb MTS schedule could be adapted for the lower limb. A descriptive analysis 
of the results for this first stage is presented below. 
 
 Ranking sections of the upper limb MTS schedule for application 
to the lower limb (Iteration 1)  
 
Table 5.9 shows the median, interquartile ranges, and range of rankings for 
each of the subsections of the upper limb MTS schedule, ranked on a scale 
from 1 (most important) to 9 (least important).  
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Table 5.9 Median, interquartile range, and range of rankings for 
subsections of the upper limb MTS schedule according to importance for 
inclusion in a lower limb MTS schedule 
 
Subsection 
 
Median Interquartile 
range 
Range  
Soft tissue stretch 2 1.25, 3.75 1–4 
Passive movements 2.5 1.00, 4.75 1–6 
Accessory movements 4.5 3.00, 7.50 1–9 
Massage 6.0 2.25, 8.75 1–9 
Placing the foot 6.0 5.00, 8.00 4–9 
Compression 6.5 3.25, 7.75 2–9 
Specific sensory input 6.5 3.25, 7.75 2–9 
Patterns of coordinated movement 
underlying functional activity 
6.5 3.25, 7.75 1–9 
Isolated selective movement 6.5 4.00, 7.75 2–9 
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 Soft tissue stretch 
All twelve participants agreed soft tissue stretch is important, giving scores 
between one and four; indeed, nine participants (75%) gave a score of either 
one or two, indicating a very high level of importance for soft tissue stretch, the 
mode was 2. 
 
 Passive movements through anatomical range  
There was consensus from the participants that passive movements are 
important (mode was 1). All twelve participants gave a score of 6 or less with 
six (50%) of the participants giving a score of one or two; indeed, four (33.33%) 
ranked this component as number 1, indicating a high level of importance for 
passive movements to be included in the lower limb MTS schedule. 
 
 Accessory movements 
There was a difference of opinion among participants regarding the importance 
of accessory movements, with six (50%) of the participants indicating they felt 
accessory movements were important by scoring this section 4 or less. 
However, six (50%) of participants scored it 5 or more indicating they felt it was 
less important, the mode was 3. 
 
 Massage 
Again, no consensus was reached regarding massage. A dichotomy was seen; 
four participants (33%) scored the section 3 or less indicating a high level of 
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importance, whereas six participants (50%) scored it 7 or more, indicating a 
lower level of importance, the mode was 9. 
 
 Placing of the foot  
There was consensus that placing of the foot is not so important, with no 
participants scoring the section with a 3 or less. The scores indicated a level of 
uncertainty relating to this section, the mode was 5.  
 
 Compression 
The scores for this section ranged widely, indicating a difference of opinions 
relating to compression, the mode was 7. 
 
 Specific sensory input 
Four participants (33%) scored this section 8 or 9 (the mode was 8), indicating 
a low level of importance. Two participants (16.6%) indicated they felt specific 
sensory input was very important to be included in the schedule by giving a 
score of one. No consensus was established at this stage.  
 
 Patterns of coordinated movement underlying functional 
activity 
Most participants indicated that this category was not important, with nine 
participants (75%) giving a score of 5 or more. However, one participant (8.3%) 
graded it as the most important section. The mode was 7. 
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 Isolated/selective joint movement 
Ten participants (83.33%) ranked this section 4 or more (the mode was 7). 
Indeed, six of the participants (50%) ranked it 7 or more. Two participants 
(16.66%) ranked the section at 2. These results indicate that the isolated or 
selective joint movement was felt to be less important; however, there was 
some difference of opinion demonstrated.  
 
 Other issues raised by the participants 
• Aims would easily be transferrable from the upper limb schedule to the 
lower limb schedule 
• Include positioning of the patient for treatment 
• A new subheading ‘joint mobilizations’ was suggested 
• A new subheading ‘soft tissue mobilizations’ was suggested 
• All joint names, movements and activities needed to be altered to reflect the 
lower limb, as opposed to the upper limb. 
 
Following analysis of the comments (Appendix 21) and rankings provided by 
the participants, the second iteration of the lower limb MTS treatment schedule 
was developed (Appendix 18). The changes made to the schedule are 
summarized in table 5.10; the main changes were: to reflect treatment applied 
to the lower limb as opposed to the upper limb, for example altering the wording 
of the aims of the schedule and joints and muscles to reflect lower limb instead 
of upper limb; two of the sections, placing the hand on a flat surface or 
edge/corner, and the compression components that related to the upper limb, 
were also removed.   
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Table 5.10 Summary of main changes made to adapt the upper limb 
MTS schedule to formulate the lower limb MTS schedule (iteration two) 
 
 
Subsection Alteration made to adapt the schedule 
Aims Hypersensitivity and pain were put together in one 
bullet point, since stroke survivors rarely complain of 
foot pain, whereas hand pain is more prevalent 
Passive 
Movements 
       A new subsection ‘joint mobilizations’ was 
       included to encompass both these elements.  
       Names of joints changed to reflect lower limb  
       Anatomy 
Accessory 
movements 
Massage 
 
       A new subsection ‘soft tissue mobilization’ was 
       included, to encompass both massage and soft 
       tissue stretch. Participants felt these aspects  
       were often combined during treatments 
Soft tissue stretch 
 
Placing of hand Altered to ‘creating an active foot in preparation for 
stance/gait’ and compression was incorporated into this 
Section 
Specific sensory 
input 
Altered to reflect the foot and hot/cold stimulation added 
Isolated selected 
movement 
Descriptions altered to reflect application to the lower 
limb 
Patterns of 
coordinated 
movement 
Descriptions altered to reflect application to the lower 
limb 
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 Phase two 
All 12 participants commented on any alterations considered necessary to 
iteration two suggesting changes, which are summarized in table 5.11, and on 
the usability and appropriateness of the content of the lower limb schedule, 
indicating whether they felt it reflected clinical practice (Appendix 22). 
 
Table 5.11 Changes made to iteration two to develop iteration three of 
the lower limb MTS schedule 
 
Subsection Changes made to schedule 
1. Massage and soft 
tissue stretch 
Techniques added: stretch of extensor hallucis 
longus; massage in between the toes and down 
the length of the toes; and dissociation of 
gastrocnemius and soleus. 
2. Creating an active 
foot in preparation for 
stance/ balance 
Techniques added: lumbrical exercises; 
compression through the lateral border of the foot.  
Correction of a typographical error. 
Also, additional space created for further details to 
be added in relation to the placing of the foot on 
different surfaces. 
6. Patterns of 
coordinated movement 
underlying functional 
activity 
Techniques added: heel raise; sit-to-stand was 
changed to sit-to-stand-to-sit; a functional mobility 
section including transfers, obstacle course and 
manoeuvring was added. 
Tick boxes were added for the position of sitting 
and standing and moving sideways in relation to 
weight transference, and to enable documentation 
of whether the person was walking independently 
or required assistance from a therapist to walk.   
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The alterations (table 5.11) were then clearly highlighted in iteration three 
(Appendix 19), which was sent out to the participants in advance of the mNGT 
meeting. Specific points were noted for discussion and clarification at the 
mNGT meeting, and clear objectives for the meeting were set around seeking 
agreement or consensus on: 
i) whether the hip and knee should be placed in a specific position during 
passive movements 
ii) dose and intensity of the intervention (Hoffmann et al., 2014), and of 
individual subsections of the intervention, such as number of repetitions of 
passive or accessory movements, and duration of soft tissue or joint stretch 
iii) the range of movement to be achieved during passive and accessory 
movement 
iv) who would deliver the treatments, and adherence to the intervention, in 
line with the TIDieR framework (Hoffmann et al., 2014) 
v) Final content and format of the MTS schedule for the lower limb 
 
Participant’s comments (see below, with further examples in Appendix 22, 
presented with pseudonyms) in relation to iteration two, were extremely 
encouraging, confirming that the schedule was a) comprehensive, b) easy to 
use, and c) accurately reflected current clinical practice: 
 
“The new schedule is very comprehensive and there doesn’t seem to be 
anything missing”. (Participant 10). 
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“Overall, in terms of the actual treatment carried out, I think it is 
pretty comprehensive and accurately reflects practice”. 
(Participant 5). 
 
“The treatment schedule is great, very thorough” … “very detailed but 
easy to read and follow”. (Participant 1).  
 
“The treatment protocol is very comprehensive and good that it 
is on one page. The aims of treatment section would cover my 
aims of treatment fully. The specific treatment sections also 
reflect my current practice”. (Participant 6). 
 
 Phase three 
Eight of the 12 participants who contributed to the pre-group activity attended 
the group meeting (participants 1, 2, 5, 6, 8, 9,10 and 12). There was a range of 
experience with NHS bands 6, 7 and 8 represented, and participants from two 
of the three trusts. The other four participants were unable to attend due to a 
car accident on the way to the meeting (participant 3), work commitments 
(participant 4), personal commitments (participant 7) and illness (participant 
11). 
 
All participants’ views were considered in relation to Iteration 3 of the MTS 
schedule, and the specific objectives were addressed. Discussion took place 
concerning the hip and knee position during passive movements. There was 
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100% consensus that the specification of the hip and knee being in ‘alignment’, 
should be removed from the schedule. The rationale behind this decision was 
that participants felt it was important to individualize the passive movements, 
making them relevant for each individual patient; this may necessitate working 
with the hip and knee in different positions (objective i).  
 
Detailed discussions took place with the eight clinicians at the mNGT meeting 
in relation to an appropriate length of time (intervention dose) for the MTS 
treatment. Based upon the information in the literature and their clinical 
experience as to what was likely to be required, a decision was made that an 
intervention length of time of 30-60 minutes would be appropriate, allowing for 
MTS to be delivered according to the needs of the individual participant. This 
reflected the optimum dose suggested by Hunter et al (2011) of 37–66 minutes 
(objective ii). It was important that the dose was feasible, for both the 
researchers and participants to facilitate adherence to the intervention 
(objective iv). Specific numbers of repetitions of dose and intensity of the 
intervention (Hoffmann et al., 2014), and of passive or accessory movement, 
and duration of soft tissue or joint stretch the range of movement would be 
participant-specific according to need (objectives ii and iii). It was deemed to be 
important that the research therapists delivering the MTS protocol have the 
expertise to be able to deliver it appropriately and should be appropriately 
trained to deliver standardized MTS treatments, individualized to the 
participant’s needs (objective iv). All the participants agreed with the content of 
the final MTS schedule for the lower limb (objective v), stating it closely 
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resembled techniques undertaken in clinical practice. The final agreed lower 
limb MTS schedule is presented in figure 5.5.  
 
It is acknowledged that some of the rehabilitation strategies in the MTS protocol 
overlap with those in the TSGT e.g. stepping, sit to stand to sit; however, the 
way that these rehabilitation tasks would be undertaken are different, because 
MTS is hands-on therapy and TSGT is delivered as a hands-off approach.  
 
The mNGT session was observed by a second researcher and a critique was 
undertaken; positive feedback in the report confirmed the success of the 
session (Appendix 23).  
  
190 
 
    TREATMENT SCHEDULE FOR MOBILIZATION AND TACTILE STIMULATION  
                        TO THE LOWER LIMB (MoTaStim-Foot)                                      FORM N (i) 
                  Date:                Pt ID                    Position of patient:                    Length of session:            Therapist: 
   
         
 
Treatment  
No:  
Name  Signature (person completing form) D        D      M      M      Y      Y     Y    Y 
Version 1_ 1-12-15 
    
AIMS (Please tick) 
❑ Regain normal extensibility of skin, muscle, connective tissues, tendons and joints to enable foot to accept base of support 
❑ Reduce hypersensitivity or pain 
❑ Heighten awareness foot position and posture 
❑ Normalize tempero-spatial activation of muscle during functional activity (accuracy, quality of movement, normalise balance reactions) 
❑ Normalize afferent stimulation arising from functional activity 
❑ Normalize performance parameters (smoothness, accuracy, co-ordination, reciprocal activation, strength) for movement, balance and gait. 
JOINT MOBILZATIONS: 
1a)   PASSIVE MOVEMENTS THROUGH ANATOMICAL RANGE (NB NOTE  ANY RESTRICTIONS) 
❑ Knee flexion / extension 
❑ Talo-crural (ankle) joint – dorsiflexion / plantarflexion                                                                                   
❑ Talocalcaneal (subtalar) joint – Supination – adduction, inversion and plantar flexion of calcaneus  
❑                                                   Pronation – abduction, eversion and dorsiflexion 
❑ Metatarsophalangeal joints - flexion / extension / abduction / adduction 
❑ Interphalangeal joints – flexion / extension 
❑ 1st ray (hallux)  – Flexion / extension 
1b)   ACCESSORY MOVEMENTS (TICK AND INDICATE TYPE e.g. GLIDE, DISTRACTION, AND DIRECTIONS e.g. AP, PA, etc.) 
❑ Talocrural (ankle)      Sub talar        Talonavicular  
❑ Calcaneal glide – inversion / eversion (medial /lateral) / A-P glide, distraction 
❑ Calcaneocuboid A/P 
❑ Naviculocuneiform 
❑ Cuboid – 4-5 metatarsal 
❑ Tarsometatarsal 
❑ Metatarsophalangeal Jts 1-5 A/P 
❑ Interphalangeal Jts 1-5 
SOFT TISSUE MOBILIZATIONS: 
2) MASSAGE AND SOFT TISSUE STRETCH (TICK AND NAME BODY PARTS MASSAGED / TISSUES STRETCHED) 
❑ Effleurage for oedema management 
❑ Gastrocnemius and soleus mobilization - kneading      picking up     dissociation of gastrocnemius from soleus     
❑ Deep soft tissue massage to the tendo Achillis 
❑ Stretch to gastrocnemius 
❑ Stretch to soleus 
❑ Stretch to tendo Achillis 
❑ Extensor hallucis stretch 
❑ Anterior tibialis mobilization (kneading/ picking up) 
❑ Abductor Hallucis mobilization (stretch / kneading/picking up) 
❑ Abductor Digiti Minimi mobilization (stretch / kneading/picking up) 
❑ Deep soft tissue massage to the plantar fascia (sole of foot) 
❑ Sustained stretch – flexor digitorum                                                               
❑ Sustained stretch – flexor hallucis 
❑ Massage in between and along length of toes 
❑ Other (state)                                                                                                               
PREPARATION FOR FUNCTION: 
3) CREATING AN ACTIVE FOOT IN PREPARATION FOR STANCE / BALANCE 
❑ Compression - MTP joints 
❑ Talocalcaneal compression  
❑ Compression through lateral border of the foot and little toe 
❑ Compression through shank of LL 
❑ Placing the foot orientation to the floor, sitting      perched standing       standing  
❑ Placing the foot on different surfaces - Details............................................................................................................................................ 
❑ Lumbricals strengthening 
❑ Heel contact with floor 
❑ Other (state) 
4) SPECIFIC SENSORY INPUT (TICK AND NAME OBJECTS OR BODY PARTS) 
❑ Visual 
❑ Tactile stimulation, use of different textures/surfaces, somatosensory input, varying speed and depth of contact, to stimulate and also 
desensitise 
❑ Hot/cold stimulation 
❑ Active touch (objects e.g. changing surfaces, uneven ground) 
❑ Passive touch (objects e.g. rolling foot over a ball) 
5) ISOLATED / SELECTIVE JOINT MOVEMENT (TICK AND STATE DIRECTION OF MOVEMENT) 
❑ Talocrural joint (Ankle) – dorsiflexion/ plantarflexion           Passive          Active assisted          Active  
❑ Subtalar joint – inversion / eversion  
❑ Toe flexion / extension 
6) PATTERNS OF CO-ORDINATED MOVEMENT UNDERLYING FUNCTIONAL ACTIVITY 
❑ Activities in sitting e.g. rolling foot over ball, facilitated heel strike, heel raise                
❑ Sit to stand to sit 
❑ Weight transference -  in sitting       standing       medial / lateral       Forwards / backwards      sideways        
❑ Stepping (including toe off and heel strike) – forwards       backwards 
❑ Functional mobility      Transfers       Obstacle course        Manoeuvring                        
❑ Stairs                                                                                                                                     Assistance required         Independent 
❑ Other (please state) 
Comments:  
Comments:  
Comments: 
Comments: 
Comments: 
Comments: 
  
Figure 5.5  Final treatment schedule for delivering MTS to the lower limb 
191 
 
The process and success of Study 2, the intervention modelling study, as well 
as strengths and limitations will be deliberated in the discussion chapter 
(chapter seven). 
 
The findings from Study 2, including the standardized protocols for MTS, 
wearing TIs and TSGT were used to inform Study 3 MoTaStim-Foot – the 
mixed methods, randomized blinded feasibility study exploring somatosensory 
stimulation of the foot and ankle early post-stroke.  
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6 CHAPTER SIX: STUDY 3 - SENSORY STIMULATION 
OF THE FOOT AND ANKLE EARLY POST-STROKE: 
A FEASIBILITY STUDY (MoTaStim-Foot) 
 
 Introduction 
Following the successful development, in Study 2, of protocols for the three 
interventions, MTS, TI wearing, and TSGT, the aim of Study 3 was to 
investigate the feasibility of a future adequately powered RCT of MTS plus 
TSGT compared to the wearing of TIs plus TSGT for the lower limb in stroke 
survivors. This chapter will consist of the methods and results for Study 3.  
 
The objectives for the feasibility study were stated in chapter four, section 
4.4.2.3, and for convenience are restated here. The purpose of a feasibility 
study is solely to explore the feasibility of delivering the study interventions 
(research objective 3.1), recruitment methods (objective 3a), attrition rates 
(objective 3b), acceptability of interventions (objective 3d), potential response to 
treatment (objective 3g) and suitability of OMs (objective 3f), these were, 
therefore, the aspects monitored. Examining the effectiveness of the chosen 
interventions was not an aim of this study.  
 
Criteria for determining feasibility were: demonstration of the successful 
recruitment of stroke survivors meeting the inclusion criteria, and ability to 
deliver the interventions, as well as whether the interventions and OMs are 
acceptable to stroke survivors. 
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Objective 2.1 related to Study 2 and the development of the three standardized 
protocols, and objective 3.1 was to determine feasibility of delivering a trial 
comparing MTS+TSGT with TIs+TSGT. Objectives 3a-3h relate to Study 3, the 
MoTaStim-Foot feasibility study and were to: 
3a Find out if recruitment methods are effective, analysing the recruitment rate 
and associated data including:  
i. number of people invited to participate. 
ii. number and proportion of those agreeing to consent to participate. 
iii. number of those eligible to participate. 
3b Monitor and analyse the number of people who drop out of the trial (attrition 
rate). 
3c Gain pertinent information to inform an appropriate and feasible sample size 
for a future study. 
3d Explore participants’ experiences of interventions and their views on the 
acceptability of the treatments and method of delivery as interventions for a 
future study. 
3e Investigate whether daily diaries and FGs are suitable ways to capture and 
explore stroke survivors’ experiences of the interventions. 
3f Investigate feasibility (cost and acceptability to participants) of a battery of 
OMs for sensorimotor impairment (feeling/sensation and movement) and 
lower limb function and balance, to inform the choice of primary and 
secondary OMs for a future trial. 
3g Explore responses to either intervention (MTS plus TSGT, or TIs plus 
TSGT) over time and in relation to the number of treatment sessions 
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delivered; this will help to determine the most appropriate duration of 
therapy in a future trial. 
3h Generate information regarding the participants recruited i.e. participant 
demographics, clinical characteristics, including time since stroke, type of 
stroke and previous impairment affecting the ability to walk, to ensure 
baseline characteristics of the two groups are comparable and to inform 
future studies. 
 
 Research ethics approval 
Research ethics approval for this study was obtained from the National 
Research Ethics Service (4/3/16), IRAS No: 171968 / REC Ref 16/WM/0080 
(Appendix 24). The ISRCTN trial registration number is 13676183 and Central 
Portfolio Management System ID 30449. Keele University was the sponsor of 
the trial. 
 
 Methods 
 Trial design 
A randomized, single-blinded feasibility trial was undertaken, using a mixed-
methods design involving the collection of both quantitative (experimental) and 
qualitative (daily diaries and FGs) data. An overview of the trial is given in figure 
6.1. Full details regarding the trial processes can be found in the MoTaStim-
Foot trial protocol (Appendix 25), which was scrutinized and subsequently 
approved by the University of East Anglia Clinical Trials Unit Protocols 
Committee on 14/1/16.  
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The OMs were undertaken at baseline (prior to randomization), after twenty 
sessions of the intervention of either MTS+TSGT or TI+TSGT (delivered within 
a 6-week period, according to the agreed protocols reported in Study 2, chapter 
five), and at one-month follow-up. Inter-intervention phase OMs were also 
undertaken after five, ten and fifteen interventions, and participants kept a daily 
diary during the intervention phase. Post-trial, participants were invited to 
participate in a FG to explore the acceptability and feasibility of the 
interventions and OMs. If participants were receiving NHS therapy (usual care), 
this continued alongside the trial interventions and the dose and content of 
routine lower-limb therapy provided was recorded on a therapy treatment 
record (Pomeroy et al., 2005) by the clinicians delivering routine care (Appendix 
26). A post hoc analysis of usual care will be undertaken as part of a separate 
research study. 
 
As detailed in the MoTaStim-Foot protocol (Appendix 25) ethical approval was 
also granted for including blood flow studies to ascertain the effects of the 
treatments, endeavoring to develop the scientific basis behind the interventions, 
for example establishing if changes to sensation, movement and blood flow are 
seen following MTS, and also the wearing of TIs. However, the researcher who 
intended to undertake the blood flow studies was unable to dedicate the 
necessary time to data collection during the MoTaStim-Foot trial, and therefore 
this aspect could not be undertaken.  
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RANDOMIZATION  
Mobilization and tactile stimulation (MTS) + 
task-specific gait training 
20 sessions over 6-week intervention phase 
Textured insoles (TIs)  
+ task-specific gait training 
 
20 sessions over 6-week intervention phase 
Data collection during intervention phase 
Daily diary relating to experience of interventions 
Lower Extremity Motricity Index and sensory threshold testing  
after 5,10 & 15 interventions 
Outcome measures 
FAC, 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing  
Within 7 days of completing the intervention 
Follow up outcome measures  
FAC, 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing 
At one month ± 7 days after completing the intervention 
Focus group 
To explore participants’ views regarding the acceptability and feasibility of 
the interventions and outcome measures 
After completion of all interventions and outcome measures 
Baseline 
Clinical Measures including: NIHSS, Functional Ambulation Classification 
(FAC), 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing 
Informed consent 
mRMI – modified Rivermead Mobility Index 
NIHSS – National Institutes of Health Stroke Scale 
Figure 6.1 Overview of the trial design 
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 Rigour of the trial 
The rigour of this feasibility study was improved by following the CONSORT 
2010 statement: extension to randomized pilot and feasibility trials guidelines 
(Eldridge et al., 2016; Moher et al., 2012). As this was a mixed-methods design 
rigour needed to be considered for collecting both quantitative and qualitative 
data; a methodology was chosen for the feasibility study that increased the 
internal and external validity of the research. External validity relates to whether 
the findings from the study sample can be generalized to the population from 
which the sample was selected (Sim and Arnell, 1993), whereas, internal 
validity is dependent upon the design of the research enabling variations to be 
directly attributable to changes in the independent variable (Polgar and 
Thomas, 2000).  
 
For quantitative research designs the terms internal validity, external validity 
and reliability are used when considering the rigour of the research design. 
Guba and Lincoln (1989, p.233-243) suggested alternative terminology when 
considering the rigour of qualitative research designs, advocating the use of the 
term ‘trustworthiness’, which consists of ‘credibility, transferability, 
dependability, and confirmability’, and it has been reported that it is the 
responsibility of the researcher to ensure rigour and trustworthiness (Nowell et 
al., 2017). A robust methodology enables credibility to be achieved, obtaining 
and analyzing appropriate data to address the research question (White et al., 
2012). Transferability relates to the generalizability of the information to other 
cases, and dependability can be achieved by implementing a systematic audit 
trail, enabling an external person to understand how the researcher reached 
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their conclusions, with reflexivity (consideration and documentation of the 
researcher’s opinions and biases) a key element (Tobin and Begley, 2004). In 
order to address reflexivity, consideration of the researchers own biases was 
essential, especially because the researcher was working as one of the 
research therapists in the study. This was achieved in several different ways: 
After the first participant had been treated a detailed discussion took place 
between the researcher (PhD student/NIHR fellow) and her supervisors. The 
outcome of this meeting was a deeper understanding of how important it was to 
follow protocols strictly, ensuring influences relating to previous neurological 
therapy expertise were not utilised. The specifics and outcomes of the 
discussion were considered in greater depth by undertaking a detailed 
reflection. It was important to ensure none of the researcher’s own opinions and 
biases influenced the implementation and analysis of the MoTaStim-Foot study. 
Other mechanisms built into the design to address reflexivity were the 
involvement of a PPIE advisor within the focus groups, who assisted with the 
final summary verifying the content of the discussions, helping to ensure any 
potential for researcher bias was addressed. The debrief meetings after each 
focus group enabled an opportunity for further analysis and discussion if any 
researcher bias had been present. Furthermore, the regular trial management 
group meetings ensured a rigorous overview of the trial was undertaken, 
involving many different independent people who could advise and oversee that 
researcher bias was not threatening the running of the trial.  
 
Confirmability relates to whether the themes developed have resulted from the 
data itself, rather than the researcher’s opinions and pre-conceptions (Tobin 
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and Begley, 2004). All these aspects were taken into consideration when 
designing the MoTaStim-Foot feasibility study, for example, triangulation 
occurred in relation to the use of more than one method of data collection and 
several researchers analysing the FG data, both enhancing credibility.  
 
The OMs for the feasibility study were carefully selected. Psychometric 
properties of the measurement tools were considered to enhance the internal 
validity of the feasibility study. There are four distinct forms of measurement 
validity when considering quantitative data: face validity is present if the chosen 
tool or assessment measures the variable of interest; content validity is 
concerned with the ability of a tool to measure all the individual aspects of a 
domain (Sim and Wright, 2000); criterion-related validity exists when a 
measurement tool or instrument accurately represents the measurements that 
would be obtained when an accepted validated measure is used (Sim and 
Arnell, 1993); and construct validity depends upon the theoretical background 
within which a measure is used (Sim and Wright, 2000).  Reliability of OMs was 
also researched prior to using them in the MoTaStim-Foot feasibility study.   
 
Other aspects of the trial which increased the internal validity were 
randomization, which will be discussed in section 6.3.8 and blinding (section 
6.8). Internal validity was also increaed by ensuring the research staff were 
suitably trained to enable standardization of procedures for delivery of both 
interventions and OMs, following strict protocols (reducing external factors and 
variables which may influence the results, (Hicks, 2010)). These aspects 
relating to Study 3 (the mixed-methods feasibility study) all increased the 
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internal validity within the trial (Downs and Black, 1998), an aspect which will be 
important for the future adequately powered RCT.  
 
 Population and sample 
Participant inclusion and exclusion criteria  
 Inclusion criteria 
(i) Adult stroke survivors (aged 18 years or older), with anterior or 
posterior circulation stroke, occurring 6–16 weeks (42–112 days) 
earlier. 
(ii) Able to walk independently prior to stroke with or without a walking 
aid. 
(iii) Able to follow simple commands and imitate actions, using the non-
paretic upper limb. 
(iv) Unable to step on and off a 7·5 cm high block more than 12 times in 
15 seconds with either their paretic or non-paretic leg  (Hill et al., 
1996). 
(v) Able to provide written informed consent. 
 
Careful consideration was given to the time post- stroke for inclusion within the 
trial. The chosen timing aligns well with advice from SRRR (Bernhardt et al., 
2017b) falling between the early subacute phase (seven days to three months) 
and the late subacute phase (three to six months) in a time-period where there 
is still potential for endogenous plasticity and improvement of impaired function. 
Furthermore, the most likely period for recovery of walking post-stroke is 
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between 4-7 weeks (Kollen et al 2006); in order to explore the effects of 
mobilization and tactile stimulation (MTS) / TIs – as opposed to natural, 
expected recovery – participants were recruited at the end of this period 
associated with best recovery.  
 
The justification for including posterior circulation strokes as well as anterior 
circulation relates to the importance of the cerebellum for balance and gait, as 
discussed in chapter two (section 2.5). There will be further discussion relating 
to this aspect in chapter seven. 
 
It was intentional that there were no inclusion criteria relating to specific sensory 
impairment; the inclusion criteria were kept intentionally wide, because part of 
the reason for the feasibility study was to explore the appropriateness of the 
inclusion criteria. Proprioceptive awareness occurs at both a conscious (Cohen, 
1999) and subconscious level (Takakusaki, 2017) and therefore it was important 
to be inclusive, in order to inform selection of inclusion criteria for future studies.  
 
 
 Exclusion Criteria 
(i) Pre-existing conditions affecting sensation (feeling) of the foot and 
lower limb e.g. diabetic neuropathy, polyneuropathy, peripheral nerve 
lesion, previous stroke affecting the sensation of the lower limb. 
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(ii) Fixed contracture of the tendo Achillis, assessed by being unable to   
achieve 90 degrees dorsiflexion at the ankle, either actively or 
passively, with the knee extended. 
(iii) Pressure sores or ulcers on the foot or ankle (hemiparetic limb), due 
to the risk of infection. 
(iv) Deep vein thrombosis, because some of the MTS techniques would 
be contraindicated. 
(v)      Other conditions that affect the blood supply to or from the foot, e.g. 
heart failure with peripheral oedema. 
(vi) Botulinum toxin injection to the lower-limb in the previous six months,  
because it may have an impact on the results. 
(vii) Pain sufficient to prevent delivery of treatments or outcomes. 
(viii) Known HIV, hepatitis non-A or related condition (to meet sponsor  
requirements). 
 
 Sample size 
The sample size for the quantitative element of the feasibility study was 
calculated as 34. A sample size of 30 has been suggested as the lower limit for 
calculating the number of participants that will be required for future studies in 
terms of an estimate of the standard deviation of values on a continuous OM 
(Browne, 1995). Recruitment of a sample of 34 participants was planned to 
account for approximately 10% drop out and enable potentially equal numbers 
(n=17) in each arm of the trial; this was the largest sample size considered to 
be feasible in the available time-period. Whilst it was not the aim of the 
feasibility study to demonstrate effectiveness, it is acknowledged that a sample 
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size of 34 is relatively small and could influence the results of the trial. 
Nevertheless, the sample size for a feasibility study just needs to be large 
enough to assess the aspects identified in the study’s objectives (Thabane et 
al., 2010). It can, therefore, be argued that a sample size of 34 was adequate to 
meet the needs of this feasibility study. 
 
As this was mixed-methods research, FGs were also undertaken, with all trial 
participants being invited to attend. Two FGs were conducted for each arm of 
the trial. A PPIE adviser was note taker, writing the field notes during each FG. 
Furthermore, the PPIE volunteer assisted the researcher with a summary at the 
end of each FG, helping to ensure the researcher had interpreted the 
participants’ opinions appropriately, by offering a lay opinion from someone who 
has experience of stroke rehabilitation. In addition, the participation of three 
different researchers and a PPIE advisor when analyzing the data ensured 
investigator triangulation occurred, providing opportunities for individual 
opinions to inform a collective analysis enabling robust conclusions to be drawn 
(Carter et al., 2014).  
 
 Setting 
The trial was set in a local NHS Trust hospital in which stroke rehabilitation 
occurred as an in-patient, or as part of the early supported discharge services, 
in conjunction with a community-based stroke team. The stroke team clinicians 
had been involved with other similar studies and were supportive of the 
research, which was an essential element since their assistance was required 
when identifying suitable participants. All treatments and assessments were 
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delivered either in the hospital or at the participant’s place of residence in the 
community. 
 
 Recruitment 
Adult stroke survivors meeting the criteria for the study, who were undertaking 
in-patient rehabilitation on the ward at the hospital or receiving treatment as 
part of the Early Supported Discharge team were invited to participate in the 
study. Potential participants were identified by research nurses or the 
multidisciplinary teams caring for the stroke survivors in keeping with Good 
Clinical Practice (GCP) and Data Protection Act standards.  
 
A clinical team member or Clinical Research Network (CRN) research nurse 
initially approached potential participants to establish whether they would like to 
find out more about the trial.  Oral consent was sought for a member of the 
research team to look at their medical notes. The screening and consenting 
processes are summarized below, and detailed in figures 6.2, 6.3 and 6.4 and 
in the MoTaStim-Foot protocol (Appendix 25). 
 Screening and consent 
 Stage one of the screening process 
Stage one of the screening process (case note review) (figure 6.2) occurred to 
determine whether the stroke survivor was potentially eligible for the trial 
according to age, time since stroke and type of stroke, in accordance with 
inclusion criteria (i), and had a previous ability to walk independently (inclusion 
criteria ii). 
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If potential participants were interested but did not meet the inclusion criteria, a 
member of the research team met with the participant and thanked them for 
their interest and explained that, at the current time, they did not currently meet 
the criteria. If there was a chance the potential participant may become eligible 
in the future, for example, according to time after stroke or a healing wound, it 
was explained that they could be reassessed for the trial later.  For interested 
potential participants who met the inclusion criteria, the purposes of the trial 
were explained by a member of the research team, clearly delineating what is 
research and what is clinical practice; explaining potential benefits and risks 
and going through the PIS (Appendix 27). PIS refers to the summary and full 
PISs, which were developed in collaboration with PPIE representatives; emails 
relating to their comments about the PIS information are available at Appendix 
28. Any questions the potential participant had were answered, and the 
potential participant was left with a PIS to read and consider further. A record 
was kept of the contact and leaving of the PIS, and members of the clinical 
team were also informed either orally or in writing. 
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.. 
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…at date of screening 
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Record and monitor if potential 
for meeting criteria or else end 
Figure 6.2  Initial screening process 
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Figure 6.3  Participant eligibility pathway 
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Once participants had been given as much time as they needed, had any 
further questions answered, and established that they wished to take part in the 
trial, written informed consent was taken (Appendix 29). Details regarding 
consent to participate in the trial were then documented in the participant’s 
medical notes and discussed with members of the clinical team.  
 
In view of (a) the inclusion and exclusion criteria necessary for this trial (section 
6.3.3), and (b) the wish not to create conflicts of interest or create extra work for 
the clinical team, further eligibility screening (Stage 2) (figure 6.4) of potential 
participants was required after participants had given consent. Participants 
were informed that, if they provided consent, there would be a few measures 
undertaken to check they met all the eligibility criteria for the trial. 
  
 Stage 2 of the screening process 
Stage two of the screening process involved additional tests being explained to 
the participant and subsequently undertaken by a research therapist: 
(i) Assessment for fixed flexion contracture of the tendo Achillis 
(ii) The step test (Hill et al., 1996), which was used to avoid recruitment 
of stroke survivors who only had minimal lower-limb dysfunction. The 
number of steps in 15 seconds onto a 7.5cm step (>12 each leg) was 
decided upon after researching normal values in healthy patients and 
stroke survivors (Hill et al., 1996).   
(iii) Ability to follow simple commands by imitating actions.  Simple 
screening procedures were used, in the stage 2 screening process, 
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to make sure the potential participants could follow simple commands 
and undertake a task involving imitating actions.  
 
If a participant did not meet the eligibility (inclusion and exclusion) criteria but 
indicated continuing interest, then he or she was followed up no more than 
three times a week (frequency depended on speed of recovery) until he or she 
either (i) withdrew consent, (ii) met all eligibility criteria, or (iii) reached the 
maximum time since stroke for recruitment into the trial. 
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Figure 6.4 Stage 2 eligibility screening 
211 
 
Some stroke survivors have trouble making decisions. Before approaching a 
potential participant, the researcher discussed the decision-making capacity of 
individuals with the clinical team. If the clinical team believed that the 
communication impairment was too great to allow an individual to give informed 
consent, then the potential participant was not approached. If the clinical team 
conclusion was that informed consent was possible, albeit with the use of 
enhanced communication strategies, then the researcher approached the 
potential participant and adapted their communication strategies, as required, in 
relation to the provision of information relating to the trial. It was ensured that 
the participant understood the information about the trial and potential 
consequences of being involved in a trial before being asked to provide written 
informed consent. 
 
At all times during the consent process, it was made explicit that the participant 
was free to refuse to participate in all or any aspect of the trial, at any time and 
for any reason, without incurring any penalty or affecting their treatment. 
Important aspects regarding consent were considered and consent was only 
taken by researchers who had completed GCP training and had a working 
knowledge of the Mental Capacity Act (2005). The important aspects of 
consent, include: (i) understanding the purpose and nature of the research; (ii) 
understanding what the research involves, its benefits (or lack of benefits), risks 
and burdens; (iii) understanding the alternatives to taking part; (iv) able to retain 
the information long enough to make an effective decision; (v) able to make a 
free choice; and (vi) capable of making this particular decision at the time it 
needs to be made (NIHR, 2016).  
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Some participants had dominant arm weakness and difficulty signing the form, 
or speech problems. If this was the case, an independent witness signed the 
consent form, if required, on behalf of the participant. This was either a family 
member or one of the clinical team working with the patient, but not a member 
of the trial team.  
 
 Randomization 
After providing informed consent and undertaking the baseline measures, 
participants were randomized to receive one of the two study interventions.  
The randomization procedure was in a 1:1 ratio, with stratification by left or right 
stroke.  Stratification aimed to ensure an equal number of right-and left-sided 
strokes in each treatment group. This was achieved using permuted block 
randomization in blocks of four and two. The decision to stratify in accordance 
with side of the stroke was made because it has been reported that the 
rehabilitation potential for people with right and left-sided strokes may differ. 
Alexander (1994) demonstrated that there was significantly less reported 
change for people with a right-sided lesion than a left (p =.0354) when the 
Functional Independent Measure was assessed at admission and discharge. 
 
The randomization sequence was generated before the trial commenced and 
Professor Julius Sim, the statistician for the trial, provided the randomization 
order to Norwich Clinical Trials Unit (CTU).  The allocation order was concealed 
from the research team (Clark et al., 2016) by using a 3rd party randomization 
service  (Norwich CTU).  The order was revealed to the research therapists 
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after baseline measures were made for a participant by an automated computer 
randomization system.  
 
 Baseline characteristics 
To meet objective 3h, information was collected regarding the participants 
recruited – i.e. participant demographics, clinical characteristics, including time 
since stroke, type of stroke and previous impairment affecting the ability to 
walk. The National Institutes of Health Stroke Scale5  (NIHSS) (Appendix 30) 
and FAC (Appendix 31) were used to characterize the clinical presentation of 
the participants.  
 
The FAC is a six-point scale used to assess walking ability and categorize 
functional walking according to basic motor skills, resulting in ordinal data. It 
has been found to be valid and responsive, with excellent intra-rater reliability 
(Cohen k=.950) and inter-rater reliability (k=.905) in stroke survivors (Mehrholz 
et al., 2007). The assessments were standardized by ensuring appropriate 
training of the assessors, and if any issues relating to recording of scores 
arose, discussions involving the Chief Investigator took place until consensus 
was reached.  
 
The NIHSS is an established, valid, widely used assessment tool that provides 
a quantitative measure of stroke-related neurologic deficit (Meyer and Lyden, 
2009). The maximum total is 42; however, due to the inherent design of the 
 
5 http://www.nihstrokescale.org/ 
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scale, even a patient in a coma can only reach a maximum score of 39 (Lyden, 
2017); a lower score indicates less impairment, with the optimum score being 0 
(no impairment). Also, the weighting within the NIHSS is organized such that 
someone with a left hemisphere lesion with stroke and speech and language 
difficulties will score four additional points over and above someone with a right-
sided lesion (Lyden, 2017). It was designed for use in trials involving stroke 
participants (Brott et al., 1989) with overall interobserver reliability >.98 reported 
for physicians and study coordinators following training (Goldstein and Samsa, 
1997). Although responsiveness of the NIHSS is not as high as the Stroke 
Impairment Assessment set and the Canadian Neurological scale (Seki et al., 
2014), this was not considered to be relevant in this study since the 
assessment of clinical presentation of the participants was only undertaken at 
baseline. The NIHSS assessment is relatively quick to undertake (less than ten 
minutes) (Brott et al., 1989), and on-line training is now readily available, which 
has been shown to be useful for standardization of assessment scales (Lyden 
et al., 1994). This was deemed to be an important resource for ensuring 
appropriate training of the research therapists in this trial. Consequently, all 
research therapists and assessors undertaking the NIHSS in this trial were 
trained in this way, being required to complete the online NIHSS training and 
therefore be certified prior to assessing any participants.  
 
 Outcome measures 
To address study objective 3f, (sections 4.4 and 6.1), a range of OMs were 
included in this study. As this was a feasibility trial, one of the objectives was to 
identify which measure should be the primary OM for future trials. 
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Consequently, each OM used was evaluated according to acceptability for 
participants (from the information in the daily diaries and FGs), clinical 
relevance (from evidence in the literature and FG analysis), ease of use 
(feedback from research therapists and assessors and also from the FGs), 
quality of data collected (from analysis of the results), validity and reliability 
(from information in the literature). The outcomes evaluated are summarized 
(including their psychometric properties) in table 6.1 and described in more 
detail within this chapter.  
 
 Consideration of alternative outcome measures 
When deciding the measures that should be used to screen participants, 
screening for unilateral spatial neglect was also considered; however, a 
decision was made that as this was a feasibility study it was important to be as 
inclusive as possible. When designing the trial, the inclusion of a quality of life 
measure was also considered. However, quality of life is a multi-faceted 
construct, influenced by, for example, age, gender, marital status, 
socioeconomic status, level of education, extent of disability after stroke, 
depression or anxiety, cognitive impairment, incontinence and other 
comorbidities, as well as social factors and self-management strategies (Wang 
and Langhammer, 2018); it was not the purpose of the feasibility study to 
explore issues relating to quality of life. Any quality of life issues directly 
relevant to the trial experience could be explored through the daily diaries and 
FGs. Other outcome assessments such as the Nottingham Extended Activity of 
Daily living were also considered; however, as some of the participants were to 
be in a hospital setting when receiving the research interventions, it was felt not 
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to be the most appropriate functional OM, and the mRMI was selected instead. 
Gait speed was deemed essential as an OM for the trial, so results can be 
compared to other studies and since it links with assessment of potential as a 
functional ambulator (Perry et al., 1995).  
 
 During intervention phase experience 
Throughout the intervention period, participants were asked to keep a written or 
audio daily diary to help them 'focus their thoughts' (Jacelon and Imperio, 2005, 
p.993), providing qualitative data contemporaneously, relating any changing 
perceptions of their lower-limb, and experiences of the interventions and 
outcomes. The format of the diary involved spaces each day to record aspects, 
for example, whether their foot felt hot or cold, whether the MTS, TIs or TSGT 
were comfortable or uncomfortable etc., as well as space for comments relating 
to the various aspects (Appendix 32 and 33).  
 
As this was a feasibility study it was important to explore whether participants 
perceived any variations to their foot (feeling and movement) or function 
(standing, balancing and walking); any changes, or comments about the 
treatment interventions could be documented in the daily diary sheets, 
contributing a fuller understanding of the comfort and acceptability of the 
interventions and outcome measurements.  The use of diaries during the six-
week intervention period, therefore, facilitated a better insight into the 
participants’ trial experience; an important aspect towards meeting objective 3e.  
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Table 6.1  Summary of outcome measures for the feasibility study 
 
Outcome Measurement tool  Frequency of 
measurement  
Additional information  
 
 
 
 
 
 
 
 
Sensorimotor 
impairment 
Ankle range of motion – 
dorsiflexion/plantarflexion 
Inversion/eversion 
Electrogoniometer 
attached to lower leg 
(lateral border) of 
contralesional foot 
Baseline  
Post-intervention 
One-month follow-up 
Provides ratio-level data (cm) 
Intra-rater reliability r = 0.979 
(Bronner et al., 2010). 
Touch/pressure sensory 
threshold of plantar skin - 
under heel, hallux,1st 
metatarsal phalangeal 
(MTP) joint and 5th MTP 
joint 
Semmes Weinstein 
Monofilaments (SWMs) 
Baseline  
After 5, 10 and 15 
treatments, 
Post-intervention 
One-month follow-up 
Provides ordinal data; filaments are 
numbered 1-20. One represented 
the smallest force (0.008g, 1.65) 
and 20 the largest force (300g, 
6.65).  Intra-rater reliability has been 
reported to be an r value of >0.9 
when a specific protocol was 
followed (Tracey et al., 2012). 
Motor impairment 
(strength) of hip flexors, 
knee extensors and ankle 
dorsiflexors 
Lower Extremity 
Motricity Index (LEMI) 
Baseline  
After 5, 10 and 15 
treatments, 
Post-intervention 
One-month follow-up 
Provides interval level data, for 
individual actions (ankle dorsiflexion, 
knee extension and hip flexion) and 
all actions combined, Pearson 
correlations - good to excellent 
(r = 0.78–0.91), significant  
(p < 0.001), and of high power 
(≥99%) (Cameron and Bohannon, 
2000). Excellent test-retest intra-
rater reliability of the Lower 
Extremity Motricity Index (LEMI) as 
a measure of strength (ICC= 0.93) 
(Fayazi et al., 2012). 
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Lower limb 
function  
and  
balance 
Walking ability Functional Ambulation 
Classification (FAC) 
Baseline  
Post-intervention 
One-month follow-up 
Provides categorical/nominal data.  
Valid and responsive, with excellent 
intra-rater reliability (Cohen k=.950) 
and inter-rater reliability (k=.905) in 
stroke survivors (Mehrholz et al., 
2007). 
Walking speed 5-metre walk test 
(5MWT) (videoed) 
Baseline  
Post-intervention 
ne-mnth follow-up 
Provides ratio-level data (seconds). 
5MWT was shown to have a 
standardized response mean 
(95%CI) of 1.22 (.93–1.50) at a 
comfortable pace and 1.00 (.68–
1.30) at a maximum walking pace 
(Salbach et al., 2001). 
Pressure under the feet 
during stance phase of 
walking 
TEKSCAN pressure 
insoles to record force-
time integral (FTI) and 
centre of force velocity 
(COFV) in an AP 
direction 
Baseline  
Post-intervention 
One-month follow-up 
Provides ratio-level data force time 
integral (FTI) (N/sec) and (COFV) 
(cm/sec). Foot Scan pressure insole 
systems have been found generally 
to provide reliable force and 
pressure data (ICC > 0.75) (Low 
and Dixon, 2010). Pressure insoles 
have shown a very strong degree of 
association when measuring COP in 
an AP direction with Pearson’s 
correlation coefficients - greater than 
0.90 for 67/67 trials (100%) 
(Chesnin et al., 2000).  
Functional mobility Modified Rivermead 
Mobility Index (mRMI) 
Baseline  
Post-intervention 
One-month follow-up 
Provides ordinal level data.  Inter-
rater reliability excellent = 0.98; 
(p<0.001) (Lennon and Johnson, 
2000). 
The minimal clinically relevant 
difference is 4.5 points. 
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Abbreviations: 5MWT Five metre walk test, AP Anterior-posterior, Cm Centimetres, COFV Centre of force velocity, COP Centre of pressure, FAC Functional 
Ambulation Classification, FG Focus group, FTI Force time integral, ICC Intraclass correlation co-efficient, LEMI Lower Extremity Motricity Index, N/sec Newtons 
per second, SWMs Semmes Weinstein Monofilaments.
Participants’ perceptions of the 
acceptability of the interventions and 
Oms 
Daily diaries and FGs Information recorded daily 
throughout the intervention 
period. Attendance at an 
FG on completion of all the 
interventions and 
measures 
FGs were used to provide an insight 
into the participants’ trial 
experiences (Krueger and Casey, 
2000). Interview schedules were 
used. A PPIE advisor assisted with 
note-taking and summarizing the 
information discussed at the end of 
each FG. Braun and Clarke’s (2006) 
six-stage process for thematic 
analysis was broadly followed. 
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 Assessment of sensorimotor impairment 
 Ankle range of motion (dorsiflexion and inversion)  
Ankle range of movement was measured during stance phase, using an 
electrogoniometer6 attached to the lateral border of the lower leg, collecting ratio 
data (degrees). The sensor was set up in accordance with figure 6.5, and the data 
log acquisition unit was calibrated (zeroed) with the participants standing in a 
neutral position (Moriguchi et al., 2007). Dorsiflexion was taken to be positive 
(meaning that movement of the foot up towards the shin resulted in a positive 
reading from the goniometer and plantar flexion was taken as a negative reading); 
the maximum range of dorsiflexion and inversion movement at the ankle was 
recorded during the 5-metre walk test (5MWT). Data were extracted from the 
Biometrics programme and run through a Matlab programme by a technician to 
achieve the results in degrees of movement. Reliability of the electrogoniometer for 
the ankle has been established, with intra-rater reliability r = 0.979 (Bronner et al., 
2010).  
 
  
 
6 http://www.biometricsltd.com/gonio.htm 
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Figure 6.5  Set up for placement of the goniometer 
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 Touch/pressure sensory thresholds (plantar surface of the foot)  
SWMs measure touch/pressure threshold. They comprise a set of 20 filaments7 
that deliver a range of forces, from 0.008g to 300g, when applied perpendicular to 
the skin. The touch test sensory evaluator (table 6.2) was used for the MoTaStim-
Foot trial. 
Table 6.2 Touch-test sensory evaluator8 
 
7 Patterson Medical Ltd. 
8 Sensory evaluator chart, Adapted from North Coast Medical, Inc. (2000) 
SWM 
Number 
SWM 
Code 
Target Force 
(grams) 
Threshold 
 
1 1.65 0.008  
2 2.36 0.02 
3 2.44 0.04                    
4 2.83 0.07 
5 3.22 0.16 
6 3.61 0.4 
7 3.84 0.6  
8 4.08 1 
9 4.17 1.4 
10 4.31 2 
11 4.56 4 
 
12 4.74 6 
13 4.93 8 
14 5.07 10  
15 5.18 15 
16 5.46 26 
17 5.88 60 
18 6.10 100 
19 6.45 180 
20 6.65 300 
 Deep pressure sensation 
only 
Normal plantar 
threshold 
Diminished light touch 
Diminished protective 
sensation 
Loss of protective 
sensation 
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SWMs are the most common method of identifying loss of protective sensation 
(Mayfield and Sugarman, 2000); the assessment involves touching the plantar skin 
using a nylon filament that exerts a specific force when bowed into a C shape 
against the skin for 1 second, as shown in figure 6.6. Intra-rater reliability has been 
reported to be an r value of >0.9 when a specific protocol was followed (Tracey et 
al., 2012), and these filaments have been used previously to record sensation in 
the feet of stroke survivors (Hillier and Dunsford, 2006). 
 
The Nottingham Sensory Assessment was considered; however, it has been 
suggested it is more of a screening tool rather than a detailed somatosensory 
assessment (Connell et al., 2008). The Rivermead Assessment of Somatosensory 
Performance (RASP) (Winward et al., 2002) was also considered as an alternative 
tool for measuring various aspects of sensation (sharp/dull, surface localization, 
temperature, proprioception, sensory extinction and two-point discrimination, as 
well as touch sensation). However, the RASP can take up to 30 minutes to 
complete, and in view of the large battery of OMs already included within the trial, 
it was felt this would be too burdensome for the participants to include. 
Furthermore, the ability to feel touch and pressure was considered to be more 
relevant to this trial, than for example, temperature perception, as the interventions 
were designed to improve awareness of the sensations important for balance and 
gait. Also, the force delivered by the RASP tool for testing pressure is not 
calibrated or standardized, whereas the force delivered by the SWMs is, and 
therefore is more consistent/repeatable (Bell-Krotoski and Tomancik, 1987). 
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 Testing site 
Identification of the minimum pressure/force required to accurately identify 
touch/pressure sensation was measured at four different points on the plantar 
surface of the foot, under the: heel; pad of the hallux; 1st metatarsophalangeal 
(MTP) joint; and 5th MTP joint (figure 6.7). There is no agreement regarding the 
optimum areas to test on the plantar surface of the foot and tailoring of sites to the 
disorder has been suggested (Collins et al., 2010); areas of the foot that are 
important for weight bearing during gait were therefore selected.   
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 Figure 6.6  Demonstrating SWMs used to test the touch/pressure sensory 
threshold 
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Figure 6.7 Points tested with SWMs: 
1. Under the heel, in the midline of the foot, 1 cm forwards of the back of the heel. 
2. Under the pad of the hallux 
3. Under the 1st metatarsal joint 
4. Under the 5th metatarsal head 
Diagram of the foot drawn by P Bailey (2017) 
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 Testing protocol 
There is no consensus relating to the number of monofilaments to use when 
assessing the feet, but the use of all twenty monofilaments is discouraged due to 
the time involved to implement the testing (Collins et al., 2010). In view of this, and 
following consultation of related literature, a strict protocol was developed for the 
MoTaStim-Foot trial (Appendix 34). This protocol took into account that Tracey et 
al., (2012) demonstrated that a three-down-one-up rule was more reliable than a 
two-down-one-up rule, because people were able to differentiate better with a 
larger difference between the forces produced by the SWMs; similarly, the 4-2-1 
stepping algorithm, designed by Snyder et al., (2015), was considered. This 
protocol was rejected in relation to concerns regarding commencing with SWM 
number 12, (4.74, 6g/mm). This force is aligned with diminished sensation (table 
6.2), and not normal plantar threshold sensation; starting at this force could 
sensitise the area being tested, affecting the results. Merkel cells (which detect 
deformation of the skin) are extremely sensitive to the position and velocity of a 
stimulus (Abraira and Ginty, 2013); therefore, this could influence the results of 
subsequent SWM testing.  A starting point of SWM number 4 (2.83, 0.07g/mm) 
was decided upon because it is at the midpoint of the normal threshold for plantar 
threshold normative touch-pressure data. Other protocols commenced using the 
number 12 (4.74,6g/mm) SWM (Snyder et al., 2015), or a 4.5g/mm SWM 
(SENSELab Aesthesiometer, Hörby, Sweden) (Tracey et al., 2012), but no 
justification was offered as to why this level was used as a starting point. In view of 
the fact that stimulation of a site with a SWM with more force than necessary could 
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enhance the next response – that is, it would potentiate synaptic transmission 
(Izhikevich, 2006) –  it was deemed to be important to commence testing at a level 
with less force. 
 
When a level was tested and the participant was able to feel the SWM, the testing 
ensured that the next SWM assessed was at least 3 steps downwards, and the 3 
down one up rule as tested by Tracey et al., (2012) was basically followed. 
However, to ensure all possible SWMs were tested, on two occasions the protocol 
necessitated a jump down of 5 SWMs (due to the larger spread of the normal 
plantar threshold and loss of protective sensation sections). 
 
 Recording results 
In order to record the results, the SWM code, e.g. 4.31, was documented in the 
case report forms. This code represents a log value of the actual force delivered by 
the monofilament (e.g. 2g for the 4.31 coded filament). For the purpose of analysis, 
the results were graded from one to twenty, with one representing the smallest 
force (0.008g, 1.65) and 20 the largest force (300g, 6.65) required to achieve the 
threshold of sensation, resulting in ordinal data. It was decided this was the 
optimum way to record the data. Many researchers consider the SWMs to give 
ratio-level data; however, the force produced by the SWMs does not increase in a 
way that means the increments between each SWM are equal.  
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If a participant was unable to feel any stimulation this was noted, and if the 
research assessor felt the participant’s response was unreliable, this was also 
recorded appropriately.  
 
 Lower Extremity Motricity Index (LEMI) 
The Motricity Index is quick to undertake and is a valid scale for measuring motor 
impairment in the upper and lower limbs after stroke, according to a 6-point scale 
(0–5), based upon the MRC grading (0–5) of muscle strength (table 6.3) (Collin 
and Wade, 1990). It does not assess the quality of movement. Motricity Index 
scores are weighted, taking into consideration the difficulty experienced by patients 
when progressing from one MRC grade to the next, with scores ranging from 0 (no 
movement) to 33 (full strength) for each of three joints tested in a limb, i.e. hip, 
knee and ankle; a final one point is added so it can be scored out of 100 (Collin 
and Wade, 1990). Scores can be treated as interval data (Cameron and 
Bohannon, 2000).  
 
 Reliability and validity 
The Motricity Index has been found to possess criterion-related validity in a group 
of stroke survivors (n=15), with individual joints (ankle dorsiflexion, knee extension 
and hip flexion) and all actions combined; Pearson correlations were good to 
excellent (r = 0.78–0.91), significant (p < 0.001), and of high power (≥99%) for both 
the individual joint scores and the total scores showing good to excellent 
correlations with hand held dynamometer readings (Cameron and Bohannon, 
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2000). A further study with stroke survivors (n=20) also demonstrated excellent 
test-retest intra-rater reliability of the LEMI as a measure of strength (ICC= 0.93) 
(Fayazi et al., 2012).  
 
In the MoTaStim-Foot trial, the LEMI was used to measure motor impairment (loss 
of muscle strength) in the hip flexors, knee extensors and ankle dorsiflexors. Trial 
research therapists (for monitoring fatigue) and assessors (for blinded 
assessment) were trained prior to undertaking the LEMI. Opportunities were 
created to practice using the LEMI, to improve the reliability of the measurements, 
particularly in relation to differentiating between a score of 25 (full movement 
against gravity but weaker than the other side) or 33 (normal power). A 
standardized protocol was developed and followed to further increase reliability 
(Appendix 35).  
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Table 6.3  Lower extremity weighted scores for muscle strength using the 
Motricity Index, compared to MRC unweighted scores 
 
Quality of muscle contraction Motricity Index 
score 
MRC grade 
No movement 0 0 
Palpable contraction in muscle, but no 
movement 
9 1 
Visible movement, but not full range 
against gravity 
14 2 
Full range of movement against 
gravity, but not against resistance 
19 3 
Full movement against gravity, but 
weaker than the other side 
25 4 
Normal power 33 5 
    
 (Demeurisse et al., 1980) 
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 Assessment of lower limb function and balance 
 Pressure under the feet during stance phase of walking 
Force-time integral and centre of force velocity (COFV) in AP direction, including 
centre of force trajectory were measured via pressure insoles, using the F-Scan 
system developed by Tekscan,9 which collects interval data relating to the vertical 
ground reaction force.  
 
The Tekscan F-Scan pressure assessment system uses thin resistive sensors that 
can be inserted into the shoe (figure 6.8) and records ongoing plantar forces 
during gait. Each sensor has 960 separate pressure sensing cells arranged in rows 
and columns. The top and bottom layers of the sensor are 0.02mm thick and made 
of a sheet of polyester, which is laminated (0.076mm) to aid handling of the 
sensor. Pressure insole systems can be portable (MacWilliams and Armstrong, 
2000), flexible, and are worn in the shoe; they measure the contact between the 
foot and the inside of the shoe (Razak et al., 2012), and can provide detail relating 
to abnormal biomechanics within the foot (MacWilliams and Armstrong, 2000).  
 
The only contact between the body and the floor surface when walking 
independently is via the plantar surface of the feet (Ofek et al., 2018; Razak et al., 
2012), and measuring the pressure or force under the feet can give an indication of 
how well the feet are making contact with the floor. The ground reaction force is 
 
9 https://www.tekscan.com/products-solutions/systems/f-scan-system 
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equal in size but in the opposite direction to the force created by the weight-
bearing limb, and can be discussed as a vector with both magnitude and direction 
(Perry and Burnfield, 2010). The combined COPnet of both feet is situated at the 
site of the ground reaction vector (Winter, 1995). The ground reaction force 
waveforms during gait correlate with the COPnet (Winter, 1995).  
 
 Reliability and validity 
Foot Scan pressure insole systems have been found to provide reliable force and 
pressure data (ICC > 0.75) (Low and Dixon, 2010), and have been advocated as a 
suitable method for measuring ground reaction forces, as the COP movement over 
time will correlate with the ground force reaction vector (Winter, 1995). However, 
this conclusion was drawn from analyzing Pedar® insoles which contain 85-99 
capacitive sensors, whereas, Tekscan F-Scan insoles work with resistive sensors 
(Koch et al., 2016). Nevertheless, a study that compared a Parotec insole (which 
has 24 separate resistive sensors, which is the same type as the Tekscan F-scan 
system) data to a force plate, also found a very strong degree of association when 
measuring COP in an AP direction, with Pearson’s correlation coefficients greater 
than 0.90 for 67/67 trials (100%) (Chesnin et al., 2000).  
 
A validated method involving inverse dynamics to calculate the complete ground 
reaction force components from the vertical ground reaction force (both force and 
moment) from the motion data measured with pressure insoles has been 
developed (Forner Cordero et al., 2004). This method was used by Fong et al. 
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(2008) to explore the correlation of pressure insole readings with force plate data; 
excellent levels of correlation in an AP direction (correlation coefficient=0.928) and 
vertical direction (correlation coefficient=0.989) were established, and moderate 
correlation in a medial-lateral direction (r=0.719) (Fong et al., 2008).  
 
Although early studies challenged the validity and reliability of the Tekscan F-Scan 
in-shoe system (McPoil and Cornwall, 2006), the system has been subjected to 
rigorous assessment by Giacomozzi (2010) including a whole-surface static 
pressure test, local static pressure tests (5 areas), sinusoidal test (5 areas) to 
measure hysteresis, creep (5 areas) and COP estimation (5 areas). The Tekscan 
unit demonstrated high linearity (R2=0.995), moderate spatial variability, low creep, 
low hysteresis, high correlation with sinusoidal loading, as well as good accuracy 
and precision of the COP estimations. The benefit of an in-shoe system is that 
there is continuous collection of data with every step taken (MacWilliams and 
Armstrong, 2000). 
 
 Recording results 
When deciding what pressure insole measurements to record, informal 
discussions took place with some stroke survivors/service users, regarding their 
concerns in relation to their walking pattern and asymmetry of gait; therefore, a 
decision was made to record the force-time integral (FTI) (which takes into account 
the length of time spent on the hemiparetic foot as well as the force through the 
plantar surface), and the centre of force velocity (COFV) in an AP direction (to give 
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an indication of how well participants transferred their weight forwards over their 
affected leg).   
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 Set up for MoTaStim-Foot trial: Tekscan 
F-ScanTM pressure insoles and photo of 
pressure insole which was cut down to 
size and placed in the shoe. 
Electrogoniometer is also shown insitu 
 
Figure 6.8 
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 Testing procedure 
Pressure insole readings were undertaken during a timed 5MWT. Calibration of the 
insoles prior to each measurement being undertaken was built into the protocol for 
the pressure insole assessments. This involved doing a step calibration, which 
required participants to stand on one leg for up to two seconds, and then change 
to stand on the other leg. On commencement of the study, it was anticipated that 
this would not be possible for the participants to do, so it was written into the 
protocol that a researcher of a similar weight could calibrate the insoles for the 
participants if required, as recommended by a representative from Tekscan, the 
company who made the insoles.  
 
 Walking speed 5-metre walk test (5MWT)  
Walking speed gives an indication of the overall walking ability of stroke survivors 
(Olney et al., 2006). A 5MWT was used to assess walking speed (seconds), 
producing ratio level data for analysis, and meaningful results of gait speed that 
can be compared to published gait speeds post-stroke (Salbach et al., 2001). 
 
 Reliability and responsiveness 
The 5MWT has been found to be reliable for use with stroke survivors (Collen et 
al., 1990). The 5MWT has been recommended as the most appropriate OM for 
both researchers and clinicians to select when measuring a change in walking 
ability post-stroke, when compared to the 10MWT, Stroke Rehabilitation 
Assessment of Movement, BBS, Barthel Index and the TUG (Salbach et al., 2001). 
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When the standardized response mean and 95% CIs were analysed the 5MWT 
was shown to have the best responsiveness at 1.22 (.93–1.50) at a comfortable 
pace and 1.00 (.68–1.30) at a maximum pace; this compared to .92 (.64–1.18) and 
.83 (.52–1.12) for the 10MWT. Although the 10MWT has also been shown to be 
reliable (Wade et al., 1987), the 5MWT was selected because many of the 
assessments were to be undertaken in the community and therefore it was felt the 
5MWT would be more practical.  
 
 Testing procedure 
A 5-metre distance was marked out on the floor and participants were asked to 
walk at a self-selected speed, as fast as they could walk comfortably and safely; 
the time to walk 5-metres was recorded by using the timer on an iPhone. At the 
point when the first foot crossed the 5-metre line, the timer was stopped. In 
addition to quantifying variables such as walking speed for the 5MWT, an 
observational analysis of the quality of gait was undertaken and whether walking 
aids or support were required was noted, as is common practice in therapy 
rehabilitation; the 5MWT was videoed using a web-cam, attached to a computer. It 
is acknowledged that using an aid to walk could influence the validity of the results; 
it was possible that someone could walk faster with an aid or assistance at 
baseline than they did at the end of intervention if they were walking 
independently. However, this does reflect clinical practice, with stroke survivors 
altering their need for use of an aid or assistance as they progress.  
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 Modified Rivermead Mobility Index  
The mRMI (Lennon and Johnson, 2000) was developed from the Rivermead 
Mobility Index (Collen et al., 1991), It involves eight tasks: 
1. Turning over in lying 
2. Lying to sitting 
3. Sitting balance 
4. Sitting to standing 
5. Standing 
6. Transfers from plinth/bed to chair 
7. Walking indoors  
8. Stairs  
 
A stopwatch, tape measure, chair and access to a bed (at a height of 45 cm) and a 
flight of stairs, are required. Participants are requested to perform each item as 
independently as possible with both sides assessed, towards the ipsilesional side 
first (when rolling or transferring), with the score towards the contralesional side 
reported separately. A limitation of this measure is that the exact number of stairs 
is not specified.  
 
Ordinal data are produced, with a rating given relating to the amount of assistance 
the person required, either physical assistance from the assessor or from an aid 
e.g. pulling on the edge of the bed when rolling. The total score possible is 40 
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points, with each item allocated a potential five points from 0 (unable to perform) to 
5 (independent).  
 
 Validity and reliability 
The mRMI is valid (face and content validity established via a consensus 
exercise), reliable in a population of stroke survivors (Intraclass correlation co-
efficient (ICC) was calculated to explore inter-rater reliability and found to be 
excellent = 0.98; p<0.001), and responsive (effect size = 1.15) as a measure of 
mobility in the early stages of stroke rehabilitation; the degree of measurement 
error was found to be 4.46 using an ANOVA to calculate the variance within the 
patients (Lennon and Johnson, 2000). Use of effect sizes to indicate 
responsiveness of a clinical measure has been advocated by Kazis  et al. (1989), 
and an understanding of the measurement error is important when calculating the 
minimal clinically important difference (Rai et al., 2015). 
 
The mRMI was selected for use within MoTaStim-Foot because of its psychometric 
properties and the fact it is relatively quick to complete (10–15 minutes), a valid 
tool for assessing mobility following a stroke, and good reliability can be 
established with minimal experience (Lennon and Johnson, 2000). 
 
 Testing procedures 
For full details and instructions regarding the mRMI assessment see Appendix 36. 
Training was provided to all assessors to ensure a standardized approach; any 
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uncertainties were addressed by discussions within the team until a consensus 
relating to the correct scoring was reached. 
 
 Focus groups 
All participants from both arms of the trial were invited to an FG, on completion of 
the intervention and all follow-up OMs The purpose of the FGs was to provide an 
insight into the participants’ individual trial experiences (Krueger and Casey, 2000). 
All participants were approached using a personalized telephone call (Krueger and 
Casey, 2000), and this was followed up with a letter addressed to the individual 
concerned, with details of the FG they were invited to attend (Appendix 37). Two 
FGs, aiming for a sample of 6–8 participants in each group, which has been 
suggested as being an ideal size to promote discussion in a FG (Krueger and 
Casey, 2000), were conducted for each arm of the trial.  
 
An FG interview schedule, with open-ended questions (Kitzinger, 1995), for both 
the MTS + TSGT group (Appendix 38) and the TI + TSGT group (Appendix 39, 
was developed in advance by the researcher and members of the supervisory 
team, with input from PPIE advisors. The interview schedules were developed with 
a researcher who was not a physiotherapist to further reduce the chance of data 
collection bias (Carter et al., 2014), and decreasing the influence of the 
researcher’s personal beliefs (Smith and Noble, 2014). Objectives 3d and 3f of the 
feasibility study were: to explore participants’ experiences of the interventions and 
the battery of OMs, and their views on the acceptability of the treatments and 
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method of delivery as interventions for a future study, and to explore perceived 
responses to the interventions over time. Open-ended questions were used to 
facilitate a greater understanding of the participants’ experiences, enabling the 
participants to take a lead with the information shared (Krueger and Casey, 2000). 
Specific topics relating to the acceptability of the interventions and the OMs, and 
perceived changes in the leg or in lower-limb functions of standing, balancing and 
walking following intervention were explored.  
 
The FGs were moderated by the researcher (AA) actively participating in the 
research process and facilitating discussion (Morgan, 1996); an independent PPIE 
volunteer took field notes during the discussions, noting any relevant interactions 
between group members. The final question of the FG asked participants to 
summarize in one word, or one sentence, their opinion on being involved within the 
trial, enabling reflection upon this important aspect, as suggested by Krueger and 
Casey (2000). The moderator (AA) summarized the discussions at the end of the 
group (with assistance from the PPIE advisor) and sought validation of her 
understanding of the issues from the participants (Krueger and Casey, 2000).  
 
All the FGs were audio-taped with consent from participants, and transcribed 
verbatim, with analysis occurring as the study progressed, ensuring each FG was 
listened to, transcribed and analysed prior to the next FG specific to either MTS or 
TIs, so that any emerging ideas could be included in subsequent discussions if 
required (Kisely and Kendall, 2011). 
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Debrief meetings were held involving the PPIE volunteers, supervisor and the 
group facilitator (AA) after each FG; this enabled discussion relating to the main 
topic areas and emergent themes (Boysen et al., 2016), and identification of 
missing topic areas (McMahon and Winch, 2018), that should be considered for 
exploration in future FGs. Another purpose of the debriefing involves evaluation of 
the moderator’s role and consideration of researcher reflexivity increasing the 
trustworthiness of the data (McMahon and Winch, 2018). The researcher’s 
assumptions prior to undertaking the FGs were considered (Appendix 40). 
Bracketing of these ideas and thoughts continued throughout the data collection 
and analysis phases, as recommended by Fischer (2009). Another purpose of the 
debriefing meetings was to offer psychological support in case of unpredictable 
emotional response (Copeland and Liska, 2016); this was important because the 
PPIE volunteers may have been affected by comments made within the FG. 
 
 Interventions 
Research therapists delivered all the interventions, MTS and TSGT, as well as 
encouraging the participants in the TI group to wear their insoles. A log was kept 
detailing, for each participant, which therapist delivered the treatment. 
Standardization of treatment intervention delivery was facilitated by the 
development of the standardized protocols, which were followed by all the 
research therapists.  
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 Mobilization and Tactile Stimulation (MTS) for the lower limb 
Each participant in the MTS group received 30–60 minutes of standardized MTS 
treatment to the lower limb, described fully in Study 2, to prepare the sensorimotor 
system prior to TSGT. The actual treatment techniques delivered were recorded by 
ticking boxes on the MTS treatment schedule (figure 5.5, section 5.3.14). In view of 
the heterogeneity of stroke and specific needs of the participants, treatment was 
individualized for each participant. The specific content of each treatment session 
was adapted according to need, e.g. to address foot hypersensitivity, and to take 
into account the tolerance of each technique.  
 
Research therapists (experienced Chartered Physiotherapists, NHS Bands 6 and 7 
equivalent) selected and delivered appropriate combinations of pertinent 
techniques from the MTS treatment schedule for each session. It was not 
necessary, or appropriate, to include all the techniques in the schedule; selections 
and combinations were based upon the clinical decisions of the research 
therapists delivering the treatment. MTS was delivered with no medium, such as 
aqueous cream, whenever possible (except for example, if the participant's skin 
was particularly dry and fragile), to ensure there was maximum stimulation of the 
cutaneous mechanoreceptors.  
 
The research therapists were all trained in delivering MTS, to ensure they were 
delivering the interventions to protocol. To assess fidelity to protocol, the research 
therapists were observed by a research supervisor (SH) at various points in the 
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research trial to ensure they were complying with working to protocol. A report 
relating to these observations is provided in Appendix 41. 
 
 Wearing the textured insole (TI)  
Participants were encouraged to wear the insoles daily, with one TI in the 
contralesional shoe, and a smooth insole in the ipsilesional shoe (details of insoles 
are reported in section 5.3.4, chapter five). Advice was given to the participants 
that they should gradually build up the time wearing the insoles; however, they had 
the autonomy to choose how long they wore the insoles each day during the 4–6-
week period of intervention, apart from when the outcomes were assessed. This 
was in accordance with the TI wearing protocol developed in Study 2 (chapter 
five), provided in section 5.3.4. The insoles were individually made, participant-
specific, and cut to size to fit in the participant’s shoes. The purpose of the TI was 
to ‘augment’ the sensorimotor system by providing sensory feedback from the 
plantar surface of the contralesional foot. The duration of wearing the insoles was 
recorded by the participant in the daily diary (Appendix 32).  
 
 Task-specific gait training (TSGT) 
Thirty minutes of TSGT was delivered to both groups, either immediately following 
30–60 minutes of MTS treatment (MTS group), or whilst the participants wore TIs 
(TI group). The specific content of each gait training session was documented 
using the comprehensive list of interventions identified in Study 2, the intervention 
modelling study, described in the TSGT protocol (chapter five, section 5.3.8). 
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 Observer-blinding of outcome assessment  
Research therapists were employed specifically and suitably trained as blinded 
assessors for the MoTaStim-Foot trial, undertaking a battery of OMs with 
participants. These therapists had experience of working in the NHS, in a relevant 
field. Research therapists or the blinded assessor undertook the baseline 
assessments, prior to randomization. However, all OMs in which observer bias 
could occur (the FAC, LEMI, sensory threshold testing with SWMs and the mRMI) 
were undertaken by assessors who were blinded to treatment group allocation. 
Measures were employed to enhance blinding, for example, all participants within 
the trial were given a pair of TIs (even if they were in the MTS group), so a chance 
observation of insoles in the home would not unblind the assessor. Also, 
participants were asked not to disclose to the blinded assessor which group they 
were in, and the case report forms were hidden from the blinded assessor. At the 
one-month follow-up, the blinded assessor was asked to indicate to which group 
they thought the participant had been allocated; this allowed for assessment of the 
success of the observer blinding procedure.  
 
 Statistical analysis of quantitative data 
All data from the trial were entered into the database and checked systematically 
for accuracy by two independent researchers. Baseline characteristics were 
summarized according to the intervention group. Count variables were presented 
as frequencies and proportions, ordinal variables as medians and interquartile 
ranges, and numerical variables as means and SDs (or medians and interquartile 
247 
 
ranges, if data were skewed). When analyzing the results of the pressure insole 
readings, a blinded assessor selected the representative steps to analyse 
(according to clearly defined criteria) from the force-time curve on the Tekscan 
(pressure insole) software.  
 
As this was a feasibility study, no formal hypothesis testing was undertaken. 
Instead, point estimates, with 95% CIs for within-group changes (using medians 
and interquartile ranges), were calculated for key OMs (where appropriate). The 
variance of scores for OMs was calculated, providing information for the sample 
size calculation for a subsequent main trial. The distribution of outcome variables 
was also assessed, to further inform the sample size calculation and guide the 
choice of analysis in the main study. The number of eligible patients recruited, and 
the proportion of those recruited who were lost to follow-up at one-month were also 
calculated.  
 
Research objective 3d (sections 4.4 and 6.1) also included informing the choice of 
primary and secondary OMs in readiness for a future trial. In order to facilitate 
these choices, such aspects as clinical relevance, validity, reliability, floor and 
ceiling effects, as well as acceptability were explored. It was not the purpose of the 
study to consider the effectiveness of the interventions, and therefore no between-
group analysis was undertaken. However, to inform the choice of primary and 
secondary OMs for the potential subsequent study (objective 3f), some within-
group analysis was undertaken to indicate the responsiveness of the OMs and 
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potential efficacy of the interventions, and to identify any issues relating to floor or 
ceiling effects with the OMs. Medians and IQRs were produced through IBM SPSS 
statistics, version 24 and CIs were generated through the Confidence Interval 
Analysis (CIA) program (Gardner et al., 1991). 
 
To fulfil objective 3g of the feasibility study (sections 4.4 and 6.1), relating to 
responses to the interventions over time, within-group analysis was undertaken 
exploring changes from baseline to end of intervention, from baseline to one-
month follow-up, and also from end of intervention to one-month follow-up. 
Differences between the medians and 95% CIs were calculated; these were 
approximate CIs, because the programme used to calculate non-parametric CIs 
does not always produce CIs at the exact confidence level specified.  
 
Consideration was given to analysing the extent of clustering of observations by 
each therapist, using an intra-cluster correlation coefficient to assess the extent to 
which outcomes are correlated (clustered) within therapists.  This analysis would 
have given greater insight into whether specific experience in neurological skills or 
a particular personality had an influence upon the outcomes within the trial. 
However, as the research therapists were all part-time and, on many occasions, 
more than one therapist was involved in delivering each participant’s interventions, 
this analysis was deemed to be neither possible nor appropriate. Moreover, the 
sample size would have given extremely imprecise estimates of the intra-cluster 
correlation. 
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A detailed statistical analysis plan was drawn up prior to beginning data analysis 
(Appendix 42). 
 
    Collection and analysis of qualitative data 
Daily diaries were collected weekly from the participants, comments were 
extracted, and subjected to thematic analysis, with consideration given to whether 
they were appropriate to address the objectives of the trial; the data from the daily 
diaries was also presented in two word-clouds (one for each of the intervention 
groups) giving a visual insight into the main aspects discussed in the diaries. 
 
The analysis of the diaries was mainly a content analysis (Krippendorff, 2013). 
However, inductive thematic analysis was utilized for the daily diaries comments 
and also the FGs; coding was data-driven without consideration of how the ideas 
developed may fit with pre-existing theory or the researcher’s pre-conceptions 
(Braun and Clarke, 2006). The researcher played an active role in generating the 
themes (Richards and Hemphill, 2018). 
 
The primary purpose of the analysis was to explore the feasibility of the 
interventions and OMs and understand participants’ experiences on the 
MoTaStim-Foot trial.  A priori topics relating to the interventions and participation 
within the study, as well as changes in functional ability, were developed, which 
informed the FG schedules (Appendix 43), ensuring pertinent issues were 
discussed. Therefore, there was an element of theoretical analysis driven from the 
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researcher’s analytical curiosity (Braun and Clarke, 2006) relating to the possible 
changes that may occur when somatosensory stimulation is delivered.  
 
Braun and Clarke’s (2006) six-stage process for thematic analysis of qualitative 
data was followed: 
Step 1: Familiarisation with the data 
Step 2: Generation of initial codes 
Step 3: Searching for themes 
Step 4: Reviewing themes 
Step 5: Defining and naming themes 
Step 6: Production of the final report 
However, other resources and methods were utilized too. Once initial coding for 
the FGs had taken place, the management of the data was facilitated using NVivo 
qualitative data analysis (Software QSR International Pty Ltd. Version 11, 2016), 
which is useful to assist coding processes and aid retrieval of pertinent information 
(Woods et al., 2016).  Organisation and familiarisation of data and the codes that 
were produced were also enhanced by the process of using the one sheet of paper 
method (Ziebland and McPherson, 2006). Examples with and without quotations 
are available (Appendix 44). 
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Qualitative data collected from both the FGs and diaries were subjected to a 
thematic analysis. Thematic analysis is a flexible, valuable research tool, not 
aligned with a particular epistemological or theoretical perspective, but appropriate 
to elicit richness residing in the data (Braun and Clarke, 2006), putting aspects into 
context and discovering meaning behind individual conditions and circumstances 
(Maguire and Delahunt, 2017). The thematic analysis was principally inductive, 
primarily at a semantic level, identifying explicit meanings from the data based on 
the participants’ responses (Braun and Clarke, 2006). However, some aspects 
relating to life before and after involvement in the trial were explored. There was, 
therefore, further analysis at a latent level, considering ideas and assumptions at a 
deeper level (Braun and Clarke, 2006). Nevertheless, the purpose of the study was 
not to develop understanding behind what it meant to the participants to have a 
stroke or discover detail about any differences in their quality of life.  
 
 Coding 
The researcher (AA) coded the data in the transcripts and subsequently discussed 
codes, themes and sub-themes with two other members of the research team (SH 
and SR), who had also reviewed and analysed the transcripts independently, 
identifying preliminary themes for discussion with the researcher.  
 
 Identifying themes 
Provisional themes for the qualitative data were shared and discussed in a group 
consisting of supervisors and an independent PPIE representative (PB), who had 
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also read the four FG transcripts, enabling development and progression or 
maturation of themes. Any differences of opinions were highlighted and discussed; 
the researchers and PPIE advisor collectively looked for conceptual relationships 
within and across the FGs, and final themes were identified. A table of themes 
from the daily diary comments (table 6.7) and the final themes from the FGs were 
produced (table 6.9). An audit trail was kept of how the themes were developed 
and matured (Appendix 45), enhancing transparency (Richards and Hemphill, 
2018).  
 
 Data collection 
 Data management 
All data were collected and stored in accordance with the Data Protection Acts, 
1998 and 2018 (Legislation.gov.uk, 1998; 2018). Data that could identify 
individuals were stored separately from anonymous data and the linking 
information was accessed only by members of the research team on a need to 
know basis. All data by which individuals may be identified were kept in a lockable 
storage facility within the research offices. Any electronic data by which individuals 
could be identified were placed in a password protected secure space on hard 
drives. Personal names and information were not transferred via email. Use of 
personal addresses, postcodes, faxes, emails or telephone numbers was restricted 
to the minimum number of people necessary to ensure the efficient and safe 
running of the trial. Participant numbers were used to anonymize data.  
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On transcription of the FG information, pseudonyms were used to maintain 
anonymity, prior to being stored on password protected computer or laptop.  Faces 
were blanked out on the 5MWT videos for dissemination and the videos were 
stored on a password protected computer. In writing up the findings of the study, 
all direct quotations were anonymous, and no individual is identifiable.  
 
Research therapists were appropriately trained in issues relating to confidentiality 
of personal data as part of their induction on commencement of their post. Only 
anonymous data (by means of issuing each participant a unique trial number) was 
shared with other organisations. All data will be stored securely for ten years after 
the end of study declaration, in line with Keele University policy. 
 
 Adverse events and reactions 
Adverse reactions of pain and fatigue were of clinical interest in informing the 
results of the trial and the acceptability of the interventions (research objective 3d). 
There was a small possibility that either the MTS or TSGT could be associated 
with an overuse syndrome as expressed by a participant’s experience of pain or 
fatigue. Fatigue was accounted for as it would normally be in usual therapy 
rehabilitation and both pain and fatigue were monitored throughout the intervention 
period by the research therapist. Monitoring of pain and fatigue by using 
standardized OMs such as the Short Form 36 Health Survey Questionnaire (SF-
36) (Brazier et al., 1992) and the Functional Assessment of Chronic Illness 
254 
 
Therapy Fatigue Scale (FACIT-F) (Tennant, 2019) was considered; however, the 
practicalities of completing these (approximately ten minutes each) with 
participants, almost daily, meant this was not feasible. Therefore, a pragmatic 
decision was made to monitor pain verbally (by asking the participant) and visually 
(by observing participants’ behaviours), and to monitor fatigue by assessment of 
strength using the LEMI. The method used successfully in other trials, for example 
the FAST INdiCATE trial (Hunter et al., 2018) was, therefore, followed. 
Participants were observed for signs of pain at every visit and a record of the 
response noted. The LEMI was undertaken prior to delivery of the interventions to 
monitor for any potential fatigue (Appendix 35). The motricity index has been 
shown to be an important predictor of fatigue (p=0.01) (Kim et al., 2012) and has 
been used successfully in other studies too (Hunter et al., 2018) and therefore was 
deemed to be an appropriate measure to use for this purpose. Fatigue was 
considered to be an adverse reaction if (i) a participant demonstrated a decrease 
of two levels in the LEMI score on four consecutive therapy sessions and (ii) the 
therapist and clinical team were unable to account for this in any other way than 
involvement in this trial. Murphy and Niemiec, (2014) report fatigability as the 
degree of fatigue experienced during activities and suggest modification of 
activities or adaptation of daily routines using pacing strategies. Alternatively, 
acute fatigue may be improved by resting (Egerton, 2013). In the event of a 
participant reporting pain or fatigue, the therapist would adjust the therapy as 
appropriate or, if indicated, stop the interventions on either a permanent or a 
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temporary basis. In the event of fatigue, rest periods were increased, or the 
number of prescribed exercises and length of treatment reduced as required.  
 
Pain was considered to be an adverse reaction if: (i) a participant reported the onset 
or increase of paretic lower limb pain (verbally or behaviourally); (ii) the pain was 
sustained over four consecutive therapy sessions; and (iii) the research therapist 
and clinical team were unable to account for this in any other way than involvement 
in this trial. If required this would be addressed by the research therapist adjusting 
the therapy as appropriate or, if indicated, stopping the extra therapy on either a 
permanent or temporary basis. The date of adverse reaction would be recorded as 
the date of the fourth consecutive therapy session after pain or fatigue was first 
noted. Pain and fatigue were recorded on a case report form within the MoTaStim-
Foot feasibility study (Appendix 46). 
 
  Trial management  
The trial team was led by the Chief Investigator (AA). A trial protocol (Appendix 
25), Standard Operating Procedures, intervention protocols and case report forms 
were developed prior to commencing the trial, approved by the Norwich CTU.  
 
 Trial management group 
A trial management group was set up, chaired by the Chief Investigator (AA), to 
assist with developing the design, co-ordination and strategic management of the 
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trial. The membership, frequency of meetings, activity (including trial conduct and 
data review) and authority were explicit within the trial management group terms of 
reference (Appendix 47). The trial management group consisted of: the Chief 
Investigator (AA); the researcher’s supervisory team, who have experience in 
clinical trials with stroke participants, qualitative and quantitative research 
methods, and statistics; a consultant stroke physician with experience in running 
clinical trials; the senior clinician (physiotherapist) working on the ward where 
recruitment of some of the participants took place; the senior clinical trials 
operations manager from the CTU involved with the study; and a PPIE 
representative (PB). The research delivery manager at the study recruitment site 
was also invited to be part of the trial management team because she would be 
able to advise on the day to day management of the trial. Since this was a small-
scale feasibility study, a decision was made that a trial steering committee and 
data monitoring committee were not required. The responsibilities of a trial steering 
committee and data monitoring committee were undertaken by the members of the 
trial management group. 
 
 Research therapists 
Two part-time research therapists were employed over a fifteen-month period at a 
Band six level (15 and 14 hours per week), one of whom had extensive 
neurological experience and the other who had primarily a musculoskeletal 
background. The costings for these two research therapists were based upon one 
full-time therapist for 12 months; however, in view of anticipated issues relating to 
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recruitment, it was decided to employ the therapists over a longer period. Having 
two part-time therapists added to the flexibility within the trial, giving greater ability 
to cover annual and sick leave. For the last two months of the trial, an additional 
research therapist was employed at a Band six level, on a casual basis, 
completing a total of 46 additional hours to ensure the participants could complete 
all the interventions. 
 
A researcher assessor, who was an HCPC registered occupational therapist, was 
employed at Band 5, for six hours per week, over an eighteen-month period, to 
undertake the observer-blind assessments. A further blinded researcher assessor 
(Chartered Physiotherapist) was trained and involved on an occasional basis to 
cover annual leave of the research assessor.  
 
All members of the trial team completed GCP training. All research therapists and 
the research assessor were appropriately trained by relevant members of the trial 
team (AA, SH), to ensure that they were competent prior to undertaking 
interventions and assessments.  
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       Results of study 3 
 
All the feasibility study objectives were successfully achieved and detailed in the 
following sections. 
 
 Objective 3a, relating to recruitment and flow of participants 
The information relating to recruitment and attrition is summarized in the 
CONSORT diagram (figure 6.9).  
 
In total, 70 stroke patients were assessed for eligibility over 18 months, of whom 5 
(7.14%) were not interested in the trial and declined an approach by the research 
team; 15 people (21.43%) declined to participate after reading the PIS. A further 
eight people did not meet the inclusion criteria (inappropriate diagnosis n=3; not 
42-112 post-stroke n=2; medically unstable n=1; out of area n= 2). The remaining 
42 (71.43%) provided informed consent and undertook the post-consent screening 
process. Seven of these (16.67%) were subsequently found to be ineligible to 
participate; three had skin lesions, three failed the step test, and one was 
experiencing heart failure. One participant withdrew before completing the baseline 
assessment. 
 
A total of 34 participants (48.57% of those screened) were, therefore, randomized 
to one of the two interventions, demonstrating a successful recruitment strategy.  
Following randomization, the group sizes were not completely equal, with 19 
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people randomized to the MTS+TSGT (MTS) group and 15 to the TI+TSGT (TI) 
group.  
 
 Objective 3b, relating to attrition 
The attrition rate was 5.88% at both end of intervention and one-month follow-up, 
due to two participants being withdrawn from the TI group; one participant received 
a botulinum toxin injection to his contralesional lower limb prior to completing the 
first treatment session, the other developed a problem with the ipsilesional foot (as 
opposed to the contralesional foot, which was the one in contact with the TI).  
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Figure 6.9  CONSORT diagram for the MoTaStim-Foot feasibility study 
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 Baseline characteristics of participants (Objective 3h) 
The baseline characteristics for the groups are presented in table 6.4. The mean 
(SD) age for the two groups was similar (MTS: 73.84 (14.09) years; TI: 72.40 
(9.79) years), the proportion of males to females was slightly different in each 
group with 47% males in the MTS and 60% males in the TI group. This imbalance 
could be accounted for by the small sample size. There were slightly more 
ischaemic strokes in the MTS group (89.47%) than the TI group (80%); however, 
the mean (SD) number of days post-stroke was comparable for both groups, at 
58.5 (18.13) and 54.64 (12.46) days, respectively. To give an indication of the level 
of functioning prior to the stroke, the percentage of people able to walk over one 
mile prior to the stroke is also presented in table 6.4, with a slightly higher level 
noted for the TI group (73.33%), compared to the MTS group (68.42%). The 
NIHSS results for the two groups were similar with a median of six in the MTS 
group and five in the TI group and are presented in figure 6.10. Interquartile-range 
(IQR) is also presented. There was, an even spread across the groups in relation 
to speech and language difficulties, with three participants affected in the MTS 
group and two in the TI group. 
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Table 6.4  Participant characteristics and demographics at baseline 
  MTS (n=19) TI (n=15) All (n=34) 
Age (years) Mean (SD) 73.84 (14.09) 72.40 (9.79) 73.21 (12.23) 
Sex 
Male (%) 
Female (%) 
(M: F) 
47.4 
52.6 
(9:10) 
60 
40 
(9:6) 
52.9 
47.1 
(18:16) 
Type of stroke 
Ischaemic (%) 
Haemorrhagic (%) 
89.5 
10.53 
80 
20.00 
85.3 
14.71 
Side of brain 
Left (%) 
Right (%) 
(L: R) 
57.9 
42.11 
(9:10) 
60 
40.00 
(6:9) 
58.8 
41.18 
(15:19) 
Days after stroke  
Mean (SD) 
Range 
59.47 (18.12) 
43–106 
53.87 (12.38) 
43–95 
57 (15.88) 
43–106 
Walking prior to 
stroke 
% able to walk more 
than 1 mile prior to 
stroke 
68.4 73.3 70.57 
NIHSS  
Median (IQR) 
Range 
6.00 (4.00, 7.25) 
1–11 
5.00 (4.00, 7.00) 
3–16 
5.00 (4.00, 7.00) 
1–16 
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Figure 6.10  Boxplot of NIHSS results for both groups 
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 Objective 3d, relating to acceptability of the interventions 
 Serious adverse events, adverse events and adverse reactions 
This type of therapy intervention trial is considered low risk for adverse events and 
reactions. Within this feasibility study, there were no adverse reactions to report, 
indicating that no participant reported pain or fatigue related to the trial 
interventions or a reaction to the TIs.  
 
There were three serious adverse events, which were all reported to the Norwich 
CTU/Research and the Research Governance Department at Keele University. 
None of these were related to participation in the trial: one participant suffered a 
further stroke, between completion of all the interventions and OMs and the FG; 
another had a fall and attended the Accident and Emergency department although, 
after one week, was able to resume interventions; and a third was admitted 
overnight to hospital with a suspected chest infection and after a short break of a 
few days continued in the trial.  
 
In addition, there were twenty-seven adverse events documented (Appendix 48), 
14 of which were reported from participants in the MTS group and 13 from the TI 
group. These consisted of: falls n=16; neck pain n=1; back pain n=2; heel pain 
(ipsilesional side) n=1; viral infection n=1; atrial fibrillation n=1; pressure sore n=1; 
scratch on dorsum of foot n=1; and a report of feeling tired with swollen painful 
ankles n=1, urinary tract infection n=1, hip and knee pain n=1. These were all 
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discussed with an independent assessor to ensure they were not considered to be 
related to the trial.  
 
 Delivery of trial interventions 
All of the participants in both of the groups (except for the two who were withdrawn 
from the TI group) received all twenty sessions and it was clearly demonstrated 
that it was possible to deliver the interventions and OMs.  
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  Analysis of the daily diary sheets (Objectives 3d, 3e and 3f) 
All of the participants completed the daily diary sheets either independently or with 
support from a family member – or with assistance from the research therapist, if 
required, to just document the participant’s comments or ticks in the relevant 
sections. Only one participant attempted to use the audio diary method; however, 
they struggled with this and changed to using the paper diaries.  
 
There was inconsistency between the participants regarding the number of 
comments written on the diary sheets (17/19 in the MTS group, and 10/14 of the TI 
group made comments). The section relating to whether the foot felt sensitive or 
not could have been interpreted in different ways and is therefore not reported in 
detail here but will be debated in chapter seven, the discussion section. The 
number of participants ticking each of the sections is reported in table 6.5 for the 
MTS group, and table 6.6 for the TI group. In general, the interventions were well 
tolerated over the main six-week intervention period. As participants were able to 
place a tick in each box daily (seven days a week for the duration of the 
intervention), a range of responses to each section was possible. The weekly 
average number of ticks was calculated for each section.  
 
 Comfort of the MTS 
The box titled MTS was not uncomfortable was ’ticked’ by most participants (range 
79.0%–94.7%) and when there was discomfort this was reported generally as not 
lasting a long time (figure 6.11). Only one participant ticked the ‘discomfort lasted a 
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long-time section’; this participant was suffering from chronic neuropathic pain 
following his stroke, this aspect will be discussed in chapter seven. 
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Table 6.5  Number of participants for each aspect ticked on the MTS diary sheets  
Aspect Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 
Foot feels cold 3 8 4 2 3 3 
Foot feels warm 16 18 18 17 18 7 
Foot feels sensitive 12 13 11 9 6 5 
Foot does not feel sensitive 9 13 13 10 11 4 
There is no change in the foot 5 9 7 11 7 4 
Unable to feel as much 1 2 2 1 0 0 
Can feel more 15 16 13 11 14 3 
MTS was uncomfortable 8 (42.11%) 7 (36.84%) 6 (31.58%) 6 (31.58%) 3 (15.79%) 4 (21.05%) 
Discomfort lasted long time 0 0 0 1 1 1 
Discomfort did not last long 6 6 6 6 2 4 
MTS was not uncomfortable 15 (78.95%) 18 (94.74%) 17 (89.47%) 15 (78.95%) 16 (84.21%) 8 (88.89%) 
TSGT was uncomfortable 3 5 3 3 2 2 
TSGT was not uncomfortable 18 17 18 19 19 9 
Outcome measurements were 
uncomfortable 0 0 0 0 0 0 
Outcome measurements were not 
uncomfortable 0 6 10 7 3 0 
* There were 19 participants in the MTS group. One participant completed the interventions within four weeks, nine in five weeks,15 in six weeks, 
18 in seven weeks. Due to adverse events and the Christmas period one participant took nine weeks to complete the interventions. Just the 
results of the first six weeks are presented because this is when the majority of the participants completed the interventions. NB By week six 10 
participants had already completed the 20 interventions so the results for that week are based upon just nine participants.
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Table 6.6  Number of participants for each aspect ticked on the TI group diary sheets 
Aspect Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 
Foot feels cold 4 2 3 1 2 1 
Foot feels warm 13 12 11 10 9 6 
Foot feels sensitive 4 2 3 2 1 1 
Foot does not feel sensitive 12 12 9 6 6 3 
There is no change in the foot 12 7 8 7 8 4 
Unable to feel as much 1 1 0 0 1 0 
Can feel more 7 6 6 6 3 4 
Not worn the TIs 1 3 1 2 1 1 
Worn TIs less than 1 hour 5 3 2 1 2 1 
Worn TIs 2-4 hours 3 6 2 3 3 1 
Worn TIs more than 5 hours 8 11 11 11 12 8 
Actual time worn specified Ave 6.01 hrs Ave 8.05 hrs Ave 8.02 hrs Ave 7.86 hrs Ave 7.72 hrs Ave 8.55 hrs 
TIs uncomfortable 1 1 0 0 0 0 
TIs NOT uncomfortable 13 12 12 12 13 9 
TSGT was uncomfortable 0 0 0 1 1 1 
TSGT was not uncomfortable 13 12 12 10 10 7 
Outcome measurements were 
uncomfortable 0 0 0 1 1 0 
Outcome measurements were not 
uncomfortable 3 3 5 2 4 2 
* There were 14 participants who commenced interventions in the TI group, one withdrew after the first week. Four participants completed the 
interventions in five weeks, 12 in six weeks and all 13 had completed within seven weeks. 
Weeks 2, 3 and 5 were not applicable for one participant. Week 4 was not applicable for two participants. Week 6 was not applicable for five 
participants.
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Figure 6.11  Comfort/discomfort of the MTS according to the number of 
participants (calculated from the number of ticks), and how long the 
discomfort lasted (n=19)  
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 Comfort of TIs 
The TIs were tolerated well, with only one person reporting some discomfort. Most 
of the ticks were in the ‘TIs not uncomfortable’ section, often with 100% of 
participants agreeing (figure 6.12).  
 
Participants were in control of how long they chose to wear the insoles each day, 
and the diary sheets were a useful way of recording the number of hours 
participants wore the TIs. The mean (SD) number of hours the TIs were worn each 
week were, week one 6.01 (3.79) week two 8.05 (3.46); week three 8.02 (3.18); 
week four 7.86 (3.34); week five 7.72 (3.41); and week six 8.55 (3.84). Thus, 
overall, the mean length of time wearing the TIs was 7.70 hours per day (SD 0.80, 
range: 0.5–12 hours), which is a good indication that the majority of participants 
found the TIs comfortable (figure 6.13). One participant was unable to ‘don’ and 
‘doff’ the TIs without assistance, and therefore only wore the TIs during the 30 
minutes of TSGT each day, with assistance provided by the research therapist.  
 
 Comfort of the TSGT 
The TSGT was also found to be well-tolerated in both groups, with most 
participants ticking the ‘TSGT was not uncomfortable’ section, indicating the 
intervention was comfortable, range in MTS group: 89.47–100% and TI group: 
76.92–100% (figure 6.14).  
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Figure 6.12  Number of participants ticking TIs were uncomfortable or not 
uncomfortable (n=13)  
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Figure 6.13  Number of participants and average time wearing TIs according 
to the number of ticks on diary sheets 
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Figure 6.14 Number of participants in the MTS and TI groups who ticked the 
TSGT was uncomfortable/not uncomfortable sections 
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 Comfort of the outcome measures 
Participants’ experiences of the OMs were also very positive, with no participants 
in the MTS group and only 4.23% in the TI group stating that having the OMs 
undertaken was uncomfortable (figure 6.15). 
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Figure 6.15  Comfort/discomfort of the outcome measurements according to 
group, analysed by the number of ticks   
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 Thematic analysis of the daily diaries (Objectives 3d, 3e, 3f and 3g) 
Comments made in relation to the MTS interventions, wearing TIs, and the TSGT 
intervention suggest the interventions were acceptable to the participants, 
addressing trial objective 3d. The MTS was described as being “quite intense”’ and 
“a little uncomfortable”; however, the discomfort was described as “only lasting 
very little time” and “stopping immediately when the massage discontinued”. The 
TIs occasionally caused some discomfort “due to shoe tightness”, with hot weather 
exacerbating this issue, but they were generally felt to be comfortable and 
participants suggested they helped them to feel more in their foot; “could feel 
insoles more than yesterday”.  The TSGT was described as “hard work”, 
“challenging”, “tiring” and even “scary” at times; however, it was also described as 
“enjoyable” and it appeared that many of the participants found it rewarding, 
reporting that it “helped with balance” and “greatly improved” mobility. Almost no 
negative comments were made relating to the OMs, just one person said it could 
be “tiring”.  
 
Trial objective 3e related to the suitability of the daily diaries and FGs for exploring 
stroke survivors’ experiences of receiving the treatments. Although there are 
limitations and drawbacks to the use of diaries in research, which will be discussed 
in chapter seven, it is clear a great deal of useful information has been drawn from 
the daily diaries, assisting in the decision-making process relating to whether the 
interventions and outcomes are acceptable interventions for stroke survivors.   
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Table 6.7  Topics and themes identified from the daily diaries 
MTS group 
Topic Theme  
MTS treatment Uncomfortable/intense 
Increased flexibility 
Better function 
Benefits 
Changes in feeling in 
foot/lower limb 
Temperature 
Sensitivity 
Able to feel foot more 
Sense of belonging/increased awareness 
Stability 
Better movement 
Foot feels freer 
General Valued treatment 
Progress 
Activities of daily living (ADL) 
TSGT Uncomfortable 
Tiring 
Challenging 
Scary 
Enjoyable 
Improved balance 
Improved mobility 
Ability to walk unaided 
Sense of achievement Increased confidence 
Increased strength 
Independence with personal care 
Ability to walk again 
Ability to run again 
Improved balance 
Returning to normal daily activities: 
- Car transfers 
- Kitchen skills 
- Stairs 
- Outdoor 
mobility 
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TI Group 
TIs Comfortable 
Discomfort:  
                     - Tightness in shoe 
                     - Smooth insole 
Difficult: 
                         -  Hot weather/swelling   
Forgot to wear them 
Awareness of insoles 
Change in feeling of the foot Increased feeling 
Foot feels ticklish 
Increased awareness of foot 
Pain 
Swelling 
Temperature 
Comments relating to lower 
limb 
Increased confidence 
Control 
Stability 
  
TSGT Uncomfortable 
1st class physio 
Helpful 
Enjoyable 
Balance work/cushion hard 
Increased confidence 
Tiring 
Hard work 
Challenging 
Improved movement and balance 
Sense of achievement Greater independence 
Better walking 
Increased movement and flexibility 
Improved balance 
Returning to normal daily activities:  
                                                   - Outdoor mobility 
                                                   - Steps 
                                                  - car transfers 
 
Outcome Measures Tiring 
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To give an overview of the words used in the daily diaries for each group word-
clouds have been created too: 
 
 
Figure 6.16  Word-cloud formed from the comments in the daily diaries from 
the participants in the MTS group 
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Figure 6.17 Word-cloud formed from the comments in the daily diaries from 
the participants in the TI group  
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 Focus group (FG) findings (Objectives 3d,3e,3f and 3g) 
All 32 participants who completed the study were invited to attend a FG. Details of 
numbers of participants invited and attending the FGs are given in table 6.8. Four 
FGs were held, two for the MTS group (FG1 n=5; FG3 n=8) and two for the TI 
group (FG2 n=5; FG4 n=2) 
 
Table 6.8 Number of participants invited and attending the FGs 
 MTS group TI group TOTAL 
No of 
participants 
invited 
19 13 32 
No of 
participants 
attended 
13 7 20 
% of participants 
attended 
compared to 
invited 
68.4 53.8 62.5 
 
 
In total, 62.5% of participants attended one of the FGs, with 68.4% of the 
participants in the MTS group and 53.8% of those in the TI group attending. 
Although the intended sample size for each FG was 6–8, the actual numbers of 
participants attending ranged from 2–8.  
 
 
 
283 
 
 Results of the thematic analysis of the FGs 
Some a priori topics relating to the feasibility study objectives had been identified 
(Appendix 43); however, several other themes and sub-themes were identified 
from analysis of the FG transcriptions. Some of the themes were observed from 
more than one FG. The themes from the initial analysis are presented in Appendix 
43, and summarized using the one sheet of paper technique (Ziebland and 
McPherson, 2006) (Appendix 44). The themes, which were developed over time 
with several iterations, are summarized in Appendix 45, creating an audit trail, and 
the final themes are presented in table 6.9. 
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Table 6.9 Final themes summarized 
 
Theme Sub-theme  
Acceptability of the 
interventions 
Comfort 
Perceived benefits/effects 
Dose intensity, frequency and duration 
Difficulties/challenges 
Acceptability of the 
outcome measures 
Comfort 
Perceived benefits 
Difficulties/challenges 
Use of daily diaries Ease of completion 
Difficulties/challenges 
Perceived benefits 
Overall trial experience Environment 
Confidence 
Improved function  
The beneficial and challenging effects of being 
involved in an intensive therapy trial 
End of trial 
 
 
Other aspects were also discussed within the FG relating to life after stroke, for 
example, fear of the unknown, fear of falling and feeling self-conscious. Several 
participants also discussed regaining control of their life again and developing self-
management strategies, which led to increased confidence and a sense of 
achievement, as well as independence and autonomy. Whilst these aspects do fit 
within the theoretical framework of acceptability, with increased confidence and 
self-efficacy being important in relation to the participants’ assessment of the 
acceptability of the intervention following completion of the intervention (Sekhon et 
al., 2017), it was not possible to explore these issues in any depth given the time 
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scheduled for these focus groups in this study. However, these were valuable, 
interesting discussions to be taken forwards in post-doctoral study.  
 
    Summary of themes 
There were four main themes that developed and fifteen sub-themes, which can 
be seen in table 6.9. These themes related to the trial experience, and will be 
discussed, with ideas and concepts supported by quotations from the FGs. 
Pseudonyms have been used to maintain participants’ anonymity.  
 
  Acceptability of the interventions (Objective 3d) 
 Comfort/discomfort of the interventions 
 Mobilization and tactile stimulation  
Three participants found aspects of the MTS to be painful or uncomfortable, 
particularly when the massage needed to be slightly deeper, using the thumb to 
mobilize tight tissues. 
“Some parts of it were painful ... sticking your thumb in” (Edward, 
FG3, L124-125). 
 
Although this discomfort was described as lasting “only a few seconds” (Edward, 
FG3, L129) 
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Some participants found it to be uncomfortable only early on in the treatment, but it 
was tolerable: 
“Painful for the first couple of sessions, after that it was okay” (L131, Evelyn, 
FG3).  
Mine was only [uncomfortable] for the first couple of times but I 
tolerated it” (L195, Michelle, FG3). 
 
Others disagreed and felt the MTS treatment was not uncomfortable at all and it 
was even reported to be enjoyable: 
“Mine was never painful” (L132, Dennis, FG3). 
“Mine wasn’t [painful] ever” (L133, Nancy, FG3). 
“I enjoyed it” (L636, Jackie, FG3). 
 
 TIs 
Participants generally felt that the insoles were surprisingly comfortable to wear, 
describing them as being easy to take from shoe to shoe. The appearance of the 
texture of the insole itself provided an initial impression of being quite 
uncomfortable to wear, although this turned out not to be the case: 
“I felt surprised actually because when I first saw them I thought “oh 
dear these are going to be prickly”, and they weren’t”.  (L56, Olivia, 
FG4). 
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“they were more comfortable than uncomfortable, aren’t they? Yes. so, 
they’re all right” (L155-156, Brian, FG2).  
 
Surprisingly, some participants preferred the sensation of wearing the TI rather 
than the sensation of the plain insole in the ipsilesional shoe: 
“especially … the textured one on the left foot, when you got used to it, it’s 
more comfortable than the plain one in the right foot.” (L106-107, Brian, 
FG2).      
 
Participants generally liked wearing the insoles, and wore them as much as 
possible throughout the day, some even wearing them all day: 
“once they was in the shoes they stopped there till I went to bed” (L189, 
Isaac, FG2). 
“I transferred it from different shoes that I was wearing, I even put it in my 
slippers” (L225-226, Nadine, FG2). 
 
 TSGT 
The TSGT was not reported as being uncomfortable; however, it was perceived to 
be challenging at times and this will be discussed in relation to challenges of the 
interventions (section 6.19.4). 
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 Perceived effects (Objective 3g) 
Some people clearly felt that the MTS trial intervention, particularly the massage 
component, had made a difference to them. Participants observed that the MTS 
changed the feeling within the leg, and increased the flexibility of the muscles and 
soft tissues: 
“it woke it up, it woke your leg up in the morning” (L101-102, 
Michelle, FG3)  
 “I loved the massage (L104) … Well, it kept it flexible” (L109, 
Phoebe, FG3) 
“It made everything more flexible.” (L172 -174, Michelle) 
 
Nancy was very clear that the MTS had been of great benefit to her, 
commenting on the fact that the treatment affected not only her foot but the 
whole of the lower leg, up to the knee. She described the effect of the MTS 
on the movement of her lower limb, but she had also recognized that the 
change in her ability to feel her foot had actually improved her walking: 
 “It [MTS] helped me enormously, with my feet especially because I 
couldn’t move my right foot at all, and it’s helped me 
enormously…it’s made a difference to my right leg as well, up to the 
knee... because that was all weird, couldn’t move it very much, and 
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it has made a difference with that…I can feel it more than I could, I 
know when I’m lifting it now, whereas I didn’t before, … and that 
makes walking easier it does… it’s helped me enormously in 
moving the leg up and down. My right leg, where I had all the 
massage and what-have-you, is better than my left one!”  (Nancy, 
FG3, L152–212). 
 
Two participants in the MTS group reported a change within the feeling of the foot 
or lower limb, frequently insinuating that the body part now belonged to them: 
 
“Well, I’d like to say that…I found that…it was part of me…part of my other 
leg, you know? It was…”  (L34), “… like…knowing I’ve got two legs instead 
of one” (L37), “It brought them together” (L39, Harry, FG1). 
 
“I think it is my brain realising that it’s got a left side to the body and I think 
the treatment has brought that on” (L72-74) ... “I could feel that I’ve got a left 
side I didn’t realise” (L88, Frank, FG1).  
 
Indeed, Frank said it now felt the same as the other foot: 
“I noticed, er, textures beneath my foot I couldn’t feel that” (L681, 
Frank, FG1) … “They’re both the same” (L704, Frank, FG1).  
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This was corroborated by accounts from other participants, who also 
acknowledged the importance of being able to feel the foot in order to walk and a 
sense that being able to feel the foot made them want to walk:  
 
“My foot had woken up, I felt better for walking” (Michelle, FG3, 
L886). 
“I’d like to say the treatment [the MTS], it made you feel as though 
you wanted to walk.” (Harry, FG1, L158-159). 
 
Progress with rehabilitation was attributed to the massage and encouragement 
from the research therapists: 
 
“I think I’ve got more movement in my foot” (L668) … “seems to move more 
freely now” (L670) … “I think my left leg now, foot, is as strong as my right 
one; there’s not much difference in them” (L708) … “I can rely on it now, 
where I couldn’t before” (L712-713, Harry, FG1). 
 
Several of the participants appeared to attribute walking again and improved 
function to receiving MTS combined with TSGT, and participation in the MoTaStim-
Foot trial:  
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 “I couldn’t walk... I’ve learned a lot, I can walk now right, I don’t 
walk with any aid in the house. I’ve come on leaps and bounds, 
that’s what has happened. Leaps and bounds.” (L83-86, Evelyn, 
FG3). 
“The treatment’s given me the ability to walk with my partner. To get 
myself from A to B which is great.” (L125-127, Frank, FG1). 
 “It helped me enormously…. I can walk now with my sticks…I 
couldn’t… couldn’t walk at all when it started. (L152-155, Nancy, 
FG3). 
 
“I get out of bed some mornings and I don’t need sticks I walk round the 
bedroom” (L162-163) … “sometimes I feel like I can run. Honestly, I feel like 
I can run again” (L243-244, Keith, FG1). 
 
 Textured Insoles  
The stability provided by wearing an insole appeared to be a factor in participants 
feeling an effect from wearing an insole, whether textured or plain: 
 
“In fact, since I had a stroke, I’ve taken to wearing insoles inside the shoes, 
um..., white insoles that you buy, padded insoles, but I much prefer to wear 
the trial insole…because of the design of the insoles your foot wasn’t 
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flapping up and down mm, did you notice that? your foot was more stable” 
(L159–164, Nadine, FG2). 
 
“Yes, the insole made the shoe a bit more rigid.”  (L165, Henry, FG2). 
 
Loss of sensation following a stroke has an impact on the ability to feel the floor 
under the foot, and to move appropriately to function. Nadine explained the 
changes in feeling relating to her foot and function clearly: 
 
“before I had the textured insole … when I used to put my foot on the floor, 
… the sole of my foot it just felt like a plank of wood... if that makes any 
sense?” ... there’s no feeling of movement in the foot and the toes wouldn’t 
move, … when I was wearing the textured insole it gave me better 
movement in the foot, … I could feel the foot more” (L49-56, Nadine, FG2).  
 
Participants chose to wear the insoles because they felt they were having a good 
effect, although this feeling was not instant: 
 
“I preferred to wear the insole because I felt as though I was getting benefit 
from it” (L233-234, Nadine, FG2). 
 
“when I first wore it, it was a sensation I wasn’t familiar with, and it took me 
4 or 5 days to become familiar with the sensation, and then after 4 or 5 
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days, maybe a week later I could feel the texture of the insole affecting the 
foot” (L38-40, Nadine, FG2). 
 
“At first you didn’t think it was making much difference, but it was, it was a 
gradual build up” (L79-80) ... but after wearing the insole for a period of time 
that’s the feeling I had... that someone was tickling me …  which was good” 
(L90-93, Nadine, FG2). 
 
Others could also feel the TI and perceived benefits of wearing the insoles, 
describing an ability to feel changes within the foot, which in some cases were 
clearly long-lasting effects: 
 
“my left foot went from virtually no sensation … to being downright ticklish” 
(L87) “still feels different now, weeks after taking the insole out” (L1147-
1148) … “in sensitivity” (L1150) …”me foot is tingling at the moment” (1153, 
Henry, FG2). 
 
“the trial helped me to gain more feeling, more control, over my right foot 
which was the affected foot, it’s made a huge impact on me and it’s helped 
me recover even quicker” (L1459-1462, Nadine, FG2). 
 
The importance of the sensation from the plantar surface of the foot was 
recognized: 
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“what’s the first thing you do when you’re walking, when you stand up? It’s 
your feet, it’s the sensation in the sole of your foot” … “This trial helped us 
to gain the sensation back in the sole of the foot, it’s had a major impact” 
(L1414-1418, Nadine, FG2).    
 
“this morning when I got out of the car, there was lots of loose pebbles on 
the ground, and and I could feel it through my left foot” (L1419-1420, Henry, 
FG2).    
  
Isaac was unable to feel the TI and felt it made no difference to him: 
 
“I don’t think it made any difference wearing it with or without” (L62) 
“normally I just wear my lambs wool insoles” (L122) …” and there was no 
difference” (L124) … “there was no difference from start to finish for me” 
(L1542, Isaac, FG2).  
 
However, a change in sensation was linked to improved movement and function by 
some of the participants after wearing the TIs and receiving TSGT: 
 
 “I got to be able to control my knee” (L1366) …. “and have confidence to 
put weight on my left leg” (L1368) … “I could feel the muscle just above my 
knee (pause) going tighter and holding my knee in place” (L1374-1379) … 
“well if you know you’ve got control over your leg, as you can lock it up and 
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it isn’t going to cave in beneath you... that’s marvellous” (L1405-1406, 
Henry, FG2). 
 
Nadine was aware of the insole while undertaking the tasks in the TSGT session. 
She even referred to becoming dependent upon the insoles because she felt they 
were beneficial. She describes a change in feeling of her whole leg, which 
increased her confidence walking again, making her able to put weight through the 
side which was affected by her stroke:  
 
“all the time when I was using the side step I could feel the insole in the 
shoe” (L287-288, Nadine, FG2).  
 
“it feels the same as what the gentleman said it’s like a ticklish feeling, ...I’d 
look forward to getting up in the morning and putting that textured insole in 
the shoe, because it was giving me that ticklish feeling, and … gradually 
over a period of time, I found myself, wearing the insole all the time. And I 
didn’t take the insoles off until I was getting ready undressed and going to 
bed and um..., um... yep I became dependent upon the insole because it 
was bringing me sensation back into my foot”. L112-120, Nadine, FG2).        
“it gave me, more feeling in the right leg to walk without thinking that 
this leg is weak, it gave me a sense of power back” (L1359, Nadine, 
FG2).      
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Describing it as a “minor miracle” (L86, Olivia, FG4), Olivia felt wearing the TI 
contributed to her foot being straighter: 
 
 “it gradually got straighter and it’s still straight now” (L78). 
 
Afferent feedback is important for walking, assisting with moving the foot and leg, 
as well as stepping and placing the foot during gait. Nadine describes her 
awareness of the importance of somatosensory feedback to facilitate the 
movement in her foot and her ability to walk again, summarizing well the overall 
benefits she felt from wearing the TIs: 
 
“I’ve got more control over my foot since wearing the insole ... as I explained 
before, the only way I can describe it is having this foot and it didn’t move, I 
felt as though it didn’t move. But when I wore the insoles I could feel the feet 
moving I could actually move the foot, and I’ve got more control over the 
foot, I can actually... the brain ... my... I can use my brain to tell the foot to 
move it a bit, and that only happened with wearing the insole, I can send a 
signal to the brain to move the foot” (L1158-1165, Nadine, FG2). 
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 Task-specific gait training 
Participants valued the TSGT they received, indicating it had helped them to gain 
control over their body, improving their balance, walking and confidence, and 
assisting them to achieve functional activities.  
“the walking training helped me a lot, to go outside the home 
environment” (L371, Jackie, FG3). 
 
 “It’s [the TSGT] definitely helped because to start with er..., the foot had got 
a mind of its own, er it tended to want to go a different way (laughs) but after 
so long with the textured insoles and the training and all the rest of it, got 
more confidence.” (L226-230) ... “it (the TSGT) was very useful for me” 
(L378-379, Olivia, FG4). 
 
“I liked the balancing” (L263) … “that’s what seemed to have helped 
me more than anything. I don’t seem to fall... I also don’t seem to 
ever trip up” (L265-267, Phoebe, FG3).  
 
The participants clearly felt the time which had been dedicated to the TSGT and 
the hard work and effort they had put in had made a difference to them personally, 
with several participants even indicating that they did not think they would have 
walked again or managed the stairs after their stroke, without the trial intervention: 
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 “I wouldn’t have been able to walk without it” (L250, Michelle, FG3). 
 “it made a huge difference” (L319... “improved us tremendously” 
(L326, Nadine, FG2).  
 
Participants indicated that they found the TSGT worthwhile, even though it was 
hard work, because they could see results; the motivational element of working 
one to one with a therapist may have helped: 
 
“it was helpful because it got me motivated” (L476, Nancy, FG3). 
“I wouldn’t have been anywhere like I am now without these lot, you 
know with...your determination” (L79-80, Dennis, FG3). 
 
One of the participants indicated that without his participation in the trial he would 
still be in a wheelchair rather than walking, and another suggested they would not 
have been able to go on their holiday: 
 
“made me do things...I’d still have been in my bloody chair if I hadn’t have 
done that...you know, it was really good” (L 318-320, Dennis, FG3). 
“she got me to Lanzarote, she told me on day one I would go” 
(L187, Michelle, FG3). 
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 Dose intensity, frequency and duration (Objective 3d) 
The interventions took place regularly, often daily, and participants’ opinions were 
sought regarding this issue. All the participants except Trevor were happy having 
such regular treatments and many even wanted more sessions:  
“no, never too much” (L424, Marie, FG3) 
“you could have come to my house every day” (L426, Dennis, FG3) 
“it went so quick. If we had twice as many sessions, I think I would have 
been further advanced than what I am now.” (L534,536, Brian, FG2).  
 
However, Trevor (a young stroke survivor in his fifties) suggested that an intensive 
daily rehabilitation programme over a three-month period, to which the trial 
intervention had contributed, had become a burden from which he was ready to be 
relieved, even though the intensity of the trial intervention was acknowledged to 
have been “about right” (L1011, Trevor, FG1):  
 
“but after three months of day in day out I was probably thinking it was 
enough” (L334, Trevor, FG1).  
 
However, Trevor did feel the length of each treatment session (approximately 30 
minutes of MTS, plus 30 minutes of TSGT) was appropriate: 
 
“I would say that an hour was about right” (L998, Trevor FG1). 
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Due to the intense nature of the TSGT, it was important to find out whether the 
timing that was chosen (30 minutes) was acceptable to the participants. Although 
some of the participants wanted a longer treatment period and felt they “could be 
doing a bit more” (L480, Dennis, FG3), others felt the chosen intervention time 
was appropriate: “it was just enough for me” (L485, Nancy, FG3), “it was all right 
what I did but er no longer” (L 439, Isaac, FG2). 
 
 Difficulties/challenges  
Several of the participants clearly found the TSGT challenging in various ways, 
with five people describing it as “hard work” (Brian, FG2; Edgar, FG4, Henry FG2, 
Nadine, FG2, Trevor FG1): 
 
It was also perceived by four people as being tiring at times, requiring recovery 
time afterwards, with the fatigue even manifesting itself the following day: 
 
“I did need to rest afterwards” (L476-477, Nancy, FG3). 
“I used to feel tired the next day” (L447, Phoebe, FG3). 
 
Nadine also felt it was “confusing at times” and two of the participants said at times 
they had found it frightening (Dennis, FG1 and Keith, FG1). 
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 Acceptability of the outcome measures (OMs) – Objective 
3f 
 Comfort of outcome measures  
There was a generalized acceptability of the need to participate in the OMs, with 
participants clearly understanding what they had agreed to when they consented 
to be part of the trial. One person said she thought the OMs could be “challenging, 
… but that’s part and parcel” (L504, Olivia, FG4) and another said “as long as we 
all knew what they were doing, I think we were all quite happy to go along with it 
because it was part of the trial we signed up for” (L790-791, Michelle, FG3). 
 
 Perceived benefits of outcome measures  
The OMs were clearly useful to some of the participants, and this perhaps 
made them more acceptable, despite the time it took to undertake them. 
For example, Henry found the visual feedback on the computer screen 
useful: 
 
“you know the pressure sensors that you put in the er in the shoe...and then 
on the computer screen showing equal pressure on both feet I thought that 
was amazing” (L727-734), Henry, FG2). 
 
It seemed that some of the participants were encouraged and motivated by the 
positive results they saw in relation to the OMs: 
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“I thought to myself this is measuring the outcome of the progress 
that I have made and I was quite happy with that” (L740-742, 
Nadine, FG2). 
“you showed me the clip of me walking three months ago and I 
couldn’t believe it was me, I couldn’t believe it was me, and it had 
changed dramatically how you’re moving; well, one was just moving 
just through the room and, er it was quite remarkable to see the, the 
knee and this walking” (L456-460, Trevor, FG1). 
 
 Difficulties/challenges 
Generally, the participants did not have any major problems with the OMs, 
although the wires from the Tekscan pressure insole set up were occasionally an 
issue: 
“The first time it was quite difficult because I felt as though the wires 
were dragging a bit, but the last time it was brought in I was quite all 
right. I could walk down and walk back again” (L714-716, Nadine, 
FG2). 
“you’ve got to beware haven’t you of tripping?” (L 538, Edgar, FG4) 
 
One participant (Dennis, FG3) suggested a wireless system would be more 
suitable, and for others the wires were not seen as a problem: 
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“I wasn’t particularly bothered about the wires” (L717, Henry, FG2). 
 “it was fine because obviously there was someone there watching 
what... where you were putting your feet etc. so you can’t ask for 
more than that” (L555-556, Olivia, FG4). 
 
 Use of daily diaries (Objective 3e) 
 Ease of completion 
In the main participants did not have any problems completing the daily diaries, 
stating they were “very easy” (L559, Trevor, FG1, L896, Edward, FG3) and also 
that they “wish all the forms were that easy” (L874, Isaac, FG2) and “no it wasn’t 
difficult” (L889 Henry, FG2) and also “no it wasn’t a burden” (L654, Frank, FG1).  
 
 Difficulties/challenges  
Phoebe’s poor eyesight made it a little more challenging; she had to wait for 
assistance to complete the diary and therefore her ability to recall what she had felt 
or achieved was potentially reduced: 
 
“well, I’d have found it would have been a lot easier if I could have seen so 
that I could have wrote it as I felt it. Oh, but waiting for somebody to come 
and fill it in, it had gone”. (L914-916, Phoebe, FG3).  
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Other participants were honest about the fact they sometimes forgot to complete it: 
 
 “I just kept forgetting” (L1276, Evelyn, FG3). 
 
 Perceived benefits of daily diaries 
There was a perceived value in using the daily diaries to note progress: 
“because I was progressing you see with everything” (L906-907, 
Nadine, FG2). 
 
 Overall trial experience 
 Environment 
Many of the participants received their treatments in their own home environment 
and this was not seen to be an issue at all; indeed, there was unanimous 
agreement that this was preferable, and no-one reported that they felt it was 
intrusive, they just reported the benefits: 
 
“I felt comfortable because it was in my own house and felt as 
though I’d got more control over it as well” (L775-776, Nadine, 
FG2). 
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“it was ideal I felt more confident in my own surroundings” (L565) ... “so, it 
gave you the confidence to do that bit more because you were secure in 
your surroundings” (L559-560, Michelle, FG3). 
 
Participants indicated that it was easier for them to have the therapist travelling to 
their house, and one participant said she would not have completed the full course 
of treatment if it had been necessary for her to travel to receive it.  
 
 “without you coming to the house I don’t think I would have 
completed the course because I would think oh, it’s too much 
trouble to go and get ready and go out” (L568-570, Jackie, FG3). 
 
Some participants would, however, have been happy to travel to receive the 
treatment: 
“I would still have gone [to the hospital], even though, but it’s 
convenient you coming at home” (L 815-816, Dennis, FG3). 
 
Some people did receive their treatment while they were still in the hospital, but 
again this was not perceived as a problem. 
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 Confidence 
The treatment on the trial was reported as contributing to an increase in 
confidence and independence: 
“It gave me the confidence to go out, back out, and to walk with a 
stick” (L112-113, Jackie, FG3). 
 
 “Well it gave me confidence; you said to me one…one day you’re going to 
walk now without your stick” and I said to you “I can’t do it” …and you said 
to me “I’ve been in this job long enough to know that you can do it”…and I 
did it! I went from the kitchen into the living room, and I was REALLY 
surprised at that!” (L263-267, Harry, FG1). 
 
The value that the participants placed upon the treatment they received could 
perhaps in part be attributed to the skilled therapy they received, and this would, in 
turn, have made the treatments more acceptable to the participants.  
 
“having someone who knows what they’re talking about, that helps 
when you have no idea yourself and it does help with confidence” 
(L363-367, Olivia, FG4).  
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“After you lot coming around and giving it all you’re doing right, you 
know what you are doing” (L651-652) … “You know every bone in 
the body” (L654, Dennis, FG3). 
  
The confidence instilled in the participants from the research therapists was also 
discussed: 
 
“My wife isn’t the same as you standing there. You do give me confidence” 
(L771-772)...”as soon as you dropped off, my confidence dropped” (L767, 
Harry, FG1). 
 
 Improved function  
All the participants perceived benefits from being part of the MoTaStim-Foot trial, 
with many different comments made about it being enjoyable, useful, and 
beneficial in helping them to achieve their goals:  
 
“it’s helped me to achieve my goal and more um because I’m now trying 
things that I wouldn’t have tried before” (L1297-1298) ... “yes, it has 
absolutely without a doubt. I am even walking, walking on my own now 
without a walking stick” (L1301-1302, Nadine, FG2). 
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“Well, if it weren’t for that treatment I wouldn’t be walking now” 
(L193-194) “My wife thinks the same... if it wasn’t for you…I 
wouldn’t be walking now, I should be static” (L195-196, Harry, FG1). 
 
“Well, life after the trial has been good, because I’m able to get up and 
move about a bit on my own, transfers, (L1023-1024) so I’m not a burden 
on somebody else.” L1026, Henry, FG2).  
 
   The beneficial and challenging effects of being involved in an 
intensive therapy trial 
The trial involved a great deal of effort and time commitment on behalf of the 
participants. It was evident that the trial had not only had an impact on the 
participants but also on their families: 
 
“it made a big, big impact on my daughter and my husband because 
they could understand what I was going through and what was 
happening with the trial” (L1258-1259, Nadine, FG2). 
 
“yes, yes it has had an impact” (L1257) … me Dad still shouts 
“stand tall!” (laughs)” …. “don’t stick your bum out, stand tall” 
(L1264–1267, Henry, FG2). 
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Two of the participants felt that their participation in the trial had helped prevent 
them having falls: 
 
“Knowing that I’d got control of my knee meant there was no fear of falling, 
and I haven’t fallen.” (L1385-1386, Henry, FG2).    
“Where I would have gone down… now I find my balance a lot 
easier. That’s what I have found one of the biggest benefits to me”. 
(L269-270, Phoebe, FG3). 
 
However, the intense nature of almost daily treatments, often alongside NHS 
therapy was challenging for some participants: 
 
“Many people are interfering with your life” (L290, Frank, FG1). 
 
“I felt it was a bit stress … stressful, a bit ‘oh no, she’s coming again” … 
“every day, for it to be every day it seemed too much” (L285-295, Trevor, 
FG1). 
 
   End of the trial 
Some of the participants found it challenging when the trial finished and described 
a sense of disappointment or loss: 
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“After the trial finished…. I experienced a sense of loss” (L1341, Nadine, 
FG1). 
 
“let down” (L582, Brian, FG2). 
 
 “when it all finished I felt like bloody hell, what am I going to do now?” 
(L642-643, Dennis, FG3). 
 
“it feels a whole lot better but I’m gutted you’ve left” (L970, Evelyn, FG3). 
 
“I felt sorry it had finished because I felt it was doing me good” (L633-634, 
Jackie, FG3). 
 
However, by the time the trial finished many of the participants had developed 
sufficient movement and ability to undertake functional activities unaided or with 
their families and several participants were demonstrating self-management skills. 
 
The qualitative aspects of this trial have added value, and will inform the future 
RCT in many ways: ethically, it has been possible to ensure that recruitment and 
communication strategies take into account the needs of participants, ensuring 
being part of the trial is a positive experience, interventions are deemed suitable 
and appropriate for both the participants and the research therapists, internal 
validity is increased by confirming that appropriate OMs are employed. 
311 
 
Furthermore, the qualitative aspects have the potential to improve the success of 
the trial and facilitate future implementation of techniques (O'Cathain et al., 2013). 
For example, it has been possible to reflect upon the fact that such regular input 
(almost daily) leaves little time for participants to be involved in other activities and 
this can be an important aspect, particularly for younger stroke survivors.  
 
Whilst most of the feedback from the participants has been positive, when 
considering the analysis of the information from the FGs the issue of social 
desirability must not be forgotten; for example, the participants may have a 
tendency to report positive aspects that they consider the researcher and other 
participants may like to hear (Zerbe and Paulhus, 1987). 
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In order to address objective 3g, exploring the responses to the interventions over 
time, detailed within-group analysis was undertaken for each OM. As this was a 
feasibility study, between-group analysis was not appropriate and therefore not 
undertaken. 
 
 Outcomes 
 Five-metre walk test (5MWT) 
The 5MWT was undertaken at baseline, end of intervention and one-month follow-
up. The outcome was relatively quick to undertake, with very minimal cost 
implications, for example requiring use of just a timer. As the data were not 
normally distributed, median and IQR, range, within-group differences between 
medians (baseline and end of intervention, and baseline to one-month follow-up) 
and 95% CIs were calculated and are summarized in table 6.10. The box plots 
show a representation of the results of the 5MWT (figure 6.18). 
 
A reduction in time taken to complete the 5MWT was seen in both groups at end of 
intervention and at follow-up. For the MTS group, median (IQR) change in time 
from baseline to end of intervention was 10.18 (4.67,16.27) seconds                
(95% CI -15.52 to -5.45), and it was 11.49 (2.34,16.79) seconds (95% CI -22.90 to 
-1.40) for the TI group. The change in time from baseline to one-month follow-up 
was 10.33 (6.12,18.60) seconds (95% CI -17.89 to -6.15) for the MTS group, and 
13.17 (6.12,18.60) seconds (95% CI -26.08 to -0.39) for the TI group.
313 
 
Table 6.10 Results of 5MWT, at baseline, end of intervention, and one-month follow-up, including change from 
baseline to end and baseline to follow-up, showing median (IQR) and range of times (seconds), and 95% CIs 
 
Group 
 Baseline End of 
Intervention 
Change from 
baseline to end 
One-month 
follow-up 
Change from 
baseline to 
follow-up 
MTS 
group 
(18) 
Median 
(IQR) 
 
23.80 
(17.53, 31.13) 
 
13.43 
(8.70, 17.30) 
 
-10.18 
(4.67,16.27) 
 
11.41 
(6.80, 15.75) 
 
-10.33 
(6.12,18.60) 
 
Range 12.08–71.00 6.50–34.80 14.57–43.19 5.59–37.66 -25.58–56.20 
95% CI    -15.52 to -5.45   -17.89 to -6.15 
TI 
group 
(11) 
Median 
(IQR) 
 
27.65  
(16.91, 39.78) 
 
14.51 
 (11.79, 21.19) 
 
-11.49 
(2.34,16.79) 
 
14.79  
(13.64, 22.47) 
 
-13.17 
(3.58,19.07) 
 
Range 12.30–80.00 9.44–48.47 -6.32–56.00 11.33–44.80 -2.49–38.06 
    95% CI    -22.90 to -1.40  -26.08 to -0.39 
CI=Confidence interval
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Figure 6.18 Box plots for all three time-points for the 5MWT according to 
group    
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 Functional Ambulation Classification (FAC) 
The FAC was undertaken at baseline, end of intervention and one-month follow-
up, was quick to undertake and required no financial resources. Assessment and 
change scores are summarized in table 6.11.  
 
At baseline, the median (IQR) score for the MTS group was 4.0 (2.0, 5.0). 
However, at the end of intervention and one-month follow-up assessments, the 
median (IQR) score was 5.0 (4.0, 5.0) and 5.0 (5.0, 6.0) respectively. In the TI 
group, the median (IQR) score was 3.0 (1.0, 4.0) at baseline, 5.0 (4.5, 5.5) at end 
of intervention and 5.0 (5.0, 6.0) at the one-month follow-up.  
 
A visual representation of the results is displayed in figure 6.19, with each of the 
two groups represented separately. This clearly shows the change where many of 
the participants at baseline were dependent upon others, and in some cases non-
ambulatory, to cohorts in both groups who were much more independent 
ambulators.  
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Table 6.11  FAC scores at baseline, end of intervention, and one-month follow-up, including change from 
baseline to end and baseline to follow-up, showing median (IQR) and range of FAC categories 
 
Group 
 Baseline End of 
 Intervention 
Change from  
baseline to end 
One-month  
follow-up 
Change from 
 baseline to follow-up 
MTS group  
Median (IQR) 4.0 (2.0, 5.0) 5.0 (4.0, 5.0) 1.0 (1.0, 2.0) 5.0 (5.0, 6.0) 2.0 (1.0, 3.0) 
Range 1.0–5.0 3.0–6.0 0.0–3.0 4.0–6.0 0.0–4.0 
TI group  
Median (IQR) 3.0 (1.0, 4.0) 5.0 (4.5, 5.5) 2.0 (1.0, 3.0) 5.0 (5.0, 6.0) 3.0 (1.0, 3.0) 
Range 3.0–6.0 3.0–6.0 0.0–4.0 4.0–6.0 0.0–4.0 
 
MTS group n=19  TI group n=15 at baseline; n=13 at end and one-month follow-up  
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Key:           Non-functional (unable to ambulate) 
  Dependent Level II (requires continuous manual contact of one person) 
  Dependent Level I (requires intermittent manual contact of one person) 
  Dependent, supervision (level surfaces only, no manual contact required) 
  Independent, level surfaces only 
  Ambulation independent on unlevel surfaces, stairs and inclines    
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Figure 6.19  FAC results displayed as bar charts for each group at baseline, 
end of intervention, and one-month follow-up 
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 Goniometer readings – maximum dorsiflexion and maximum   
inversion for the contralesional side 
The goniometer readings were undertaken at baseline, end of intervention and 
one-month follow-up. The costs for initially purchasing the goniometry equipment 
need to be taken into consideration (£4,611). For each group, change in median 
(IQR) scores were calculated from baseline to end of intervention, and from 
baseline to one-month follow-up. The results are represented in table 6.12 and 
visually in the box plots in figures 6.20 and 6.21. 
 
6.21.6.3.1 Dorsiflexion  
Changes in median (IQR) scores from baseline to end of intervention were 0.10    
(-2.2, 5.6) (95%CI -2.20 to 6.70) for the MTS group, and -0.45 (-2.18, 6.25) (95%CI 
-9.50 to 6.70) for the TI group, and from baseline to one-month follow-up were 0.20 
(-5.40, 4.25) (95%CI -4.90 to 3.00) for the MTS group, and -2.65 (-5.93, 1.13) 
(95% CI -6.00 to 1.50) for the TI group. 
 
6.21.6.3.2 Inversion 
Changes in medians (IQR) from baseline to end of intervention, were -0.85  
(-3.05,1.33), (95%CI -6.30–8.60) for the MTS group and 1.80 (-2.60, 3.50),  
(95%CI -7.50 to 4.70) for the TI group and for baseline to one-month follow-up 
were 0.25 (-3.03, 1.38), (95%CI -3.20 to 1.60) for the MTS group and -0.19 (-6.58, 
3.05), (95%CI -6.80 to 4.10) for the TI group. 
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A few extreme values were noted. In the absence of a clear reason for these 
extreme values, the reliability of the goniometer measurements was questioned. 
This issue will be further discussed in chapter seven. 
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Table 6.12  Goniometer readings for maximum dorsiflexion and inversion at baseline, end of intervention, and 
one-month follow-up, including change from baseline to end and baseline to follow-up, showing median (IQR) 
and range movement (degrees) 
Group 
 Baseline End of 
Intervention 
Change from 
baseline to end 
One-month 
follow-up 
Change from 
baseline to follow-up 
MTS group 
Maximum 
dorsiflexion 
Median 
(IQR) 
9.9 (5.05, 12.35) 9.85 (6.50,12.70) 0.10 (-2.2, 5.6) 8.5 (7.20, 11.50) 0.20 (-5.40, 4.25) 
Range 2.40–24.30 2.30–41.50 -13.70–26.30 2.90–29.20 -17.16–19.30 
95% CI   -2.20 to 6.70  -4.90 to 3.00 
TI group 
Maximum 
dorsiflexion 
Median 
(IQR) 
9.45 (7.30, 9.80) 10.10 (8.90, 11.70) -0.45 (-2.18, 6.25) 5.80 (4.60, 11.30) -2.65 (-5.93, 1.13) 
Range 2.20–18.60 3.70–15.30 -13.70 – 6.25 3.20–11.90 -7.8–5.60 
95% CI   -9.50 to 6.70  -6.00 to 1.50 
MTS group 
Maximum 
inversion 
Median 
(IQR) 
8.30 (5.85, 10.8) 6.15 (4.55, 11.40) -0.85 (-3.05,1.33) 8.20 (5.95, 9.80) 0.25 (-3.03, 1.38) 
Range 2.80–19.00 1.10–14.10 -6.30–8.60 1.20–13.40 -7.20–9.10 
95% CI   -3.10 to 1.80  -3.20 to 1.60 
TI group 
Maximum 
inversion 
Median 
(IQR) 
7.0 (3.40, 11.50) 7.70 (6.60, 11.10) 1.80 (-2.60, 3.50) 6.10 (4.50, 8.10) -0.19 (-6.58, 3.05) 
Range 2.80–19.00 2.40–17.00 -5.00–7.10 1.60–20.20 -8.30–15.90 
95% CI   -7.50 to 4.70  -6.80 to 4.10 
MTS group n=16  TI group n=10 
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Figure 6.20  Box plot of maximum dorsiflexion results at baseline, end and 
follow-up 
  
 
 
322 
 
 
Figure 6.21  Boxplot of maximum inversion at baseline, end and follow-up 
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 The modified Rivermead Mobility Index (mRMI) 
The mRMI was undertaken at baseline, end of intervention and one-month follow-
up. There were no costs associated with implementation of the mRMI. Results are 
presented in table 6.13. The mRMI is usually scored out of 40; however, an issue 
arose in that it was not possible standardize the number of stairs participants were 
assessed on, in view of the multiple venues used for testing, and that some 
participants in their home environment did not have access to a flight of stairs.  It 
was, therefore, impossible to assess this section in these cases. To ensure parity 
between the scores, a pragmatic decision was made to remove the stairs score 
from all the participants, scoring the mRMI for all participants out of 35 instead.  
 
The mRMI score increased for both groups from baseline to end of intervention. 
Towards the ipsilesional side, there was a change in median (IQR) score from 33 
(29, 34) to 34 (33, 35) in the MTS group, and from 23.5 (20, 33) to 34 (33,34) for 
the TI group. Towards the contralesional side: there was a change in median (IQR) 
score from 33 (28, 33) to 34 (34,34) in the MTS group, and from 24.5 (20, 31) to 34 
(33,34) in the TI group. 
 
The range of scores for both groups decreased, from 19–34 (ipsilesional) and 14–
34 (contralesional) at baseline to 26–35 (ipsilesional) and 21–35 (contralesional) at 
end of intervention for the MTS group; and from 12–34 (ipsilesional) and 12–35 
(contralesional) at baseline to 26–35 (ipsilesional) and 25–35 (contralesional) for 
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the TI group, as can be seen in table 6.13 and visually represented in the boxplots 
in figures 6.22 and 6.23. 
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Table 6.13  mRMI at baseline, end of intervention, and one-month follow-up, including change from baseline to 
end and baseline to follow-up, showing median (IQR) and range of scores    
Group 
 Baseline End of 
Intervention 
Change from 
baseline to end 
One-month 
follow-up 
Change from 
baseline to 
follow-up 
MTS group 
towards 
ipsilesional 
side  
Median 
(IQR) 
33 (29, 34) 
 
34 (33, 35) 
 
3.24 (0.00, 4.50) 34 (34, 35) 
 
3.94 (1.00, 6.00) 
Range 
19–34 26–35 -3.00–14.00 32–35 -2.00–15.00 
TI group 
towards 
ipsilesional 
side  
Median 
(IQR) 
 
23.5 (20, 33) 
 
34 (33, 34) 
 
7.5 (1.00, 14.25) 34 (31, 35) 
 
8.2 (1.00, 13.25) 
Range 12–34 26–35 1.00–15.00 28–35 1.00–20.00 
MTS group 
towards 
contralesional 
side  
Median 
(IQR) 
33 (28, 33) 
 
34 (34, 34) 
 
2.00 (1.00, 5.50) 34 (34, 35) 
 
2.00 (1.00, 6.50) 
Range 
14–34 21–35 0.00–20.00 31–35 -2.00–20.00 
TI group 
towards 
contralesional 
side TI group  
Median 
(IQR) 
 
24.50 (20, 31) 
 
34 (33, 34) 
 
6.00 (2,50, 11.75) 34 (31, 34) 
 
9.00 (1.50, 12.00) 
Range 12–35 25–35 0.00–15.00 29–35 0.00–17.00 
MTS group n=17  TI group n=10 
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Figure 6.22  Box plot for all three time-points according to group for the 
mRMI on ipsilesional side  
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Figure 6.23  Boxplot for all three time-points according to group for the 
mRMI to contralesional side
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 Pressure insole readings 
The pressure insole measurements were undertaken at baseline, end of 
intervention and one-month follow-up. There were large costs involved with the 
purchase of the Tekscan (F-Scan) equipment (approximately £14,000). The two 
aspects analysed were: (i) FTI, and (ii) mean COFV in an AP direction. The 
differences between medians and 95% CIs from baseline to end of intervention, 
and from baseline to one-month follow-up were calculated.  
 
Most participants were able to calibrate their own insoles, with the assistance of a 
vertical surface (for stability only and not for putting weight through), and 
assistance of a researcher, if required. It is acknowledged that this may have 
affected the total weight taken through the one leg; however, in view of the 
significant impairment of many of the participants it was necessary to take a 
pragmatic approach to the calibration procedure and this was another important 
aspect for analysis as part of the feasibility study. 
 
For FTI: The 95% CI for the differences between medians from baseline to end of 
intervention were -292.37 to 178.92 for the MTS group, and -66.78 to 181.28 for 
the TI group; and from baseline to one-month follow-up -211.62 to -34.82 for the 
MTS group and -245.87 to 318.84 for the TI group. 
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For COFV: The 95% CI for the differences between medians from baseline to end 
of intervention, were -1.40 to 4.60 for the MTS group and -0.30 to 3.40 for the TI 
group and for baseline to one-month follow-up were -1.00 to 5.50 for the MTS 
group and -0.50 to 3.60 for the TI group. 
 
The results are presented in tables 6.14 and 6.15 and in the box plots in figures 
6.24 and 6.25, and an example representation of the presentation of the pressure 
under the feet at baseline, end of intervention and one-month follow-up is shown in 
figure 6.26. 
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Table 6.14  Force time integral (FTI) from pressure insole readings from contralesional foot at baseline, end of 
intervention, and one-month follow-up, including change from baseline to end and baseline to follow-up, showing 
median (IQR) and range of results (Newtons/sec)   
 
Group 
 Baseline End of Intervention Change from 
baseline to end 
One-month 
follow-up 
Change from 
baseline to follow-up 
MTS  
Median 
(IQR) 
756.39 
(564.06, 928.30) 
500.02 
(467.78, 724.75) 
-102.04 
(-292.37,178.92) 
554.74 
(377.70, 748.90) 
-105.98 
(-238.59, -36.01) 
Range 32.70–1555.79 355.93–1387.43 -461.82–323.23 319.52–1438.23 -508.51–471.57 
95% CI   -292.37 to 178.92  -211.62 to -34.82 
TI  
Median 
(IQR) 
585.44 
(440.95, 766.92) 
672.97 
(535.20, 848.43) 
71.14 
(-62.80,176.48) 
707.96 
(431.62, 876.15) 
6.74 
(-210.40, 284.92) 
Range 374.34–1125.25 334.51–1927.57 -246.52–1019.23 306.77–996.93 -418.05–622.59 
95% CI   -66.78 to 181.28  -245.87 to 318.84 
MTS group n=18  TI group n=12 
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Table 6.15 Mean centre of force (AP) velocity from contralesional foot at baseline, end of intervention, and one-
month follow-up, including change from baseline to end and baseline to follow-up, showing median (IQR) and 
range of results (cm/sec)    
Group 
 Baseline End of Intervention Change from 
baseline to end 
One-month 
follow-up 
Change from 
baseline to follow-up 
MTS  
Median 
(IQR) 
3.45 
(1.30, 6.80) 
2.10 
(2.30, 8.00) 
0.80 
(-1.40,4.60) 
3.35 
(0.40, 9.40) 
1.35 
(-1.15, 5.55) 
Range 0.00–13.90 0.20–13.50 -7.60–7.00 0.00–13.90 -6.80–9.50 
95% CI   -1.40 to 4.60  -1.00 to 5.50 
TI  
Median 
(IQR) 
1.90 
(1.10, 3.55) 
3.90 
(1.55, 6.15) 
1.30 
(-0.23, 3.40) 
2.15 
(1.60, 5.90) 
0.35 
(-0.45, 3.38) 
Range 0.00–7.5 0.5–10.90 -1.70–5.30 0.40–14.20 -1.90–6.70 
95% CI   -0.30 to 3.40  -0.50 to 3.60 
 MTS group n=18  TI group n=12
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Figure 6.24  Boxplot of contralesional force time integral (FTI)  
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Figure 6.25  Boxplot of mean centre of force velocity for the contralesional 
side  
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Figure 6.26 Example of the representation of  pressure under the feet and 
centre of force trajectory: baseline, end of intervention and one-month 
follow-up  
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 Lower Extremity Motricity Index (LEMI) 
LEMI measures were undertaken regularly: at baseline; after five, ten and fifteen 
interventions; after all twenty interventions (end of intervention); and at one-month 
follow-up. This was to ascertain more clearly when any changes occurred, if 
indeed change did occur. No costs were involved in the use of this OM. 
 
The differences between medians (IQR) and 95% CIs from baseline to end of 
intervention were 16 (0,19), (95% CI 0 to 19) for the MTS group and 12 (2, 24), 
(95% CI 19 to 25) for the TI group; and from baseline to one-month follow-up were 
16 (0, 24), (95% CI 0 to 24) for the MTS group and 16 (2, 20.75) (95% CIs 0 to 21) 
for the TI group. 
 
The results are presented in table 6.16. The changes are presented in the boxplots 
shown in figures 6.27 and 6.28. A line graph is also presented for the LEMI (figure 
6.29) to give a visual representation of changes over time. 
 
It is of interest to note that there was an instant increase in median score by 8 
points in the MTS group, from baseline to interim 5 (which was then maintained at 
end of intervention and actually increased by the one-month follow-up); however, 
there was no change in median score in the TI group until the end of intervention 
assessment. This fits with the experiences of the participants in the TI group, who 
reported it taking a few weeks to feel any benefit from the TIs.  
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Table 6.16  LEMI scores at baseline, end of intervention, and one-month follow-up, including change from 
baseline to end, and baseline to follow-up, showing median (IQR), range and 95% CIs 
 
MTS group n=19  TI group n=15 at baseline; n=12 at end and one-month follow-up
Group 
 Baseline Interim 5 Change 
baseline 
to Interim 
5 
Interim 
10 
Change 
baseline 
to interim 
10 
Interim 
15 
Change 
baseline 
to interim 
15 
End of 
Inter-
vention 
Change 
from 
baseline 
to end 
One-
month 
follow-up 
Change 
from 
baseline 
to follow-
up 
MTS  
Median 
(IQR) 
76 
(59.5, 88) 
84 
(59.5, 96) 
4 
(0,16) 
84 
(70, 92) 
6 
(0,16) 
84 
(73, 92) 
4 
(0,20) 
86 
(76, 96) 
16 
(0, 19) 
92 
(84, 100) 
16 
(0, 24) 
Range 33–100 43–100 -12–27 34–100 -17–32 29–100 -22–39 48–100 -14–33 49–100 -8–39 
 95% CI         0 to 19  0 to 24 
TI  
Median 
(IQR) 
76 
(43.5, 84) 
76 
(48, 88) 
8 
(-6,14) 
76 
(62, 92) 
8 
(-.5,16.75) 
84 
(64.5, 96) 
9 
(2,24.75) 
84 
(67, 96) 
12 
(2,24) 
84 
(65, 96) 
16 
(2, 20.75) 
Range 0–100 15–100 -23–17 15–100 -18–26 29–100 -12–45 24–100 19–25 20–100 -8–24 
 95% CI         0 to 24  0 to 21 
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Figure 6.27  Box plot of LEMI results, both groups baseline, end and follow-
up only 
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Figure 6.28  Box plot of LEMI results for all six time-points according to 
group  
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The red line represents the average scores for all the participants 
X axis represents order of assessments, not actual temporal spacing: 
.00 represents baseline, 1.00 – interim 5, 2.00 – interim 10,  
3.00 – interim 15, 4.00 – end of intervention and  
5.00 – one-month follow-up. 
 
Figure 6.29  Line graph of the LEMI results over time for all participants  
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 SWM sensory threshold testing 
The SWM measures were also undertaken regularly: at baseline; after five, ten 
and fifteen interventions; after all twenty interventions (end of intervention); and at 
one-month follow-up. This was to ascertain more clearly when any changes 
occurred, if indeed change did occur. There were initial costs for purchasing the 
SWMs (approximately £240).  Both the contralesional and ipsilesional sides were 
tested, with the results reported separately. Four separate points were tested (for 
full details please see the methodology section 6.4.2). The points tested were 
under the heel, pad of the hallux, 1st MTP joint and 5th MTP joint. For ease of 
reporting, these points will just be referred to as heel, hallux, 1st MTP and 5th MTP.  
 
Contralesional side 
The results are presented in table 6.17 and figures 6.30, 6.31, 6.32 and 6.33, and 
a line graph is presented for the hallux point for all participants (figure 6.34) giving 
a visual representation of changes over time. It can be seen from the line graph 
that there is a steady increase in the ability to feel the SWMs at the hallux point 
over time up until the end of intervention assessment. There is then a decline 
observed in the ability to detect the SWMs between the end of intervention and 
one-month follow-up.  
 
From the box plots, it is also possible to observe that the median score for the 
MTS group increases steadily over time, whereas the TI group median is variable 
over time. Also, of note, is that the median scores in the MTS group were higher 
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than the median scores in the TI group. Indeed the 5th MTP score on the 
contralesional side reached a median of 14.5 (11,16) which is very close to the 
threshold for normal plantar threshold sensation (15 and above). The other three 
points were also very close to achieving a level equating with diminished sensation 
(11–14), as opposed to diminished protective sensation (8–10).  Whereas, in the TI 
group, the heel median score aligned with the loss of protective sensation category 
(2–7), and 1st MTP score was in the range of the diminished protective sensation 
category. However, both the hallux and 5th MTP results achieved a level of 
diminished light touch (11–14). The categories are explained in table 6.2, (section 
6.4.2) in a sensory evaluation chart for sensory assessment. The implications of 
these findings will be discussed in chapter seven.  
 
Ipsilesional side 
The sensory threshold level for the ipsilesional side was also measured on two 
occasions (baseline and end of intervention) as a comparison to the contralesional 
side. The results are presented in table 6.18 and figure 6.35. 
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Table 6.17  Results for sensory threshold testing of the contralesional foot with SWMs at baseline, after 5, 10 
and 15 treatments, and at end of intervention and one-month follow-up, showing median (IQR) and range of 
scores 
Group/point  
assessed 
 Baseline Interim 5 Interim 10 Interim 15 End of 
intervention 
One-month 
follow-up 
MTS         
Heel  
Median (IQR) 
6 (4,11) 6.5 (5,10) 9 (6,11) 10 (6,11) 10.5 (5,11) 10.5 (5,11) 
Range 
0–17 2–17 2–16 1–15 4–19 1–13 
Hallux  
Median (IQR) 
10.5 (6,14) 11 (5,16) 11.5 (6,15) 11 (7, 16) 10.5 (6, 12) 11 (9, 14) 
Range 
0–18 2–17 4–18 0–19 4–20 4–18 
1st MTP  
Median (IQR) 
11 (9,12) 12 (9, 17) 11 (10,16) 12.5 (8,17) 12.5 (9,16) 11.5 (10,16) 
Range 
0–18 4–18 5–20 4–20 3–19 4–18 
5th MTP  
Median (IQR) 
10 (6,13) 
 
11 (9,15) 
 
11 (10,13) 
 
12.5 (11,17) 
 
14.5 (11,16) 
 
13 (11,16) 
 
Range 
4–18 5–18 4–18 3–20 5–19 4–17 
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TI          
Heel  
Median (IQR) 
4 (3, 7) 6 (4, 10) 4 (1, 11) 6 (4, 11) 4 (4, 10) 4 (4, 10) 
Range 
0–11 0–11 0–12 0–17 0–17 0–15 
Hallux  
Median (IQR) 
5 (2,11) 11 (4, 12) 9 (5, 11) 13 (6, 17) 12 (11,16) 9 (5, 11) 
Range 
0–15 0–16 0–18 0–18 3–18 0–18 
1st MTP  
Median (IQR) 
6 (4,10) 11 (5,13) 7 (3,15) 13 (5,16) 10 (3,15) 10 (4,14) 
Range 
0–11 0–19 0–18 0–17 0–17 0–18 
5th MTP  
Median (IQR) 
7 (5,10) 11 (7,11) 11 (6,16) 11 (4,15) 11 (4,14) 11 (4,13) 
Range 
0–11 0–15 0–17 0–17 0–17 0–17 
MTS group n=19 for all assessments except interim 15, n=18.  TI group baseline, n=15, all other assessments n=13 
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Table 6.18  Results for sensory threshold testing of the ipsilesional foot with SWMs at baseline, after 5, 10 and 
15 treatments, and at end of intervention and one-month follow-up, showing median (IQR) and range of scores 
Group/point  
assessed 
 Baseline Interim 5 Interim 10 Interim 15 End of 
intervention 
One-month 
follow-up 
MTS         
Heel  Median (IQR) 11 (7.5,12)    11 (6.5,12.5)  
Range 4–18    4–20  
Hallux  Median (IQR) 16 (11,17)    12 (10,17.5)  
Range 6–20    5–19  
1st MTP  Median (IQR) 14 (9.5,17) 
 
   16 (10.5,18) 
 
 
Range 2–18    1–20  
5th MTP  Median (IQR) 12 (10.5,16) 
 
   13 (11,16) 
 
 
Range 16–18    5–18  
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TI         
Heel  Median (IQR) 6 (5,11)    8 (6,11)  
Range 0–19    0–19  
Hallux  Median (IQR) 12 (10,15)    11 (10,18)  
Range 0–20    0–18  
1st MTP  Median (IQR) 10 (6,15)    12 (6,17)  
Range 0–18    0–20  
5th MTP  Median (IQR) 11 (6,11)    11 (9,15)  
Range 0–17    0–20  
MTS group n=19 for all assessments except interim 15, n=18.  TI group baseline, n=15, all other assessments n=13 
NB Sensory threshold testing only undertaken for ipsilesional side at baseline and end of intervention.  
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Figure 6.30  Box plot of SWM results for the contralesional heel 
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Figure 6.31  Box plot of SWMs results for contralesional hallux 
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Figure 6.32  Boxplots of SWMs results for the contralesional 1st MTP 
 
B 
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Figure 6.33  Boxplots of SWMs results for the contralesional 5th MTP 
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The red line represents the average scores for all the participants 
X axis represents order of assessments, not actual temporal spacing:  
.00 represents baseline, 1.00 – interim 5, 2.00 – interim 10, 3.00 – interim 15,  
4.00 – end of intervention and 5.00 – one-month follow-up 
 
Figure 6.34  Line graph of SWMs results for the contralesional hallux 
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Figure 6.35  Boxplots of SWM results for the ipsilesional side 
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 Success of blinding  
In order to assess whether blinding was successful in the study, the blinded 
assessor was asked to give their opinion as to what group they thought the 
participant was in at the one-month follow-up. The blinded assessor was unsure in 
29 out of 32 cases (91%).  The blinded assessor accurately guessed the group 
allocation correctly of just three participants (9%). The results are shown in table 
6.14. 
 
Table 6.19  Blinded assessor rating for group allocation 
 
Description 
Assessor’s 
recording 
Confident MTS+TSGT 1/32 
Maybe MTS+TSGT 0/32 
Unsure which group 29/32 
Maybe TI+TSGT 1/32 
Confident TI+TSGT 1/32 
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 Feasibility study objectives 
Objectives 3a-3h related to Study 3 the MoTaStim-Foot feasibility study were met: 
3a  Find out if recruitment methods are effective, analysing the recruitment rate 
and associated data including:  
i. number of people invited to participate. 
ii. number and proportion of those agreeing to consent to participate. 
iii. number of those eligible to participate. 
3b Monitor and analyse the number of people who drop out of the trial (attrition 
rate). 
3c Gain pertinent information to inform an appropriate and feasible sample size 
for a future study. 
3d  Explore participants’ experiences of interventions and their views on the   
acceptability of the treatments and method of delivery as interventions for a 
future study. 
3e Investigate whether daily diaries and FGs are suitable ways to capture and 
explore stroke survivors’ experiences of the interventions. 
3f Investigate feasibility (cost and acceptability to participants) of a battery of 
OMs for sensorimotor impairment (feeling/sensation and movement) and 
lower limb function and balance, to inform the choice of primary and 
secondary OMs for a future trial. 
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3g Explore responses to either intervention (MTS plus TSGT, or TIs plus 
TSGT) over time and in relation to the number of treatment sessions 
delivered; this will help to determine the most appropriate duration of 
therapy in a future trial. 
3h Generate information regarding the participants recruited i.e. participant 
demographics, clinical characteristics, including time since stroke, type of 
stroke and previous impairment affecting the ability to walk, to ensure 
baseline characteristics of the two groups are comparable and to inform 
future studies. 
 
 Summary of results 
Following a successful recruitment strategy, 34 participants were randomized and 
32 received all twenty of the interventions, whether MTS+TSGT or TIs+TSGT. The 
interventions were found to be acceptable to the participants and possible to 
deliver for the research therapists. OMs were also both appropriate and 
acceptable. The mixed-method approach enabled detailed insight into the 
perceptions of the participants via daily diaries and FGs. Feasibility was therefore 
established. The specific criteria relating to feasibility and acceptability of the 
MoTaStim-Foot trial will be considered in chapter seven; further information from 
Studies 2 and 3 will be also be discussed prior to drawing conclusions. 
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7 CHAPTER SEVEN:  DISCUSSION CHAPTER 
In chapters one and two, the subject of somatosensory stimulation of the foot and 
ankle after stroke was introduced, and pertinent literature relating to the topic area 
was discussed; chapter 3 reported Study 1, a systematic review of the literature 
relating to somatosensory stimulation of the foot after stroke. The aims and 
objectives of the studies, and details of methodology were presented in chapter 
four. In chapters five and six, the intervention modelling study (Study 2), and the 
MoTaStim-Foot feasibility trial (Study 3) were presented, explained and justified. 
This chapter will involve a discussion concerning the findings of all three studies, 
putting them into context within existing literature. Strengths and limitations of the 
study methodologies will be highlighted, along with pertinent findings; finally, 
suggestions for future research will be made. 
 
Summary of findings in relation to stated objectives: 
 
 Study 1 - Effectiveness of somatosensory stimulation for 
the lower limb and foot after stroke: a systematic review 
 
Research objective: 
Research objective 1.1 was to systematically review the published literature 
investigating the effectiveness of somatosensory stimulation applied to the lower 
leg and foot to improve balance and mobility after stroke 
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 Discussion relating to the findings of Study 1 
The regaining of optimal functional movement post-stroke is based upon 
appropriate integration of both sensory and motor information (Bolognini et al., 
2016).  Facilitation of afferent input can be undertaken by various methods, and 
the systematic review highlighted evidence relating to the effectiveness of some of 
the different types of sensory stimulation. The indications from this systematic 
review are that sensory electrical stimulation can influence balance or gait 
parameters effectively, post-stroke, supporting the neurophysiological principles 
discussed in section 2.2. Sensory electrical stimulation selectively excites large 
diameter, low threshold non-noxious afferents (A-beta) (Johnson, 2007). A 
combination of TENS and subsequent task-related exercises resulted in a 
significant increase in the distance walked over the 6minWT, and increases in gait 
velocity in one study (Ng and Hui-Chan (2009); this study delivered the greatest 
amount of treatment (TENS 20 hours and exercise 20 hours), was assessed as 
being of good quality and included the largest sample (n=109) in the systematic 
review. These results corroborate previous findings by Levin and Hui-Chan (1992) 
who applied 15 sessions of daily TENS treatment within a three week period and 
demonstrated that TENS (but not placebo TENS) significantly reduces and also 
delays stretch responses, with a resultant decrease in clinical spasticity, measured 
by the Composite Spasticity Score (p<0.05).  In the Levin and Hui-Chan (1992) 
study an increased vibratory inhibition of the soleus H reflex (p=0.02) was noted 
and a phenomenal increase of 820% in the force of dorsiflexion following TENS 
was observed, which is clearly clinically relevant. 
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Explanations have been proposed for these positive effects of TENS treatment. It 
is proposed that the improved strength of dorsiflexion can be attributed to TENS 
increasing pre-synaptic inhibitory input of the soleus muscle, reducing stretch 
reflex thresholds, resulting in a reduction in excitability and decreased co-
contraction (Levin and Hui-Chan, 1992). This in turn, via neuroplastic changes 
(taking 2-3 weeks), facilitates a disinhibition of underlying neural pathways 
associated with dorsiflexion (Levin and Hui-Chan, 1992).  
 
As discussed earlier there is the potential to alter post synaptic potential of motor 
neurons following percussion to a tendon (Burke et al., 1983), and it would be 
expected that this neurophysiological mechanism could also be applied to the 
application of vibration, with expected beneficial effects post-stroke; however, it 
has not been possible to draw this conclusion from this systematic review. Two of 
the studies exploring WBV were assessed as being of good quality (Brogårdh et 
al., 2012; van Nes et al., 2006) and both concluded that there was no benefit from 
WBV as assessed by BBS. The study by Brogårdh et al. (2012) recruited a sample 
of just 16, and one of the inclusion criteria was an ability to walk >300 metres. As 
the BBS is known to have a ceiling effect, particularly in higher functioning stroke 
survivors (Salbach et al., 2001), this could be a reason why beneficial effects were 
not demonstrated. van Nes et al. (2006) recruited 53 stroke survivors, however, 
some caution should be applied to the conclusions drawn from the study by van 
Nes et al. (2006), in view of the fact that this study recruited stroke survivors in the 
acute stage post-stroke at just 36.59 (10.18) days; it is therefore impossible to 
know how much of the improvement was due to spontaneous recovery. Also, only 
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1.5 hours WBV was delivered over the six weeks and this may also help explain 
the results. A control group received ‘exercise therapy on music’, however, group 
sizes of just 27 and 26 are perhaps not sufficiently large to draw definitive 
decisions when there is such an extensive heterogeneity of clinical presentations 
seen in stroke (van Nes et al., 2006 p.2332). 
 
Proprioceptive stimulation was provided by standing on different surfaces (hard or 
soft) with eyes open and closed (Bayouk et al., 2006); wearing postural insoles 
(Ferreira et al., 2018); sensorimotor foot stimulation (Goliwas et al., 2015); ankle 
joint mobilizations (Kluding and Santos, 2008), or sensory training (Lynch et al., 
2007). There is insufficient evidence at this point in time to support effectiveness of 
these other interventions on the 10MWT (Bayouk et al., 2006), mean gait velocity 
(Ferreira et al., 2018), difference in weight distribution in standing (Goliwas et al., 
2015) or peak weight bearing difference during STS (Kluding and Santos, 2008). 
The sample sizes for these five studies were small (<30), with 27 being the largest 
(Goliwas et al., 2015) but still with just 13 in the experimental group. None of these 
studies would therefore have been adequately powered to establish effectiveness 
of these interventions. It should also be noted that in the study by Kluding and 
Santos (2008) the total number of hours of intervention was just 2.67.  
 
A meta-analysis by Kwakkel et al., (2004) concluded that at least 16 hours of 
augmented therapy time must be delivered after stroke (over and above that 
received in the control group) for an effect to be seen, and a more recent 
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systematic review and meta-analysis concurred with this view suggesting that 17 
hours extra therapy were required over a 10 week period (Veerbeek et al., 2014).  
Excluding the study by Ferreira et al., (2018) which involved wearing insoles for 
three months and no other additional intervention, only six of the included studies 
(37.5%) implemented a total intervention time of greater than 16 hours, and only 
two of these studies achieved a difference in treatment time of >16 hours between 
the experimental group and the control group (Jung et al., 2017; Ng and Hui-Chan, 
2009). Interestingly, both of these studies demonstrated positive effect sizes (0.65 
and 0.73 respectively). It has to be questioned whether studies exploring 
rehabilitation strategies post-stroke, and in particular these studies exploring 
sensory stimulation are actually delivering the interventions at an adequate dose 
and intensity for an effect to be expected, and this aspect will be discussed later in 
this chapter.  
 
Study 1, the systematic review highlighted the insufficient numbers of studies that 
are adequately powered to enable appropriate conclusions to be drawn about the 
benefits of this type of sensory input or training. The potential benefits of electrical 
sensory stimulation have been highlighted and should be considered for 
application in clinical practice and indeed they have been included in the fifth 
edition of the National Clinical Guideline for stroke (Rudd et al., 2016). It may also 
be possible to apply the neurophysiological principles behind the actions of TENS 
to the other interventions included in this systematic review. It should be 
remembered that within this systematic review the majority of studies included had 
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small sample sizes, and many of the studies were not adequately powered or were 
assessed as being of poor methodological quality.  
 
 Conclusions from Study 1, the systematic review 
Implementing evidence-based practice within stroke rehabilitation is challenging, 
due to an insufficient understanding and knowledge underpinning therapeutic 
interventions (Langhorne et al., 2011), and their complex nature (Craig et al., 
2006). Rehabilitation strategies to address the impact of sensory impairment on 
motor activity and function have not been thoroughly investigated (Carey et al., 
1993), and there is a lack of research related to sensory dysfunction of the feet 
post-stroke (Lynch et al., 2007). This systematic review has highlighted promise for 
electrical stimulation to facilitate balance and gait following stroke by an expected 
decrease and delay in stretch responses, resulting in reduced spasticity, and a 
potential improvement in dorsiflexor activity. The receptors stimulated by electrical 
stimulation are not the mechanoreceptors that provide proprioception. There is 
very limited research about the effects of intensive proprioception (this could be 
any stimulus that is received by the mechanoreceptors in the glabrous skin – so 
Merkel’s disks, Pacinian corpuscles, Ruffini endings, or Meissner’s corpuscles – 
which respond to pressure, stretch, touch, and vibration – or muscle (muscle 
spindle) joints and ligaments (Ruffini endings)). TENS, on the other hand, 
delivered at a frequency and pulse width to initiate sensory input stimulates non-
noxious large diameter afferents, which is not proprioception. 
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Research objective 1.1 was completed. The review identified a distinct lack of 
good quality, rigorous research (with sufficiently large sample sizes, delivering an 
adequate dose of intervention) exploring the effects of sensory stimulation of the 
foot/lower limb on balance and gait post-stroke. It is not known whether application 
of somatosensory input which primes or augments normal afferent input facilitates 
a change in balance or gait or not. There is a need for further research in this area 
to be conducted.  
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 Study 2 – Intervention modelling study 
 
Research objective: 
The objective of Study 2 (objective 2.1) was, in conjunction with expert clinicians 
and informed by the literature, to develop and gain consensus on standardized 
treatment protocols for delivering a) MTS for the lower limb, b) wearing TIs, and c) 
TSGT to stroke survivors.  
 
 Discussion relating to Study 2 
The mNGT was a successful method for developing standardized interventions, 
which enabled consensus regarding the protocols to be achieved in a relatively 
short period of time. However, it must be remembered that it is human nature to be 
hopeful and, therefore, it is a possibility that the therapists in the mNGT possessed 
optimistic bias (Weinstein, 1980) because they may have wanted the therapeutic 
interventions to be suitable and could have been optimistic that they will be helpful 
for stroke survivors in the future. Another issue to consider is the possibility of 
group think, whereby the participants of a group take a unified approach and are 
reluctant to upset the harmony in the group (Janis, 1991). However, various 
strategies were employed to reduce the risk of group think, for example, 
participants’ individual views were sought in advance of the mNGT meeting, and 
also at the meeting, by following the stages advocated by (Potter et al., 2004). 
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The method allowed for full participation from the involved therapists, but part of 
the work was undertaken via email communication limiting the face-to-face contact 
time for the busy clinicians to just one afternoon. Another potential limitation, which 
must be acknowledged, is that the number of participants involved in the initial 
stages of the mNGT work was small (n=12) and only eight clinicians attended the 
final mNGT meeting, and they were all from a similar geographical area in the UK. 
Other methodologies such as a Delphi study would have enabled greater insight 
from different regions who may be less familiar with MTS as a therapy intervention. 
This would have made the results more generalizable.   
 
Reporting of intervention development is notoriously poor within published studies 
(Duff et al., 2010; Glasziou et al., 2008), hence, the need for documents such as 
the TIDieR guidelines (Hoffmann et al., 2014). Study 2 was one of the few studies 
in which the interventions are reported according to the TIDieR guidelines. It was 
deemed to be important that adequate time and care was taken when developing 
the interventions for the MoTaStim-foot feasibility study. The mNGT was an 
appropriate method for developing and validating the three protocols: MTS to the 
lower limb, TSGT and wearing of TIs. It was a rigorous method, drawing upon 
information, summarized from the literature, which was considered in conjunction 
with the opinions of expert clinicians. However, limitations of the study need to be 
acknowledged, in that there was a relatively small number of primary participants 
(n=12) and it is also not known if the work is generalizable to other services.  
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Nonetheless, a key strength is that the interventions described can be replicated in 
subsequent research and are transferable to other stroke rehabilitation services. 
 
 Conclusions from Study 2 
The mNGT enabled discussion and debate, facilitated by the researcher; 
achievement of 100% consensus from the participants relating to the three 
developed protocols was possible.  Three valid protocols were, therefore, 
developed in readiness for evaluation in Study 3, the randomized, single-blinded, 
mixed-methods feasibility trial.  
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 Study 3, Sensory stimulation of the foot and ankle early 
post-stroke: a feasibility study (MoTaStim-Foot) 
 
The research objectives for Study 3 were associated with the undertaking of a 
feasibility study, relating to the overall feasibility of a future large RCT of 
MTS+TSGT compared to the wearing of TIs+TSGT.  
 
Research objectives: 
Objective 3.1 was to determine the feasibility of delivering a trial comparing 
MTS+TSGT with TIs+TSGT. This was achieved through a number of specific 
objectives within the feasibility study: 
3a  Find out if recruitment methods were effective, by analysing the recruitment 
rate and associated data including number of people invited to participate, the 
number and proportion of those agreeing to consent to participate, and those 
eligible to participate. 
3b  Monitor and analyse the number of people who drop out of the trial (attrition 
rate).  
3c  Gain pertinent information to inform an appropriate and feasible sample size 
for a future study.  
3d  Explore participants’ experiences of interventions and their views on the 
acceptability of the treatments and method of delivery as interventions for a 
future study. 
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3e  Investigate whether daily diaries and FGs are suitable ways to capture and 
explore stroke survivors’ experiences of the interventions. 
3f  Investigate feasibility (cost and acceptability to participants) of a battery of 
OMs for sensorimotor impairment and lower limb function and balance, to 
inform the choice of primary and secondary OMs for a future trial. 
3g  Explore responses to the interventions (MTS plus TSGT or TIs plus TSGT) 
over time and in relation to the number of treatment sessions delivered; this will 
help to determine the most appropriate duration of therapy in a future trial. 
3h  Generate information regarding the participants recruited i.e. participant 
demographics, clinical characteristics, including time since stroke, type of 
stroke and previous impairment affecting the ability to walk to ensure baseline 
characteristics of the two groups are comparable and to inform future studies. 
 
 Recruitment and attrition (Objectives 3a and 3b) 
 MoTaStim-Foot findings 
The successful recruitment of all 34 stroke survivors, as planned, indicated 
success in relation to the recruitment methods (objective 3a). The rate of 
recruitment for MoTaStim-Foot was 48.57%, calculated as the percentage of 
people recruited out of the number assessed for eligibility. The attrition rate 
(objective 3b) within MoTaStim foot, was low, at both the end of intervention and 
one-month follow-up (5.88% at both time-points). From these comparisons, it is 
clear to see that from a point of recruitment and attrition, feasibility was achieved in 
the MoTaStim-Foot trial. Greater insight has been achieved regarding the number 
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of potential participants who may need to be approached, and the number likely to 
drop out, as well as expected adverse events and serious adverse events, and 
these aspects will be important for informing a prospective study.  
 
 Comparison of MoTaStim-Foot results with other trials 
The rate of recruitment for the MoTaStim-Foot trial (48.57%) compares well with 
other rehabilitation trials. Recruitment for therapy trials can be challenging. In a 
trial comparing functional strength training with movement performance therapy for 
the contralesional upper limb post-stroke, the FAST-INdICATE trial, the 
recruitment rate was only 5.7% of those screened (Hunter et al., 2018); for the 
FeSTivaLS trial, exploring functional strength training for both upper and lower 
limbs post-stroke, it was just 4.6% (Mares et al., 2014), and for the SWIFT cast 
trial (Pomeroy et al., 2016) it was similar at 4.59%. Within the MoTaStim-Foot 
feasibility study both groups received extra therapy and there was no control 
group. It is possible that this was an influencing factor in relation to the better 
recruitment levels because stroke survivors understand the value of physical 
activity to assist them to gain functional recovery (Morris et al., 2015), and 
regaining the ability to walk is important for stroke survivors (Pollock et al., 2014b). 
Another feasibility study included twelve community-dwelling stroke survivors who 
all received nine 40-minute sessions using a virtual-reality gaming system 
(Warland et al., 2018), and they also had high recruitment levels (37.5%); again, 
there was no control group. However, other reasons may exist for the high levels 
of recruitment in MoTaStim-Foot. The feasibility study was only undertaken at a 
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single site and the therapists there (who were identifying suitable participants for 
the trial) were extremely pro-research. Other trials, for example, the FAST-
INdICATE trial were multi-site trials with different recruitment strategies, for 
example, use of the Clinical Research Network. Also, the inclusion criteria for the 
MoTaStim-Foot feasibility study were kept purposefully wide, for example the 
inclusion of posterior circulation strokes as well as anterior. These aspects may 
have been influencing factors in the high recruitment rate for MoTaStim-Foot. 
Other trials have reported higher levels of attrition: within the FAST INdiCATE trial, 
an attrition rate of 12.5% at outcome and 27.8% at follow-up (six months after 
stroke) was reported (Hunter et al., 2018); in the FeSTivaLS trial a rate of 15.5% 
was reported (Mares et al., 2014), and in the SWIFT Cast trial the attrition rate 
post-intervention was 19.4%, and 19.9% at six months (Pomeroy et al., 2016).  
However, it must be remembered that the sample size for MoTaStim-Foot was 
only small and this could have affected the attrition levels, because if a sample 
size is larger more adverse events predisposing to attrition would be likely. 
Nevertheless, this is not always the case; a small sample size also means that 
even if only a few people drop out there can be a large effect on the attrition rates, 
as seen in the trial by Warland et al. (2018), where the rate was 16.7%. Another 
consideration is that the MoTaStim-Foot trial only had a one-month follow up 
where other trials, e.g. FAST INdICATE, had a six-month follow up. 
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 Implications for a future RCT 
A total of 18 months was required to complete recruitment in this feasibility study, 
equating to an average of just under two participants per month (1.89). 
Recruitment rate was limited because of the capacity of the team of research 
therapists; the time available to deliver the interventions to participants in various 
locations, e.g. hospital and community, was fixed per day. Consequently, the 
maximum feasible capacity for the team had to be calculated accordingly, and this 
limited the number of participants that could be enrolled in the trial at any one time. 
This will need to be considered again for a larger trial and careful forward planning 
of recruitment and enrolment carried out, according to the sample size calculated, 
with consideration of how many sites would need to be identified, and how many 
therapists would be required. There is a clear cost implication for this. The 
recruitment site for MoTaStim-Foot had previously been involved in other 
rehabilitation trials, and the clinicians were very supportive of the research. It is not 
known if the same levels of recruitment would apply to other sites, further multi-site 
piloting is needed to test this out.  
 
 Evaluating the selected screening tools 
 MoTaStim-Foot findings 
The screening tools selected for the MoTaSTim-Foot feasibility study were found 
to be quick and effective in screening out participants who did not meet the 
eligibility criteria. The step test (Hill et al., 1996) was appropriate for excluding 
three potential participants with minimal disability to the lower limbs after stroke. 
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Participants were also screened for their level of understanding of simple 
instructions, to ensure they would be able to complete informed consent and 
cooperate with instructions within the interventions. No participants were excluded 
following this test; all the participants recruited possessed a sufficient level of 
understanding to comply with instructions within the treatment sessions.  
 
 Comparison of MoTaStim-Foot results with other trials 
The step test (Hill et al., 1996), was also used in the FeSTivaLS trial (Mares et al., 
2014), and the screening process used for MoTaStim-Foot was the same as the 
one that had been successfully used in FAST INdICATE (Hunter et al., 2018). 
 
 Implications for a future RCT 
The findings suggest that both of these screening tools would be appropriate to 
take forward to a subsequent RCT.  
 
 Inclusion/exclusion criteria 
 MoTaStim-Foot findings 
Both anterior and posterior circulation stroke lesions were considered to be 
appropriate for inclusion in this feasibility study, and justification for this was 
provided in the methodology section. The wider trial team was consulted in relation 
to this aspect and a decision was made to include people with a posterior 
circulation stroke, on the basis that between 10–15% of people admitted to the 
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local stroke service are diagnosed with posterior circulation stroke. It was felt that 
for this feasibility study it was important to be as inclusive as possible. Indeed, Tao 
et al. (2012) have shown that the symptoms of both anterior and posterior strokes 
can be very similar. The opinions of expert clinicians were also sought and there 
was agreement; it was felt that because the cerebellum (which is supplied by the 
posterior circulation) is key for balance and important in automatic walking it would 
be appropriate to include people with a posterior circulation stroke. Clinicians also 
reported that they may use MTS for people following a posterior circulation stroke 
as well as people with an anterior circulation stroke (Email, from participant 1 in the 
mNGT work, Appendix 49).  
 
The timing chosen post-stroke falling between the early subacute phase (seven 
days to three months) and the late subacute phase (three to six months), in a time-
period where there is still potential for improvement of impaired function, was 
appropriate (evidenced by the response to interventions); however, the challenges 
of this time period are discussed in section 7.5.4.  
 
It should be noted that there was no sensory assessment to ascertain if the stroke 
survivors had sensory impairments on recruitment to the MoTaStim-Foot trial. This 
was intentional to ensure that the inclusion criteria could be kept wide; as this was 
a feasibility study, it was important to include as many people as possible, enabling 
exploration of who might respond to the interventions. However, this is an aspect 
that warrants further consideration when moving forward to a future study, and the 
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reason for this is highlighted in section 7.3.5.4. Further post-hoc analysis will 
inform decisions as to whether presence of somatosensory impairment should be 
one of the inclusion criteria for future studies.  
 
The exclusion criteria for the trial were generally appropriate and effective; 
however, the exclusion criterion related to having botulinum toxin needs to be 
reviewed. Also, the ceiling threshold was reached for the mRMI for some of the 
participants. A further screening tool, in addition to the step test, to exclude higher 
functioning stroke survivors should be considered if the mRMI is to be used in a 
future study.  
 
 Comparison of MoTaStim-Foot results with other trials 
Some other rehabilitation trials have not included posterior circulation trials, e.g. 
FAST-INdICATE trial, which explored functional strength training for the upper limb 
post-stroke (Hunter et al., 2018). Others have included both anterior and posterior 
circulation strokes e.g. the FeSTivaLS trial, which explored both upper and lower 
extremity rehabilitation post-stroke (Mares et al., 2014). The differences in 
neurophysiological control of the upper limb and lower limb were discussed in 
chapter two (sections 2.6 and 2.8.3). Control of balance and gait can involve many 
different systems and is more automatic than control of the upper limb which is 
dependent upon the corticospinal system; in view of these differences it is a logical 
decision that including posterior circulation strokes is appropriate for lower limb 
trials analyzing balance and gait but would not be indicated for upper limb trials. 
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Only one study in the systematic review reported in this thesis also excluded 
anyone who had received a botulinum toxin injection in the previous six months 
(Ferreira et al., 2018).  
 
 Implications for a future RCT 
A challenge arose in relation to the issue of including participants with a posterior 
circulation stroke; during the randomization process, to allocate participants to one 
of the two groups in the MoTaStim-Foot trial, an ‘affected side’ had to be stipulated 
enabling stratification for the side of the lesion. For those participants with anterior 
circulation stroke lesions, the ‘affected’ side was the contralesional side, and this 
was the expected scenario when the randomization procedure was set up. 
However, there were three participants with posterior circulation stroke lesions, 
which were located in the cerebellum in two cases; consequently, either the 
ipsilesional side or both sides of the body were ‘affected’. When required, a 
consultation took place with the participant’s NHS therapist, their opinion was 
accepted in relation to identifying the side which was more affected. This was a 
useful finding of this feasibility study and must be considered carefully when 
planning a larger trial.  
 
There was a rationale for exclusion of participants who had received botulinum 
toxin injections, in that it could be a confounding factor, so it would be impossible 
to know whether any changes were due to the trial intervention or the effects of the 
injection. This was not a major concern for this feasibility study because efficacy of 
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the treatments was not part of the remit of the study; however, it could be an 
important consideration for a future trial. The senior clinician who was part of the 
trial management group had concerns regarding this exclusion criterion because 
the use of botulinum toxin to manage spasticity is increasing with stroke survivors, 
and she felt this may be an issue when recruiting to future trials. Interestingly, 
there was one participant who was considered for botulinum toxin after she had 
received just a few of the trial interventions. The participant chose not to have the 
injection at that point in time. Her foot control improved, and she was pleased with 
the progress she made during her time on the trial, particularly when her 5MWT 
time decreased from 54.9 seconds at baseline to just 6.2 seconds at the one-
month follow-up. There are clearly pros and cons to having botulinum toxin as an 
exclusion criterion; this aspect will need further exploration with experienced 
clinicians and PPIE volunteers prior to undertaking future trials.  
 
 Feasibility of delivering the interventions (Objective 3d) 
 MoTaStim-Foot findings  
It was important to establish if it was feasible to deliver the interventions to the 
stroke survivors. The successful delivery of all 20 sessions to all the participants 
completing the trial indicates that it is possible to deliver these treatments. The 
effective delivery of the treatment interventions to protocol was also ascertained by 
the findings of the independent reviewer (Appendix 41) who observed all the 
different research therapists within MoTaStim-Foot and confirmed that it was 
possible to deliver the interventions following the standardized protocols. The 
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detailed schedules allowed for specific documentation of the combined 
interventions that were selected and delivered in both the MTS and TSGT 
interventions for each participant. Additional post-hoc analysis of this information 
has been undertaken10 and will inform future studies; this is discussed further in 
section 7.5.1.  However, an acknowledged limitation of the study is that formal 
feedback was not obtained from the research therapists involved; this would have 
enabled an understanding of their opinions regarding fidelity of delivering the 
interventions. This will be even more important to build into future trial designs, 
when effectiveness of interventions is investigated.  
 
It should be noted that there were differences in dose of the somatosensory 
stimulation between the two groups. The MTS group received 20 treatment 
sessions lasting between 30-60 minutes per day, over the 6 week period; however, 
the TI group could potentially wear the TIs for anything up to 12 hours per day for 
the 4-6 weeks they were receiving the TSGT. When developing the trial protocol, 
these differences were discussed in detail. This final trial design was chosen 
because it was acknowledged that the two interventions aim to stimulate in 
different ways: MTS is a priming intervention, given prior to retraining motor 
activity, whereas TIs augment sensory feedback during the retraining of motor 
 
10 Samuel, E., Hunter, S.M., Aries, A.M. (2019) Analysis of the content and dose of mobilization and 
tactile stimulation (MTS) and task-specific gait training (TSGT) for the lower limb after stroke 
delivered as part of the MoTaStim-Foot feasibility trial. (unpublished). 
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activity. Thus, both interventions (MTS+TSGT, and TIs+TSGT) were delivered in a 
way that had the optimal potential to achieve their purpose, and to be effective.  
 
 Implications for a future RCT 
The protocols which were developed were successfully delivered and will be 
appropriate to take forwards to a future RCT. 
 
 Acceptability of the interventions (Objective 3d) 
 MoTaStim-Foot findings 
In order to successfully deliver the interventions participants had to be willing to 
participate in therapy, often working hard within sessions, on a daily basis. The 
information extracted from the daily diaries clearly indicated that the interventions 
were acceptable to the participants with 85.72% stating that the MTS was not 
uncomfortable, and 96.49% of the people in this group stating that the TSGT was 
not uncomfortable either. The TIs were also well accepted with unanimous 
agreement: 100% of participants stated they were not uncomfortable. Indeed, the 
analysis showed that only 2.58% of the participants had any discomfort with the 
TIs at any point in time during the six-week intervention period. The TSGT in the TI 
group was also well received with 90.96% of people saying it was not 
uncomfortable. The findings of the FGs corroborate the general acceptability of the 
interventions. Information regarding acceptability of interventions is imperative to 
decide whether a larger future study is feasible and appropriate. The MRC 
guidance advises that it is important to evaluate the impact of the interventions and 
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understand participants’ responses to intervention (Moore et al., 2015), and this 
aspect was therefore important for achieving objective 3d, confirming the 
acceptability of the interventions to the participants. The perception by the 
participants of perceived benefits would be likely to make the treatments more 
acceptable, despite the fact the participants had to put significant effort into the 
TSGT.  
 
 TSGT 
TSGT is an intensive form of rehabilitation involving repetition of functional 
activities such as sitting to standing, stepping, squats etc. (French et al., 2016). 
Numerous repetitions are required to facilitate neuroplastic changes within the 
CNS (Birkenmeier et al., 2010; Nudo, 2011) and it was important to find out 
whether this level of intense rehabilitation was acceptable to the participants. Level 
1a evidence already exists supporting TSGT as an appropriate therapy 
intervention post-stroke. However, it is not known whether potential enhancement 
of sensorimotor activity via priming with MTS or augmentation via wearing TIs will 
improve stroke survivors’ response to TSGT and increase rehabilitation potential 
still further or not. The decision to include TSGT for both arms of this study was 
based upon the known and agreed benefits of TSGT. In conventional therapy, 
MTS may be implemented to mobilize joints and soft tissues and facilitate the 
activity of the foot and lower limb; however, it would then be followed by TSGT, 
putting any additional range and control of movement into functional activities. 
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When TIs have been worn within studies, normal function is usually encouraged. 
Hence, the decision to use TSGT within the MoTaStim-Foot trial.  
 
Four participants (20%) reported in the FGs that they found the TSGT tiring, with 
the other 16 (80%) reporting it to be comfortable, despite the fact that the research 
therapists pushed the participants quite hard, ensuring multiple repetitions of 
exercises in line with the recommendations in the literature to facilitate function 
and neuroplastic changes (French et al., 2016; Lang et al., 2009). The 
acceptability of the interventions for the participants would be expected to increase 
if the participants felt they were gaining something from taking part in the trial 
(Baron et al., 2014). Several participants stated that they felt that if it was not for 
the treatment, they would not have ever walked again, and the benefit was 
attributed to both the sensory stimulation (MTS or TIs) and the TSGT. 
 
 Implications for a future randomized controlled study 
Tailoring of the TSGT to individual participants was necessary in view of the 
heterogeneity of stroke and differing levels of functional ability; however, it was 
also important to standardize the TSGT delivered, which was achieved via rigorous 
protocol development in conjunction with the expert clinicians who participated in 
the mNGT involved in Study 2. One aspect that was addressed through training of 
research therapists was that the TSGT was primarily a ‘hands-off’ therapy 
treatment and did not involve facilitatory techniques. The independent observation 
of the research therapists, built into the MoTaStim-Foot methodology (Appendix 
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41), confirmed the fact that research therapists were adhering to protocol when 
delivering the TSGT. Appropriate training for research therapists in relation to how 
the TSGT protocol should be undertaken and tailored for individual participants 
must be built into plans for a future trial.  
 
 Mobilization and tactile stimulation 
Two participants in the trial did report severe discomfort or pain during the MTS 
intervention. One of these participants reported that the pain did not last long and 
that, after approximately three or four treatments, the MTS was no longer painful, 
and he then had an increased awareness of his left side. An experienced 
physiotherapist with extensive neurological skills was involved in the treatment of 
this participant. The hypersensitivity was purposefully addressed by handling and 
desensitization work. This finding corroborates with the work of Hunter et al., 
(2006) who advocate MTS as a means of decreasing hypersensitivity in the upper 
limb post-stroke.  
 
A second participant also complained of pain and discomfort in response to the 
MTS treatment, reporting that the discomfort lasted a long time (although the 
actual time was not specified on the diary sheets). This participant regularly 
complained of pain and discomfort (not just as a response to the MTS), although 
this was not of sufficient consistency for it to be considered an adverse reaction. It 
may have been that this participant was also suffering from an additional disorder, 
such as complex regional pain syndrome. However, although it may not have been 
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possible to deliver the full 30–60 minutes of treatment on every occasion for this 
participant, the pain was never at a level that prevented participation within the 
study; indeed, he was happy to complete the full course of twenty sessions of 
intervention on the trial. Interestingly, this participant was treated by a research 
therapist with more limited neurological rehabilitation handling skills, and it is not 
known whether this had any influence on the outcome.  
 
The mechanism of how somatosensory stimulation may have an effect needs to be 
considered. Physiotherapeutic facilitation techniques applied to the upper limb, 
including methods to facilitate afferent input, have been shown to influence the 
frequency of muscular response potentials, increasing amplitude as well as 
reducing the latency of response, measured using single transcranial magnetic 
stimuli (Hummelsheim et al., 1995). Although direct muscular contraction of the 
wrist extensors instigated the maximum response in the study by Hummelsheim et 
al. (1995), it was also found that cutaneous and proprioceptive stimuli had an 
excitatory effect in severely affected people with stroke. It is not known whether 
these principles are also applicable to sensory stimulation of the foot and lower 
limb.  
 
It is anticipated that the techniques within the MTS protocol will deliver a similar 
effect via the mechanoreceptors to the lower limb, with rapid skin displacement 
stimulating the quickly adapting mechanoreceptors (discussed in chapter two, 
section 2.3.2), from the massage and soft tissue mobilization, exciting Meissner’s 
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corpuscles and SA Merkel’s discs, as well as passive and accessory movements 
stretching the skin and stimulating the Ruffini Endings (Vallbo and Johansson, 
1984).  
 
Participants reported in both the daily diaries and FGs that the foot felt different 
following MTS, and this could be due to improved proprioceptive awareness of the 
foot, through the intrinsic feedback given during the MTS treatment. This increase 
in afferent feedback can influence the activity within cortical circuits (Ridding and 
Rothwell, 1999) increasing the muscular response potential (Hummelsheim et al., 
1995; Laaksonen et al., 2012). It is therefore proposed that MTS is expected to 
have an effect by mobilizing and activating the foot, optimizing contact of the whole 
foot, including the heel with the floor and preparing it for standing and walking, 
together with assisting with the ability to move the tibia over the stabilized foot 
during the stance phase of gait. The increased activity within the foot and lower 
extremity following MTS is therefore expected to facilitate functional activity 
because MTS is a priming technique, which enhances the excitability of the motor 
system (Pomeroy et al., 2011). It has been demonstrated that MTS can alter 
activity and motor impairment in the upper limb in sub-acute (Hunter et al., 2008) 
and chronic stroke (Winter et al., 2013). Further research is required in relation to 
MTS delivery to the lower limb post-stroke.  
 
An alternative hypothesis for a mechanism of potential effect for MTS is that it may 
have similar effects to TENS described by Levin and Hui-Chan (1992) influencing 
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pre-synaptic inhibitory input and reducing stretch reflex thresholds; a resultant 
decrease in excitability of the soleus muscle would enable dorsiflexion with 
reduced antagonistic resistance, thereby facilitating activity of tibialis anterior and 
selective dorsiflexion. Some potential for efficacy related to MTS treatment has 
been noted within the MoTaStim-Foot trial, so there is a possibility, that afferent 
input has a direct effect upon motor control resulting in balance and gait changes; 
however, these concepts need to be explored in a larger, powered RCT. 
 
It should be noted that Hummelsheim et al. (1995) found that the physiotherapeutic 
techniques including tapping/rubbing of the skin and weight-bearing, actually had 
an inhibitory effect on healthy individuals, but a beneficial effect (increasing 
muscular response potentials) in severely affected stroke patients. It would, 
therefore, be useful to undertake further post hoc analysis looking into whether 
there was a link between NIHSS score, or in particular, the lower limb section of 
the NIHSS/LEMI score too, and any in-group changes observed for the OMs to 
inform inclusion criteria for future studies.  
 
 Implications for a future RCT 
The skill level of the research therapists needs to be considered carefully for any 
subsequent trial: hands-on therapy requires skill in terms of assessing the 
condition, extensibility, and range of movement in soft tissues and joints, in order 
to determine the appropriate intensity of application for each patient; and although 
it may be possible to delegate components of MTS to a less qualified or even non-
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qualified therapist or carer, it is not known if this approach to delivery would be as 
effective as treatment delivered by a skilled qualified therapist. This clearly 
warrants further investigation to explore the feasibility and potential effectiveness 
of alternative methods of delivering an intensive therapist-dependent intervention 
that has resource implications. Stroke survivors’ opinions of what they feel could 
be delegated to an assistant or carer, and which aspects require specialist therapy 
handling, have been explored via a focus group undertaken after the MoTaStim-
Foot study was completed.11  
 
 Wearing of TIs 
The concept that the TI and smooth insole used within MoTaStim-Foot was 
acceptable to the participants can be confirmed in view of the unanimous 
agreement of the participants. Not only did the participants find the insoles 
comfortable, but they also reported that they had an influence on the feeling within 
the foot and their ability to balance and walk. Some of these findings are in 
contrast to those of (Baron et al., 2014), who undertook an exploratory study in a 
cohort of people with multiple sclerosis, which was embedded within a RCT. 
Participants in her study wore a smooth insole or a TI (made from the same 
material, from the same manufacturer as that used in the MoTaStim-Foot trial). 
Perceptions relating to wearing TIs were explored using semi-structured FGs and 
 
11 Barwell, K., Aries, AM., Hunter, SM 2019 Stroke survivors’ perceptions and 
opinions of receiving aspects of hands-on physical therapy interventions from a 
trained carer or other health professional (UK Stroke Forum) 
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1:1 interviews. Baron et al. (2014) reported that participants’ perceptions of both 
the comfort and potential efficacy of the TIs varied amongst the 13 participants in 
the qualitative study. A willingness to wear the TIs was found to be linked with 
participants perceptions of the potential efficacy associated with wearing TIs. 
These different findings (a lack of consensus) may perhaps be linked to working 
with people with multiple sclerosis as opposed to stroke, in view of the potential for 
people with multiple sclerosis to relapse, which could have influenced the results. 
However, the texture of the insoles used in the MoTaStim-Foot trial are considered 
to be acceptable for further study with stroke survivors. 
 
The choice of material for the TIs proved to be suitable with many participants able 
to perceive the TI underfoot and commenting on the difference in feeling. However, 
it was interesting to hear that it sometimes took a period of time of adjustment 
(approximately a week to feel the TI, and four to five weeks to notice a change in 
sensation). Another reflection of the appropriateness of the TI selected is that there 
were no adverse reactions related to the TI throughout the whole trial period. This 
was an initial concern of the researcher in case of rubbing/reaction to the insole. It 
is difficult to compare this issue with other studies because they have not included 
this information, so a comparison is not possible (Dixon et al., 2012; Kelleher et al., 
2010).  
 
Participants in the MoTaStim-Foot trial also reported that wearing a TI increased 
the sense of stability in the shoe. This is an interesting and important point for 
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consideration, as it is unclear whether the perceived benefits were simply from the 
increased stability created by inserting an insole into a shoe, thus providing a 
general sense of compression around the whole foot, or from the sensation arising 
from textures stimulating the plantar surface of the foot. Including a smooth insole 
in the ipsilesional shoe was done to eliminate a feeling of left and right shoes 
feeling different according to compression and height.  
 
 Implications for a future RCT 
The perceived benefits by the participants and the lack of adverse reactions within 
MoTaStim-Foot, would seem to support the fact that these specific TIs would be 
suitable to take forward to a larger study. A decision was made that the insoles 
should be removed before undertaking the OMs. In view of the potential for 
augmentation, facilitating sensorimotor control while wearing the TIs, it was 
important that they were removed to enable parity between the groups, and this 
should be undertaken in future trials. 
 
A further aspect worth exploration is whether wearing a TI had a different effect on 
balance and walking than wearing a smooth insole post-stroke. This has not been 
explored yet. 
 
Inserting the insoles into the shoes was challenging for only one participant out of 
the 34 (3%). Nevertheless, the ability to insert insoles should be considered 
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carefully when planning inclusion/exclusion criteria for a larger trial in order to 
increase standardization of the dose. 
 
 Acceptability and use of the selected outcome measures (Objective 
3f) 
 MoTaStim-Foot findings 
Research objective 3f related to the feasibility of a battery of OMs for sensorimotor 
impairment. Various issues related to the OMs will be discussed. The battery of 
OMs was chosen with consideration given to appropriateness of each OM for 
measuring sensorimotor impairment or lower limb function and balance, as well as 
attention to validity (George et al., 2000), reliability (Hicks, 2010) and 
responsiveness to change (objective 3g) (Sim and Wright, 2000), which are 
required for rigorous clinical research. Several of the OMs were expected to 
assess change at an impairment level (SWMs to ascertain sensory threshold, 
LEMI for motor impairment, and electrogoniometer for range of movement). This 
would give an indication of changes representing restitution i.e. return of structures 
and function to their previous state (Levin et al., 2009). Other OMs were selected 
to establish functional changes (5MWT, FAC, pressure insoles and mRMI) and it 
was anticipated these would give an indication of recovery i.e. returning to pre-
stroke body function and structure, and activity level (Bernhardt et al., 2017b). 
However, it must also be considered that these functional measures may show 
changes as a result of compensation utilising other strategies to achieve functional 
gain, rather than reducing impairment (Krakauer et al., 2012). 
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Most of the OMs were shown to be valid, reliable and responsive to change, 
however, some (mRMI, electrogoniometer) did have their limitations, which will be 
discussed; all were acceptable to the participants. The timings of the OMs were 
found to be appropriate with all outcomes assessed at baseline, end of intervention 
and one-month follow-up. The LEMI and SWMs were measured more frequently 
(after five, ten and fifteen treatments).  
 
 LEMI 
Interestingly, the strength observed at end of intervention for the LEMI was 
maintained at follow up (chapter 6, figure 6.29), perhaps because the participants’ 
functional level was maintained, and repetitive practice continued, for example, by 
walking and practicing sitting to standing etc.  
 
Although strict protocols were followed when undertaking the OMs, there was one 
issue which arose with the LEMI testing for one participant that had not been 
anticipated. It was noted that if she wore shoes, she could achieve dorsiflexion; 
however, if she was in bare feet she was unable to achieve even a flicker of 
activity from the dorsiflexors. This could perhaps have been because of sensory 
stimulation from the shoe. Following discussions between the chief investigator 
and research therapists, it was decided that all participants should be tested 
without their shoes on. This was a useful finding of the feasibility study to inform 
protocols for future studies.  The LEMI was an appropriate OM to use in the 
MoTaStim-Foot trial and is valid, reliable (Cameron and Bohannon, 2000; Fayazi 
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et al., 2012) and responsive, as well as quick to administer and would be a suitable 
secondary OM to use for future studies.  
 
 Sensory threshold testing using SWMs 
The contralesional side was measured for sensory threshold, using the SWMs at 
baseline, after five, ten and fifteen interventions, as well as end of intervention and 
one-month follow-up. The line-graph for the sensory threshold of the contralesional 
hallux (chapter 6, figure 6.34) showed an upward trajectory until the end of 
intervention (although not as steep as for the LEMI, chapter 6, figure 6.29). 
However, changes observed at end of intervention were not carried over to the 
one-month follow-up; it is not known if the results would have continued to 
increase if a greater number of sessions had been delivered. Although participants 
may have been continuing functional activities between end of intervention and the 
one-month follow-up it was unlikely they were receiving the same degree of 
afferent stimulation as they were during the intervention phase.  
 
Another point to consider in relation to the SWM is that measuring of sensory 
thresholds in four locations in one assessment is time-consuming, and this needs 
consideration for future trials. Repeated testing of sensation has the potential to 
increase testing fatigue, or alternatively to enhance sensibility of the area being 
tested. Using an algorithm for SWM testing in this trial (Appendix 34) decreased 
the burden of testing for participants by reducing the number of filaments that 
needed to be used at each location on the foot. Further consideration needs to be 
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given to the testing site, and whether just one site should be tested (if assessment 
at this site indicates either fully intact or absent sensation) (Busse and Tyson, 
2009), in accordance with the rationale that if one site is affected by stroke, it is 
likely that all sites will be affected due to the nature of stroke being an upper motor 
neurone lesion rather than a peripheral nerve lesion, in which dermatomal 
distributions might be differentiated in sensory testing.  
 
Decreased sensation, for example at the level of loss of protective sensation 
increases the potential of injury (Boulton et al., 2008), and any loss of sensation in 
the foot can make balance and walking difficult, predisposing the person to falls 
(Perry, 2006). It was perhaps surprising that greater changes were not observed 
for the SWMs results for any of the four points on the plantar surface. However, it 
must be remembered that the participants in the FGs reported that it took time to 
feel the TIs, perhaps six weeks was too short a time to see changes in sensory 
threshold. Also, the dose of the treatment delivered could have been an influence. 
As discussed in section 7.1.1, trials investigating rehabilitation often do not deliver 
the intervention at a sufficient dose (frequency, duration and number of sessions); 
at least 16 hours of additional therapy is required over and above what is delivered 
in the control group (Kwakkel et al., 2004). This feasibility study was not looking at 
effectiveness, however it is essential that dose is taken into consideration for a 
larger trial in the future. From the systematic review undertaken (reported in 
chapter three, and discussed in section 7.1) it is evident that most of the studies 
exploring sensory stimulation post-stroke have not delivered the interventions at an 
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adequate intensity, indeed only two (Jung et al., 2017; Ng and Hui-Chan, 2009) of 
the studies in the systematic review achieved the suggested additional 16 hours of 
intervention in the experimental group. This is in agreement with the findings of 
another systematic review exploring dose of therapy interventions (Cooke et al., 
2010a). 
 
However, a study which did report a clinically meaningful change for the 10MWT 
was undertaken by Renner et al., (2016). This study explored delivery of an 
intensive daily rehabilitation programme for sub-acute stroke survivors with 
moderate to severe disability, delivering 45 hours of therapy over a six-week 
period (over double the amount delivered in the MTS group and over four times 
that delivered in the TI group).  The results from this study by Renner et al., (2016) 
not only question the intensity of rehabilitation required to see a clinically 
meaningful effect, but it also raises the issue relating to severity of disability post-
stroke and who may respond best to different types of therapy, because they only 
included stroke survivors who were moderate to severely affected. It is 
acknowledged that delivering a trial of purely task orientated training is not the 
same as delivering a sensory stimulation intervention (priming or augmenting) 
combined with TSGT. However, it would be valuable to analyse the MoTaStim-
Foot results in relation to the NIHSS and sensory threshold changes to see if 
perhaps stroke survivors with greater sensory loss respond differently from higher 
functioning stroke survivors with intact sensation. It could then be considered 
whether an inclusion criterion should be added related to only including people 
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with somatosensory loss. This would be in alignment with the work undertaken by 
Hummelsheim et al., (1995) discussed in section 7.3.5.4. 
 
It must also be considered as to whether the touch sensory threshold is the most 
appropriate OM to use. Cutaneous tactile assessment in a non-weight bearing 
position may not reflect sensory input requirements during standing; integration of 
other afferent information, for example, from ankle proprioceptors, may decrease 
the importance of cutaneous input from the plantar surface of the foot during 
balance (Marigold et al., 2004). Although MTS results in cutaneous input, an 
important aim of the technique is to provide intensive proprioceptive stimulation 
(Hunter et al., 2006). Perhaps measurement of proprioception would be more 
relevant; inter-rater reliability of the Erasmus version of the NSA and the sensory 
section of the Fugl–Meyer Assessment have been advocated for clinical 
application, although careful standardized testing procedures is necessary 
(Connell and Tyson, 2012). Some additional piloting relating to this aspect would 
also be valuable.  
 
 Electrogoniometry 
Bronner et al., (2010) demonstrated excellent intra-rater reliability (r = 0.979)  of 
the electrogoniometer for the ankle. However, there is generally a deficit of 
literature exploring the inter-rater reliability of the electrogoniometer. Despite 
following a strict protocol for the goniometry assessment within MoTaStim-Foot, 
with the data acquisition log calibrated to zero as recommended by Moriguchi et al. 
392 
 
(2007), and standardization of the positioning of the goniometer, concerns arose 
relating to reliability. During the assessments some participants mentioned that 
there was discomfort over the lateral side of the ankle due to the pressure of the 
shoe pressing on the electrogoniometer, although no-one mentioned this issue in 
the FG discussions. The pressure from the shoe may have resulted in slight 
movement of the goniometer which may have affected the validity and reliability of 
the results, due to a possible malalignment of the equipment. These issues may be 
able to account for the fact there were several extreme outliers noted for the 
electrogoniomery assessments. The other aspect to consider is that Bronner et al., 
(2010) tested the goniometer in a group of dancers, as opposed to stroke 
survivors, who may have altered alignment due to adaptive shortening or 
spasticity. Further reliability studies would perhaps be appropriate prior to using an 
electrogoniometer to measure ankle range of movement in future studies.  
 
 Implications for a future RCT 
The burden of undertaking the battery of OMs must be considered when designing 
a future trial. Undertaking this feasibility trial has enabled a detailed insight into 
potential burden of each OM for both the participants and the research assessors. 
The extra burden on the participants and research therapists of the interim 
assessments (LEMI and SWMs) is an important consideration. At the 
commencement of the trial, the pressure insole measures, goniometry and 5MWT 
were also undertaken after five, ten and fifteen interventions, but this was quickly 
found to be too much of a burden and an amendment to protocol had to be sought 
393 
 
to decrease these assessments to just baseline, end of intervention and one-
month follow-up. This was another useful finding of the feasibility study. 
 
 Measures of balance and gait 
 MoTaStim-Foot findings 
The 5MWT, FAC and mRMI were responsive to change in both groups, reflected in 
improvements in function and the ability to balance and walk.  
 
 mRMI 
A concern with the mRMI was that a potential ceiling effect was observed 
(Johnson and Selfe, 2004), with many participants reaching top scores by end of 
intervention/one-month follow-up. Another issue relating to the mRMI was access 
to stairs. The validated OM involves allocation of five points for a stair assessment 
(total score of 40). However, there was inconsistent access to stairs for 
participants, many of whom were in their home environment, with several living in 
bungalows. In view of this issue, to enable consistency and parity across the 
cohort of participants, the stairs assessment results were removed from the final 
score and a score out of 35 was used, rather than a maximum possible score of 
40, eliminating the score for stairs. It must be remembered that this may have 
affected the validity of the measure. This aspect will require further consideration 
prior to moving forward with future trials and is an indication that the mRMI may 
not be suitable as a primary OM for a future trial.  
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 5MWT 
For this feasibility study, there was no primary OM. It was one of the objectives of 
the feasibility study (3f) to identify an appropriate primary OM for future trials 
(Lancaster et al., 2004). Various aspects need to be considered when selecting a 
primary OM, including the acceptability for the participants, clinical relevance, 
psychometric properties of the tool e.g. validity, reliability, floor and ceiling effects, 
responsiveness, and the level of measurement.  
 
 Implications for a future RCT  
The 5MWT has been shown to be reliable (Collen et al., 1990), and responsive to 
change in walking ability after stroke (Salbach et al., 2001), which was 
demonstrated within the MoTaStim-Foot trial, and it clearly has clinical relevance. 
It was also quick and easy to set up and measure. After due consideration of these 
characteristics, the 5MWT was considered to be the most appropriate tool to take 
forward as the primary OM for future trials. It needs to be acknowledged, however, 
that since this trial ended, the SRRR guidelines for research have been published 
(Kwakkel et al., 2017) and these guidelines advocate the use of the 10MWT. 
Nevertheless, whichever of these OMs is taken forwards it will be necessary to 
consider the environment for undertaking the assessment and standardization of 
the measure. Suzuki et al. (1990) advocated a 3 metre lead up and Salbach et al. 
(2001) advised 2 metres to allow acceleration and a further two metres at the end 
for deceleration. Working in people’s homes this space was not available in the 
MoTaStim-Foot trial. In order to allow further standardization for future trials a 
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larger space in an appropriate location in the university or the hospital will need to 
be identified.  
 
 FAC 
The FAC has been found to be valid and reliable in stroke survivors (Mehrholz et 
al., 2007), is quick to undertake, and was clearly responsive to change within 
MotaStim-Foot; it is deemed suitable as a secondary OM for future trials.  
 
 Pressure insoles and implications for future studies 
Setting up and recording measurements with the pressure insoles was challenging 
at times. In order to achieve accurate measurements from the pressure insoles, it 
was necessary to calibrate the insoles prior to each measurement being 
undertaken; this was an issue for some of the participants, and, the process of 
calibrating the insoles could be extremely time-consuming; this should be built into 
planning, if the pressure insoles are to be used within future studies. Also, the 
system used within MoTaStim-Foot necessitated a great deal of time to set up and 
extreme care with the wires while undertaking the measurement was required. 
Although participants’ safety was maintained at all times, some of the participants 
said in the FGs that they thought a wireless system would be better. However, this 
has additional cost implications that need to be considered if the pressure insoles 
were to be used in a further trial. 
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Also, the specific aspects of the pressure insole information that were chosen in 
the MoTaStim-Foot trial for data analysis (FTI and COFV) did not demonstrate a 
change correlating with the improvements in gait observed for the 5MWT. Further 
consideration needs to be given as to what information would be most clinically 
useful in future studies. For example, the centre of force trajectory (Figure 6.26) 
represents well the ability to transfer weight forwards over both the ipsilesional and 
contralesional feet during gait, giving a useful visual representation of changes, 
and would be worth considering for future studies.  
 
 Response of outcome measures over time (Objective 3g) 
Research objective 3g related to whether the OMs demonstrated a response to 
treatment. It was not the purpose of the feasibility study to demonstrate the 
effectiveness of the interventions; however, the results do indicate that a potential 
efficacy was demonstrated for several of the OMs, for both groups. This aspect (in 
relation to choosing a primary OM for the subsequent trial) will be discussed. The 
purpose of regular LEMI and SWM measurements was to enable a more detailed 
understanding of potential changes occurring in relation to the number of sessions 
delivered, to inform regarding intervention requirements for a future trial. These 
regular measurements did meet their purpose. 
 
 LEMI 
The combined LEMI scores for all 34 participants clearly showed a trend of 
continued increasing strength throughout the intervention period. No plateau in 
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strength was observed and the indications are that at least the full twenty 
treatments are required to aim for optimum change for the participants. 
It is possible that greater benefit may have been seen if more than 20 sessions 
were undertaken. A large trial in America (n=347) explored the response to therapy 
in stroke survivors receiving locomotor training (gait training on a treadmill with 
bodyweight support and over ground training) or strength and balance training, as 
a secondary analysis of the Locomotor Experience Applied Post-Stroke (LEAPS) 
RCT (Rose et al., 2017). Participants received 36 sessions (3 times per week for 
12 weeks) for 90 minutes in duration and OMs were undertaken after 12, 24, 30 
and 36 interventions. The participants in both groups were still showing responses 
to treatments even after 36 sessions; however, the improvement slowed down 
between 25 and 36 sessions. To put into perspective the amount of therapy 
delivered within the LEAPS trial compared to MoTaStim-Foot, after just 12 
sessions of 90 minutes duration the participants in the LEAPS trial had received 18 
hours of treatment, and by the full 36 sessions, they received 54 hours of 
treatment. In MoTaStim-Foot the MTS group received approximately 20 hours of 
treatment (MTS+TSGT) and the TI group just 10 hours of TSGT (although they did 
benefit from being able to wear the TIs as much as they wanted during their daily 
activities). This brings into question whether additional sessions in MoTaStim-Foot 
may have resulted in greater within-group changes; this should be taken into 
consideration for future trials. However, the LEAPS trial investigated training rather 
than the effect of combining sensory stimulation (priming or augmenting) with 
training; it is not known whether the results are directly applicable.  
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 Implications for a future RCT 
In view of the fact that no plateau was observed for the LEMI results it is not known 
whether delivering more than 20 treatments would have enabled participants to 
achieve greater muscle strength and function. Hence, there is a need for some 
further piloting in advance of a large trial. 
 
 Adverse events   
 MoTaStim-Foot findings 
Some adverse events within a trial are expected, both serious and non-serious 
complications occur (Johnston et al., 1998). It is well known that mobility and 
balance are affected after a stroke (Sullivan et al., 2009; Tyson et al., 2006b), and 
the rate of falls within the population of people post-stroke is high. It is, therefore, 
unsurprising that 16 of the 27 (59.3%) adverse events within MoTaStim-Foot were 
due to a fall; ten participants reported falling, representing 29.4% of the cohort of 
34 participants.  
 
 Comparison of MoTaStim-Foot results with other trials 
This result for the MoTaStim-Foot trial is similar, but less, than a cohort of 41 
stroke survivors of whom over half had reported experiencing a fall, and 80% 
admitted to near fall events (Hyndman et al., 2002). 
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 Feasibility methodology 
The chosen methodology for this thesis enabled a systematic review of current 
literature (Study 1), and dedicated time to be devoted to developing standardized 
protocols for the three interventions to be delivered within the MoTaStim-Foot trial 
(MTS, wearing TIs, and TSGT) (Study 2). This is in alignment with the stages 
advocated within the MRC framework (Craig et al., 2006). Study 3 of the trial 
allowed for exploration relating to acceptability and feasibility of delivering the 
interventions, with qualitative aspects complimenting the quantitative study, and 
enabling the question ‘can this study be done’ (NIHR, 2017, p.2) to be answered. 
As this study was undertaken early in the research process, the design as a 
feasibility study was more appropriate than attempting to undertake a pilot study 
where a miniature replica of the main study is undertaken (NIHR, 2017). It was 
important to explore the OMs for feasibility and acceptability and to choose a 
potential primary OM for the future trial.  
 
 Assessment of the success of the MoTaStim-Foot feasibility trial 
The MoTaStim-Foot trial can be judged as being successful because it met most of 
the criteria relating to feasibility and acceptability (section 4.4.2). All 34 participants 
were recruited within the 18-month period, achieving a recruitment rate of > 5% 
and an attrition rate of <15%. The interventions were delivered in various venues 
according to protocol.  
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An analysis was undertaken of the aims and content of the MTS and TSGT 
interventions delivered.12 The most commonly used aim of the MTS intervention 
was to heighten awareness of foot position and posture; normalizing performance 
parameters, afferent stimulation and temporo-spatial activation, as well as 
regaining extensibility of the foot were also regularly used. Reducing 
hypersensitivity and pain was not such a common aim of treatment (Figure 7.1). 
 
12 Samuel, E., Hunter, S.M., Aries, A.M. (2019) Analysis of the content and dose of mobilization and 
tactile stimulation (MTS) and task-specific gait training (TSGT) for the lower limb after stroke 
delivered as part of the MoTaStim-Foot feasibility trial. (unpublished). 
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Figure 7.1 Number of times each aim of MTS treatment was selected  
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Analysis of fidelity relating to the interventions identified that the overall mean 
duration of MTS treatment delivered was 31.13 minutes, (standard error (SE) 1.94) 
with 84% of the participants in the MTS group receiving the full 30–60 minutes. All 
the MTS treatment options were used; however, passive movements 
(metatarsophalangeal joints flexion/extension/abduction/adduction; talocrural joint 
dorsiflexion/plantarflexion) and massage/soft tissue stretch (deep soft tissue 
massage to the tendoachiles; deep soft tissue massage to the plantarfascia; 
gastrocnemius and soleus mobilization) were the treatments most commonly 
selected by the research therapists to apply. The least commonly applied were 
patterns of coordinated movements underlying functional activity which included 
stair practice, obstacle course, manoeuvring, transfers and functional mobility. 
Figure 7.2 gives a visual representation of the treatments selected. 
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Figure 7.2 Number of times each MTS intervention was used 
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The content analysis of the TSGT (Figure 7.3) showed that the most commonly 
used interventions included gait re-education with or without aids (all participants, 
except two), standing balance/balance control, and sit to stand. During the TSGT 
there were several interventions that were not used at all including leisure/hobbies, 
leg press, raising and lowering a 1.4kg; 55cm exercise ball, shuttle walking, and 
standing chest press. This indicates that a review of the TSGT protocol is required 
prior to the next study being undertaken.  
 
The mean duration of TSGT was 29.49 minutes (SE 2.10). A few of the 
participants, therefore, did not receive the full expected amount of MTS or TSGT; 
this was due to tiredness or fatigue on some occasions, however, reasons were 
not always stated. Data from the daily diaries and FGs demonstrated acceptability 
of both interventions and OMs for the participants, and >50% of participants 
attended an FG. OMs were completed for all participants, although there was 
some missing data, particularly at the beginning of the trial. Research therapists 
struggled initially to collect the goniometer, pressure insole and 5MWT 
contemporaneously; however, appropriate data were collected to enable a sample 
size calculation to be undertaken prior to a future trial.  
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Figure 7.3 shows the frequency and 100% use of each of the interventions included in the TSGT treatment 
schedule. 
406 
 
 Pros and cons of delivering a trial in the community (Objective 3f) 
Most of the interventions were delivered in the home environment (81.46%) with 
just 18.54% delivered in a hospital environment (ward or gymnasium). There were 
advantages and disadvantages associated with delivering the MoTaStim-Foot trial 
within the community setting. As alluded to, one of the main disadvantages was 
the lack of space in some people’s homes. Finding a stretch longer than five 
metres was often challenging, and invariably there was no opportunity for two 
metres before and after the five-metre stretch, which would have enabled 
recording of a steady gait pattern without acceleration or deceleration. The lack of 
access to stairs was another issue in some people’s homes affecting the results of 
both the mRMI and the FAC assessments.  
 
Travel costs and time commitments must also be considered when travelling to 
people’s homes. A pragmatic decision early on in MoTaStim-Foot had to be made 
to exclude two geographical areas of Stoke-on Trent which were too far away and 
involved nearly one hour each way travelling time for the research therapist 
delivering the intervention. Not only would this have been time consuming, but 
potentially overly costly in terms of travel expenses for the trial. This needs careful 
consideration in planning the next study, as this will have implications for the 
funding application and overall trial costs.  
 
A concern of the researcher at the start of the trial was that it may be perceived as 
intrusive to be visiting participants in their own home on an almost daily basis. 
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However, this concern was unfounded, and it generally worked well to treat the 
participants in their own environment. Participants reported feeling secure in their 
own home and liked the convenience of the therapist travelling to them. Indeed, in 
the FGs, some of the participants suggested they would not have continued with 
the full course of treatment if they had a need to travel to receive the interventions. 
In view of these findings it would be appropriate to deliver interventions (sensory 
stimulation plus TSGT) in the participant’s own environment in future trials. 
 
There are many principles upon which neurorehabilitation should be based and 
these include ‘use it or lose it’, specificity, repetition and intensity (Kleim and 
Jones, 2008, p.S227). Task-specific training encompasses these features and 
principles, and along with occupational adaptation (which focusses on the 
importance or value of the task in hand), make the home environment ideal for 
implementing task-specific practice (Rowe and Neville, 2018b). Therapy goals can 
be set collaboratively and put into context in the home environment (Rowe and 
Neville, 2018b) and this ownership of goals by the stroke survivor increases 
motivation and self-efficacy; the home environment can therefore facilitate 
progress, enhanced by encouragement from others (Rowe and Neville, 2018a). 
 
 The challenge of completing 20 sessions in a six-week period 
(Objective 3d) 
For many of the participants it worked well treating them almost daily and they 
were happy to have regular treatments; most participants completed the twenty 
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sessions in approximately five weeks. However, some participants, particularly the 
younger stroke survivors found that it did not offer much flexibility for undertaking 
other activities; increasing the period of time when the treatments need to be 
delivered should be considered for future trials. Greater flexibility would also assist 
with working around any other therapy commitments of the participants.  However, 
if the duration of time for delivering the interventions is extended this will mean a 
reduction in the frequency of the treatments (times per week) and the implications 
of this in terms of potential effectiveness requires careful consideration. In the first 
few weeks after stroke, brief but regular treatments have been found to be most 
beneficial (Bernhardt et al., 2017a). There are indications that a higher dose of 
therapy enhances recovery of movement, and in a dose finding study for the upper 
limb, higher intensity learning-based sensorimotor training resulted in better 
outcomes (Byl et al., 2008). Literature relating to this aspect is limited and further 
dose-finding studies are required (Cooke et al., 2010a). Several of the participants 
in the MoTaStim-Foot trial reported that it took several weeks to perceive changes 
to plantar sensation, therefore, extending the time for delivery of the interventions 
may potentially optimize opportunity to see a change in effect. This issue requires 
further discussion with expert clinicians and PPIE volunteers prior to undertaking 
the future trial.   
 
 The timing of recruitment post-stroke (Objective 3a) 
Several of the participants were still receiving early supported discharge care 
under the NHS when they were recruited into the trial. This complicated the 
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arrangements for research therapy and, although a record was kept of the 
additional treatment received, it did add a confounding factor. The purpose of this 
feasibility study was not to investigate effectiveness of treatment; however, for 
future studies, the timing post-stroke for recruitment should be considered. If 
participants were perhaps recruited slightly later, for example, between 10-20 
weeks post-stroke, instead of 6-16 weeks, they would still have the potential for 
good recovery but would be less likely to still be under the care of the NHS 
therapists, eliminating a potential confounder.  
 
 Daily diaries and FGs (Objective 3e) 
Research objective 3e related to exploring whether the daily diaries and FGs are 
suitable ways to explore stroke survivors’ experiences (Mackrill, 2008) of receiving 
the treatment. The FGs clearly met their purpose, and the daily diaries brought a 
different perspective to the study, enabling participants’ daily thoughts to be 
documented, sharing information about the lived experience of participating in the 
trial. Much of the data collected from the daily diaries was analysed at a semantic 
level, for example, whether a participant’s foot was hot or cold (and this could be 
affected by issues such as a change in weather), or if there were any changes 
relating to the feeling within the foot, or for how long the participants wore the TIs. 
The participants’ acceptance of treatment and OMs (trial objectives 3d and 3f) was 
difficult to assess from the tick box sections of the diary sheet, but thematic 
analysis (see tables 6.7 and 6.9 for themes) of the daily diary comments and FGs, 
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gave an insight into both acceptance and response to the interventions (objective 
3g).   
 
Diaries are said to help prevent issues related to recall (Roghmann and Haggerty, 
1972); however, some of the participants reported that they occasionally forgot to 
complete them on the day, and therefore there could have been recall bias, 
introducing error within the study (Hufford and Shiffman, 2003). Nevertheless, 
there was a great deal of useful information extracted from the daily diaries, 
although it would have been helpful to have included greater clarity in relation to 
the sections ‘Today my foot felt sensitive’ and ‘Today my foot did not feel 
sensitive’. It was not possible to ascertain from the diaries whether the sensitivity 
was a good indication i.e. able to feel more generally in the foot, or a problem, for 
example, a foot that is hypersensitive and potentially perceived as painful. On 
analysis of these sections, it appears that participants have interpreted the 
requirements of some of these sections in different ways. Several of the diary 
sections were, therefore, perceived as being inconsistent in view of the differing 
interpretations and the findings from these sections have not been reported within 
this thesis. It was, nevertheless, useful to establish that the recording of the daily 
diaries was not felt to be a burden to the participants, and therefore they could be 
used for future studies, if appropriate, but they would need to have a specific 
purpose.   
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Another point worth noting is that although participants were all invited to an FG, 
this could have been several weeks after completing their intervention; this may 
have affected both take up of the offer to attend, and the ability to remember 
events accurately.  
 
 Participant characteristics (Objective 3h) 
In line with research objective 3h, it has been possible to understand the likely 
participant demographics and clinical characteristics including time since stroke, 
type of stroke and previous impairment affecting the ability to walk, again this 
information will be used to inform a future study. The sample was representative of 
the stroke population. The mean age (SD) for participants in MoTaStim-Foot (MTS: 
73.84 (14.09) years; TI: 72.40 (9.79) years), which is slightly lower than the median 
age 78 years, (IQR 69–86) identified from Sentinel Stroke National Audit 
Programme data based upon 2584 admitted to a Gloucester Royal Hospital 
between 2014 and 2017. However, it is similar to other rehabilitation trials: CIRCIT 
trial, mean (SD) 69.9 (12.7) years (English and Hillier, 2011), and the FAST 
INdiCATE trial, Mean (SD) 72.2 (12.5) years) (Hunter et al., 2018), for example.  
Within the MoTaStim-Foot trial were 52.9% male participants and this value is 
slightly lower than some other trials, such as the CIRCIT trial (59%), FAST 
INdiCATE trial (64.6%) and FeSTivaLS trial (67.3%), differing perhaps due to the 
small sample size. 
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 Strengths of the three studies 
 Strengths of the systematic review (Study 1) 
There were several strengths to the methodology undertaken for the systematic 
review. The search strategy was robust, with clear terms and would be repeatable. 
The inclusion and exclusion criteria were clearly specified. Two researchers (AA, 
SH) screened the results and checked articles against the inclusion and exclusion 
criteria. Any discrepancies were discussed, and authors of the articles were 
contacted if further clarification was required. A third researcher (VP) was available 
in case of any disagreements, but this was not required. A rigorous analysis of the 
included articles was undertaken, synthesizing and evaluating the information. 
Effect sizes were calculated for all but two of the articles (where SD was not 
available). Also, a valid, reliable tool was used for quality assessment, the 
Cochrane Collaboration tool to assess risk of bias in RCTs (Higgins et al., 2011).  
 
 Strengths of the intervention modelling study (Study 2) 
Study 2 followed a methodology involving a mNGT. A rigorous approach was 
adopted, enabling development of standardized protocols for all three interventions 
(MTS, wearing TIs and TSGT), formulated in conjunction with 12 experienced 
clinicians. The process itself allowed for both face and content validity of the 
protocols to be established, with comments from the clinicians to support this 
notion. The standardized protocols developed allowed for consistency of 
techniques to be applied in each intervention and were representative of clinical 
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practice. However, they enabled adaptation on an individual basis (as would be 
done in conventional therapy rehabilitation), with progression strategies built in, 
which had been discussed during the mNGT process, adding to the transparency 
of the methodology for the study.  
 
There were numerous strengths to Study 2. These include: use of detailed, 
systematic, repeatable scoping reviews to inform the discussion, involvement of 
expert clinicians with the skills to inform the protocol development phase, and 
consideration of the aspects contained in the CONSORT 2010 and 2013 
guidelines (Chan et al., 2013; Schulz et al., 2011) and the TIDieR guidelines 
(Hoffmann et al., 2014).  The mNGT enabled consideration of the views of all the 
participants involved and was a transparent process, which could be replicated. 
The mNGT session was observed by a second researcher and a positive critique 
of the session recorded (Appendix 23).  
 
 Strengths of Study 3, the MoTaStim-Foot feasibility study  
Study 3, the randomized, single-blinded mixed-methods feasibility study, followed 
an equally rigorous methodology. The protocol for MoTaStim-Foot was developed 
in conjunction with Norwich CTU. The randomization process was set up in 
advance with a statistician from Keele University collaborating with a statistician 
from Norwich CTU. The members of the research team delivering the interventions 
or OMs had no influence upon the randomization method. Participants were 
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stratified according to the side of the stroke lesion to help take into account 
potential differences in response to rehabilitation, balancing the groups.  
 
There were several ways in which internal and external validity were addressed 
within this feasibility study. For example, randomization (Altman, 1991) and 
blinding (Armijo-Olivo et al., 2017; Eldridge et al., 2016) were implemented and 
importantly successful, as well as the use of standardized interventions and OMs 
(Bodner, 2018); the methodology was rigorous for both the randomized trial and 
the qualitative aspects of the research design. The inclusion and exclusion criteria 
were carefully selected and were applicable to many stroke survivors, increasing 
the external validity of the trial. Stroke survivors with aphasia were included within 
the MoTaStim-Foot trial, providing they were able to consent and follow simple 
instructions. This increases the clinical validity of the study findings (Brady et al., 
2013). 
 
The recruitment procedures were clearly effective, demonstrated by the successful 
recruitment of all 34 participants in the allocated time-period. The OMs used within 
MoTaStim-Foot were selected carefully, with consideration of validity and 
reliability.  
 
Within therapy practice, clinicians work to improve weight-bearing through the 
hemiparetic (contralesional) side, gaining a better transfer of weight throughout the 
stance phase and thereby increasing the symmetrical pattern of gait, so the choice 
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of pressure insole measures aligned well with clinical practice. This decision to 
consider a measure aligned with asymmetry of gait was corroborated by some of 
the quotations within the FGs, with one participant feeling that how he walked was 
an issue to him and he reported feeling that people stared at him when he was out 
in public.   
 
 Training of trial therapists 
The comprehensive training of research therapists and blinded assessors assisted 
in ensuring standardized protocols were followed for both treatments and OMs; the 
independent assessment of research therapists to ensure standardized protocols 
were being implemented also enhanced the study. All staff were GCP trained and 
required to be competent prior to undertaking assessments and treatments. As an 
example, all staff were required to complete the online competencies for the 
NIHSS prior to undertaking a baseline assessment with participants.  
 
 Triangulation of findings through mixed-methods 
The use of daily diaries and FGs to explore participants views relating to the 
acceptability of the interventions enabled triangulation of methods (Polgar and 
Thomas, 2000). Diaries have been used successfully in a similar way to give an 
indication of compliance with intervention (Askim et al., 2018).  
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 Rigorous documentation 
A further strength of the study was the rigorous documentation of all aspects 
related to both Study 2 and Study 3 of the MoTaStim-foot trial. The Chief 
investigator worked closely with both Research Governance at Keele and Norwich 
CTU. This included quality assurance processes, for example, the monitoring of 
correct processes in relation to informed consent within the trial. However, there 
was a burden to the research therapists in completing all the case report forms and 
electronic documentation should be explored prior to undertaking another study.  
 
 Patient and Public Involvement and Engagement (PPIE) 
The value of PPIE in health research has been increasingly recognized, with the 
NIHR and stroke research networks embracing strategies to increase PPIE input 
(Ardron and Kendall, 2010). The involvement of PPIE volunteers at all stages of 
the MoTaSTim-Foot feasibility trial was another strength. This involvement began 
at an early stage when initial research ideas were considered. PPIE advisors also 
assisted with both the fellowship and ethics applications, offering invaluable input 
into the lay summary for the study and development of the PIS, ensuring that 
suitable language was used that would be understandable to the participants. A 
further PPIE workshop was funded by a Research Design Service grant prior to 
submitting the fellowship application and this enabled further discussion relating to 
details about the intervention and final decisions regarding appropriate OMs. 
Clinicians were also involved at this early stage to finalize the research design for 
MoTaStim-Foot. PPIE advisors have been an integral part of the MoTaStim-Foot 
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team, throughout the research process, with advisors sitting on the trial 
management group and participating in meetings, as well as assisting with note 
taking in the FGs. Indeed, PPIE advisors have been a constant source of support 
and advice throughout, from inception of the research ideas to implementation of 
the trial and dissemination of the work. 
 
Their input was exceptionally useful in relation to the FGs, taking on a valued role 
as note taker to document the field notes, and assisting with summarizing the 
themes at the end of each FG, adding credibility to the findings (Krueger and 
Casey, 2000). Furthermore, involvement of a PPIE advisor (PB) in the thematic 
analysis of the FGs was important, enabling confirmability of the findings of the 
study. FG transcripts were shared with PB and he worked in partnership with the 
other researchers (Baines and Regan de Bere, 2018); he agreed that the identified 
themes fitted with his understanding of the content of the FGs, from his original 
involvement as notetaker, and also from reading the transcripts. His role was 
viewed as essential in the methodology, with him contributing to the discussions 
relating to the themes, which evolved from each individual FG, and also the overall 
themes that were finally developed from the data relating to all of the four FGs. 
Analysis of the field notes recorded by the FG observer (PPIE advisor) also 
provided additional insights and context behind the interactions of participants and 
was important to enhance the rigour of the qualitative aspects of the feasibility 
study. One PPIE advisor (PB) also assisted with providing images for this thesis 
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and with dissemination of the work relating to the MoTaStim-Foot feasibility study 
at the UK Stroke Forum. 
 
  Limitations of the studies 
 Limitations of the systematic review (Study 1) 
It would have been valuable to have two researchers extracting the data, 
assessing the quality of the literature and synthesizing and evaluating the findings 
of this systematic review to increase the rigorous nature of the methodology.  
 
 Limitations of the intervention modelling study (Study 2) 
One possible limitation is that although participants were included from three 
different trusts, the experts were all from the same region, and therefore it is not 
possible to be sure that their views would be generalizable to clinicians in other 
regions. The small number of participants (n=12) is also a limitation. 
 
 Limitations of Study 3, the MoTaStim-Foot feasibility study  
Some limitations to the MoTaStim-Foot study are also acknowledged. The 
randomization within the study resulted in uneven groups. Block randomization 
was used in blocks of four and two.  A situation may have occurred where, 
fortuitously, the randomization was halfway through both blocks, in the two strata, 
with the first two subjects in each block allocated to the MTS group. The 
discrepancy between the groups perhaps reflects the small numbers in the 
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feasibility study. The result of this was the maximum difference possible in number 
between the two groups with 19 people in the MTS group and 15 people in the TI 
group. It was then unfortunate that a further two people were withdrawn from the TI 
group too.  
 
As discussed in section 7.3.4.1, formal feedback was not obtained from the 
research therapists involved; this would have provided opportunity for gaining 
insight into and understanding of the research therapists’ perspective relating to 
the fidelity of delivering the interventions. 
 
Measuring knee range of movement in addition to ankle range of movement could 
have been undertaken in this study. The degree of dorsiflexion of the ankle is 
altered if the angle of the knee changes. It may, therefore, have been 
advantageous to measure the range of movement at the knee too to enable 
comparisons with normal gait during analysis.  
 
The 5MWT was successfully implemented within MoTaStim-Foot. However, there 
were restrictions in relation to space on many occasions, because the OMs were 
undertaken in participants’ homes. Consequently, whilst five metres was made 
available in each location by moving furniture and other obstacles in the 
participants’ homes, it was not generally possible to have a two metres lead up 
and run out, before and after the marked out five-metre walkway. This might have 
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affected the reliability of the 5MWT data and should be considered prior to taking 
this OM forward to a future trial. 
 
Measurement of light touch/pressure of the feet has been found to be related to 
activity OMs (Connell and Tyson, 2012) and, therefore, SWM sensory threshold 
testing was selected as an OM in the MoTaStim-Foot trial. However, within the 
literature review, discussed in chapter two, stimulation of mechanoreceptors is also 
reported to occur with somatosensory interventions, and alignment of the foot and 
ankle is highlighted as an important aspect to enable normal balance and gait. 
Therefore, it would also have been useful to assess proprioception, perhaps of the 
ankle joint. Proprioception deficits post-stroke have been found to be more 
prevalent than tactile sensory loss (34-64% as opposed to 7-53%) (Connell et al., 
2008). When this is considered, in conjunction with the importance of 
proprioception to enable controlled movement, it can be speculated that analysis of 
proprioception, as opposed to touch/pressure sensation, may have been more 
appropriate within the MoTaStim-Foot trial. This requires further consideration prior 
to a future trial and indicates that it would be more appropriate to measure 
proprioception in addition to tactile sensory loss in future trials. 
 
The sensory threshold testing with the SWMs was undertaken using a newly 
developed protocol. This protocol was developed following consultation with the 
literature, and it was successfully used within MoTaStim-Foot following training of 
the assessors. It would, nevertheless, have enhanced the rigour of the study if 
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reliability of the protocol had already been established. This is currently being 
explored and will inform protocols for the future. 
 
It was appropriate to be inclusive and include people with aphasia in the 
MoTaStim-Foot trial; however, although participants were briefed prior to the focus 
groups and the facilitator specifically ensured that people with aphasia were able 
to contribute to the FG discussion and communicate their opinions as well, the 
degree of interaction for some of the participants was limited. People with aphasia 
use various different communication strategies, for example, non-verbal 
communication, picture books and environmental props (Luck and Rose, 2007) 
and therefore video recording, rather than simply audio recording, the focus groups 
may have captured more input from people with aphasia, and should be 
considered for further studies.  
 
Another aspect to consider is that this study was only undertaken at one site. This 
site had been involved in other trials relating to aspects of therapy interventions 
previously and therefore some prior knowledge may have existed. The results of 
this feasibility study may, therefore, not be transferrable to other sites and regions. 
Further piloting at different sites is recommended before undertaking a phase III 
trial. 
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 Aspects to take forward to a future study 
This feasibility work justifies the importance of further investigation of  
somatosensory interventions to improve function of the lower limb after stroke, with 
a view to bridging the practice-to-evidence gap (Negrini et al., 2016). Prior to 
finalizing plans for a future study, consideration needs to be given to the 
challenges relating to implementation of evidence into clinical practice. This is 
important to optimize the potential of implementing any relevant research findings. 
 
 Following a successful feasibility study, meeting all the objectives, the intention is 
now to plan to take this work forwards to a large multi-centred RCT, to test two 
hypotheses: 
1. There is a difference in outcomes of balance and gait when TSGT alone is 
compared with priming the sensorimotor system using MTS prior to TSGT. 
2. There is a difference in outcomes of balance and gait when TSGT alone is 
compared with augmenting the sensorimotor system by wearing TIs prior to 
and during TSGT. 
 
This study would need to include a third group receiving just TSGT as the control, 
or possibly a fourth group too receiving usual care. This design would enable 
exploration of whether TSGT following sensory stimulation (either priming the 
system using MTS or augmenting by wearing a TI) is more effective than TSGT 
alone or solely conventional therapy.  
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Prior to undertaking a definitive clinical trial, it would be valuable to complete some 
further piloting. MoTaStim-Foot has only been implemented within one local NHS 
Trust, and the clinicians at this site are familiar with MTS as a technique and 
supportive of the research. It is anticipated that recruitment would be more 
challenging across multiple sites. It is also not known whether the interventions 
would be so well accepted at different sites. Additional piloting would also give 
better insight into which participants in terms of the level of disability/type of stroke 
may potentially benefit from the interventions, and an opportunity to monitor the 
number of participants injected with botulinum toxin, helping to ensure optimum 
inclusion criteria in a future study. Standardization of the 5MWT (or 10MWT) with 
acceleration and deceleration space included could also be established. Several 
other aspects would benefit from further piloting, including consideration of a 
change in time post-stroke to perhaps 10–20 weeks, or later, as opposed to 6–16 
weeks. Although the largest improvement is observed in the first 30 days post-
stroke (Duncan et al., 1994), the potential for further recovery continues for six 
months (Bonita and Beaglehole, 1988). This would still align with the late subacute 
phase post-stroke (3–6 months) at a point in time when there is still potential for 
motor recovery and response to therapy intervention (Bernhardt et al., 2017b) but 
would mean fewer clashes with NHS therapy, reducing the confounders. Further 
exploration in relation to a potential increase in the number of sessions delivered 
would also be valuable, in view of the fact that changes were still occurring after 
twenty sessions. It should also be considered as to whether proprioception should 
be assessed in a future trial.  
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A traffic light system (Meijel et al., 2015; Sheron et al., 2012) could be applied 
when considering which aspects of the MoTaStim-Foot feasibility study to take 
forward to a future trial, and which should not be taken forwards. Table 7.1 shows 
the aspects of this feasibility study which should not be continued (red), could be 
continued but some changes are required (amber) or could be taken forward to the 
main study without any changes (green). 
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Table 7.1  Planning a future trial: Feasibility study aspects considered within a traffic light system 
Traffic 
light 
colour 
Aspect of feasibility trial Considerations/changes required 
                          mRMI 
 
 Ankle range of movement   
measured with a goniometer  
Ceiling effect with mRMI is a concern, as well as access to stairs – unlikely to meet 
the requirements for the next trial. 
 Electrogoniometry - not to be used unless there is further reliability testing. It is 
inappropriate to measure just the ankle and not the knee ankle. Use of the tibia to 
vertical angle (Kerr et al., 2019) may be more clinically useful and could be piloted 
for further studies.  
 Daily diaries Unlikely to be required for the future trial.  
 Trial Management group This worked well; however, for future trials independent steering and data 
monitoring committees will be required. 
 Case report forms Although the case report forms worked well it should be considered whether there 
would be greater efficiency if the forms are electronic for future trials. 
 Recruitment procedures Although recruitment was successful within MoTaStim-Foot it was extremely time-
consuming for the trial staff. It would be useful to involve the Clinical Research 
Network to assist in recruitment for future studies if possible. 
 Exclusion criteria Consider whether botulinum toxin should be an exclusion to the trial or not. 
 
 NIHSS People with left hemisphere stroke score 4 points less than people with right 
hemisphere stroke, this is just a consideration, although the NIHSS worked well in 
MoTaStim-Foot. Training of staff is essential – must be competent to undertake the 
assessment. 
 Randomization procedures Need to consider whether posterior circulation strokes should be included or not 
and how they would be dealt with during randomization. 
Outcome 
measures 
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 Monitoring length of time wearing TIs If daily diaries are not used in a future trial, there needs to be a mechanism for 
recording the length of time TIs are worn. 
 
 
                           Protocols for undertaking 
                           OMs 
 
                            LEMI 
                            
     FAC 
 
     Pressure insole 
                             measurements 
 
                            Sensory threshold testing   
                            with the SWMs 
LEMI – must specify removal of footwear prior to testing. 
 Suitable and quick to administer but need to consider standardization – no 
footwear. 
 Need to consider access to stairs and inclines to ensure the ability to score 
accurately. 
 Need to consider the purchase of a wireless system to increase the safety of 
participants and speed of conduction of the testing. Need to build in time for setting 
up the equipment and calibrating the insoles.   
 Due to the lack of significant results for all but the hallux point in the TI group and 
the fact that the SWMs take considerable time to test, consideration needs to be 
given as to whether this OM should be used in further trials or not, and alternatives 
explored. 
                            Proprioception Plan to include an OM for assessing proprioception in future trials 
 Patient and public involvement and 
engagement 
The PPIE within MoTaStim-Foot was thorough and beneficial. This level of PPIE 
should also be sought for future studies. 
                             Step test for screening 
 
    Ability to follow simple 
    commands screening  
    test 
This worked well, screening out stroke survivors who functioned at too high a level. 
 This served its purpose. All participants recruited had capacity to consent and could 
follow instructions for therapy.  
                             MTS protocol 
 
 Interventions      TI protocol  
 
                            TSGT protocol 
 
Thorough training must be undertaken for research therapists to ensure adherence 
to protocol. 
 
 
 
Outcome
Measures 
 
Screening 
tools 
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 5MWT or 10MWT Videoing of the 5MWT was useful to enable assessment of whether the participant 
required assistance to walk or an aide. Consider whether it would be possible to 
have 1-2m at the start and end of the 5MWT/10MWT. 
 Blinded Assessment  This worked well and should be continued for future trials 
 Therapy treatment record (to record 
conventional therapy taking place 
alongside the trial treatments 
It is important to keep a record of the NHS therapy intervention received. 
 Pain/fatigue assessment process and form This is important to use to monitor pain and fatigue. 
 Use of FGs to explore participants 
perceptions of their trial experience 
This will allow the participants’ opinions to be heard which is an important in relation 
to a therapy trial because they play an active part in rehabilitation. It also allows for 
triangulation of methods. 
 FG schedules Will need to be adapted as required for a future trial. 
 Thematic analysis  The use of thematic analysis for the FGs was successful in giving an insight into the 
participants’ trial experiences.  
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Suggestions and reasoning for further studies relating to sensory stimulation of the 
foot and ankle post-stroke are summarized in table 7.2. Also, the estimates of 
standard deviations, attrition and missing data obtained in this study can be used 
to calculate an appropriate sample size for the primary OM in a main trial 
(Objective 3c), which is planned in the future.  
 
A power calculation was undertaken (Figure 7.4) using the data from the 5MWT 
and the suggested meaningful gait speed improvement during the first 60 days 
post stroke i.e. the minimal clinically important difference, which was found to be 
0.16m/s x60 = 9.6m/min (Tilson et al., 2010). Based upon these calculations with a 
significance level of 0.5, for a power of 0.8, 35 people would be required in each 
arm of the trial, whereas, for a power of 0.9, 47 people would need to be recruited 
in each of the two arms of the trial.  
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𝑛 ≥
2(Za + Zb)2 x 𝜎²
𝛿²
 
 
 
𝑛 ≥
2(1.960 + 0.842)2 x 14.22²
9.6²
 
𝑛 ≥
2(2.802)2 x 14.22²
9.6²
 
𝑛 ≥
15.702 x 202.21
92.16
 
𝑛 ≥
3,175.10
92.16
 
𝑛 ≥ 35 
 
𝑛 ≥
2(1.960 + 1.282)2 x 14.22²
9.6²
 
𝑛 ≥
2(3.242)2 x 14.22²
9.6²
 
𝑛 ≥
21.022 x 202.21
92.16
 
𝑛 ≥
4,250.86
92.16
 
𝑛 ≥ 47 
Figure 7.4 Power calculation based on the 5m walk change scores from 
baseline to end of intervention using a pooled standard deviation  
 
Alpha (α) 0.5, Power 0.8 
Alpha (α) 0.5, Power 0.9 
A minimum 
number of 
participants in 
each group, 
rounded up 
Z score for 
significance level 
Z score for 
power 
Pooled standard deviation for the 
5MWT change scores baseline to end 
Minimum clinically important 
difference – the difference in 
population means deemed 
important to detect 
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Table 7.2 Suggestions and reasoning for further research 
Suggestion for future 
research 
Purpose 
Further studies exploring effects of 
sensory stimulation. 
Studies with larger numbers are required so 
subgroup analysis can be undertaken to determine 
the characteristics (e.g. in terms of disability, and 
whether stroke survivors with more severe disability 
respond differently from those who are mildly 
affected). This will help inform inclusion criteria for 
future studies.  
Exploration of whether MTS could 
be delivered by a carer or an 
assistant. 
It needs to be understood whether skilled handling is 
essential when undertaking MTS, or whether carers 
and assistants can be trained to undertake MTS with 
the same effect. This has cost implications for 
implementation of MTS within the NHS in the future. 
Comparison of a smooth insole 
with a TI in stroke survivors. 
This is to ascertain whether the perceived benefits of 
wearing the TIs in MoTaStim-Foot are related to 
increased plantar sensation or the feeling of 
improved stability. 
Reliability studies for ankle 
electrogoniometry in healthy 
participants and stroke survivors. 
This will inform a decision as to whether or not ankle 
electrogoniometry should be considered for further 
studies. 
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 Summary 
Within this chapter, the findings from the studies have been discussed, along with 
potential neurophysiological changes associated with the interventions. The 
strengths and limitations of the studies have been presented accompanied by 
plans for how this research can be taken forwards in the future. The following, final 
chapter will include concluding remarks from this body of work.  
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8 CHAPTER EIGHT: CONCLUSIONS 
 
 The importance of afferent input and development of the 
protocols 
The importance of afferent input to facilitate balance and mobility has been 
discussed in detail, utilising pertinent literature. A systematic review has been 
undertaken and two sensory stimulation intervention protocols, MTS to prime the 
CNS, and wearing of TIs to augment the system, have been developed, along with 
a TSGT protocol for the lower limb. A rigorous process involving a consensus 
methodology and twelve experienced clinicians was implemented for developing 
the protocols. All three of the interventions have been delivered as two separate 
treatment combinations (MTS+TSGT and TIs+TSGT) in a randomized, single-
blinded, mixed-methods feasibility study. 
 
 Success of the feasibility study and plans for the future 
The MoTaStim-Foot feasibility study has been completed successfully, 
demonstrated by recruitment to time and target of the planned number of stroke 
survivors meeting the inclusion criteria, and delivery of the interventions, which 
have been found by the participants to be acceptable. The mixed-methods design 
enabled insight into participants’ perceptions of the interventions and the overall 
trial experience.  
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In conclusion, the chosen methodology was appropriate to meet the objectives of 
the feasibility study. The importance of sensory stimulation post-stroke has been 
highlighted and a necessity for further research exploring the effectiveness of 
MTS+TSGT and TIs+TSGT in a large, adequately powered RCT has been 
established. Based upon the findings of the MoTaStim-Foot feasibility study other 
potential areas for investigation are summarized in table 7.2.  
 
A critique of all three studies has been undertaken describing their strengths and 
limitations. Following the MoTaStim-Foot feasibility study, suggestions have been 
made for further piloting of certain aspects prior to undertaking a large phase III 
RCT; other studies relating to somatosensory stimulation of the lower limb post-
stroke deemed important for undertaking in the future have also been highlighted 
(table 7.2).  
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Appendix 1 Upper limb mobilization and tactile stimulation (MTS) schedule 
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Appendix 2  Full search strategy for systematic review (Study 1) 
Search Search term 
S1 CEREBROVASCULAR ACCIDENT   
S2 stroke 
S3 “cerebrovascular accident” 
S4 “CVA” 
S5 “acquired brain injury” 
S6 “traumatic brain injury” 
S7 “head injury” 
S8 “TBI”  
S9 “ABI”  
S10 hemiplegia  
S11 hemiparesis  
S12 “upper motor neuron lesion”  
S13 ACQUIRED BRAIN INJURY   
S14 TRAUMATIC BRAIN INJURY  
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 
OR S11 OR S12 OR S13 OR S14  S16 FOOT  
S17 LEG  
S18 “lower limb”  
S19 “lower extremity” 
S20 S16 OR S17 OR S18 OR S19  
S21 sens*  
S22 stimulat*  
S23 somatosens*  
S24 propriocept*  
S25 afferent  
S26 mobilisation  
S27 mobilization  
S28 manipulat*  
S29 SOMATOSENSORY STIMULATION  
S30 PROPRIOCEPTION 
S31 S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR 
S29 OR S30  
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S32 WALKING  
S33 GAIT  
S34 WEIGHT BEARING  
S35 walk*  
S36 gait  
S37 mobil*  
S38 step  
S39 stance  
S40 ambulat*  
S41 “weight bear” 
S42 S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41  
S43 Randomised controlled trial 
S44 “Randomised controlled trial” 
S45 RANDOMIZED CONTROLED TRIAL 
S46 “Randomized controlled trial” 
S47 RCT 
S48 S43 OR S44 OR S45 OR S46 OR S47  
S49 Functional electrical stimulation 
S50 “Functional electrical stimulation” 
S51 FES 
S52 S49 OR S50 OR S51  
S53 S15 AND S20 AND S31 AND S42 AND S48  
S54 S53 NOT S52 
Limiters: English language 
Thesaurus terms are shown in capital letters 
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Appendix 3  Data extraction form for systematic review (Study 1) 
 
482 
 
 
  
483 
 
 
  
484 
 
Appendix 4  Details of the number of citations from each database 
 
 
Database No. of citations 
Ageline 0 
Amed 12 
Cinahl Plus 61 
Medline 64 
PsycArticles 0 
PsycINFO 9 
SPORTdiscus 30 
Web of Science 249 
Cochrane Library trials 8 
PEDro 0 
TOTAL 433 
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Appendix 5   Studies excluded after reading full texts and reason for 
exclusion 
 
Author and date of 
publication 
Reason for exclusion 
An and Jo (2017) Involved muscle contraction 
Bae et al. (2015) No clear statement of appropriate ethics 
approval 
Chen et al. (2011) Involved muscle contraction 
Cheng et al. (2010) Involved muscle contraction 
Choi et al. (2013) Not sensory stimulation 
Ertzgaard et al. (2018) Involved muscle contraction 
Hsu et al. (2013) Involved muscle contraction 
Knutson et al. (2013) Involved muscle contraction 
Koseoglu et al. (2017) Not an RCT 
Kwong et al. (2018) Sensory stimulation not manipulated  
Lau (2011) Thesis 
Lau (2013) Abstract only 
Lee et al. (2016) Involved muscle contraction 
Liang et al. (2012) Involved muscle contraction 
Maupas et al. (2017) No gait or balance outcome measure 
Morreale et al. (2016) Involved muscle contraction 
Ng (2005) Thesis 
Okawara and Usuda (2015) Not an RCT 
Park et al. (2015) Not an RCT 
Ribeiro et al. (2013) Involved muscle contraction 
Spaich et al. (2014) Involved muscle contraction 
Sungkarat et al. (2011) Auditory stimulation 
Xu et al. (2017) Not sensory stimulation and involved FES 
Yavuzer et al. (2006) Not sensory stimulation – involved muscle 
contraction 
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Appendix 6  Articles identified from reference lists and indication for 
inclusion or reason for exclusion 
Author Included 
or not 
Reason for exclusion 
Brogårdh et al. (2012) (from 
Tankisheva et al., 2014) 
 
√  
Chan et al. (2012) (from Guo 
et al., 2015) 
X No clear statement of ethical 
approval 
Cho et al. (2013) (from Suh et 
al., 2014) 
√  
Cordo et al. (2009) (from 
Paoloni et al., 2010) 
X Not an RCT 
Geiger (2001) (from Goliwas 
et al., 2015) 
X Involved visual feedback 
Lau et al. (2012) (from 
Tankisheva et al., 2014) 
√  
Lee et al. (2013) (from Guo et 
al., 2015)) 
X Both groups had FES 
Magnusson et al. (1994) (from 
Goliwas et al., 2015) 
X Acupuncture and muscle contraction 
Morioka and Yagi (2003) 
(from Lynch et al., 2007) 
X No clear statement of ethical 
approval 
Ng and Hui-Chan (2007) 
(from Jung et al., 2017) 
X No clear statement of ethical 
approval 
Ng and Hui-Chan (2009) 
(from Suh et al., 2014) 
√  
Park et al. (2014) (from Jung 
et al., 2017) 
√  
Tyson et al. (2013b) (from 
Goliwas et al., 2015) 
X Not an RCT 
van Nes et al. (2006) (from 
Tankisheva et al., 2014) 
√  
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Appendix 7  Chronicity of stroke in trial samples 
 
Authors Stroke chronicity 
Bayouk et al., 2006 Mean (SD) time post-stroke: 6.3 (9.7) years 
Brogårdh et al., 2012 Mean (SD) time post-stroke: 35.3 (30.5) months 
 Cho et al., 2013 Mean (SD) time post-stroke:14.5 (5.0) months 
 Ferreira et al., 2018 Mean (SD) time post-stroke: 9.1 (1.3) years 
 Goliwas et al., 2015 Mean (SD) time post-stroke: 4.3 (3.0) years 
Guo et al., 2015 Mean (SD) time post-stroke: 63.2 (52.2) days 
 Jung et al., 2017 Mean (SD) time post-stroke: 6.6 (2.6) months  
 
 
Kluding and Santos, 2008 Mean (SD) time post-stroke: 21.4(13.8) months 
Lau et al., 2012 Mean (SD) Time post-stroke: 5.0 (3.9) years 
 Lynch et al., 2007 Mean (SD) time post-stroke: 48.7(31.1) days  
Ng and Hui-Chan, 2009 Mean (SD) time post stroke: 4.7(3.4) years  
 Paoloni et al., 2010 Mean (SD) time post stroke: 1.9 (0.59) years  
Park et al., 2014 Mean (SD) time post stroke: 18.6 (2.1) months 
 Suh et al., 2014 Mean (SD) time post-stroke: 14.5 (5.0) months 
Tankishieva et al., 2014 Mean (SD) time post-stroke: 6.5 (6.1) years 
van Nes et al., 2006 Mean (SD) time post-stroke: 36.6 (10.2) days 
 Yan and Hui-Chan, 2009 Mean (SD) time post-stroke: 9.3 (3.4) days  
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Appendix 8  Summary of interventions and findings 
 
Authors Intervention Main finding 
   
Bayouk et 
al., 2006 
Task-oriented exercise 
under varying conditions 
(eyes open/eyes closed) 
and on different surfaces 
(firm/soft) 1hr/wk x8 wks 
Total=16hrs 
10m walk test: Both groups significantly decreased time 
(p<.05): 12.2% for experimental group (EG) and 12% for control 
group (CG). No significant main effects or group x test 
interaction. COP variability: EG significantly reduced COP 
variability (p<.05) in ML (eyes open, firm surface) and AP 
directions (eyes open, soft surface). 
Brogårdh 
et al., 2012 
Whole body vibration 
(WBV) Training. All 
participants underwent 12 
sessions of WBV training 
(twice weekly during 6wk) 
Total=9 hrs 
Significant but small improvements were found within both 
groups after the WBV training. EG improved significantly in 
balance (4%; p<.05) and in gait performance (TUG, 8%; CGS 
and 6minWT, 5%; p <.05). Control group improved sig. in 
isometric knee extensor strength (paretic limb) (12%; p <.05) 
and gait performance (TUG & 6 Minute Walk Test, (6minWT) 
6%; p <.05). The differences in all OMs after the training were 
nonsignificant. 
Cho et al., 
2013 
In addition to physical 
therapy based on the 
Bobath-concept for 30 min 
before TENS application: 
Experimental group: 
TENS stimulation 
(frequency 100 Hz, pulse 
width 200 μs, with 2 to 3 
times the sensory 
threshold) applied 
gastrocnemius for 60 min.  
Total=1 hr 
 
Spasticity (MAS) Spasticity reduced by 29% in EG and by 13% 
in CG; HHD-based resistance measurement: reduced by 30% 
(EG) and by 19% (CG) (p<.05) and difference between groups 
was significant (p<.05); Postural sway length (PSL) reduced 
by 54.3cm, and the postural imbalance of the placebo-TENS 
group was reduced by 9% after the intervention. All results for 
both groups returned to the baseline values after a day. 
Postural imbalance: Eyes-open condition: PSL reduced by 
16% (from 64.5cm to 54.3cm) in EG, and by 9% in CG. Both 
groups returned to baseline values after one day Eyes closed 
condition:  PSL decreased significantly (p<.05) by 23% (from 
89.8cm to 69.1cm) in the EG, and by 8% (from 85.3cm to 
78.2cm) in CG. Both groups returned to baseline values after 
one day. Unstable surface eyes open: PSL decreased by 16% 
(from 209.4cm to 174.6cm) for the EG but returned to the pre-
application values after one day. PSL decreased by 9% (from 
218.3cm to 197.5cm) in CG and returned almost to baseline 
values after one day.  
Ferreira et 
al., 2018 
Postural insoles with 
pronating heel wedge, a 
pronating band and MTP 
inlay for the stabilization of 
the different segments of 
the foot in the neutral 
position (3 months of insole 
use) 
A tendency was found toward improvements in spatiotemporal 
gait variables in the EG immediately following the placement of 
insoles. However, the differences did not achieve stat. sig. After 
three months of insole use, sig. improvements were found in the 
gain of ankle dorsiflexion, peak knee flexion as well as range of 
motion of the ankle and knee in comparison to the CG. 
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Goliwas et 
al., 2015 
Standard programme of 
rehabilitation 5x/week, 45 
mins for control group and 
30-minute sessions + 
15mins (or 20 mins – 
UNCLEAR) sensorimotor 
foot stimulation (SFS)  
Total =22.5 hrs 
EG: For differences in weight distribution: End test with eyes 
open and eyes closed – significant difference (p<0.05) between 
baseline and end, Exp group: 30.6 ± 19.6% to 17.8 ± 15.2% 
(p<.05), Control group: 20.1 ± 18.4% 18.7 ± 18.2% (p>.05) 
Reduction of the differences in weight distribution: 
Significant difference seen between the EG (12.2 ± 12.9%, 
p<.05 vs CG, which was 2.4 ± 4.9% with eyes open (p>0.05). 
CG: No sig. differences seen at all 
Guo et al., 
2015 
Whole body vibration (I-
VIB5050, Body Green, 
Taiwan) with a magnitude 
of 6~10Hz and amplitude of 
4.0mm. 
For 8 wks ? 5 x/wk 8 sets 
per day (80mins) 
(Total=53.33hrs WBV)a 
The Fugl-Meyer lower extremity score and 10m max walking 
speed test of both groups were improved sig (P=0.000/P=0.000, 
d=1.500/d=1.952, 95%CI [3.309, 9.891]/ 95%CI [5.549,12.45]; 
P=0.000/P=0.000, d=2.015/d= 2.952, 95%CI 
[5.214,11.39]/95%CI [9.423,15.98]), and the times of knee 
hyperextensions decreased significantly (P= 0.000/P=0.000, 
d=3.537/d=5.108, 95%CI [19.05,12.35]/95% CI [16.52,22.28]; 
Compared with the CG after treatment, the WBV’s 10 m 
maximum walking speed and times of knee extension had 
significant statistical differences (P=0.001, d=1.345, 95%C 
I[1.896,6.704]; P=0.000, d=1.749, 95%CI [2.915,7.285]) 
Jung et al., 
2017 
TENS and sham groups 
had sit-to- stand training. 
The training lasted for 15 
min a day, 5x/wk for 6 
weeks. Prior to training 
sessions, subjects in the 
TENS group received 
electrical stimulation for 30 
min (two times the sensory 
threshold without muscle 
contraction). Pulse width of 
200 ms /frequency 100 Hz.  
(Total=37.5 hrs) 
Results table difficult to interpret; however, text states: the 
training caused a more significant decrease in postural sway 
when subjects stood with their eyes open and eyes closed in the 
TENS group (mean change, each 21.0 (16.2), 26.4 (19.9) cm) 
than in the placebo stimulation group (mean change, each 8.8 
(13.1), 13.1(13.0) cm). After training muscle strength of hip 
extensors was sig. inc. in the TENS group than in the placebo 
stimulation group. No sig. difference was found in muscle 
strength of knee & ankle extensors between TENS and placebo 
stimulation groups. Spasticity score sig. decreased in the TENS 
group (mean change, 2.6 (0.8) score) compared with the 
placebo stimulation group (mean change, 0.7 (0.8) score), 
p<.05. 
Kluding 
and 
Santos, 
2008 
Ankle joint mobilisations + 
functional training + activity 
vs functional training + 
activity (Total 2.67hrs)b 
Joint mobilisations + functional training may increase ankle 
ROM (passive ROM 95%CI 2.5, 8.6, effect size .88, active 
ROM 95%CI 0.5, 16.6; effect size .72) and improve speed of 
sit→ stand (95%CI -1.9, -0.1s, effect size = .6), and sig. increase 
peak weight-bearing during sit→stand (95% CI 3.59, 29.37, 
effect size =.85) more than functional training +activity alone  
Lau et al., 
2012 
WBV training (frequency 
20-50Hz) 3x/wk for 8 wks. 
Each session included 15 
min of warm-up exs. in the 
sitting position. (Total 10 
hrs, 4.2 were WBV)  
The addition of the present WBV protocol to the dynamic leg 
exercise program confers no supplementary benefits for 
improving neuromotor performance and reducing falls when 
compared with leg exercise alone in chronic stroke patients with 
mild to moderate motor impairments. 
Lynch et 
al., 2007 
Sensory training + standard 
care vs standing with eyes 
closed and relaxation + 
standard care (Total 12.5 
hrs) 
Sensory retraining programme of the feet + standard care was 
no more effective than standard care + standing with eyes 
closed + relaxation  
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Ng and 
Hui-Chan, 
2009 
20 sessions over 4 weeks. 
TENS group: 60 mins 
TENS, on four acupuncture 
points (100 Hz /pulse width 
0.2 ms) at twice each 
patient’s sensory threshold. 
TENS and exercise 
group: 60 minutes, same 
TENS protocol plus 60 
minutes of task-related 
exercises. (Total = 40 hrs, 
20hrs TENS and 20 hrs 
exercise) The placebo 
stimulation exercise 
group - 60 mins of the 
same exercise after 
receiving 60 mins of 
placebo stimulation. 
Control group: No 
treatment - just attended 
four assessment sessions 
Only the members of the TENS +exercise group demonstrated 
sig improvements in gait velocity from week 2 onwards 
(baseline: 47.9 (26.8), week 2 63.2(32.2)) (p<0.01). the 
improvements were maintained at follow-up, four weeks after 
treatment ended (70.2 (32.7)). When compared with the control 
group, the two exercise groups (TENS+exercise baseline 191.9 
(89.4) to follow up 245.5 (99.7) and placebo Stimulation + 
exercise (baseline: 175.9 (81.9) to follow up 206.82 (85.8)) 
showed significantly greater absolute and percentage increases 
in the average distance they covered in the 6minWT (p <0.01) at 
follow up. All three intervention groups showed significant 
decreases in their average TUG time scores (p <0.01) at week 4 
compared with that of the control group, but only the two 
exercise groups (TENS + exercise and placebo stimulation + 
exercise) maintained the improvements at follow-up. Compared 
with the control and TENS groups, only the combined TENS + 
exercise group covered significantly more distance in the 6 
Minute Walk Test from week 2 onwards. 
Paoloni et 
al., 2010 
SMV therapy + general 
care vs general care (Total 
= 10 hrs) 
SMV + general care may improve gait in pts with foot drop 
secondary to chronic stroke more than general care alone 
Park et al., 
2014 
TENS + exercise (30 mins) 
A frequency of 100 Hz and 
a pulse width 200 μs were 
used. Participant pre-
stimulation threshold was 
measured from 0.01 mA 
and stimulated by 90% 
amplitude using the sub-
sensory threshold. Control, 
placebo TENS + ex 30 m 
(Total =30 hrs, 15 hrs 
TENS and 15 hrs exercise) 
Exercise therapy with TENS improves spasticity, balance, and 
gait in chronic stroke patients TENS group showed more 
reductions of MAS than the placebo TENS group (p <.05) Static 
balance: A sig. difference in eyes closed and opened, AP, ML 
postural sway velocity, and velocity moment was observed in 
the TENS group before and after the test (p<.05), and in mean 
difference from pre- and post-test between the 2 groups (p<.05). 
TUG: A sig. difference in before and after the test was observed 
in the TENS group (p<.05) and the TENS group was more 
improved than the placebo TENS group (p<.05). Gait analysis 
test: Sig. difference in velocity, cadence, and step length and 
stride length of the paretic side were observed in the TENS 
group before and after the test (p<.05), but in the placebo TENS 
group, only velocity showed a sig. difference. before and after 
the test (p<.05) and the TENS group showed more 
improvements of cadence, step length of the paretic side, and 
stride length of the paretic side than the placebo TENS group 
(p<.05) 
Suh et al., 
2014 
ES (interferential therapy) + 
standard care vs sham ES 
+ standard care (Total 1 
hour) 
ICT + standard care applied to spastic gastrocnemius reduced 
spasticity and improved gait in chronic stroke compared to sham 
ICT + standard care or standard care alone 
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Tankisheva 
et al., 2014 
Training program on a 
vertical vibration platform 
(Power Plate) 3 times a 
week for 6 weeks. CG were 
not involved in any 
additional training 
programme. (Total 9 hrs) 
Ashworth scale – no sig. differences (p >.05). Muscle strength  - 
sig. between-group differences in favor of the vibration group 
only in isometric knee extension strength (paretic leg) (WBV 
baseline: 43.1 (10.1), follow up: 48.1 (7.9), Control: baseline: 
30.5 (27.2), follow up: 35.2 (25.7) , (knee angle, 60˚) (p =.022) 
after 6 weeks of intervention and in isokinetic knee extension 
strength (velocity, 240˚/s) after a 6-week follow-up period (p 
=.005), both for the paretic leg. Postural control improved after 6 
weeks of vibration in the intervention group when the patients 
had normal vision and a sway-referenced support surface (p 
<.05). 
Van Nes et 
al., 2006 
Whole body vibration 
(WBV) on each working 
day during 6 weeks of their 
admission in the 
rehabilitation centre. Four 
sessions of 45 seconds 
stimulation with 1-minute 
break between each 
session. A total of 120 
treatment sessions were 
given per patient (Total = 9 
hrs,1.5 hrs were WBV) 
Both groups showed a main effect of time on the Berg Balance 
Scale score (F[2,50]=56.67, P<0.01) as well as the Barthel 
Index  F[2,50]=97.12, P<0.01), Rivermead Mobility Index 
F[2,50]=76.20, P<0.01), Trunk Control Test (F[2,50]=11.83, 
P_0.01), FAC score (F[2,50]_76.48, P<0.01), Motricity Index 
(F[2,50]=26.85, P<0.01), and somatosensory threshold 
(F[2,50]=3.92, P<0.05). Improvements were most pronounced 
during the intervention period, but patients continued to improve 
during the follow-up period. There were no group time 
interactions, indicating similar recovery profiles for both 
treatment groups 
Yan & Hui-
Chan, 2009 
TES with electro-
acupuncture to LL + 
standard care vs Placebo 
TES acupuncture to LL + 
standard care vs standard 
care alone (Total =15 hrs) 
TES with electroacupuncture to LL + standard care reduced 
spasticity and increased strength of dorsiflexion compared to 
placebo TES + standard care or standard care alone 
a Largest dose b Smallest dose 
Abbreviations: 6minWT 6 minute walk test; AP Anterior-posterior; Cm Centimetres; CG Control 
group; CGS Comfortable gait speed; COP Centre of pressure; EG Experimental group; ES Electrical 
stimulation; HHD Hand held dynamometer, Hr hour; ICT Interferential current therapy; LL Lower limb; 
MAS Modified Ashworth Scale; ML Mediolateral; MTP Metatarsal phalangeal; PSL Postural sway 
length; ROM Range of movement; SFS Sensorimotor foot stimulation; sig Significant; SMV 
Segmental muscle vibration; stat sig Statistically significant; SWMs Semmes Weinstein 
Monofilaments; TENS/TES Transcutaneous electrical (neuromuscular) stimulate; TUG Timed up and 
go;  vs Versus; WBV Whole body vibration; Wk week. 
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Appendix 9  List of outcome measures used according to study 
Outcome Outcome measure Authors 
 Ashworth Scale Tankisheva et al., 2014 
Passive 
resistance / 
spasticity in 
spasticity:  
 
Modified Ashworth Scale  
 
Brogårdh et al., 2012, Cho et 
al., 2013, Kluding and Santos, 
2008; Park et al., Suh et al., 
2014, van Nes et al., 2006 
Composite Spasticity Scale Jung et al., 2017, Yan & Hui-
Chan, 2009 
Hand-held dynamometry Cho et al., 2013, 
Motor 
impairment / 
muscle 
strength (LL) 
MRC scale 0–5 Jung et al., 2017 
Fugl-Meyer (LL) Guo et al., 2015 
Maximum isometric voluntary 
contraction 
Brogårdh et al., 2012, Yan & 
Hui-Chan, 2009 (with EMG) 
Cybex dynamometer Computer 
(isometric muscle strength) Lau et al., 2012 
Isokinetic knee muscle strength Brogårdh et al., 2012 
Isokinetic dynamometer (Biodex 
System) Tankisheva et al., 2014 
EMG Paoloni et al., 2010 
Chedoke–McMaster stroke 
assessment. 
Lau et al., 2012 
Motricity Index van Nes et al., 2006 
LL function Brunnstrom-Fugl-Meyer test Tankisheva et al., 2014 
ROM e.g. d/flex  Goniometer Kluding and Santos, 2008 
Walking speed  
Timed 10m walk Bayouk et al., 2006, Lynch et al., 2007; Suh et al., 2014;  
GAITRite mat Ng and Hui-Chan, 2009 
ELITE stereophotogrammetric system Paoloni et al., 2010 
Functional 
independence 
Barthel Index  Tankisheva et al., 2014, van Nes et al., 2006 
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Participation Stroke Impact Scale Brogårdh et al., 2012 
Walking ability 
and mobility 
function 
 
Functional Ambulation Category (FAC) Tankisheva et al., 2014, van Nes et al., 2006 
Timed up and go (TUG) 
Brogårdh et al., 2012, Ny and 
Hui-Chan, 2009, Park et al., 
2014, Suh et al., 2014; Yan & 
Hui-Chan, 2009 
Level of Assistance Scale  Lynch et al., 2007 
Timed sit→stand Kluding and Santos, 2008 
Rivermead Mobility Index (RMI) Kluding and Santos., 2008, van Nes et al., 2006 
10MWT Guo et al 2015, Lau et al., 2012, Lynch et al., 2007 
10MWT at comfortable and fast gait 
speeds Brogårdh et al., 2012, 
6 Minute walk test (6minWT) 
Brogårdh et al., 2012, Lau et 
al., 2012, Ng and Hui-Chan, 
2009 
Exertion Borg’s perceived exertion scale Tankisheva et al., 2014 
Balance / 
postural 
control: 
 
 
Berg Balance Scale  
Brogårdh et al., 2012, Lau et 
al., 2012, Lynch et al., 2007, 
Suh et al., 2014, van Nes et 
al., 2006 
Centre of pressure displacement Bayouk et al., 2006 
Postural sway length Cho et al., 2013, 
Anterior-posterior and medial-lateral 
postural sway, speed, and speed 
moment 
Park et al., 2014 
Dynamic posturography platform 
(Equitest) Tankisheva et al., 2014 
Weight distribution on the feet using the 
Zebris FDM-TDL treadmill Goliwas et al., 2015 
Functional Reach Test Suh et al., 2014 
Limits of stability Lau et al., 2012 
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Ability to maintain postural control - 
Sensory Organization Test (SOT) Tankisheva et al., 2014 
Force platform (Wii Balance Board) Jung et al., 2017 
Balance confidence (ABC) scale to 
measure falls efficacy Lau et al., 2012 
Trunk control Trunk control test  van Nes et al., 2006 
Sensory 
impairment 
(light touch 
and 
proprioception) 
Semmes-Weinstein Monofilaments 
(SWM) Lynch et al., 2007 
Somatosensory threshold 
(monofilaments) van Nes et al., 2006 
Distal Proprioception Test Lynch et al., 2007 
Gait 
observation 
Subjective observation of knee 
hyperextension 
Guo et al., 2015 
Gait analysis Gait analyzer (OptoGait, Microgate 
S.r.l, Italy, 2010) sensed and 
transmitted through the infrared ray 
sensor, collecting temporal and spatial 
variables  
Park et al., 2014 
Gait 
kinematics 
Step length  
% stance phase  
Kinematics of hip, knee, ankle  
Cadence (ELITE 
stereophotogrammetric system) 
Paoloni et al., 2010 
Time-distance data (ELITE 
stereophotogrammetric system) 
Paoloni et al., 2010 
3-dimensional gait analysis on 10m 
walkway: Displacement from the center 
of pressure and the time of contact 
between the foot and force plate. 
Ferreira et al., 2018 
Sit to stand 
analysis 
Ankle kinematics – WB symmetry 
during functional activity – 3D motion 
analysis 
Kluding and Santos, 2008 
Timed sit→stand Kluding and Santos, 2008 
Weight-bearing – peak dorsiflexion 
during sit→stand; weight bearing 
difference during sit→stand and in 
static standing 
Kluding and Santos, 2008 
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Appendix 10    Keele University ethics approval for mNGT work (Study 2) 
 
 RESEARCH AND ENTERPRISE SERVICES 
 ERP1230  
10th April 2015  
Alison Aries  
School of Health and Rehabilitation, MacKay Building  
Keele University  
Dear Alison  
Re: Development and initial evaluation of the efficacy of afferent reawakening 
treatment of the foot on lower limb function after stroke: A feasibility study  
Thank you for submitting your application for review. The proposal was reviewed at the 
Ethical Review Panel meeting on Thursday 2nd April. The PaneI would like to commend you 
for a clear and well produced application and I am pleased to inform you that your 
application has been approved by the Ethics Review Panel. However, the Panel would like 
to make the following recommendations for consideration: -  
Application Form  
Section A  
The section entitled status should be revised to state ‘Post Graduate Research Student’ only 
and the details for the School of Health and Rehabilitation should be removed from section 
entitled Research Institute or School if not in a Research Institute. This information should 
also be amended accordingly throughout all the study documentation.  
Summary Document  
Within the information about the sample it stated that ‘…. recruited from NHS Trusts in the 
North Midlands, Staffordshire and Shropshire.’ It is recommended that this is revised to read 
‘…. Recruited from NHS Trusts in Staffordshire and Shropshire.’  
Information Sheet  
Under the heading How will information about me be used it is recommend that a line space 
is inserted between the following two sentences; ‘However, individual therapists and trusts 
involved in this study will not be identified.’ And ‘Personal information such as contact details 
……… group meeting.’  
Consent Form  
It is recommended that the asterisk in point 5 is deleted and that the document is formatted 
as appropriate so that it does not exceed one page.  
If you revise any study documentation, please send a copy of the revised documents to 
uso.erps@keele.ac.uk for our records.  
 
 
 
Research and Enterprise Services, Keele University, Staffordshire, ST5 5BG, UK Telephone: + 44 (0)1782 
734466 Fax: + 44 (0)1782 733740 
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The following 
documents have 
been reviewed and 
approved by the 
panel as follows: 
Document  
  
 
RESEARCH AND 
ENTERPRISE 
SERVICES 
 
 
 
 
Version  
 
 
 
 
 
 
 
Date  
Summary Document   1  19/03/2015  
Letter of Invitation   1  19/03/2015  
Information Sheet   1  19/03/2015  
Consent Form   1  19/03/2015  
Consent Form (for 
use of quotes)  
 1  19/03/2015  
Appendix 1 Principles 
of the Nominal Group 
Process  
 1  19/03/2015  
Appendix 2 Final 
treatment schedule 
for the upper limb  
 
 
 
 
 
 1  19/03/2015  
 
 
 
  
If the fieldwork goes beyond the date stated in your application 30th November 2015, 
you must notify the Ethical Review Panel via the ERP administrator at 
uso.erps@keele.ac.uk stating ERP1 in the subject line of the e-mail.  
If there are any other amendments to your study you must submit an ‘application to 
amend study’ form to the ERP administrator stating ERP1 in the subject line of the e-
mail. This form is available via 
http://www.keele.ac.uk/researchsupport/researchethics/  
If you have any queries, please do not hesitate to contact me via the ERP 
administrator on uso.erps@keele.ac.uk Stating ERP1 in the subject line of the e-mail. 
Yours sincerely  
 
Dr Jackie Waterfield  
Chair – Ethical Review Panel  
CC RI Manager 
 
Research and Enterprise Services, Keele University, Staffordshire, ST5 5BG, UK Telephone: + 44 
(0)1782 734466 Fax: + 44 (0)1782 733740 
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 Appendix 11     Consent form for mNGT work (study 2) 
   
 
 
 
CONSENT FORM 
 
Title of Project:  Development and initial evaluation of the efficacy of afferent reawakening 
treatment of the foot on lower limb function after stroke: A feasibility study. Phase 1 – protocol 
development. 
Name and contact details of Principal Investigator:  
Alison Aries 
National Institute for Health Research (NIHR) Research Fellow 
School of Health and Rehabilitation 
MacKay Building 
Keele University 
ST5 5BG 
Email: a.m.aries@keele.ac.uk 
Tel: 01782 734418 
 
1. I confirm that I have read and understood the information sheet dated 20/5/15  
(version no.2) for the above study and have had the opportunity to ask questions 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
  time 
 
3. I agree to take part in this study.  
 
4. I understand that data collected about me during this study will be anonymised  
 before it is submitted for publication. 
 
5. I understand that, although data will be anonymised, it may be possible 
  that I could be identifiable in reports and publications because of my professional role 
 
6. I agree to the nominal group technique discussion group being audio recorded 
 
7.  In the discussion group (Nominal Group Technique): 
 I agree to keep the issues discussed within the discussion group confidential and,  
in particular, to avoid identifying any of the participants in relation to any issues/individual  
comments made during the session 
 
8. I agree to allow the dataset collected to be used for future research projects 
 
  
_______________________ 
Name of participant 
__________________
Date 
____________________ 
Signature 
_______________________  
Researcher 
__________________ 
Date 
___________________ 
Signature 
For nominal group technique discussion group: 
If you consent to participate in this study, it should be drawn to your attention that the researcher has a professional 
obligation to act upon any aspects of poor practice and/or unprofessional behaviour that may be disclosed during the 
research activity.  Researchers should use the appropriate reporting mechanisms if they have witnessed or 
experienced poor practice and/or professional behaviour.    
 
 
 
 
 
 
 
Please tick box if 
you 
agree with the 
statement 
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CONSENT FORM 
(for use of quotes) 
 
 
Title of Project:  Development and initial evaluation of the efficacy of afferent 
reawakening treatment of the foot on lower limb function after stroke: A feasibility study. 
Phase 1 – protocol development. 
Name and contact details of Principal Investigator:  
Alison Aries 
National Institute for Health Research (NIHR) Research Fellow 
School of Health and Rehabilitation 
MacKay Building 
Keele University 
ST5 5BG 
Email: a.m.aries@keele.ac.uk 
Tel: 01782 734418 
 
Please tick box if you  
agree with the statement 
 
 
 
1. I agree for my quotes to be used 
 
 
 
 
2. I do not agree for my quotes to be used  
 
 
 
 
 
 
_______________________ 
Name of participant 
__________________
Date 
____________________ 
Signature 
_______________________  
Researcher 
__________________ 
Date 
___________________ 
Signature 
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Appendix 12 Letter of invitation for mNGT work (Study 2) 
 
 
8/5/15            
Re: Invitation to participate in research relating to stroke rehabilitation 
I am writing to invite you to take part in some research that is being held in the School 
of Health and Rehabilitation at Keele University.  
The title of the project is:  Development and initial evaluation of the efficacy of 
afferent reawakening treatment of the foot on lower limb function after stroke: A 
feasibility study. Phase 1 – protocol development. 
You have been invited to take part in this study because you are a clinician 
(physiotherapist or occupational therapist) working in the NHS with experience in 
neurological rehabilitation. Participation is completely voluntary and if you do not want 
to take part it will have no impact on your future involvement with the University.  
The researcher is Alison Aries, a National Institute for Health Research (NIHR) Fellow. 
The plan is to undertake a feasibility study within the next three years, exploring the 
possibility of evaluating sensory stimulation to the foot / lower limb post stroke. In 
preparation for this it is important to develop standardised protocols for the treatments 
which will be explored. These include mobilization and tactile stimulation (MTS), use 
of textured insoles (TIs) and task-specific gait training (TSGT), which is often used in 
clinical practice following preparatory stimulation techniques.  
This phase of the project will use a modified nominal group technique (full details of 
which will be available in the information sheet): a total of nine to twelve experienced 
clinicians will be recruited and invited to comment on two versions of the MTS protocol 
being developed for the lower limb (it is expected this may take approximately 30-45 
minutes), and then to attend a group discussion (lasting no longer than three hours) 
to finalise the protocols for MTS, TIs and TSGT.  
You can choose whether you would like to take part or not, and you can withdraw at 
any point in time.  Should you decide you are interested in participating in the research 
then please let us know (contact details below), by the 18th May 2015. If you are not 
interested in participating, please disregard this letter.  For further information or to 
express an interest, please email Alison Aries on a.m.aries@keele.ac.uk or telephone 
on 01782 734418.  
Yours sincerely 
Alison Aries 
Contact details 
Any questions or concerns the please contact us on the contact details below.  
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Principal Investigator                                                                     Supervisor 
Alison Aries                                                                               Dr Sue Hunter 
NIHR Clinical Academic Research Fellow                                       Senior Lecturer  
School of Health and Rehabilitation                                                 School of Health and Rehabilitation 
MacKay Building                                                                               MacKay Building                                                                                        
Keele University                                                                                Keele University 
Email: a.m.aries@keele.ac.uk                                                         Email: s.m.hunter@keele.ac.uk 
Tel: 01782 734418                                                                            Tel: 01782 733809 
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Appendix 13 Participant information sheet for 
the mNGT (Study 3) 
 
 
 
Information Sheet  
Study Title: Development and initial evaluation of the efficacy of afferent 
reawakening treatment of the foot on lower limb function after stroke: A 
feasibility study. Phase 1- protocol development 
Aims of the Research 
Sensory stimulation techniques to the foot and ankle are commonly used in rehabilitation 
following stroke, and are often applied prior to activities to retrain standing balance and 
walking. In the near future a study is to be undertaken as part of a doctoral fellowship to 
explore the feasibility of a randomised controlled trial investigating sensory stimulation 
techniques post-stroke. Prior to undertaking the feasibility study it is necessary to develop 
intervention protocols for sensory stimulation and balance/gait retraining that closely 
resemble current conventional therapy.  
 
The objective of this phase is to develop the standardised post-stroke intervention 
protocols informed by literature and expert opinion of experienced therapists for the delivery 
of:  
a) a module of Mobilisation and Tactile Stimulation (MTS) for the foot and ankle 
b) enhanced sensory stimulation during activity (sensory augmentation) using a textured 
insole (TI) 
c) task-specific gait training (TSGT) to the lower limb (LL) post-stroke. 
 
Invitation 
You are being invited to consider taking part in this first phase of a research project 
entitled: Development and initial evaluation of the efficacy of afferent reawakening 
treatment of the foot on lower limb function after stroke: A feasibility study.  This project 
is being undertaken by Alison Aries (National Institute for Health Research (NIHR) 
Research Fellow). Before you decide whether or not you wish to take part, it is 
important for you to understand why this research is being done and what it will 
involve. Please take time to read this information carefully and discuss it with friends 
and relatives if you wish. Please ask us if there is anything that is unclear or if you 
would like more information (contact details at the end of the document).  
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Why have I been invited? 
You have been invited to take part in this study because you are a clinician (physiotherapist 
or occupational therapist) working in the NHS, with experience in neurological rehabilitation.  
 
Do I have to take part? 
You are free to decide whether you wish to take part or not.  If you do decide to take part you 
will be asked to sign two consent forms, one is for you to keep and the other is for our records. 
You are free to withdraw from this study at any time and without giving reasons.  
 
What will happen if I take part? 
Following receipt of this information sheet, and appropriate time allowed for consideration as 
to whether you wish to participate, please contact Alison Aries, Principal Investigator (details 
at the bottom of this sheet) if you would like more information or if you would like to take 
part. You will have an opportunity to ask the research team any questions you may have 
about the project. You will then be asked to complete a consent form either via email or in 
person.  
You will be involved in the development of the three separate protocols: a) MTS; b) TIs; and 
c) TSGT.  
 
 
 
This will be done in several stages: 
 
Stage 1.  
a) Prior to a consensus meeting, you will be sent a copy of the MTS schedule previously 
developed for the upper limb (UL) post-stroke and asked to consider, independently and 
without collaboration with colleagues, how the subsections of the UL schedule might be 
appropriately adapted as an intervention for the LL. You will be asked to annotate the 
schedule according to how it should be modified to reflect current conventional therapy for 
the foot and ankle, in preparation for standing and balance. In addition, you will be asked to 
rank the order of importance / frequency of use of each of the intervention subsections (it is 
anticipated this process will take no longer than 15-30 minutes), and then return the 
schedule with your comments to the research team, who will collate all the responses.  
b) You will subsequently receive a second iteration of the modified schedule and be asked 
to independently review this second draft and provide feedback (anticipated to take no 
longer than 15 minutes) on: a) how comprehensive the schedule is; and b) how accurately it 
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reflects your experiences and practice of retraining somatosensation in the foot and 
preparing the foot for standing and balance in standing. You will return this feedback to the 
research team who will collate and draft a third version of the schedule.  
Stage 2 
You will be invited to attend a group discussion meeting with the other nine to twelve 
clinicians involved in the study (lasting no longer than one morning or afternoon), within the 
School of Health and Rehabilitation at Keele University. This meeting will be audio-taped to 
ensure accurate information is recorded. Group members will be asked to consent to 
maintaining confidentiality regarding group membership and any discussion that takes place 
within the group. The purpose of this group meeting will be to discuss the proposed 
protocols for MTS, TI and TSGT.  
a)  Version three of the MTS schedule will be discussed and modified until consensus is 
attained on the content and format of the schedule.   
b) A selection of commercially available TIs will be considered, discussed and evaluated in 
order to seek agreement by the group; issues such as size, nature and type of texture, 
accompanying footwear, cost, and potential comfort/discomfort will all be considered, along 
with the length of time and activity involved during the pre-gait training phase of wearing the 
insoles. A TI protocol will be developed and agreed by the group.  
c) The group will also be asked to consider and discuss the protocol for TSGT which will be 
adapted from the protocol developed by Dean et al (2000), and agree on an appropriate TSGT 
protocol for the feasibility trial. TSGT will be delivered in addition to the sensory interventions 
(MTS or TI). 
 
What are the benefits (if any) of taking part? 
There are no direct benefits to you in taking part but you will be assisting with the 
development of standardised protocols which will be used in further research to evaluate 
therapy for stroke.   
 
What are the risks (if any) of taking part? 
There are no expected risks involved with your participation. However, as the final 
discussions will take place in a group situation though there is always the potential that you 
feel your opinion is not heard. The group facilitator will ensure everyone has the opportunity 
to participate in the discussions. If you have any concerns or queries after the discussions 
the facilitator will be available to discuss these issues with you.     
 
How will information about me be used? 
Some demographic information will be collected i.e. age/date of birth, gender, profession 
and NHS band, along with information about how long you have been qualified, your 
professional background and experience and any post-registration training. It will be used to 
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provide a summary of the expertise of the group overall. However, individual therapists and 
trusts involved in this study will not be identified. 
 
Personal information such as contact details will be used only to make contact with you, to 
send you the various iterations of the MTS schedule, and to arrange for you to attend the 
group meeting.  
 
 
  
Who will have access to information about me? 
Personal information will only be accessible to the researcher and the supervisor and will be 
anonymised and stored securely on a password-protected computer or in a locked filing 
cabinet at Keele University, in accordance with the requirements of the sponsor (Keele 
University) and the Data Protection Act (1998). On completion of the project, all personal 
information of participants will be deleted.  
 
Please note, however, that it is necessary to work within the confines of current legislation 
over such matters as privacy and confidentiality, data protection and human rights and so 
offers of confidentiality may sometimes be overridden by law. For example in circumstances 
whereby I am concerned over any actual or potential harm to yourself or others I must pass 
this information to the relevant authorities. 
 
Who is funding and organising the research? 
This research is funded by the National Institute for Health Research (NIHR) as part of a 
Clinical Academic Fellowship doctoral study. Keele University is the sponsor for the 
research.  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you may wish to speak to the research 
team who will do their best to answer your questions.  You should contact Alison Aries on 
a.m.aries@keele.ac.uk or Tel: 01782734418.  Alternatively, if you do not wish to contact 
Alison, the Principal Investigator, you may contact the supervisor for the research, Dr Susan 
Hunter, on s.m.hunter@keele.ac.uk or 01782 733809. 
 
If you remain unhappy about the research and/or wish to raise a complaint about any aspect 
of the way that you have been approached or treated during the course of the study please 
write to Nicola Leighton who is the University’s contact for complaints regarding research at 
the following address:- 
 
Nicola Leighton 
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Research Governance Officer 
Research & Enterprise Services 
Dorothy Hodgkin Building 
Keele University  
ST5 5BG 
E-mail: n.leighton@uso.keele.ac.uk 
Tel: 01782 733306 
 
Principal Investigator                                                                     Supervisor 
Alison Aries                                                                   Dr Sue Hunter 
NIHR Clinical Academic Research Fellow                                        Senior Lecturer  
School of Health and Rehabilitation                                                 School of Health and Rehabilitation 
MacKay Building                                                                            MacKay Building                                                                                        
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Appendix 14 Table of data extracted from textured insoles (TI) articles 
Author and 
date and 
sample 
Objective Study 
design 
Type of TI Details of inter- 
vention 
Outcome 
measures 
Results Conclusions Comments 
Aruin et al., 
2000 
 
 n=8, acute and 
chronic stroke 
(0.16 – 5 years) 
All subjects 
ambulatory with 
assistive device. 
n=5 subjects 
wore AFO (not 
during testing) 
n=1 had a 6/52 
therapy 
programme)  
Explore  
1) 
symmetry 
of weight 
bearing in 
stroke 
survivors 
with shoe 
lift on non-
paretic LL 
2) 
compelled 
weight 
bearing 
from shoe 
lift + 
targeted 
exercise 
helps to 
overcome 
learned 
non-use of 
hemipareti
c limb.  
(Pre-) 
experimental 
single group, 
pre- and 
post inter-
vention 
No blinding 
No random 
allocation 
Lift put in shoe 
on non-paretic 
side. 
Regular shoes 
worn.  
Just worn for 
testing. Although 
n=1 has a six-
week therapy 
programme – 
insole worn all 
day and during 
all daily 
activities. 
n=8 Just wore the 
shoe lift for testing  
 
n=1 had a 6/52 
therapy 
programme, with 
a shoe lift in situ 
all day and for 
exercises 
Weight bearing on 
paretic side- quiet 
standing, and 
compelled weight 
shift with Balance 
Master 
computerised force 
platform system 
Fugl Meyer 
Balance Scale 
n=1 Timed 5MWT in 
motion analysis lab 
Symmetry of weight bearing 
increased gradually with 
increasing lift height, reaching 
almost 50:50 weight 
distribution at 10 mm lift 
condition. Authors claim: 
Significant results (p<0.05) 
achieved for all three lift 
heights. Carry over seen when 
weight bearing was measured 
without a lift insitu (after the 
testing with lifts).  
Authors suggest it 
helps overcome 
learned disuse of 
the affected side. 
They claimed there 
was an increase in 
weight to the 
affected side after 
the lift was removed 
from the unaffected 
limb.  
No mention of 
how the sample 
was recruited 
Likely bias high 
NOT TIs – not 
really relevant to 
my study.  
Student’s t test is 
used for a small 
sample n=8, no 
discussion as to 
whether data was 
normally 
distributed. 
Only n=8 – not 
appropriate to use 
students t-test 
Aruin & 
Kanekar, 2013  
 
n=11 healthy 
subjects 
 
Pilot data from 
individuals with 
stroke n=4 
Investigate  
effect of a 
novel 
discomfort-
induced 
approach 
on the 
alteration 
in 
symmetry 
(Pre-) 
Experimental
(pre-post 
intervention, 
single group) 
 
No control 
No blinding 
No random 
allocation 
Single TI, 
standardised 
footwear. Just 
worn for testing. 
Novel discomfort-
induced approach. 
No control group 
but participants 
were tested 
without an insole 
too 
NB – only wore 
TIs for testing 
GaitRite system 
SMAR Equi Test 
(balance) 
TIs only worn for 
testing 
 
Significant immediate effect 
seen for static (weight 
bearing), and dynamic (weight 
symmetry index, strength 
symmetry) balance tests. 
Static balance: ANOVA 
revealed significant side insole 
interaction for the % Wt 
bearing F9,2 =50.44, p<0.001) 
Dynamic: Effect of D-insole – 
when considering in right shoe 
Results indicate that 
a TI can 
significantly modify 
symmetry of stance 
and gait in healthy 
individuals.  
Pilot data from 
individuals with 
stroke showed a 
reduction in 
asymmetry of gait 
No mention of 
how the sample 
was recruited 
ANOVA and t test 
used when 
sample size was 
just 10 (should 
have been 
Kruskal-Wallis 
(not ANOVA) and 
xxxii 
 
of gait and 
balance 
/ left shoe statistically 
significant for large (F9,2 =47.3, 
p<.001 / F9,2 =58.65, p<.001), 
medium (F9,2 =43.8, p<.001 / 
F9,2 =41.92, p<.001) and small 
(F9,2 =30.2, p<.001 / F9,2 
=28.79, p<.001) perturbations. 
Gait velocity – no significant 
difference (p = 0.6). Significant 
side-insole interaction was 
observed for swing phase 
(F10,2 = 15.3, p <.0001) and 
stance phase phase (F10,2 = 
16.6, p <.0001) 
when walking with 
single TI in shoe of 
unaffected side.  
Mann- Whitney U 
not t-test. 
Likely bias high  
Baron et al., 
2014  
 
(conference 
presentation 
PRS 2014) 
n=46 Patients 
with MS. Able to 
walk 100m 
To explore 
perception
s of people 
with MS on 
the effect 
and 
comfort of 
two 
different 
TIs: a 
qualitative 
study. 
Exploratory 
Semi-
structured 
interviews 
with 
participants 
on study 
exploring the 
effects of 
three 
different TIs  
Control: smooth 
Algeos TI  
Crocs TI 
Part of Dixon et 
al. (2014) trial – 
told to wear 
them as much 
as possible for 
two weeks 
26 wore insoles 
daily, 13 wore 
them frequently 
and 7 wore them 
infrequently 
N/A Croc insoles: 
81.82% said they would wear 
again, 13.64% said they would 
not wear them again, 4.5% 
said they would possibly wear 
them again 
Algeos insoles: 
62.5% said they would wear 
again, 33.33% said they would 
not wear them again, 4.17% 
said they would possibly wear 
them again 
Subjective 
experiences of 
wearing TIs are 
highly individual. 
Acceptability and 
efficacy were linked 
to perception of 
benefit. 
Some useful 
information for my 
study, relating to 
comfort of TIs 
Christovão et 
al., 2013 
1) Controlled 
clinical trials 
2)intervention – 
insole,  
3) OM related to 
postural balance 
4) published 
2005-2012 
12 studies 
(n=392) 
Majority 
included ‘older 
volunteer 
Systematic 
review of 
literature 
on effect of 
different 
insoles on 
postural 
balance 
Systematic 
review 
Quick comfort 
insole, soft gel 
and hard insole, 
TI, vibrating 
insole, insole 
with spikes, 
insole with 
wedge, balance 
enhancing 
insole, flat insole 
N/A Articles used force 
plates, EMG, gait 
disturbance 
protocol, electronic 
version of the 
Romberg test + 
camera on motion 
analysis 
Quality assessed with PEDro 
scale – papers scored at 3 or 4 
Insoles have 
benefits which 
favour better 
postural balance 
and control.  
Papers evaluated 
by 2 blinded 
researchers 
Insufficient details 
given regarding 
the participants in 
each study to 
assess the 
relevance of this 
review to my 
study. Few stroke 
patients (n=15), 
mainly older 
adults.  
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Clark et al., 
2014 
 
n=14 older 
adults with mild 
mobility deficits 
and mild 
somatosensory 
deficits  
Determine 
if 
enhancing 
somatosen
sory 
feedback 
can reduce 
controlled 
processing 
during 
walking, as 
assessed 
by 
prefrontal 
cortical 
activation 
Experimental 
study  
No blinding 
No random 
allocation 
Used 
functional 
near infra-
red spect-
roscopy, 
quantifying 
cortical 
activity by 
measuring 
tissue 
oxygenation 
index (TOI) 
Made of thin 
semi-rigid plastic 
with firm raised 
(1.5mm) 
nodules 1.5 cm 
apart on a grid 
pattern. Just 
worn for testing. 
Just worn for 
testing. Treadmill 
walk and 
overground with & 
without shoes and 
walking with a TI 
and while dual 
tasking. Metabolic 
activity L & R 
prefrontal cortices 
assessed with 
fNIRS monitor 
A split belt treadmill 
with embedded 
force plates and 
GAITRite walkway – 
used to acquire 
spatiotemporal gait 
measures.  
SWMs 
Primary finding: is enhanced 
somatosensory feedback 
during walking reduced 
metabolic activity of prefrontal 
cortex. (Left hemisphere: TOI 
= -0.85+/- 0.35, p=.01, right 
hemisphere: TOI = -1.19 +/- 
0.46, p=.01) The prefrontal 
cortex is important for 
attention, this indicates that 
walking became more 
automatic with increased 
somatosensory input with TIs - 
only seen for treadmill walking 
and not overground walking.  
‘Our findings 
support the 
hypothesis that 
enhanced 
somatosensory 
feedback of the feet 
reduces prefrontal 
metabolic activity. 
This finding is 
consistent with 
lower utilization of 
attention-
demanding 
controlled 
processing during 
walking in older 
adults' 
Data is presented 
for 11 of the 14 
participants but 
the other 3 are not 
accounted for. No 
raw data is given  
Corbin et al., 
2007 
 
n=33 healthy 
participants  
To 
compare 
postural 
control 
measures 
between 
different 
balance 
conditions, 
with and 
without 
TIs.  
A cross over 
trial  
No blinding 
No random 
allocation  
Just worn for 
testing 
TIs of plastic 
floor matting, 
with rounded 
plastic nubs, 
raised about ¼ 
cm off the 
surface. 
Participants 
wore thin socks 
and own athletic 
shoes for testing 
Subjects 
performed 24, 10 
second bipedal 
and unilateral 
stance balance 
trials eyes 
open/closed, with 
and without TIs  
Average velocity 
and area of COP 
excursions using 
the Accusway 
PLUS Balance 
Platform 
Significant interaction between 
eyes and texture for COP area 
measures in bilateral stance 
(p=0.03) 
Significant differences in area 
and velocity of COP 
excursions observed during 
bilateral stance only when 
subjects not wearing TIs (t32 = 
-2.9, p =.008). No significant 
difference when wearing TIs 
(t32 = -0.53, p =.60).    
Increased afferent 
information from TIs 
improves postural 
control in bilateral 
stance. Postural 
control improved 
while subjects wore 
TIs during bilateral, 
eyes-closed stance.  
Crossover design 
meant subjects 
served as their 
own control. 
TIs were only 
worn for testing 
Dixon et al., 
2014 
 
Part 1: n=46 
with MS, who 
could walk 100m 
unassisted or 
using one stick / 
crutch.  
  
To 
investigate 
immediate 
effects of 
TIs on 
balance 
and gait in 
people with 
MS and 
explore 
any effects 
after 2 wks 
Design:  
3 groups, 
within- 
session 
repeated-
design with 
exploratory 
follow up 
period.  
 
Blinding. 
 
1) Control 
(smooth 
surface) 
2) Texture 1 - 
Algeos Evalite 
Pyramid EVA, 
3mm thickness, 
with small 
pyramidal 
peaks, centre to 
centre distances 
Part 1 – testing 
with the three 
different insoles 
(randomised 
order) 
Part 2 – 2 weeks 
wearing of a TI 
randomly 
allocated. 
Participants 
encouraged to 
wear insoles as 
Double limb stance 
measured using 
Kistler force 
platform  
 
COP velocity 
 
Level overground 
walking measured 
using GAITrite 
system 
Balance: 
significant increase observed 
in AP range during double-limb 
standing with eyes open, with 
texture 2 insoles. (p<.05) 
The mean difference was 4.5 
(95% confidence interval (CI) 
0.6,8.4mm) 
Effects of 2 wks wear: 
Stride length in both legs 
increased significantly in both 
Partial evidence of 
immediate increase 
in AP sway when 
wearing texture 2 
insole. After 2 wks 
of wear, no effects 
on standing 
balance. Gait: 
increased stride and 
step length.  
Authors suggest 
that TIs may 
Details written 
regarding the 
insoles used – 
helpful for my 
study. 
Order of testing 
was randomised  
Blinded assessor 
used. 
 
Rigorous 
methodology, 
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of wear 
(mean no 
of days 
reported as 
11) 
Random 
allocation of 
order of 
insole 
wearing.  
approximately 
2.mm 
3) Texture 2 - 
Crocs silver 
insoles with 
small nubs of 
approx. 1mm 
height and 2mm 
diameter.  
often as possible, 
but actual wear 
was at the 
discretion of 
participant.   
the TI groups relative to 
control conditions: 
 
provide sensory-
motor training 
effect, giving 
improvement in 
walking, which is 
still exhibited 
without the TIs, 
rather than just a 
mechanical effect.  
useful study for 
informing my 
study.  
Donzé, 2015  
NO details given 
re literature 
search strategy 
or numbers of 
articles identified 
etc, 
To study 
what is 
new in 
rehab 
approach 
to balance 
and 
impairment 
in people 
with MS  
Literature 
review 
No details stated 
– just states TI 
are used to 
increase plantar 
stimulation 
N/A - Review N/A  Effectiveness of TIs 
not been 
demonstrated by 
large RCT but TIs 
could represent a 
complementary 
service to other PT 
technique in specific 
indications 
No details given 
regarding search 
terms and 
methodology. Not 
reproducible 
Hartmann et 
al., 2010 
 
n=28 
Independent 
living, or older 
adults aged 65 
to 91 years  
Investigate 
effects of 
physical 
exercise 
combined 
with 
wearing 
MedReflex 
shoe 
insoles on 
gait 
performanc
e and 
muscle 
power in 
older 
adults  
RCT 
pre/post 
intervention. 
3 groups: 
Insole plus 
training (IG) 
group 
Just training 
group (TG) 
CG (no 
intervention) 
 
Random 
allocation 
 
No blinding  
Med Reflex 
shoe insoles 
with raised 
projections to 
improve afferent 
feedback from 
the foot  
Subjects asked 
to wear insoles 
as much as 
possible and 
use them during 
everyday life 
and during 
training 
sessions. 
n=14 Insole group 
(training plus 
wearing insoles 
during everyday 
life and during 
training sessions) 
 
n=14 training 
session: aerobic 
exs, progressive 
resistance 
strength training 
and stretching 
exercises twice 
per week for 12 
weeks.  
 
Control group had 
no exercise or 
insoles 
Falls efficacy scale, 
gait analysis and 
muscle power 
measurements of 
knee and ankle 
joints pre- and post-
training. 
Spatio-temporal gait 
parameters 
determined using 
DynaPort (trunk 
triaxial 
accelerometer) 
During usual 
walking speed gait 
evaluated in 4 
conditions: 
1.On gym floor 
2.Gym floor + dual 
task 
3.On soft foam 
rubber walkway 
Significant time x group 
interactions  
All subjects: 
(Walking speed: F3,156 = 6.59, 
p<.001, 
Cadence: F3,156 = 12.71, 
p<.001, step duration: F3,156 = 
12.42, p<.001, step length: 
F3,156 = 0.71, p<.55) 
The IG and TG group did not 
differ significantly in their 
improvements. The CG 
showed a trend to 
deterioration.  
Significant 
improvements in 
gait performance 
and muscle power 
after conventional 
training programme 
in independent 
living, older adults.  
However, no 
additional effect of 
long-term 
adaptation of gait 
caused by wearing 
insoles concurrent 
to physical training 
Subjects wore 
insoles as much 
as possible. Four 
subjects wore the 
insoles all day, 
four subjects wore 
them half a day, 
and two less than 
1 hour per day. 
There was no 
mention of blinded 
assessors. 
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4.Soft walkway + 
dual task 
Hatton et al., 
2009 
 
n =24  
Young adults  
In to 
investigate 
whether 
textured 
surfaces 
alter 
postural 
stability 
and lower 
limb 
muscle 
activity 
during 
quiet 
bipedal 
standing 
balance 
with eyes 
open. 
Within 
subject 
Experiment 
 
Sequence of 
test 
condition 
randomized 
 
No blinding 
Just worn for 
testing 
3 different 
textured 
surfaces: 
1: Evalite to 
pyramid EVA 3 
mm thickness, 
with small 
pyramidal peaks 
texture 
2: nora Luna 
soft mini non-
slip 3 mm 
thickness with 
convex circular 
patterning 
3: control 
condition -flat 
surface medium 
density Eva 
three mm 
thickness.  
Participants 
randomized to 
three conditions: 
1) control surface  
2) texture one and 
3) texture two 
AP and ML or so 
sway variables and 
intensity of EMG 
activity in the eight 
dominant lower limb 
muscles collected 
synchronously over 
30 seconds. 
Under specific conditions of 
this study, with young, healthy 
participants, texture did not 
affect either postural sway or 
lower limb muscle activity in 
static bipedal standing. 
From the repeated measures 
ANOVAs there were no 
statistically significant 
differences among the three 
conditions for any of the 
postural sway variables: AP 
SD (F 2,21 = 2.366, p = 0.105), 
AP (F 2,21 = 1.583, p = 0.216), 
ML SD (F 2,21 = 0.406, p = 
0.669) and ML range (F 2,21 = 
0.021, p = 0.957). 
Results of study 
point to three areas 
of further work 
including: 
1) effect of textured 
surfaces on postural 
stability and lower 
limb muscle activity 
under more 
vigorous dynamic 
balance tests  
2) post –fatigue 
3) in older adults 
presenting age 
related 
deterioration. 
Participants only 
stood on the 
textured surfaces 
for testing 
Hatton et al., 
2011  
 
n=50 healthy 
older adults 
To explore 
effects of 
standing 
on textured 
surfaces 
on double-
limb 
balance in 
older 
adults and 
changes in 
muscle 
activity as 
possible 
mechanis
m of effect 
Within 
subject 
experimental  
Sequence of 
trials 
randomised /  
 
No blinding 
Texture 1: 
Evalite to 
pyramid EVA 3 
mm thickness, 
with small 
pyramidal peaks  
 
Texture 2:  
nora Luna soft 
mini non slip 3 
mm thickness 
with convex 
circular 
patterning. 
Eyes open and 
closed on two 
different textured 
surfaces and a 
smooth surface 
control.  
ML and AP sway 
and COP velocity 
measured on a 
force platform. 
LL muscle activity 
collected using 
surface EMG.  
ANOVA calculated for each 
variable. The ML range with 
eyes closed showed a 
statistically significant effect of 
texture (F2,47= 3.840, p=0.033). 
Texture 1- mean diff for ML 
range was -1.7 (-3.3, -0.2) and 
for texture 2 -1.1 (-2.3,0.1)  
Effect of standing 
on textured 
surfaces on ML 
sway in older 
adults, supporting 
therapeutic benefits 
of textured surfaces 
as intervention to 
improve balance.   
Effects with texture 
1 but not texture 2 
shows that texture 
type important e.g. 
shape, thickness, 
density, spacing or 
contouring affecting 
deformation of 
plantar skin and 
Good details 
given regarding 
textured surfaces 
Only stood on 
textured surfaces 
for testing.  
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stimulation of 
mechanoreceptors.  
Hatton et al., 
2012 
 
n= 30 older 
adults, with self-
reported history 
of falls 
To 
investigate 
immediate 
effects of 
wearing 
TIs on gait 
and double 
limb 
standing 
balance in 
older 
fallers.  
Within 
subject 
experimental  
 
Sequence of 
textures 
worn and 
eyes open or 
closed  
 
Randomized 
 
No blinding 
  
TIs: Evalite to 
pyramid EVA 3 
mm thickness, 
with small 
pyramidal 
peaks. Centre to 
centre distance 
approx. 2.5mm 
Control - flat 
surface texture 
medium density 
Eva three mm 
thickness. 
No intervention as 
such, insoles just 
worn for testing 
Level ground 10 m 
walk with Gait Rite 
System, and 
double-limb 
standing with eyes 
open and closed 
over 30 seconds 
using Kistler force 
platform under two 
conditions: 
wearing TIs 
(intervention), and 
smooth (control) 
insoles in usual 
footwear.  
2-way ANOVAs were 
calculated as within subjects’ 
differences. Wearing TIs 
caused significantly lower gait 
velocity (p=0.02), step length 
(p=0.04) and stride length 
(p=0.03) compared with 
wearing a smooth insole. No 
significant differences were 
found with the balance 
parameters 
 
F statistics and CIs are not 
stated. 
Gait velocity, step 
length and stride 
length significantly 
reduced when 
wearing TIs 
 
Plantar surface of 
the feet remained in 
contact with 
indentations of the 
TI.  This may have 
stimulated slow 
adapting 
mechanoreceptors 
which are reported 
to respond to 
maintained and 
prolonged skin 
indentation. 
Again, good detail 
given regarding 
the TIs 
No blinding 
 
The effects of 
prolonged wear of 
TIs remain to be 
investigated. 
Kalron et al., 
2015 
 
n=25 relapsing 
remitting MS 
patients  
1. 
Determine 
whether 
TIs have 
immediate 
effects on 
postural 
control and 
spatiotemp
oral 
parameters 
of gait and 
plantar 
sensation 
in people 
with MS 
 
2. Explore 
effects of 
four weeks 
Within 
subject 
experimental 
design with a 
four-week 
intervention 
phase  
 
No blinding 
No 
randomisatio
n 
Insoles 
customised for 
left and right 
feet. Insoles 
3mm thick and 
made of elastic 
rubber and 
fabric. Coarse 
texture of insole 
designed with 
miniature square 
pyramids 
organised in a 
grid pattern  
Participants 
instructed to wear 
TIs constantly 
throughout the 
day for four weeks 
and continue with 
usual activities 
Spatiotemporal 
parameters of gait 
and centre of 
pressure excursions 
during static 
postural control 
using the Zebris 
FDM-T treadmill.  
 
Light touch and 
pressure sensation 
thresholds using 
Semmes Weinstein 
monofilaments  
Data was normally distributed 
according to the Kolmogorov-
Smirnov test. Spearman rho 
correlation analysis to assess 
relationship between postural 
control parameters and 
sensory evaluation 
measurements, plus paired 
sample t tests.  
Examination during the eyes 
closed task demonstrated an 
immediate reduction in the 
COP path length (298.4 mm, 
SE = 49.7 mm, versus 369.9 
mm, SE = 56.3 mm; p = .04) 
and sway rate (12.0 mm/s, SE 
= 1.4 mm/s versus 15.1 mm/s, 
SE = 1.6 mm/s, p = .03) after 
insertion of TIs compared to 
wearing casual shoes without 
Although there were 
improvements in 
some aspects of 
balance, efficacy of 
TIs in the MS 
population remains 
unclear 
Good justification 
for why insoles 
were 3mm thick 
with coarse 
texture with 
miniature square 
pyramids 
organised in a grid 
pattern. – ‘provide 
sensory feedback, 
yet not too rough 
enough to cause 
skin discomfort’.   
Treadmill used - 
not the same as 
over ground 
walking.  
Sample size at 
follow-up relatively 
small but I could 
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wearing, 
and 
whether 
immediate 
effects 
maintained 
over time. 
insoles. TIs did not alter static 
postural control parameters 
when examined with eyes 
open.  Examination during 
eyes closed task 
demonstrated immediate 
reduction in COP path length. 
Findings maintained at 
termination of four-week 
intervention. 
not find how many 
dropped out. 
Kelleher et al., 
2010 
 
n=14 
patients with MS 
and 10 healthy 
controls 
To inspect 
effect on 
gait 
patterns in 
a group of 
patients 
with MS 
Experimental 
with control 
group  
 
No control 
healthy age 
matched /  
 
No blinding 
 
Trials with 
and without 
insoles were 
randomised. 
Fine leather 
insoles were cut, 
Grade P80 wet 
and dry 
sandpaper 
adhered to 
leather base, 
'considered 
sufficiently 
rough to provide 
sensory 
feedback but not 
so rough as to 
cause skin 
discomfort’.  
Participants tested 
with and without 
TIs. TIs only worn 
for testing, no 
actual 
intervention. Pts 
asked to walk 6m 
at a self-selected 
walking velocity. 
Data collected 
from first heel 
strike on force 
platform.  
Plantar sensation 
using SWMs. 
Kinematic and 
kinetic EMG data. 
Eight Vicon 612 
cameras and two 
Kistler force plates. 
Details given 
regarding 
methodology used. 
EMGs measured for 
tib ant, gastrocs and 
soleus 
Wilcoxon Signed Ranks test 
used. Significant reduction in 
sensation in MS group 
compared to control group 
(p<.05), especially at medial 
forefoot. Maximum dorsiflexion 
angle increased whilst wearing 
TIs (p<.05). Significant 
increase in knee extension at 
heel strike whilst wearing TIs. 
Max knee flexion also 
increased significantly. Whilst 
wearing TIs there was 
significant increase in 
accelerating (max AP) ground 
reaction force (GRF), getting 
closer to values recorded for 
controls.   
Slight ↑ in velocity + 
↑ braking and 
acceleration GRF's,  
Also ‘relationship 
between increases 
in gait velocity and 
max and min AP 
GRFs is a positive 
indication of 
benefits of using TIs 
to alter gait patterns 
in MS by enhancing 
afferent feedback 
from sole of foot'. 
Authors suggest 
that ‘by changing 
the texture in 
contact with the 
sole of the foot, it 
may be possible to 
alter gait patterns, 
thus supporting 
theories that 
sensory feedback 
from the plantar 
surface of the foot is 
important in 
determining 
movement 
strategies during 
human locomotion’. 
NB Gives details 
regarding SWMs 
used for 
measuring 
sensory threshold. 
Good description 
of methodology 
throughout. 
Immediate effects 
of TIs not 
measured, all 
participants 
walked approx 
15m whilst 
wearing TIs 
before data was 
collected.  
 
Some useful info 
in this study which 
I can use for my 
study.  
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Nurse et al., 
2005 
 
n=15 
healthy 
participants  
Determine 
effects of 
textured 
footwear 
on lower 
extremity 
muscle 
activity, 
limb 
kinematics 
and joint 
kinetics 
while 
walking 
Experimental 
design  
No blinding 
No 
randomisatio
n 
Two shoe insert 
conditions.  
Control insert 
made from 3mm 
thick EVA foam 
(shore C 60) 
Textured insert 
3 mm thick EVA 
foam insert cut 
from 
commercially 
available sandal; 
textured with 
semi-circular 
mounds with 
center distances 
of 8 mm.  
For testing only 
N/A 3-dimensional lower 
extremity 
kinematics and 
EMG 
Three spherical 
reflective markers 
attached to right 
limb segments of 
interest, rear-foot, 
shank, and thigh.  
Analysis of 
movement data 
using KinTrak 
software.  
Emg of soleus, 
medial 
gastrocnemius, 
tibialis anterior, 
vastus medialis, 
rectus femoris, and 
biceps femoris 
Wilcoxon Signed Ranks test 
used to analyse muscle data 
and paired t test to analyse 
kinematic and kinetic data. NB 
raw data not provided. 
Significant decrease in total 
tibialis anterior energy (13% 
less) for entire stance phase 
while wearing textured insert. 
Changing only 
texture of shoe 
insert resulted in 
significant changes 
in EMG activity of 
both ankle flexor 
and extensor 
muscles, ankle joint 
kinematics, and 
moments generated 
at knee joint. There 
is strong indication 
that changes in gait 
patterns were due 
to change in 
sensory feedback 
from plantar surface 
of the foot. This 
supports the theory 
that sensory 
feedback from 
cutaneous 
receptors in the 
plantar surface of 
the foot is important 
in determining 
movement 
strategies during 
human locomotion. 
No randomisation, 
no blinding but 
OMs used 
perhaps did not 
require blinding.  
Orth et al., 2013  To 
evaluate 
the efficacy 
of textured 
materials 
for 
enhancing 
perceptual 
motor 
functionalit
y 
Systematic 
review 
 N/A - Review  23 eligible - 21 published peer 
reviewed research articles and 
two published 
conference proceedings. Two 
distinct age 
groupings identified (young 
from 18 to 51.1 yrs 
and,elderly, from 64.7 [to 79.4 
yrs ) which could be further 
characterized by presence of 
ailment (with or without) 
Forest plot 
summarizing the of 
textures clearly 
suggests a trend 
toward improved 
perceptual-motor 
performance 
 
Methodological 
quality assessed 
independently 
' unequivocal’ 
support for 
utilising textured 
materials in 
young healthy 
populations for 
improving 
perceptual-motor 
performance. 
In elderly and 
ailing further 
research required  
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by lead author and 
research assistant 
using Cochrane 
risk-of–bias tool. 
 
Palluel et al., 
2008 
 
19 healthy 
elderly 
participants and 
19 healthy 
young adults. 
 
Explore 
contributio
n of plantar 
cutaneous 
inputs 
induced by 
spike 
support 
surface to 
control of 
stance 
Within 
subject 
experimental 
design  
 
No blinding 
 
No 
randomisatio
n 
Footwear 
consisted of 
Arena® 
NewMarco 
sandals Entire 
insole had 
spikes made 
with semi-rigid 
PVC (density: 4 
spikes/cm2 ; 
height of a 
spike: 5 mm; 
diameter: 3 mm) 
and uniformly 
distributed under 
feet except on 
medial arch 
where spikes 
were bigger 
(density: 2 
spikes/cm2 ; 
height: 1 cm; 
diameter: 5 mm) 
Both groups came 
for two sessions - 
one standing and 
one walking and 
were tested with 
and without spikes 
COP motion 
processed through 
mean COP location 
(in mm), surface 
area (in mm2), 
mean speed (in 
mm.s-1), root mean 
square (RMS in 
mm) and median 
frequency (Hz) on 
the AP and ML 
axes. 
In the elderly, post-hoc 
analysis showed improvement 
of postural control in both 
sessions. In standing session, 
there was decrease of COP 
surface area and AP RMS 
between t0’ and t5’ of spike 
condition (p =0.001, p=0.003, 
respectively) and between t5’ 
of both conditions (p =0.001, p 
= 0.004, respectively).  
Significant difference of mean 
speed in spike condition 
between t0’ and t5’ of 
condition (p =0.005), with 
lower values occurring at t5’ 
(10.6% of improvement in 
standing session and 3.9% in 
walking session 
Results provided 
evidence that 
wearing sandals 
with spike insoles 
can contribute, at 
least temporarily, to 
improvement of 
unperturbed stance 
in elderly with 
relatively intact 
plantar cutaneous 
sensation, and also 
in young adults. 
standing or walking 
for 5 min with these 
spike sandals led to 
a significant 
improvement of 
balance in both 
groups for AP and 
ML planes. In the 
elderly, effects were 
more pronounced in 
standing than in 
walking session 
Limitations 
acknowledged: 
Potential 
limitations of the 
experiment 
pertain to the 
subjects’ 
selection, the 
quantification of 
postural 
performances, 
and statistical 
analyses. 
 
Did not randomise 
order of testing so 
there could have 
been a learning 
effect  
Palluel et al., 
2009 
 
n=19 healthy 
elderly, n=17 
healthy young 
adults  
 
To explore 
lasting 
effects of 
tactile 
sensitivity 
enhancem
ent 
induced by 
spike 
insoles on 
control of 
Within 
subject 
experimental 
design  
 
No blinding 
 
No 
randomizatio
n  
Entire insole had 
spikes made 
with semi-rigid 
PVC (density: 4 
spikes/cm2 ; 
height of a 
spike: 5 mm; 
diameter: 3 mm) 
and uniformly 
distributed under 
feet except on 
medial arch 
Participant 
exposed to 
standing and to 
walking sessions, 
counterbalanced 
across 
participants. In 
both sessions, 
postural 
responses 
assessed during 
unperturbed 
COP of foot motion 
calculated through 
surface area (i.e., 
90% confidence 
ellipse area, in mm, 
mean speed 
(mm.s1 ), root mean 
square (RMS) on 
AP RMS and ML 
RMS axes (mm). 
Mean of three trials 
calculated at t1, t2, 
ANOVA with repeated 
measures. Adjustments of p 
values for the violation of the 
spherical assumption were 
made with a multivariate test 
(Hotelling-Lawley Trace). 
Three-way interaction of age x 
session x time was significant 
for CoP surface (p= .028) and 
the AP root mean square 
(RMS) (p < .001). In elderly 
subjects, post hoc analysis 
Results confirmed 
reorganization of 
hierarchy of sensory 
inputs and inability 
of elderly people to 
rapidly reconfigure 
postural set when 
sensory context is 
modified. 
Did not randomise 
order of testing so 
there could have 
been a learning 
effect. 
Even 5 mins 
wearing the spike 
insoles was 
uncomfortable. 
Placed control 
insoles on top of 
xl 
 
stance in 
elderly 
where spikes 
were bigger 
(density: 2 
spikes/cm2 ; 
height: 1 cm; 
diameter: 5 mm) 
stance (Equi, 
model PF01, Aix 
les Bains, France) 
force platform. 
Eyes closed 
t3, and t4 for 
standing and 
walking sessions, 
respectively. 
showed improvement of CoP 
surface and AP RMS after 
standing for 5 minutes (t2) with 
spike insoles, compared to t1 
(p < .001 and p = .048, 
respectively). When spike 
insoles were removed (t3), 
benefits were immediately lost 
for both variables (p < .001) 
with values returning to 
baseline. 
In walking session, decrease 
of CoP surface and AP RMS 
not significant between t1 and 
t2 (p = .26 and p > .99, 
respectively), but higher 
values observed immediately 
after removing insoles (t3; p 
<.001) and after rest of 5 
minutes (t4) for CoP surface, 
only (p < .001) 
Raw data not provided 
spike insoles for 
testing 
Preszner-
Domjan et al., 
2012 
 
n=50 healthy 
young adults  
Investigate 
effect of 
different 
types of 
mechanical 
stimulation 
of sole on 
standing 
postural 
stability in 
healthy, 
young 
adults 
Experimental 
study  
 
No blinding 
 
No 
randomisatio
n 
Thin elastic 
layer of 
rubber with 
spiked layer 
(density 5 
spikes/cm2, 
height of 
spikes 7 mm, 
diameter of 
spikes 2 mm), 
and it was 
placed onto the 
force plate 
Displacement of 
COG, subjects 
stood on stable 
platform 
Measurements 
performed in three 
sessions (3 9 10 
s) in open & 
closed eyes. Then 
supporting surface 
altered from the 
firm to foam with 
added spiked 
layer, first open 
eyes and then 
closed eyes. 
Spiked layer 
affected sole just 
during 
COP - sway paths, 
AP & ML 
Static balance 
parameters were 
measured before 
and after manual 
stimulation. The 
baseline 
measurement of the 
static postural 
stability without any 
stimulation served 
as a control 
condition. 
Participants were 
asked to stand up 
for 20 s after the 
stimulation, in this 
way the negative 
Wilcoxon Signed Ranks test 
used to compare tactile 
threshold medians of left and 
right feet with normal though 
threshold. Two-way ANOVA 
used to analyse sway data. 
Sway paths increased 
significantly in both directions 
and in both surface conditions 
when there was no visual 
input. Standing on foam 
surface significantly 
increased the sway path in 
both directions, in both eye 
conditions compared with 
standing on firm surface.  
A main effect of vision was 
observed in both directions 
‘Activation of plantar 
mechanoreceptors 
by 10-minute 
manual stimulation 
can partially 
compensate 
subjects for the 
absence of visual 
input and the lack of 
accurate pressure 
information’ 
To investigate the 
effect of different 
types of 
mechanical 
stimulation of the 
sole on standing 
postural stability in 
healthy, young 
adults 
Just for testing 
xli 
 
posturographic 
measure 
Baseline 
measurement of 
static postural 
stability 
without stimulation 
served as 
control.Manual 
technique -static 
and glide pressure 
focus on 
supporting 
surfaces of sole, 
especially 
heel and 
metatarsal heads. 
10 mins. 
Stimulation 
performed 
simultaneously 
both feet  
effect of sudden 
standing up was 
avoided. Manual 
stimulation was 
applied at least 30 
min after the 
stimulation of the 
spiked 
layer. 
(AP p<0.001; ML p<0.001) in 
the baseline measurement: the 
absence of visual input (EC) 
caused a significant increase 
in the sway path, however, 
these changes disappeared in 
the AP and ML directions after 
manual stimulation, and on the 
spiked layer in ML direction. 
Results showed a significant 
two–way interaction of 
vision x stimulation for the 
sway path in both AP 
(p<0.001) and ML (p<0.001) 
directions on firm surface. 
The main effect of manual 
stimulation was observed in 
both AP (p=0.001) and ML 
(p<0.001) directions when 
subjects stood on firm platform 
with closed eyes compared to 
baseline data, i.e., the sway 
paths decreased significantly. 
We noticed an additional 
main effect of stimulation, the 
spiked layer caused significant 
decreased sway path in both 
AP (p<0.001) and ML 
(p<0.001) directions in EC 
condition. In ML direction, this 
effect was more prominent, 
thus, subjects were fully 
compensated by the spiked 
layer for the missing visual 
information. 
No raw data presented. 
Qiu et al., 2012 
 
10 younger and 
7 older 
participants 
Study 
investigate
d the 
effects of 
textured 
Experimental 
study  
Order of 
insoles were 
randomised 
Both insole 
surfaces 
(International 
Children’s 
Orthotic 
Participants were 
tested under two 
vision conditions 
(eyes open, 
closed) on two 
Centre of pressure 
measurements 
included the range 
and standard 
deviation of AP and 
A mixed model ANOVA 
comparing young with old and 
also within participant factors 
(insole surface, vision and 
standing surface), Post hoc 
These findings 
suggest that 
textured insole 
surfaces can reduce 
postural sway in 
Anecdotally 
participants 
reported that the 
harder insoles 
were 
xlii 
 
were randomly 
selected from a 
database of 
healthy older 
adults.  
insole 
surfaces 
on postural 
sway in ten 
younger 
and seven 
older 
participant
s 
performing 
standing 
balance 
tests on a 
force plate 
under 
three 
insole 
surface 
conditions: 
(1) 
barefoot; 
(2) with 
hard; and 
(3), soft 
textured 
insole 
surfaces 
Laboratory, 
Australia) were 
1.5 mm thick 
and had 
granulations 
with a diameter 
of 5.0 mm and a 
height of 3.1 mm 
that were 
distributed 
evenly across 
the upper 
surface 
standing surfaces 
(firm, foam). Four 
30 s trials were 
collected for 
different 
combinations of 
insole surface, 
standing surface 
and vision.  
ML displacement, 
path length and the 
90% confidence 
elliptical area. 
comparisons with Fisher’s 
least significant difference test.  
Results revealed a significant 
Group*Surface* Insole 
interaction for five of the 
dependent variables (90% 
confidence elliptical area, path 
length, AP and ML sway and 
ML standard deviation) 
(p<.05). Compared to younger 
individuals, postural sway was 
greater in older people on both 
standing surfaces in the 
barefoot condition (p<.05). 
However, both textured insole 
surfaces reduced postural 
sway for the older group 
especially in the eyes closed 
condition on a foam surface 
(p<.05). 
Raw data not provided.  
older people, 
particularly during 
more challenging 
balance tasks 
uncomfortable 
over an extended 
period of time 
Qiu et al., 2013 
 
20 healthy older 
adults (controls) 
and 20 
participants with 
Parkinson’s 
Disease (PD) 
   Experimental 
study  
Order of 
testing was 
randomised 
No blinding 
Insoles 1.5mm 
thick with soft 
insole (270 
density Ethylene 
Vinyl Acetate 
(EVA). Textured 
surface - 
granulations 
measuring 
5.0mm in 
diameter and 
3.1mm in height 
distributed 
evenly across 
Participants 
performed 
standing tests, on 
two different 
surfaces (firm and 
foam), under three 
footwear 
conditions: 1) 
barefoot; 2) 
smooth insoles; 
and 3) TIs  
Standing balance 
was evaluated 
using a force plate 
yielding data on the 
range of anterior-
posterior and 
medial-lateral sway, 
as well as standard 
deviations for 
anterior-posterior 
and medial-lateral 
sway. 
A mixed model ANOVA with 
one between -participant and 3 
within-participant factors. 
Greatest benefits were 
observed in the PD group 
while wearing the TIs, and 
when standing on the foam 
surface with eyes closed. 
Relative to the barefoot and 
smooth insole conditions, the 
PD ppts demonstrated 
significantly reduced ML 
postural sway while wearing 
the TIs (Fisher’s least 
Demonstrated that 
TIs provide a 
passive intervention 
that is an 
inexpensive and 
accessible means 
to enhance the 
somatosensory 
input from the 
plantar surface of 
the feet, which may 
provide a low-cost 
means of improving 
postural stability in 
No blinding – 
potential for bias 
xliii 
 
upper surface, 
accentuated by 
two raised 
compliant ridges 
measuring 
3.1mm in height 
and 3.1mm in 
width located 
around lateral 
perimeter of 
insole and 
around heel 
Smooth insoles - 
same materials 
height and 
dimensions  
significant difference test: 
textured v barefoot: p =.040, 
textured vs smooth: p=.001)  
high falls-risk 
groups, such as 
people with PD 
Silva et al., 
2015 
 
n=12 with type II 
diabetes  
To 
evaluate 
the effects 
of 
somatosen
sory 
training on 
the mean 
amplitude 
of the 
COP in the 
upright 
position 
and the 
sustained 
benefits 
after 6-
months 
Experimental 
design  
No 
randomizatio
n 
No blinding 
13 stations with 
different 
textures.  
1st) 10 cm thick 
foam with high 
density; 
2nd) wooden 
box with beans; 
3rd) 2 cm thick 
mat, with a 
density lower 
than the station 
foam;  
4th) wooden box 
with cotton; 5th) 
2 cm thick mat; 
6th) 
balance board to 
train mid-lateral 
balance; 7th) 
participants 
sat down and 
grabbed a towel 
spread on the 
floor using their 
Somatosensory 
training for 45 
mins twice a week 
for 12 weeks.  
A circuit was 
composed of 13 
stations with 
different 
textures. The 
participant was 
instructed to 
remain for 
2 min at each 
station, following 
the rhythm of 
slow-paced 
and fast-paced 
songs. 
SWMs 
The balance 
evaluation was 
performed through 
COP 
analyses, which 
were obtained in 
bipodal position 
under 
two conditions: eyes 
open and eyes 
closed. No details 
are given regarding 
the equipment used 
to perform the 
assessment.  
Kolmogorov-Smirnov test used 
to determine the consistence 
of the stabilographic data, 
followed by the analysis of 
variance (ANOVA) and the 
Tukey- Kramer Multiple 
Comparisons Test  
Eyes open: The results 
showed a significant decrease 
(p < 0.001) in the AP 
oscillation of the COP 
comparing the initial (2.17– 
0.72 cm) and after 12 weeks 
(0.62–0.42 cm). 
Significant difference was 
found (p < 0.01) between the 
initial and after 6-month follow-
up (1.34–0.68 cm) 
Eyes closed: The results 
obtained with eyes closed 
showed significant 
differences (p < 0.001) in the 
anterior-posterior oscillation 
of the COP between the initial 
(2.47 _ 0.75 cm) and after 
The somatosensory 
training reduced the 
mean amplitude of 
the AP oscillation 
with sustained 
benefits after 6-
month follow up in 
elderly individuals 
with type II diabetes 
mellitus 
No randomisation, 
no blinding and 
insufficient 
reporting of 
methodology to 
allow the study to 
be reproduced. 
Potential for a 
high level of bias 
is noted 
xliv 
 
toes (foot 
strengthening 
exercise); 8th) 
10 cm thick 
foam; 9) 
proprioceptive 
balls with 8 cm 
diameter and 
external 
projections 
placed on the 
floor for 
somatosensory 
stimuli in 
different regions 
of the foot; 10th) 
wooden box 
with millet; 11th) 
2 cm thick mat; 
and 13th) 
sandpaper 
(abrasive 
mineral) to slide 
the feet for 
somatosensory 
12 weeks (0.84 _ 0.61 cm). 
The comparison between the 
initial and after 6-month 
follow-up (1.22 _ 0.79 cm) 
showed significant difference 
(p < 0.01). 
Raw data not provided. F-
statistics from ANOVA not 
provided. 
Wilson et al., 
2008 
 
Convenience 
sample of 40 
healthy female 
subjects (Age 
51.1 +/- 5.8 
years) 
To develop 
a standard-
ised 
methodolo
gy and 
evaluate 
the clinical 
effectivene
ss of four 
differently 
textured 
foot 
orthoses 
on static 
and 
dynamic 
Test-re-test 
Prospective 
pilot single-
blind 
randomised 
clinical trial  
Subjects wore 
shoes for 4 
weeks, minimum 
6 hrs per day 
Control group 
(n=10) fitted with 
shoes with a 
standard Hotter 
shoe insole 
(Shore value 
A20 – soft)  
n=10 - shoes 
fitted with a flat, 
plain, and 
smooth surface, 
made of 3mm 
Postural stability 
was assessed on 
a Kistler force 
platform (Model 
9286AA, Kistler, 
Alton, UK) by 
recording the 
differences 
between the 
maximum and 
minimum ranges 
of centre of 
pressure (COP) in 
the ML and AP 
directions. 
Subjects stood on 
Medial / Lateral and 
anterior -/posterior 
postural stability: No 
significant 
differences found 
between groups at 
either baseline or 
post intervention.  
Base of support: 
No significant 
differences seen 
either at baseline or 
post intervention 
2 x 4 repeated measures 
ANOVA to assess postural 
stability. Dynamic postural 
stability was measured using a 
repeated measures ANOVA. 
Data from 37 subjects were 
available for final analysis.  
Three subjects withdrew from 
the study during the 4- week 
period (one from the control 
group and two from the dimple 
FO group). Data from 37 
subjects were available for 
final analysis.  
No significant differences 
found between groups at 
‘Static balance and 
in our 30-m walk, 
there were no 
decrements or 
improvements in 
postural or walking 
stability over a 4-
week period of 
continuously 
wearing any of the 
shoes with any of 
the FO’ 
Limitations:‘Our 
findings may have 
limited application 
to an older, frailer 
female population, 
as we sampled a 
relatively healthy 
middle-aged 
female population 
recruited from the 
staff and student 
community. There 
is therefore the 
possibility of 
sample bias. Each 
of the FO groups 
xlv 
 
balance 
variables in 
an older 
female 
population 
thick EVA. 2nd 
intervention 
group n =10 – 
shoes- dimpled 
surface (1 mm 
raised circles, 
with a diameter 
of 3 mm spaced 
5 mm apart 
covering the 
entire surface 
n=10 - raised 
grid pattern 
fitted into their 
shoes (1 mm 
raised square 
pyramid shapes, 
side length two 
point 5 mm, 
peaks spaced 
2.5mm apart 
covering the 
entire surface  
the force platform 
wearing the shoes 
and FO. Base of 
support was 
evaluated during 
walking using the 
GAITRite system 
 
 
 
either baseline or post 
intervention. Medial / Lateral 
(F=0.273, p=0.605) and with 
foot orthosis (FO):(F=0.677, 
p=0.572) and no significant 
interaction of visual conditions 
and FO: (F=0.590, p=0.626) 
Anterior -/posterior postural 
stability: (F=3.029, p=0.091), 
FO conditions: (F=0.567, 
p=0.641) 
and no significant interaction 
of visual conditions and FO: 
(F=0.213, p=0.887) 
Base of support: 
No significant differences seen 
either at baseline or post 
intervention (F=0.019, 
p=0.892) or for FO conditions: 
(F=1.481, p=0.238)  and no 
significant interaction of visual 
conditions and FO: (F=0.265, 
p=0.850) 
contained only 10 
subjects. This 
raises the 
possibility of type 
II sampling errors, 
and erroneous 
acceptance of the 
null hypothesis 
Abbreviations: 5MWT 5 metre walk test; AFO Ankle foot orthosis; AP Anterior-posterior; CI Confidence Interval; COP Centre of pressure; EMG 
Electromyography; EVA Ethylene Vinyl Acetate; FO Foot orthosis; GRF Ground reaction force; LL Lower limb; ML Mediolateral; MS Multiple Sclerosis; OM 
Outcome measure; PD Parkinson’s Disease; PT Physical therapy; PVC Polyvinyl Chloride; SWMs Semmes Weinstein Monofilaments; RMS Root mean square; 
TI textured insole; TOI Tissue oxygenation index. 
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Appendix 15 Study details relating to TSGT including type of study, sample size and details of intervention 
Study type, author and 
sample size 
Details of intervention 
Blennerhassett and 
Dite (2004)  
Prospective randomized 
single-blind clinical trial 
(n=30) 
Participants randomized to either the upper limb or mobility training group. Additional task-related practice 
for 1 hour a day, five days per week for four weeks.  Each session consisted of a circuit of ten 5-minute work 
stations, with up to four subjects in each session.  All activities were customised and progressed to suit the 
individual subjects. Mobility group activities included warm up and endurance tasks using stationary bikes 
and treadmills, followed by functional tasks such sit to stands, step ups, obstacle course, walking, standing 
balance, stretching is required and strengthening using traditional gymnasium equipment.   
Cooke et al (2010) 
Phase 1 RCT (n=102) 
Intensity: Up to 1 hour per day, 4 days a week for 6 weeks (24 hours) 
The content of functional strength training focused on repetitive, progressive resistive exercise during goal-
directed functional activity.  The emphasis was on producing appropriate muscle force for the functional 
activity being practiced.  Treatment progressed systematically using repetition and increasing resistance by, 
for example, changing the limb’s relationship to gravity, increasing the range of movement or distance over 
which body weight was transported, and changing the weight of the external objects used to provide 
resistance.  Treatment activities progressed systematically from light to heavy loads and from few to many 
repetitions.  Participants performed the repetitive exercise of functional tasks such as sit to stand to sit, stair 
climbing /step ups, inside and outside walking, transfer training, bed mobility and treadmill training with and 
without the use of a body weight support system. 
Dean et al (2000) 
A randomized, 
controlled pilot trial 
(n=12) 
Intervention: exercise classes three times a week for four weeks (one-hour task-related training). The 
exercise class for the experimental group focused on strengthening the affected lower limb and practicing 
functional tasks involving the lower limbs, while the control group practice upper limb tasks. There were 10 
workstations incorporated into the circuit.  The work stations were designed to strengthen the muscles of the 
affected leg in a functional way and provide for practice of locomotor-related tasks: 
1. Sitting at a table and reaching in different directions for objects in the of the located beyond arm’s 
length to promote loading of the affected leg and activation of affected leg muscles 
2. Sit to stand from various chair heights to strengthen the affected leg extensor muscles and practice 
this task 
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3. Stepping forward, backward, and sideways onto blocks of various heights to strengthening affected 
leg muscles. 
4. Heel lifts in standing to strengthen the affected plantar flexor muscles 
5. Standing with the base of support constrained, with feet in parallel and tandem conditions reaching for 
objects, including down to the floor, to improve standing balance. 
6. Reciprocal leg flexion and extension using the Kinetron in standing to strengthen leg muscles. 
7. Standing up from a chair, walking and short distance, and returning to the chair to promote a smooth 
transition  
8. Walking on a treadmill 
9. Walking over various surfaces and obstacles 
10. Walking over slopes and stairs providing the opportunity for walking of practice under variant 
conditions 
Donaldson et al (2009)  
Randomized phase two 
study (n=30) 
Although lower limb is mentioned in the article the functional strength training was for the upper limb – not 
appropriate 
French et al (2007) 
Systematic review 
(Randomized/quasi-
randomized trials) 
Fourteen trials with 17 intervention-control pairs and 659 participants were included (adults, post-stroke). 
Interventions included an active motor sequence performed repetitively within a single training session, 
aimed towards a clear functional goal, and where the amount of practice could be quantified 
Jonsdottir et al (2010)  
RCT (n=20) 
20 sessions of 45 mins each. Electromyographic bio feedback applied in a task orientated approach based 
on principles of motor learning to increase peak ankle power of the affected leg and gait velocity in patients 
with chronic mild to moderate hemiparesis. In sufficient detail is given in relation to the intervention it would 
not be repeatable, and it is not helpful for the current study. 
McDonnell et al (2007) 
A pilot RCT (n=20) 
Nine sessions of task-specific physiotherapy training over three weeks.  To determine whether combining 
appropriate afferents stimulation with task-specific training resulted in greater improvements than training 
alone in patients with impaired upper limb function in the sub-acute phase following stroke. NB for upper limb 
– not appropriate 
Mead et al (2007) 
RCT (n=66) 
  
Each session lasted 1 hour 15 minutes (including ‘‘tea and chat’’ after the interventions). Interventions were 
held three times a week for 12 weeks randomized exploratory trial comparing exercise training (including 
progressive endurance and resistance training) with relaxation (attention control). Mode of exercise, initial 
exercise level, and rate of progression were based on the Falls and Exercise Management Study to reduce 
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falls in older frailer participants. The endurance component began in Week 1 as a circuit of cycle ergometry, 
raising and lowering a 1.4-kg, 55-cm exercise ball, shuttle walking, and standing chest press performed 
consecutively. Between each circuit station, patients walked or marched in place to ensure continuous 
movement. A stair climbing, and descending exercise was added in Week 4. The circuit duration increased 
from 9 minutes to 21 minutes by Week 12. Cycling intensity was increased weekly by small increments in 
pedalling resistance, cadence or both while maintaining perceived rate of exertion in the range of 13 to 16. 
The resistance training included upper back strengthening and triceps extension exercise, both performed 
seated using elastic resistance training bands and progressing from four repetitions using the lowest-
resistance band to 10 repetitions using the highest-resistance band by Week 12; a pole-lifting exercise 
performed standing, progressing from four repetitions with a 0.22-kg pole to 15 repetitions with a 3.6-kg pole 
by Week 12; and a sit-to-stand exercise, resisted by body mass, progressing from four to 10 repetitions by 
Week 12 and becoming more difficult by introducing pauses during lowering into the chair and then 
increasing the frequency and duration of the pauses and increasing the angle of the knee bend and the 
upper body levers (i.e., the arms). 
Monger et al (2002) 
A pre-test, post-test 
design 
Three-week home-based exercise programme. The task-specific training protocol was supervised by one of 
the investigators who visited the subjects in their homes three times weekly. Subjects were also asked to 
practise on their own each day for approximately 20 minutes. Each supervised exercise session was of 20 
minutes duration. The number of repetitions and intensity of each exercise was graded to subject’s level of 
ability and progressed as they improved. Subjects were encouraged to exercise as hard as possible and to 
perform their maximum number of repetitions without pause, repeating three times. Seat and step heights 
were set at a level to encourage force generation in the affected lower limb. Exercises were progressed in 
difficulty in several ways including decreasing the height of the seat, increasing the height of the step, 
increasing speed and increasing the number of repetitions. Verbal feedback, e.g. about weight distribution 
and speed, as well as encouragement were provided. Subjects were given a copy of the protocol, a diagram 
of the step-up exercises and a diary in which to record the number of repetitions done each day. 
The daily exercise protocol: 
Sit-stand–sit 10 times (or maximum number up to 10 that can be performed without a rest). Repeat 3 times 
(30 repetitions in total). Move feet backward, look straight ahead, swing trunk forward at the hips and stand 
up with weight evenly distributed through both feet. Do not use your arms. 
Step-ups Standing, affected foot on 8-cm block, step up and down with other leg (a) to shift body mass 
forward on to affected leg and (b) to shift body mass sideways on to affected leg. Exercise near furniture to 
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steady yourself if necessary. Do 3 sets of 10 repetitions (or maximum number up to 10 that you can perform 
without a rest). 
Calf stretch Standing with affected knee straight and extended arm/s resting on wall: keeping body straight, 
pivot the body forward at the ankles keeping heel on the floor until you feel the calf muscle is stretched. 
Pang et al (2005) 
A randomized, 
controlled trial (n=63) 
1-hour sessions, three sessions/week, for 19 weeks. The intervention group underwent a fitness and mobility 
exercise (FAME) program designed to improve cardiorespiratory fitness, mobility, leg muscle strength, 
balance, and hip bone mineral density. The control group underwent a seated upper extremity program.  
Peurala et al (2007) 
Randomized trial (n=22) 
Patients spent a daily maximum of 1hr therapy time to obtain 20 min of walking. Additional physiotherapy 
was also provided during the 3 wk therapy period. Patients spent a daily maximum of 1hr therapy time to 
obtain 20 min of walking. Additional physiotherapy was also provided during the 3 wk therapy period. Each 
patient also received other gait-oriented physiotherapy for 55 minutes each day, according to individually set 
goals. 
Pollock et al (2007) 
Systematic review 
(randomized/quasi-
RCTs) 
Twenty trials (1087 patients) were included in the review related to physiotherapy 
treatment approaches aimed at promoting postural control and lower limb function 
Pollock et al (2014) 
Cochrane review 
included randomized 
trials 
To review the evidence of the effectiveness of interventions aimed at improving sit to stand ability after 
stroke. 13 studies with 603 participants met the inclusion criteria for the review and data from 11 of these 
studies were included within the meta-analysis.   
Salbach et al (2004) 
RCT 
Subjects in both groups attended sessions three times a week for six weeks. 
The experimental intervention comprised of 10 functional tasks designed to strengthen the lower extremities 
and enhance walking balance, speed and distance.  The interventions: subjects in both groups participated 
in 18 sessions of task orientated training, given three times a week for six weeks in a rehabilitation or 
hospital setting.  The mobility intervention inspired by Dean et al. (2000) was a standardised programme 
supervised by a or physical or occupational therapist, of 10 walking related tasks designed to strengthen the 
lower extremities and enhance walking balance, speed and distance in a progressive manner. * For 
components of the intervention see table (Appendix4.7) 
Scianni et al (2010) 
Randomized trial – 
protocol only 
The experimental group would undertake task-specific walking training, plus targeted strength training three 
times per week over 10 weeks, while the control group will only undertake task-specific walking training. $ 
For details of proposed intervention see table (Appendix 4.8) 
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Straube et al (2014) 
Repeated measures 
(n=22) 
Practice of multiple stepping tasks was provided in variable environments or contexts at high aerobic 
intensities for >40 sessions over 10 weeks. 
Sullivan et al (2007) 
A phase II, single-
blinded, randomized 
clinical trial (n=80) 
Exercise sessions were four times a week for for 6 weeks (total of 24 sessions). The exercise interventions 
consisted of body-weight-supported treadmill training, limb-loaded resistive leg cycling (CYCLE), LE muscle-
specific progressive resistive exercise (LE-EX), and upper-extremity ergometry (UE-EX). Lower extremity 
exercise: Progressive-resistive exercise program for paretic hip flexors and extensors, knee flexors and 
extensors, and ankle dorsiflexors anti plantar flexors.  
Training Parameters Exercise selection and resistance: Participant attempts the baseline exercise for 
each muscle group. The baseline exercise position for each muscle group specifically targets the isolated 
muscles and requires the participant to move in an antigravity  range deviating from synergy. 
If the participant cannot perform the baseline exercise movement, deviating from synergy a decrease in 
progression is made incorporating movement patterns within synergy.  If the participant can complete the 
baseline exercise, the exercise is continued, or progressive resistive loading is initiated until the 10-
Repetition maximum (RM) load is 
determined. Repetitions: 10 Sets: 3 (for each muscle group). 
Exercise selection and resistance: Determined by the participant's success in completing 10-RM. If the 
participant is able to perform 10 repetitions with ease. then a progression is applied (increase exercise level 
or resistance). If the participant is able to complete only 8 repetitious in each set but can complete 10 
repetitions with ease when the load is decreased, then the current exercise level or resistance is maintained. 
If the participant is able to do less than 8 
repetitions in each set. then the exercise is decreased (either in exercise level or resistance).  
Repetitions: 10 Sets: 3 
Van der Port et al 
(2009) 
Multicentre single-
blinded randomized trial 
(n= 220) [Protocol only] 
Task-oriented circuit class training (CCT) two times a week for 12 weeks Primary aim of the FIT-Stroke trial 
is to evaluate the effects and cost-effectiveness of a structured, progressive task-oriented CCT programme, 
compared to usual physiotherapeutic care during outpatient rehabilitation in a rehabilitation centre. The task-
oriented CCT will be applied in groups of 4 to 6 patients. Patients assigned to the intervention group (two 
participants or more) will receive a 90-minute structured progressive task-oriented CCT programme twice a 
week over a twelve-week period (24 sessions). The programme includes 4 stages: (1) warming up (5 
minutes), (2) circuit class training (60 minutes), (3) evaluation and a short break (10 minutes) and (4) group 
game (15 minutes). 
li 
 
The training programme includes 8 different workstations, intended to improve meaningful tasks related to 
walking competency, such as balance control, stair walking, turning, transfers and speed walking. The eight 
workstations 
incorporated in the circuit are: (1) standing and reaching; (2) stair walking including transfer; (3) walking and 
picking up various objects from the ground; (4) kicking a ball; (5) stepping up and down; (6) walking course 
with obstacles; (7) transfers (lying to standing and sitting); and (8) speed walking. Graded progression will be 
achieved by (1) increasing the difficulty of the task; (2) adding weights; or (3) increasing the number of 
repetitions. No special (fitness) equipment is needed to perform the tasks. Each workstation will be done for 
3 minutes, followed by 3 minutes of rest and 1 minute to change to the next workstation. The participants will 
complete the exercises in pairs, where one does the exercise while the 'partner' has a rest period and helps 
the other by keeping track of the number of repetitions and stimulates him/her to perform at their best. Time 
will be kept by the supervisors. The precise composition of the treatment package for each patient, in terms 
of appropriate selection of type of workstation, number of repetitions and intensity, will be determined at 
baseline, based on patients' profiles in terms of muscle strength, physical fitness and mobility status. All 
patients will keep an activity log in which they record the number of repetitions at each workstation during the 
sessions, which they will then use as feedback in the next session. The one-hour session of 
workstation training will be followed by a 15-minute group game, in which the whole group performs a game 
to improve walking competency. Games will vary across the sessions. Options include a game in which 
walking tasks are combined with a cognitive task, or a game consisting of fast walking and changing 
directions. Ball games can, of course, be used as well, as long as they serve to train walking performance. 
Control group: Received regular care. 
Wevers et al 2009 
(Systematic review of 
RCTs) 
To systematically review randomized, controlled trials of task-oriented circuit class training on gait and gait-
related activities in patients with stroke. Six of the 445 studies screened, comprising 307 participants, were 
included. 
Yang et al (2006) 
Single-blind, RCT 
(n=48) 
Subjects in the control group did not receive any rehabilitation training. Subjects in the experimental group 
were put on a four-week task-oriented progressive resistance strength training. 
Abbreviations: CCT Circuit class training; Hr Hour; LE-EX Lower extremity exercise; UL-Ex Upper extremity exercise 
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Appendix 16  Details from Salbach et al (2004): Components of the mobility intervention 
Task Target Description and progression 
Warm up Range of 
movement and 
flexibility 
Marching on-the-spot, arm lifts, ankle circles, stretching of the trunk, thigh, and 
calf muscles.   
Step ups Balance 5 minutes of placing each foot alternately on a step, progressing to stepping 
onto a step (step ups), to a higher step, and to decreasing upper extremity 
support; time divided evenly between leading with right vs. left foot 
Balance beam Balance 5 minutes of walking forwards, sidewards, and backwards between two parallel 
lines, 20 cm apart, progressing to using one line, to using a balanced beam, 
and finally to the lateral stepping on the floor, feet crossing over in front or in 
back, and then alternating 
Kicking ball Balance 5 minutes of kicking a ball against a wall, progressing to decreasing upper 
extremity support, to increasing the distance from the wall, to kicking to a target, 
and to dribbling the ball around pylons; time divided evenly between kicking with 
right verses left foot 
Stand up and 
walk 
Balance lower 
extremity 
strength walking 
With four standard on chairs placed at four corners of a square, five minutes of 
repeatedly standing up and walking to the chair directly in front, sitting, then 
standing up and walking to the chair on the left, etc. progressing from using the 
arms to not using the arms, and to decreasing the seat height 
Obstacle course Walking balance 5 minutes of stepping over an obstacle, stepping onto, along, and down from an 
aerobics step, walking over a mat, or a ramp, and returning, progressing by 
increasing the heights and number of obstacles, and from completing the 
course walking forwards to walking backwards. 
Treadmill Walking 
endurance 
10 minutes of walking pattern comfortable pace, progressing from using arms to 
not using arms, by the increasing treadmill speed, and by adding an inclination 
Walk and carry Walking balance 5 minutes of continuous walking carrying a grocery bag, progressing to carrying 
a bag in each hand, to increasing the weight of the bag, to carrying a laundry 
basket, and to stopping on command. 
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Speed walk Walking 
endurance 
5 minutes of continuous walking at maximum speed, progressing to running 
Walk backwards Walking 5 minutes of continuously walking backwards, progressing from receiving 
physical assistance to receiving no assistance 
Stairs Lower extremity 
strength 
5 minutes of going up and down a flight of stairs, progressing from taking one 
step at a time to taking alternating steps, from using then not using the handrail, 
and to achieving a greater number of flights 
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Appendix 17  Details from Scianni et al (2010): Walking activity characteristics of the task-specific walking 
training 
Activity  
 
Type Practice Progression 
Step on block with the paretic limb Segmented Swing Diminishing hand support and increasing 
speed 
Step on block with nonparetic limb 
Step on block with nonparetic limb  Stance Diminishing hand support 
Stand on one leg (paretic leg)  Stance Diminishing hand support 
Squat on one leg  Stance Diminishing hand support and increasing 
speed 
Stand on paretic leg, then perform 
plantarflexion 
 Stance Diminishing hand support 
Step sideways   Lateral 
movement 
Diminishing hand support and increasing 
speed 
Step sideways on a block  Lateral 
movement 
Diminishing hand support 
Walk on footprints Complete Whole task Increasing stride length 
Walk between lines  Whole task Decreasing stride width 
Speed walk  Whole task Increasing speed 
 
Strength Training: 
 
Grade 1 
Focus on the mid-range of muscle length 
Decrease the effects of gravity 
Decrease friction 
Decrease the lever arm 
 
Grade 3 and 4   Resistance exercises using weight machines, free weights and body weight (initial load: 50% of 1 RM; then 80% of 1 RM) 
 
 
Grade 2 
Focus on range of motion 
Sustain contractions and increase speed 
Begin to add resistance at mid-range 
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TREATMENT SCHEDULE FOR MOBILIZATION AND TACTILE STIMULATION  
TO THE LOWER LIMB – ITERATION 2 
 
Date:                         Pt ID                       Position of patient:                    Length of session:                  Therapist: 
   
 
AIMS (Please tick) 
 
❑ Regain normal extensibility of skin, muscle, connective tissues, tendons and joints to enable foot to accept base of support 
❑ Reduce hypersensitivity or pain 
❑ Heighten awareness foot position and posture 
❑ Normalize tempero-spatial activation of muscle during functional activity (accuracy, quality of movement, normalise balance reactions) 
❑ Normalize afferent stimulation arising from functional activity 
❑ Normalize performance parameters (smoothness, accuracy, co-ordination, reciprocal activation, strength) for movement, balance and 
gait. 
JOINT MOBILZATIONS: 
      1a)   PASSIVE MOVEMENTS THROUGH ANATOMICAL RANGE (WITH HIP AND KNEE IN NEUTRAL ALIGNMENT, NB NOTE 
      ANY RESTRICTIONS) 
❑ Knee flexion / extension 
❑ Talo-crural (ankle) joint – dorsiflexion / plantarflexion 
❑ Talocalcaneal (subtalar) joint – Supination – adduction, inversion and plantar flexion of calcaneus  
❑                                                   Pronation – abduction, eversion and dorsiflexion 
❑ Metatarsopharangeal joints  - flexion / extension / abduction / adduction 
❑ Interphalangeal joints – flexion / extension 
❑ 1st ray (hallux)  – Flexion / extension 
       1b)   ACCESSORY MOVEMENTS: (TICK AND INDICATE TYPE e.g. GLIDE, DISTRACTION, AND DIRECTIONS e.g. AP, PA, etc.) 
❑ Talocrural (ankle)    
❑ Sub talar  
❑ Talonavicular  
❑ Calcaneal glide – inversion / eversion (medial /lateral) / A-P glide, distraction 
❑ Calcaneocuboid A/P 
❑ Naviculocuneiform 
❑ Cuboid – 4-5 metatarsal 
❑ Tarsometatarsal 
❑ Metatarsophalangeal Jts 1-5 A/P 
❑ Interphalangeal Jts 1-5 
SOFT TISSUE MOBILIZATIONS: 
2) MASSAGE AND SOFT TISSUE STRETCH (TICK AND NAME BODY PARTS MASSAGED / TISSUES STRETCHED) 
❑ Effleurage for oedema management 
❑ Gastrocnemius and soleus mobilization (kneading/ picking up) 
❑ Deep soft tissue massage to the tendo achillis 
❑ Stretch to gastrocnemius 
❑ Stretch to soleus 
❑ Stretch to tendo achillis 
❑ Anterior tibialis mobilization (kneading/ picking up) 
❑ Abductor Hallucis mobilization (stretch / kneading/picking up) 
❑ Abductor Digiti Minimi mobilization (stretch / kneading/picking up) 
❑ Deep soft tissue massage to the plantar fascia (sole of foot) 
❑ Sustained stretch – flexor digitorum 
❑ Sustained stretch – flexor hallucis 
❑ Other (state) 
PREPARATION FOR FUNCTION: 
3) CREATING AN ACTIVE FOOT IN PREPARATION FOR STANCE / BALANCE 
❑ Compression - MCP joints 
❑ Talocalcaneal compression  
❑ Compression through lateral border of little toe 
❑ Compression through shank of LL 
❑ Placing the foot orientation to the floor, sitting      perched standing       standing  
❑ Placing the foot on different surfaces 
❑ Heel contact with floor 
❑ Other (state) 
4) SPECIFIC SENSORY INPUT (TICK AND NAME OBJECTS OR BODY PARTS) 
❑ Visual 
❑ Tactile stimulation - use of different textures/surfaces, somatosensory input, varying speed and depth of contact, to stimulate and also 
desensitise 
❑ Hot/cold stimulation 
❑ Active touch (objects e.g. changing surfaces, uneven ground) 
❑ Passive touch (objects e.g. rolling foot over a ball) 
5) ISOLATED / SELECTIVE JOINT MOVEMENT (TICK AND STATE DIRECTION OF MOVEMENT) 
❑ Talocrural joint (Ankle) – dorsiflexion/ plantarflexion 
❑ Subtalar joint – inversion / eversion  
❑ Toe flexion / extension 
6) PATTERNS OF CO-ORDINATED MOVEMENT UNDERLYING FUNCTIONAL ACTIVITY 
❑ Activities in sitting e.g. rolling foot over ball, facilitated heel strike 
❑ Sitting to standing 
❑ Weight transference medial / lateral       Forwards / backwards  
❑ Stepping (including toe off and heel strike) – forwards       backwards 
❑ Stairs 
❑ Other (please state) 
TREATMENT SCHEDULE FOR MOBILIZATION AND TACTILE STIMULATION  
TO THE LOWER LIMB – ITERATION 2 
 
Date:                         Pt ID                       Position of patient:                    Length of session:                  Therapist: 
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Appendix 20 Plan for the mNGT session 
Nominal Group Technique session - Wednesday 30th September 2015 
Plan for the afternoon: 
 
1pm start please - do feel free to bring your lunch. Drinks and light refreshments 
will be provided. 
 
1pm: Welcome and introduction       
 AA 
 
1.15pm: Nominal Group Technique work related to the Mobilization  
and Tactile Stimulation (MTS) protocol.       
 ALL 
 
2pm: Discussion related to textured insoles     
 ALL 
 
2.30pm: Tea / coffee 
 
2.45pm: Group work to develop the Task-Specific Gait Training  
(TSGT) protocol         
 ALL 
 
3.30pm: Practical work related to the MTS protocol (please bring shorts!) 
 ALL            
4pm:  Summary          
 AA  
 
4.15pm: FINISH  
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Appendix 21 Comments from participants relating to the 1st iteration 
AIMS 
❑ 1. Regain normal extensibility of skin, muscle, connective tissues, tendons 
and joints to enable the foot to accept a base of support, ensuring optimum 
contact with the floor 
❑ Improve strength and activation of p/f and d/f 
❑ 2. Reduce hypersensitivity (wearing of socks and shoes, BOS) 
❑ 3. Reduce pain (importance for weight bearing), but removed by one person 
❑ 4. Heighten awareness of foot position and posture (improve stance leg, 
increase orientation, automatic gait, ankle strategy. Neutral foot posture 
important for balance and afferent stimulation (‘ready to go’) also 
proprioception  
❑ 5. Normalize temporo-spatial activation of muscle during functional activity 
(accuracy, quality of movement) Normalise balance/ righting reactions 
❑ 6. Normalize afferent stimulation arising from functional activity (Improve 
automatic balance and gait) 
❑ 7. Normalize performance parameters (smoothness, co-ordination, selective 
activation) of lower limb movement.  
 
Comments: 
Consider – in what position patient would be? Sitting, supine, Prone…. 
- The aims from the UL schedule would appear appropriate and could easily be 
transferred to the foot and ankle 
1-4 &6 – same aims for foot. 
- Not sure about: 
❑   Normalize temporo-spatial activation of muscle during functional activity 
 
- Foot position is required for foot contact and normal gait cycle 
- Increased hypersensitivity is bad to decrease foot contact and poor gait 
cycle, same for pain – leads to change in gait cycle 
- Pain inhibits weight-bearing and normal movement / gait cycle 
- Posture is essential to assist balance / gait speed 
- Normal feedback leads to more normal gait 
- Aims 1-6 will lead to the last aim (7) being achieved. Normalising 
performance parameters requires that most of the aims 1-6 are already in 
place and gait would be the end point.  
- All aims relate to falls risk, speed and distance, function and safety.  
- Patients do not normally complain of foot pain, whereas this is much more 
prevalent in UL 
- One therapist ticked all the aims for the UL but suggested they were 
linked to a specific goal - ? state that working towards standing / mobility 
 
? NEW SUB HEADING: JOINT MOBILISATIONS: 
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PASSIVE MOVEMENTS THROUGH ANATOMICAL RANGE (with knee and hip 
in neutral alignment): (NOTE ANY RESTRICTIONS) 
Knee flexion / extension 
Talo-crural (ankle) joint – dorsiflexion / plantarflexion 
Talocalcaneal (subtalar) joint – Supination – adduction, inversion and plantar 
flexion of calcaneus  
                                                  Pronation – abduction, eversion and dorsiflexion  
Metatarsopharangeal joints  - flexion / extension / abduction / adduction 
Interphalangeal joints – flexion / extension 
Hallux – Flexion / extension 
Comments  
– consider positive support reaction / flexor withdrawal 
- Change to reflect normal foot movements, which are required for stability 
- Movements may be more general i.e. plantar flexion, dorsiflexion, 
pronation / supination 
- Foot movements are less specific in function and passive movements 
would reflect this and would be done with an element of stretch if indicated 
by stiffness 
- One person suggested hip flexion / extension, ab/adduction, rotations and 
lumbar rotation 
-  - another suggested need to check knee and hip and neutral alignment 
-  
ACCESSORY MOVEMENTS: (TICK AND INDICATE TYPE e.g. GLIDE, 
DISTRACTION, AND DIRECTIONS e.g. AP, PA, etc.) 
- Distal fibula 
- Talocrural (ankle)    
- Sub talar  
- Talonavicular  
- Calcaneal glide – inv / eversion (med/lat) /AP glide, distraction 
- Calcaneocuboid AP 
- Naviculocuneiform 
- Cuboid – 4-5 metatarsal 
- Tarsometatarsal 
- Metatarsophalangeal Jts 1-5 AP 
- Interphalangeal Jts 1-5 
 
Comments: 
- Rotation – feel this is an important aspect of sensory stimulation! 
 
Plan for new sub heading: 
SOFT TISSUE MOBILISATION  
 
MASSAGE (tick and name body parts massaged) 
Comments: 
- Abductor halluces - picking up 
- Kneading - draw out lateral border / 'scoop out'  
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- Abductor digiti minimi, I feel working on this is very important, but links in 
with soft tissue stretch. Gaining length and rotating it out.  
- This section is very specific and often mobilisation is more overall with joint 
movement.  
- This would be used for oedema management to gain range 
- Muscles - effleurage - gastr/ tibial is muscles, peroneus brevis/ longus, 
circular  
- kneading - anterior tibialis, picking up – gastrocnemius 
- Effleurage - for fluid (all other sections crossed out)  
- Effleurage and picking up kept (other sections crossed out - massage to 
gastrocnemius and soleus 
- If it is just ankle and foot, then some of the massage techniques are 
irrelevant eg picking up 
- I also use heel deep pressure massage, deep foot sole massage with 
forefoot stretch (arch)' trigger points 
- Effleurage up low leg, only ok,If there is swelling.  
- Picking up to accentuate the arches of the foot 
- Other - deep soft tissue massage to plantar fascia and Achilles' tendon. 
Both often tight  
SOFT TISSUE STRETCH (tick and state which tissues) 
Comments: 
- Soleus stretch, gastro said stretch, abductor dig min 
- TA very important. Gaining length and rotating it out ( or was this comment 
relating to abductor digits minimi?) 
- TA stretch, gastroc length - longitudinal, end of range, transverse 
- Passive movements and soft tissstretches would often be combined to 
gain position and the specific soft tissue manipulation used to gain extra 
length. This would also extend up to the knee including gastrocnemius and 
soleus.  
- Longitudinal extensor - Hallucis longus, extensor digitorum 
- End of range - gastroc/ soleus 
- Sustained - flexor digiti 
- diagonal crossed out - plantar fascia, gastroc, soleus for two people 
- After a period of massage to decrease sensitivity I then work on this I find 
it very important          
- Massage - same as upper limb 
PLACING THE FOOT ON 
Comments: 
- Foot to floor contact 
- Edge/ corner crossed out and just flat surface left for four people 
- Would still place the foot on the floor or a mat to gain interaction 
- Placing barefoot on floor or carpet to increase sensory awareness  
- One person originally left this out stating they would work in a more 
dynamic position. Is placing the foot the same as stepping activities? 
lxii 
 
- Placing on a flat surface - plantar surface, edge / corner - proximal mets   
- Placing foot on an even rough surface, balancing board     
- One person added bed/floor stating it was important 
- This I do in bare feet on a mat, sitting if possible patient perched to 
progress 
- Place foot  on flat surface or spiky ball 
- Floor contact, toe contact, toe activity, orientation to surface/ floor, 
talocrural, calcaneal 
 
ISOLATED /SELECTIVE JOINT MOVEMENT (tick and state direction of 
movement) 
Comments: 
- Ankle, metatarsopharangeal, interphalangeal 
- Ankle, MCP Jt 1, MCP Jt 2-5, IP Jt -5 
- Ankle, metatarsals, phalanges 
- Change to reflect the foot- toe flexion/ extn, pronation, supination, 
dorsiflexion, plantarflexion, tends to be done more as a group to reflect 
loss of selective nature of foot and function 
- Dorsiflexion, plantar flexion, prox met ext., prox met flex, eversion 
- Ankle selective d/f and p/f, selective toe flex and ext , MTP 
- Ankle d/f and p/f, toe MTP flex/ ext 
- True ankle joint, subtalar, interphalangeal and metatarsopharangeal  
- Adapt to foot/lower limb 
COMPRESSION  
Comments:  
- Compression into metatarsal joints ('shorten' feet) 
- MTPs IP jts 
- plantar aspect of foot 
- Number two as I would put it with number one. Would this be just put in 
with accessory movements for the foot? 
- Ankle d/f/ plantar flexion, metatarsals, phalanges 
- Crossed out and not initially numbered by one therapist 
- calcaneus, MTP 
- palm and wrist crossed out, MCP jts ticked, lateral border of foot/little toe, 
calcaneum   
- MTP, calcaneum 
- compression is good together with distraction (traction) in all foot joints 
- adapt to foot /lower limb   
- I do compression at MTPs if tone in the foot is low 
I would do this through stretching or accessory movement, or it would be around 
weight-bearing/gait, not specific compression            
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SPECIFIC SENSORY INPUT (TICK AND NAME OBJECTS OR BODY PARTS)  
Comments: 
- tactile stimuli - use of different textures/surfaces somatosensory input vary 
speed, 
depth of contact etc.       
- same as for upper limb 
- Active touch object/body parts crossed out - I don't think I'd use active 
touch for the foot 
- Visual, active touch, passive touch 
- Floor surfaces for desensitisation and foot mobility 
- Hot /cold bathing, proprioception/texture work 
- Visual ticked auditory crossed out  
- Visual, different surfaces, hot /cold, socks shoes on/off 
-  I think this is very important re somatosensory input. Could a picture of 
the foot/lower limb with areas shaded, to illustrate specific areas to be 
managed be used? 
- stepping, standing, gait, swing phase, stance phase, steady stance, 
adaptation to changing surfaces, stairs, uneven surfaces 
 
PATTERNS OF CO-ORDINATED MOVEMENT UNDERLYING FUNCTIONAL 
ACTIVITY 
COMMENTS: 
- stepping, standing, gait, swing phase, stance phase, steady stance, 
adaptation to changing surfaces, stairs, uneven surfaces 
- coordination of movement, e.g. Ball under foot, break down gait cycle, 
facilitate patterns of weight transfer, varying the degree of weight bearing? 
%, uneven surface/balance ball, increase proprioceptive stimuli  
- ? Use FES as an adjunct I.e. Prepare foot/ ankle prior to standing/ gait, 
sensory feedback, soft tissue stretch 
- weight bearing/ weight transfer, squat/ sit to stand, facilitated step, prone 
standing, step up 
- sit to stand, forward step, backward step 
- facilitated heel strike in perch sitting, banging heel on floor 
- weight bearing through limb, PNF patterns- distal activation to initiate 
proximal control/ activity 
- weight transference, lateral (weight bearing), weight transference AP 
(weight bearing), heel raise, toe off, heel strike, step forward and back 
practice 
- weight bearing through limb ticked by 6 people 
- heel raises, gastroc propulsion, stepping in sitting or standing, forwards, 
backwards, sideways 
- seated or standing, foot placement multidirectional, heel raises 
- dorsiflexion, inversion, eversion, rolling ball forward and back (foot on top 
of ball), swiping tissue from one side to another with foot (hip and knee in 
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neutral position), grasp and release tissue with toes, can use static pedals, 
wobble board, trampoline, steps, ball, TES 
- after a period of weight bearing I sit the patient down and spend some time 
on active movements at ankle and foot- d/f and p/f, then stand again and 
work on stepping or stance phase. 
-  p/f, d/f, toe wiggling, heel to toe tip toes 
 
 
 
ADDITIONAL GENERAL COMMENTS: 
- I feel the protocol should start with somatosensory input (of which I would 
put the first 3 (Sensory input, Massage, Compression within this scope) 
then I would move onto different types of movement (the next 4  -Soft 
tissue stretch, Passive movements, Accessory movements ,Isolated 
selective joint movement would fit within this scope). 
- I’m a little lost where to put placing the foot (I’ve put it at no.8)– it seems 
reasonable to put it after passive / active movements before moving onto 
function but am not quite sure as my second thought would be to put it 
before movement as in testing acceptance of different types of surfaces 
before moving onto movement patterns. 
- I would recommend categories for: 
Position:   Details regarding position of patient – are they sitting / lying / 
standing? If working within on all three or just one / two this could be added as 
separates categories 
Previous restriction / injuries / pain –   This would greatly impact on aims 
 Aims -    Could these be linked with goal?  Do we need to state here that aim 
would be to work towards standing / mobility if appropriate as our patients can 
vary greatly within these areas 
I would have separate categories for: (listed below in order that I would assess in) 
however I may not act in this order when I am treating if that makes sense). See 
sheet attached for comments 
ASSESSMENT: 
1.Patient awareness: 
-              how aware is the patient of their lower limb / foot? 
2. Observation: 
-              How does lower limb and foot present to observation, what does it look 
like, i.e. colour / oedema / flaccid / high tone?How does it react to the floor / bed 
as in accepting surfaces? What position is it in? What position / placement do you 
want it in? 
3. Range of movement available: 
- range of active movement initiated by patient 
- passive and active movements (could include accessory movement and 
isolated movements) within these sections and could be broken down as on your 
form 
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4.Somatosensory input: 
-  level of sensation? 
- Within that you could then list the areas of sensory input and how 
needed: 
                Massage / stretching / compression etc. 
5. Patterns of movement (including functional activity) wanted: 
- heel to toe / tip toes etc. 
 If treating I would probably list it in order of: 1 / 2 / 4 / 2 & 4 again then 3 & 5 
If this were a protocol would it be helpful and sure this is what you are doing to 
have a guide as to completion and to the categories listed. 
On a personal note as an OT, I am fully aware that our anatomical knowledge is 
not as technical as physio’s in relation to lower limb / foot and that reliance on 
technical terms may be off putting to OT’s or they may lack a level of 
understanding / knowledge of the terms.  I think this may have some relevance 
for use of the protocol if wanting it to be a multi-disciplinary tool between OT/PT. 
Ideally I would like to think of this as being a tool that could be used together or 
by either profession. 
 
Conventional therapy to prepare foot and ankle for standing. 
1) B.O.S.: Alignment and acceptance of B.O.S. is required for lower limb to 
act effectively as a support in order to allow standing /transferring/gait. We 
need mobility in the foot as well as stability. Ensure that foot is accepting 
the B.O.S. 
2) (+) Reaction in the foot/Flexor withdrawal. 
3) Handling /desensitisation of foot. 
4) Stretching/Mobilisation of foot. 
5) Length of soft tissue gastroc . 
6) Oedema. 
7) Pain/in growing toe nails. 
8) Muscle Power. 
9) Tone. 
10) Perception/cognition/proprioception 
11) ROM. 
Principles of Treatment 
 
Low Tone: Brisk movement, small ROM, loud voice, Small BOS, higher 
COG.  
High Tone: Slower Movements, Supportive inhibitory Handling, Larger 
BOS, lower COG, Calm voice, quieter, slower and encouraging. 
I think I left them out (placing the foot and compression) because I would do the 
work in a more dynamic position on that basis placing the foot would be 8 
although I would do more placing foot but in context of stepping. I wasn't sure if 
placing in stepping activities was the same as placing the foot or whether it came 
under gait; then I would put compression as 9 but having thought about it this 
would come in on mobilisation dorsiflexion/stretching but not distinct on its own  
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Appendix 22 Comments from participants relating to the 2nd iteration 
NGT work: details of comments made relating to 2nd Iteration: 
Daisy - 'the treatment schedule is great, very thorough' Only thing Daisy could 
think of extra was working on the 'lumbricals' of the foot (using your toes to 
scrunch up a towel which has been placed under the foot). Daisy thinks this could 
come under section 3 or 6. Other than that Daisy felt it is 'very detailed but easy 
to read and follow’.  
Debra -  Comment on: 
Section 2 - May also stretch extensor hallucis, although if consistent issues 
botulinum toxin would be used, especially if interfering with therapy / progress.  
Section 3 - CORRECTION MTP NOT MCP joints! 
Section 6 -  Add in sideways on stepping section.? also add in walking obstacle 
course / manoeuvring, transfers / functional mobility.  
Further comment: One of the things which is not mentioned is stabilisation 
splinting and use of electrical stimulation, as both stimulation and muscle 
activation technique. Patients have exercise stimulators which they use to gain 
muscle activation. 
 
Grace - Section 3: Specify which for continuity (in relation to placing foot on 
different surfaces) 
Section 6: Is the weight transference medial / lateral / fwds bkwds in standing or 
seated? 
 
Isabelle - Section 2: In point 2 - ? add dissociation of gastrocs and soleus 
Section 3: In relation to point 3 (compression through lateral border of little toe) 
add lateral border of the foot. 
 
Lydia - 'Overall in terms of the actual treatment carried out, I think it is pretty 
comprehensive and accurately reflects practice. I guess the only thing I was 
thinking was is further detail required to quantify the amount of input given i.e. 
number of repetitions, duration of stretch, range achieved. Maybe this is 
something which needs further discussion. I guess it depends how the protocol is 
used. Particularly in a clinical setting if a patient was having treatment from 
different staff of different grades, greater documentation of dosage would be 
helpful, as well as clearly highlighting markers to monitor progress. ' 
 
Rachel -  'The treatment protocol is very comprehensive and good that it is 
on one page. The aims of treatment section would cover my aims of 
treatment fully. The specific treatment sections also reflects my current practice’. 
  
I was just wondering if there is a reason the passive movements have to be done 
with the hip and knee in neutral alignment? I am assuming this means in 
anatomical position so patient would need to be lying down. I would sometimes 
do this with the patient supine but more generally I would do it with the patient in 
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sitting on the side of the plinth and I raise the plinth up so their head is 
approximately where it is when they are standing.  
  
I also wondered where massage in between the toes and down the length of the 
toes would fit in? Does it need its own bit in the massage section rather than just 
going under the other box? Or would it go in section 4 under the tactile 
stimulation box? I think it is quite an important part of stimulating the foot and 
perhaps needs its own heading in the massage section.  
 
Hazel - Section 2: other (state) - illiotibial band, gluteal, piriformis stretches 
Section 6: Other (please state) - weight bearing/pressures applied to the foot in 
supine towards the head.  
 
Olivia - 'All looks good just little comment to add. In sections 3,5 and 6 we need 
to specify how much assistance was given or if the patients performed all 
movements independently. Hope in September we can go through the treatment 
protocol practically to see how straightforward it is and if we all assess the same’.  
 
Nicola - 'Looks very good, must say pretty technical for me and would need 
some training but covers everything that you'd need I think' 
 
Kelly - 'The new schedule is very comprehensive and there doesn’t seem to be 
anything missing’.  
The practicality of all of these things being done in one treatments session is 
probably not what happens in reality however it would be the ideal!  
The only difference to the schedule in our practice is that we do use electrical 
stimulation and also taping (Kinesio) as preparation to aid sensory 
stimulation/feedback and muscle length/facilitation. I don’t know whether this is 
appropriate to add but thought it was worth a mention.  
I would say that on observation of practice over the years there is much more 
effort made on preparing the hand before tasks/activities than the foot, however 
as more people go on courses etc. there is a definite change in practice towards 
preparing the foot more.' 
Tracy - 'I am not sure whether we have to comment on sub part of each section 
or collectively just comment? 
Looking at the treatment schedule there are quite few things that I don’t do as I 
don't know. Hopefully after my Bobath course I will be able to do all these 
techniques.  
Like accessory movements – I don’t do all of them, not in that detail i.e. 
Calaneocuboid AP,Talonavicular.  
Joint mobilisation: all except? 1st ray (hallux) flex/ext. Do the flex/ext of the big 
toe if that's the same thing? 
  
Soft Tissue mobilisation: Again not on that much detail specially Abdutor hallucis 
mobilisation, abductor digiti minimi,or the sustained stretch.  
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Prepration for the function: do practise all of them.  
Sensory input: all of them.  
Isolated joint movement: all of them.  
Patterns of coordinated movement: all of them.  
I hope I am on the right track if not please let me know.' 
  
Terry - Section 3: 'Does this include less affected side’ e.g. working on 
overactivity? Add prone stand  
Section 6: 1st point add 'heel raise'  
2nd point add 'stand to sit  
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Appendix 23 Critique of the mNGT session 
 
Observation of Alison Aries facilitating group discussion (n=8 experienced clinicians) as part of 
NGT 
Alison was very well prepared for the session - she had sent out clear information to all 
participants in advance, detailing the timed plan for the afternoon, car parking and directions 
etc. She had also arranged for refreshments to be available and had booked appropriate rooms 
for the tasks. She had also brought two audio-taping devices, with one as a back-up. 
Alison had prepared some overhead slides to summarise some of the background, and to 
highlight important points. On some of the slides, the text was rather small and there was a lot 
of information; but on others this was not the case. All slides were clear and easy to read - Alison 
had chosen a blue background with yellow text which made the text stand out clearly. 
At the start, Alison revisited issues around consent, timings, audiotaping, confidentiality, and 
explanation of what to expect of the afternoon.  She went on to set the context for the meeting, 
with a review of what had been done so far (participants had previously been invited to 
comment on drafts of the MTS schedule and feed back their comments to Alison individually). 
This provided a clear update and context for the afternoon session. 
During the discussion, Alison was inclusive and encouraged all participants to contribute and to 
voice their individual opinions. She addressed each participant around the table to ask for their 
view. She provided reassurance about the project where this was needed (e.g. that the 
therapists involved in delivering the intervention would be given training), and she gave clear 
explanations for why some ideas of interventions that had been fed back to her from the drafts 
(e.g. FES, splinting) had been subsequently removed or omitted from the draft schedule. 
Consensus was actively sought with regards to any further inclusions/omissions/change to 
wording (eg. “in neutral alignment”) and sought agreement from the group. 
The literature around TIs and TSGT was summarised for the group with a clear explanation about 
which literature had been reviewed (search terms stated clearly etc). Voting was used to 
determined the level of agreement in response to the question about whether Tis should be 
provided for both feet, or just one foot (affected foot), or whether textured and non-textured 
should be used for affected and non-affected respectively; 100% agreement was attained with 
clear rationale for why this decision was made.  
Finally, the group was split into two smaller groups of 4 and asked to discuss and rank the TSGT 
activities. Small groups specifically included therapists from different work bases / Trusts. On 
completion of the small group discussion, there was a whole group plenary with in-depth 
discussion about how the study will sit alongside conventional therapy services. Alison had some 
specific questions for the group and pursued agreement on the appropriate answer. 
Alison ended the discussion group with an expression of her gratitude for the participants’ input 
to the whole NGT process, and the offer of practice of some of the techniques. She answered 
final questions competently and clearly.  
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1 Administrative information 
This document was constructed using the Norwich Clinical Trials Unit (NCTU) Protocol 
template Version 2.0. It describes the Sensory Stimulation of the Foot and Ankle Post-
stroke Trial (MoTaStim-Foot), sponsored by Keele University and co-ordinated by 
NCTU.  
It provides information about procedures for entering participants into the trial, and 
provides sufficient detail to enable: an understanding of the background, rationale, 
objectives, trial population, intervention, methods, statistical analyses, ethical 
considerations, dissemination plans and administration of the trial; replication of key 
aspects of trial methods and conduct; and appraisal of the trial’s scientific and ethical 
rigour from the time of ethics approval through to dissemination of the results. The 
protocol should not be used as an aide-mémoire or guide for the treatment of other 
patients. Every care has been taken in drafting this protocol, but corrections or 
amendments may be necessary. These will be circulated to registered investigators in 
the trial. Sites entering participants for the first time should confirm they have the 
correct version through a member of the trial team at NCTU. 
NCTU supports the commitment that its trials adhere to the SPIRIT guidelines. As 
such, the protocol template is based on an adaptation of the University College London 
CTU protocol template (2012) and the Standard Protocol Items: Recommendations 
for Interventional Trials (SPIRIT) 2013 Statement for protocols of clinical trials (Chan 
et al 2013). The SPIRIT Statement Explanation and Elaboration document (Chan et al 
2013) can be referred to, or a member of NCTU Protocol Review Committee can be 
contacted for further detail about specific items.  
1.1 Compliance 
The trial will be conducted in compliance with the approved protocol, the Declaration 
of Helsinki (2008), the principles of Good Clinical Practice (GCP) as laid down by the 
Commission Directive 2005/28/EC with implementation in national legislation in the 
UK by Statutory Instrument 2004/1031 and subsequent amendments, the Human 
Tissue (Quality and Safety for Human Application) Regulations 2007, the UK Data 
Protection Act, and the National Health Service (NHS) Research Governance 
Framework for Health and Social Care (RGF). Agreements that include detailed roles 
and responsibilities will be in place between participating sites and NCTU. 
Participating sites will inform NCTU as soon as they are aware of a possible serious 
breach of compliance, so that NCTU can fulfil its requirement to report the breach if 
necessary within the timelines specified in the UK Clinical Trials Regulations (currently 
7 days). For the purposes of this regulation a ‘serious breach’ is one that is likely to 
affect to a significant degree: 
• The safety or physical or mental integrity of the subjects in the trial, or 
• The scientific value of the trial. 
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1.2 Sponsor 
Keele University is the trial sponsor and has delegated responsibility for the overall  
management of the Sensory Stimulation of the Foot and Ankle Post-stroke trial (MoTaStim- 
Foot) to the Chief Investigator and NCTU.  Queries relating to sponsorship of this trial should 
be addressed to the Director, NCTU, or via the trial team.  
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1.3 Structured trial summary 
Primary Registry and Trial 
Identifying Number 
Name of primary registry, and the unique ID number 
assigned by the primary registry to this trial. 
Date of Registration in 
Primary Registry 
Date when trial was officially registered in the primary 
registry. 
Secondary Identifying 
Numbers 
Other identifiers besides the trial identifying number 
allocated by the primary registry, if any. These include:  
• The Universal Trial Number (UTN) 
• Identifiers assigned by the sponsor  
• Other trial registration numbers issued by other 
registries (both primary and partner registries in 
the WHO Registry Network, and other 
registries) 
• Identifiers issues by funding bodies, 
collaborative research groups, regulatory 
authorities, ethics committees, institutional 
review boards etc. 
Source of Monetary or 
Material Support 
National Institute for Health Research (NIHR) as part 
of a Clinical Academic Doctoral Fellowship - CDRF-
2014-05-065 
Sponsor Keele University  
Contact for Public Queries ctu.enquiries@uea.ac.uk 
Contacts for Scientific Queries 
 
 
 
 
 
 
 
 
 
 
 
 
Key Trial Contacts: 
Mrs Alison Aries MSc MCSP (Chief Investigator / NIHR 
Doctoral Fellow/PhD student) 
School of Health and Rehabilitation,  
Mackay Building,  
Keele University,  
Keele,  
Staffordshire,  
ST5 5BG. 
Email: a.m.aries@keele.ac.uk 
Tel: 01782 734418 
 
Dr Sue Hunter PhD BA(OU) GradDipPhys MCSP 
FHEA (Primary supervisor),  
Senior Lecturer,  
School of Health and Rehabilitation, 
Keele University 
Keele,  
Staffordshire,  
ST5 5BG. 
Email:s.m.hunter@keele.ac.uk 
Tel: 01782 733809 
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Scientific Title Sensory stimulation of the foot and ankle early post-
stroke: A feasibility study (MoTaStim-Foot) 
Countries of Recruitment England 
Health Condition(s) or 
Problem(s) Studied 
Stroke 
Intervention(s) Mobilization and Tactile Stimulation (MTS) Group: 
Up to 60 minutes of MTS treatment to the lower limb 
plus standardized TSGT (30 minutes). 20 treatment 
sessions of MTS and TSGT will be given.  
Textured Insole (TI) Group: 
This group of participants will be encouraged to wear 
the TIs as much as possible, during their normal every 
day activities, and in addition they will be worn during 
20 sessions of TSGT (30 minutes for each session). A 
daily diary will be kept to monitor duration of use. 
Key Inclusion and Exclusion 
Criteria 
Inclusion criteria: 
• Adult stroke survivors (aged 18 years or older), with 
anterior or posterior circulation stroke occurring 6-
16 weeks earlier. 
• Ability to walk independently prior to stroke 
• Participants must also be able to follow simple 
commands using the non-paretic upper limb  
• Participants must be unable to step on and off a 7·5 
cm high block more than 12 times in 15 seconds 
with either their paretic (affected) or non-paretic leg 
(Step test). 
 
Exclusion criteria: 
• Pre-existing conditions affecting sensation (feeling) 
of the foot and lower limb e.g. diabetic neuropathy, 
polyneuropathy, peripheral nerve lesion, previous 
stroke affecting sensation of the lower limb 
• Fixed contracture of the tendoAchillis 
• Pressure sores or ulcers on the foot or ankle 
(hemiparetic limb) 
• Deep vein thrombosis 
• Other conditions that affect the blood supply 
to/from the foot e.g. heart failure with peripheral 
oedema 
• Botulinum toxin injections to the lower limb in the 
previous six months 
• Pain sufficient to prevent delivery of treatments or 
outcomes. 
• Known HIV, Hepatitis non-A or related condition 
Study Type A randomized, single blinded feasibility trial is being 
undertaken as part of a PhD fellowship (overview of 
trial available in figure 1). A mixed-methods design will 
be undertaken, which will involve both quantitative 
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(experimental) and qualitative (diaries and focus 
groups) methods. 
Randomisation 
Participants will be randomised to the interventions using 
1:1 randomisation with stratification by left or right stroke. 
An independent web-based or telephone interactive voice 
response system randomisation service and electronic 
case record form will maintain concealment of the treatment 
allocation from investigators, research therapists and 
blinded assessors prior to randomisation of a participant 
(i.e. each participant allocation cannot be predicted from the 
allocation of the previous participant). Baseline data will be 
entered into the randomisation system and the system will 
randomize, sending an email confirmation of the allocation 
group for the participant. 
Blinding 
Outcome measurements that are subject to observer bias 
will be undertaken by assessors who are blinded to 
treatment group allocation.  Participants will be asked not 
to inform assessors as to what treatment they are 
randomised to receive.  
Purpose 
To establish the feasibility of conducting a randomised 
trial comparing delivery of MTS plus TSGT, or wearing 
TIs plus TSGT. The results of this feasibility trial will be 
used to inform the design and delivery of a definitive 
trial.  
It is not the purpose of the feasibility study to 
demonstrate if the treatments are effective. The 
purpose is to provide data informing the main trial. For 
example, it will be possible to see if the way 
participants are recruited is effective, assess the 
willingness of participants to be randomized, assess 
how acceptable the treatments are, calculate how 
many participants drop out, and work out how many 
people would need to be recruited in a future larger 
trial.  
 
Primary Research Aim: 
1. To explore the feasibility of delivering treatment 
designed to increase the feeling within the foot after 
stroke in a randomized trial. The treatments being 
evaluated are Mobilization and Tactile Stimulation 
(MTS) with TSGT versus wearing of TIs plus 
TSGT.  
 
 
 
Research Objectives: 
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1. To find out if the treatments (MTS plus TSGT, and 
the wearing of TIs plus TSGT) are acceptable 
treatments for stroke survivors. 
2. To find out the response to treatment (if any), in 
relation to the number of treatment sessions delivered. 
3. To find out which measures will be most appropriate 
to measure outcomes of: sensorimotor impairment 
(feeling / sensation and movement), blood flow and 
lower limb function and balance. 
4. To find out if daily diaries and focus groups are 
suitable ways to explore stroke survivors’ experiences 
of receiving the treatments. 
5. To find out if recruitment methods are effective, 
noting the number of people invited to participate, 
agreeing to consent and eligible to participate, as well 
as the number of people who drop out of the trial. The 
information will be used to inform a power calculation 
for a future study.  
6. To generate information regarding the participants 
recruited i.e. population participant demographics, 
clinical characteristics, including time since stroke, 
type of stroke and previous impairment affecting the 
ability to walk.  
Date of First Enrolment It is anticipated that identification of participants will 
commence in March 2016 and the first participant will 
be recruited in April 2016.  
Target Sample Size 34 
Outcomes 
 
As this is a feasibility trial one of the objectives is to 
identify which measure should be the primary outcome 
measure for future trials.  
The following clinical outcomes will therefore be 
evaluated as detailed below: 
Outcome: 
1. Characterization of clinical presentation of 
participants (to give an overview of the participants to 
assist with evaluation of the interventions) using the 
following tools: 
(i) National Institutes of Health Stroke Scale 
(NIHSS) - This includes assessment of the level of 
consciousness, vision, motor activity (face, arm and 
leg), coordination, sensation and speech. It is 
anticipated this will take a maximum of 15 minutes to 
complete. Timepoint: Baseline 
(ii) Functional Ambulation category, which 
assesses walking ability and categorizes according to 
basic motor skills necessary for functional walking. It is 
anticipated this will take a maximum of 2 minutes for 
the researcher to complete. It will not require additional 
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time of the participant because the assessment can be 
made following the 5 metre walk test. 
Timepoints: Baseline, on completion of the twenty 
treatments and at one-month follow up. 
2. Sensorimotor impairment:  
The following measurements will be undertaken at 
baseline, after 5, 10, 15 and 20 treatments and one-
month (+/-7 days) after last treatment (treatment 
number 20).  
a) Pressure under the feet during stance phase of 
walking (measured with insoles).  
This is important to measure because in order to walk 
there is a dependence upon the interaction between 
the feet and the environment. It is anticipated this will 
take a maximum of 10 minutes to complete.  
b) Ankle range of motion (dorsiflexion and 
plantarflexion) during stance phase 
This will be measured by an electrogoniometer (an 
electronic piece of equipment), in stance phase of 
walking. It is anticipated this will take a maximum of 10 
minutes to complete.  
 
c) Touch/pressure sensory thresholds (sole of 
foot) (the ability to feel at different points on the 
sole) of the foot 
This will be measured using Semmes Weinstein 
Monofilaments. This involves touching the sole of the 
foot using a nylon filament which exerts a force when 
bowed into a C shape against the skin for 1 second. It 
is anticipated this will take a maximum of 5 minutes to 
complete. 
 
d) Lower Extremity Motricity Index 
This will measure motor impairment (strength) of hip 
flexors, knee extensors and ankle dorsiflexors (moving 
the foot upwards). This will be undertaken with the 
participant in sitting with the hip and knee at 90 
degrees. It is anticipated this will take a maximum of 5 
minutes to complete.  
Regular outcome measurements (a, b, c, and d) are 
being recorded to ascertain at what stage any changes 
are seen, to inform the dose (duration) of the 
intervention for the subsequent trial. 
2. Lower limb function and balance: 
Measures e) and f) will be collected at baseline, on 
completion of the twenty treatments and at one month 
follow up. 
e) Walking speed 5 metre walk test (self-selected 
walking speed), gives an indication of the overall 
walking ability of stroke survivors). To enable more 
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detailed analysis the 5 metre walk test will be videoed. 
It is anticipated this will take a maximum of 10 minutes 
to complete.  
f) Modified Rivermead Mobility Index 
The test involves eight tasks including bed mobility, 
sitting and standing balance, transfers, walking and 
stairs. A rating is given relating to the amount of 
assistance the person requires. It is anticipated this will 
take a maximum of 17 minutes to complete. 
 
3. Lower leg blood flow: 
gi) Peak systolic velocity (PSV) (cm/s) (an indicator 
of blood flow) and vessel diameter (mm) of the 
posterior tibial and the dorsalis pedis artery, measured 
using a portable ultrasound machine (MyLabFive, 
Esoate). Left- and right-limb measures will be 
undertaken to determine if effects are local or 
systemic, possibly indicating altered sympathetic 
vasoconstrictor nerve activity. There will first be a period 
of 10 minutes rest, then the measurements will take 
approximately 15 minutes. 
Timepoints: Baseline, on completion of the twenty 
treatments and at one-month follow up.  
gii) In order to ascertain the effects of one 
individual treatment (acute effects), participants in 
the MTS group will have PSV and arterial diameter 
measured before and immediately after one of the first 
10 MTS treatments. On this one occasion the 
participant will require an extended visit that will last 
between one and a half and two hours (MTS treatment 
30-60 mins, blood flow studies 25 mins plus TSGT 30 
mins). 
h) Blood pressure, height and weight – Resting 
blood pressure will be taken before each 
measurement of blood flow.  Participant’s height and 
weight will be measured at baseline to allow 
calculation of Body Mass Index (BMI).   
Research Setting 
Participants will be asked to attend an outpatient 
setting or a university rehabilitation research facility for 
baseline, post intervention assessment and one-
month follow up, in order to ensure standardisation of 
the 5 metre walk test. All treatment and all other 
assessments undertaken after treatments 5, 10 and 15 
will be undertaken in the setting of the participant, such 
as the in-patient setting or in the participant’s home. 
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1.4 Roles and responsibilities 
1.4.1 Protocol contributors 
 
Name Affiliation Role  
Alison Aries Keele 
University  
NIHR 
Chief Investigator/ Principal Investigator for 
Staffordshire and Stoke on Trent Partnership 
Trust (SSOTP) /PhD student (Doctoral Fellow) 
Chief Investigator roles: 
1. Review all SAEs for seriousness, 
expectedness and causality in accordance with 
agreed process for the trial.  
2. All other responsibilities as assigned by 
regulating bodies, the funder or the sponsor not 
otherwise delegated. In addition to the 
responsibilities set out above, responsibilities 
will be delegated by the CI to PIs, research 
therapists, blinded assessors, research 
technicians and others as appropriate and 
recorded on delegation logs.  
As this is a doctoral study the Chief Investigator 
is also the Clinical Trial Manager and therefore 
is also responsible for: 
1. Preparing reports to Main REC, 
Sponsor, Funder and other such bodies  
2. Providing strategic supervision and 
management of the project 
 
Principal Investigator roles: 
1. Review, record and report all Adverse 
Events for seriousness and causality  
2. All other responsibilities as listed on SSI form 
for the site which he or she has authorised. 
Dr Sue Hunter Keele 
University 
Primary supervisor 
Professor Val 
Pomeroy 
University of 
East Anglia 
(UEA) 
Supervisor 
Professor Sue Read Keele 
University 
Supervisor and qualitative expert 
Professor Julius Sim Keele 
University 
Supervisor and statistician 
Dr Claire Stapleton Keele 
University 
Research therapist / sonographer 
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1.4.2 Role of trial sponsor and funders 
Name Affiliation Role  
Sponsor:  
Contact: Keele 
University, 
Directorate of 
Engagement and 
Partnerships, 
IC2, Keele University, 
Keele,  
Staffordshire,  
ST5 5BG. 
Email: 
e.skinner@keele.ac.uk 
Tel: 01782 733374 
Keele 
University 
 
Responsibility for the initiation, management 
and financing for the research, ensuring that 
the design of the study meets appropriate 
standards and that arrangements are in 
place to ensure appropriate conduct and 
reporting. 
Funder: 
Funding for this study 
has been approved as 
part of an NIHR 
Clinical Academic 
Doctoral Research 
Fellowship award 
(CDRF-2014-05-065) 
NIHR 
 
It is an expectation by the NIHR that this 
work will be published and disseminated 
appropriately and the NIHR will ensure this. 
 
1.4.3 Trial Team 
Name Affiliation Role and responsibilities 
Alison Aries Keele 
University 
Chief Investigator (CI), Principal Investigator 
(PI) and Research Therapist (1) – roles to 
include Recruitment (once potential 
participants have been identified by research 
nurses / clinical team), consenting, screening, 
appropriate outcome measurements that do 
not require blinding e.g. (baseline 
measurements, objective measurements not 
subject to bias), interventions 
Dr Sue Hunter Keele 
University 
Supervisor; Participation in trial team and trial 
management group (TMG) meetings. 
Researcher 
Therapist (2) 
(0.8FTE) 
Keele 
University 
Recruitment (once potential participants have 
been identified by research nurses / clinical 
team), consenting, screening, appropriate 
outcome measurements that do not require 
blinding e.g. (baseline measurements, 
objective measurements not subject to bias), 
interventions 
Blinded Assessor 
(0.19FTE) 
Keele 
University 
Clinical measurements at baseline, after 5, 10 
and 15 interventions and outcome 
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measurements (at completion of intervention 
and one month follow up)  
Dr Claire Stapleton Keele 
University 
Research Therapist (3) - Sonographer 
Dr Erika Sims Norwich 
Clinical Trials 
Unit 
Operational oversight for the set-up, conduct 
and delivery of the study. 
 
1.4.4 Trial Management Group 
Name Affiliation Role and responsibilities 
Alison Aries Keele 
University 
CI, PI, Research Therapist;  
Dr Sue Hunter Keele 
University 
Primary Supervisor 
Professor Val 
Pomeroy 
UEA Supervisor 
Professor Sue Read Keele 
University 
Supervisor 
Professor Julius Sim Keele 
University 
Supervisor  
Professor Christine 
Roffe 
University 
Hospital of 
North 
Midlands 
(UHNM) 
Consultant Stroke Physician 
Carolyn Belford Staffordshire 
and Stoke-on-
Trent 
Partnership 
Trust 
(SSOTP) 
Clinical Specialist Physiotherapist 
Frances Davies SSOTP Research Delivery Unit Manager 
Melvyn Jackson  Patient and Public Involvement (PPI) advisor 
Alan Earp  PPI advisor 
Dr Erika Sims Norwich 
Clinical Trials 
Unit 
Operational oversight for the set-up, conduct 
and delivery of the study. 
 
 
1.4.5 Trial Steering Committee  
Trial Steering Committee responsibility will be undertaken by the Trial Management 
Group 
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1.4.6 Data Monitoring Committee  
Data monitoring responsibility will be undertaken by the Trial Management Group.  
 
1.4.7 Other Trial Oversight Groups 
Name Affiliation Role and responsibilities 
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2 Trial Diagram 
 
 
  
QUANTITATIVE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-------------------------------------------------------------------------------------------------------------------------------------- 
QUALITATIVE STUDY 
 
 
 
 
 
Figure 1:  Overview: Sensory stimulation of the foot and ankle post stroke:  
A feasibility study (MoTaStim-Foot) 
BASELINE 
Clinical measurements  
RANDOMISATION 
(immediately post 
baseline clinical 
measurements) 
Textured Insoles (TI) Group:  
TIs plus 30 mins of Task 
Specific Gait Training (TSGT), 
20 sessions within 6 weeks 
Mobilization and Tactile 
Stimulation (MTS) Group: 
Up to 60 mins MTS plus 30 
mins of Task Specific Gait 
Training (TSGT), 20 sessions 
within 6 weeks 
 
 
SELECTIVE CLINICAL OUTCOMES 
after 5,10 & 15 interventions: 
• Pressure under feet 
• Ankle ROM d/flexion / p/flexion 
• Sensory threshold testing 
 
OUTCOME 
Clinical outcomes, within 7 days of 
completing the 20 sessions 
FOLLOW UP 
Clinical outcomes, within one 
calendar month (±7 days) after the 
completion of the intervention 
Focus group lasting 
up to 90 mins 
with 6-8 participants 
 
 
Focus group lasting 
up to 90 mins 
with 6-8 participants 
 
 
Daily Diary record kept throughout intervention and follow-up (n=34) 
 
Acute blood flow 
studies before and 
after one treatment 
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3 Abbreviations 
 
AE Adverse Event 
ALARA As Low As Reasonably 
Achievable 
AR Adverse Reaction 
BMUS British Medical Ultrasound 
Society 
CI Chief Investigator 
CNS Central Nervous System 
CONSORT Consolidated Standards 
of Reporting Trials 
CRF Case Report Form 
CTU Clinical Trials Unit 
DVT Deep vein thrombosis 
FAC Functional Ambulation 
Category 
GCP Good Clinical Practice 
MRC Medical Research Council 
MTS Mobilization and Tactile 
Stimulation 
NCTU Norwich Clinical Trials 
Unit 
NIHR National Institute for 
Health Research 
PI Principal Investigator 
PIS Participant Information 
Sheet 
PPI Patient and Public 
Involvement 
PSV Peak systolic velocity 
QA Quality Assurance 
QC Quality Control 
RCT Randomized Controlled 
Trial 
R&D Research and 
Development 
REC Research Ethics 
Committee 
SAE Serious Adverse Event 
SAP Statistical Analysis Plan 
SSOTP Staffordshire and Stoke-
on-Trent Partnership 
Trust 
TI Textured insole 
TSGT Task-specific gait training 
TMF Trial Master File 
TMG Trial Management Group 
TMT Trial Management Team 
ToR Terms of Reference 
TSC Trial Steering Committee 
UEA University of East Anglia 
UHNM University Hospitals of 
North Midlands 
UK United Kingdom 
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4 Glossary 
 
Central Nervous System (CNS) This is the part of the nervous system which consists 
of the brain and spinal cord.  
Focus groups Focus groups are a form of interview conducted with 
a few people who discuss topics, actively interacting 
with other group members and the moderator 
(Puchta and Potter 2004). 
Mobilization and Tactile 
Stimulation (MTS): 
A term given to a form of hands-on therapy treatment 
which is often delivered in conventional therapy, with 
an aim of mobilizing the area (e.g. hand or foot) and 
enhancing sensory input (feeling). It involves 
massage and tactile stimulation of the area and joint 
and soft tissue mobilisation techniques (passive 
movements, accessory movements, soft tissue 
stretching). 
Sensory Pertaining to systems which enable input to the 
central nervous system e.g. the ability to feel 
following tactile stimulation.  
Task-specific Gait Training 
(TSGT) 
A form of therapy which involves repetition of various 
activities e.g. sitting to standing, stepping etc. with 
an aim of improving the ability to walk. 
Textured Insoles (TIs) Insoles made of material with projections. The aim of 
these peaks is to stimulate the sole of the foot, 
increasing sensory input. 
5 Introduction 
5.1 Background and Rationale 
Strokes are common. Indeed, every year 15 million people in the world have a stroke 
(Mackay and Mensah, 2004), and with an ageing population the financial burden of 
stroke is set to increase. This project is focused on a priority area for stroke survivors; 
namely, better treatments to enable them to recover the ability to balance and walk 
again.  Although there is strong evidence that physical therapies do enhance recovery 
of balance and walking, many stroke survivors report that difficulty walking affects their 
quality of life (Algurén 2012).  Neuroscience findings indicate that feedback to the brain 
via sensory processes is essential (Chersi et al. 2011, Laaksonen et al. 2012, 
Rossignol et al. 2006), and therefore information originating in the foot is important for 
balance and walking.  Indeed, in clinical practice physiotherapists use an intervention 
called Mobilization and Tactile Stimulation (MTS) to enhance these sensory feedback 
processes.  Yet there is a paucity of robust research to evidence this intervention. This 
project is an important step towards developing evidence based practice, in relation to 
treatment of the lower limb post-stroke. 
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Walking is a priority for many stroke survivors, confirmed by studies undertaken to 
define a national research agenda, which identified physical therapy to address balance 
and gait (walking) post-stroke within the top ten research priorities (James Lind 
Alliance, Pollock et al 2012). Often, challenging difficulties need to be overcome, and 
sometimes balance and walking are difficult because of: loss of control of movement 
(Zissimopoulos 2014); loss of feeling (sensation) (Feigenson 1977; which occurs in 
approximately 65% of people post stroke); problems with eyesight (Ali et al 2013); 
and/or challenges to understanding (Robinson et al 2011). 
Loss of control of movement, for example difficulty controlling foot placement during 
walking (Zissimopoulos 2014), has an effect on functional ability, and it is clear that a 
loss of feeling also affects the capacity to undertake everyday activities (Patel et al 
2000). The ability to move and feel are inextricably linked, with changing sensory input 
(feeling) altering the brain itself (Laarksonen 2012).  Research findings indicate that the 
sensory input (feeling) from the sole (bottom) of the foot is important to achieve balance 
(Kavounoudias et al 1999, Maurer et al 2001, Meyer et al 2004, Horak et al 1990). Even 
a slight loss of this information from the sole of the foot can make it difficult to balance 
(Wang and Lin 2008). Some 83% of stroke survivors have difficulty balancing and 
therefore walking after stroke, especially if the sense of feeling or movement in the foot 
has altered. Increasing the ability to feel may, therefore, help a stroke survivor to 
balance and walk. However, despite the importance of sensory input being highlighted 
in the literature, therapy to increase the ability to feel is not always common in therapy 
treatment (Schabrun and Hillier 2009). There has been very little robust research 
looking at increasing sensory input (or feeling) after stroke (Carey et al 1993). The other 
important challenges of eyesight and understanding are also not to be forgotten, 
however, it is not the purpose of this feasibility study to address these issues.  
Physical therapy involving joint and soft tissue mobilisation and stretching, manipulation 
and massage, to enhance the ability to feel with the arm and hand has been shown to 
improve function (Hunter and Crome 2002, Yekutiel and Guttman 1993), in both sub-
acute (Hunter 2008) and chronic (Winter et al 2013) stroke survivors. MTS is a part of 
routine physical therapy used in clinical practice to prepare the foot and leg for standing 
and walking, but its effects have not yet been explored.  
In clinical practice, physiotherapists use hands-on facilitation techniques to treat 
postural control and mobility problems (Tyson et al 2009), and this includes treatment 
such as muscle stretching, joint movement, and stimulation of the skin over the foot 
and ankle, with the aim of improving standing balance and walking after stroke. The 
limited number of studies that have investigated sensory stimulation to the lower limb 
include a pilot study (n=3) (Hillier and Dunsford 2006), and a randomized controlled 
pilot study (n=21) (Lynch et al 2007). It is not clear whether either of these studies 
included ‘hands on’ interventions such as MTS or not. These studies were not able to 
either support or negate the inclusion of routine sensory retraining to the lower limb in 
clinical practice. A further study investigated perceptual learning involving hardness 
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discrimination (n=28) (Morioka and Yagi 2003) and although postural sway was 
reduced, the findings cannot be generalized with such small samples. Although sensory 
stimulation is potentially key to influencing motor control and function it is not known if 
there are also other effects resulting from the MTS.  Some of the techniques used are 
similar to massage techniques, which have been shown to provide several benefits to 
the body, such as increased blood flow, reduced muscle tension and neurological 
excitability (Weeraponng et al., 2005). A reduction in peripheral blood flow and arterial 
diameter is thought to be negatively associated with disease risk (Dinenno et al., 1999); 
however, it is not known whether treatments that mobilize and stimulate the foot may 
alter the blood flow to the limb post stroke, which could be beneficial for the stroke 
survivor.   
The plantar (sole of the foot) mechanoreceptors are key, sending information to the 
central nervous system, and plantar stimulation has been shown to result in increased 
control of body sway (Watanabe and Okubo 1981). In view of the importance of 
cutaneous information from the sole of the foot to control balance (Kennedy and Inglis, 
2002), other potential mechanisms of increasing plantar stimulation have been 
explored, and TIs have been shown to improve postural control in standing in healthy 
participants (Corbin et al 2007), and to improve walking patterns for people with multiple 
sclerosis (Dixon et al 2014). However, none of these specific or combined treatments 
have been evaluated robustly to determine their benefits for balance and walking 
recovery early after stroke. The use of TIs in the shoes of stroke survivors involves a 
hands-off (therapist independent) approach, which may potentially be a more 
economical option for achieving increased sensory stimulation to the foot and is 
therefore important to investigate.  
Developing evidence and applying it to practice within stroke rehabilitation is difficult, 
due to a limited understanding and knowledge of therapy treatments (Langhorne et al 
2011), which involve many different aspects (MRC 2008). There is strong evidence that 
task-specific gait (walking) practice can be used to improve walking after stroke (Foley 
et al 2013). However, for those stroke survivors who have a lot of muscle weakness 
and are therefore unable to do the task-specific training, other treatments are needed 
to prepare or enhance the sensorimotor system [the sensory 'feeling' system and the 
motor 'movement' systems] (Hunter et al, 2011), to help improve movement and 
function. The impact of the loss of feeling on movement and function, and what 
treatments are best to address the issue, have not been explored appropriately (Carey 
et al 1993). It is clear sensory rehabilitation requires further study (Magnusson et al 
1994, Schabrun and Hillier 2009), and research involving the leg and foot with larger 
sample sizes is necessary (Lynch et al 2007, Hillier and Dunsford, 2006). It is also 
important to develop the scientific basis behind therapy treatments, for example 
establishing if changes to sensation, movement and blood flow are seen following MTS, 
and also the wearing of TIs.  
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This feasibility study involves a mixed-methods design and will be an important step in 
the research pathway, ensuring treatments are properly developed and procedures are 
tested in a rigorous manner, and participants’ perceptions explored. It is necessary to 
see if it is possible to deliver the treatments (MTS or TIs followed by TSGT) and the 
outcome measurements before undertaking a larger study in the future. Both anterior 
and posterior circulation strokes (strokes involving blood vessels going to either the 
front or back of the brain) will be included in this feasibility study, because it is not yet 
known which stroke patients may respond to the treatments being investigated. Timing 
post stroke has been given careful consideration and participants will be included if 
they meet the other inclusion criteria, and have presented with a stroke 6-16 weeks 
(42-112 days) earlier. This time post stroke has been selected because starting 
rehabilitation early has been shown to be better for functional recovery, and the effects 
are maintained on long-term follow up at one year post stroke (Huang et al 2009). The 
most likely period for recovery of walking post stroke is between 4-7 weeks (Kollen et 
al 2006). In order to explore the effects of mobilization and tactile stimulation (MTS) / 
TIs – as opposed to natural, expected recovery – participants will be recruited at the 
end of this period associated with best recovery. The design of the research was 
chosen because it is vital that adequate time is spent developing standardized 
rehabilitation interventions, such as MTS, prior to undertaking a large randomized 
controlled trial looking at effectiveness; hence the decision to undertake a feasibility 
study.   
5.1.1 Explanation for choice of comparators 
Mobilization and tactile stimulation (MTS) is a treatment used in conventional 
physiotherapy practice to prepare or ‘prime’ the central nervous system (CNS), 
facilitating movement and function, by giving sensory input via the foot and ankle. TIs 
are a different way of delivering sensory information to the CNS, enabling 
‘augmentation’ of sensory input to the CNS as a means of facilitating movement and 
function. It is important to explore in the future which sensory stimulation is more 
effective, hence this feasibility study to establish if it is possible to deliver these 
interventions in a research setting.  
5.2 Objectives 
Primary Research Aim: 
To explore the feasibility of delivering treatment designed to increase the feeling within 
the foot after stroke in a randomized trial. The treatments being evaluated are 
Mobilization and Tactile Stimulation (MTS) with TSGT versus wearing of TIs plus 
TSGT.  
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Research Objectives: 
1. To find out if the treatments (MTS plus TSGT, and the wearing of TIs plus TSGT) 
are acceptable treatments for stroke survivors. 
2. To find out the response to treatment (if any), in relation to the number of treatment 
sessions delivered. 
3. To find out which measures will be most appropriate to measure outcomes of: 
sensorimotor impairment (feeling / sensation and movement), blood flow, and lower 
limb function and balance. 
4. To find out if daily diaries and focus groups are suitable ways to explore stroke 
survivors’ experiences of receiving the treatments. 
5. To find out if recruitment methods are effective, noting the number of people invited 
to participate, agreeing to consent and eligible to participate, as well as the number of 
people who drop out of the trial. The information will be used to inform a power 
calculation for a future study.  
6. To generate information regarding the participants recruited i.e. population 
participant demographics, clinical characteristics, including time since stroke, type of 
stroke and previous impairment affecting the ability to walk. 
5.3 Trial Design 
A randomized, single blinded feasibility trial is being undertaken as part of an NIHR 
funded Clinical Doctoral Research Fellowship (overview of trial available in figure 1). A 
mixed-methods design will be adopted, which will involve both quantitative 
(experimental) and qualitative (focus groups) methods. 
 
6 Methods 
6.1 Site Selection 
The trial sponsor has overall responsibility for site and investigator selection and has 
delegated this role to the Chief Investigator. 
6.1.1 Study Setting 
A case note review will be undertaken of stroke patients admitted to Staffordshire and 
Stoke on Trent Partnership Trust (SSOTP). Eligible participants will be identified and 
invited to participate. Participants may be inpatients or outpatients at the point of 
consent. For participants who are inpatients, consent, baseline measures, treatments 
and assessments will be completed within the hospital setting. Participants who are 
outpatients at the point of consent will be invited to attend either a hospital outpatient 
setting or university research facility for the baseline, post-intervention and one-month 
follow-up clinical measurements. The treatment sessions and interim outcome 
measurements (after 5, 10 and 15 treatment sessions) will take place in the 
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participant’s own home. In the event that a participant enters the study as an inpatient 
and is then discharged during the study, provision will be made for the participant to 
continue to participate in the study by arranging for treatment sessions and 
assessments to be delivered at home, apart from the baseline, post-intervention and 
one-month follow-up clinical measurements, which will be undertaken in either a 
hospital out-patient setting or a university research facility.  
6.1.2 Site/Investigator Eligibility Criteria 
This is a single centre study. The Chief Investigator has written the NIHR funded 
Fellowship application and this protocol. It is not anticipated that additional investigators 
or sites will be recruited to the study.   
6.1.2.1 Principal Investigator’s (PI) Qualifications and Agreements 
The Principal Investigator is the Chief Investigator and recipient of a NIHR Fellowship 
for this study. The PI will confirm qualifications, familiarity with the appropriate use of 
any assessment and treatment procedures and GCP training, to permit monitoring and 
audit as necessary at the site, and to maintain documented evidence of all staff at the 
site who have been delegated significant trial related duties. 
6.1.2.2 Resourcing at site 
The principal investigator will be able to demonstrate a potential for recruiting the 
required number of suitable subjects within the agreed recruitment period.  An 
adequate number of qualified staff and facilities will be available for the foreseen 
duration of the trial to enable the trial to be conducted properly and safely.  
A delegation of responsibilities log will be completed and staff contact details provided.  
6.2 Site approval and activation 
As this feasibility study is part of a doctoral training plan Alison Aries is the trial 
manager, CI and PI. The signed clinical trial agreement, or investigator agreement, 
approved delegation of responsibilities log and staff contact details will be checked by 
Dr Susan Hunter (Supervisor), and a written record of the plans for the site will be kept.  
The site will conduct the trial in compliance with the protocol as agreed by the Sponsor 
and, by the regulatory authority(ies) (as appropriate), and which was given favourable 
opinion by the Research Ethics Committee (REC). Alison Aries as the trial manager 
and PI will document and explain any deviation from the approved protocol, and report 
this to the Trial Management Group. A list of activated sites may be obtained from the 
Trial Manager. 
6.3 Participants 
6.3.1 Eligibility Criteria 
Please see sections 6.3.1.2 and 6.3.1.3 and figures 2, 3 and 4 (appendices pages 
59, 60 and 61) 
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6.3.1.1 Participant selection 
There will be NO EXCEPTIONS (waivers) to eligibility requirements at the time of 
randomisation. Questions about eligibility criteria should be addressed PRIOR to 
attempting to randomize the participant.  
The eligibility criteria for this trial have been carefully considered and are the standards 
used to ensure that only medically appropriate participants are entered, and this will be 
checked by reading the participant’s medical notes / liaising with the clinical team, as 
appropriate. Participants not meeting the criteria should not be entered into the trial for 
their safety, and to ensure that the trial results can be appropriately used to inform 
future research and guide future treatment decisions for other people with similar 
diseases or conditions. It is therefore vital that exceptions are not made to these 
eligibility criteria. 
Participants will be considered eligible for enrolment in this trial if they fulfil all the 
inclusion criteria and none of the exclusion criteria as defined below. 
6.3.1.2 Participant Inclusion Criteria 
Inclusion criteria: 
• Able to provide written informed consent 
• Adult stroke survivors (aged 18 years or older), with anterior or posterior circulation 
stroke, occurring 6-16 weeks (42-112 days) earlier.  
• Ability to walk independently prior to stroke. 
• Participants must also be able to follow simple commands and imitate actions, using 
the non-paretic upper limb (the arm that has not been affected by the stroke).  
• Participants must be unable to step on and off a 7·5 cm high block more than 12 
times in 15 seconds with either their paretic (affected) or non-paretic leg (Step test, 
Hill et al 1996).  
6.3.1.3 Participant Exclusion Criteria 
• Pre-existing conditions affecting sensation (feeling) of the foot and lower limb e.g. 
diabetic neuropathy, polyneuropathy (degeneration of the peripheral [not in the 
brain and spinal cord] nerves), peripheral nerve lesion [injury to a peripheral nerve], 
previous stroke affecting sensation of the lower limb. 
• Fixed contracture of the tendoAchillis, assessed by being unable to achieve 90 
degrees dorsiflexion at the ankle, either actively or passively with the knee 
extended. 
• Pressure sores or ulcers on the foot or ankle (hemiparetic limb), due to the risk of 
infection. 
• Deep vein thrombosis, because some of the MTS techniques would be 
contraindicated. 
• Other conditions that affect the blood supply to/from the foot e.g. heart failure with 
peripheral oedema 
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• Botulinum toxin injections to the lower limb in the previous six months, because it 
may have an impact on the results 
• Pain sufficient to prevent delivery of treatments or outcomes 
• Known HIV, Hepatitis non-A or related condition 
 
6.3.1.4 Eligibility Criteria for Individuals Performing the Interventions 
The research therapists delivering the interventions will have sufficient neurological 
therapy expertise to deliver the interventions. Protocols are being developed in 
advance of the study and the research therapists will be trained to ensure delivery of 
standardized protocols for MTS, TIs and TSGT. 
6.3.1.5 Co-enrolment Guidance 
The issue of co-enrolment has been discussed with the Acute Research Team Sister 
at UHNM. She is responsible for the majority of the trials for stroke patients within the 
area. Details of this current study will be shared with the Principal Investigators 
responsible for other trials running, and discussed as applicable, and appropriate 
decisions made regarding any issues of co-enrolment.  If a potential participant is 
already enrolled on a trial involving rehabilitation of the lower limb it may not be 
appropriate for them to be enrolled on this trial. The CI will discuss potential co-
enrolment issues with the relevant PI where required, so an informed decision can be 
made. The burden on potential participants will also be considered. The CI will seek 
guidance from the TMG should co-enrolment issues arise. Due to the proposed timing 
of this trial major issues are not anticipated. 
6.3.1.6   Retrospective case review 
Potentially eligible participants will be referred by a member of the clinical team to the 
Chief Investigator or delegate, where appropriate. A retrospective case review of all 
participants will be conducted. The data will be collected using an anonymised form. 
The data captured will consist of: patient demographics, clinical characteristics, 
including time since stroke, type of stroke and previous impairment affecting the ability 
to walk. This will generate a reference population against which generalisability will be 
demonstrated for the randomised study population (feasibility objective number 6). 
Patients who meet inclusion criteria 2 and 3 and who do not obviously meet any 
exclusion criteria at pre-screening will be approached.   
6.3.1.7 Screening Procedures and Baseline Investigations 
Patients determined eligible to approach for the study, as established by the 
retrospective case review outlined above, will be provided with a participant information 
sheet. Written informed consent to enter and be randomized into the trial will be 
obtained from participants, after the explanation of the aims, methods, benefits and 
potential hazards of the trial and BEFORE any trial-specific procedures are performed. 
The only procedures that will be performed in advance of written informed consent 
being obtained are those that would be performed on all patients in the same situation 
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as a usual standard of care. Eligibility screening (figure 4, page 61) will take place after 
consent, conducted by a research therapist, and will include a test for fixed contracture 
of tendoAchillis, the step test and an ability to follow simple commands by imitating 
actions.  
 
6.4 Interventions 
Interventions:  
The intervention phase will be 20 treatment sessions delivered within a 6-week period, 
after the completion of baseline measurements. Interventions will follow the agreed 
protocols, and research therapists will be appropriately trained to ensure they follow 
the protocol. If participants are receiving routine therapy, this will continue alongside 
the MTS / TIs research schedule, which will therefore be in addition to routine therapy. 
Fatigue will be accounted for as it would in usual therapy rehabilitation. 
6.4.1 Arm A: Mobilization and Tactile Stimulation (MTS) Group: 
Prior to each standardized TSGT session (30 minutes), each participant will receive 
30-60 minutes of MTS treatment to the lower limb, to prepare the sensorimotor system. 
In total each participant will receive 20 sessions of MTS plus TSGT within a 6 week 
period. The MTS schedule has been developed and the treatment schedule will be 
submitted with the ethics application. The specific content of each treatment session 
will be individualised for each participant according to need e.g. to address a 
hypersensitive foot and to take into account tolerance, and will be recorded by ticking 
boxes on a treatment schedule (Hunter et al 2006). A research therapist will undertake 
the standardized MTS treatment. The schedule for the TSGT (for both groups) will also 
be available prior to commencement of the trial. A research therapist will deliver this 
intervention and will be appropriately trained so it can be ensured the same treatment 
is given to each group. A log will be kept regarding which research therapist delivers 
which session, and an exploratory analysis undertaken. 
6.4.1.1 Products 
Not applicable 
6.4.1.2 Treatment Schedule 
A standardized treatment schedule will be followed for both the MTS and TSGT. 
6.4.1.3 Dispensing 
Not applicable 
6.4.1.4 Dose Modifications, Interruptions and Discontinuations 
Not applicable, unless there is an adverse reaction – see section 6.4.6 for details 
6.4.2 Arm B: Textured Insole (TI) Group 
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This group of participants will be encouraged to wear the TI on the hemiparetic side 
(and a smooth insole on the opposite side), as much as possible (to ‘augment’ the 
sensorimotor system), during the 4-6-week period of intervention, apart from when the 
outcomes are being assessed. In addition to wearing the TIs participants will also 
receive 20 sessions of TSGT (30 minutes for each session), during the 4-6-week 
intervention period.  If help is required to put the TIs into shoes and put on footwear 
(and no family support is available), a research therapist will assist. The specific content 
of each treatment session will be documented and daily diaries will inform the 
researcher of the extent of wearing of the TIs. Outcome measurements will be 
undertaken without the participant wearing TIs, so that conditions are the same as for 
the MTS group. 
6.4.2.1 Products 
Smooth insoles and TIs will be used. The insole with the smooth surface will be of 
medium density EVA, 3-mm thickness, shore value A50, black, OG1304 manufactured 
by Algeos UK Ltd., Liverpool, UK. The TI has small, pyramidal peaks with centre-to-
centre distances of approximately 2.5 mm Evalite Pyramid EVA, 3-mm thickness, shore 
value A50, black, OG1549 manufactured by Algeos UK Ltd. The insoles will be 
participant specific and cut to size so they fit in the participant’s shoe.  
6.4.2.2 Treatment Schedule 
Participants will be encouraged to wear the TIs as much as possible and a standardized 
treatment schedule will be followed for the TSGT. 
6.4.2.3 Dispensing 
Not applicable 
6.4.2.4 Dose Modifications, Interruptions and Discontinuations 
Not applicable, unless there is an adverse reaction – see section 6.4.6 for details 
6.4.3 Accountability 
Not applicable 
6.4.4 Compliance and Adherence 
Although participants in the TI group will be encouraged to wear the TIs as often as 
possible, it will ultimately be the participants own choice how long they wear them for 
each day. Completion of a daily diary (by the participant), which will record the daily 
wearing duration, will be encouraged. 
6.4.5 Concomitant Care 
If participants are receiving routine therapy, this will continue alongside the MTS / TIs 
research schedule, which will therefore be in addition to routine therapy. Fatigue will be 
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accounted for as it would in usual therapy rehabilitation, for example by reducing the 
number of exercises prescribed, or the time of the intervention. 
6.4.6 Overdose of Trial Intervention 
There is a small possibility that either the MTS or TSGT could be associated with an 
overuse syndrome as expressed by a participant’s experience of pain or fatigue.  
a. Pain will be considered to be an adverse reaction if (i) a participant reports the onset 
or increase of paretic lower limb pain (verbally or behaviourally), (ii) the pain is 
sustained over four consecutive therapy sessions and (iii) if the research therapist and 
clinical team are unable to account for this in any other way than involvement in this 
trial. This will be addressed by the research therapist adjusting the therapy as 
appropriate or, if indicated, stopping the extra therapy on either a permanent or 
temporary basis. The date of adverse reaction will be the date of the fourth consecutive 
therapy session on which pain was apparent.  
b. Fatigue will be considered to be an adverse reaction if (i) a participant demonstrates 
a decrease of two levels in the Lower Extremity Motricity Index score on four 
consecutive therapy sessions and (ii) the therapist and clinical team are unable to 
account for this in any other way than involvement in this trial. This will be addressed 
by the therapist adjusting the therapy as appropriate or, if indicated, stopping the extra 
therapy on either a permanent or temporary basis. The date of adverse reaction will be 
the date of the fourth consecutive therapy session in which fatigue was indicated.  
Potential discomfort of wearing the TIs has been considered; however, work 
undertaken with people affected by multiple sclerosis has shown general acceptability 
of this intervention (Baron et al., 2014). Participants will be in control of how often, and 
for how long, they wear the TIs. If discomfort is felt the TIs can therefore be removed. 
It will be ensured that the participant is able to remove the TIs and if there is any doubt 
the research therapist will remove them at the end of the TSGT each time. Participants 
will be asked to record all experiences in their daily diaries as part of the feasibility trial, 
so any discomfort can be noted and the length of time participants wear the insoles can 
be monitored. Discomfort will be considered to be an adverse event if a participant is 
unable to wear the TIs for over four consecutive therapy sessions, due to discomfort, 
and the research therapist and clinical team are unable to account for this discomfort 
in any other way than involvement in this trial. This will be addressed by the research 
therapist advising the participant to reduce the time wearing the TIs or to stop wearing 
them altogether, either on a permanent or temporary basis. The date of adverse 
reaction will be the date of the fourth consecutive therapy session in which discomfort 
from insoles was reported. 
 
 
 
 cv 
 
6.4.7 Protocol Treatment Discontinuation 
In consenting to the trial, participants are consenting to trial treatments, trial follow-up 
and data collection. However, an individual participant may stop treatment early or be 
stopped early for any of the following reasons: 
• Unacceptable treatment response or adverse event 
• Inter-current illness that prevents further treatment 
• Any change in the participant’s condition that in the clinician’s opinion justifies 
the discontinuation of treatment 
• Withdrawal of consent for treatment by the participant 
As participation in the trial is entirely voluntary, the participant may choose to 
discontinue trial treatment at any time without penalty or loss of benefits to which they 
would otherwise be entitled. Although not obliged to give a reason for discontinuing 
their trial treatment, a reasonable effort should be made to establish this reason, whilst 
remaining fully respectful of the participant’s rights. 
Participants who discontinue protocol treatment, for any of the above reasons, should 
remain in the trial for the purpose of follow-up and data analysis.  
 
6.5 Outcomes 
The study outcomes include assessment of whether the way participants are recruited 
is effective, the number of people who consent to participate, the willingness of 
participants to be randomized, how acceptable the treatments are, how many 
participants drop out, and to work out how many people would need to be recruited in 
a future larger trial.  
As this is a feasibility trial one of the objectives is to identify which measure should be 
the primary outcome measure for future trials.  
The following outcomes will therefore be evaluated as detailed below: 
Outcomes: 
1. Characterization of clinical presentation of participants (to give an overview of 
the participants to assist with evaluation of the interventions) using the following 
measurement tools: 
(i) National Institutes of Health Stroke Scale (NIHSS) - This includes assessment of 
the level of consciousness, vision, motor activity (face, arm and leg), coordination, 
sensation and speech. It is anticipated this will take a maximum of 15 minutes to 
complete. Timepoint: Baseline 
(ii) Functional Ambulation category, which assesses walking ability and categorizes 
according to basic motor skills necessary for functional walking. It is anticipated this will 
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take a maximum of 2 minutes for the researcher to complete. It will not require 
additional time of the participant because the assessment can be made following the 5 
metre walk test. It is anticipated that the step test will exclude people who would achieve 
a FAC level 6, requiring assessment on uneven surfaces and stairs.  
Timepoints: Baseline, on completion of the twenty treatments and at one-month follow 
up. 
2. Sensorimotor impairment:  
The following outcome measurements will be undertaken at baseline, after 5, 10, 
15 and 20 treatments and one-month (+/-7 days) after last treatment (treatment 
number 20).  
a) Pressure under the feet during stance phase of walking (measured with 
insoles).  
This is important to measure because in order to walk there is a dependence upon the 
interaction between the feet and the environment. It is anticipated this will take a 
maximum of 10 minutes to complete.  
b) Ankle range of motion (dorsiflexion and plantarflexion) during stance phase 
This will be measured by an electrogoniometer (an electronic piece of equipment), in 
stance phase of walking. It is anticipated this will take a maximum of 10 minutes to 
complete.  
 
c) Touch/pressure sensory thresholds (sole of foot) (the ability to feel at different 
points on the sole) of the foot 
This will be measured using Semmes Weinstein Monofilaments. This involves touching 
the sole of the foot using a monofilament nylon wire which exerts a force when bowed 
into a C shape against the skin for 1 second. It is anticipated this will take a maximum 
of 5 minutes to complete. 
 
d) Lower Extremity Motricity Index 
This will measure motor impairment (strength) of hip flexors, knee extensors and ankle 
dorsiflexors (moving the foot upwards). This will be undertaken with the participant in 
sitting with the hip and knee at 90 degrees. It is anticipated this will take a maximum of 
5 minutes to complete.  
Regular outcome measurements (a), b), c) and d)) are being recorded to ascertain at 
what stage any changes are seen, to inform the dose (duration) of the intervention for 
the subsequent trial. 
3. Lower limb function and balance: 
Measures e) and f) will be collected at baseline, on completion of the twenty treatments 
and at one month follow up. 
e) Walking speed 5 metre walk test (self-selected walking speed), gives an indication 
of the overall walking ability of stroke survivors). To enable more detailed analysis, the 
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5 metre walk test will be videoed. It is anticipated this will take a maximum of 10 minutes 
to complete.  
f) Modified Rivermead Mobility Index 
The test involves eight tasks including bed mobility, sitting and standing balance, 
transfers, walking and stairs. A rating is given relating to the amount of assistance the 
person requires. It is anticipated this will take a maximum of 17 minutes to complete. 
 
 
 
3. Measurements of blood flow: 
gi) Peak systolic velocity (PSV) (cm/s) (an indicator of blood flow) and vessel 
diameter (mm) of the posterior tibial and the dorsalis pedis artery, measured using a 
portable ultrasound machine (MyLabFive, Esoate). Left- and right-limb measures will 
be undertaken to determine if effects are local or systemic, possibly indicating altered 
sympathetic vasoconstrictor nerve activity. There will first be a period of 10 minutes rest, 
then the measurements will take approximately 15 minutes. 
Timepoints: Baseline, on completion of the twenty treatments and at one-month follow 
up.  
gii) In order to ascertain the effects of one individual treatment (acute effects), 
participants in the MTS group will have PSV and arterial diameter measured before and 
immediately after one of the first 10 MTS treatments. On this one occasion the 
participant will require an extended visit that will last between one and a half and two 
hours (MTS treatment 30-60 mins, blood flow studies 25 mins plus TSGT 30 mins). 
h) Blood pressure, height and weight – Resting blood pressure will be taken before 
each measurement of blood flow.  Participant’s height and weight will be measured at 
baseline to allow calculation of Body Mass Index (BMI).   
Research Setting 
Participants will be asked to attend an outpatient setting or a university rehabilitation 
research facility for baseline, post intervention assessment and one-month follow up, 
in order to ensure standardisation of the 5 metre walk test. All treatment and all other 
assessments undertaken after treatments 5, 10 and 15 will be undertaken in the setting 
of the participant, such as the in-patient setting or in the participant’s home. 
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6.6 Participant Timeline 
Table 1: Timeline for participants 
STUDY PERIOD 
   **t1 - t4 will be completed within 4-6 weeks    
TIMEPOINT** -t1 0 
t1 
After 5 
treatments 
t2 
After 10 
treatments 
t3 
After 15 
treatments 
t4 
At end of 20 
sessions of 
intervention 
(+/- 7 days) 
t5 
Follow-
up One-
month 
after t4  
(+/- 7 
days) 
 
t6 
Focus 
Group 
 
t7 
Completion 
of trial 
ENROLMENT:          
Retrospective case 
review X       
  
Informed consent   X        
Baseline measures  X        
Randomisation  X        
INTERVENTIONS:          
Intervention A: 
 MTS +TSGT 
    
 
 
 
 
 
 
 
 
 
 
 
Intervention B: 
 TIs +TSGT 
    
 
   
 
 
 
 
 
 
 
[Daily Diaries          
Focus groups         X  
 
ASSESSMENTS: 
(See table below for 
details) 
       
  
Characterization of 
clinical presentation 
of participants: 
       
  
(i) National Institutes of 
Health Stroke Scale 
(NIHSS)   
 X      
  
(ii) Functional 
Ambulation category  X    X X 
  
Measures of 
sensorimotor 
impairment: 
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a) Pressure under the 
feet during stance phase 
of walking 
 X X X X X X 
  
b) Ankle range of motion 
during stance phase   X X X X X X 
  
c) Touch/pressure 
sensory thresholds of 
the foot 
 X X X X X X 
  
d) Lower Extremity 
Motricity Index  X X X X X X 
  
Measures of lower 
limb function and 
balance: 
       
  
e) Walking speed 5 
metre walk test   X    X X 
  
f) Modified Rivermead 
Mobility Index.  X    X X 
  
Measurements of 
blood flow:        
  
gi) Peak systolic velocity (blood 
flow) (cm/s) and vessel diameter 
(mm) of posterior tibial artery and 
dorsalispedis artery 
 X    X X 
  
gii) Acute blood flow studies 
before and after one MTS 
treatment 
  X* X*    
  
h) Blood Pressure (prior to blood 
flow studies)  X    X X 
  
 
* Please note blood flow will be assessed before and after one MTS treatment at some stage within the first 10 
treatments (during t1 or t2). 
 
BOTH ARMS: 
It is anticipated that the intervention therapy may not be given when: (1) the participant 
is otherwise unwell; (2) on the day of the baseline, outcome or follow up assessments; 
(3) the participant is out of the area due to holiday or other personal reasons; (4) there 
is a public holiday; or (5) during therapist sickness or annual leave, which cannot be 
covered by the 2nd research therapist. If a participant misses a planned treatment for 
any of these instances, it will be recorded. 
If participants have been discharged from in-patient rehabilitation before the end of the 
6-week intervention period, then they will either attend an out-patient setting or the 
research therapist will visit them in their ‘home’ to receive their allocated treatment. If it 
is most suitable for any participant to travel to an out-patient setting, then a pre-paid 
return taxi journey will be provided.  
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Protocols for MTS, TIs and TSGT are being developed in consultation with 12 
experienced neurological therapists. The standardized protocols will be available, prior 
to commencement of the feasibility trial. Training in delivering the interventions will be 
provided before the trial begins. Fidelity to the protocol will be assessed through 
observation by an appropriately experienced member of the trial management team, at 
the beginning and at regular points throughout the trial, with little prior warning to the 
therapist. 
 
Daily Diaries 
Throughout the intervention period, participants will be asked to keep a daily diary (with 
appropriate prompts), helping the participants 'focus their thoughts' (Jacelon & Imperio 
2005 p 993) on how their lower limb is ‘feeling’, or if there are any changes following 
intervention or outcome measurements.  
Diaries have been suggested as a useful tool to reflect on issues that are of interest to 
the researcher, providing insight into the importance of events for participants (Jacelon 
& Imperio 2005). Diaries will either be written, or saved as a daily video or audio clip, 
according to participant preference. This will enable information relating to comfort of 
interventions, outcome measurements and TIs to be evaluated, and will also find out if 
participants have reported any changes to feeling within the foot and ankle or changes 
in daily activities during the six weeks. 
Focus groups: 
The sample will be drawn from the participants of the feasibility study. All participants 
from both arms of the trial will be invited to a focus group, on completion of the 
intervention and outcome measurements. Two focus groups, with ideally 6-8 
participants, if feasible, (as suggested by Krueger and Casey (2000) as being an ideal 
size to promote discussion), will be conducted for each arm of the trial. Focus groups 
have been used as an appropriate method for exploring views on interventions and 
research (Tong et al 2007), providing a large quantity of rich data in a short period of 
time, allowing the researcher to find out 'what people really think and feel' (Krueger and 
Casey 2000 p7). Experience of taking part in the trial, and perceptions as to any 
changes following intervention will be explored. The focus groups are planned to last 
no longer than 90 minutes and a focus group schedule will be developed to facilitate 
the discussion (Bowling 2009). 
Procedures: 
The focus group will be held in a suitable quiet room at Keele University or local 
community venue (e.g. local church hall) and transport will be provided, or alternative 
travel costs reimbursed. A researcher will facilitate each group, which will be 
audiotaped; a Patient and Public Involvement (PPI) volunteer will assist at each group 
by taking field notes. 
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The following areas will be explored: 
• The participants’ individual responses to the MTS and insole protocols, including any 
changes noticed since the intervention e.g. changes in sensation (feeling), function and 
participation. 
• Participants’ experiences of being involved in the research project, to include their 
experiences of receiving the interventions and completing the outcome measures. This 
will be important to inform the subsequent trial. 
6.6.1 Early Stopping of Follow-up 
If participants choose to discontinue their trial treatment, they should continue to be 
followed up as closely as possible to the follow-up schedule defined in the protocol, 
providing they are willing. They should be encouraged and facilitated not to leave the 
whole trial, even though they no longer take the trial treatment. If, however, the 
participant expresses the view that he or she no longer wishes to be followed up either, 
this view must be respected and the participant withdrawn entirely from the trial. NCTU 
should be informed of the withdrawal in writing using the MoTaStim-Foot trial 
documentation. Data already collected will be kept and included in analyses. 
Participants who stop the trial follow-up early will not be replaced. 
6.6.2 Participant Transfers 
As this is a feasibility study, with only one participating site, it will not be possible to 
follow up participants at a different centre if they move from the area. However due to 
the age of the potentially eligible population transfer away from the participating site is 
unlikely.  
6.6.3 Loss to Follow-up 
As follow-up will be at only one month it is not anticipated this will be a major issue. 
One of the purposes of the feasibility study is to monitor loss to follow-up. A decision 
will be made that a participant has been lost to follow-up if there have been three 
unsuccessful attempts to contact the participant (e.g. by telephone call or letter). 
However due to the age of the potentially eligible population transfer away from the 
participating site is unlikely. 
6.6.4 Trial Closure 
End of Trial 
Participants are considered to have reached the end of the trial when the first of the 
following occurs: (1) completion of all data collection e.g. 1 month follow up outcome 
measurements, focus group; (2) withdrawal of consent; (3) SAE resulting in withdrawal 
of participant or death; (4) loss to follow-up. Loss to follow-up will be declared following 
three unsuccessful attempts (letter or telephone call) to contact the participant.  If during 
therapy pain or fatigue (as defined above) or discomfort from insoles occurs, the MTS, 
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TSGT or TIs will be temporarily or permanently stopped depending on whether or not 
the symptoms dissipate.  
After the one-month follow-up and the qualitative aspect of the study, for all 34 
participants, any outstanding queries or adverse events will be resolved by the Chief 
Investigator on termination of the trial and correct storage of study documentation will 
be verified.  
The end of the trial is defined as the collection of the last piece of data for the last 
participant; however, this will be followed by a further period of twelve months, during 
which the data will be analysed and prepared for dissemination.  
6.7 Sample Size 
A sample size of 30 has been suggested as the lower limit for working out how many 
participants will be required for future studies in terms of an estimate of the standard 
deviation of values on a continuous outcome measure (Browne 1995). Recruiting a 
sample of 34 participants will account for 10% drop out, and enable potentially equal 
numbers (n=17) in each arm of the trial. As the whole study needs to be completed 
within three years this sample size was deemed to be the largest feasible in the time 
frame. 
6.8 Recruitment and Retention 
6.8.1 Recruitment 
Adult stroke survivors (n= 34) will be recruited from the North Staffordshire Stroke 
Service, identified by research nurses or the multidisciplinary teams caring for the 
stroke survivors. Stroke survivors (6-16 weeks or 42-112 days) expressing an interest 
in participating will be given a participant information sheet. The first seventeen right 
hemisphere and the first seventeen left hemisphere stroke survivors meeting the 
inclusion criteria and providing written informed consent will be recruited. It is 
anticipated that it will be necessary to recruit over a period of 18 months; recruitment 
levels will be monitored monthly.  
6.8.2 Retention 
As follow-up will be at only one month, following completion of the last interventional 
therapy, it is not anticipated this will be a major issue. One of the purposes of the 
feasibility study is to monitor loss to follow up.  
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6.9 Assignment of Intervention 
6.9.1 Allocation 
6.9.1.1 Sequence generation 
The randomisation sequence will be generated before the trial commences and Professor 
Julius Sim, the statistician for the trial, will provide the randomisation order to Norwich 
CTU. Participants will be randomised to the interventions using 1:1 randomisation with 
stratification by left or right stroke. Stratified randomisation will ensure an equal number of right 
and left sided strokes in each treatment group.   
 
6.9.1.2 Allocation concealment mechanism 
An independent telephone interactive voice response system randomisation service and 
electronic case record form will maintain concealment of the treatment allocation from 
investigators, research therapists and blinded assessors prior to randomisation of a participant 
(i.e. each participant allocation cannot be predicted from the allocation of the previous 
participant). Baseline data will be entered into the randomisation system and the system will 
randomize, sending an email confirmation of the allocation group for the participant. 
Concealment of group allocation from the blinded assessor with continue throughout the trial 
process.   
 
6.9.1.3 Allocation Implementation 
Baseline data will be entered into the randomisation system and the system will 
randomize, sending an email confirmation of the allocation group for the participant.  
6.9.2 Blinding 
All outcome measurements in which observer bias could occur will be undertaken by 
assessors who are blinded to treatment group allocation. The touch/pressure sensory 
thresholds, Lower Extremity Motricity Index and Modified Rivermead Mobility Index will 
all be undertaken by a blinded assessor. However, a research therapist will undertake 
the five metre walk test, pressure under the feet and ankle range of movement 
assessments. As these are objective assessments the risk of bias is low. An 
experienced sonographer (not blinded to group allocation) will undertake the blood flow 
studies.  As part of clinical decision making, in order to assess for possible fatigue, the 
research therapists will also measure the Lower Extremity Motricity Index, at each 
intervention; however, it will be the Lower Extremity Motricity Index measurement 
undertaken by the blinded assessor which will be formally analysed.  Participants will 
be asked to refrain from telling the assessors which treatment they are receiving. To 
assess whether blinding of assessors was achieved, we will ask assessors, at the one-
month follow-up point, to guess which group they think participants were assigned to. 
Agreement with actual allocation will be assessed with the kappa statistic. 
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6.9.3 Emergency Unblinding 
Neither the participant nor the therapist is blinded therefore this is not relevant.  
6.10 Data Collection, Management and Analysis 
6.10.1 Data Collection Methods 
The Chief Investigator will ensure that blinded assessors and research therapists 
undertaking any of the outcome measurements will be appropriately trained.  
1. Characterization of clinical presentation of participants (to give an overview of 
the participants to assist with evaluation of the interventions): 
(i) National Institutes of Health Stroke Scale (NIHSS) - reliability has been 
demonstrated by Goldstein and Samsa (1997).  
(ii) Functional Ambulation category, which assesses walking ability and categorizes 
according to basic motor skills necessary for functional walking and has been found to 
be valid and responsive, with excellent reliability in stroke survivors (Mehrholz et al 
2007). 
2. Sensorimotor impairment: 
a) Pressure under the feet during stance phase of walking (measured with 
insoles).  
This is important to measure because in order to walk there is a dependence upon the 
interaction between the feet and the environment (Rasak et al 2012).  The pressure 
measurements will be obtained by using a Tekscan F-Scan VersaTek clinical in-shoe 
pressure measurement kit system.  
b) Ankle range of motion (dorsiflexion and plantarflexion) during stance phase 
This will be measured by an electrogoniometer (an electrical piece of equipment, which 
has been shown to be valid and reliable (Bronner et al 2010), in stance phase of 
walking.  
c) Touch/pressure sensory thresholds (sole of foot) (the ability to feel at different 
points on the sole) of the foot 
This will be measured using Semmes Weinstein Monofilaments, which have been 
found to be reliable and responsive (Tracey et al 2012).  
d) Lower Extremity Motricity Index 
This will measure motor impairment (strength) of hip flexors, knee extensors and ankle 
dorsiflexors (moving the foot upwards). This will be undertaken with the participant in 
sitting with the hip and knee at 90 degrees. This was found to be a valid measure by 
Cameron and Bohannon (2000), which is reliable (Fayazi et al 2012). 
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3. Lower limb function and balance: 
e) Walking speed 5 metre walk test (self-selected walking speed), gives an indication 
of the overall walking ability of stroke survivors (Olney et al 2006).  A web-cam, attached 
to a computer will be used to video the 5 metre walk test enabling a more detailed 
analysis. 
f) Modified Rivermead Mobility Index. 
A valid, reliable, responsive measure of mobility in the early stages of stroke 
rehabilitation (Lennon and Johnson 2000). 
4. Measurements of blood flow: 
g) Peak systolic velocity (blood flow) (cm/s) and vessel diameter (mm) of 
posterior tibial artery and dorsalis pedis artery, measured using a portable 
ultrasound machine (MyLabFive, Esoate), following a 10 minute rest period, during 
which blood pressure will be taken. Posterior tibial artery reliability measures for vessel 
diameter at rest are good to excellent with intraclass correlation coefficient [ICC] of 0.95 
(Sabatier et al., 2006).  
h) Blood pressure, height and weight – Although not required as outcome measures, 
resting blood pressure will be taken before the measurements of blood flow.  
Participant’s height and weight will be measured to allow calculation of Body Mass 
Index (BMI).  Together with resting blood pressure these measures will provide some 
basic descriptive data related to the participants’ health status. 
Research therapists / blinded assessors who will be undertaking the above outcome 
measurements will be fully trained and procedures for each outcome measurement will 
be standardized.  
Data collection  
A Protocol, Standard Operating Procedures, Intervention protocols and Case Report 
Forms (CRFs) will be available at SSOTP. Data will be sent to the Norwich Clinical 
Trials Unit (CTU) for entry and quality control in a secure standardized manner. 
 
Pre-study site visits  
Before the study commences, SSOTP, as the recruiting site, will receive training visits, 
as required, by the Chief Investigator. These visits will ensure that the research team 
at each site (including principal investigators, co-investigators, research therapists and 
blinded assessors) fully understand the protocol, CRFs and the protocols for the study.  
 
 
 cxvi 
 
Monitoring site visits  
A quality management and monitoring plan will be set up, which will detail the monitoring of 
activities to be undertaken, ensuring compliance with the protocol and that ethical and 
regulatory guidelines are met.  
 
6.10.2 Non-Adherence and Non-Retention 
All outcome data will be collected and file notes (identified by the participant’s number) 
will be included as an explanation re non-adherence, as this is an important aspect of 
the feasibility trial. Analysis of file notes will be useful to ascertain links between non-
adherence/dropout and specific patient characteristics in terms of age, sex, clinical 
severity, etc., further informing the future trial.  
6.10.3 Data Management 
The NHS Code of Confidentiality and Data Protection Act will be complied with. 
Specifically, we will keep data that could identify individuals separate from anonymous 
data and ensure that the linking information is accessed only by those who need to 
know. All data by which individuals may be identified will be kept in a lockable storage 
facility within the research offices or research laboratories. Any electronic data by which 
individuals can be identified will be placed in a password protected secure space on 
hard drives. Personal names and information will not be transferred via email.  
Only members of the research team directly involved in the study will have access to 
identifiable data, and this will be only on a need-to-know basis. Use of personal 
addresses, postcodes, faxes, emails or telephone numbers will be restricted to the 
minimum number of people necessary to ensure the efficient and safe running of the 
trial. For example, telephone numbers will be used by members of the research team 
to organise appointments and addresses used to collect and return participants for 
appointments. Participant numbers will be utilised to anonymize data. Audio recording 
devices will be used for the planned focus groups. On transcription, pseudonyms will 
be used to maintain anonymity.  Pseudonyms will be used in the interview transcripts 
and dissemination of findings. Faces will be blanked out on the 5 metre walk videos. 
The videos will be stored on a password protected computer. Transcriptions from the 
audio/visual recording devices will be anonymized, with pseudonyms used, prior to 
being stored on password protected computer or laptop.  When the work is written up 
for publication all direct quotations will be anonymous and no individual will be 
identifiable. 
Research therapists and administration staff will be appropriately trained in issues 
relating to confidentiality of personal data as part of their induction on commencement 
of their post. Only the minimal amount of information necessary to do the job will be 
disclosed and it will be ensured that all staff who have access to personal information, 
e.g. names and addresses, will respect that it is given to them in confidence. 
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Only anonymous data (by means of issuing each participant a unique trial number) will 
be shared with other organisations. The only identifiable data will be held on purpose 
built forms and stored in lockable cabinets in lockable rooms. Where it is necessary to 
share this information between organisations, for example when reporting a safety 
incident or complaint the paper form will be scanned in and saved in a password 
protected file (password will be emailed to the PI separately), then provided to 
the Principal Investigator who will, open the file, print it and destroy the electronic copy. 
The Trial Manager will then store the paper copy in a lockable cabinet in a lockable 
room. 
All documentation including case report forms (CRFs), and clinical measurement forms 
will be photocopied and a copy stored safely in a locked cupboard prior to sending a 
copy to Norwich CTU.  
At the end of the trial all data will be archived appropriately (see section 7.10 for details).  
6.10.4 Statistical Methods 
6.10.4.1 Statistical Analysis Plan 
 
Statistical analysis (quantitative study) 
As this is a feasibility study, no formal hypothesis tests will be undertaken. For statistical 
methods please see section 6.10.4.2. 
Data collection and analysis for the qualitative study: 
Daily diaries will be collected weekly from the participants. Data will be taken from the 
daily diaries kept by the participants; the data will then be coded and thematic analysis 
undertaken. Data from the focus groups will be analysed as the study progresses, with 
each focus group being transcribed and analysed prior to the next focus group, so that 
any emerging ideas can be included in subsequent discussions (Kisely and Kendall 
2011). Discussion topics will be planned in advance and guided by the focus group 
schedule. Topics will relate to the interventions and participation within the study, as 
well as changes in functional ability. Individual responses relating to these topic areas 
will be facilitated. All the focus groups will be transcribed in full (funding has been 
incorporated into the project for this), and then analysed using a thematic content 
analysis approach, using NVivo to aid data management. The researcher and an 
independent reviewer will independently code the data in the transcripts, and identify 
themes. In addition to the themes decided in advance, others will be developed from 
analysing the data. Any differences of opinions will be highlighted and discussed, 
before agreement is reached and themes finalised. The final stage of analysis will 
involve both researchers collectively looking for conceptual relationships within and across 
the focus groups. Analysis of the field notes from the focus groups will provide 
additional insights and context behind the interactions of participants. 
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6.10.4.2 Statistical Methods – Outcomes 
As this is a feasibility study, no formal hypothesis tests will be undertaken. Instead point 
estimates, with 95% confidence intervals, will be calculated for key outcome measures. 
The variance of scores for outcome measures will be calculated, providing information 
for the sample size calculation for the subsequent large trial. The distribution of 
outcome variables, and the extent of clustering of observations by therapist, will also 
be assessed, to further inform the sample size calculation and guide the choice of 
analysis in the main study. The number of eligible patients who are recruited, and the 
proportion of those recruited who are lost to follow up at one month, will also be 
calculated. Analysis will be conducted by the applicant, with guidance from the 
supervisory team. A single formal analysis will take place at the end of the study.  
For those scaled outcomes that are recorded at each time point, a line graph of all 
individual participants’ response trajectories will be constructed for each arm of the trial; 
this graph will also include a line representing the averaged response trajectory. The 
graph will be analysed visually to determine if there is a point at which the participants’ 
responses tend to change direction upwards (indicating a response to treatment), as 
this information will provide information on the likely minimum length of treatment, or 
‘dosage’, that is required to induce an improvement on the outcome concerned. Across 
these outcomes, the latest such change in trend will suggest the minimum length of 
treatment that should be utilized in the main trial. 
Within the feasibility study, both research therapists will deliver either MTS or TSGT. A 
log will be kept detailing, for each participant, which therapist has delivered the 
treatment. An intra-cluster correlation coefficient will be calculated to assess the extent 
to which outcomes are correlated (clustered) within therapists. This information will be 
required as an adjustment factor in the sample size calculation for the subsequent main 
trial, in which it is likely that therapists will be specific to one or other arm of the trial.  
In addition to quantifying variables such as walking speed for the 5 metre walk test, an 
observational analysis of the quality will be undertaken, as is common practice in 
therapy rehabilitation.  
 
6.10.4.2.1 Economic evaluations 
6.10.4.3 Additional Analyses - Subgroup 
Not applicable, as this is a feasibility trial 
6.10.4.4 Additional Analyses – Adjusted 
6.10.4.5 Analysis Population and Missing Data 
Not applicable, as this is a feasibility trial 
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6.11 Data Monitoring 
6.11.1 Data Monitoring Committee 
As this is a small feasibility study being undertaken as part of a doctoral fellowship a 
Data Monitoring Committee has not been deemed to be necessary. The trial will be 
overseen by the Trial Management Group.  
6.11.2 Interim Analyses 
No interim analysis is planned 
6.11.3 Data Monitoring for Harm 
Adverse events and any other unintended effects of trial interventions will be reported 
monthly to the Trial Management Group.  
6.11.3.1 Safety reporting 
Adverse events and serious adverse events related to stroke and the intervention will 
be recorded during the study. The participant’s condition will be evaluated at each 
contact (treatment and assessment), in case the participant reports any of the stroke 
related expected adverse events.  
 
Stroke-related expected adverse events: 
• Death  
• A fall requiring hospitalisation  
• Further vascular events (including recurrent strokes, myocardial infarction, bowel 
ischemia)  
• Cardiac, renal or liver problems  
• Epileptic seizures  
• Revascularisation  
• Major bleed  
• A fall  
• Infections  
• Mood disturbances  
• Spasticity or contractures  
• Deep vein thrombosis (DVT) 
 
In addition to the above, potential Adverse Reactions of pain and fatigue are of clinical 
interest in informing the results of the trial. There is a small possibility that either the 
MTS or TSGT could be associated with an overuse syndrome as expressed by a 
participant’s experience of pain or fatigue.  
 
a. Pain will be considered to be an adverse reaction if: (i) a participant reports the onset 
or increase of paretic lower limb pain (verbally or behaviourally); (ii) the pain is 
sustained over four consecutive therapy sessions; and (iii) the research therapist and 
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clinical team are unable to account for this in any other way than involvement in this 
trial. This will be addressed by the research therapist adjusting the therapy as 
appropriate or, if indicated, stopping the extra therapy on either a permanent or 
temporary basis. The date of adverse reaction will be the date of the fourth consecutive 
therapy session after pain was first noted.  
 
b. Fatigue will be considered to be an adverse reaction if: (i) a participant demonstrates 
a decrease of two levels in the Lower Extremity Motricity Index score on four 
consecutive therapy sessions; and (ii) the therapist and clinical team are unable to 
account for this in any other way than involvement in this trial. This will be addressed 
by the therapist adjusting the therapy as appropriate or, if indicated, stopping the extra 
therapy on either a permanent or temporary basis. The date of adverse reaction will be 
the date of the fourth consecutive therapy session, in which fatigue was indicated.  
 
Potential discomfort of wearing the TIs has been considered; however, work 
undertaken with people affected by multiple sclerosis has shown general acceptability 
of this intervention. The participant will be in control of how often and for how long they 
wear the TIs. If discomfort is felt the TIs can be removed.  It will be ensured that the 
participant is able to remove the TIs and if there is any doubt the research therapist will 
remove them at the end of the TSGT each time. Participants will be asked to record all 
experiences in their daily diaries as part of the feasibility trial, so any discomfort can be 
noted and the length of time participants wear the insoles can be monitored. Discomfort 
will be considered to be an adverse event if a participant is unable to wear the TIs for 
over four consecutive therapy sessions, due to discomfort, and the research therapist 
and clinical team are unable to account for this discomfort in any other way than 
involvement in this trial. This will be addressed by the research therapist advising the 
participant to reduce the time wearing the TIs or to stop wearing them altogether, either 
on a permanent or temporary basis. The date of adverse reaction will be the date of the 
fourth consecutive therapy session in which discomfort from insoles was reported.  
 
 
Reporting of adverse events: 
All adverse events, including those which are expected, will be recorded from date of 
randomisation to end of trial (see below). Adverse events will be reported to the Trial 
Management Group. 
 
Safety reporting will conform to the requirements of the Safety and Progress Reports 
Table (non-CTIMPs) for UK health departments’ RES version 2.1  
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Table 1: Adverse Event Definitions 
Adverse Event (AE) Any untoward medical occurrence in a patient or 
clinical trial participant administered a study 
intervention and which does not necessarily have a 
causal relationship with this intervention. 
Adverse Reaction (AR) Any untoward and unintended response to an 
investigational intervention. 
Unexpected Adverse 
Reaction (UAR) 
An adverse reaction, the nature or severity of which is 
not consistent with the expected complications of the 
intervention. 
Serious Adverse Event 
(SAE) or Serious Adverse 
Reaction (SAR) 
Any AE or AR that: 
• results in death  
• is life threatening*  
• requires hospitalisation or prolongation of 
existing hospitalisation** 
• results in persistent or significant disability or 
incapacity 
• consists of a congenital anomaly or birth defect 
• or is otherwise considered medically significant 
by the investigator*** 
* the term life threatening here refers to an event in which the patient is at risk of 
death at the time of the event; it does not refer to an event that might hypothetically 
cause death if it was more severe (e.g. a silent myocardial infarction) 
** Hospitalisation is defined as an in-patient admission, regardless of length of stay, 
even if the hospitalisation is a precautionary measure for continued observation. 
Hospitalisation for pre-existing conditions (including elective procedures that have 
not worsened) do not constitute an SAE 
*** Clinical judgement should be exercised in deciding whether an AE or AR is 
serious in other situations. Important AEs or ARs that may not be immediately life 
threatening or result in death or hospitalisation, but may seriously jeopardise the 
participant by requiring intervention to prevent one of the other outcomes listed in 
the table above (e.g. a secondary malignancy, an allergic bronchospasm requiring 
intensive emergency treatment, seizures or blood dyscrasias that do not require 
hospitalisation, or development of drug dependency) should also be considered 
serious. 
 
Adverse events include: 
• an exacerbation of a pre-existing illness 
• an increase in the frequency or intensity of a pre-existing episodic event or 
condition 
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• a condition (regardless of whether PRESENT prior to the start of the trial) that is 
DETECTED after trial intervention. (This does not include pre-existing conditions 
recorded as such at baseline – as they are not detected after trial intervention) 
• continuous persistent disease or a symptom present at baseline that worsens 
following administration of the trial treatment 
Adverse events do NOT include: 
• Medical or surgical procedures: the condition that leads to the procedure is the 
adverse event 
• Pre-existing disease or a condition present before treatment that does not 
worsen 
• Hospitalisation where no untoward or unintended response has occurred e.g. 
elective cosmetic surgery 
• Overdose of medication without signs or symptoms 
6.11.3.2 Other Notifiable Adverse Events 
6.11.3.3 Procedures to follow in the event of female participants becoming 
pregnant 
6.11.3.4  Investigator responsibilities relating to safety reporting 
All non-serious AEs and ARs, whether expected or not, will be recorded on a case 
report form. SAEs and SARs will be notified to NCTU within 24 hours of the investigator 
being aware of the event. 
6.11.3.4.1 Seriousness assessment 
When an AE or AR occurs, the investigator responsible for the care of the participant 
must first assess whether or not the event is serious using the definition given in Table 
1. If the event is classified as ‘serious’ then an SAE form must be completed and NCTU 
(or delegated body) notified within one working day. 
6.11.3.4.2 Severity or grading of Adverse Events 
Not applicable 
6.11.3.4.3 Relatedness 
The investigator must assess the causality of all serious events or reactions in relation 
to the trial therapy using the definitions in Table 2.  
Table 2: Relatedness definitions 
Relationship Description Event type 
Unrelated There is no evidence of 
any causal relationship 
Unrelated SAE 
 cxxiii 
 
Unlikely to be related There is little evidence to 
suggest that there is a 
causal relationship (e.g. 
the event did not occur 
within a reasonable time 
after administration of the 
trial intervention). There is 
another reasonable 
explanation for the event 
(e.g. the participant’s 
clinical condition or other 
concomitant treatment) 
Unrelated SAE 
Possibly related There is some evidence to 
suggest a causal 
relationship (e.g. because 
the event occurs within a 
reasonable time after 
administration of the trial 
intervention). However, 
the influence of other 
factors may have 
contributed to the event 
(e.g. the participant’s 
clinical condition or other 
concomitant treatment)  
SAR 
Probably related There is evidence to 
suggest a causal 
relationship and the 
influence of other factors is 
unlikely 
SAR 
Definitely related There is clear evidence to 
suggest a causal 
relationship and other 
possible contributing 
factors can be ruled out. 
SAR 
 
If an SAE is considered to be related to trial treatment, and treatment is discontinued, 
interrupted or modified, refer to the relevant Interventions sections of the protocol. 
6.11.3.4.4 Expectedness 
Please see section 6.11.3.2 for possible adverse events which could be associated 
with this trial. 
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6.11.3.5 Notifications 
6.11.3.5.1 Notifications by the Investigator to NCTU 
NCTU will be notified of all SAEs within 1 working day of the investigator becoming 
aware of the event. 
Investigators will notify NCTU of any SAEs and other Notifiable Adverse Events (NAEs) 
occurring from the time of randomisation until the one month follow up measurements.  
The SAE form will be completed by the research therapist or the blinded assessor, in 
conjunction with the PI, dependent upon who becomes aware of the event occurring. 
In the absence of the responsible investigator, the SAE form will be completed and 
signed by a member of the site trial team and emailed as appropriate within the timeline. 
The responsible investigator will check the SAE form at the earliest opportunity, making 
any changes necessary, sign and then email to NCTU. Detailed written reports will be 
completed as appropriate. Systems will be in place at the site to enable the investigator 
to check the form for clinical accuracy as soon as possible. 
The minimum criteria required for reporting an SAE are the trial number and date of 
birth, name of reporting investigator and sufficient information on the event to confirm 
seriousness. Any further information regarding the event that is unavailable at the time 
of the first report will be sent as soon as it becomes available. 
The SAE form must be scanned and sent by email to the trial team at NCTU on 
MoTaStim–Foot @uea.ac.uk 
Participants will be followed up, until their final follow up measurement, one month after 
completion of the intervention. Follow-up SAE forms (clearly marked as follow-up) 
should be completed and emailed to NCTU as further information becomes available. 
Additional information and/or copies of test results etc may be provided separately. The 
participant must be identified by trial number, date of birth and initials only. The 
participant’s name should not be used on any correspondence and should be blacked 
out and replaced with trial identifiers on any test results. 
6.11.3.5.2 NCTU responsibilities 
Chief Investigator (CI or a clinically qualified delegate) will review all SAE reports 
received. In the event of disagreement between the relatedness assessment given by 
the local investigator and the CI, both opinions and any justifications will be provided in 
subsequent reports.  
The CI is undertaking the duties of trial sponsor and is responsible for the reporting of 
SARs to the REC as appropriate.  
CI will keep investigators informed of any safety issues that arise during the course of 
the trial. 
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The CI, with the support of NCTU, will submit the Annual Safety Report to the REC. 
6.11.4 Quality Assurance and Control 
6.11.4.1 Risk Assessment 
The Quality Assurance (QA) and Quality Control (QC) considerations for the “Sensory 
stimulation of the foot and ankle post-stroke” (MoTaStim-Foot) trial are based on the 
standard NCTU Quality Management Policy that includes a formal Risk Assessment, 
and that acknowledges the risks associated with the conduct of the trial and proposals 
of how to mitigate them through appropriate QA and QC processes. Risks are defined 
in terms of their impact on: the rights and safety of participants; project concept 
including trial design, reliability of results and institutional risk; project management; 
and other considerations. 
QA is defined as all the planned and systematic actions established to ensure the trial 
is performed and data generated, documented and/or recorded and reported in 
compliance with the principles of GCP and applicable regulatory requirements. QC is 
defined as the operational techniques and activities performed within the QA system to 
verify that the requirements for quality of the trial related activities are fulfilled.  
Risks and burdens: 
The intensive nature of the interventions and potential for discomfort has been 
considered during the protocol development phase, with input from both stroke 
survivors and clinicians. The Mobilization and Tactile Stimulation and TSGT are part of 
routine, conventional daily stroke rehabilitation. Potential discomfort of wearing a TI has 
been considered; however, work undertaken with people affected by multiple sclerosis 
has shown general acceptability of this intervention. Participants will be asked to record 
all experiences in their daily diaries as part of the feasibility trial. There is a small risk 
that participating in extra therapy, either MTS or TSGT, might result in an overuse 
syndrome, which presents as pain in the leg / foot and /or fatigue. At the beginning of 
each therapy session, therefore, the research therapist will check for onset/increase of 
leg/foot pain and onset/increase of fatigue. An adverse event will be deemed to have 
occurred if onset/increase of pain or fatigue is recorded on four consecutive therapy 
treatments and the clinical team cannot account for this in any other way than 
involvement in the trial. Participants so affected will be withdrawn from treatment but 
will still be invited to attend the outcome and follow up assessment sessions. 
 
In order to minimise bias in the measurement of blood flow characteristics (PSV and arterial 
diameter) participants will be requested, where possible, to adhere to the pre-test protocol 
stated below.  Adherence to the protocol will be recorded.  The pre-test protocol comprises of 
avoidance of caffeinated drinks, alcohol or smoking for 6 hours prior to data collection, no high 
fat meals or over-exertion from physical activity 2 hours prior to data collection.  Any 
medications consumed in the preceding 4 hours prior to data collection will be monitored.  
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6.11.4.2 Central Monitoring at NCTU 
NCTU will monitor site set up, delegation logs, GCP training and consent form 
completion. As this is a single centre study, data errors and missing key data points will 
be reviewed by the CI.  
6.11.4.3 On-site Monitoring 
The frequency, type and intensity of routine and triggered on-site monitoring will be 
detailed in the MoTaStim-Foot Quality Management and Monitoring Plan (QMMP). The 
QMMP will also detail the procedures for review and sign-off of monitoring reports.  
6.11.4.3.1 Direct access to participant records 
Participating investigators must agree to allow trial related monitoring, including audits, 
REC review and regulatory inspections, by providing access to source data and other 
trial related documentation as required. Participant consent for this must be obtained 
as part of the informed consent process for the trial. 
6.11.4.4 Trial Oversight 
Trial oversight is intended to preserve the integrity of the trial by independently verifying 
a variety of processes and prompting corrective action where necessary. The 
processes reviewed relate to participant enrolment, consent, eligibility, and allocation 
to trial groups; adherence to trial interventions and policies to protect participants, 
including reporting of harms; completeness, accuracy and timeliness of data collection. 
These processes will verify adherence to applicable policies detailed in the Compliance 
section of the protocol. Independent trial oversight complies with the NCTU trial 
oversight policy. 
Trial oversight will occur as described in the MoTaStim-Foot Quality Management and 
Monitoring Plan. 
6.11.4.4.1 Trial Management Team 
The Trial Management Team (TMT) will be set up to assist with developing the design, 
co-ordination and day to day operational issues in the management of the trial, 
including budget management. The membership, frequency of meetings, activity 
(including trial conduct and data review) and authority will be agreed with NCTU and 
Chief Investigator.  
6.11.4.4.2 Trial Management Group 
A Trial Management Group (TMG) will be set up to assist with developing the design, 
co-ordination and strategic management of the trial. The membership, frequency of 
meetings, activity (including trial conduct and data review) and authority will be covered 
in the TMG terms of reference. 
6.11.4.4.3 Independent Trial Steering Committee 
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This is a feasibility study so an independent trial steering committee is not required.  
6.11.4.4.4 Independent Data Monitoring Committee 
As this is a feasibility study there will not be a formal independent Data Monitoring 
Committee; however, a copy of all data will be sent back to Norwich CTU for checking.  
6.11.4.4.5 Trial Sponsor 
 
The role of the sponsor is to take on responsibility for securing the arrangements to 
initiate, manage and finance the trial. Keele University is the trial sponsor and has 
delegated the management of the trial to the Chief Investigator. Queries relating to 
sponsorship of this trial should be addressed to the Chief Investigator. 
 
7 Ethics and Dissemination 
 
7.1 Research Ethics Approval 
 
Before initiation of the trial at any clinical site, the protocol, all informed consent forms 
and any material to be given to the prospective participant will be submitted to the 
relevant REC for approval. Any subsequent amendments to these documents will be 
submitted for further approval. Before initiation of the trial at each additional clinical site, 
the same/amended documents will be submitted for local Research and Development 
(R&D) approval.  
The rights of the participant to refuse to participate in the trial without giving a reason 
must be respected. After the participant has entered the trial, the clinician remains free 
to give alternative treatment to that specified in the protocol, at any stage, if s/he feels 
it to be in the best interest of the participant. The reasons for doing so must be recorded. 
After randomisation the participant must remain within the trial for the purpose of follow 
up and data analysis according to the treatment option to which they have been 
allocated. However, the participant remains free to change their mind at any time about 
the protocol treatment and follow-up without giving a reason and without prejudicing 
their further treatment. 
 
7.2 Competent Authority Approvals 
This is not a Clinical Trial of an Investigational Medicinal Product as defined by the EU 
Directive 2001/20/EC. Therefore, a clinical trial authorisation is not required in the UK.  
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The progress of the trial, safety issues and reports, will be reported to the Competent 
Authority, regulatory agency or equivalent in accordance with relevant national and 
local requirements and practices, where applicable.  
7.3 Other Approvals 
The protocol will be submitted by those delegated to do so to the relevant R&D 
department of each participating site or to other local departments for approval as 
required in each country. A copy of the local R&D approval (or other relevant approval 
as above) and of the Participant Information Sheet (PIS) and consent form on local 
headed paper must be forwarded to the co-ordinating centre before participants are 
randomized to the trial.  
The protocol has received formal approval and methodological, statistical, clinical and 
operational input from the NCTU Protocol Review Committee. 
7.4 Protocol Amendments 
The protocol, informed consent form and participant information sheet will be submitted 
to an appropriate Research Ethics Committee (REC) via an IRAS application and to 
SSOTP R&D for written approval. The CI will submit and, where necessary, obtain 
approval from the above parties for all substantial amendments to the original approved 
documents. 
 
7.5 Consent or Assent 
This feasibility trial has been designed to avoid conflicts of interest so all of the 
recruitment process and research activity will be undertaken by either a member of the 
research team or a research nurse/therapist. Members of the research team or 
research nurses/therapists will provide the potential participants with information on the 
trial, and take informed consent where appropriate and in keeping with the principles 
of GCP. All members of the research team will have honorary contracts/letters of 
access, research passports within the NHS within which the research is conducted. All 
members of the research team will have completed GCP training and will be aware of 
how potential conflicts of interest could arise and the need to avoid these. 
Clinically trained members of the research team will also be registered with the 
appropriate section of the Health and Care Professions Council or other professional 
regulatory organisation as appropriate. Therefore, the clinically trained members of the 
research team will be subject to the same professional conduct regulations as the 
clinical team. Routine and research treatment will be kept distinct. 
PROCESS (This will take place either in the potential participant’s clinical setting within 
an NHS organisation or at their place of residence, as appropriate.) 
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1. A member of the clinical team or a research nurse will screen potential participants 
in keeping with GCP and data protection act standards. 
2. A clinical team member or research nurse will approach potential participants to 
establish whether they would like to find out more about the trial.  Verbal consent will 
be sought for a member of the research team to look at their medical notes and Stage 
1 of the screening process (case note review) will occur to determine whether the 
potential participant is potentially eligible for the trial (i.e. to check: [1] age, [2] time since 
stroke, [3] type of stroke and [4] previous ability to walk independently). 
3. Interested potential participants will be approached by a member of the research 
team or a research nurse/therapist who will: introduce him/herself and discuss the trial; 
explain the purposes of the trial; clearly delineate what is research and what is clinical 
practice; explain potential benefits and risks and go through the Participant Information 
Sheet (PIS). PIS refers to the summary and full participant information sheets, which 
will BOTH be discussed with every participant. Any questions the potential participant 
may have will be answered. The potential participant will then be left with a PIS to read 
and consider further. A record will be kept of the contact and leaving of the PIS, and 
members of the clinical team will also be informed either verbally or in writing. 
A member of the research team or research nurse/therapist will return (after the 
potential participant has been given as much time as they need), establish if the 
participant wishes to take part in the trial, answer any questions about the trial and 
participation, and take consent if appropriate. This contact and the result will be 
recorded and also communicated either verbally or in writing (in the participant’s 
medical notes) to members of the clinical team. Potential participants will also be 
encouraged to discuss their possible involvement in the trial with other people such as 
friends and relatives. If any potential participant wants the researcher to also talk to 
somebody who is significant to them then the researcher will do so. However, it must 
be ensured that informed consent is freely given (see decision making capacity section 
below). 
4. This process may need to be repeated if the potential participant requests more time 
to consider whether or not to become involved. 
Because of (i) the inclusion / exclusion criteria necessary for this trial, and (ii) the wish 
not to create conflicts of interest or create extra work for the clinical team, further 
eligibility screening (Stage 2) of potential participants is required after participants have 
given consent. Therefore, the participants will be informed that if they provide consent, 
there will be a few measures undertaken to check they meet all the inclusion / exclusion 
criteria for the trial. These measures are not a part of routine clinical practice. The need 
for informed consent prior to this additional screening will be explained to the potential 
participant.  
Stage 2: After participants have been given as much time as they need, and then 
consented to take part in the trial, if they wish, the researcher will reiterate that inclusion 
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in the trial is dependent on the potential participant’s performance on a couple of short 
assessments, and explain what these assessments are: [i] Assessment for fixed flexion 
contracture of the tendo Achillis; [ii] Step test; and [iii] ability to follow simple commands 
by imitating actions. 
Should a participant not meet the eligibility (inclusion and exclusion) criteria, but 
indicate continuing interest, then he or she will be followed up no more than three times 
a week (frequency will depend on speed of recovery) until he or she either (i) withdraws 
consent, (ii) meets all eligibility criteria, or (iii) reaches the maximum time since stroke 
for recruitment into the trial. 
At all times during the consent process it will be made explicit that the participant is free 
to refuse to participate in all or any aspect of the trial, at any time and for any reason, 
without incurring any penalty or affecting their treatment. 
Consent will only be taken by researchers or research nurses/therapists who have 
completed GCP training and have been trained in enhanced communication 
strategies*, and have a working knowledge of the Mental Capacity Act (2005) and the 
important aspects of consent, which include: (i) understanding the purpose and nature 
of the research; (ii) understanding what the research involves, its benefits (or lack of 
benefits), risks and burdens; (iii) understanding the alternatives to taking part; (iv) able 
to retain the information long enough to make an effective decision; (v) able to make a 
free choice; and (vi) capable of making this particular decision at the time it needs to 
be made. 
Some stroke survivors experience difficulty making decisions. Either (or both) language 
skills or cognition can be impaired (e.g. attention, memory) which can affect the ability 
to understand information explained to them. They may not be able to understand their 
situation or the consequences of their stroke. They also may not understand about the 
risks or benefits of taking part in the trial and therefore they may not be able to make 
the decision about whether they should participate in the trial or not. 
Before approaching a potential participant, the researcher or research nurse/therapist 
will discuss decision making capacity of individuals with the clinical team. If the clinical 
team believe that communication impairment is too great to allow an individual to give 
informed consent, then the potential participant will not be approached. If the clinical 
team conclusion is that informed consent is possible, albeit with the use of enhanced 
communication strategies, then the researcher will approach the potential participant 
and adapt their communication strategies, as required, in relation to the provision of 
information relating to the trial. 
It will be ensured that all potential participants, whether they have a communication 
impairment or not, are given sufficient time to assimilate information, understand 
information and ask questions. It will be ensured that the participant understands the 
information about the trial and potential consequences of being involved in a trial before 
asking a potential participant to provide written informed consent. 
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* Various communication strategies will be employed including: verbal, hand gestures, 
demonstrations, and diagrammatic presentation of information and checking retention 
and comprehension by asking closed questions, selection of written words or pictures 
and confirmatory checks such as repeating and rewording verbal communication. 
These strategies have proved to be useful in other trials even when potential 
participants do not have a communication impairment. 
 
Simple screening procedures will be used to make sure the potential participants can 
follow simple commands and undertake a task involving imitating actions.  Some 
participants may have dominant arm weakness and difficulty signing the form, or 
speech problems. If this is the case an independent witness will be used to sign the 
consent form, if required, on behalf of the participant. This may be a family member or 
one of the clinical team working with the patient, but not a member of the trial team. 
Consent and the means by which consent occurs (i.e. if there is an independent 
witness) will be documented in the participant's medical notes. Throughout the consent 
and trial processes it will be made clear to participants that they will be free to withdraw 
from the study at any stage. 
A copy of the approved consent form is available from the NCTU trial team.  
 
7.5.1 Consent or Assent in Ancillary Studies 
Not applicable 
7.6 Confidentiality 
Access to medical records by those outside the direct healthcare team will only take 
place after consent is obtained, or by research nurses/therapists, where appropriate 
and local R&D governance deems this acceptable. 
Only anonymous data (by means of issuing each participant a unique trial number) will 
be shared with other organisations. The only identifiable data will be held on purpose 
built forms and stored in lockable cabinets in lockable rooms. Where it is necessary to 
share this information between organisations, for example when reporting a safety 
incident or complaint the paper form will be scanned in and saved in a password 
protected file (password will be emailed to the PI separately), then provided to 
the Principal Investigator who will, open the file, print it and destroy the electronic copy. 
The Trial Manager will then store the paper copy in a lockable cabinet in a lockable 
room. 
Data will be transferred from one secure destination to another secure destination in a 
secure manner. 
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Use of personal addresses, postcodes, faxes, emails or telephone numbers will be 
restricted to the minimum number of people necessary to ensure the efficient and safe 
running of the trial. For example, telephone numbers will be used by members of the 
research team to organise appointments and addresses used to collect and return 
participants for appointments or for the research therapist to visit the participant’s 
residence. 
All electronic data will have access controls restricting the data on a need only basis. 
All data stored on university desktop and laptop computers will be password protected.  
Audio recording devices will be used for the planned focus groups. On transcription, 
pseudonyms will be used to maintain anonymity. When the work is written up for 
publication all direct quotations will be anonymous. 
Time to walk 5 metres will be assessed, and in addition a video recording will provide 
an opportunity for motion analysis, assessing the quality of the walking (gait) pattern. 
Use of videos to analyse gait is commonly used within therapy rehabilitation. An attempt 
will be made at blinding by blanking out the faces. 
7.7 Declaration of Interests 
The investigators named on the protocol have no financial or other competing interests 
that impact on their responsibilities towards the scientific value or potential publishing 
activities associated with the trial.  
7.8 Indemnity 
Keele University holds insurance to cover participants for injury caused by their 
participation in the clinical trial. Participants may be able to claim compensation if they 
can prove that Keele has been negligent.  However, as this clinical trial is being carried 
out in a hospital, the hospital continues to have a duty of care to the participant in the 
clinical trial. For any time that participants are asked to attend the Keele University 
campus, this will be covered by the University’s indemnity. Keele University and UEA 
do not accept liability for any breach in the hospital’s duty of care, or any negligence on 
the part of hospital employees. This applies whether the hospital is an NHS Trust or 
not.   
Participants who sustain injury and wish to make a claim for compensation should do so in 
writing in the first instance to the Chief Investigator, who will pass the claim to Keele University’s 
insurers, via the Sponsor’s office. 
7.9 Finance 
The MoTaStim-Foot trial is fully funded by the NIHR (CDRF-2014-05-065) 
7.10 Archiving 
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The investigators agree to archive and/or arrange for secure storage of MoTaStim-Foot 
trial materials and records for a minimum of 5 years after the close of the trial unless 
otherwise advised by the Sponsor. 
On completion of the trial all data will be stored in accordance with the Keele University 
guidelines for storage of data, (for 5 years from completion of the PhD) and the standard 
procedure guidelines for clinical trials units for any information stored within the CTU in 
Norwich. Standard operating procedures will be followed. Data will be held in a locked 
facility with access limited to appropriate staff e.g. Chief Investigator, supervisors and 
administration staff.  
 
7.11 Access to Data 
Requests for access to trial data will be considered, and approved in writing where 
appropriate, after formal application to the Chief Investigator in consultation with NCTU.  
7.12 Ancillary and Post-trial Care 
Not applicable 
7.13 Publication Policy 
7.13.1 Trial Results 
Wide dissemination within two years of the completion of the trial, utilising a variety of 
arenas from professional forums to general public resources is anticipated, including 
journal articles and conference presentations. 
 
7.13.2 Authorship 
Authorship will in line with the International Committee of Medical Journal Editors guidelines. 
 
7.13.3 Reproducible Research 
Not applicable, as this is a feasibility study. 
8 Ancillary Studies 
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9 Protocol Amendments 
This is the version 1.0 of the protocol. No prior versions of the protocol exist. [A brief 
summary of areas of the protocol that have undergone major amendment along with 
details of the ethics approval dates. Full details of old and new wording should be kept 
according to the NCTU procedures for tracking amendments.] 
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11 Appendices 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Initial screening (case note review): Sensory stimulation of the foot and ankle post stroke:  
A feasibility study (MoTaStim-Foot) 
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Figure 3: Participant eligibility pathway: Sensory stimulation of the foot and ankle post stroke:  
A feasibility study (MoTaStim-Foot) 
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Figure 4: Eligibility Screening: Sensory stimulation of the foot and ankle post stroke: A feasibility 
study (MoTaStim-Foot) 
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Appendix 26  Therapy treatment record 
 
Lower LimbTherapy Treatment Record for Patients in MoTaStim-Foot Trial 
(instructions for completion are on the back) 
 
 
Date  ............ Patient  ID  .................. Therapist  ID  ................. 
 
No. Physiotherapists used ...........No. Rehab Assistants used ..........Estimated duration 
of session ............ 
 
Aims  
1.  To  reduce pain   4. To  improve postural  control 
 
2.  To  improve  sensory awareness 
 
5. To  improve gross  mobility 
 
3.  To improve muscle activity/function    
 
6.  To  improve endurance 
 
    
Gross position of patient during activities used – what about kneeling postures? 
1. Supine lying 
2. Crook lying 
3. Paretic  side lying 
 
  
4. Non-paretic  side 
lying 
5. Sitting  – 90° 
6. Sitting  –  perch  
 
   
7. 4  pt kneeling 
8. 2  pt kneeling 
9. ½  kneeling 
 
  
10. Standing 
11. Walking 
12. Other 
    
  
Equipment used 
1. High hold/surface 
 
 
 
      4.  Perching stool 
 
 
 
 7. Walking aid 
 
 
 
10.  Other 
 
 
2.  Low hold/surface 
 
      5.  Rolled  up towel 
 
 8. Tilt table 
 
  
3.  Hip high 
hold/surface  
 
      6.  Gym ball 
 
 9.  Standing  
frame 
 
  
 
(continued) 
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Adapted from V.M. Pomeroy et al (2005) 
Specific therapy interventions 
1. Soft tissue mobilisation 
1.1 Specific soft tissue mobilisation  
1.2 Passive movement  
1.3 Muscle stretching  
2. Facilitation of activity in specific muscles 
2.1 Imagery of specific muscle activity  
2.2 Specific muscle activation  
2.3 Activation of muscle activity   during function  
3. Facilitation of isolated (selective) joint movement 
3.1 Imagery specific joint movement  
3.2 Active assisted isolated joint movement  
3.3 Facilitate specific joint movement during function  
4. Facilitation of coordinated (combined) movement 
4.1.   Imagery of coordinated patterns of movement  
4.2 Active assisted coordinated patterns of movement  
4.3 Facilitate coordinated movement during function  
4.4 Facilitate leg/foot activity from another   body part  
5. Resistive exer cise  
5.1 Resistance from therapist  
5.2 Resistance from patient’s bodyweight  
5.3 Resistance from equipment  
6. Specific sensory (tactile & proprioceptive) input 
6.1 “Hands-on” techniques  
6.2 Provision of environmental surface  
7. Splinting t e c h n i q u e s  
7.1 Strapping  
7.2 Splinting  
8. Function –  in lying  towards  sitting 
8.1 Therapy “hands-on” techniques to r e -ed posture  
8.2 Re-ed of funct act through specific   mvmnt patterns  
8.3 Rolling –  functional activity training  
8.4.   Bridging –  functional activity training  
8.5 Lying to sitting – functional   activity training  
8.6 Sitting to lying – functional   activity training  
8.7 Static sitting balance training  
9. Function –  in sitting towards s t a nd i ng  
9.1 Therapy “hands-on” techniques to r e -ed posture  
9.2 Re-ed of funct act through specific   mvmnt patterns  
9.3 Dynamic sitting balance training  
9.4 Transfers training  
9.5 Sit to standing – functional   activity training  
9.6 Stand to sit – functional   activity training  
10. Function – in standing towards    walking 
10.1 Therapy “hands-on” techniques to r e -ed posture  
10.2 Re-ed of funct act through specific   mvmnt patterns  
10.3 Static standing balance training  
10.4 Dynamic standing balance training  
10.5 One leg stands activities –    functional training  
11. Function – walking and   onward 
11.1 Therapy “hands-on” techniques to r e -ed posture  
11.2 Re-ed of funct act through specific   mvmnt patterns  
11.3 Overground indoor walking training  
11.4 Overground outdoor walking training  
11.5 Treadmill walking/bicycle training  
11.6 Obstacle negotiation training  
11.7 Ascending/descending stair training 
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 Appendix 27 Participant information sheets (full and summary) 
Study Title: Sensory stimulation of the foot and ankle early post 
stroke: 
a feasibility study (MoTaStim-Foot) 
Participant Information Sheet 
This document is associated with the study protocol version 4.0, dated 
23/10/16. 
An invitation to you 
We invite you to take part in our research study.  Before you decide, we 
would like you to understand why the research is being done and 
what it would involve for you.  One of our team will go through the 
information sheet with you and answer any questions you have.  This is 
likely to take approximately 30 minutes. 
Please talk to others about the study if you wish. 
 
Part 1 of this information sheet tells you the purpose of this study and 
what will happen if you take part. 
 
Part 2 of the information sheet gives you more detailed information 
about the conduct of the study. 
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Please ask if there is anything that is not clear.  Page 17 has the names 
and contact details of people who can help. 
  
What is the purpose of this study? 
Many people who have had a stroke may experience difficulty 
balancing and walking. Therapists (Physiotherapists and Occupational 
Therapists) use many different techniques to try and improve balance and 
walking after stroke, to help people return to their usual daily activities, for 
example walking around the house and up and downstairs.  
One technique used by therapists when treating people with stroke is ‘task 
specific walking training’. This involves the person repeating various 
tasks such as sit-to-stand, stepping onto and off a low step and walking 
training. This ‘task specific walking training’ may work better if people are 
given a therapy beforehand to prepare (stimulate) the nerves in their feet 
and ankles. The nerves can be stimulated in different ways.  
 
This is a feasibility study, a piece of research which is being done before 
a larger study in order to answer the question “Can this study be done?” 
We are checking that it is possible to deliver the treatments (the nerve 
stimulation techniques) and to undertake the necessary measurements 
prior to doing the large study. 
In the future a large study is needed to find out whether stimulating the 
nerves in the foot and ankle helps people to recover their balance and 
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walking more quickly, and to find out which nerve stimulation technique 
works best.  
 
Why have I been invited to take part in the study? 
We are looking for people who have been, or are a patient of the 
Staffordshire and Stoke-on-Trent Partnership NHS Trust Stroke 
Services and who have recently had a stroke and may benefit from 
therapy to help improve their balance and walking.   
  
 
You are the sort of person we are looking for.  For example, you  
• Are aged over 18 years; 
• Have had a stroke between 6 and 16 weeks ago (42 and 112 days); 
• Have some loss of control of your legs after your stroke; 
• Are able to use your stronger arm to imitate the action of another 
person; 
• Were able to walk without help before your stroke. 
 
Do I have to take part? 
We will explain the study by going through this information sheet with 
you.  It is then your decision whether or not you wish to participate.  
If you agree to take part, we will then ask you to sign a consent form.  
You are free to withdraw from the study at any time, without giving a 
reason.  This would not affect the standard of the care you receive.     
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If you are unable to write or hold a pen (either due to the effects of your 
stroke or for another reason), you can choose an independent person 
to sign the consent form, or if you prefer, an independent person will be 
found for you, to write on the consent form.  The independent person 
may be a member of your medical team, a family member or friend.  
This independent person cannot decide for you if you should take part 
and you will not be asked or made to do anything you do not want to 
do.   
What will happen to me if I take part? 
If you decide to take part, you will be one of 34 participants in this 
research and we will work with you and your medical team to try to make 
sure that your taking part in the  
research suits everyone.  We will tell your medical team that you have 
agreed to take part in this study. 
 
In addition to the routine therapy you may be receiving from your 
rehabilitation team, you will receive extra therapy for up to 5 days a 
week for up to 6 weeks, until you have received 20 treatments.   
 
Sometimes we do not know which way of treating patients is best.  To 
find out, we need to compare different treatments.  To try to make sure 
both groups are the same to start with, each participant will be put 
into a group by chance (randomly) using a computer programme.  
Therefore, you cannot choose which research therapy (Therapy 1 
and Therapy 2) you are given.  
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What is the extra therapy? 
Therapy 1) Mobilization and Tactile Stimulation (MTS) is a form of 
therapy treatment. It involves handling the foot and ankle, 
mobilizing and stretching the joints and tissues, preparing the 
foot for placement on the floor and for functional activities 
such as sitting to standing, balancing and walking.  
MTS patients will receive therapy lasting between 30 minutes 
and one hour, followed by up to 30 minutes of task specific 
walking training, as appropriate for you. You will receive up 
to 20 sessions of this treatment.  
Therapy 2) Textured insoles are insoles which can be inserted in your 
own shoes and can be moved from shoe to shoe. They have a 
textured surface, meaning they are covered in bumps. These 
bumps stimulate the nerves in the sole of the foot. Patients in 
this group will have a textured insole inserted in the shoe, on 
the side affected by the stroke, and a smooth insole in the other 
side, to be worn for as much of the day as possible (as 
appropriate for you), and during your 30 minutes of task 
specific walking training. You will receive up to 20 sessions of 
this task specific walking training.  
As is usual practice following a stroke, both groups will also be given task 
specific walking training. 
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What is task specific walking training?  
Task specific walking training is a part of routine therapy practice 
following a stroke. It involves practising activities such as sitting to 
standing, standing balance, stepping and walking.   30 minutes of task 
specific walking training will be given after the MTS treatment or whilst 
wearing the textured insoles. 
 
What else will I have to do? 
 
• Aside from the additional therapy provided, you will also have 
assessments, where we will measure your strength, movement, 
feeling and blood flow in your lower leg.  The first will take place 
soon after you agree to take part in the research.  Blood flow studies 
may also be done to assess the immediate effects of MTS treatment 
on blood flow, before and after a single MTS treatment (if you are 
allocated to this group).  Measures will take place after 5 treatments, 
10 treatments and then 15 treatments, with the sixth assessment 
after all 20 treatments have been delivered and the last assessment 
one month later, to check if any changes are maintained.   The 
measurement of blood flow will only be performed if our 
specialist research therapist and equipment are available.  You 
will be advised if blood flow measures are to be included when 
you discuss your participation with a member of the research 
team. 
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• All treatment sessions and assessments will either take place in your 
home, at the Haywood Hospital, Staffordshire and Stoke-on-Trent 
Partnership NHS Trust, Stoke on Trent or at Keele University 
rehabilitation research facility. 
• During your 20 sessions of treatment you, or someone on your 
behalf, will be encouraged to complete a simple daily diary, with tick 
boxes relating to how your affected leg is feeling, or if there are any 
changes following the treatment or measurements 
• After you have finished the 20 sessions you will be invited to attend 
a focus group with approximately 6-8 other people who have 
received the same treatment as you (either MTS OR textured 
insoles), this may be several months later. Focus groups are a form 
of interview where a few people discuss topics with other group 
members and the researcher and the discussion will be recorded. 
The purpose of the focus groups is to find out what you thought of 
the treatments, how your foot feels and whether it has made any 
difference in your daily activities.  
 
How long does the research last? 
The treatment and assessment phase of the research will last for up 
to 3 months.  However, you will only receive the extra therapy within 
the first 6 weeks of involvement with the study. This duration of 
treatment has been shown to be long enough to assess whether the 
treatment has any effect. You will also be invited back to take part in a 
focus group, which will take place within the following twelve months.  
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This Diagram is an overview of what taking part in the research would 
involve: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YOUR PROGRESS THROUGH THE STUDY 
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2Please note the blood flow studies will only be undertaken if the specialist 
research therapist and equipment are available 
What do the assessments involve? 
Each assessment uses a number of tests of: how well you are able to 
use your weaker leg; how well you feel with your foot; and what 
impact the stroke has had on you. The assessments will take place 
soon after agreeing to take part in the research, regularly during your 
treatment and one month after finishing the treatment.  The initial 
assessments at the start of the study, on completion of the treatments 
and at one month after completion of the treatments, will last 
approximately 1 hour and 30 minutes. The regular assessments 
throughout your treatment (assessments 3, 4 and 5) will only take 
approximately 20-30 minutes.  
 
The researcher doing some of the assessments, once you have finished 
your additional therapy, will not know which group you are in and 
cannot influence the findings. This is called “blinding”. Please do not tell 
the assessor which group you are in. 
 
In more detail the assessments are: 
• Pressure under the feet.  
For these assessments you will be asked to put a pressure measuring 
device in your shoe, which is connected to a computer. You will be 
asked to walk, providing you are able to walk. This will take 
approximately 10 minutes. 
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• Ankle range of movement 
You will be asked to walk and the movement in the ankle affected by 
your stroke will be measured. This will take approximately 10 minutes. 
 
• Sensory testing 
The foot affected by your stroke will be tested to see whether and how 
much you can feel, and compared to the other side. It involves 
touching the sole of your feet. This will take approximately 5 minutes. 
 
• Lower Extremity Motricity Index (a quick test of your leg strength in 
sitting) 
This will measure the strength of your hips, knees and ankles. This will 
take approximately 5 minutes. 
 
• 5 metre walk test 
If you are able to walk, you will be asked to walk 5 metres (m) as 
quickly as you feel able. If you are unable to walk you will not be 
expected to undertake this assessment. A video recording will be 
made of your 5m walk. This will take approximately 10 minutes.  
 
• Blood flow studies 
The flow of blood in your legs may be assessed at the beginning of the 
study, after all 20 interventions and at one month follow up taking 
approximately 25 minutes to complete.  If you are in the MTS therapy 
group, this may also be done before and after one of your first ten 
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treatments (to assess the immediate effects of the treatment). Firstly, your 
resting blood pressure will be taken (and your height and weight, if not 
available in your medical notes). An ultrasound machine will be used on 
the surface of your skin. It is important to examine your blood flow at 
approximately the same time each day, on each occasion. A record of your 
age, height, weight and resting blood pressure will be required for this 
assessment.  If having blood flow studies you will also be asked to: 
- Not drink caffeinated drinks e.g. coffee, tea and coke, and also alcohol 
or smoking for 6 hours prior to assessment 
- Not take medications (if feasible and safe) for 4 hours prior to 
assessment 
- Avoid physical activity for 2 hours prior to assessment 
- Avoid high fat meals 2 hours prior to assessment 
• Modified Rivermead Mobility Index 
This is a specific test which looks at what you are able to do. It will 
assess your ability to do some functional activities e.g. rolling over in 
bed, sitting, and standing. This will take approximately 17 minutes.  
 
• Functional Ambulation Category 
This will assess your walking ability and how much help you require. It 
will be undertaken by the researcher – you will not have to do 
anything. The researcher will just assess your ability to walk following 
the 5m test. This will not take any extra time for you, it will just take the 
researcher 2 minutes to complete. 
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• National Institutes of Health Stroke Scale 
This is an assessment of how your stroke has affected you and will 
only be completed once, at the beginning of the study. This will take 
approximately 15 minutes.  
 
Focus Groups 
Within twelve months of you completing your 20 sessions of treatment 
you will be invited to attend a focus group (lasting no longer than 1½ 
hours). You will be given the opportunity to tell us about your experiences 
(physical and emotional) as a participant in the study. The focus group 
will be audio taped.  
 
Expenses and payments 
We cannot pay you to take part in the research but will arrange and 
pay for any taxi journeys you may need, to take you to and from the 
assessments, or to go for extra therapy. It will not cost you money to take 
part in the research. 
 
Will I stop getting any treatment? 
If you take part in the research, you will still receive all the treatment 
that you would receive if you did not take part. 
 
What are the possible disadvantages and risk of taking part? 
There is a small risk that you may experience some discomfort caused 
by working muscles or mobilization techniques during the extra therapy, 
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or from pressure from the textured insoles.  If you tell us you are in 
discomfort we can stop the extra therapy that day. You will be able to 
choose how long to wear the textured insoles for, so if they are 
uncomfortable you can just take them out of your shoes.  
 
Blood flow will be assessed by applying a gel to the skin of your leg / foot 
and using an ultrasound machine to measure the flow of blood in your 
vessels. There is, to date, no evidence that diagnostic ultrasound has 
produced any harm to humans and it is commonly used in pregnant 
women. 
 
Before all of the assessments we will ask you questions to ensure it 
is safe for you to continue. If we think that it is not safe for you to 
proceed then you will not have that particular assessment. 
 
We will make every effort to minimise any risk to you as we follow a 
range of safety standards and best practice policies. 
  
What are the possible benefits of taking part in the study? 
All participants will undergo a comprehensive assessment and will 
receive extra therapy. However, we do not know if this will lead to health 
benefits. The information we get from the study may help improve the 
treatment for other people in the future who have survived a stroke. 
What happens when the study stops?  
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When the study stops, you will return to the usual care provided by the 
local stroke team. Whether or not you take part in this research will make 
no difference to either the type or amount of therapy you may receive from 
the clinical team 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study 
or any possible harm you might suffer will be addressed.  Detailed 
information on this is given in part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about 
you will be handled in confidence.  The details are included in Part 2. 
 
This completes Part 1. 
If the information in Part 1 interests you and you are considering taking 
part, please read the information in Part 2 before making any decision.
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Part 2 
What happens if new information becomes available?   
Very few studies have been done about Mobilization and Tactile 
Stimulation (MTS) or the use of textured insoles after stroke. But, 
sometimes we get new information.  If this happens, your researcher will 
tell you and discuss whether you should continue in the study.  If you 
decide not to carry on, your usual routine care would still continue.  If you 
decide to continue with the study, we may record the fact that we 
discussed the new information with you.   
 
What happens if I do not want to carry on in the study? 
You may withdraw at any time without giving a reason.  
Withdrawing from the study will not affect your treatment now or at any 
time in the future by any healthcare team. If you withdraw from the study, 
any information already collected may still be used. 
 
What if there is a problem? 
If you have a concern about this study, you should ask to speak to your 
researcher who will answer any questions or find someone who can.  Your 
researcher’s contact details can be found on page 18. 
If you remain unhappy or wish to complain formally, you can do this 
through the NHS Complaints Procedure. Details can be obtained from:     
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/complaints/Pages/
NHScomplaints.aspx. Alternatively, you could call the Stoke-on-Trent, 
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North Staffordshire and South Staffordshire Team Patient Advice and 
Liaison Services (PALS) on 0800 783 2865. 
What if I am harmed? 
If something does go wrong and you are harmed during the research study 
there are no special compensation arrangements.   
If you are harmed due to someone’s negligence, then you may have 
grounds for legal action for compensation against this, but you may have 
to pay your own legal costs. 
 
Will anyone else know that I am in this study? 
We will inform your medical team that you are taking part in the study.  
 
If we are concerned at any time about your health during your 
participation in this study we will report this to someone in your medical 
team. 
 
We will not inform your GP directly that you are taking part in this study, 
however, if there are any concerns about your health we will report this 
issue, with your permission to your consultant, your GP, or one of the 
clinicians involved in your care.  
 
Who is organising the research? 
This research is funded by the National Institute for Health Research 
(NIHR) as part of a Clinical Academic Doctoral Programme.   The 
clinical centre is Staffordshire and Stoke-on-Trent Partnership Trust. The 
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Research Team at Keele University, with support from Norwich Clinical 
Trials Unit are responsible for organising and running the study, led by 
Alison Aries, supervised by Dr Susan Hunter, both from the School 
of Health and Rehabilitation, Keele University. 
 
Will my taking part in the study be kept confidential? 
The research team will be able to access information about you that is 
relevant to the study, from your medical notes. All information which is 
collected about you during the course of the research will be kept 
strictly confidential, and except for the consent form information about 
you will have your name removed, so that you cannot be recognised. 
Your face will be blanked out if video recordings are used in the 
presentation of the research findings, to try to ensure anonymity. 
Pseudonyms (false names) will be used when reporting findings from the 
focus groups.  
 
The data will only be accessed by authorised persons within the 
Research Team, Research and Development Office of the NHS 
Trusts and trial Sponsor representatives, who ensure the quality of the 
research carried out. Information may include details such as your date 
of birth and the date and diagnosis of your stroke.  Personal 
information such as your address will be required to allow us to send you 
information about the results when the study is finished and visit you at 
home during the research, if this is appropriate.  This information along 
with your NHS number may be collected from your medical notes. 
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You will be given a study number for the purpose of collecting and 
analysing data. This means you will remain anonymous. 
 
 
How will my information be stored?  
Data will be stored securely in research offices at Keele University and 
Norwich Clinical Trials Unit during the study and for 1 year after the 
study. On completion of the study all data will be stored in accordance 
with the Keele University guidelines for storage of data, (for 5 years from 
completion of the feasibility study).  All procedures for handling, 
processing, storage and destruction of data are compliant with the 
Data Protection Act 1998. All computer files will either be stored in a 
secure user authenticated area or encrypted to protect them from 
unauthorised access.  All the computer files will be anonymous. 
What will happen to the results of the research study? 
The results of the study will be analysed and used to inform the design of 
a future, larger study about MTS and textured insoles. 
The results will be published in academic journals and shared with 
colleagues at conferences but individual participants will not be 
identifiable. In some cases, information e.g. from the daily diaries may be 
presented in an anonymised case study format to show the participant’s 
journey through the trial. If this is the case for you the researcher will 
discuss this with you and offer you the opportunity to read the information 
and verify that you think it is accurate. Participants can be sent a report of 
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the study when it has been completed. Please contact the researcher 
Alison Aries to request this. 
Who has reviewed the study?  
The study has been reviewed by the National Institute for Health 
Research. 
The study will be monitored by a Trial Management Group who will put 
your safety above everything else. 
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Further Information and Contact Details  
      
     Alison Aries      
 Chief Investigator / Research Therapist 
 a.m.aries@keele.ac.uk 
 
       
OR 
Dr Susan Hunter, Supervisor 
s.m.hunter@keele.ac.uk 
  
All of the research therapists can be contacted by post:  
School of Health and Rehabilitation, Keele University, Keele,  
Staffordshire, ST5 5BG. 
 
Independent Contact Details: 
If you wish to discuss this study with someone who is not involved in the 
research then you can contact the Stoke-on-Trent, North Staffordshire and 
South Staffordshire Team Patient Advice and Liaison Services (PALS) 
on0800 783 2865. 
Thank you for taking the time to read this information. If you choose 
to participate, you will keep a copy of this participant information 
sheet and the completed consent form. 
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Sensory stimulation of the foot and ankle early post stroke: 
a feasibility study (MoTaStim-Foot) 
Participant Information Sheet – SUMMARY SHEET  
This document is associated with the study protocol version 4.0 dated 
23/10/2016 and the full participant information sheet (Version 1.4). 
What is the purpose of this study? 
Many people who have had a stroke may experience difficulty balancing and 
walking. This is a feasibility study, which is being done before doing a larger 
study. The study will look at stimulation of the foot (by a therapist massaging and 
stretching, a treatment called Mobilization and Tactile Stimulation [Therapy 
1], or wearing a textured insole, which is covered in small bumps [Therapy 2]).  
In total 34 people will take part in this trial. We are offering you a chance to be 
included. In addition to your routine therapy you would receive one of the above 
therapies plus ‘task specific walking training’ (20 sessions in total over 4-6 
weeks). You will be asked to keep a short, simple diary of your experiences and 
how your leg feels and invited to a meeting (focus group) afterwards. There will 
also be assessments, to measure the strength, movement, feeling in your 
lower leg.  Blood flow measures may also be taken along with your blood 
pressure, height and weight. You would be involved for a maximum of four 
months. 
Why have I been invited to take part in the study? 
We are inviting you to take part because we are looking for people who have 
recently had a stroke. We want to find out if therapy can change balance and 
walking. 
Do I have to take part? 
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We will explain the study to you, going through the full information sheet, 
which will take approximately 30 minutes.  It is then your decision whether 
you wish to participate in this study.  If you agree to take part, we will then 
ask you to sign a consent form.  You are free to withdraw from the study 
at any time, without giving a reason.  This would not affect the standard of 
the care you receive.     
Further Information and Contact Details  
      
     Alison Aries      
 Chief Investigator / Research Therapist 
 a.m.aries@keele.ac.uk     OR 
Dr Susan Hunter, Supervisor s.m.hunter@keele.ac.uk 
All of the research therapists can be contacted by post:  
School of Health and Rehabilitation, Keele University, Keele,  
Staffordshire, ST5 5BG. 
 
Independent Contact Details: 
If you wish to discuss this study with someone who is not involved in the 
research then you can contact the Stoke-on-Trent, North Staffordshire and 
South Staffordshire Team Patient Advice and Liaison Services (PALS) on 
0800 783 2865. 
Thank you for taking the time to read this summary information sheet.  
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Appendix 28  Emails relating to the summary and full participant 
information sheets 
Date: Fri, 7 Aug 2015 21:30:30 +0100 
Subject: Re: Participant Information Sheet (PIS) 
From: a.m.aries@keele.ac.uk 
To  
CC: a.m.aries@keele.ac.uk 
 
Dear Alan 
Thank you - that is absolutely perfect feedback but it is an expectation that everything is explained fully to 
the participant so they can make an informed choice as to whether they wish to take part or not. I probably 
do not have a lot of choice about that - sorry! 
Many thanks once again. 
Ali  
 
 
Alison Aries MSc MCSP  
National Institute for Health (NIHR) Research Fellow 
School of Health and Rehabilitation 
Keele University 
Staffordshire 
ST5 5BG 
01782 734418 
 
On 7 August 2015 at 20:24, alan > wrote: 
hello Alison, thank you for you e mail and the information sheets,which I am having a look through, and will 
get back to you asap, while I am on though, may I ask you a question regarding the info sheets,    there are 
20 sheets in total and as you say will take approx. 30 mins to explain to participants,   do you think it is a lot 
for a person who has had a stroke maybe 6 or so months previous to take in, please do not think I am being 
too forward in thinking this but I know from past experience the situation a stroke survivor is in for a long 
time, and obviously you and mel know far far better than I do,   please correct me if you think I am being too 
much,and please excuse if I am speaking out of turn, meanwhile I will continue to read the sheets,   our best 
wishes as always  
  
 
Date: Wed, 5 Aug 2015 23:03:23 +0100 
Subject: Participant Information Sheet (PIS) 
From: a.m.aries@keele.ac.uk 
To:   
CC: a.m.aries@keele.ac.uk 
Dear  
I have made a few changes to the participant information sheet (easy to see because they are all in red!). 
The reason for the changes are:  
1)Some of the wording was too similar / identical to another study which I based the PIS on. 
2) We will also be looking at blood flow so I have added some information about this too. 
I would be grateful if you have the time to look at it and let me know if you think it is OK or not. 
Many thanks 
Ali  
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Re: Summary participant information sheet. 
  
 
  
 
 
 
01/12/201
5 
 
 
 
 
 
Dear Alison 
My apologies for the delay in replying to your e-mails but unfortunately it is just over a 
week since my last discharge from hospital. I have, however, found time to read both 
PIS docs. I  found them both to be excellent pieces of work & totally fit for purpose. 
My congratulations on a job well done!!!! 
 
From: Alison Aries <a.m.aries@keele.ac.uk> 
To:  >  
Cc: Alison Aries <a.m.aries@keele.ac.uk> 
Sent: Thursday, 26 November 2015, 14:25 
Subject: Summary participant information sheet. 
 
Dear  
Please find attached a summary participant information sheet (PIS). In view of the 
length of the other PIS I felt it may be useful to have an introductory sheet. It would 
have to be used in addition to the other PIS (because of the required information). I 
would be very interested in hearing your opinions on this summary sheet too. It is 
literally one sheet (front and back). Please let me know if you require a hard copy of 
this. 
Many thanks in anticipation. 
Best wishes 
Alison 
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Appendix 29  
                                                 
CONSENT FORM 
Study Title: Mobilization and sensory stimulation of the foot and ankle 
post stroke: a feasibility study 
 
Name of researcher: ___________________________ 
 
Name of participant: ___________________________ 
 
NB If the potential participant is unable to write, please find an independent 
witness who may complete this form as verbal consent is given by the potential 
participant. The independent witness should read each of the five items to the 
potential participant and if the participant agrees, the independent witness 
should initial each of the boxes with his/her own initials.  
The purpose of the independent witness is to physically complete this consent 
form on the instruction of the participant in the instance that the participant 
cannot do so for himself or herself due to physical inability to hold and or use a 
pen, or in the instance in which attempting to do so would or appears to cause 
distress to the participant. The independent witness cannot provide consent on 
behalf of a participant.  
An independent witness must: 
• Not be a part of the research team 
• Not be managed by a member of the research team 
One original copy of this form should be completed. The original should be 
stored in the investigator site file. Two photocopies should be made of the 
original, one copy for the participant and one copy to be placed in the 
participant’s medical notes.  
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 This document should be used together with the Participant 
Information Sheet Version 1.4 dated 23/10/16 
1. I confirm that I have read and understood the Participant Information 
Sheet dated 23/10/16 (Version 1.4) for the above study. I have had the 
opportunity to consider the information and ask questions, and have had 
these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical care or 
legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals for the 
research team, from regulatory authorities, Norwich Clinical Trials Unit or 
from the NHS Trust to allow trial related monitoring, including audits, REC 
review and regulatory inspections, where it is relevant to my taking part in 
this research. I give permission for these individuals to have access to my 
records.  
 
4. I understand that the information collected about me will be used to support 
other research in the future, and may be shared anonymously with other 
researchers.  
 
5. I consent to the focus groups being audio-taped. 
 
6. If I choose to record daily diary information by audio clip, I give permission 
for the transcribed information to be used to support other research in the 
future, and that it may be shared anonymously with other researchers 
 
7. I consent for my walking to be videoed. 
 
8. I agree that my consultant, nurses and therapists in the clinical team can 
be informed of my participation in the study. I agree for them to be told of 
any concerns the research team may have about my health during the 
study. 
 
9. I agree to keep the issues discussed within the focus group confidential, in 
particular to avoid identifying any of the participants involved. I understand 
that all data collected about me during this study will be anonymised before 
it is submitted for publication. 
 
 
10. I agree to the use of any quotes. 
 
 
11. I agree to take part in the above study 
Please 
initial 
each 
box 
below 
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Please ask either the participant or, if appropriate, the independent witness to sign, 
print their name and date this form in long format below. Please then countersign, 
print and date in long format in the spaces below.  
 
 
 
Signed (participant):   _______________________________________ 
 
 
Print name (participant): _______________________________________ 
 
 
Date: (DD-MM-YYYY)         _ _. _ _ . _ _ _ _ 
 
or 
 
Signed (independent witness):   
 
 _______________________________________ 
 
 
Print name (independent witness):   
 
_______________________________________ 
 
 
Date: (DD-MM-YYYY)         _ _. _ _ . _ _ _ _ 
 
 
And 
 
 
 
Signed (researcher):   _______________________________________ 
 
 
Print name (researcher):   _______________________________________ 
 
 
Date: (DD-MM-YYYY)          _ _. _ _ . _ _ _ _  
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Appendix 30  National Institutes for Health Stroke Scale (NIHSS) 
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Appendix 31 Functional Ambulation Classification (FAC)
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Appendix 32 TI daily diary
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Appendix 33 MTS daily diary 
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Appendix 34 SWMs protocol for testing 
Protocol for the Semmes Weinstein Monofilament (SWM) testing 
The Semmes Weinstein Monofilament (SWM) testing allows for the assessment of light 
touch sensation. The calibrated 20-piece SWM kit (Patterson Medical) should be used.  
Four points of the plantar surface of the foot should be tested: 
1. Under the heel, in the midline of the foot, 1 cm forwards of the back of the heel.  
2. Under the pad of the hallux 
3. Under the 1st Metatarsal joint 
4. Under the 5th metatarsal head 
 
Commence by explaining the testing procedure to the participant and letting them feel 
the 2.83 SWM, on the hand (thenar eminence), of the side which is less affected by their 
stroke.  
 
Then proceed to test each point in turn using the following procedure: 
When applying the stimulation, you should take 1.5 seconds to apply the SWM, leave it in 
touch with the skin for 1.5 seconds and then remove for 1.5 seconds (one touch – do not 
repeat). The instruction to the participant is ‘tell me when you can feel something’. NB 
Filaments must be applied at a 90-degree angle to the skin which is being tested. 13 
 
 
13 Adapted from 2000 North Coast Medical Inc. Morgan Hill 
 SWM Code Target Force (grams) Threshold 
1 1.65 0.008  
2 2.36 0.02 
3 2.44 0.04                    
4 2.83 0.07 
5 3.22 0.16 
6 3.61 0.4 
7 3.84 0.6  
8 4.08 1 
9 4.17 1.4 
10 4.31 2 
11 4.56 4 
12 4.74 6 
Touch-Test Sensory Evaluator 
Normal plantar 
threshold 
Diminished light 
touch 
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Commencing at 
SWM 2.83 
(which is in the 
middle of the 
normal 
threshold for 
plantar 
threshold 
normative 
touch-pressure 
data). Please 
follow the flow 
chart below: 
 
 
 
The decision to apply a thinner or thicker diameter SWM is determined by the subject’s 
positive or negative detection of the stimulus. A positive detection is observed when 
13 4.93 8 
 
14 5.07 10  
15 5.18 15 
16 5.46 26 
17 5.88 60 
18 6.10 100 
19 6.45 180 
20 6.65 300 
 Deep pressure sensation 
only 
Start with SWM 2.83 – 
able to feel it? 
Yes Test with SWM 1.65, then 2.36, then 2.44 
No Test with SWM 3.22, then 3.61 
Able to feel SWM 3.61? 
Yes Test with SWM 1.65, then 2.36, then 2.44 
No Test with SWM 4.31 
Able to feel SWM 4.31? 
Yes Test with SWM 3.84, then 4.08, then 4.17 
No Test with SWM 5.07 
Able to feel SWM 5.07? 
Yes Test with SWM 4.56, then 4.74, then 4.93 
No Test with SWM 6.65 
Able to feel SWM 6.65? 
Yes Test with SWM 5.18, 5.46, 5.88, 6.10, then 6.45 
No Record a score of 0 – unable to feel 
Diminished protective 
sensation 
Loss of protective 
sensation 
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subjects indicate verbally that they feel the stimulus within 1 second of the stimulus being 
removed, by saying “yes.” If subjects do not indicate they feel the stimulus or have a 
delayed response (saying “yes” greater than 1 second following removal of the stimulus), 
it should be considered a negative detection. A positive detection should lead to a thinner 
diameter being tested. A negative detection (i.e., no verbal response) should lead to a 
thicker diameter SWM being tested. Time between stimuli should be varied so the subject 
does not preempt the application pattern. 
The SWM perceived most consistently should be recorded as the sensation threshold. 
Thicker diameter SWMs involve a greater force and are associated with decreased light 
touch sensitivity. 
 
NB For baseline and end of intervention both sides should be assessed with the 
SWMs, however, for all other assessments just the affected foot should be 
assessed.  
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Appendix 35 LEMI protocol 
Lower Extremity Motricity Index (LEMI) Protocol 
Motricity Index (MI) 
 
The LEMI is a valid and reliable measure used to determine the strength of the 
paretic limb (leg). Scores range from 0 (no activity) to 33 (maximum muscle force) for 
each dimension.  
The procedure described by Fayazi (2011) should be followed: 
Participants should sit in a chair with a back support.  
Dorsiflexion: should be assessed from a position of relaxed plantar flexion. The 
assessor should place a hand on the forefoot. The participant should be asked to 
dorsiflex the foot (as if standing on your heels’), and the assessor should resist the 
contraction of tibialis anterior and palpate for muscle activity.  
Knee extension: should be tested from a position where the knee is bent at 90° 
flexion with the foot unsupported (if possible).  The assessor should ask the 
participant to extend the knee. During this movement the assessor should monitor the 
contraction of the quadriceps with the other hand. The score should be recorded (see 
below).  
Hip flexion:  should be tested with the hip joint with a 90 ° bent. Instruction to the 
participant is ‘to bring the knee towards the chin, assessor should monitor the 
contraction of hip flexors (iliopsoas) by placing a hand on the anterior of the distal of 
thigh. The assessor should then resist the movement. The quality of muscle 
contraction score should be recorded in accordance with the quality of the contraction 
(see below). The assessor should be aware of any trick movements e.g leaning 
backwards during the movement. This should be monitored by placing one hand on 
the participant’s back.  
Finally, all three scores should be added together and the Motricity Index for the lower 
extremity should be calculated.  
 Tests for Each Leg:  
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(1) ankle dorsiflexion with foot in a plantar flexed position  
• 14 points are given if there is less than a full range of dorsiflexion  
(2) knee extension with the foot unsupported and the knee at 90°  
• 14 points are given for less than 50% of full extension (i.e. 45 degrees 
only) 
• 19 points are given for full extension yet it can be easily pushed down  
(3) hip flexion with the hip bent at 90° moving the knee towards the chin  
• 14 points are given if there is less than a full range of possible passive 
flexion, check ROM  
• 19 points are given if the hip is fully flexed yet it can be easily pushed 
down 
                                                                  
                          
                                                                                                 
                                                                      
 
 
 
 
 
        MRC Grade 
 
        MRC Score        Points for Tests 
      no movement  
 
0 0 
      palpable flicker but no 
      movement 
 
1 9 
     movement but not 
     against gravity 
 
2 14 
     movement against 
gravity 
 
3 19 
     movement against 
resistance 
4 25 
     Normal 
 
5 33 
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NB Only give a score of 33 for normal if both legs are the same i.e. the 
resistance applied when testing is equal. 
 Total score for each leg should be recorded. i.e. all three scores should be added up 
+1 point 
Minimum score: 0  
Maximum score: 100 
 
 References:  
Wade D. Measurement in Neurological Rehabilitation 1992 Oxford University Press, 
New York. 
Fayazi M, Dehkordi S N, Dadgoo M, Salehi M 2012 Test-retest reliability of Motricity 
Index 
strength assessments for lower extremity in post stroke hemiparesis. Medical Journal 
of Islamic 
Republic of Iran, Vol. 26, No. 1, Feb. 2012, pp. 27-30 
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Appendix 36 modified Rivermead Mobility Index 
Guidelines for the Modified Rivermead Mobility Index  
 
PREPARATION  
• The assessor needs a stopwatch, a tape measure, a chair and access to a bed 
and a flight of stairs. The patient should be wearing his/her normal clothes and 
footwear.  
 
GENERAL OBSERVATIONS  
• It is essential that the patient perform each item as independently as possible. 
The assessor should only assist the patient if safety is at risk.  
The assessor should not facilitate the patient’s performance to improve 
the quality of the movement.  
• It is preferable to score the patient’s performance at the beginning of a therapy 
session to minimize any potential carryover effects of the therapy session.  
• The assessor should always carry out the test in the same way for example by 
the patient’s bedside or in the gym using a plinth and using the same chair. The 
height of the bed or plinth should be adjusted to 45 cm. If this is not possible 
note down the height of the bed and the chair used for re-testing purposes at a 
later date.  
• The instruction is verbal supplemented by demonstration where necessary.  
• The patient is instructed to start performing each item towards the unaffected 
side. If you wish to score appropriate activities bilaterally, please start with the 
unaffected side first. You will need to prepare a separate column for each side, 
please add up the score independently for each side.  
• If the overall score is to be used as a basis of comparison between patients, 
there needs to be a difference of more than 4.5 points in the overall score to 
detect actual changes in the patient’s level of mobility.  
 
SCORING OF ITEMS  
(1) If the patient turns over in bed by pulling himself/herself over with his/her unaffected 
arm, this counts as using an aid. The patient should be asked to roll onto his unaffected 
side first. Both sides can be tested if appropriate.  
(2) The patient should be asked to sit up while lying on his/her unaffected side first. 
Pulling himself/herself up on the edge of the bed with the unaffected arm counts as 
using an aid.  
(3) The use of the hands to hold on constitutes an aid.  
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(4) The use of the hands to push up into standing constitutes an aid.  
(5) The patient should start the transfer towards the unaffected side.  
(6) Using a railing constitutes using an aid.  
(7) Supervision or verbal instruction excludes any physical contact 
 
Reference: Lennon, S, Johnson, L 2000 The Modified Rivermead Mobility Index: validity and 
reliability. Disability & Rehabilitation 12/15/2000, Vol. 22 Issue 18, p833 7p 
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The Modified Rivermead Mobility Index 
 
Patient’s name :      Test date :  
 
Assessor’s name :     Test location :  
 
Scoring:  0 unable to perform  
1 assistance of 2 people  
2 assistance of 1 person  
3 requires supervision or verbal instruction  
4 requires an aid or an appliance  
5 independent Item  
ITEM Score 
1 
 
Turning over: Please turn over from your back to your ...... side.  
2 
 
Lying to sitting: Please sit up on the side of the bed.  
3 
 
Sitting balance: Please sit on the edge of the bed  
4 
 
Sitting to standing: Please stand up from your chair  
5 
 
Standing: Please remain standing (The assessor times the patient for 10 
seconds) 
 
6 
 
Transfers: Please go from your bed to the chair and back again (The 
assessor places the chair on the patient’s unaffected side) 
 
7 
 
Walking indoors:  Please walk for 10 meters in your usual way  
8 
 
Stairs: Please climb up and down this flight of stairs in your usual way  
 
 
Reference: Lennon, S, Johnson, L 2000 The Modified Rivermead Mobility Index: validity and 
reliability. Disability & Rehabilitation 12/15/2000, Vol. 22 Issue 18, p833 7p 
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Appendix 37 Letter of invitation to the focus group 
Study Title: Sensory stimulation of the foot and ankle early post stroke:  
a feasibility study (MoTaStim-Foot) 
 
(Date) 
Dear ……………………… 
Following our telephone conversation, I am writing to formally invite you to attend the 
focus group for the MoTaStim-Foot trial, which is being held on ???????? 
Venue:  Wolstanton Methodist Church, Grosvenor Place, Wolstanton, Newcastle-
under-Lyme, ST5 0HE. There is plenty of free parking in the church car-park. 
Time: Please try to arrive by 11am. The focus group will commence at 11.30am and 
will last for up to a maximum of 90 minutes.  
Refreshments: 
Refreshments (tea and coffee) will be available on arrival, and a light lunch will be 
provided after the focus group.  
Travel arrangements / costs: We can book a taxi for you if required, or you can be 
reimbursed for your own travel costs. If you would like to claim your travel costs you 
will need to complete a form on the day please, and you will then be reimbursed from 
Keele University via your bank account. 
If you have any queries regarding any aspects related to the focus group please 
phone Alison Aries (Chief Investigator) on ?????????????. 
We look forward to seeing you on ????????. 
Thank you once again for your participation in this research trial. 
Best wishes 
 
Alison Aries 
(Chief Investigator for MoTaStim-Foot trial) 
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Appendix 38 MTS focus group schedule 
Title:  Sensory stimulation of the foot and ankle early post stroke: a  
     feasibility study (MoTaStim –Foot) 
Date:  
Nature of Group: Mobilization and Tactile Stimulation (MTS) Group  
Name of Facilitator: Alison Aries 
Name of Note taker:  
Introduction to the process 
Thank the participants for agreeing to attend a focus group discussion regarding their 
participation in the study Mobilization and sensory stimulation of the foot and ankle 
post stroke: a feasibility study (MoTaStim-Foot). Provide the participant with a copy of 
the consent form which has previously been completed. Answer any questions that 
may arise as comprehensively as possible. Emphasise to the participant that: 
1. The Focus Group interview will take no longer than one and a half hours. 
 
2. To accurately capture what is being said the interview will be audiotaped 
         
3. All information that is collected about the participant during the course of the 
study will be kept strictly confidential. Everyone needs to respect this please.  
 
4. Any participants will remain anonymous in any dissemination work undertaken 
external or internal to the University 
 
5. In addition to consenting to be interviewed, the participant will also have given 
consent for direct quotations from the interview to be used in the write up of the 
evaluation. Please note that should you choose to withdraw at any point in time 
any information already collected will be used. 
 
6. Any quotations that are used will be completely anonymous 
 
7. The information provided by the participant will be used to inform a future study 
looking at Mobilization and Tactile Stimulation to the foot post stroke and in 
dissemination activities (conference presentations/ paper etc). 
 
Ensure that the above points have been fully considered by the participant. Ask 
if they have any questions and then 
Introduce the team:  
When verbal consent on the day has been obtained, ask the participants if it is OK to 
turn on the tape recorder and conduct the interview. Remind people that there is no 
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right or wrong answer and they should just give their honest opinion. Switch on the 
audiotape. 
Focus Group Schedule 
The following topic areas will be explored and similar questions to 
those below will be asked:  
A. About the interventions – Remind participants that they had two 
different types of intervention at each treatment session – Mobilization and 
Tactile Stimulation and TaskSpecific Walking Training.  
1.0 Mobilization and Tactile Stimulation (MTS)  - I want to find out more 
about how the MTS felt 
1.0 Can you tell me how you found the Mobilization and Tactile Stimulation 
(MTS)?  
More specifically: 
I want to find out more about how the treatment felt 
1.1  If you were describing the MTS treatment to someone else – from your 
experience what would you say?  
1.2  Was it comfortable or uncomfortable? – What did you do if it became 
uncomfortable?  
1.3  How long did any discomfort last? 
1.4  Have you any other comments to make about the treatment?  
 
2.0 Task Specific Gait Training: I want to find out more about how the Task 
Specific Walking Training felt. 
2.1  If you were describing the Task Specific Walking Training treatment to 
someone else – from your experience what would you say? 
2.2 Was it comfortable or uncomfortable?  – What did you do if it became 
uncomfortable?  
2.3  How long did any discomfort last? 
2.4 Have you any other comments to make about the treatment?  
 
3.0 How was it for you when you had your treatments?  
3.1 Treatment took place regularly – can you tell us how it felt to have 
people coming to you that regularly?  
3.2 How easy was it to access your treatment?...or did you have your 
treatment at home? 
3.3 Did you feel comfortable with the situation? 
3.4  How did you feel when the treatments finished? 
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B. About the outcome measurements: 
 
4.0  Can you say a little about the outcome measures? 
4.1 Were the outcome measures uncomfortable or difficult?  
4.2 Was there anything in particular about a specific outcome measure and  
why? 
 
When you went for the outcome measures, can you say what was it like? 
4.3 Was it easy to find? 
4.4 Did you have to travel far? 
4.5 Did you feel comfortable? 
 
C. About the daily diaries: 
5.0 Can you say a little about using the daily diaries? 
5.1 How did you find filling in the daily diaries? 
5.2 Can you say how easy or difficult you found them to complete? 
5.3 Did you develop any particular patterns for filling them in? 
5.4 Did you personally get anything from filling in the diaries?  
5.5 Can you make any suggestions for changing the diaries in any way? 
 
D. About any changes the participants may have perceived: 
6.0 Have you noticed any changes?  
6.1 Have you noticed any differences in your foot at all? 
6.2 Can you say if your ability to walk / function has changed in any way? 
6.3 Can you say if your confidence whilst walking changed at all? 
6.4 Has the treatment made any difference to your lives?  
6.5 What impact has it had on you....and your family?  
6.6 Have we helped you achieve your goals for the future?  
Please can you describe your experience on the trial in one word or one 
sentence? 
Is there anything else you would like to tell me about your experiences of MTS 
and task specific gait training? 
Thank you for your time today. 
Debriefing session - Check if there is anything else which should be added.  
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Appendix 39 TI focus group schedule 
Title:  Sensory stimulation of the foot and ankle early post stroke: a  
     feasibility study (MoTaStim –Foot) 
Date: 
Nature of Group: Textured Insoles Group  
Name of Facilitator: Alison Aries 
Name of Note taker:  
Introduction to the process 
Thank the participants for agreeing to attend a focus group discussion regarding 
their participation in the study Mobilization and sensory stimulation of the foot and 
ankle post stroke: a feasibility study (MoTaStim-Foot). Provide the participant with 
a copy of the consent form which has previously been completed. Answer any 
questions that may arise as comprehensively as possible. Emphasise to the 
participant that: 
1. The Focus Group interview will take no longer than one and a half hours. 
 
2. To accurately capture what is being said the interview will be audiotaped 
         
3. All information that is collected about the participant during the course of 
the study will be kept strictly confidential. Everyone needs to respect this 
please.  
 
4. Any participants will remain anonymous in any dissemination work 
undertaken external or internal to the University 
 
5. In addition to consenting to be interviewed, the participant will also have 
given consent for direct quotations from the interview to be used in the write 
up of the evaluation. Please note that should you choose to withdraw at any 
point in time any information already collected will be used. 
 
6. Any quotations that are used will be completely anonymous 
 
7. The information provided by the participant will be used to inform a future 
study looking at Mobilization and Tactile Stimulation to the foot post stroke 
and in dissemination activities (conference presentations/ paper etc). 
 
Ensure that the above points have been fully considered by the participant. 
Ask if they have any questions.  
Introduce the team:  
When verbal consent on the day has been obtained, ask the participants if it is OK 
to turn on the tape recorder and conduct the interview. Remind people that there is 
no right or wrong answer and they should just give their honest opinion. Switch on 
the audiotape. 
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Focus Group Schedule 
The following topic areas will be explored and similar questions 
to those below will be asked:  
A. About the interventions – Remind participants that they had two 
different types of intervention at each treatment session – Wearing textured 
Insoles and Task Specific Walking Training.  
1.0 Textured Insoles - I want to find out more about what it was like to 
wear the textured insoles 
1.1 Can you tell me how the textured insoles felt to wear?  
More specifically: 
I want to find out more about how the treatment felt 
1.2  If you were describing what it was like to wear textured insoles to someone 
else – from your experience what would you say?  
1.3  Was it comfortable or uncomfortable? – What did you do if they became 
uncomfortable?  
1.4  How long did any discomfort last? 
1.5 What could you say about the time given for you wearing the textured 
insoles? 
1.6  Was the time too long / too short or, just right? 
1.7 How might you describe the ease of wearing the textured insoles? 
1.8 Were they easy to put in your footwear? 
1.9 Have you any other comments to make about wearing textured insoles?  
2.0 Task Specific Gait Training: I want to find out more about how the 
Task Specific Walking Training felt. 
2.1 If you were describing the Task Specific Walking Training treatment to 
someone else – from your experience what would you say? 
2.2 Was it comfortable or uncomfortable?  – What did you do if it became 
uncomfortable?  
2.3  How long did any discomfort last? 
2.4 Have you any other comments to make about the treatment?  
 
3.0 How was it for you when you had your treatments?  
3.2 Treatment took place regularly – can you tell us how it felt to have 
people coming to you that regularly?  
3.3 How easy was it to access your treatment?....or did you have your 
treatment at home? 
3.4 Did you feel comfortable with the situation? 
3.5 How did you feel when the treatments finished? 
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B. About the outcome measurements: 
4.0 Can you say a little about the outcome measures? 
4.1 Were the outcome measures uncomfortable or difficult?  
4.2 Was there anything in particular about a specific outcome 
measure and why? 
 
When you went for the outcome measures, can you say what was it 
like? 
4.3 Was it easy to find? 
4.4 Did you have to travel far? 
4.5 Did you feel comfortable? 
 
C. About the daily diaries: 
5.0 Can you say a little about using the daily diaries? 
5.1 How did you find filling in the daily diaries? 
5.2 Can you say how easy or difficult you found them to complete? 
5.3 Did you develop any particular patterns for filling them in? 
5.4 Did you personally get anything from filling in the diaries?  
5.5 Can you make any suggestions for changing the diaries in any 
way? 
 
D. About any changes the participants may have perceived: 
6.0 Have you noticed any changes?  
6.1 Have you noticed any differences in your foot at all? 
6.2 Can you say if your ability to walk / function has changed in any 
way? 
6.3 Can you say if your confidence whilst walking changed at all? 
6.4 Has the treatment made any difference to your lives?  
6.5 What impact has it had on you?....and your family?  
6.6 Have we helped you achieve your goals for the future?  
Please can you describe your experience on the trial in one word or one 
sentence? 
Is there anything else you would like to tell me about your experiences of TIs 
and task-specific gait training? 
Thank you for your time today. 
Debriefing session - Check if there is anything else that should be added. 
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Appendix 40 Researcher’s assumptions 
Researcher’s (AA’s) assumptions prior to undertaking MoTaStim-Foot: 
 
• Participants will notice a change in feeling within the foot and ankle in the 
MTS group 
• Participants will notice a change in movement within the foot and ankle in 
the MTS group 
• Participants will feel the benefit of the extra treatments in both groups 
because it is known that TSGT will improve function 
• Function and ability to undertake ADL will improve for all participants 
• Participants might find it uncomfortable to wear the TIs 
• AA has concerns about the possibility of TIs rubbing the sole of the foot 
• AA has no idea whether participants will be able to feel the TIs or whether 
wearing them will make a difference to the feeling of the plantar surface of 
the foot.  
• Participants may not be very compliant with wearing the TIs 
• Although participants will value the extra treatment received almost daily 
treatment may be too much for them 
• The TSGT will push the participants hard and this may be too much for 
some participants 
• AA is concerned that the battery of outcome measures will take too long, 
and participants may not cope with them. 
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Appendix 41 Report on observations of research therapists 
MoTaSTim-Foot Trial – observation of research therapists delivering MTS 
and TSGT 
 
As an independent assessor of practice, I carried out observation visits with four 
research therapists, and observed treatment with five participants, between 
February and October 2017. 
  
Visit 1 – 24th February 2017 
Participant 017 
All treatment was delivered in accordance with the protocols. TSGT was delivered 
in the downstairs living area, and relevant equipment was used – e.g. football, 
balance cushion. After the visit, we had some discussion around the content of the 
TSGT schedule and checked under which sections the treatments / interventions 
would be recorded.  
 
Visit 2 – 12th July 2017 
Participant 026 
All treatment was delivered in accordance with the protocols. MTS was delivered 
with the pt in supine lying on the bed, with his wife present. TSGT was delivered 
downstairs in the living room using relevant equipment e.g. football, balance 
cushion. 
 
Visit 3 – 12th July 2017 
Participant 030 
 All treatment was delivered in accordance with the protocols. MTS was delivered 
with the pt in supine lying on the sofa. TSGT was delivered in a downstairs area 
and consisted of specific components of walking and balance activities. 
 
Visit 4 – 11th August 2017 
Participant 033 
All treatment was delivered in accordance with the protocols. MTS was delivered 
with the pt sitting in an armchair. TSGT was delivered both indoors and outdoors, 
culminating in walking across the grass. 
 
Visit 5 – 19th October 2017 
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Participant 035 
All treatment was delivered in accordance with the protocols. MTS was delivered 
with the pt sitting over the side of the bed. TSGT was delivered indoors, using 
relevant equipment e.g. football, and included muscle strengthening activities e.g. 
repeated sit→stand. 
 
 
In summary, I was happy that all treatments were delivered in accordance with the 
protocols and could be recorded on the treatment schedules. There was no 
treatment delivered that did not feature in the schedules (MTS or TSGT). I did note 
a difference in delivery between the therapists, which I attribute to their differences 
in experience of treating stroke survivors in general. However, this is 
representative of the differences likely to be seen in clinical practice amongst and 
across different NHS Grades and according to individual skills and expertise. All 
treatments were delivered safely and competently. 
 
SMH  
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Reflections: 
Two Research Therapists were particularly skilled in neurological rehabilitation 
and this was evident from the confidence and expertise in handling with which they 
provided both MTS and TSGT. TSGT activities were progressed quickly and 
appropriately, and the pt’s ability was challenged to a high level. Whilst the 
activities were clearly difficult, they were managed by the pt, who was not at risk of 
any adverse event e.g. fall at any time. Indeed, pts appeared to fully appreciate 
the benefit of the challenges they were given during the TSGT. 
 
The Research Therapist who was least skilled in neurological rehabilitation had 
less confidence and skill in the handling used to deliver MTS which was more 
focussed on massage and pressure stimulation than on specific mobilisation of 
soft tissues. TSGT was challenging but the participant was very chatty, which 
detracted from the intensity of the therapy at times. 
 
One other Research Therapist was very careful to ensure that the MTS treatment 
followed the protocol, and this was delivered carefully but perhaps not with the 
same depth of soft tissue mobilisation as that seen by the more skilled and 
experienced neurological therapists. TSGT was less challenging than I had seen 
with other pts, but the importance of participant safety was a key focus throughout. 
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Appendix 42 Statistical Analysis plan for MoTaStim-Foot 
Sensory stimulation of the foot and ankle early post-stroke: A 
feasibility study (MoTaStim – Foot): statistical analysis plan 
Sponsor:   Keele University 
Trial registration: ISRCTN registry 13676183  
   Central Portfolio Management System ID 30449 
NRES:  IRAS No:  171968 / REC Ref 16/WM/0080 
Study team:  
Alison Aries (Chief Investigator/Research Therapist/PhD Student) 
  Dr Susan Hunter (Blinded Assessor/Lead Supervisor) 
Professor Valerie Pomeroy (Supervisor) 
  Professor Julius Sim (Statistician/Supervisor) 
       
Authors of the SAP:  
Statistician:   PROFESSOR JULIUS SIM   
Lead Supervisor:    Dr SUSAN HUNTER    
Chief Investigator:   ALISON ARIES      
 
 
Declaration regarding undertaking of the analysis 
Alison Aries (Chief Investigator and PhD student) will be undertaking data cleaning 
and analysis of the study data under the guidance and supervision of Professor 
Julius Sim (statistician/supervisor/advisor) and Dr Susan Hunter (Lead Supervisor).  
 
With reference to Protocol version:   v 4.0 – dated 23rd October 2016  
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1. Abbreviations (list) 
 
AE Adverse event 
AR Adverse reaction 
CI Chief Investigator 
CNS Central Nervous System 
CONSORT Consolidated Standards of 
Reporting Trials 
CTU Clinical Trials Unit 
DVT Deep vein thrombosis 
FAC Functional Ambulation 
Category 
MRC Medical Research Council 
MTS Mobilization and tactile 
stimulation 
NCTU Norwich Clinical Trials 
Unit 
NIHR National Institute for 
Health Research 
RCT Randomized controlled 
trial 
REC Research Ethics 
Committee 
SAP Statistical analysis plan 
SSOTP Staffordshire and Stoke-
on-Trent Partnership Trust 
TI Textured insole 
TSGT Task-specific gait training 
UK United Kingdom 
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2. Glossary of terms 
 
 
  
Mobilization and tactile stimulation 
(MTS): 
A term given to a form of hands-on 
therapy treatment which is often 
delivered in conventional therapy, with 
an aim of mobilizing the area (e.g. 
hand or foot) and enhancing sensory 
input (feeling). It involves massage and 
tactile stimulation of the area and joint 
and soft tissue mobilisation techniques 
(passive movements, accessory 
movements, soft tissue stretching). 
Task-specific gait training (TSGT) A form of therapy which involves 
repetition of various activities e.g. 
sitting to standing, stepping etc. with an 
aim of improving the ability to walk. 
Textured insoles (TIs) Insoles made of material with 
projections. The aim of these peaks is 
to stimulate the sole of the foot, 
increasing sensory input. 
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3. Background and Aims 
Strokes are common. Indeed, every year 15 million people in the world have a stroke 
(Mackay and Mensah, 2004). Neuroscience findings indicate that feedback to the brain 
via sensory processes is essential for motor function (Chersi et al. 2011, Laaksonen et 
al. 2012, Rossignol et al. 2006), and therefore information originating in the foot is 
important for balance and walking 
Mobilization and tactile stimulation (MTS) is a treatment used in conventional 
physiotherapy practice to prepare or ‘prime’ the central nervous system (CNS), 
facilitating movement and function, by giving sensory input via the foot and ankle. MTS 
is a part of routine physical therapy used in clinical practice to prepare the foot and leg 
for standing and walking, but its effects have not yet been explored.  
The plantar (sole of the foot) mechanoreceptors are key, sending information to the 
CNS, and plantar stimulation has been shown to result in increased control of body 
sway (Watanabe and Okubo 1981). In view of the importance of cutaneous information 
from the sole of the foot to control balance (Kennedy and Inglis, 2002), other potential 
mechanisms of increasing plantar stimulation have been explored, and texture insoles 
(TIs) have been shown to improve postural control in standing in healthy participants 
(Corbin et al 2007), and to improve walking patterns for people with multiple sclerosis 
(Dixon et al 2014). However, none of these specific or combined treatments have been 
evaluated robustly to determine their benefits for balance and walking recovery early 
after stroke. The use of TIs in the shoes of stroke survivors involves a hands-off 
(therapist independent) approach, which may potentially be a more economical option 
for achieving increased sensory stimulation to the foot and is therefore important to 
investigate. TIs are a different way of delivering sensory information to the CNS, 
enabling ‘augmentation’ of sensory input to the CNS as a means of facilitating 
movement and function. It is important to explore in the future which sensory stimulation 
is more effective, hence this feasibility study to establish if it is possible to deliver these 
interventions in a research setting.  
This feasibility study involves a mixed-methods design and will be an important step in 
the research pathway, ensuring treatments are properly developed and procedures are 
tested in a rigorous manner, and participants’ perceptions explored. It is necessary to 
see if it is possible to deliver the treatments (MTS or TIs followed by TSGT) and the 
outcome measurements before undertaking a larger study in the future.  
Primary Research Aim: 
To explore the feasibility of delivering treatment designed to increase the feeling within 
the foot after stroke in a randomized trial. The treatments being evaluated are MTS with 
TSGT versus wearing of TIs plus TSGT.  
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Research Objectives: 
1. To find out if the treatments (MTS plus TSGT, and the wearing of TIs plus TSGT) 
are acceptable treatments for stroke survivors. 
2. To explore the response to treatment (if any), in relation to the number of treatment 
sessions delivered. 
3. To find out which measures will be most appropriate to measure outcomes of: 
sensorimotor impairment (feeling/sensation and movement), and lower-limb function 
and balance. 
4. To find out if daily diaries and focus groups are suitable ways to explore stroke 
survivors’ experiences of receiving the treatments. 
5. To find out if recruitment methods are effective, noting the numbers of people invited 
to participate, eligible to participate, and agreeing to consent as well as the number of 
people who drop out of the trial. The information will be used to inform a power 
calculation for a future study.  
6. To gather data on outcome measures, and their completion, that will inform a sample 
size calculation for a subsequent main trial. 
4. Design 
This is a single-site, randomized, single-blinded feasibility trial, being undertaken as 
part of an NIHR funded Clinical Doctoral Research Fellowship (CONSORT diagram, 
figure 1 and overview of trial, figure 2). A mixed-methods design will be adopted, which 
will involve both quantitative (experimental) and qualitative (focus groups) methods. 
The randomisation sequence was generated before the trial commenced and Professor 
Julius Sim, the statistician for the trial, provided the randomisation order to Norwich 
CTU. Participants are randomised to the interventions using 1:1 randomisation, with 
stratification by left or right stroke to ensure an equal number of right- and left-sided 
strokes in each treatment group.   
Allocation concealment mechanism 
An independent telephone interactive voice response system and computer system 
randomisation service and electronic case record form maintained concealment of the 
treatment allocation from investigators, research therapists and blinded assessors prior 
to randomisation of a participant (i.e. each participant’s allocation could not be 
predicted from the allocation of the previous participant).  
Allocation Implementation 
Baseline data was entered into the randomisation system and the system randomized, 
sending an email confirmation of the allocation group for the participant. Concealment 
of group allocation from the blinded assessor continued throughout the trial process.   
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Blinding 
All outcome measurements in which observer bias could occur will be undertaken by 
assessors who are blinded to treatment group allocation. The touch/pressure sensory 
thresholds, Lower Extremity Motricity Index and modified Rivermead Mobility Index will 
all be undertaken by a blinded assessor. However, a research therapist will undertake 
the five-metre walk test, pressure under the feet and ankle range of movement 
assessments. As these are objective assessments, the risk of bias is low. As part of 
clinical decision making, to assess for possible fatigue, the research therapists will also 
measure the Lower Extremity Motricity Index, at each intervention; however, it will be 
the Lower Extremity Motricity Index measurement undertaken by the blinded assessor 
that will be formally analysed.  Participants will be asked to refrain from telling the 
assessors which treatment they are receiving. To assess whether blinding of assessors 
was achieved, we will ask assessors, at the one-month follow-up point, to guess which 
group they think participants were assigned to. Agreement with actual allocation will be 
assessed. 
 
5. Study and population 
 
Study setting: 
Participants will be stroke patients admitted to Staffordshire and Stoke-on-Trent 
Partnership Trust (SSOTP), both inpatients and outpatients. 
Inclusion criteria: 
• Able to provide written informed consent 
• Adult stroke survivors (aged 18 years or older), with anterior or posterior 
circulation stroke, occurring 6–16 weeks (42–112 days) earlier.  
• Ability to walk independently prior to stroke. 
• Participants must also be able to follow simple commands and imitate actions, 
using the non-paretic upper limb (the arm that has not been affected by the 
stroke).  
• Participants must be unable to step on and off a 7·5 cm high block more than 12 
times in 15 seconds with either their paretic (affected) or non-paretic leg (Step 
test: Hill et al., 1996).  
 
 
Exclusion criteria: 
 
• Pre-existing conditions affecting sensation of the foot and lower limb e.g. diabetic 
neuropathy, polyneuropathy (degeneration of the peripheral [not in the brain and 
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spinal cord] nerves), peripheral nerve lesion [injury to a peripheral nerve], previous 
stroke affecting sensation of the lower limb. 
• Fixed contracture of the tendo Achilles, assessed by being unable to achieve 90 
degrees dorsiflexion at the ankle, either actively or passively with the knee 
extended. 
• Pressure sores or ulcers on the foot or ankle (hemiparetic limb), due to the risk of 
infection. 
• Deep vein thrombosis, because some of the MTS techniques would be 
contraindicated. 
• Other conditions that affect the blood supply to/from the foot, e.g. heart failure with 
peripheral oedema 
• Botulinum toxin injections to the lower limb in the previous six months, because 
these might have an impact on the results 
• Pain sufficient to prevent delivery of treatments or outcomes 
• Known HIV, hepatitis non-A or related condition 
• The participant’s home address is outside of a feasible recruitment zone (for 
example ST10 or ST13). 
 
Monitoring of recruitment: 
The number of potential participants approached will be recorded and a note taken, as 
appropriate, of why people were excluded at first screening, with reasons documented. 
The number of potential participants excluded on post consent screening will also be 
noted. 
A record will be kept of all participants required to withdraw from the study, with reasons 
noted. Any participant found to be ineligible after randomisation will be noted and 
reasons explored.  
Monitoring non-compliance to protocol:  
Conduction of the trial is in compliance with the approved protocol, the Declaration of 
Helsinki (2008), the principles of Good Clinical Practice (GCP) as laid down by the 
Commission Directive 2005/28/EC with implementation in national legislation in the UK 
by Statutory Instrument 2004/1031 and subsequent amendments, the Human Tissue 
(Quality and Safety for Human Application) Regulations 2007, the UK Data Protection 
Act, and the National Health Service (NHS) Research Governance Framework for 
Health and Social Care (RGF). A record of any non-conformances to protocol will be 
maintained and these will be summarised by type and treatment group. 
 
Serious breaches: 
Should a serious breach occur it will be recorded and notified within the necessary 
timelines specified in the UK Clinical Trials Regulations (currently 7 days). 
Serious adverse events: 
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All serious adverse events will be recorded and notified to the Sponsor within the 
necessary 24-hour time period.  
Adverse events: 
A record will be kept of the number of adverse events and the reason for these adverse 
events. 
Adverse reactions: 
All adverse reactions will be documented and monitored.  
In relation to adverse reactions related to overdose of intervention: 
There is a small possibility that either the MTS or TSGT could be associated with an 
overuse syndrome as expressed by a participant’s experience of pain or fatigue.  
a. Pain will be considered to be an adverse reaction if (i) a participant reports the onset 
or increase of paretic lower-limb pain (verbally or behaviourally), (ii) the pain is 
sustained over four consecutive therapy sessions and (iii) if the research therapist and 
clinical team are unable to account for this in any other way than involvement in this 
trial. This will be addressed by the research therapist adjusting the therapy as 
appropriate or, if indicated, stopping the extra therapy on either a permanent or 
temporary basis. The date of adverse reaction will be the date of the fourth consecutive 
therapy session on which pain was apparent.  
b. Fatigue will be considered to be an adverse reaction if (i) a participant demonstrates 
a decrease of two levels in the Lower Extremity Motricity Index score on four 
consecutive therapy sessions and (ii) the therapist and clinical team are unable to 
account for this in any other way than involvement in this trial. This will be addressed 
by the therapist adjusting the therapy as appropriate or, if indicated, stopping the extra 
therapy on either a permanent or temporary basis. The date of adverse reaction will be 
the date of the fourth consecutive therapy session in which fatigue was indicated.  
 
6. Outcomes 
Statistical analysis 
As this is a feasibility study, no formal hypothesis tests will be undertaken. All data 
analysis will take place after data lock down 
 
Statistical Methods – Outcomes 
Point estimates, with 95% two-sided confidence intervals, will be calculated for key 
variables. For proportions, the Wilson interval will be used in view of the small sample 
size, as recommended by Brown et al (2001). The variance of scores for outcome 
measures will be calculated, providing information for the sample size calculation for 
the subsequent large trial. Outcome measures resulting in numerical data will be 
presented as mean and standard deviation, unless the data are skewed, in which case 
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the median and interquartile range will be reported.  Ordinal data will be presented as 
medians and interquartile ranges. The NIHSS will be treated as ordinal data as 
recommended by Harrison et al (2013). The distribution of outcome variables will also 
be assessed, to evaluate the suitability for a main trial, to further inform the sample size 
calculation, and to guide the choice of analysis in the main study. Additionally, 95% 
confidence intervals will be calculated for within-group effects on the outcome 
variables, so as to indicate a range of plausible effects of the study interventions in a 
main trial.  
The number of eligible patients who are recruited, and the proportion of those recruited 
who are lost to follow-up at one month, will also be calculated. In accordance with the 
CONSORT (2010) guidelines, baseline demographics and characteristics of the two 
groups will be transparent.  Analysis will be conducted by the applicant, with guidance 
from the supervisory team. A single formal analysis will take place at the end of the 
study.  
For those scaled outcomes that are recorded at each time point, a line graph of all 
individual participants’ response trajectories will be constructed for each arm of the trial; 
this graph will also include a line representing the averaged response trajectory. The 
graph will be analysed visually to determine if there is a point at which the participants’ 
responses tend to change direction upwards (indicating a response to treatment), as 
this information will provide information on the likely minimum length of treatment, or 
‘dosage’, that is required to induce an improvement on the outcome concerned. Across 
these outcomes, the latest such change in trend will suggest the minimum length of 
treatment that should be utilized in the main trial. 
Within the feasibility study, both research therapists will deliver either MTS or TSGT. A 
log will be kept detailing, for each participant, which therapist has delivered the 
treatment.  
1. Characterization of clinical presentation of participants (to give an overview of 
the participants to assist with evaluation of the interventions) using the following tools: 
(i) National Institutes of Health Stroke Scale (NIHSS) - This includes assessment of 
the level of consciousness, vision, motor activity (face, arm and leg), coordination, 
sensation and speech. This assessment is only occurring at baseline. This assessment 
indicating the level of disability will be summarised according to intervention group. 
 
(ii) Functional Ambulation category, which assesses walking ability and categorizes 
according to basic motor skills necessary for functional walking. Point estimates, 
interquartile ranges, and the variance of scores will be calculated. The time-points for 
this assessment are baseline, end of intervention and one-month follow-up. 
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2. Sensorimotor impairment:  
a) Pressure under the feet during stance phase of walking (measured with 
insoles).  
The force time integral and centre of force velocity (COF) will be calculated for each 
participant. Centre of force trajectory will be analysed visually. Point estimates, with 
95% confidence intervals, will be calculated as well as the variance of scores. The time-
points for this assessment are baseline, end of intervention and one-month follow-up. 
Pressure will be measured in KiloPascals (kPa) and COF velocity in cm/second. 
 
b) Ankle range of motion (dorsiflexion, plantarflexion, inversion, eversion) during 
stance phase 
This will be measured by an electrogoniometer, in stance phase of walking. Maximum 
and minimum angles of dorsiflexion and inversion will be calculated. Point estimates, 
with 95% confidence intervals or interquartile ranges (as appropriate), will be calculated 
and the variance of scores calculated. The time-points for this assessment are 
baseline, end of intervention and one-month follow-up. Range will be measured in 
degrees of movement. 
 
c) Touch/pressure sensory thresholds on the sole of foot (to determine the ability 
to feel at different points)  
This is measured using Semmes Weinstein Monofilaments and reported on a scale of 
1-20, correlating with the force measured in mg. The median value and interquartile 
ranges for the point of sensory detection for each of the four areas on the foot (heel, 
under pad of hallux, under 1st metatarsal and under 5th metatarsal) will be calculated, 
and the variance of scores will be established. The time-points for this assessment are 
baseline, after five interventions, after 10 interventions, after 15 interventions, end of 
intervention and one-month follow-up. 
 
 
d) Lower Extremity Motricity Index (LEMI) 
Mean strength of hip flexors, knee extensors and ankle dorsiflexors and total LEMI 
score will be calculated. Point estimates, with 95% confidence intervals, will be 
calculated and the variance of scores noted if data is normally distributed. Alternatively, 
median and interquartile ranges will be calculated. The time-points for this assessment 
are baseline, after five interventions, after 10 interventions, after 15 interventions, end 
of intervention and one-month follow-up. 
 
Regular outcome measurements (c and d) are being recorded to ascertain at what 
stage any changes are seen, to inform the dose (duration) of the intervention for the 
subsequent trial. 
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For c) and d) a line graph of all individual participants’ response trajectories will be 
constructed for each arm of the trial; this graph will also include a line representing the 
averaged response trajectory. The graph will be analysed visually to determine if there 
is a point at which the participants’ responses tend to change direction upwards 
(indicating a response to treatment), as this information will provide information on the 
likely minimum length of treatment, or ‘dosage’, that is required to induce an 
improvement on the outcome concerned. Across these outcomes, the latest such 
change in trend will suggest the minimum length of treatment that should be utilized in 
the main trial. 
3. Lower limb function and balance: 
Measures e) and f) will be collected at baseline, on completion of the twenty treatments 
and at one-month follow-up. 
e) Walking speed 5-metre walk test (self-selected walking speed), gives an indication 
of the overall walking ability of stroke survivors (measured in metres per second). Point 
estimates, with 95% confidence intervals or median and interquartile ranges (as 
appropriate), will be calculated and the variance of scores noted. 
To enable more detailed analysis, the 5-metre walk test is videoed. In addition to 
quantifying variables such as walking speed for the 5-metre walk test, an observational 
analysis of the quality will be undertaken, as is common practice in therapy 
rehabilitation. The time-points for this assessment are baseline, end of intervention and 
one-month follow-up.  
 
f) Modified Rivermead Mobility Index 
The test involves eight tasks including bed mobility, sitting and standing balance, 
transfers, walking and stairs. A rating is given relating to the amount of assistance the 
person requires.  
Point estimates, with 95% confidence intervals, will be calculated for the both the 
affected and unaffected side results, and the variance of scores noted. The time-points 
for this assessment are baseline, end of intervention and one-month follow-up. 
 
 
 
7. Sample size 
One of the aims of the study is to be able to undertake a sample size calculation prior 
to a follow up study. A sample size of 30 has been suggested as the lower limit for 
working out how many participants will be required for future studies in terms of an 
estimate of the standard deviation of values on a continuous outcome measure 
(Browne 1995). Recruiting a sample of 34 participants will account for 10% attrition, 
and enable potentially equal numbers (n=17) in each arm of the trial. As the whole 
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study needs to be completed within three years this sample size was deemed to be the 
largest feasible in the time frame. 
8. Participant (baseline) characteristics 
Baseline characteristics will include age, gender, ability to walk independently prior to 
the stroke, level of stroke severity (NIHSS), as well as the outcome measures: 
touch/pressure sensory threshold measured with Semmes Weinstein monofilaments; 
Lower Extremity Motricity Index; five-metre walk test; force time integral (force through 
foot and time spent on the foot) and centre of force velocity from the pressure insoles; 
ankle range of movement; modified Rivermead Mobility Index; and Functional 
Ambulation category. Information will be generated regarding the participants recruited; 
i.e. population participant demographics, clinical characteristics, including time since 
stroke, type of stroke and previous impairment affecting the ability to walk, and these 
will be summarised according to intervention group. Count variables will be presented 
as frequencies and proportions, ordinal variables as medians and interquartile ranges, 
and numerical variables as means and standard deviations (or medians and 
interquartile ranges if skewed).  
 
9. Health Economics 
N/A for this feasibility study. 
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11. Tables/Figures 
 
 
Figure 1: CONSORT 2010 Flow Diagram 
 
 
Analysis 
Enrolment 
Randomized 
(n=34) 
Follow-Up 
Allocation 
Allocated to TI+TSGT intervention:  
Received allocated intervention:  
Did not receive allocated 
intervention: 
  
Allocated to MTS+TSGT 
intervention:  
Received allocated intervention:  
  
  
Lost to follow-up:  
Discontinued intervention:  
  
  
Lost to follow-up:  
Discontinued intervention: 
Discontinued intervention:  
  
Analysed:  
Excluded from analysis:  
  
Analysed:  
Excluded from analysis:  
  
Assessed for 
eligibility 
Non-recruitment: 
 Not interested in the trial  
 Declined after reading 
participant information 
sheet  
 Not meeting inclusion 
criteria  
 Failed post consent 
screening  
 Other reasons  
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Figure 2: Overview: Sensory stimulation of the foot and ankle post stroke: 
A feasibility study (MoTaStim-Foot) 
 
  
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RANDOMIZATION  
Mobilization and tactile stimulation (MTS) + 
task-specific gait training 
20 sessions over 6-week intervention phase 
Textured insoles (TIs)  
+ task-specific gait training 
 
20 sessions over 6-week intervention phase 
Data collection during intervention phase 
Daily diary relating to experience of interventions 
Lower Extremity Motricity Index and sensory threshold testing  
after 5,10 & 15 interventions 
Outcome measures 
FAC, 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing  
Within 7 days of completing the intervention 
Follow up outcome measures  
FAC, 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing 
At one month ± 7 days after completing the intervention 
Focus group 
To explore participants’ views regarding the acceptability and feasibility of 
the interventions and outcome measures 
After completion of all interventions and outcome measures 
Baseline 
Clinical Measures including: NIHSS, Functional Ambulation Classification 
(FAC), 5m walk, Lower Extremity Motricity Index, pressure insole readings, 
ankle range of movement, mRMI and Sensory threshold testing 
Informed consent 
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Appendix 43 A priori topics and initial themes identified from the FGs 
A priori 
topics 
Themes (FGs) FG 1 FG 2 FG 3 FG 4 
MTS  Uncomfortable/challenging / too long 
(1,3) 
Benefits (1,3) 
Foot feeling different (3) 
Info re MTS being given by a carer 
(3) 
 
 
 
 
Wearing TIs Comfort (2,4) 
Benefits (2,4) 
TIs were helpful (2) 
Increased stability of the foot (2) 
Length of time wearing TIs (4) 
General information relating to 
wearing TIs (4) 
Difficulties (4) 
General concerns/perceptions (4) 
Uncomfortable (4) 
 
 
 
 
TSGT  Benefits (1,2,3,4) 
Too much/too long/frustrating/ painful 
or frightening (1,3) 
Difficult/challenging (2,4) 
Comfort (2,4) 
Convenience (2,4) 
General comments (2,4) 
    
Outcome 
measures 
 
    
Venue  
 
 
 
 
Daily 
diaries 
 
    
Changes in 
the foot or 
leg 
Sensory awareness of the foot or leg 
(1,2) 
Change in movement (1,2,3) 
Change in temperature of the foot (2) 
Change of feeling (1,2) 
Increased stability of the foot (2) 
    
Overall 
experience 
Feeling when MoTaStim-Foot 
finished (1,3)     
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on 
MoTaStim - 
Foot 
Re daily/regular interventions (2,3) 
Impact (2) 
Impact on family (2) 
Venue (2,3) 
Length of sessions (2) 
Number of sessions (2) 
Life after 
MoTaStim-
Foot 
  
  
 
 
 
Themes 
identified on 
analysis 
Sub-themes FG 1 FG 2 FG 3 FG 4 
Life after 
stroke but 
before 
MoTaStim-Foot 
Challenges (1) 
   
 
Confidence  
    
Function Improved function (1) 
Difficulties undertaking 
functional activities (2) 
   
 
Meeting / 
achieving 
goals 
 
 
  
 
Feeling of 
control or 
autonomy or 
achievement 
  
 
  
Sense of 
achievement/g
oals achieved 
   
 
 
Empowerment  
 
   
Self-conscious  
 
   
Fear of falling  
    
Upper limb 
treatment 
 
 
 
 
 
Impact    
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Appendix 44 One sheet of paper analysis of focus groups  examples- 
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Appendix 45 Audit trail – how the themes were developed
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Appendix 46 Fatigue and pain monitoring form 
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Appendix 47 Trial management group terms of reference 
                                                  
      
 
 
 
Document Title: MoTaStim-Foot 
Trial Management Group 
(TMG) Terms of Reference 
 
 
 
 
 
Document Type: Terms of Reference (ToR)  
Version Number: 1.0  
Date of Final Release: 5
th May 2016  
Review Date: 
1 year from initial release and 2 years 
thereafter 
  
(If applicable) Version of ToR being 
superseded: 
 
 
  
Author Title Signature Date 
Alison Aries 
 
Chief Investigator   
Reviewer Title Signature Date 
Dr Sue Hunter 
 
Supervisor   
 
 
ccxxxiv 
 
Details of NCTU Trial Management Group (TMG) 
Introduction  
Name of trial 
 
 
Name of Trial 
Management Group 
(TMG) 
 
MoTaStim-Foot – Sensory training for the 
foot and ankle early post stroke: A 
feasibility study.  
 
MoTaStim-Foot TMG 
 
 
Sponsors Name & ID 
 
Keele University / 2013-338. 
 
 The purpose of this document is to describe 
the membership, terms of reference, roles, 
responsibilities, authority, decision-making 
and relationships of the TMG for the 
MoTaStim-Foot trial, including the timing of 
meetings, methods of providing information 
to and from the TMG, frequency and format of 
meetings and relationships with other trial 
committees. 
Facilitation The Chief Investigator (Alison Aries) will act 
as Facilitator for the TMG. The Facilitator will 
be responsible for the organisation of 
meetings and should be copied into all 
communications with the TMG and other 
bodies and between the TMG members. 
Roles and Responsibilities 
 
A broad statement of the 
aims of the TMG 
The TMG is led by the Chief Investigator (CI) 
who is responsible for leading the activities 
associated with trial management.    
  
Specific roles of TMG • provide expert input into the 
development of trial specific 
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Details of NCTU Trial Management Group (TMG) 
 
 
 
documents and procedures necessary 
to run the trial 
• monitor patient safety in order to 
protect the rights, safety and wellbeing 
of patients 
• monitor recruitment rates and develop 
strategies to deal with any recruitment 
problems 
• review regular reports of the trial from 
the Chief Investigator (Alison Aries) 
and Norwich CTU 
• be aware of and provide to other TMG 
members any accumulating external 
evidence relevant to the intervention 
or treatment of patients  
• monitor completion rates of CRFs and 
assist the trial team to encourage 
satisfactory completion in the future 
• monitor follow-up rates and develop 
strategies to deal with problems 
• review reports of quality management 
and monitoring activities from the trial 
team and advise on and help to 
promote strategies to maintain the 
collection of high quality data 
• advise on any amendments to the 
protocol, where appropriate 
• provide input into any issues with 
patient recruitment and sample 
collection for mechanistic sub studies 
• propose any changes to the design of 
the trial, including additional sub 
studies 
• provide input into the timely reporting 
of trial results 
 
 
ccxxxvi 
 
Details of NCTU Trial Management Group (TMG) 
• develop the publication strategy for the 
main trial and any secondary 
publications 
• provide input into the main trial 
manuscript and secondary publications 
where appropriate 
• provide input into any abstracts and 
presentations of any results during the 
running of the trial 
• review external or early internal 
requests for release of data or subsets 
of data or samples including clinical 
data and stored biological samples 
Before or early in the trial 
 
Protocol Input 
 
All TMG members will be given a copy of 
the protocol for MoTaStim-Foot, which has 
been developed in collaboration with 
Norwich CTU and PPI advisors.  
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Details of NCTU Trial Management Group (TMG) 
 Composition  
 
Membership  
 
The TMG membership includes: 
Alison Aries (Chief Investigator/ Principal 
Investigator / Research Fellow) 
Dr Sue Hunter (Primary Supervisor, Keele 
University)  
Prof Valerie Pomeroy (Supervisor, UEA) 
Prof Sue Read (Supervisor, Keele 
University) 
Prof Julius Sim (Supervisor, Keele 
University) 
Patient and Public Involvement (PPI) 
advisor 
Carolyn Belford, Clinical Specialist (Band 
8) Physiotherapist from the recruiting 
centre (SSOTP). 
Frances Davies (Research Delivery Unit 
Manager)   
Prof Christine Roffe (Consultant Stroke 
Physician, UHNM) 
Dr Erika Sims (Senior Clinical Trials 
Operations Manager Norwich Clinical Trials 
Unit (CTU)) 
 
Responsibilities of the 
NCTU Trial Team 
The Chief Investigator will produce a short 
report on the trial before each meeting of 
the TMG. 
Relationships 
 
Relationships with Chief 
Investigators, other trial 
committees (e.g. TSC 
and DMC), 
The responsibilities of each trial 
committee are detailed in the protocol and 
in the respective Terms of Reference.  The 
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Details of NCTU Trial Management Group (TMG) 
Sponsor/Funder and 
regulatory bodies 
relationships between these groups are 
summarised in figure 1.   
Payments to TMG 
members  
 
Reasonable travel costs (where 
necessary) and other expenses will be 
reimbursed. No other payments or 
rewards will be given to professional 
members.   
The need for TMG 
members to disclose 
information about any 
real or potential 
competing interests 
Any competing interests, either real or 
potential, should be disclosed. These are 
not restricted to financial matters – 
involvement in other trials or intellectual 
investment could be relevant.  Although 
members may well be able to act 
objectively despite such connections, 
complete disclosure enhances credibility 
(Annexe 1) 
TMG members should not use any trial 
data to inform trading of products related 
to the trial e.g. textured insoles, and 
careful consideration should be given to 
trading in stock of companies with 
competing products.  Changes in 
declarations of real or potential competing 
interests should be minuted at the start of 
each meeting. 
Organisation of meetings  
 
Expected frequency of 
TMG meetings 
The TMG will plan to meet 4 monthly. At 
the request of the TMG interim meetings, 
in person or by teleconference, will be 
organised.  Trial issues may need to be 
dealt with between meetings, by phone or 
by email.  TMG members should be 
prepared for such instances. 
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Details of NCTU Trial Management Group (TMG) 
Attendance of TMG 
members at meetings 
 
Effort will be made for all members to 
attend.  The Facilitator will work for a date 
that enables this.  Members who cannot 
attend in person should be encouraged to 
participate by teleconference.  If, at short 
notice, any TMG members cannot attend 
then the TMG may still meet if at least 
two independent members, including the 
Chair – Alison Aries, (unless otherwise 
agreed), will be present as well as a 
representative of the trial team.  If the 
TMG is considering a major action after 
such a meeting the TMG Chair should 
communicate with the absent members, 
including the CI, as soon after the 
meeting as possible to check that they 
agree. If they do not, a further 
teleconference should be arranged with 
the full TMG. Similarly, if the Chair is 
unavoidably absent and there are difficult 
issues or disagreements raised at the 
meeting, these issues should be dealt with 
by telephone discussion, or email, through 
the Chair, as soon after the meeting as 
possible and, if necessary, a 
teleconference arranged with the full 
TMG. 
How TMG meetings will 
be organised, especially 
regarding open and 
closed sessions, 
including who will be 
present in each session 
Presence will be usually limited to the 
TMG members, observers from the 
Sponsor/Funder, trials unit and the 
Facilitator.  Other attendees may be 
invited for all or part of the meeting as 
required.   
Can TMG members who 
cannot attend the 
meeting input? 
If the report is circulated before the 
meeting, TMG members who will not be 
able to attend the meeting may pass 
comments to the TMG Chair/Facilitator or 
MoTaStim-Foot trial team for 
consideration during the discussions.    
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Details of NCTU Trial Management Group (TMG) 
 
What happens to 
members who do not 
attend meetings? 
If a member does not attend a meeting or 
provide comments when requested between 
meetings, it should be ensured, where 
possible, that the member is available for the 
next meeting.  If a member does not attend 
the next meeting or provide comments when 
next requested, they should be asked if they 
wish to remain part of the TMG.  If a member 
does not attend a third meeting, strong 
consideration should be given to replacing 
that member. 
Trial documentation and procedures to ensure confidentiality and proper 
communication 
Intended content of 
material to be considered 
during meetings  
 
A short report will be prepared by the 
Chief Investigator following a standard 
template.  This will report on accrual and 
any matters affecting the trial.  
Additionally, the material may include 
draft publications.  No trial outcome 
measure data will be presented by arm.  
Where relevant, accrual, compliance with 
follow-up and adherence to treatment 
may be presented. 
Responsibility for 
identifying and 
circulating external 
evidence (e.g. from 
other trials/ systematic 
reviews) 
Identification and circulation of external 
evidence (e.g. from other trials/ 
systematic reviews) is a responsibility of 
the TMG.   
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Details of NCTU Trial Management Group (TMG) 
What will happen to the 
papers after the meeting 
TMG members should delete, destroy or 
store securely copies of the reports to and 
from the TMG, agenda and minutes, as 
well as copies of communications between 
meetings.  All documentation should be 
considered confidential.  The Chief 
Investigator/Facilitator (Alison Aries) will 
keep a central record of all minutes, 
reports and correspondence by the TMG.   
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FIGURE 1: RELATIONSHIPS WITHIN THE MoTaStim-Foot TRIAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPONSOR 
 
FUNDER 
 
Trial Management 
group 
NCTU PPI advisors 
Local consultant / 
Clinicians 
Local R & D 
support 
Supervisors of the 
fellow (Alison Aries) 
Abbreviations:  
NCTU= Norwich Clinical Trials Unit 
PPI – Patient and Public Involvement 
R & D = Research and development 
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Main point of contact is Alison Aries the Fellow / Chief Investigator / 
Facilitator via email: a.m.aries@keele.ac.uk  
ANNEXE 1: AGREEMENT AND POTENTIAL COMPETING INTERESTS FORM FOR MEMBERS 
MoTaStim-Foot: Agreement to join the Trial Management Group and 
disclosure of potential competing interests 
 
Please complete the following document and return to the Facilitator. 
(Please initial box to agree) 
 I have read and understood the TMG Terms of Reference version 1.0 6/4/16 
 
 I agree to join the TMG for this trial  
 
 I agree to treat all sensitive trial data and discussions confidentially 
 
 
The avoidance of any perception members of a TMG may be biased in some fashion is 
important for the credibility of the decisions made by the TMG and for the integrity of 
the trial. 
Potential competing interests should be disclosed via Alison Aries (Chief Investigator 
for MoTaStim-Foot trial).  In many cases simple disclosure up front should be 
sufficient.  Otherwise, the (potential) TMG member should remove the conflict or 
stop participating in the TMG.  The table below lists potential competing interests.  
 
 
Potential Competing Interests for TMG Members 
• Stock ownership in any commercial companies involved 
• Stock transaction in any commercial company involved (if previously holding stock) 
• Career tied up in a product or technique assessed by trial 
• Intellectual conflict e.g. strong prior belief in the trial’s experimental arm 
• Involvement in regulatory issues relevant to the trial procedures 
• Investment (financial or intellectual) or career tied up in competing products 
•  
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(Please tick as appropriate) 
 
 No, I have no potential competing interests to declare 
 Yes, I have potential competing interests to declare (please detail below) 
 
Please provide details of any potential competing interests: 
  
  
  
 
 
Name: ___________________________ 
 
Signed: __________________________    Date: ______________
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Appendix 48   Adverse events 
 
List of adverse events 
 
Pain ? Flare up of Polymyalgia Rheumatica  
Falls x 16 
Back pain x2 
Painful heel (ipsilesional side) 
Viral infection 
Atrial fibrillation 
Pain back of heel (pressure sores) 
Scratch on dorsum of foot 
Tired with swollen painful feet 
UTI 
Pain hip and knee 
Slip off bed – laceration of shin 
 
 
 
Serious adverse events x3 
Fall – hip pain no bony injury 
Chest infection admitted to hospital overnight 
Further stroke 
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Appendix 49 Email from participant one re inclusion of people with a 
posterior circulation stroke 
 
23/11/
2015 
 
 
 
 
to me, Sue 
 
 
Hi Ladies 
 
 
 
I hope you are both well and not working too hard!!! 
 
 
 
1) The main difference between anterior and posterior strokes for me would be the ataxia that some 
posterior stroke patients suffer from. The severity of the ataxia certainly does vary an great deal from 
patient to patient with some being affected a great deal and some not at all. there's also the visual 
problems that some posterior stroke patients suffer from. 
 
 
 
2) I would definitley use MTS and foot prep in these groups of patients as I think it is important that the 
patients have a stable base to mobilise on when they are unsteady. In the early days it is successful as it 
can stimulate and strenghten otherwise weak feet and improve activation of dorsiflexion. 
 
I have used MTS in more chronic patients too as I find that ataxic patients can end up with tight, 
inflexible feet as they adopt and 'fix'. So MTS has been useful too. I learnt this from a training day we 
had at the haywood years ago with an ex Bobath tutor on the best way to treat ataxic patients. I used it 
ever since. 
 
 
 
Hope that helps and makes sense!! 
 
 
 
Clare 
 
